,CID,name,smiles,7.1-Drug Indication,8.1-Pharmacodynamics,8.2-MeSH Pharmacological Classification,"8.5-Absorption, Distribution and Excretion",8.6-Metabolism/Metabolites,8.7-Biological Half-Life
0,160001,"Phenol, 4,4'-(1-methylethylidene)bis-, polymer with 1,1'-sulfonylbis[4-chlorobenzene]",CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O.C1=CC(=CC=C1S(=O)(=O)C2=CC=C(C=C2)Cl)Cl,,,,,,
1,160002,"Urea, polymer with formaldehyde and 2-furanmethanol",C=O.C1=COC(=C1)CO.C(=O)(N)N,,,,,,
2,160003,4-Chlorophenelzine,C1=CC(=CC=C1CCNN)Cl,,,,,,
3,160004,"2-Propenoic acid, 2-methyl-, butyl ester, polymer with ethenylbenzene",CCCCOC(=O)C(=C)C.C=CC1=CC=CC=C1,,,,,,
4,160005,But-2-enedioic acid--ethenylbenzene (1/1),C=CC1=CC=CC=C1.C(=CC(=O)O)C(=O)O,,,,,,
5,160006,Bruceine A,CC1=C(C(=O)C[C@]2([C@H]1C[C@@H]3[C@]45[C@@H]2[C@H]([C@@H]([C@]([C@@H]4[C@H](C(=O)O3)OC(=O)CC(C)C)(OC5)C(=O)OC)O)O)C)O,,,,,,
6,160007,2-S-Cysteinyldopa,C1=CC(=C(C(=C1C[C@@H](C(=O)O)N)SC[C@@H](C(=O)O)N)O)O,,,,,,
7,160008,Dimethylaminoethyl methacrylate acrylamide polymer,CC(=C)C(=O)OCCN(C)C.C=CC(=O)N,,,,,,
8,160009,Poly(vinyl acetate-co-crotonic acid),CC=CC(=O)O.CC(=O)OC=C,,,,,,
9,160010,CID 160010,CC1=CC(=CC2=C1O[C@](CC2)(C)CCC=C(C)CCC=C(C)CCC=C(C)C)O,,,,,,
10,160011,"[3-Hydroxy-6-[[9-hydroxy-2-[4-hydroxy-5-[(4-hydroxy-6-methyl-5-methylsulfanyloxan-2-yl)oxyamino]-3-[4-methoxy-5-(propan-2-ylamino)oxan-2-yl]oxy-6-methyloxan-2-yl]oxy-12-(methoxycarbonylamino)-13-[2-(methyltetrasulfanyl)ethylidene]-11-oxo-10-bicyclo[7.3.1]trideca-1(12),5-dien-3,7-diynyl]oxy]-2-methyloxan-4-yl] 4,5-dimethoxy-2-(2-methoxyprop-2-enoylamino)benzoate",CC1C(C(C(C(O1)OC2C#CC=CC#CC3(C(C(=O)C(=C2C3=CCSSSSC)NC(=O)OC)OC4CC(C(C(O4)C)O)OC(=O)C5=CC(=C(C=C5NC(=O)C(=C)OC)OC)OC)O)OC6CC(C(CO6)NC(C)C)OC)O)NOC7CC(C(C(O7)C)SC)O,,,,,,
11,160012,Diamminecyclohexanoaminotrismethylenephosphonatoplatinum(II),[H+].[H+].[H+].[H+].C1CCC(C(C1)N)N.C(N(CP(=O)([O-])[O-])CP(=O)([O-])[O-])P(=O)([O-])[O-].[Pt+2],,,,,,
12,160013,Thielocin A1beta,CC1=C(C(=C(C(=C1C(=O)O)OC)C)OC(=O)C2=C(C(=C(C(=C2C)C)OC(=O)C3=C(C(C4(C(C3=O)(CC5=C(C(=C(C(=C5O4)C)OC)C(=O)OC6=C(C(=C(C(=C6C)C)C(=O)O)OC)C)C)C)O)(C)O)C)C)OC)C,,,,,,
13,160014,1-Methyl-3-propylimidazole-2-thione,CCCN1C=CN(C1=S)C,,,,,,
14,160015,CID 160015,C1=CC=C2C(=C1)C3=NNN(C(=O)C3=N2)N,,,,,,
15,160016,3-amino-N-(benzylideneamino)-1H-indole-2-carboxamide,C1=CC=C(C=C1)C=NNC(=O)C2=C(C3=CC=CC=C3N2)N,,,,,,
16,160017,"9-((2-Hydroperoxy-3-methyl-3-butenyl)oxy)-7H-furo(3,2-g)(1)benzopyran-7-one",CC(=C)C(COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2)OO,,,,,,
17,160018,"{5b-[(2,3-Dimethylbutanoyl)oxy]-9a-(dodecanoyloxy)-5,5a-dihydroxy-1,1,6a,8-tetramethyl-10-oxo-1a,2,5,5a,5b,6a,7,8,9,9a-decahydro-1h-2,7a-methanocyclopropa[5',6']cyclodeca[1',2':3,4]cyclopenta[1,2-b]oxiren-4-yl}methyl hexadecanoate",CCCCCCCCCCCCCCCC(=O)OCC1=CC2C3C(C3(CC(C4(C2=O)CC5(C(C4(C1O)O)(O5)OC(=O)C(C)C(C)C)C)C)OC(=O)CCCCCCCCCCC)(C)C,,,,,,
18,160019,Tetrindole,C1CCC(CC1)C2=CC3=C(C=C2)N4CCNC5C4=C3CCC5.Cl,,,,,,
19,160020,"8-Cyclohexyl-2,3,3a,4,5,6-hexahydro-1H-pyrazino[3,2,1-jk]carbazole",C1CCC(CC1)C2=CC3=C(C=C2)N4CCNC5C4=C3CCC5,,,,,,
20,160021,"6-[[9-Acetyloxy-11-carboxy-4-(hydroxymethyl)-4,6a,6b,8a,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-5-[5,6-dihydroxy-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-3-yl]oxy-3,4-dihydroxyoxane-2-carboxylic acid",CC1C(C(C(C(O1)OC2C(COC(C2O)O)OC3C(C(C(OC3OC4CCC5(C(C4(C)CO)CCC6(C5CC=C7C6(CCC8(C7CC(CC8OC(=O)C)(C)C(=O)O)C)C)C)C)C(=O)O)O)O)O)O)O,,,,,,
21,160022,"(2S,3S,4S,5R,6R)-6-[[(3S,4S,4aR,6aR,6bS,8aR,12aS,14aR,14bR)-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-9-oxo-2,3,4a,5,6,7,8,10,12,12a,14,14a-dodecahydro-1H-picen-3-yl]oxy]-5-[(2S,3R,4S,5R)-4,5-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxyoxane-2-carboxylic acid",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H](CO[C@H]2O[C@@H]3[C@H]([C@@H]([C@H](O[C@H]3O[C@H]4CC[C@]5([C@H]([C@@]4(C)CO)CC[C@@]6([C@@H]5CC=C7[C@]6(CC[C@@]8([C@H]7CC(CC8=O)(C)C)C)C)C)C)C(=O)O)O)O)O)O)O)O)O,,,,,,
22,160023,"N-(1'-(2-(5-Benzofurazanyl)ethyl)-3,4-dihydro-4-oxospiro(2H-1-benzopyran-2,4'-piperidin)-6-yl)methanesulfonamide",CS(=O)(=O)NC1=CC2=C(C=C1)OC3(CCN(CC3)CCC4=CC5=NON=C5C=C4)CC2=O,,,,,,
23,160024,Fidarestat,C1[C@H](OC2=C([C@]13C(=O)NC(=O)N3)C=C(C=C2)F)C(=O)N,,,,,,
24,160025,Beticolin 2,CC12C3C4=C(CC5(C1O2)C(=C(C6=C(C=CC(=C6C5=O)O)O)O)C3=O)C(=C7C(=C4O)C(=C8C(=O)CCC(C8(O7)C(=O)OC)O)O)Cl,,,,,,
25,160026,Axinastatin 1,CC(C)[C@H]1C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3CCC[C@H]3C(=O)N1)C(C)C)C(C)C)CC4=CC=CC=C4)CC(=O)N,,,,,,
26,160027,Ukrain,C[N+]1(CC2=C(C=CC3=C2OCO3)[C@@H]4[C@H]1C5=CC6=C(C=C5C[C@@H]4O)OCO6)CCNP(=S)(NCC[N+]7(CC8=C(C=CC9=C8OCO9)[C@@H]1[C@H]7C2=CC3=C(C=C2C[C@@H]1O)OCO3)C)NCC[N+]1(CC2=C(C=CC3=C2OCO3)[C@@H]2[C@H]1C1=CC3=C(C=C1C[C@@H]2O)OCO3)C.[OH-].[OH-].[OH-],,,"['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)', 'Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)']",,,
27,160028,Ukrain cation,C[N+]1(CC2=C(C=CC3=C2OCO3)[C@@H]4[C@H]1C5=CC6=C(C=C5C[C@@H]4O)OCO6)CCNP(=S)(NCC[N+]7(CC8=C(C=CC9=C8OCO9)[C@@H]1[C@H]7C2=CC3=C(C=C2C[C@@H]1O)OCO3)C)NCC[N+]1(CC2=C(C=CC3=C2OCO3)[C@@H]2[C@H]1C1=CC3=C(C=C1C[C@@H]2O)OCO3)C,,,,,,
28,160029,Ac-DL-Cys(1)-DL-Asn-DL-Pro-DL-Arg-Gly-DL-Asp-DL-Tyr(Me)-DL-Arg-DL-Cys(1)-NH2,CC(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C2CCCN2C(=O)C(NC1=O)CC(=O)N)CCCN=C(N)N)CC(=O)O)CC3=CC=C(C=C3)OC)CCCN=C(N)N)C(=O)N,,,,,,
29,160030,CID 160030,CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)OP(=O)(O)[O-])O)O)C(CC(=O)N)O)O)O)O.[Na+],,,,,,
30,160031,"[4-[2-[3-(3-Amino-1-hydroxy-3-oxopropyl)-18-(10,12-dimethyltetradecanoylamino)-11,20,21,25-tetrahydroxy-15-(1-hydroxyethyl)-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-6-yl]-1,2-dihydroxyethyl]phenyl] dihydrogen phosphate",CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)OP(=O)(O)O)O)O)C(CC(=O)N)O)O)O)O,,,,,,
31,160032,2-[[(2S)-4-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-3-methyl-2-(2-methylpropoxycarbonylamino)butanoyl]amino]-3-phenylmethoxypropanoyl]amino]-5-oxopentanoyl]amino]-4-oxobutanoyl]amino]-3-[4-[(4-bromophenyl)methoxycarbonyloxy]phenyl]propanoic acid,CC(C)COC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](COCC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)NC(CC2=CC=C(C=C2)OC(=O)OCC3=CC=C(C=C3)Br)C(=O)O,,,,,,
32,160033,(2S)-1-[(2S)-2-[[(2S)-4-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-3-methyl-2-(2-methylpropoxycarbonylamino)butanoyl]amino]-3-phenylmethoxypropanoyl]amino]-5-oxopentanoyl]amino]-4-oxobutanoyl]amino]-3-[4-[(4-bromophenyl)methoxycarbonyloxy]phenyl]propanoyl]pyrrolidine-2-carboxylic acid,CC(C)COC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](COCC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC2=CC=C(C=C2)OC(=O)OCC3=CC=C(C=C3)Br)C(=O)N4CCC[C@H]4C(=O)O,,,,,,
33,160034,"1,2-Chrysenediol, 1,2-dihydro-5,6-dimethyl-",CC1=C(C2=C(C=CC3=C2C=CC(C3O)O)C4=CC=CC=C14)C,,,,,,
34,160035,"10,11,16-Trihydroxy-7,14,15,19-tetramethyl-12-methylidene-2-(4-methylpenta-1,3-dienyl)-3,26,27-trioxatricyclo[21.2.1.16,9]heptacos-13-ene-4,18,21-trione",CC1CC2C(C(C(=C)C=C(C(C(CC(=O)C(CC(=O)CC3CCC(O3)C(OC(=O)CC1O2)C=CC=C(C)C)C)O)C)C)O)O,,,,,,
35,160036,CID 160036,[H+].[H+].[H+].CC1=NC=C(C(=C1[O-])CN(CCN(CC2=C(C(=NC=C2COP(=O)([O-])[O-])C)[O-])CC(=O)[O-])CC(=O)[O-])COP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Mn+2],['This medicinal product is for diagnostic use only.'],,['Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)'],,,
36,160037,Tetrasodium;8-hydroxy-7-[[4-[2-[4-[(8-hydroxy-5-sulfonatoquinolin-7-yl)diazenyl]-2-sulfonatophenyl]ethenyl]-3-sulfonatophenyl]diazenyl]quinoline-5-sulfonate,C1=CC2=C(C=C(C(=C2N=C1)O)N=NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)N=NC5=CC(=C6C=CC=NC6=C5O)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
37,160038,8-Hydroxy-7-[[4-[2-[4-[(8-hydroxy-5-sulfoquinolin-7-yl)diazenyl]-2-sulfophenyl]ethenyl]-3-sulfophenyl]diazenyl]quinoline-5-sulfonic acid,C1=CC2=C(C=C(C(=C2N=C1)O)N=NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)N=NC5=CC(=C6C=CC=NC6=C5O)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
38,160039,3dTDP-Pyrdg,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OP(=O)(O)OCC1CCC(O1)N2C=C(C(=O)NC2=O)C)OC(=O)CCCCCCCCCC3=C4C=CC5=CC=CC6=C5C4=C(C=C6)C=C3,,,,,,
39,160040,Ruthenium-metronidazole complex,CC1=NC=C(N1CCO)[N+](=O)[O-].C1=CC=CC=C1.[Cl-].[Cl-].[Ru+2],,,,,,
40,160041,"Chryseno(4,5-bcd)thiophene-4,4-dioxide",C1=CC=C2C3=C4C(=CC2=C1)S(=O)(=O)C5=CC=CC(=C54)C=C3,,,,,,
41,160042,N-(3-N-(Ethylenediamino)propyl)acridine-4-carboxamide dichloroplatinum(II),C1=CC=C2C(=C1)C=C3C=CC=C(C3=N2)C(=O)NCCCNCCN.[Cl-].[Cl-].[Pt+2],,,,,,
42,160043,N-[3-[(2-Aminoethyl)amino]propyl]acridine-4-carboxamide,C1=CC=C2C(=C1)C=C3C=CC=C(C3=N2)C(=O)NCCCNCCN,,,,,,
43,160044,"6,9,11-trihydroxy-7-(3-hydroxy-4,5-dimethoxy-6-methyloxan-2-yl)oxy-4-methoxy-3,9-dimethyl-8,10-dihydro-7H-tetracene-5,12-dione",CC1C(C(C(C(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=C(C=C5)C)OC)O)(C)O)O)OC)OC,,,,,,
44,160045,CID 160045,CC(=CC(=CC1=CCOC1=O)C)C=CC=C(C)C(=O)C23[C@@H](O2)[C@@](NC3=O)(CCO)O,,,,,,
45,160046,CID 160046,CCC1=C(C2=NC1=CC3=C(C(=C(O)O)C(=N3)C(=C4[C@H]([C@@H](C(=CC5=NC(=C2)C(=C5C)CC)N4)C)CCC(=O)NCCN)CC(=O)O)C)C,,,,,,
46,160047,Oracine,C1=CC=C2C(=C1)C3=C(C4=CC=CC=C4C3=O)N(C2=O)CCNCCO,,,,,,
47,160048,Butyl(3-hydroxybutyl)tin;dodecanoic acid,CCCCCCCCCCCC(=O)O.CCCCCCCCCCCC(=O)O.CCCC[Sn]CCC(C)O,,,,,,
48,160049,Butyl(3-hydroxybutyl)tin,CCCC[Sn]CCC(C)O,,,,,,
49,160050,"[(4aS,4bR,6aS,8S,10aS,10bS,12aS)-10a,12a-dimethyl-2-oxo-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-tetradecahydro-1H-naphtho[2,1-f]quinolin-8-yl] 2-[bis(2-chloroethyl)amino]benzoate",C[C@]12CC[C@@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC(=O)N4)C)OC(=O)C5=CC=CC=C5N(CCCl)CCCl,,,,,,
50,160051,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-],"['For use, alone or in combination with an HMG-CoA reductase inhibitor, as adjunctive therapy to diet and exercise for the reduction of elevated LDL cholesterol in patients with primary hypercholesterolemia (Fredrickson Type IIa).']","['Colesevelam is a high capacity bile-acid binding molecule. Colesevelam binds to bile acids in the intestine which reduces the amount of bile acids that are returned to the liver via enterohepatic circulation. Clinical studies have demonstrated that elevated levels of total cholesterol (total-C), LDL-C, and apolipoprotein B (Apo B, a protein associated with LDL-C) are associated with an increased risk of atherosclerosis in humans. Similarly, decreased levels of high-density lipoprotein cholesterol (HDL-C) are associated with the development of atherosclerosis. Epidemiological investigations have established that cardiovascular morbidity and mortality vary directly with the levels of total-C and LDL-C, and inversely with the level of HDL-C. The combination of colesevelam and an HMG-CoA reductase inhibitor is effective in further lowering serum total-C and LDL-C levels beyond that achieved by either agent alone.']",['Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)'],"['Not hydrolyzed by digestive enzymes and is not absorbed.', 'Excretion:  In 16 healthy volunteers, an average of 0.05% of administered radioactivity from a single 14C-labeled colesevelam hydrochloride dose was excreted in the urine.']",['Not applicable (not hydrolyzed by digestive enzymes and not absorbed).'],
51,160052,6-(Allylamino)hexyltrimethylaminium,C[N+](C)(C)CCCCCCNCC=C,,,,,,
52,160053,N-allyldecylamine,CCCCCCCCCCNCC=C,,,,,,
53,160054,"Oxirane, reaction products with ammonia, distn. residues",C1CO1.N,,,,,,
54,160055,"Benzene, mixed with toluene, dealkylation product",CC1=CC=CC=C1.C1=CC=CC=C1,,,,,,
55,160056,"Aluminate(1-), mu-chlorohexachlorodi-, hydrogen, compd. with (1-methylethyl)benzene (1:2)",[H+].CC(C)C1=CC=CC=C1.CC(C)C1=CC=CC=C1.[Al+3].[Al+3].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-],,,,,,
56,160057,CID 160057,CCCCCCCCCCCCCCCCCC.OP(=O)(O)O.[KH],,,,,,
57,160058,"1,4-Benzenedicarboxylic acid, mixed esters with diethylene glycol, ethylene glycol and triethylene glycol",C1=CC(=CC=C1C(=O)O)C(=O)O.C(CO)O.C(COCCO)O.C(COCCOCCO)O,,,,,,
58,160059,C.I. Reactive Red 24,CN(C1=CC=CC=C1)C2=NC(=NC(=N2)NC3=C4C(=CC(=C3)S(=O)(=O)[O-])C=C(C(=C4O)N=NC5=CC=CC=C5S(=O)(=O)[O-])S(=O)(=O)[O-])Cl.[Na+].[Na+].[Na+],,,,,,
59,160060,"2,7-Naphthalenedisulfonic acid, 5-((4-chloro-6-(methylphenylamino)-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-((2-sulfophenyl)azo)-",CN(C1=CC=CC=C1)C2=NC(=NC(=N2)NC3=C4C(=CC(=C3)S(=O)(=O)O)C=C(C(=C4O)N=NC5=CC=CC=C5S(=O)(=O)O)S(=O)(=O)O)Cl,,,,,,
60,160061,"Trisodium 5-[[4-chloro-6-(methylphenylamino)-1,3,5-triazin-2-YL]amino]-4-hydroxy-3-[(4-methyl-2-sulphonatophenyl)azo]naphthalene-2,7-disulphonate",CC1=CC(=C(C=C1)N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)[O-])S(=O)(=O)[O-])NC4=NC(=NC(=N4)Cl)N(C)C5=CC=CC=C5)O)S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
61,160062,"5-((4-Chloro-6-phenylamino-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-((4-methyl-6-sulfophenyl)azo)-2,7-naphthalenedisulfonic acid",CC1=CC(=C(C=C1)N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)O)S(=O)(=O)O)NC4=NC(=NC(=N4)Cl)N(C)C5=CC=CC=C5)O)S(=O)(=O)O,,,,,,
62,160063,"Benzoic acid, 2-hydroxy-, polymer with formaldehyde, 4-nonylphenol and zinc oxide (ZnO)",CCCCCCCCCC1=CC=C(C=C1)O.C=O.C1=CC=C(C(=C1)C(=O)O)O.[O-2].[Zn+2],,,,,,
63,160064,2-Ethylhexyl isononanoate,CCCCC(CC)COC(=O)CCCCCC(C)C,,,,,,
64,160065,1-Ethyl-1-methyl-3-phenylpropyl acetate,CCC(C)(CCC1=CC=CC=C1)OC(=O)C,,,,,,
65,160066,"Nitric acid, reaction products with cyclododecanol and cyclododecanone, by-products from, high-boiling fraction",C1CCCCCC(CCCCC1)O.C1CCCCCC(=O)CCCCC1.[N+](=O)(O)[O-],,,,,,
66,160067,Neplanocin C,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@]4([C@@H]3O4)CO)O)O)N,,,,,,
67,160068,"N-(4-ethoxyphenyl)-N-methyl-4-[2-(1,3,3-trimethylindol-1-ium-2-yl)ethenyl]aniline;chloride",CCOC1=CC=C(C=C1)N(C)C2=CC=C(C=C2)C=CC3=[N+](C4=CC=CC=C4C3(C)C)C.[Cl-],,,,,,
68,160069,"2-(2-{4-[(4-Ethoxyphenyl)(methyl)amino]phenyl}ethenyl)-1,3,3-trimethyl-3H-indol-1-ium",CCOC1=CC=C(C=C1)N(C)C2=CC=C(C=C2)C=CC3=[N+](C4=CC=CC=C4C3(C)C)C,,,,,,
69,160070,"Glycine, N-(naphthenylsulfonyl) derivs., compds. with triethanolamine (1:1)",C(CO)N(CCO)CCO.C(C(=O)O)N,,,,,,
70,160071,Ferrocene carbamate,CN=C([O-])OC1=CC=C(C=C1)NC=C2C=CC=C2.C1C=CC=C1.[Fe+2],,,,,,
71,160072,"[4-(cyclopenta-2,4-dien-1-ylidenemethylamino)phenyl] N-methylcarbamate",CNC(=O)OC1=CC=C(C=C1)NC=C2C=CC=C2,,,,,,
72,160073,"2-(1,1'-Biphenyl-4-yl)-1,2,4-triazole(5,1-a)isoquinoline",C1=CC=C(C=C1)C2=CC=C(C=C2)C3=NN4C=CC5=CC=CC=C5C4=N3,,,,,,
73,160074,CID 160074,CN(C)CCC=C1C2=CC=CC=C2OCC3=C1C4=CC=CC=C4O3.C(=CC(=O)O)C(=O)O,,,,,,
74,160075,"3-(6H-[1]benzofuro[2,3-c][1]benzoxepin-12-ylidene)-N,N-dimethylpropan-1-amine",CN(C)CCC=C1C2=CC=CC=C2OCC3=C1C4=CC=CC=C4O3,,,,,,
75,160076,4-Bromo-7-hydroxyindan oxime,C1CC(=NO)C2=C(C=CC(=C21)Br)O,,,,,,
76,160077,Tetrabromophthalic acid mixed esters with diethylene glycol and propylene glycol,CC(CO)O.C(COCCO)O.C1(=C(C(=C(C(=C1Br)Br)Br)Br)C(=O)O)C(=O)O,,,,,,
77,160078,2-Hydroxyaclacinomycin A,CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C3=O)C(=CC(=C4)O)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CCC(=O)C(O7)C)O)N(C)C)O,,,,,,
78,160079,"4-(Phenylazo)benzene-1,3-diamine acetate",CC(=O)O.C1=CC=C(C=C1)N=NC2=C(C=C(C=C2)N)N,,,,,,
79,160080,CID 160080,CCCCCCCCCCCC(=O)N[C@H](C)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC[C@@H](C(=O)NC(=O)CN)N)C(=O)O)C(=O)O,,,,,,
80,160081,Chimassorb 905 LD,CCCCN(C1CC(NC(C1)(C)C)(C)C)C2=NC(=NC(=N2)NCCCN(CCN(CCCNC3=NC(=NC(=N3)N(CCCC)C4CC(NC(C4)(C)C)(C)C)N(CCCC)C5CC(NC(C5)(C)C)(C)C)C6=NC(=NC(=N6)N(CCCC)C7CC(NC(C7)(C)C)(C)C)N(CCCC)C8CC(NC(C8)(C)C)(C)C)C9=NC(=NC(=N9)N(CCCC)C1CC(NC(C1)(C)C)(C)C)N(CCCC)C1CC(NC(C1)(C)C)(C)C)N(CCCC)C1CC(NC(C1)(C)C)(C)C,,,,,,
81,160082,"N,N-dimethyl-4,4-diphenylbut-3-en-2-amine;1-[4-(3-hydroxyphenyl)-1-methylpiperidin-4-yl]propan-1-one;hydrochloride",CCC(=O)C1(CCN(CC1)C)C2=CC(=CC=C2)O.CC(C=C(C1=CC=CC=C1)C2=CC=CC=C2)N(C)C.Cl,,,,,,
82,160083,CID 160083,C[C@H]1[C@@H](CC=CC=CC=C[C@@H](CC(=O)NC2=CC(=O)C=C(C2=O)CCC=C([C@H]1O)C)OC)O,,,,,,
83,160084,CID 160084,C[C@@H]1[C@@H](CC=CC=CC=C[C@@H](CC(=O)NC2=CC(=O)C=C(C2=O)CCC=C([C@@H]1O)C)OC)OC(=O)[C@@H](C)NC(=O)C3CCCCC3,,,,,,
84,160085,CID 160085,C[C@@H]1[C@H](CC=CC=CC=C[C@@H](CC(=O)NC2=CC(=CC(=C2O)CCC=C([C@@H]1O)C)O)OC)OC(=O)[C@H](C)NC(=O)C3CCCCC3,,,,,,
85,160086,"Oxirane, methyl-, polymer with oxirane, dibenzoate",CC1CO1.C1CO1.C1=CC=C(C=C1)C(=O)O,,,,,,
86,160087,CID 160087,C1=CC=C(C(=C1)C(=O)[O-])C(=O)OO.C1=CC=C(C(=C1)C(=O)[O-])C(=O)OO.O.O.O.O.O.O.[Mg+2],,,,,,
87,160088,Lanasol Red 6G,CC1=C(C=C(C=C1)S(=O)(=O)C2=C(C=CC(=C2)NC(=O)C(=C)Br)N=NC3=C(C=CC4=C3C=CC(=C4)S(=O)(=O)[O-])N)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
88,160089,6-Amino-5-((4-((2-bromo-1-oxoallyl)amino)-2-((4-methyl-3-sulphophenyl)sulphonyl)phenyl)azo)naphthalene-2-sulphonic acid,CC1=C(C=C(C=C1)S(=O)(=O)C2=C(C=CC(=C2)NC(=O)C(=C)Br)N=NC3=C(C=CC4=C3C=CC(=C4)S(=O)(=O)O)N)S(=O)(=O)O,,,,,,
89,160090,"N-Methyl-N-((2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl)nonanamide",CCCCCCCCC(=O)N(C)C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O,,,,,,
90,160091,N-Octanoyl-N-methylglucamine,CCCCCCCC(=O)N(C)C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O,,,,,,
91,160092,3'-Deoxy-N(6)-butyryladenosine,CCCC(=O)NC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H](C[C@H](O3)CO)O,,,,,,
92,160093,3-Hydroxyhydroquinidine,CC[C@]1(CN2CC[C@H]1C[C@@H]2[C@H](C3=C4C=C(C=CC4=NC=C3)OC)O)O,,,,,,
93,160094,Saframycin R,CC1=C(C2=C([C@H]3[C@@H]4CC5=C([C@@H](N4[C@H]([C@@H](C2)N3C)C#N)CNC(=O)C(=O)C)C(=O)C(=C(C5=O)C)OC)C(=C1OC)OC(=O)CO)O,,,,,,
94,160095,"4-Ethylidene-7-hydroxy-6-(hydroxymethyl)-7-methyl-2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione",CC=C1CC(C(C(=O)OCC2=CCN3C2C(CC3)OC1=O)(C)O)CO,,,,,,
95,160096,CID 160096,C[C@@H](C(=O)[C@@]1(CCCN1C(=O)C(C)CS)C(=O)O)NC(=O)C2CCCCC2.C[C@@H](C(=O)[C@@]1(CCCN1C(=O)C(C)CS)C(=O)O)NC(=O)C2CCCCC2.[CaH2],,,,,,
96,160097,CID 160097,C[C@@H](C(=O)[C@@]1(CCCN1C(=O)C(C)CS)C(=O)O)NC(=O)C2CCCCC2,,,,,,
97,160098,CID 160098,CC[C@H](C)[C@@H](C(=O)N[C@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](C)NC(=O)C2=CC=CC=C2,,,,,,
98,160099,Monoperoxydecanoic acid,C(CCCCC(=O)O)CCCCOO,,,,,,
99,160100,3-Carbethoxypyranocoumarin,CCOC(=O)C1=CC2=CC3=C(C=C2OC1=O)OCC=C3,,,,,,
100,160101,CID 160101,CC(C)COC(=NCC=C)S,,,,,,
101,160102,Antibiotic WF 3161,CC(C)C[C@H]1C(=O)N2CCCC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](C(=O)N1)CC3=CC=CC=C3)CCCCCC(=O)C4CO4,,,,,,
102,160103,2-(2-(2-(2-Aminoethoxy)ethoxy)ethoxy)ethanol,C(COCCOCCOCCO)N,,,,,,
103,160104,"Naphthalenesulfonic acid, dinonyl-, barium salt",CCCCCCCCCC1=CC2=CC=CC=C2C(=C1CCCCCCCCC)S(=O)(=O)[O-].CCCCCCCCCC1=CC2=CC=CC=C2C(=C1CCCCCCCCC)S(=O)(=O)[O-].[Ba+2],,,,,,
104,160105,Ederpin,COC1=CN=C(N=C1)NC(=O)NP(=O)(N2CC2)N3CC3,,,,,,
105,160106,"3,6-Acridinediamine, N,N-dimethyl-",CN(C)C1=CC2=C(C=C1)C=C3C=CC(=CC3=N2)N,,,,,,
106,160107,Sodium 7-phenyl-5-[(4-sulfonatophenyl)amino]benzo[a]phenazin-7-ium-6-sulfonate,C1=CC=C(C=C1)[N+]2=C3C(=C(C4=CC=CC=C4C3=NC5=CC=CC=C52)NC6=CC=C(C=C6)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+],,,,,,
107,160108,7-Phenyl-5-(4-sulfoanilino)benzo[a]phenazin-7-ium-6-sulfonic acid,C1=CC=C(C=C1)[N+]2=C3C(=C(C4=CC=CC=C4C3=NC5=CC=CC=C52)NC6=CC=C(C=C6)S(=O)(=O)O)S(=O)(=O)O,,,,,,
108,160109,"1,3-Benzenediol, 2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-, (E)-",CCCCCC1=CC(=C(C(=C1)O)CC=C(C)CCC=C(C)C)O,,,,,,
109,160110,CID 160110,CC1=CC(=CC(=C1C)S(=O)(=O)NCCO)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)[O-].[Na+],,,,,,
110,160111,"2-Anthracenesulfonic acid, 1-amino-9,10-dihydro-4-[[3-[[(2-hydroxyethyl)amino]sulfonyl]-4,5-dimethylphenyl]amino]-9,10-dioxo-",CC1=CC(=CC(=C1C)S(=O)(=O)NCCO)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)O,,,,,,
111,160112,"Quinolinium, 2-(N-(p-(bis(2-chloroethyl)amino)phenyl)formimidoyl)-1-methyl-, chloride",C[N+]1=C(C=CC2=CC=CC=C21)C=NC3=CC=C(C=C3)N(CCCl)CCCl.[Cl-],,,,,,
112,160113,"N,N-bis(2-chloroethyl)-4-[(1-methylquinolin-1-ium-2-yl)methylideneamino]aniline",C[N+]1=C(C=CC2=CC=CC=C21)C=NC3=CC=C(C=C3)N(CCCl)CCCl,,,,,,
113,160114,O-2-Methylthymine,CC1=CN=C(NC1=O)OC,,,,,,
114,160115,Cephalochromin,CC1CC(=O)C2=C(O1)C=C3C(=C2O)C(=CC(=C3C4=C(C=C(C5=C(C6=C(C=C54)OC(CC6=O)C)O)O)O)O)O,,,,,,
115,160116,"(1R,2R,4R,6S,8S,9S)-1,9,10,11,12,12-hexachloro-5-oxatetracyclo[7.2.1.02,8.04,6]dodec-10-ene",C1[C@@H]2[C@H](C[C@H]3[C@@H]1O3)[C@@]4(C(=C([C@]2(C4(Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
116,160117,Dichexamethylenecarbamide,C1CCCN(CC1)C(=O)N2CCCCCC2,,,,,,
117,160118,CID 160118,CCCC1C(C2=NC1=C3C(C(=O)C4=C3[N-]C(=C4C)C=C5C(=C(C(=N5)C=C6C(=C(C(=C2)[N-]6)C)C=C)C)CC)C)C.[Cu+2],,,,,,
118,160119,"16-Ethenyl-11-ethyl-3,12,17,21,26-pentamethyl-22-propyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-4-ol",CCCC1C(C2=CC3=NC(=CC4=NC(=CC5=C(C6=C(C(C(=C1N2)C6=N5)C)O)C)C(=C4C)CC)C(=C3C)C=C)C,,,,,,
119,160120,"2-[3-(Diaminomethylideneamino)-4-[3-[4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine",CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)CO,,,,,,
120,160121,Morpholinoiminoacetonitrile,C1COCCN1N=CC#N,,,,,,
121,160122,D-threo-Pentos-2-ulose,C([C@H]([C@@H](C(=O)C=O)O)O)O,,,,,,
122,160123,"Chromate(1-), chlorotrioxo-, (T-4)-, hydrogen, compd. with pyridine (1:1:1)",[H+].C1=CC=NC=C1.O=[Cr](=O)=O.[Cl-],,,,,,
123,160124,"1-Decanol, aluminum salt",CCCCCCCCCC[O-].CCCCCCCCCC[O-].CCCCCCCCCC[O-].[Al+3],,,,,,
124,160125,CID 160125,COC1=CC(=CC(=C1OC)OC)C=CC(=O)N2CCN(CC2)CC(=O)N3CCCC3.C(=CC(=O)[O-])C(=O)[O-],,,,,,
125,160126,"7-[(1R,2R,3R)-3-hydroxy-5-oxo-2-(3-oxooct-1-enyl)cyclopentyl]hept-5-enoic acid",CCCCCC(=O)C=C[C@H]1[C@@H](CC(=O)[C@@H]1CC=CCCCC(=O)O)O,,,,,,
126,160127,"12,21-Dihydroxynonacyclo[18.10.2.22,5.03,16.04,13.06,11.017,31.022,27.028,32]tetratriaconta-1(31),2,4,6,8,10,12,14,16,18,20,22,24,26,28(32),33-hexadecaene-29,30-dione",C1=CC=C2C(=C1)C3=C4C(=C2O)C=CC5=C6C=CC7=C(C8=CC=CC=C8C9=C7C6=C(C(=C54)C=C3)C(=O)C9=O)O,,,,,,
127,160128,Daunosamine,C[C@@H]([C@H]([C@H](CC=O)N)O)O,,,,,,
128,160129,"2,6-Piperidinedione, 4-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-",C1C(CC(=O)NC1=O)N2CC3=CC=CC=C3C2=O,,,,,,
129,160130,"1,7-Dimethylguanosine",CN1C=[N+](C2=C1C(=O)N(C(=N2)N)C)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)[O-],,,,,,
130,160131,CID 160131,CN1C=[N+](C2=C1C(=O)N(C(=N2)N)C)[C@H]3[C@@H]([C@@H](C(O3)CO)O)O,,,,,,
131,160132,CID 160132,CC[N-]C1=NC(=NC(=N1)N[N+]#N)NC2CC2,,,,,,
132,160133,CID 160133,CCNC1=NC(=NC(=N1)N[N+]#N)NC2CC2,,,,,,
133,160134,Clofibride,CC(C)(C(=O)OCCCC(=O)N(C)C)OC1=CC=C(C=C1)Cl,,,,,,
134,160135,5-[Bis(4-chlorophenyl)methyl]pyrimidine,C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C3=CN=CN=C3)Cl,,,,,,
135,160136,"(3aR,7S,8aS)-7-methyl-3-methylidene-6-(3-oxobut-1-enyl)-4,7,8,8a-tetrahydro-3aH-cyclohepta[b]furan-2-one",C[C@H]1C[C@H]2[C@H](CC=C1C=CC(=O)C)C(=C)C(=O)O2,,,,,,
136,160137,Isooctyl ((tributylstannyl)thio)acetate,CCCC[Sn](CCCC)(CCCC)SCC(=O)OCCCCCC(C)C,,,,,,
137,160138,Tricyclodecanedimethanol,C1CC2C3CC(C2C1CO)CC3CO,,,,,,
138,160139,Deacetoxycephalosporin C,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CCC[C@H](C(=O)O)N)SC1)C(=O)O,,,,,,
139,160140,5-Benzamido-2-(4-thiazolyl)benzimidazole,C1=CC=C(C=C1)C(=O)NC2=CC3=C(C=C2)N=C(N3)C4=CSC=N4,,,,,,
140,160141,"Butanal, 3-(ethylthio)-",CCSC(C)CC=O,,,,,,
141,160142,Miltirone,CC(C)C1=CC2=C(C3=C(C=C2)C(CCC3)(C)C)C(=O)C1=O,,,,,,
142,160143,"3-(2-((4aS,5R,8aS)-5,8a-Dimethyl-2-methylene-5-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)decahydronaphthalen-1-yl)ethyl)furan-2(5H)-one",C[C@]1(CCC[C@@]2([C@@H]1CCC(=C)C2CCC3=CCOC3=O)C)CO[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
143,160144,"4,5-Bis(hydroxymethyl)-2-methylpyridin-3-ol;2-methylidenepentanedioate",CC1=NC=C(C(=C1O)CO)CO.C=C(CCC(=O)[O-])C(=O)[O-],,,,,,
144,160145,Pyridoxine alpha-Ketoglutarate,CC1=NC=C(C(=C1O)CO)CO.C(CC(=O)O)C(=O)C(=O)O,,,,,,
145,160146,Antimony tris(isooctyl thioglycolate),CC(C)CCCCCOC(=O)C[S-].CC(C)CCCCCOC(=O)C[S-].CC(C)CCCCCOC(=O)C[S-].[Sb+3],,,,,,
146,160147,CID 160147,C1CCC(CC1)C=CC(=O)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4[C@@H](C=CO3)[C@@H]([C@H]5[C@@]4(O5)CO)O)O)O)O,,,,,,
147,160148,"Chromate(2-), (3-(hydroxy-kappaO)-4-((2-(hydroxy-kappaO)-1-naphthalenyl)azo-kappaN1)-1-naphthalenesulfonato(3-))(1-((2-(hydroxy-kappaO)-5-((2-methoxyphenyl)azo)phenyl)azo-kappaN1)-2-naphthalenolato(2-)-kappaO)-, disodium",COC1=CC=CC=C1N=NC2=CC(=C(C=C2)[O-])N=NC3=C(C=CC4=CC=CC=C43)[O-].C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=C(C4=CC=CC=C43)S(=O)(=O)[O-])[O-])[O-].[Na+].[Na+].[Cr+3],,,,,,
148,160149,1-[[2-Hydroxy-5-[(2-methoxyphenyl)diazenyl]phenyl]diazenyl]naphthalen-2-ol,COC1=CC=CC=C1N=NC2=CC(=C(C=C2)O)N=NC3=C(C=CC4=CC=CC=C43)O,,,,,,
149,160150,Kobusine,C[C@@]12CCC[C@]34[C@@H]1[C@@H]5CC67[C@H]3[C@H]([C@H](C[C@@H]6C4N5C2)C(=C)[C@H]7O)O,,,,,,
150,160151,CID 160151,C1=CC(=CC(=C1)C(=O)O)C2=C3C=CC(=N3)C(=C4C=CC(=C(C5=NC(=C(C6=CC=C2[N-]6)C7=CC=C(C=C7)C(=O)O)C=C5)C8=CC=C(C=C8)C(=O)O)[N-]4)C9=CC=C(C=C9)C(=O)O.[Zn+2],,,,,,
151,160152,CID 160152,C1=CC(=CC(=C1)C(=O)O)C2=C3C=CC(=N3)C(=C4C=CC(=N4)C(=C5C=CC(=C(O)O)C=C5)C6=NC(=C(C7=CC=C2N7)C8=CC=C(C=C8)C(=O)O)C=C6)C9=CC=C(C=C9)C(=O)O,,,,,,
152,160153,Arbusculin A,C[C@]12CCC[C@@]([C@@H]1[C@@H]3[C@@H](CC2)C(=C)C(=O)O3)(C)O,,,,,,
153,160154,Apovincaminic acid,CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4C(=C2)C(=O)O,,,,,,
154,160155,5-Propyl-2'-deoxyuridine,CCCC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)O,,,,,,
155,160156,Chol-3-en-24-oic acid,C[C@H](CCC(=O)O)C1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CCC=C4)C)C,,,,,,
156,160157,Oxidopamine hydrochloride,C1=C(C(=CC(=C1O)O)O)CCN.Cl,,,"['Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (See all compounds classified as Adrenergic Agents.)', 'Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)']",,,
157,160158,"Octanoic acid, compd. with 2-aminoethanol (1:1)",CCCCCCCC(=O)O.C(CO)N,,,,,,
158,160159,CID 160159,CCC1=C2C=C3C(=C(C(=C(C4=NC(=CC5=NC(=CC(=N2)C1=C[O-])C(=C5C)C=C)[C@H]([C@@H]4CCC(=O)[O-])C)CC(=O)[O-])[N-]3)C(=O)[O-])C.[Cu+2],,,,,,
159,160160,"21H,23H-Porphine-7-propanoic acid, 3-carboxy-5-(carboxymethyl)-13-ethenyl-18-ethyl-17-formyl-7,8-dihydro-2,8,12-trimethyl-, (7S,8S)-",CCC1=C2C=C3C(=C(C(=N3)C(=C4[C@H]([C@@H](C(=CC5=NC(=CC(=N2)C1=CO)C(=C5C)C=C)N4)C)CCC(=O)O)CC(=O)O)C(=O)O)C,,,,,,
160,160161,CID 160161,C(C(CSP(=O)(O)[O-])O)N.[Na+],,,,,,
161,160162,CID 160162,CC1=CC=C(C=C1)S(=O)(=S)[O-].[K+],,,,,,
162,160163,4-Methylbenzenesulfonothioic o-acid,CC1=CC=C(C=C1)S(=O)(=S)O,,,,,,
163,160164,"3,4-Dihydro-3,4-chrysenediol",C1=CC=C2C(=C1)C=CC3=C2C=CC4=C3C(C(C=C4)O)O,,,,,,
164,160165,"5,6-Dihydro-5,6-chrysenediol",C1=CC=C2C(=C1)C=CC3=C2C(C(C4=CC=CC=C34)O)O,,,,,,
165,160166,2-(4-Carbamimidoylphenyl)-1h-indole-6-carboximidamide dihydrochloride,C1=CC(=CC=C1C2=CC3=C(N2)C=C(C=C3)C(=N)N)C(=N)N.Cl.Cl,,,,,,
166,160167,"Glycine, N-(N-L-gamma-glutamyl-S-(2-hydroxyethyl)-L-cysteinyl)-",C(CC(=O)N(CC(=O)O)C(=O)[C@H](CSCCO)N)[C@@H](C(=O)O)N,,,,,,
167,160168,2-(4-Cyclohexylphenoxy)ethanol,C1CCC(CC1)C2=CC=C(C=C2)OCCO,,,,,,
168,160169,Cyclobuta-dithymidine,CC1=CNC(=O)NC1=O.CC1=CNC(=O)NC1=O,,,,,,
169,160170,CID 160170,CC1=NC(=NC(=N1)N2CCOCC2)NC3=CC=C(C=C3)S(=O)(=O)[O-].CNC1=CC(=C(C=C1)C=CC2=C(C=C(C=C2)NC3=NC(=NC(=N3)NC4=CC=C(C=C4)S(=O)(=O)[O-])N5CCOCC5)S(=O)(=O)[O-])S(=O)(=O)[O-].[NaH].[NaH].[NaH].[NaH],,,,,,
170,160171,"4-[(4-Methyl-6-morpholin-4-yl-1,3,5-triazin-2-yl)amino]benzenesulfonic acid",CC1=NC(=NC(=N1)N2CCOCC2)NC3=CC=C(C=C3)S(=O)(=O)O,,,,,,
171,160172,CID 160172,CNC1=CC(=C(C=C1)C=CC2=C(C=C(C=C2)NC3=NC(=NC(=N3)NC4=CC=C(C=C4)S(=O)(=O)O)N5CCOCC5)S(=O)(=O)O)S(=O)(=O)O,,,,,,
172,160173,"(7R)-11-[(2R,3R)-3-(hydroxymethyl)-4-oxooxetan-2-yl]-3,5,7-trimethylundeca-2,4-dienoic acid",C[C@H](CCCC[C@@H]1[C@H](C(=O)O1)CO)CC(=CC(=CC(=O)O)C)C,,,,,,
173,160174,Methylmercury;methylmercury(1+);(4-methylphenyl)sulfonylazanide,CC1=CC=C(C=C1)S(=O)(=O)[NH-].C[Hg].C[Hg+],,,,,,
174,160175,"[(2S)-2-aminopropanoyl] (2S)-2-amino-3-[(1R,6R)-5-oxo-7-oxabicyclo[4.1.0]heptan-2-yl]propanoate",C[C@@H](C(=O)OC(=O)[C@H](CC1CCC(=O)[C@H]2[C@@H]1O2)N)N,,,,,,
175,160176,CID 160176,CCCN(CCC(=O)N)C1=NC(=NC(=N1)NC2=CC=C(C=C2)S(=O)(=O)[O-])C.CNC1=CC(=C(C=C1)C=CC2=C(C=C(C=C2)NC3=NC(=NC(=N3)NC4=CC=C(C=C4)S(=O)(=O)[O-])N(CC=O)CC(=O)N)S(=O)(=O)[O-])S(=O)(=O)[O-].CO.[NaH].[NaH].[NaH].[NaH],,,,,,
176,160177,"4-[[4-[(3-Amino-3-oxopropyl)-propylamino]-6-methyl-1,3,5-triazin-2-yl]amino]benzenesulfonic acid",CCCN(CCC(=O)N)C1=NC(=NC(=N1)NC2=CC=C(C=C2)S(=O)(=O)O)C,,,,,,
177,160178,CID 160178,CNC1=CC(=C(C=C1)C=CC2=C(C=C(C=C2)NC3=NC(=NC(=N3)NC4=CC=C(C=C4)S(=O)(=O)O)N(CC=O)CC(=O)N)S(=O)(=O)O)S(=O)(=O)O,,,,,,
178,160179,Perlolyrine,C1=CC=C2C(=C1)C3=C(N2)C(=NC=C3)C4=CC=C(O4)CO,,,,,,
179,160180,Lucidinprimeveroside,C1[C@H]([C@@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(C(=C4C(=C3)C(=O)C5=CC=CC=C5C4=O)O)CO)O)O)O)O)O)O,,,,,,
180,160181,CID 160181,CC.C[C@]12CC[C@H](C([C@@H]1CC[C@]3([C@@H]2C[C@H]([C@@H]4[C@@]3(CC[C@H]4[C@@](C)(CCC=C)O)C)O)C)(C)C)O[C@@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)CO[C@@H]6[C@@H]([C@@H]([C@@H](CO6)O)O)O)O)O)O[C@@H]7[C@@H]([C@@H]([C@H]([C@@H](O7)CO)O)O)O,,,,,,
181,160182,CID 160182,C[C@]12CC[C@H](C([C@@H]1CC[C@]3([C@@H]2C[C@H]([C@@H]4[C@@]3(CC[C@H]4[C@@](C)(CCC=C)O)C)O)C)(C)C)O[C@@H]5C([C@@H]([C@H]([C@@H](O5)CO[C@@H]6[C@@H]([C@@H]([C@@H](CO6)O)O)O)O)O)O[C@@H]7C([C@@H]([C@H]([C@@H](O7)CO)O)O)O,,,,,,
182,160183,CID 160183,CC1CCC(CCCC(CCCC(C(CC(C(CC(CC(CC(CC(CCCCC(=CC(C(CC(=O)C(C1O)C(C)(C)C)C(C)C(CCCN=C(N)N)O)C)C)O)O)O)O)O)OC2C(C(C(O2)OO)O)O)C)O)O)O.OS(=O)(=O)O,,,,,,
183,160184,CID 160184,CC1CCC(CCCC(CCCC(C(CC(C(CC(CC(CC(CC(CCCCC(=CC(C(CC(=O)C(C1O)C(C)(C)C)C(C)C(CCCN=C(N)N)O)C)C)O)O)O)O)O)OC2C(C(C(O2)OO)O)O)C)O)O)O,,,,,,
184,160185,"2,2,6,6-Tetramethylquinuclidine hydrobromide",CC1(CC2CCN1C(C2)(C)C)C.Br,,,,,,
185,160186,"2,2,6,6-Tetramethyl-1-azabicyclo[2.2.2]octane",CC1(CC2CCN1C(C2)(C)C)C,,,,,,
186,160187,CID 160187,C1CCC(CC1)C(=O)NC2=C3C(=NC=N2)N(C=N3)C4[C@@H]([C@H]5[C@H](O4)COP(O5)(O)O)O,,,,,,
187,160188,1'-Oxosafrole,C=CC(=O)C1=CC2=C(C=C1)OCO2,,,,,,
188,160189,14-O-Acetyldoxorubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)COC(=O)C)O)N)O,,,,,,
189,160190,Aloesin,CC1=CC(=C(C2=C1C(=O)C=C(O2)CC(=O)C)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O,,,,,,
190,160191,"1,1,1-Trifluoro-5-methylhexane-2,4-dione",CC(C)C(=O)CC(=O)C(F)(F)F,,,,,,
191,160192,N-(3-(Trimethoxysilyl)propyl)butylamine,CCCCNCCC[Si](OC)(OC)OC,,,,,,
192,160193,"2-(4,5-Dihydroxy-2-methylphenyl)-4-methoxybenzenecarboperoxoic acid",CC1=CC(=C(C=C1C2=C(C=CC(=C2)OC)C(=O)OO)O)O,,,,,,
193,160194,"3-(2-(2,4-Di-tert-pentylphenoxy)acetamido)-N-(5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl)benzamide",CCC(C)(C)C1=CC(=C(C=C1)OCC(=O)NC2=CC=CC(=C2)C(=O)NC3=NN(C(=O)C3)C4=C(C=C(C=C4Cl)Cl)Cl)C(C)(C)CC,,,,,,
194,160195,Heptyl-2-naphthol,CCCCCCCC1=C(C=CC2=CC=CC=C21)O,,,,,,
195,160196,"2-Oxazolamine, N-(2,6-dimethylphenyl)-4,5-dihydro-",CC1=C(C(=CC=C1)C)NC2=NCCO2,,,,,,
196,160197,p-Nitrophenyl iodoacetate,C1=CC(=CC=C1[N+](=O)[O-])OC(=O)CI,,,,,,
197,160198,"1,2-Ethanediamine, N,N,N'-tris(2-aminoethyl)-",C(CNCCN(CCN)CCN)N,,,,,,
198,160199,Oudenone,CCC[C@H]1CCC(=C2C(=O)CCC2=O)O1,,,,,,
199,160200,Neopentyl glycol dicaprylate,CCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCC,,,,,,
200,160201,"[[2-[(2S,3R,4S,5S,6R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)-2-sulfanyl-oxan-2-yl]-3-oxidanyl-pent-4-enoyl]amino] hydrogen sulfate",C=CC(C(C(=O)NOS(=O)(=O)O)[C@@]1([C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)S)O,,,,,,
201,160202,Dihydrotriazine derivative,CCS(=O)(=O)O.CC1(N=C(N=C(N1C2=CC(=C(C=C2)CCCCC3=C(C=C(C=C3)S(=O)(=O)F)Cl)Cl)N)N)C,,,,,,
202,160203,"Ethanesulfonic acid, compd. with 3-chloro-4-(4-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl)butyl)benzenesulfonyl fluoride (1:1)",CC1(N=C(N=C(N1C2=CC(=C(C=C2)CCCCC3=C(C=C(C=C3)S(=O)(=O)F)Cl)Cl)N)N)C,,,,,,
203,160204,Calcium;5-oxopyrrolidine-2-carboxylate,C1CC(=O)NC1C(=O)[O-].[Ca+2],,,,,,
204,160205,"13-Oxooctadeca-9,11-dienoic acid",CCCCCC(=O)C=CC=CCCCCCCCC(=O)O,,,,,,
205,160206,Isotridecyl stearate,CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCC(C)C,,,,,,
206,160207,"(2s,3r,4s,5r)-3,4,5-Trihydroxy-6-oxopiperidine-2-carboxylic acid",[C@@H]1([C@@H]([C@H](NC(=O)[C@@H]1O)C(=O)O)O)O,,,,,,
207,160208,Dimethyl(2-methacryloyloxyethyl)(3-trimethoxysilylpropyl)ammonium chloride,CC(=C)C(=O)OCC[N+](C)(C)CCC[Si](OC)(OC)OC.[Cl-],,,,,,
208,160209,"N,N-Dimethyl-N-[2-[(2-methyl-1-oxo-2-propenyl)oxy]ethyl]-3-(trimethoxysilyl)-1-propanaminium",CC(=C)C(=O)OCC[N+](C)(C)CCC[Si](OC)(OC)OC,,,,,,
209,160210,"Propanamide, 2-amino-N,3-dihydroxy-, (S)-",C([C@@H](C(=O)NO)N)O,,,,,,
210,160211,Decidin,CCCCCCCCCCCC(C)N.C(CCC(=O)O)CC(=O)O,,,,,,
211,160212,2-Chloro-3-oxo-n-phenylbutanamide,CC(=O)C(C(=O)NC1=CC=CC=C1)Cl,,,,,,
212,160213,"1,8,1',8'-Tetrahydroxybisanthrone",C1=CC2=C(C(=C1)O)C(=O)C3=C(C2C4C5=C(C(=CC=C5)O)C(=O)C6=C4C=CC=C6O)C=CC=C3O,,,,,,
213,160214,5-(2-Hydroxyethylidene)-4-(hydroxymethyl)furan-2-one,C1=C(C(=CCO)OC1=O)CO,,,,,,
214,160215,2-(1-Methyl-5-nitroimidazol-2-yl)-1-(3-morpholinopropyl)benzimidazole,CN1C(=CN=C1C2=NC3=CC=CC=C3N2CCCN4CCOCC4)[N+](=O)[O-],,,,,,
215,160216,Hexadecenyl succinic anhydride,CCCCCCCCCCCCCCC=CC1CC(=O)OC1=O,,,,,,
216,160217,"alpha-(1,4-Dioxido-3-methylquinoxalin-2-yl)-N-methylnitrone",CC1=C([N+](C2=CC=CC=C2N1[O-])([O-])[O-])C=NC,,,,,,
217,160218,"1-(1-hydroxy-3-methyl-1,4-dioxidoquinoxalin-1-ium-2-yl)-N-methylmethanimine",CC1=C([N+](C2=CC=CC=C2N1[O-])(O)[O-])C=NC,,,,,,
218,160219,CID 160219,C1C2=CC=CC=C2C3=C1C=C(C=C3)NC4=NC5=C(N4)C(=O)N=C(N5)N,,,,,,
219,160220,Tiadenol disulfoxide,C(CCCCCS(=O)CCO)CCCCS(=O)CCO,,,,,,
220,160221,CID 160221,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=CC=C(C=C2)C3=CC(=C4C(=O)C=C(C(=C4O3)[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O)O)O)O,,,,,,
221,160222,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-[(2-hydroxypropyl)amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-, disodium salt",CC(CNC1=NC(=NC(=N1)NC2=CC(=C(C=C2)C=CC3=C(C=C(C=C3)NC4=NC(=NC(=N4)NC5=CC=CC=C5)NCC(C)O)S(=O)(=O)[O-])S(=O)(=O)[O-])NC6=CC=CC=C6)O.[Na+].[Na+],,,,,,
222,160223,"4,4'-Bis[[6-anilino-4-[(2-hydroxypropyl)amino]-1,3,5-triazin-2-YL]amino]stilbene-2,2'-disulphonic acid",CC(CNC1=NC(=NC(=N1)NC2=CC(=C(C=C2)C=CC3=C(C=C(C=C3)NC4=NC(=NC(=N4)NC5=CC=CC=C5)NCC(C)O)S(=O)(=O)O)S(=O)(=O)O)NC6=CC=CC=C6)O,,,,,,
223,160224,N-Hydroxy-N-myristoyl-2-aminofluorene,CCCCCCCCCCCCCC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C2)O,,,,,,
224,160225,CID 160225,CCNC(=O)C=C(C)CCC=C(C)CCC1C(O1)(C)C,,,,,,
225,160226,Sulfoacetaldehyde,C(C=O)S(=O)(=O)O,,,,,,
226,160227,"3beta,17beta-Di-(1-pyrrolidinyl)-5alpha-androstane",C[C@]12CC[C@@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4[N+]5(CCCC5)C)C)[N+]6(CCCC6)C.[I-].[I-],,,,,,
227,160228,Dipyrandium,C[C@]12CC[C@@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4[N+]5(CCCC5)C)C)[N+]6(CCCC6)C,,,,,,
228,160229,CID 160229,C1(=C(C(=O)C(=C(C1=O)Cl)[O-])Cl)[O-].[Hg+2],,,,,,
229,160230,Dihydrotestosterone heptanoate,CCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CCC(=O)C4)C)C,,,,,,
230,160231,Nitroso-L-citrulline,C(C[C@@H](C(=O)O)N)CN(C(=O)N)N=O,,,,,,
231,160232,beta-Hydroxypiromidic acid,CCN1C=C(C(=O)C2=CN=C(N=C21)N3CCC(C3)O)C(=O)O,,,,,,
232,160233,CID 160233,CC=C(C[C@@H](C)[C@](CO)(C(=O)O)O)C(=O)O,,,,,,
233,160234,"3-Methoxy-5-methyl-4-oxo-2,5-hexadienamide",CC(=C)C(=O)C(=CC(=O)N)OC,,,,,,
234,160235,6-Fluorobenzo[c]phenanthrene,C1=CC=C2C(=C1)C=CC3=C2C4=CC=CC=C4C=C3F,,,,,,
235,160236,1-Methoxypyrene,COC1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C=C1,,,,,,
236,160237,Cirsiliol,COC1=C(C(=C2C(=C1)OC(=CC2=O)C3=CC(=C(C=C3)O)O)O)OC,,,,,,
237,160238,"(2S,3S,4S,5R,6R)-6-[[(6aR,6bS,8aS,12aR,14bR)-4,4,6a,6b,11,11,14b-heptamethyl-8a-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3,4-dihydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2-carboxylic acid",C[C@]12CCC(C(C1CC[C@@]3(C2CC=C4[C@]3(CC[C@@]5([C@@H]4CC(CC5)(C)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)(C)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O,,,,,,
238,160239,"Magnesium,bis(1,2,3,6-tetrahydro-2,6-dioxo-4-pyrimidinecarboxylato-kN3,kO4)-, (T-4)-",C1=C([N-]C(=O)NC1=O)C(=O)[O-].C1=C([N-]C(=O)NC1=O)C(=O)[O-].[Mg+2],,,,,,
239,160240,"1-(3,4-Dichlorobenzyl)-3,4,5,6-tetrahydro-2(1H)-pyrimidone",C1CNC(=O)N(C1)CC2=CC(=C(C=C2)Cl)Cl,,,,,,
240,160241,"1,1'-(9H-Fluorene-2,7-diyl)bis(4-piperidinobutan-1-one)",C1CCN(CC1)CCCC(=O)C2=CC3=C(C=C2)C4=C(C3)C=C(C=C4)C(=O)CCCN5CCCCC5,,,,,,
241,160242,"1-(m-Trifluoromethylphenyl)-3-(2-hydroxyethyl)-quinazoline-2,4(1H,3H)-dione",C1=CC=C2C(=C1)C(=O)N(C(=O)N2C3=CC=CC(=C3)C(F)(F)F)CCO,,,,,,
242,160243,Timepidium bromide,C[N+]1(CC(CC(=C(C2=CC=CS2)C3=CC=CS3)C1)OC)C.[Br-],,,,,,
243,160244,Di-N-acetylchitobiose,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O[C@H]([C@@H](CO)O)[C@@H]([C@H](C=O)NC(=O)C)O)CO)O)O,,,,,,
244,160245,10-alpha-Methoxydihydrolysergol,CN1C[C@@H](CC2([C@H]1CC3=CNC4=CC=CC2=C34)OC)CO,,,,,,
245,160246,Methyl aristolate,COC1=CC=CC2=C1C=CC3=C2C4=C(C=C3C(=O)OC)OCO4,,,,,,
246,160247,2-(O-tolylcarbamoyl)naphthalen-3-yl 2-chloroacetate,CC1=CC=CC=C1NC(=O)C2=CC3=CC=CC=C3C=C2OC(=O)CCl,,,,,,
247,160248,"3,7-Dimethyl-2,6-octadien-1-amine",CC(=CCCC(=CCN)C)C,,,,,,
248,160249,"4,5-Dihydroanthanthrene",C1CC2=CC3=CC=CC4=C3C5=C(C=C4)C=C6C=CC=C1C6=C25,,,,,,
249,160250,6-Hydroxyazapropazone,CCCC1C(=O)N2C3=C(C=C(C(=C3)C)O)N=C(N2C1=O)N(C)C,,,,,,
250,160251,"methyl (1R,15S,17R,18R,19S,20S)-17-[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyloxy]-6,18-dimethoxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate",CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C=CC6=CC(=C(C=C6)O)OC,,,,,,
251,160252,"N(1),N(1)-Bis(2-chloroethyl)-3-methyl-1,4-benzenediamine",CC1=C(C=CC(=C1)N(CCCl)CCCl)N,,,,,,
252,160253,N(sup 5)-(Iodoacetyl)-L-ornithine,C(C[C@@H](C(=O)O)N)CNC(=O)CI,,,['Substances and drugs that inhibit or block the activity of ORNITHINE DECARBOXYLASE. (See all compounds classified as Ornithine Decarboxylase Inhibitors.)'],,,
253,160254,Cryptotanshinone,C[C@H]1COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4(C)C,,,,,,
254,160255,"(3R,6R,8S,10S)-8-hydroxy-6-methyl-3-prop-1-en-2-ylspiro[4.5]decane-10-carbaldehyde",C[C@@H]1C[C@@H](C[C@@H](C12CC[C@H](C2)C(=C)C)C=O)O,,,,,,
255,160256,5-Hydroxy-4-methoxy-5-(1-methylethyl)-2(5H)-furanone,CC(C)C1(C(=CC(=O)O1)OC)O,,,,,,
256,160257,Fenton's reagent,OO.OS(=O)(=O)O.[Fe+2],,,,,,
257,160258,11alpha-Bromoacetoxyprogesterone,CC(=O)[C@H]1CC[C@@H]2[C@@]1(C[C@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)OC(=O)CBr)C,,,,,,
258,160259,Acetoxyoxirane,CC(=O)OC1CO1,,,,,,
259,160260,RMI-11567 dihydrochloride,CN(C)CC(=O)C1=CC2=C(C=C1)OC3=C2C=C(C=C3)C(=O)CN(C)C.Cl.Cl,,,,,,
260,160261,"2,8-Bis(2-(dimethylamino)acetyl)dibenzofuran dihydrochloride",CN(C)CC(=O)C1=CC2=C(C=C1)OC3=C2C=C(C=C3)C(=O)CN(C)C,,,,,,
261,160262,CID 160262,CC=C1CN2CCC3=C([C@@H]2C[C@@H]1CC4=C5C(=C6C=CC=CC6=N5)C=CN4)NC7=CC=CC=C37,,,,,,
262,160263,(R)-Rhazinilam,CCC12CCCN3C1=C(C=C3)C4=CC=CC=C4NC(=O)CC2,,,,,,
263,160264,"2-Methyl-5,6-cyclopentapyrimidine",CC1=NC=C2CCCC2=N1,,,,,,
264,160265,25-Isosolafloridine,C[C@H]1CCC(=NC1)[C@@H](C)C2[C@@H](C[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC[C@@H]5[C@@]4(CC[C@@H](C5)O)C)C)O,,,,,,
265,160266,Zinc Aspartate 20% 40M,C([C@H](C(=O)[O-])N)C(=O)O.C([C@@H](C(=O)[O-])N)C(=O)O.[Zn+2],,,,,,
266,160267,"Benzoic acid, 2-(acetyloxy)-3,5-diiodo-",CC(=O)OC1=C(C=C(C=C1I)I)C(=O)O,,,,,,
267,160268,2-Benzyl-1-naphthol,C1=CC=C(C=C1)CC2=C(C3=CC=CC=C3C=C2)O,,,,,,
268,160269,Hydridodihydroxidooxidoarsenic,O[AsH](=O)O,,,,,,
269,160270,Dracorubin,CC1=C2C3=C(C=C(OC3=CC1=O)C4=CC=CC=C4)C5=C6C(=C(C=C5O2)OC)CC[C@H](O6)C7=CC=CC=C7,,,,,,
270,160271,"3,3',3'',3'''-(1,4,8,11-Tetraazacyclotetradecane-1,4,8,11-tetrayl)tetrapropanamide",C1CN(CCN(CCCN(CCN(C1)CCC(=O)N)CCC(=O)N)CCC(=O)N)CCC(=O)N,,,,,,
271,160272,"(6,8-Dichloro-2-phenyl-1,2,3,4-tetrahydroquinolin-4-yl)(piperidin-2-yl)methanol hydrochloride(1:1)",C1CCNC(C1)C(C2CC(NC3=C2C=C(C=C3Cl)Cl)C4=CC=CC=C4)O.Cl,,,,,,
272,160273,"(6,8-Dichloro-2-phenyl-1,2,3,4-tetrahydroquinolin-4-yl)-piperidin-2-ylmethanol",C1CCNC(C1)C(C2CC(NC3=C2C=C(C=C3Cl)Cl)C4=CC=CC=C4)O,,,,,,
273,160274,"6-Chloro-3-hydroxy-7-methyl-3-(2-oxo-2-phenylethyl)-1,3-dihydro-2h-indol-2-one",CC1=C(C=CC2=C1NC(=O)C2(CC(=O)C3=CC=CC=C3)O)Cl,,,,,,
274,160275,"(3beta,5beta)-3,5,14-Trihydroxy-19-(hydroxyimino)card-20-enolide",C[C@]12CC[C@H]3[C@H]([C@]1(CC[C@@H]2C4=COC(=O)C4)O)CC[C@]5([C@@]3(CC[C@@H](C5)O)C=NO)O,,,,,,
275,160276,CID 160276,CCCNC1=NC2=C(S1)C3=C(C4=C2C5=C(C(=C4O)C)OC(C5=O)(OC=CC(C(C(C(C(C(C(C(C=CC=C(C(=O)N3)C)C)O)C)O)C)OC(=O)C)C)OC)C)O,,,,,,
276,160277,CID 160277,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2SC(=N5)NCC=C)O)C,,,,,,
277,160278,CID 160278,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2SC(=N5)N)O)C,,,,,,
278,160279,CID 160279,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2NC=N5)O)C,,,,,,
279,160280,CID 160280,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2NC(=N5)C6=CC=CC=C6)O)C,,,,,,
280,160281,CID 160281,CC1C=CC=C(C2=NC3=CC(=C4C(=C3O2)C(=C(C5=C4C(=O)C(O5)(OC=CC(CC(C(C(C(C1O)C)O)C)OC(=O)C)OC)C)C)O)O)C,,,,,,
281,160282,CID 160282,CC[C@H](C)C=C(C)[C@@H]([C@H](C)C=C(C)C=CC=CC=CC=C(C)C(=O)N[C@H](C)CO)O,,,,,,
282,160283,Motoma,COC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)NOC)OC)OC,,,,,,
283,160284,"3a,4,13,13a-Tetrahydro-5,6,7,10,11-pentamethoxydibenzo(4,5:6,7)-cycloocta(1,2-c)furan-3(1H)-one",COC1=C(C=C2C(=C1)CC3COC(=O)C3CC4=C(C(=C(C=C42)OC)OC)OC)OC,,,,,,
284,160285,CID 160285,CC=C1C[N+]2([C@H]3C[C@@H]1C([C@@H]2CC4=C3NC5=C4C=CC(=C5)OC)(CO)C(=O)OC)C,,,,,,
285,160286,CID 160286,C1=NC2=C(N1SC[C@@H](C(=O)N(CC(=O)O)C(=O)CC[C@@H](C(=O)O)N)N)C(=O)N=C(N2)N,,,,,,
286,160287,CID 160287,CCCC=CC=CC(=O)O[C@@H]1C2=CC(=O)O[C@@H]2[C@H]3CC(OC(=O)C[C@@H](C[C@@H]4C[C@@H](C([C@@](O4)(C[C@@H]5CC(=CC(=O)OC)C[C@@H](O5)C=CC([C@@]1(O3)O)(C)C)O)(C)C)OC(=O)C)O)[C@@H](C)O,,,,,,
287,160288,Ditrisarubicin C,CC[C@]1(C[C@@H](C2=C([C@H]1O[C@H]3C[C@@H]([C@@H]([C@@H](O3)C)O[C@H]4CCC([C@@H](O4)C)O[C@H]5C=CC(=O)[C@@H](O5)C)N(C)C)C(=C6C(=C2O)C(=O)C7=C(C6=O)C=CC=C7O)O)O[C@H]8C[C@@H]([C@@H]([C@@H](O8)C)O[C@H]9C[C@H]1[C@@H]([C@@H](O9)C)O[C@H]2[C@@H](O1)CC(=O)[C@@H](O2)C)N(C)C)O,,,,,,
288,160289,CID 160289,CCC1(CC(C2=C(C1OC3CC(C(C(O3)C)OC4CC5C(C(O4)C)OC6C(O5)CC(=O)C(O6)C)N(C)C)C(=C7C(=C2O)C(=O)C8=C(C7=O)C=CC=C8O)O)OC9C(OC(CC9N(C)C)OC1CC2C(C(O1)C)OC1C(O2)CC(=O)C(O1)C)C)O,,,,,,
289,160290,"Phosphonic acid, (((phosphonomethyl)imino)bis(6,1-hexanediylnitrilobis(methylene)))tetrakis-, reaction products with ammonia-diethylene glycol reaction product morpholine derivs. residues",C1COCCN1.C(CCCN(CP(=O)(O)O)CP(=O)(O)O)CCN(CCCCCCN(CP(=O)(O)O)CP(=O)(O)O)CP(=O)(O)O.C(COCCO)O.N,,,,,,
290,160291,Ditrisarubicin A,CCC1(CC(C2=C(C1OC3CC(C(C(O3)C)OC4CC(C(C(O4)C)OC5CCC(=O)C(O5)C)O)N(C)C)C(=C6C(=C2O)C(=O)C7=C(C6=O)C=CC=C7O)O)OC8CC(C(C(O8)C)OC9CC1C(C(O9)C)OC2C(O1)CC(=O)C(O2)C)N(C)C)O,,,,,,
291,160292,Empedopeptin,CCCCCCCCCCCC1CC(=O)N2CCCC2C(=O)NC(C(=O)N3CCCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4CCC(C4C(=O)NC(C(=O)O1)C(C(=O)O)O)O)CO)C(C(=O)O)O)CCCN=C(N)N)CO,,,,,,
292,160293,CID 160293,CC1=CC2=C([C@H]3[C@@H]4CC5=C([C@@H](N4C[C@@H](C2)N3C)CNC(=O)[C@H](C)N)C(=O)C(=C(C5=O)C)OC)C(=C1OC)O,,,,,,
293,160294,Safracin B,CC1=CC2=C([C@H]3[C@@H]4CC5=C([C@@H](N4[C@H]([C@@H](C2)N3C)O)CNC(=O)[C@H](C)N)C(=O)C(=C(C5=O)C)OC)C(=C1OC)O,,,,,,
294,160295,Lipid Y,CCCCCCCCCCCCCCCC(=O)O[C@H](CCCCCCCCCCC)CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1OP(=O)(O)O)CO)O)OC(=O)C[C@@H](CCCCCCCCCCC)O,,,,,,
295,160296,O-Desmethylbouvardin,CC1C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)N(C2C(C3=CC=C(C=C3)OC4=C(C=CC(=C4)CC(C(=O)N1)N(C2=O)C)O)O)C)C)CC5=CC=C(C=C5)O)C)C,,,,,,
296,160297,"1,3-Cyclopentadiene-1-carboxylic acid, 5-diazo-, 6-(9-acridinylamino)hexyl ester",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCCOC(=O)C4=CC=CC4=[N+]=[N-],,,,,,
297,160298,CID 160298,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCCOC(=C4C=CC=C4[N+]#N)O,,,,,,
298,160299,CID 160299,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCCN=C(C4=CC=C(C=C4)N[N+]#N)[O-],,,,,,
299,160300,CID 160300,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCCNC(=O)C4=CC=C(C=C4)N[N+]#N,,,,,,
300,160301,Bouvardin catechol,CC1C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)N(C2C(C3=CC=C(C=C3)OC4=C(C=CC(=C4)CC(C(=O)N1)N(C2=O)C)O)O)C)C)CC5=CC(=C(C=C5)O)O)C)C,,,,,,
301,160302,CID 160302,CC1=CCC[C@]2([C@@H](O2)C[C@H]3CC[C@]([C@@H](CC1)O)(OC(=O)C3=C)C)C,,,,,,
302,160303,Aquilide A,CC1CC2(C=C(C3(CC3)C(C2C1=O)(C)O)C)OC4C(C(C(C(O4)CO)O)O)O,,,"['Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)', 'Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)']",,,
303,160304,"anti-9-Hydroxychrysene-1,2-diol-3,4-epoxide",C1=CC(=CC2=C1C=CC3=C2C=CC4=C3[C@H]5[C@H](O5)[C@@H]([C@H]4O)O)O,,,,,,
304,160305,CID 160305,C[C@H]1CC(=CC=C[C@@H](C(OC(=O)C(=CC(=C[C@H]([C@H]1O)C)C)OC)[C@@H](C)[C@H]([C@H](C)[C@]2(C[C@H]([C@@H]([C@H](O2)C(C)C)C)OC(=O)C=CC(=O)NC3=C(CCC3=O)O)O)O)OC)C,,,,,,
305,160306,Territrem C,C[C@@]12CC[C@@]3([C@@]([C@]1(CC4=C(O2)C=C(OC4=O)C5=CC(=C(C(=C5)OC)O)OC)O)(C(=O)C=CC3(C)C)C)O,,,,,,
306,160307,"[(1S,3aS,3bR,10aR,10bS,12aS)-10a,12a-dimethyl-7-oxo-2,3,3a,3b,4,5,8,9,10,10b,11,12-dodecahydro-1H-indeno[4,5-i][3]benzazepin-1-yl] 2-[4-[bis(2-chloroethyl)amino]phenoxy]acetate",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)COC4=CC=C(C=C4)N(CCCl)CCCl)CCC5=CC(=O)NCC[C@]35C,,,,,,
307,160308,Akrobomycin,CCC1=CC2=C(C(C1)OC3CC(C(C(O3)C)O)N)C(=C4C(=C2O)C(=O)C5=C(C4=O)C(=CC=C5)O)O,,,,,,
308,160309,"2,5-Bis(tert-nonyldithio)-1,3,4-thiadiazole",CCCCCCC(C)(C)SSC1=NN=C(S1)SSC(C)(C)CCCCCC,,,,,,
309,160310,"Propanoic acid, 2-(4-((3,5-dichloro-2-pyridinyl)oxy)phenoxy)-, (trimethylsilyl)methyl ester",CC(C(=O)OC[Si](C)(C)C)OC1=CC=C(C=C1)OC2=C(C=C(C=N2)Cl)Cl,,,,,,
310,160311,"7,8-Dihydroxy-9,10-epoxy-8-methyl-7,8,9,10-tetrahydrobenzo(a)pyrene",CC1(C2C(O2)C3=C(C1O)C=C4C=CC5=C6C4=C3C=CC6=CC=C5)O,,,,,,
311,160312,"3-[[13-[12-(Diaminomethylideneamino)-4-methyldodec-8-en-2-yl]-5,7,9,19,21,23,27,29,30,31-decahydroxy-8,12,18,22,26-pentamethyl-15-oxo-14,33-dioxabicyclo[27.3.1]tritriaconta-10,16-dien-3-yl]oxy]-3-oxopropanoic acid",CC1CCC(C(C(CC(C(C=CC(=O)OC(C(C=CC(C(C(CC(CC(CC2CC(C(C(O2)(CC1O)O)O)O)OC(=O)CC(=O)O)O)O)C)O)C)C(C)CC(C)CCCC=CCCCN=C(N)N)C)O)O)C)O,,,,,,
312,160313,Copper-putrescine-pyridine,C1=CC=NC(=C1)C=NCCCCN=CC2=CC=CC=N2.[O-]Cl(=O)(=O)=O.[Cu+2],,,,,,
313,160314,"1,4-Butanediamine, N,N'-bis(2-pyridinylmethylene)-",C1=CC=NC(=C1)C=NCCCCN=CC2=CC=CC=N2,,,,,,
314,160315,"[(1R,6R,7S)-4-ethyl-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadeca-4,11-dien-7-yl] acetate",CCC1=C[C@H]([C@](C(=O)OCC2=CCN(CC[C@H](C2=O)OC1=O)C)(C)OC(=O)C)C,,,,,,
315,160316,CID 160316,C[C@@H]1CC2([C@H](O2)C)C(=O)O[C@@H]3CCN(CC=C(C3=O)COC(=O)[C@@]1(C)OC(=O)C)C,,,,,,
316,160317,"Sulfurous acid, monosodium salt, reaction products with bisphenol A disodium salt and formaldehyde",CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O.C=O.OS(=O)O.[Na+].[Na+].[Na+],,,,,,
317,160318,"4-Hydroxy-4-[18-(4-hydroxy-2,6,6-trimethylcyclohexen-1-yl)-3,7,12,16-tetramethyl-2-oxooctadeca-3,5,7,9,11,13,15-heptaen-17-ynyl]-3,5,5-trimethylcyclohex-2-en-1-one",CC1=C(C(CC(C1)O)(C)C)C#CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C(=O)CC2(C(=CC(=O)CC2(C)C)C)O)C)C,,,,,,
318,160319,Rhnaa,C=CCNC1=CC=CC=C1.C=CCNC1=CC=CC=C1.C=CCNC1=CC=CC=C1.[Cl-].[Cl-].[Rh].[Rh],,,,,,
319,160320,Schaunardimycin,CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C=CC(=C4C3=O)O)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O)O)NC)O,,,,,,
320,160321,"11-Ethylidene-6-hydroxy-7,9,13-trioxatetracyclo[6.5.1.01,10.04,14]tetradec-2-en-12-one",CC=C1C2C3(C=CC4C3C(O2)OC(C4)O)OC1=O,,,,,,
321,160322,cis-Pt-Mfba,C1CCC(C(C1)N)N.C1=CC(=CC(=C1)F)C(=O)[O-].C1=CC(=CC(=C1)F)C(=O)[O-].[Pt+2],,,,,,
322,160323,CID 160323,[Cu].[Zn].[Ag].[SnH2].[Hg],,,,,,
323,160324,"Carbonic dichloride, polymer with 4,4'-(1-methylethylidene)bis(2,6-dibromophenol) and phenol",CC(C)(C1=CC(=C(C(=C1)Br)O)Br)C2=CC(=C(C(=C2)Br)O)Br.C1=CC=C(C=C1)O.C(=O)(Cl)Cl,,,,,,
324,160325,"1,3-Propanediol, 2-ethyl-2-(hydroxymethyl)-, polymer with 1,3-bis(1-isocyanato-1-methylethyl)benzene",CCC(CO)(CO)CO.CC(C)(C1=CC(=CC=C1)C(C)(C)N=C=O)N=C=O,,,,,,
325,160326,"4,4'-(2,2-Bis((4-(aminoiminomethyl)-2-bromophenoxy)methyl)-1,3-propanediyl)bis(oxy))bis(3-bromobenzenecarboximidamide",C1=CC(=C(C=C1C(=N)N)Br)OCC(COC2=C(C=C(C=C2)C(=N)N)Br)(COC3=C(C=C(C=C3)C(=N)N)Br)COC4=C(C=C(C=C4)C(=N)N)Br,,,,,,
326,160327,"4-Ethylidene-7-hydroxy-7-methylspiro[2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-ene-6,2'-oxirane]-3,8-dione",CC=C1CC2(CO2)C(C(=O)OCC3=CCN4C3C(CC4)OC1=O)(C)O,,,,,,
327,160328,"ethyl 3-[[6-[(3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl)oxy]-3-hydroxy-2-methyloxan-4-yl]amino]but-2-enoate",CCOC(=O)C=C(C)NC1CC(OC(C1O)C)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O,,,,,,
328,160329,"2-Naphthalenesulfonic acid, 6-hydroxy-5-((4-methyl-2-sulfophenyl)azo)-, calcium salt (1:1)",CC1=CC(=C(C=C1)N=NC2=C(C=CC3=C2C=CC(=C3)S(=O)(=O)[O-])O)S(=O)(=O)[O-].[Ca+2],,,,,,
329,160330,6-Hydroxy-5-[(4-methyl-2-sulfophenyl)diazenyl]naphthalene-2-sulfonic acid,CC1=CC(=C(C=C1)N=NC2=C(C=CC3=C2C=CC(=C3)S(=O)(=O)O)O)S(=O)(=O)O,,,,,,
330,160331,"Pyreno(1,2-b)furan",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4OC=C5)C=C2,,,,,,
331,160332,"Pyreno(1,2-b)furan, 8-nitro-",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4OC(=C5)[N+](=O)[O-])C=C2,,,,,,
332,160333,"Pyreno(2,1-b)furan",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C=CO5)C=C2,,,,,,
333,160334,"Pyreno(2,1-b)furan, 8-nitro-",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C=C(O5)[N+](=O)[O-])C=C2,,,,,,
334,160335,"[12-Acetyloxy-1,11,21-trihydroxy-17-(1-hydroxyethyl)-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-25-yl] 3-methylbutanoate",CC(C)CC(=O)OC1CC2CC(CC(=O)OC(CC3CC(=CC(=O)OC)C(C(O3)(C(C=CC4CC(=CC(=O)OC)CC(O4)CC(C1(C)C)(O2)O)(C)C)O)OC(=O)C)C(C)O)O,,,,,,
335,160336,"1,3-Propanediamine, N,N-dimethyl-, reaction product with chlorinated polyisobutylene",CC(=C)C.CN(C)CCCN,,,,,,
336,160337,Ferric-adenosine triphosphate complex,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N.[Fe],,,,,,
337,160338,"Dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination",CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC.CC(C)(C)CC(C)(C)C1=CC=C(C=C1)O.C=O.C1CO1,,,,,,
338,160339,Dipalmitoyl phosphatidylcholine,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC,,,,,,
339,160340,[2-(Hydroxymethyl)-3-phosphonooxy-5-(3-tetradecanoyloxytetradecanoylamino)oxan-4-yl] tetradecanoate,CCCCCCCCCCCCCC(=O)OC1C(COC(C1OP(=O)(O)O)CO)NC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC,,,,,,
340,160341,CID 160341,C[C@H]1C[C@H]2CC[C@H]3C(=C)C[C@@H](O3)CC[C@@]45C[C@@H]6[C@@H](O4)[C@H]7[C@@H](O6)[C@H](O5)[C@H]8[C@H](O7)CC[C@H](O8)CC(=O)O[C@@H]9[C@H]([C@@H]3[C@@H](C[C@@H]4[C@H](O3)C[C@]3(O4)C[C@@H]4[C@H](O3)[C@@H](C[C@]3(O4)C[C@H]([C@@H]4[C@H](O3)C[C@@H](O4)[C@H](C[C@H](CO)O)O)C)C)O[C@@H]9C[C@@H](C1=C)O2)C,,,,,,
341,160342,CID 160342,C[C@@H]1[C@@H](C[C@@H]([C@@H]([C@H](C[C@@H]2CC=C[C@H](O2)C[C@H](CC=C(C=CC(=O)OC1[C@@H](C)[C@H]([C@H](C)CCC(=O)[C@H](C)[C@@H]([C@H](C)C=CN(C)C=O)OC)O)C)O)OC)CO)OC)OC,,,,,,
342,160343,CID 160343,C[C@@H]1[C@H]([C@H](C[C@@H](O1)ONC2[C@H](O[C@H]([C@@H]([C@H]2O)O[C@H]3C[C@@H]([C@H](CO3)NC(C)C)OC)O[C@H]4C#CC=CC#C[C@]5([C@@H](C(=O)C(=C4C5=CCSSSC)NC(=O)OC)O)O)C)O)SC,,,,,,
343,160344,CID 160344,C([C@H]1[C@H]2[C@H]([C@H]([C@@H](O1)O[C@H]3[C@@H](O[C@H]([C@@H]([C@@H]3O)O)O[C@H]4[C@@H](O[C@H]([C@@H]([C@@H]4O)O)O[C@H]5[C@@H](O[C@H]([C@@H]([C@@H]5O)O)O[C@H]6[C@@H](O[C@H]([C@@H]([C@@H]6O)O)O[C@H]7[C@@H](O[C@H]([C@@H]([C@@H]7O)O)O[C@H]8[C@@H](O[C@@H](O2)[C@@H]([C@@H]8O)O)CO)CO)CO)CO)CO)CO)O)O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O,,,,,,
344,160345,CID 160345,[H+].CC(=N[O-])C(C)(C)[N-]CCC[N-]C(C)(C)C(=N[O-])CN1C=CN=C1[N+](=O)[O-].O=[99Tc+3],,,,,,
345,160346,CID 160346,CC(=N[O-])C(C)(C)NCCCNC(C)(C)C(=N[O-])CN1C=CN=C1[N+](=O)[O-],,,,,,
346,160347,"(4R,5S,6R)-6-(1-Hydroxyethyl)-3-[(3S,5R)-5-[(1R)-1-hydroxy-3-(methylamino)propyl]pyrrolidin-3-yl]sulfanyl-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;hydrochloride",C[C@@H]1[C@@H]2[C@@H](C(=O)N2C(=C1S[C@H]3C[C@@H](NC3)[C@@H](CCNC)O)C(=O)O)C(C)O.Cl,,,,,,
347,160348,"(4R,5S,6R)-6-(1-hydroxyethyl)-3-[(3S,5R)-5-[(1R)-1-hydroxy-3-(methylamino)propyl]pyrrolidin-3-yl]sulfanyl-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid",C[C@@H]1[C@@H]2[C@@H](C(=O)N2C(=C1S[C@H]3C[C@@H](NC3)[C@@H](CCNC)O)C(=O)O)C(C)O,,,,,,
348,160349,"Dibenzo(k,mno)acephenanthrylene",C1=CC=C2C3=C4C(=CC2=C1)C=C5C=CC6=C5C4=C(C=C6)C=C3,,,,,,
349,160350,"Dibenzo(j,mno)acephenanthrylene",C1=CC=C2C(=C1)C=C3C=CC4=C5C3=C2C=C6C5=C(C=C4)C=C6,,,,,,
350,160351,"[(1R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol;4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one;1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-].C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4C[C@H](C=C4)CO.C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N,,,,,,
351,160352,Lamivudine and zidovudine,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-].C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N,,,"['Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)', 'Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. (See all compounds classified as Reverse Transcriptase Inhibitors.)']",,,
352,160353,Quillifoline,COC1=C(C=C2C3CC(CCN3CCC2=C1)C4=CC=C(C=C4)Cl)OC,,,,,,
353,160354,Quinazosin hydrochloride,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)CC=C)N)OC.Cl.Cl,,,,,,
354,160355,Seliciclib,CC[C@H](CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3,"['Investigated for use/treatment in breast cancer, lung cancer, lymphoma (unspecified), multiple myeloma, leukemia (lymphoid), and cancer/tumors (unspecified).']",,"['Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)', 'Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)', 'Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)']",,,
355,160356,"Ethanimidamide, monoacetate",CC(=N)N.CC(=O)O,,,,,,
356,160357,"2,4,6(1H,3H,5H)-Pyrimidinetrione, 5,5'-(1H-isoindole-1,3(2H)-diylidene)bis-",C1=CC=C2C(=C1)C(=C3C(=O)NC(=O)NC3=O)N=C2C4=C(NC(=O)NC4=O)O,,,,,,
357,160358,"5-Cyclohexyl-2,4-dimethoxy-gamma-oxobenzenebutyric acid",COC1=CC(=C(C=C1C2CCCCC2)C(=O)CCC(=O)O)OC,,,,,,
358,160359,CID 160359,CC(=CC(=O)C)[O-].CC(=CC(=O)C)[O-].C(C[O-])C[O-].[Ti+4],,,,,,
359,160360,CID 160360,COCC1COC2=C(O1)C=C3C(=C2Cl)C(=O)C(=CN3)C(=O)OC,,,,,,
360,160361,"2-[4,6-Diethyl-6-(4-ethyloct-5-enyl)dioxan-3-yl]acetic acid",CCC=CC(CC)CCCC1(CC(C(OO1)CC(=O)O)CC)CC,,,,,,
361,160362,"4,6,8,10-Tetraethyl-4,6-dihydroxytetradeca-2,7,11-trienoic acid",CCC=CC(CC)CC(=CC(CC)(CC(CC)(C=CC(=O)O)O)O)CC,,,,,,
362,160363,"4,6,10-Triethyl-4,6-dihydroxy-8-methyltetradeca-2,7,11-trienoic acid",CCC=CC(CC)CC(=CC(CC)(CC(CC)(C=CC(=O)O)O)O)C,,,,,,
363,160364,Dbadptx,COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)NC6CCN(CC6)CC7=CC=CC=C7,,,,,,
364,160365,Ddadptx,CN(C)CCN[C@H]1[C@H]2COC(=O)[C@@H]2[C@@H](C3=CC4=C(C=C13)OCO4)C5=CC(=C(C(=C5)OC)O)OC,,,,,,
365,160366,Ddpdptx,CN(C)CCCN[C@H]1[C@H]2COC(=O)[C@@H]2[C@@H](C3=CC4=C(C=C13)OCO4)C5=CC(=C(C(=C5)OC)O)OC,,,,,,
366,160367,Pareirubrine B,COC1=C(C2=C3C(=C1)C=CN=C3C4=CC(=O)C(=CC=C42)O)OC,,,,,,
367,160368,CID 160368,C1[C@@H](C2=C(N1)NC(=NC2=O)N)CCC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
368,160369,"1-Naphthalenepropanoic acid, alpha-((3,3,3-trifluoro-2-(mercaptomethyl)-1-oxopropyl)amino)-",C1=CC=C2C(=C1)C=CC=C2CC(C(=O)O)NC(=O)C(CS)C(F)(F)F,,,,,,
369,160370,"6-(7-(Heptyloxy)-3,4-dihydro-4,4-dimethyl-1,1-dioxido-2H-1-benzothiopyran-6-yl)-2-naphthalenecarboxylic acid",CCCCCCCOC1=CC2=C(C=C1C3=CC4=C(C=C3)C=C(C=C4)C(=O)O)C(CCS2(=O)=O)(C)C,,,,,,
370,160371,"[(1R,2R,3R,4R,5S,6R)-2-amino-3,5-dihydroxy-4,6-diphosphonooxycyclohexyl] dihydrogen phosphate",[C@H]1([C@H]([C@H]([C@@H]([C@H]([C@@H]1OP(=O)(O)O)OP(=O)(O)O)O)OP(=O)(O)O)O)N,,,,,,
371,160372,"1H-Benze(de)isoquinoline-1,3(2H)-dione, 2-(3-((4-(5-nitro-1,3-dioxo-1H-benz(de)isoquinolin-2(3H)-yl)butyl)amino)propyl)-5-nitro-, monomethanesulfonate",CS(=O)(=O)O.C1=CC2=CC(=CC3=C2C(=C1)C(=O)N(C3=O)CCCCNCCCN4C(=O)C5=CC=CC6=CC(=CC(=C65)C4=O)[N+](=O)[O-])[N+](=O)[O-],,,,,,
372,160373,"5-Nitro-2-[4-[3-(5-nitro-1,3-dioxobenzo[de]isoquinolin-2-yl)propylamino]butyl]benzo[de]isoquinoline-1,3-dione",C1=CC2=CC(=CC3=C2C(=C1)C(=O)N(C3=O)CCCCNCCCN4C(=O)C5=CC=CC6=CC(=CC(=C65)C4=O)[N+](=O)[O-])[N+](=O)[O-],,,,,,
373,160374,CID 160374,C[C@H](C=C[C@@H](C)C(=C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=C[C@H]([C@@]4([C@@]3(CC[C@@H](C4)O)C)O)O)C,,,,,,
374,160375,Ncdac,[C-]#[N+][C@H]1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)N)CO)O,,,,,,
375,160376,CID 160376,C1C[C@H](C2=NN(C(=C2C1)C=C[C@H](C[C@H](CC(=O)O)O)O)C3=CC=C(C=C3)F)CC4=CC=C(C=C4)C5=CC=CC=C5,,,,,,
376,160377,[(3S)-4-hexadecylsulfanyl-3-methoxybutyl]-[2-(trimethylazaniumyl)ethoxy]phosphinate,CCCCCCCCCCCCCCCCSC[C@H](CCP(=O)([O-])OCC[N+](C)(C)C)OC,,,,,,
377,160378,"N,N,N-Trimethyl-2-[[[(S)-3-methoxy-5-thiahenicosan-1-yl]phosphinato]oxy]ethanaminium",CCCCCCCCCCCCCCCCSC[C@H](CCP(=O)(O)OCC[N+](C)(C)C)OC,,,,,,
378,160379,4-O-Butanoyl-4'-demethylpodophyllotoxin,CCCC(=O)O[C@@H]1[C@H]2COC(=O)[C@@H]2[C@@H](C3=CC4=C(C=C13)OCO4)C5=CC(=C(C(=C5)OC)O)OC,,,,,,
379,160380,"25,26,26,26,27,27,27-Heptafluorocholesterol",C[C@H](CCCC(C(F)(F)F)(C(F)(F)F)F)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
380,160381,"n-[2-(Dimethylamino)ethyl]benzo[b][1,5]naphthyridine-6-carboxamide",CN(C)CCNC(=O)C1=CC=CC2=CC3=C(C=CC=N3)N=C21,,,,,,
381,160382,2-Acetyl-6-isothiocyanatonorbornane,CC(=O)[C@H]1C[C@@H]2C[C@H]1[C@H](C2)N=C=S,,,,,,
382,160383,Axinastatin 2,CC(C)C[C@H]1C(=O)N2CCC[C@H]2C(=O)N[C@@H](C(=O)N[C@H](C(=O)N3CCC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)C(C)C)CC4=CC=CC=C4)CC(=O)N)C(C)C,,,,,,
383,160384,Cyclo(pro-val-asn-pro-phe-ile-leu),CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](C(=O)N[C@H](C(=O)N3CCC[C@H]3C(=O)N[C@H](C(=O)N1)CC4=CC=CC=C4)CC(=O)N)C(C)C)CC(C)C,,,,,,
384,160385,"4-O-Tetradecanoyl-2,3-dideoxyglucono-1,5-lactone",CCCCCCCCCCCCCC(=O)O[C@H]1CCC(=O)O[C@@H]1CO,,,,,,
385,160386,"2-Methyl-4-(phenylimino)naphth(2,3-d)oxazol-9-one",CC1=NC2=C(O1)C(=O)C3=CC=CC=C3C2=NC4=CC=CC=C4,,,,,,
386,160387,CID 160387,CC1(CC(C(N1[O-])(C)C)C(=O)NCCCCCCCCCCCC(=O)O)C.[Na+],,,,,,
387,160388,"12-[(2,2,5,5-Tetramethyl-1-oxidopyrrolidine-3-carbonyl)amino]dodecanoic acid",CC1(CC(C(N1[O-])(C)C)C(=O)NCCCCCCCCCCCC(=O)O)C,,,,,,
388,160389,N-(2-(2-Methyl-5-nitro-1H-imidazolyl)ethyl)-4-(2-nitro-1H-imidazolyl)butanamide,CC1=NC=C(N1CCNC(=O)CCCN2C=CN=C2[N+](=O)[O-])[N+](=O)[O-],,,,,,
389,160390,Cysfluoretin,CC(=O)N[C@@H](CSCC1=CC2=C(C(=C1)OC)C3=C(C2)C(=C4C(CCC(=O)C4=C3O)OC)O)C(=O)O,,,,,,
390,160391,"1,6,10-Trihydroxy-2,8,10-trimethyl-9(10H)-anthracenone",CC1=C(C2=C(C=C1)C(C3=C(C2=O)C(=CC(=C3)O)C)(C)O)O,,,,,,
391,160392,"1,6,10-Trihydroxy-2-(hydroxymethyl)-8,10-dimethyl-9(10H)-anthracenone",CC1=CC(=CC2=C1C(=O)C3=C(C2(C)O)C=CC(=C3O)CO)O,,,,,,
392,160393,Azicemicin A,CN1CC1C2(CC3CC(=O)C4=C(C5=C(C(=C(C=C5C(=C4C3(C(=O)C2)O)OC)O)OC)O)O)O,,,,,,
393,160394,"N-(3-(1-Aziridinyl)propyl)-1,4-butanediamine",C1CN1CCCNCCCCN,,,,,,
394,160395,"N-(4-(1-Aziridinyl)butyl)-1,3-propanediamine",C1CN1CCCCNCCCN,,,,,,
395,160396,2'-Hydroxymatteucinol,CC1=C(C(=C2C(=C1O)C(=O)C[C@H](O2)C3=C(C=C(C=C3)OC)O)C)O,,,,,,
396,160397,Phylpa 18,CCCCCCC1CC1CCCCCCCCCC(=O)OC2COP(=O)(O2)O.[Na+],,,,,,
397,160398,"(2-Hydroxy-2-oxo-1,3,2lambda5-dioxaphospholan-4-yl) 10-(2-hexylcyclopropyl)decanoate",CCCCCCC1CC1CCCCCCCCCC(=O)OC2COP(=O)(O2)O,,,,,,
398,160399,"1-Piperazineethanol, 4-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-yl)-alpha-((5-quinolinyloxy)methyl)-, (S)-",C1CC2=CC=CC=C2C(C3=CC=CC=C31)N4CCN(CC4)C[C@@H](COC5=CC=CC6=C5C=CC=N6)O,,,,,,
399,160400,Panudial,CC1(CCC(=O)[C@H]2[C@@H]1CC=C([C@@H]2C=O)C=O)C,,,,,,
400,160401,4-[[(2S)-1-[[1-[(2S)-2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid,CC(C)C[C@H](C(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H]3CCCN3C(=O)C(CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)CCC(=O)O,,,,,,
401,160402,"7,7'-(Carbonyl-bis-(imino-N-methyl-4,2-pyrrolcarbonylimino(N-methyl-4,2-pyrrol)carbonylimino))-bis(1,3,5-naphthalenetrisulfonic acid)",CN1C=C(C=C1C(=O)NC2=CC3=C(C=C(C=C3S(=O)(=O)[O-])S(=O)(=O)[O-])C(=C2)S(=O)(=O)[O-])NC(=O)C4=CC(=CN4C)NC(=O)NC5=CN(C(=C5)C(=O)NC6=CN(C(=C6)C(=O)NC7=CC8=C(C=C(C=C8S(=O)(=O)[O-])S(=O)(=O)[O-])C(=C7)S(=O)(=O)[O-])C)C.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,,,,,
402,160403,"7-[[1-Methyl-4-[[1-methyl-4-[[1-methyl-5-[[1-methyl-5-[(4,6,8-trisulfo-2-naphthyl)carbamoyl]pyrrol-3-yl]carbamoyl]pyrrol-3-yl]carbamoylamino]pyrrole-2-carbonyl]amino]pyrrole-2-carbonyl]amino]naphthalene-1,3,5-trisulfonic acid",CN1C=C(C=C1C(=O)NC2=CC3=C(C=C(C=C3S(=O)(=O)O)S(=O)(=O)O)C(=C2)S(=O)(=O)O)NC(=O)C4=CC(=CN4C)NC(=O)NC5=CN(C(=C5)C(=O)NC6=CN(C(=C6)C(=O)NC7=CC8=C(C=C(C=C8S(=O)(=O)O)S(=O)(=O)O)C(=C7)S(=O)(=O)O)C)C,,,,,,
403,160404,1-(1-Decanoylpyrrolidin-2-yl)propan-2-yl 2-methylbut-2-enoate,CCCCCCCCCC(=O)N1CCCC1CC(C)OC(=O)C(=CC)C,,,,,,
404,160405,1-(1-Decanoylpyrrolidin-2-yl)propan-2-yl 4-hydroxy-2-methylbut-2-enoate,CCCCCCCCCC(=O)N1CCCC1CC(C)OC(=O)C(=CCO)C,,,,,,
405,160406,Gypsetin,CC(C)(C=C)[C@@]12[C@@](C[C@@H]3N1C(=O)[C@@H]4C[C@@]5(C6=CC=CC=C6N[C@@]5(N4C3=O)C(C)(C)C=C)O)(C7=CC=CC=C7N2)O,,,,,,
406,160407,"2,4-Dimethyl-6H-pyrido(3,2-b)carbazole",CC1=CC(=C2C=C3C(=C4C=CC=CC4=N3)C=C2N1)C,,,,,,
407,160408,Bmbhtd,CCCCN(C)C(=O)CCCCCCCCCCSC(CC1=CC=C(C=C1)O)C2=CC=C(C=C2)O,,,,,,
408,160409,Renytoline,C1=CC=C2C(=C1)C3=CC=CC=C3C2=CC4=CC=C(C=C4)C(=N)N,,,,,,
409,160410,Ciclopramine,CNC1CCN2C3=CC=CC=C3CCC4=C2C1=CC=C4,,,,,,
410,160411,CID 160411,C1C(C(CS1)NC2=C(C=CC=C2Cl)Cl)C(=O)O,,,,,,
411,160412,Cloponone,C1=CC(=CC=C1C(=O)C(CCl)NC(=O)C(Cl)Cl)Cl,,,,,,
412,160413,Detanosal,CCN(CC)CCOC(=O)C1=CC=CC=C1O,,,,,,
413,160414,3-(1H-Imidazol-4-ylmethyl)-2-methylbenzoic acid,CC1=C(C=CC=C1C(=O)O)CC2=CN=CN2,,,,,,
414,160415,Diphoxazide,CC(=O)NNC(=O)CC(C1=CC=CC=C1)(C2=CC=CC=C2)O,,,,,,
415,160416,2-Aminopurine nitrate,C1=C2C(=NC(=N1)N)N=CN2.[N+](=O)(O)[O-],,,,,,
416,160417,5-Valyl angiotensin II,CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)C[C@@H](C(=O)O)N,,,,,,
417,160418,"Benzimidazole, 4,5,6-trichloro-1-beta-D-ribofuranosyl-",C1=C2C(=C(C(=C1Cl)Cl)Cl)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
418,160419,Succinate,C(CC(=O)[O-])C(=O)[O-],,,,,,
419,160420,Isoproterenol bitartrate,CC(C)NCC(C1=CC(=C(C=C1)O)O)O.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O,,,,,,
420,160421,[[Amino-(5-nitrofuran-2-yl)methylidene]amino] acetate,CC(=O)ON=C(C1=CC=C(O1)[N+](=O)[O-])N,,,,,,
421,160422,"3H-Indol-3-one, 5-bromo-2-(5-bromo-1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,2-dihydro-",C1=CC2=C(C=C1Br)C(=C(N2)C3=NC4=C(C3=O)C=C(C=C4)Br)O,,,,,,
422,160423,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-formylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate",C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O)C=O,,,,,,
423,160424,CID 160424,[C@@H]1([C@@H]([C@H](O[C@H]([C@@H]1O)OC(Cl)(Cl)Cl)C(=O)O)O)O,,,,,,
424,160425,4-[(4-Methoxyphenyl)amino]benzenediazonium chloride,COC1=CC=C(C=C1)NC2=CC=C(C=C2)[N+]#N.[Cl-],,,,,,
425,160426,4-[(4-Methoxyphenyl)amino]benzenediazonium,COC1=CC=C(C=C1)NC2=CC=C(C=C2)[N+]#N,,,,,,
426,160427,CID 160427,CN1CC[C@]23[C@@H]4[C@@H]1CC5=CC(=C(C(=C52)O[C@H]3[C@H](C=C4)O)O)C6=C(C7=C8C(=C6)C[C@H]9[C@H]1[C@]8(CCN9C)[C@@H](O7)[C@H](C=C1)O)O,,,,,,
427,160428,"3-[4,5-Dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-2-hydroxy-2-(1-hydroxyethyl)butanedial",CC(C(C=O)(C(C=O)OC1C(C(C(C(O1)CO)O)O)NC)O)O,,,,,,
428,160429,CID 160429,C1=CC(C=CC1O)(CC(C(=O)O)O)C(O)O,,,,,,
429,160430,"Acetic acid, mercapto-, compd. with 2-aminoethanol (1:1)",C(CO)N.C(C(=O)O)S,,,,,,
430,160431,CID 160431,C(=O)(C(=O)O)O.C(=O)(C(=O)O)O.[KH],,,,,,
431,160432,CID 160432,CC1=CC(=O)C(=C2C(=O)C=C(C(=O)C2=O)C)C(=C1O)O,,,,,,
432,160433,alpha-Ribazole,CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
433,160434,Malate,C(C(C(=O)[O-])O)C(=O)[O-],,,,,,
434,160435,Carbodiimide,C(=N)=N,,,,,,
435,160436,Serotonin hydrochloride,C1=CC2=C(C=C1O)C(=CN2)CCN.Cl,,,,,,
436,160437,Argininic acid,C(C[C@@H](C(=O)O)O)CN=C(N)N,,,,,,
437,160438,Oxirene,C1=CO1,,,,,,
438,160439,"1,6-Dioxaspiro[2.5]octane",C1COCCC12CO2,,,,,,
439,160440,"1,5-Dioxaspiro[2.5]octane",C1CC2(COC1)CO2,,,,,,
440,160441,"Phenanthro[3,4-b]thiophene",C1=CC=C2C(=C1)C=CC3=C2C4=C(C=C3)SC=C4,,,,,,
441,160442,"Acenaphtho[1,2-b]quinoline",C1=CC=C2C(=C1)C=C3C4=CC=CC5=C4C(=CC=C5)C3=N2,,,,,,
442,160443,"13h-Indeno[1,2-c]phenanthrene",C1C2=CC=CC=C2C3=C1C4=C(C=CC5=CC=CC=C54)C=C3,,,,,,
443,160444,"Phenanthro[2,1-b]thiophene",C1=CC=C2C(=C1)C=CC3=C2C=CC4=C3C=CS4,,,,,,
444,160445,"Phenanthro[3,2-b]thiophene",C1=CC=C2C(=C1)C=CC3=CC4=C(C=C32)SC=C4,,,,,,
445,160446,"6H-(1)Benzopyrano(4,3-b)quinoline",C1C2=CC3=CC=CC=C3N=C2C4=CC=CC=C4O1,,,,,,
446,160447,Benz(h)isoquinoline,C1=CC=C2C(=C1)C=CC3=C2C=NC=C3,,,,,,
447,160448,"Pyrido[3,4-d]pyridazine",C1=CN=CC2=CN=NC=C21,,,,,,
448,160449,"1h-Naphth[2,3-d]imidazole",C1=CC=C2C=C3C(=CC2=C1)NC=N3,,,,,,
449,160450,3-Amino-L-tyrosine,C1=CC(=C(C=C1C[C@@H](C(=O)O)N)N)O,,,,,,
450,160451,Lead bis(2-ethylhexanoate),CCCCC(CC)C(=O)[O-].CCCCC(CC)C(=O)[O-].[Pb+2],,,,,,
451,160452,"Cyclohexanamine, 1,2,2,3,3,4,4,5,5,6,6-undecafluoro-N,N-bis(pentafluoroethyl)-",C1(C(C(C(C(C1(F)F)(F)F)(F)F)(F)F)(F)F)(N(C(C(F)(F)F)(F)F)C(C(F)(F)F)(F)F)F,,,,,,
452,160453,N-Phthaloyl-L-glutamic acid,C1=CC=C2C(=C1)C(=O)N(C2=O)[C@@H](CCC(=O)O)C(=O)O,,,,,,
453,160454,CID 160454,CC(=O)C1=C[N+](=CC=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(CP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)OP(=O)(O)O)O)[O-])O)O,,,,,,
454,160455,CID 160455,CC(=O)C1=C[N+](=CC=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(CP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)OP(=O)(O)O)O)O)O)O,,,,,,
455,160456,3-Fluoro-4-hydroxybenzoic acid,C1=CC(=C(C=C1C(=O)O)F)O,,,,,,
456,160457,"7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoctyl]-5-oxocyclopentyl]hept-5-enoic acid",CCCCC[C@@H](CC[C@H]1[C@@H](CC(=O)[C@@H]1CC=CCCCC(=O)O)O)O,,,,,,
457,160458,4-Fluorocatechol,C1=CC(=C(C=C1F)O)O,,,,,,
458,160459,7-Fluoroquinoline,C1=CC2=C(C=C(C=C2)F)N=C1,,,,,,
459,160460,3'-Hydroxyhexobarbital,CC1(C(=O)NC(=O)N(C1=O)C)C2=CC(CCC2)O,,,,,"['3p-Hydroxy-hexobarbital has known human metabolites that include (2S,3S,4S,5R)-6-[3-(1,5-dimethyl-2,4,6-trioxo-1,3-diazinan-5-yl)cyclohex-2-en-1-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid.']",
460,160461,3'-Oxohexobarbital,CC1(C(=O)NC(=O)N(C1=O)C)C2=CC(=O)CCC2,,,,,"['3p-Oxohexobarbital has known human metabolites that include (2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[1-(1,5-dimethyl-2,4,6-trioxo-1,3-diazinan-5-yl)-3-oxocyclohexyl]sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid.']",
461,160462,Costaclavin,C[C@@H]1C[C@@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)C,,,,,,
462,160463,6-Hydroxytryptamine,C1=CC2=C(C=C1O)NC=C2CCN,,,,,,
463,160464,delta-Guanidinovaleric acid,C(CCN=C(N)N)CC(=O)O,,,,,,
464,160465,Bassic acid,C[C@@]12CC[C@]3(CCC(C[C@H]3C1=CC[C@H]4[C@]2(CC=C5[C@@]4(C[C@@H]([C@@H]([C@@]5(C)CO)O)O)C)C)(C)C)C(=O)O,,,,,,
465,160466,Wieland-gumlich aldehyde,C1CN2CC3=CCO[C@H]([C@@H]4[C@H]3C[C@H]2[C@@]15[C@H]4NC6=CC=CC=C56)O,,,,,,
466,160467,"5,6-Dihydroxy-4-(3-methylbutanoyl)-2,6-bis(3-methylbut-2-en-1-yl)cyclohex-4-ene-1,3-dione",CC(C)CC(=O)C1=C(C(C(=O)C(C1=O)CC=C(C)C)(CC=C(C)C)O)O,,,,,,
467,160468,beta2-Chaconine,C[C@H]1CC[C@@H]2[C@H]([C@H]3[C@@H](N2C1)C[C@@H]4[C@@]3(CCC5[C@H]4CC=C6[C@@]5(CCC(C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)O)O)C)C)C,,,,,,
468,160469,"Kestose, 1-",C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H](C([C@H](O2)CO)O)O)CO[C@]3([C@H]([C@@H]([C@H](O3)CO)O)O)CO)O)O)O)O,,,,,,
469,160470,Carbazic acid,C(=O)(NN)O,,,,,,
470,160471,2-Methyl-3-hydroxybutyric acid,CC(C(C)O)C(=O)O,,,,,,
471,160472,Lycorenine,CN1CCC2=CC[C@@H]3[C@H]([C@@H]21)C4=CC(=C(C=C4[C@H](O3)O)OC)OC,,,,,,
472,160473,Homolycorine,CN1CCC2=CC[C@@H]3[C@H]([C@@H]21)C4=CC(=C(C=C4C(=O)O3)OC)OC,,,,,,
473,160474,Damnacanthol,COC1=C2C(=CC(=C1CO)O)C(=O)C3=CC=CC=C3C2=O,,,,,,
474,160475,Digitolutein,CC1=CC2=C(C(=C1O)OC)C(=O)C3=CC=CC=C3C2=O,,,,,,
475,160476,Munjistin,C1=CC=C2C(=C1)C(=O)C3=CC(=C(C(=C3C2=O)O)C(=O)O)O,,,,,,
476,160477,Elliptone,COC1=C(C=C2C(=C1)[C@H]3[C@@H](CO2)OC4=C(C3=O)C=CC5=C4C=CO5)OC,,,,,,
477,160478,Flaviolin,C1=C(C=C(C2=C1C(=O)C(=O)C=C2O)O)O,,,,,,
478,160479,CID 160479,COC1=C(C=C(C=C1)C2=C(C(=C3C(=CC(=C(C3=O)OC)OC)O2)O)OC)O,,,,,,
479,160480,CID 160480,COC1=C(C2=C(C=C(OC2=CC1=O)C3=CC=CC=C3)O)O,,,,,,
480,160481,Isosakuranetin,COC1=CC=C(C=C1)[C@@H]2CC(=O)C3=C(C=C(C=C3O2)O)O,,,,,,
481,160482,Lophenol,C[C@@H]1[C@H](CC[C@]2([C@H]1CC=C3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4[C@H](C)CCCC(C)C)C)C)O,,,,,,
482,160483,Endocrocin,CC1=CC2=C(C(=C1C(=O)O)O)C(=O)C3=C(C2=O)C=C(C=C3O)O,,,,,,
483,160484,"1,2-Cyclopentenophenanthrene",C1CC2=C(C1)C3=C(C=C2)C4=CC=CC=C4C=C3,,,,,,
484,160485,Toddalolactone,CC(C)([C@@H](CC1=C(C=C2C(=C1OC)C=CC(=O)O2)OC)O)O,,,,,,
485,160486,CID 160486,CC(=CCC1=C2C(=CC=C(O2)O)C=CC1=O)C,,,,,,
486,160487,Coclaurine,COC1=C(C=C2[C@@H](NCCC2=C1)CC3=CC=C(C=C3)O)O,,,,,,
487,160488,(2R)-3-(1H-indol-3-yl)-2-(trimethylazaniumyl)propanoate,C[N+](C)(C)[C@H](CC1=CNC2=CC=CC=C21)C(=O)[O-],,,,,,
488,160489,(2R)-2-(Trimethylaminio)-3-(1H-indole-3-yl)propanoic acid anion,C[N+](C)(C)[C@H](CC1=CNC2=CC=CC=C21)C(=O)O,,,,,,
489,160490,Matteucinol,CC1=C(C(=C2C(=C1O)C(=O)C[C@H](O2)C3=CC=C(C=C3)OC)C)O,,,,,,
490,160491,Cyclocolorenone,C[C@@H]1CC[C@@H]2[C@@H](C2(C)C)C3=C(C(=O)C[C@H]13)C,,,,,,
491,160492,Guvacoline,COC(=O)C1=CCCNC1,,,,,,
492,160493,"2,6,8,10-Dodecatetraenamide, N-(2-methylpropyl)-, (2E,6E,8E,10E)-",CC=CC=CC=CCCC=CC(=O)NCC(C)C,,,,,,
493,160494,11-Docosaenoic acid,CCCCCCCCCCC=CCCCCCCCCCC(=O)O,,,,,,
494,160495,"(3R,4S,4aR,6aR,6aS,6bR,9S,10S,12aR,14bR)-9-(hydroxymethyl)-2,2,4a,6a,6b,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-3,4,10-triol",C[C@]12CC[C@@H]([C@](C1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@@H]4CC([C@H]([C@H]5O)O)(C)C)C)C)C)(C)CO)O,,,,,,
495,160496,"(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(1S,2S,10R,14S,15R,16S,17R,20S,23S)-10,14,16,20-tetramethyl-22-azahexacyclo[12.10.0.02,11.05,10.015,23.017,22]tetracos-4-en-7-yl]oxy]oxane-3,4,5-triol",C[C@H]1CC[C@@H]2[C@H]([C@H]3[C@@H](N2C1)C[C@@H]4[C@@]3(CCC5[C@H]4CC=C6[C@@]5(CCC(C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C)C)C,,,,,,
496,160497,Cycloartane,C[C@H](CCCC(C)C)[C@H]1CC[C@@]2([C@@]1(CC[C@]34[C@H]2CC[C@@H]5[C@]3(C4)CCCC5(C)C)C)C,,,,,,
497,160498,Smilagenone,C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@H]6[C@@]5(CCC(=O)C6)C)C)C)OC1,,,,,,
498,160499,Cortolone,C[C@]12CC[C@H](C[C@H]1CC[C@@H]3[C@@H]2C(=O)C[C@]4([C@H]3CC[C@@]4([C@H](CO)O)O)C)O,,,,,,
499,160500,Corytuberine,CN1CCC2=CC(=C(C3=C2[C@@H]1CC4=C3C(=C(C=C4)OC)O)O)OC,,,,,,
500,160501,Stephanine,CN1CCC2=CC3=C(C4=C2[C@H]1CC5=C4C=CC=C5OC)OCO3,,,,,,
501,160502,Actinodaphnine,COC1=C(C=C2C[C@H]3C4=C(C2=C1)C5=C(C=C4CCN3)OCO5)O,,,,,,
502,160503,Xylopine,COC1=CC2=C(C=C1)C3=C4[C@@H](C2)NCCC4=CC5=C3OCO5,,,,,,
503,160504,Mycaminose,C[C@H]([C@H]([C@@H]([C@H](C=O)O)N(C)C)O)O,,,,,,
504,160505,Sulochrin,CC1=CC(=C(C(=C1)O)C(=O)C2=C(C=C(C=C2OC)O)C(=O)OC)O,,,,,,
505,160506,2-Diphenylmethylpiperidine,C1CCNC(C1)C(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
506,160507,"methyl (1R,2R,3S,5S)-8-methyl-3-(3-phenylprop-2-enoyloxy)-8-azabicyclo[3.2.1]octane-2-carboxylate",CN1[C@H]2CC[C@@H]1[C@H]([C@H](C2)OC(=O)C=CC3=CC=CC=C3)C(=O)OC,,,,,,
507,160508,"2-Methyl-3-(3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl)naphthalene-1,4-dione",CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,,,,,,
508,160509,"3-Methoxy-6-methylidene-[1]benzofuro[3,2-c]chromene-1,8,9-triol",COC1=CC(=C2C(=C1)OC(=C)C3=C2OC4=CC(=C(C=C43)O)O)O,,,,,,
509,160510,Harmalan,CC1=NCCC2=C1NC3=CC=CC=C23,,,,,,
510,160511,Abrine,CN[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O,,,,,,
511,160512,ar-Turmerone,CC1=CC=C(C=C1)[C@@H](C)CC(=O)C=C(C)C,,,,,,
512,160513,Barium dibenzoate,C1=CC=C(C=C1)C(=O)[O-].C1=CC=C(C=C1)C(=O)[O-].[Ba+2],,,,,,
513,160514,Cellobiotol,C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](CO)O)O)O)O)O)O,,,,,,
514,160515,"1-[2-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3-[4-hydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-2-en-1-one",C1=CC(=C(C=C1C=CC(=O)C2=C(C=C(C=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O,,,,,,
515,160516,Cerium(III) carbonate,C(=O)([O-])[O-].C(=O)([O-])[O-].C(=O)([O-])[O-].[Ce+3].[Ce+3],,,,,,
516,160517,"4-[2-(3,5-Dimethoxyphenyl)ethenyl]phenol",COC1=CC(=CC(=C1)C=CC2=CC=C(C=C2)O)OC,,,,,,
517,160518,"(8R,9S,10R,14S,17R)-4,4,10,14-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,5,6,7,8,9,11,12,13,15,16,17-tetradecahydrocyclopenta[a]phenanthrene",C[C@H](CCCC(C)C)[C@H]1CC[C@]2(C1CC[C@H]3[C@H]2CCC4[C@@]3(CCCC4(C)C)C)C,,,,,,
518,160519,CID 160519,CC1CC(C(C(O1)OC2C(C(C(C(=O)OC(C3(C=C(C4(O3)C(CC2(O4)C)C)C)C)C)C)O)C)O)N(C)C,,,,,,
519,160520,"5beta-Cholestane-3alpha,7alpha,12alpha-triol",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,,,,,"['Trihydroxycoprostane has known human metabolites that include Cholestane-3,7,12,25-tetrol.']",
520,160521,Isolariciresinol,COC1=C(C=C2[C@@H]([C@H]([C@@H](CC2=C1)CO)CO)C3=CC(=C(C=C3)O)OC)O,,,,,,
521,160522,Oxyhydrastinine,CN1CCC2=CC3=C(C=C2C1=O)OCO3,,,,,,
522,160523,Zinc benzoate,C1=CC=C(C=C1)C(=O)[O-].C1=CC=C(C=C1)C(=O)[O-].[Zn+2],,,,,,
523,160524,CID 160524,[Li+].C(#N)[S-],,,,,,
524,160525,"Aspidofractinine-3-carboxylic acid, methyl ester, (2alpha,3beta,5alpha)-",COC(=O)[C@@H]1C[C@]23CCCN4C2[C@@]5([C@]1(CC3)NC6=CC=CC=C65)CC4,,,,,,
525,160526,"9-Hydroxyandrost-4-ene-3,17-dione",C[C@]12CCC3([C@H]([C@@H]1CCC2=O)CCC4=CC(=O)CC[C@@]43C)O,,,,,,
526,160527,Isosolanidine,C[C@@H]1CC[C@H]2[C@H]([C@H]3[C@@H](N2C1)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O)C)C)C,,,,,,
527,160528,CID 160528,CC1=CC(=O)C2=C(C1=O)C(=O)C3=C(C=CC(=O)C3=C2O)C4=C5C(=C(C=C4)O)C(=C6C(=CC(=C(C6=C5O)O)C)O)O,,,,,,
528,160529,alpha-Kosin,CC1=C(C(=C(C(=C1OC)C(=O)C(C)C)O)CC2=C(C(=C(C(=C2O)C)OC)C(=O)C(C)C)O)O,,,,,,
529,160530,"3beta,12alpha-Dihydroxy-5beta-cholan-24-oic Acid",C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@@H](C4)O)C)O)C,,,,,,
530,160531,"Androst-5-ene-3,17-dione",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CCC(=O)C4)C,,,,,,
531,160532,2-Fluoroquinoline,C1=CC=C2C(=C1)C=CC(=N2)F,,,,,,
532,160533,Xanthinin,CC1CC2C(CC=C1C(CC(=O)C)OC(=O)C)C(=C)C(=O)O2,,,,,,
533,160534,2-Hydroxybut-3-enoic acid,C=CC(C(=O)O)O,,,,,,
534,160535,CID 160535,C1=CC(=N)C(=O)C(=C1)N(O)O,,,,,,
535,160536,2-Amino-1-naphthyl hydrogen sulfate,C1=CC=C2C(=C1)C=CC(=C2OS(=O)(=O)O)N,,,,,,
536,160537,Einecs 210-122-8,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[O-])[O-])N.C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[O-])[O-])N.[Na+].[Na+].[Na+].[Na+],,,,,,
537,160538,2-Nitroheptane,CCCCCC(C)[N+](=O)[O-],,,,,,
538,160539,"1,2-Dihydroaceanthrylene",C1CC2=C3C1=CC=CC3=CC4=CC=CC=C24,,,,,,
539,160540,D-Abequose,C[C@@H]1[C@@H](C[C@H](C(O1)O)O)O,,,,,,
540,160541,Ethyl methylphosphonofluoridate,CCOP(=O)(C)F,,,,,,
541,160542,O-Carbamoylhydroxylamine,C(=O)(N)ON,,,,,,
542,160543,Unii-27F71M186X,C1CN2C[C@H]3C[C@@H]([C@H]2C[C@H]1O)CN4C3=CC=CC4=O,,,,,,
543,160544,"4-[(3,3-Dimethyloxiran-2-yl)methoxy]furo[3,2-g]chromen-7-one",CC1(C(O1)COC2=C3C=CC(=O)OC3=CC4=C2C=CO4)C,,,,,,
544,160545,10-Hydroxyimipramine,CN(C)CCCN1C2=CC=CC=C2CC(C3=CC=CC=C31)O,,,,,,
545,160546,"3,3,3-Trichloro-1,2-propanediol",C(C(C(Cl)(Cl)Cl)O)O,,,,,,
546,160547,6-Aminophenanthridine,C1=CC=C2C(=C1)C3=CC=CC=C3N=C2N,,,,,,
547,160548,CID 160548,C[O-].[K+],,,,,,
548,160549,4-(Hydroxymethyl)benzonitrile,C1=CC(=CC=C1CO)C#N,,,,,,
549,160550,1-Cyclohexyl-1-nitrosourea,C1CCC(CC1)N(C(=O)N)N=O,,,,,,
550,160551,7-Aminodesmethylflunitrazepam,C1C(=O)NC2=C(C=C(C=C2)N)C(=N1)C3=CC=CC=C3F,,,,,,
551,160552,"(2S,3R)-2-hydroxy-3-propan-2-ylbutanedioic acid",CC(C)[C@H]([C@@H](C(=O)O)O)C(=O)O,,,,,,
552,160553,Dihydroelatericin A,C[C@@]12C[C@H]([C@@H]([C@]1(CC(=O)[C@@]3([C@H]2CC=C4[C@H]3C[C@H](C(=O)C4(C)C)O)C)C)[C@](C)(C(=O)CCC(C)(C)O)O)O,,,,,,
553,160554,Manganese(III) acetate,CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].[Mn+3],,,,,,
554,160555,O-(2-Aminoethyl)-L-serine,C(COC[C@@H](C(=O)O)N)N,,,,,,
555,160556,L-Saccharopine,C(CCN[C@@H](CCC(=O)O)C(=O)O)C[C@@H](C(=O)O)N,,,,,,
556,160557,3-[(3-Amino-3-oxopropyl)dithio]propanamide,C(CSSCCC(=O)N)C(=O)N,,,,,,
557,160558,Benzyl 4-methylbenzenesulfonate,CC1=CC=C(C=C1)S(=O)(=O)OCC2=CC=CC=C2,,,,,,
558,160559,2-Chloro-10-(3-(diethylamino)propionyl)-10H-phenothiazinium chloride,CCN(CC)CCC(=O)N1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl.Cl,,,,,,
559,160560,Tetrabutoxyzirconium,CCCC[O-].CCCC[O-].CCCC[O-].CCCC[O-].[Zr+4],,,,,,
560,160561,"S-(1,2-Dicarboxyethyl)cysteinyl-N-gamma-glutamylglycine",C(CC(=O)N(CC(=O)O)C(=O)[C@H](CSC(CC(=O)O)C(=O)O)N)[C@@H](C(=O)O)N,,,,,,
561,160562,Isohomovanillic acid,COC1=C(C=C(C=C1)CC(=O)O)O,,,,,,
562,160563,Methylisopropylamiloride,CC(C)N(C)C1=NC(=C(N=C1Cl)C(=O)N=C(N)N)N,,,,,,
563,160564,5-(Ethylpropyl)amiloride,CCCN(CC)C1=NC(=C(N=C1Cl)C(=O)N=C(N)N)N,,,,,,
564,160565,"3,5-Diiodothyropropionic acid",C1=CC(=CC=C1O)OC2=C(C=C(C=C2I)CCC(=O)O)I,,,['Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. (See all compounds classified as Hormones.)'],,,
565,160566,"Dibenz(a,j)acridine, 7-oxide",C1=CC=C2C(=C1)C=CC3=[N+](C4=C(C=C32)C5=CC=CC=C5C=C4)[O-],,,,,,
566,160567,"Bis(2,4,6-trichlorophenyl) oxalate",C1=C(C=C(C(=C1Cl)OC(=O)C(=O)OC2=C(C=C(C=C2Cl)Cl)Cl)Cl)Cl,,,,,,
567,160568,Coenzyme Q10-d6,CC1=C(C(=O)C(=C(C1=O)OC)OC)CC=C(C)CCC=C(C)CCC=C(C)C,,,,,,
568,160569,CID 160569,C1=CC(=CC=C1[O-])Cl.[Na+],,,,,,
569,160570,Cannabidiolic acid,CCCCCC1=CC(=C(C(=C1C(=O)O)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O,,,,,,
570,160571,"2-Chloro-3-(3,7,11,15-tetramethyl-2-hexadecen-1-yl)-1,4-naphthalenedione",CC(C)CCCC(C)CCCC(C)CCCC(=CCC1=C(C(=O)C2=CC=CC=C2C1=O)Cl)C,,,,,,
571,160572,"8,16-Pyranthrenedione, tribromo-",C1=CC=C2C(=C1)C3=CC4=C5C6=C(C=CC(=C36)C2=O)C=C7C5=C(C=C4)C(=O)C8=C(C(=C(C=C78)Br)Br)Br,,,,,,
572,160573,Catalpin,C1[C@H]2[C@@H](C[C@@]3(C2[C@@H](OC3)O[C@@H]1O)O)OC(=O)C4=CC=C(C=C4)O,,,,,,
573,160574,CID 160574,CN1CC(C2=CC(=C(C=C21)O)N=NC(=O)N)S(=O)(=O)[O-].[Na+],,,,,,
574,160575,"5-(Carbamoyldiazenyl)-6-hydroxy-1-methyl-2,3-dihydroindole-3-sulfonic acid",CN1CC(C2=CC(=C(C=C21)O)N=NC(=O)N)S(=O)(=O)O,,,,,,
575,160576,Pentadecanedioic acid,C(CCCCCCC(=O)O)CCCCCCC(=O)O,,,,,,
576,160577,Deacetylcephalosporin C,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)CCC[C@H](C(=O)O)N)C(=O)O)CO,,,,,,
577,160578,2-Fluoro-ATP,C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)F)N,,,,,,
578,160579,5-Nitro-2-(p-carboxy styryl)-furan,C1=CC(=CC=C1C=CC2=CC=C(O2)[N+](=O)[O-])C(=O)O,,,,,,
579,160580,CID 160580,C(CS(=O)(=O)[O-])O.[K+],,,,,,
580,160581,"7-Methyl-6H-(1)benzopyrano(4,3-b)quinoline",CC1=C2COC3=CC=CC=C3C2=NC4=CC=CC=C14,,,,,,
581,160582,O-Acetyl-N-(p-nitrobenzoyl)hydroxylamine,CC(=O)ONC(=O)C1=CC=C(C=C1)[N+](=O)[O-],,,,,,
582,160583,Helminthosporol,CC1=C([C@H]2[C@H](CC[C@@]1([C@H]2CO)C)C(C)C)C=O,,,,,,
583,160584,4-Hydroxyaminopyridine 1-oxide,C1=CN(C=CC1=NO)O,,,,,,
584,160585,"1-Butanamine, acetate",CCCCN.CC(=O)O,,,,,,
585,160586,Dichloromethane-d2,[2H]C([2H])(Cl)Cl,,,,,,
586,160587,2-(4-Chlorophenyl)-2-methyloxirane,CC1(CO1)C2=CC=C(C=C2)Cl,,,,,,
587,160588,"3-(2-chloro-10-oxido-10-phenothiazin-10-iumyl)-N,N-dimethyl-1-propanamine",CN(C)CCC[N+]1(C2=CC=CC=C2SC3=C1C=C(C=C3)Cl)[O-],,,,,,
588,160589,CID 160589,C1CN(CCN1CCCN2C3=CC=CC=C3S(C4=C2C=C(C=C4)C(F)(F)F)[O-])CCO,,,,,,
589,160590,CID 160590,C1CN(CCN1CCCN2C3=CC=CC=C3S(C4=C2C=C(C=C4)C(F)(F)F)O)CCO,,,,,,
590,160591,"2-Piperidinone, 1,3-dimethyl-",CC1CCCN(C1=O)C,,,,,,
591,160592,N-Hydroxy-N-formyl-2-aminonaphthalene,C1=CC=C2C=C(C=CC2=C1)N(C=O)O,,,,,,
592,160593,Guanidine Phosphate,C(=N)(N)N.OP(=O)(O)O,,,,,,
593,160594,"2-Propenoic acid, 3-(3,4-dihydroxy-5-methoxyphenyl)-",COC1=CC(=CC(=C1O)O)C=CC(=O)O,,,,,,
594,160595,"Propanoic acid, 2,2-dihydroxy-",CC(C(=O)O)(O)O,,,,,,
595,160596,Fonsecin B,CC1(CC(=O)C2=C(C3=C(C=C(C=C3C=C2O1)OC)OC)O)O,,,,,,
596,160597,Anonaine,C1CN[C@@H]2CC3=CC=CC=C3C4=C2C1=CC5=C4OCO5,,,,,,
597,160598,"Uridine, 2'-dehydroxy-, 4-oxime",C1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)NO)CO)O,,,,,,
598,160599,"(2S,3S)-(-)-3-(4-Nitrophenyl)glycidol",C1=CC(=CC=C1[C@H]2[C@@H](O2)CO)[N+](=O)[O-],,,,,,
599,160600,Oroselol,CC(C)(C1=CC2=C(O1)C=CC3=C2OC(=O)C=C3)O,,,,,,
600,160601,CID 160601,C(C(=O)[O-])O.[K+],,,,,,
601,160602,Phenethyl isocyanate,C1=CC=C(C=C1)CCN=C=O,,,,,,
602,160603,Allysine,C(CC=O)C[C@@H](C(=O)O)N,,,,,,
603,160604,3-Cyclohexylbiphenyl,C1CCC(CC1)C2=CC=CC(=C2)C3=CC=CC=C3,,,,,,
604,160605,4-Acetylaminohippuric acid,CC(=O)NC1=CC=C(C=C1)C(=O)NCC(=O)O,,,,,,
605,160606,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecyl methacrylate",CC(=C)C(=O)OCCC(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
606,160607,Isonicotinylglycine,C1=CN=CC=C1C(=O)NCC(=O)O,,,,,,
607,160608,3-Hydroxystigmast-5-en-7-one,CC[C@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C(=O)C=C4[C@@]3(CC[C@@H](C4)O)C)C)C(C)C,,,,,,
608,160609,Cholesteryl ester hydroperoxide,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OO)C)C,,,,,,
609,160610,"11-[3-(Dimethylamino)-2-methylpropyl]-5,6-dihydrobenzo[b][1]benzazepin-3-ol",CC(CN1C2=C(CCC3=CC=CC=C31)C=C(C=C2)O)CN(C)C,,,,,"['11-[3-(Dimethylamino)-2-methylpropyl]-5,6-dihydrobenzo[b][1]benzazepin-3-ol is a known human metabolite of (r)-trimipramine.']",
610,160611,4-Hydroxybenzyl isothiocyanate,C1=CC(=CC=C1CN=C=S)O,,,,,,
611,160612,CID 160612,CC1=CC(=C(C=C1)CNNC=NC(=O)C2=C(N=C(C(=N2)Cl)N)N)C,,,,,,
612,160613,"1,2,2,2-Tetrafluoroethanesulfonyl fluoride",C(C(F)(F)F)(F)S(=O)(=O)F,,,,,,
613,160614,"5,6-Didehydrosparteine",C1CCN2C[C@@H]3C[C@H]([C@@H]2C1)CN4C3=CCCC4,,,,,,
614,160615,4-Hydroxytestosterone,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C(C(=O)CC[C@]34C)O,,"['Aanabolic steroids have a similar effect to testosterone in the body. Effects include an increase in protein production within cells, (ie. skeletal muscle cells) and well as the development and maintenance of masculine characteristics.']",,"['Renal elimination following hepatic metabolism.', 'Clearance is via the urine. Excretion studies were performed using 200mg of 4-hydroxytestosterone administered to healthy male volunteers. Urine samples were then analyzed for metabolic products using conventional gas chromatography-mass spectrometry approaches.  One metabolite, 3-beta,4-alpha-dihydroxy-5alpha-androstan-17-one was identified as a long term metabolite which can be detected for 90 hours. Longer detection times are possible with the use of alternative monitoring technique in sports drug testing.']",['Hepatic.'],
615,160616,"Benzenediazonium, 4-sulfo-, tetrafluoroborate",[B-](F)(F)(F)F.C1=CC(=CC=C1[N+]#N)S(=O)(=O)O,,,,,,
616,160617,Orotidine-5'-monophosphate,C1=C(N(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)C(=O)O,,,,,,
617,160618,Direct Red 45,CC1=C(C2=C(C=C1)N=C(S2)C3=CC=C(C=C3)N=NC4=C(C5=CC=CC=C5C(=C4)S(=O)(=O)[O-])O)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
618,160619,"C.I. Direct Red 45, disodium salt",CC1=C(C2=C(C=C1)N=C(S2)C3=CC=C(C=C3)N=NC4=C(C5=CC=CC=C5C(=C4)S(=O)(=O)O)O)S(=O)(=O)O,,,,,,
619,160620,Victoria blue 4R,CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C3=CC=CC=C3)C4=CC=CC=C24)C5=CC=C(C=C5)N(C)C.[Cl-],,,,,,
620,160621,victoria blue 4R(1+),CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C3=CC=CC=C3)C4=CC=CC=C24)C5=CC=C(C=C5)N(C)C,,,,,,
621,160622,CID 160622,C1[NH+]([N-]C(N1C2=CC=CC=C2)NC3=CC=CC=C3)C4=CC=CC=C4,,,,,,
622,160623,"N,1,4-triphenyl-1,2,4-triazolidin-3-amine",C1N(C(NN1C2=CC=CC=C2)NC3=CC=CC=C3)C4=CC=CC=C4,,,,,,
623,160624,Nickel(II) stearate,CCCCCCCCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCCCCCCCC(=O)[O-].[Ni+2],,,,,,
624,160625,Ammonium succinate,C(CC(=O)[O-])C(=O)[O-].[NH4+].[NH4+],,,,,,
625,160626,CID 160626,COC1=C2C3=C4C(=CC(=O)C(=C4OC(=C3C=C1O)O)OC)C(=O)O2,,,,,,
626,160627,"N,N',N''-[Phosphinylidynetris(oxyethane-2,1-diyl)]tris[N-ethylheptadecafluorooctane-1-sulfonamide]",CCN(CCOP(OCCN(CC)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)OCCN(CC)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
627,160628,"Dipotassium 2-(4b-fluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxohexadecahydro-6bH,8H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl phosphate",C[C@]12CCC(=O)C[C@@H]1CCC3C2([C@H](C[C@]4(C3C[C@H]5[C@]4(OC(O5)(C)C)C(=O)COP(=O)([O-])[O-])C)O)F.[K+].[K+],,,,,,
628,160629,"[2-[(4S,8S,9S,11S,13S,18S)-12-fluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosan-8-yl]-2-oxoethyl] dihydrogen phosphate",C[C@]12CCC(=O)C[C@@H]1CCC3C2([C@H](C[C@]4(C3C[C@H]5[C@]4(OC(O5)(C)C)C(=O)COP(=O)(O)O)C)O)F,,,,,,
629,160630,"Phosphine oxide, bis(1-aziridinyl)propyl-",CCCP(N1CC1)N2CC2,,,,,,
630,160631,"N~3~,N~3~,N~20~,N~20~,4,4,14-Heptamethyl-9,19-cyclopregnane-3,20-diamine",C[C@@H]([C@H]1CCC2([C@@]1(CCC34[C@H]2CC[C@@H]5[C@]3(C4)CC[C@@H](C5(C)C)N(C)C)C)C)N(C)C,,,,,,
631,160632,Desmethyltrimipramine,CC(CNC)CN1C2=CC=CC=C2CCC3=CC=CC=C31,,,,,['Desmethyltrimipramine is a known human metabolite of (r)-trimipramine.'],
632,160633,"4-(((2,3-Dichloro-6-quinoxalinyl)carbonyl)amino)-5-hydroxy-6-((2-sulfophenyl)azo)-2,7-naphthalenedisulfonic acid, trisodium salt",C1=CC=C(C(=C1)N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)[O-])S(=O)(=O)[O-])NC(=O)C4=CC5=C(C=C4)N=C(C(=N5)Cl)Cl)O)S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
633,160634,"5-[(2,3-Dichloroquinoxaline-6-carbonyl)amino]-4-hydroxy-3-[(2-sulfophenyl)diazenyl]naphthalene-2,7-disulfonic acid",C1=CC=C(C(=C1)N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)O)S(=O)(=O)O)NC(=O)C4=CC5=C(C=C4)N=C(C(=N5)Cl)Cl)O)S(=O)(=O)O,,,,,,
634,160635,2-Amino-3-guanidino-propionic acid,C([C@@H](C(=O)O)N)N=C(N)N,,,,,,
635,160636,Allocholic acid,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,,,,,,
636,160637,Vanillactic acid,COC1=C(C=CC(=C1)CC(C(=O)O)O)O,,,,,,
637,160638,Estriol-3-glucuronide,C[C@]12CCC3C(C1C[C@H]([C@@H]2O)O)CCC4=C3C=CC(=C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O,,,,,,
638,160639,CID 160639,CC=C(C)C(=O)O[C@@H]1CCN2[C@@H]1[C@H](CC2)COC(=O)C(=CC)CO,,,,,,
639,160640,5-Hydroxy-6-methoxy-1h-indole-2-carboxylic acid,COC1=C(C=C2C=C(NC2=C1)C(=O)O)O,,,,,,
640,160641,Ethyl 2-cyclohexylpropionate,CCOC(=O)C(C)C1CCCCC1,,,,,,
641,160642,12-Acetoxymethyl-7-methylbenz(a)anthracene,CC1=C2C=CC3=CC=CC=C3C2=C(C4=CC=CC=C14)COC(=O)C,,,,,,
642,160643,CID 160643,CC(C(C1=CN=C2C(=NC(=NC2=O)N)N1)O)O,,,,,,
643,160644,Liensinine,CN1CCC2=CC(=C(C=C2[C@H]1CC3=CC=C(C=C3)O)OC4=C(C=CC(=C4)C[C@@H]5C6=CC(=C(C=C6CCN5C)OC)OC)O)OC,,,,,,
644,160645,3-Mercaptolactic acid,C(C(C(=O)O)O)S,,,,,,
645,160646,Ergosine monomethanesulfonate,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C)NC(=O)[C@H]4CN([C@@H]5CC6=CNC7=CC=CC(=C67)C5=C4)C)O.CS(=O)(=O)O,,,,,,
646,160647,3-deoxy-D-arabino-heptulosonate-7-phosphate,C([C@H]([C@@H]([C@@H](COP(=O)(O)O)O)O)O)C(=O)C(=O)O,,,,,,
647,160648,"8,9,10,10a-Tetrahydro-6,10b-methanofuro[2,3-c]pyrrolo[1,2-a]azepin-2(6H)-one",C1C[C@@H]2C34C[C@H](N2C1)C=CC3=CC(=O)O4,,,,,,
648,160649,"2,3-Dichloro-2-propene-1-ol",C(C(=CCl)Cl)O,,,,,,
649,160650,Anagestone,C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)O)C)[C@@]4(C1=CCCC4)C,,,,,,
650,160651,Hisphen,COC(=O)[C@H](CC1=CN=CN1)NC(=O)CC2=CC=C(C=C2)N(CCCl)CCCl,,,,,,
651,160652,"9-(2-Carboxyphenyl)-3,6-bis(ethylamino)xanthylium chloride",CCNC1=CC2=C(C=C1)C(=C3C=CC(=[NH+]CC)C=C3O2)C4=CC=CC=C4C(=O)O.[Cl-],,,,,,
652,160653,"N,N'-Diethylrhodamine-",CCNC1=CC2=C(C=C1)C(=C3C=CC(=NCC)C=C3O2)C4=CC=CC=C4C(=O)O,,,,,,
653,160654,"(2|A,17xi)-17-hydroxy-2-(hydroxymethyl)pregn-4-en-20-yn-3-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2(C#C)O)CCC4=CC(=O)[C@@H](C[C@]34C)CO,,,,,,
654,160655,1-(2-Hydroxyethyl)-5-nitropyrrole-2-carboxamide,C1=C(N(C(=C1)[N+](=O)[O-])CCO)C(=O)N,,,,,,
655,160656,N-((1-(p-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetyl)glycine,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)NCC(=O)O,,,,,,
656,160657,"(6aR,9R)-N-[(1S,2S,4R,7R)-7-benzyl-4-ethyl-2-hydroxy-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide",CC[C@@]1(C(=O)N2[C@@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@H]5CN([C@@H]6CC7=CNC8=CC=CC(=C78)C6=C5)C,,,,,,
657,160658,1-Nitrophenazine,C1=CC=C2C(=C1)N=C3C=CC=C(C3=N2)[N+](=O)[O-],,,,,,
658,160659,CID 160659,C1=CC=C(C=C1)CN=C(NCCN(CCNC(=NCC2=CC=CC=C2)S)C(=S)SCCCS(=O)(=O)[O-])S.[Na+],,,,,,
659,160660,CID 160660,C1=CC=C(C=C1)CN=C(NCCN(CCNC(=NCC2=CC=CC=C2)S)C(=S)SCCCS(=O)(=O)O)S,,,,,,
660,160661,"Pyrrole, 2,4-dinitro-1-propyl-",CCCN1C=C(C=C1[N+](=O)[O-])[N+](=O)[O-],,,,,,
661,160662,CID 160662,CCN(C(C(=O)NC1=C(C=CC=C1C)C)N(CC)[O-])[O-],,,,,,
662,160663,beta-Ureidoisobutyric acid,CC(CNC(=O)N)C(=O)O,,,,,,
663,160664,CID 160664,C(C(=O)C(=O)[O-])F.[Na+],,,,,,
664,160665,5alpha-Cyprinol,C[C@H](CCCC(CO)CO)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,,,,,,
665,160666,Saicar,C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O,,,,,,
666,160667,CID 160667,CC1=C(C=C(C=C1)N=NC2=C(C3=CC=CC=C3C(=C2)S(=O)(=O)[O-])O)S(=O)(=O)NC4=CC=CC=C4.[Na+],,,,,,
667,160668,"3-{2-[4-Methyl-3-(phenylsulfamoyl)phenyl]hydrazinylidene}-4-oxo-3,4-dihydronaphthalene-1-sulfonic acid",CC1=C(C=C(C=C1)N=NC2=C(C3=CC=CC=C3C(=C2)S(=O)(=O)O)O)S(=O)(=O)NC4=CC=CC=C4,,,,,,
668,160669,N~2~-methyl-L-glutamine,CN[C@@H](CCC(=O)N)C(=O)O,,,,,,
669,160670,"N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide",CNC(=O)C1=CNC=CC1=O,,,,,,
670,160671,Me-Bis(ADP),C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)NCNC4=C5C(=NC=N4)N(C=N5)[C@H]6[C@@H]([C@@H]([C@H](O6)CO)O)O,,,,,,
671,160672,Ferric octanoate,CCCCCCCC(=O)[O-].CCCCCCCC(=O)[O-].CCCCCCCC(=O)[O-].[Fe+3],,,,,,
672,160673,"2H-Pyran-2-one, 4-methoxy-6-(2-phenylethyl)-",COC1=CC(=O)OC(=C1)CCC2=CC=CC=C2,,,,,,
673,160674,Salicylidene benzhydrazide,C1=CC=C(C=C1)C(=O)NN=CC2=CC=CC=C2O,,,,,,
674,160675,Niobium(5+) ethanolate,CC[O-].CC[O-].CC[O-].CC[O-].CC[O-].[Nb+5],,,,,,
675,160676,alpha-Aceto-beta-vinyl-gamma-valerolactone,CC1C(C(C(=O)O1)C(=O)C)C=C,,,,,,
676,160677,n-[(1e)-4-{Bis[4-(dimethylamino)phenyl]methylidene}naphthalen-1(4h)-ylidene]cyclohexanaminium chloride,CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[NH+]C3CCCCC3)C4=CC=CC=C24)C5=CC=C(C=C5)N(C)C.[Cl-],,,,,,
677,160678,"4-[(4-cyclohexyliminonaphthalen-1-ylidene)-[4-(dimethylamino)phenyl]methyl]-N,N-dimethylaniline",CN(C)C1=CC=C(C=C1)C(=C2C=CC(=NC3CCCCC3)C4=CC=CC=C24)C5=CC=C(C=C5)N(C)C,,,,,,
678,160679,4-Amino-2-methoxypyrimidine,COC1=NC=CC(=N1)N,,,,,,
679,160680,Bis(4-methylpentyl) but-2-enedioate,CC(C)CCCOC(=O)C=CC(=O)OCCCC(C)C,,,,,,
680,160681,"1H-Imidazole-4,5-dicarboxamide, N,N'-dimethyl-1-propyl-",CCCN1C=NC(=C1C(=O)NC)C(=O)NC,,,,,,
681,160682,"11,12-Cholanthrenediol, 11,12-dihydro-3-methyl-",CC1=C2CCC3=C2C(=CC4=C3C(C(C5=CC=CC=C54)O)O)C=C1,,,,,,
682,160683,(2S)-2-(butan-2-ylamino)-4-sulfanylbutanoic acid,CCC(C)N[C@@H](CCS)C(=O)O,,,,,,
683,160684,Manganese stearate,CCCCCCCCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCCCCCCCC(=O)[O-].[Mn+2],,,,,,
684,160685,Acid green 16,CCN(CC)C1=CC=C(C=C1)C(=C2C=CC(=[N+](CC)CC)C=C2)C3=C4C=CC(=CC4=CC(=C3)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+],,,,,,
685,160686,"Pregn-4-ene-3,20-dione, 21-(acetyloxy)-17-hydroxy-6-methyl-, (6alpha)-",C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)COC(=O)C)O)C)[C@@]4(C1=CC(=O)CC4)C,,,,,,
686,160687,CID 160687,CC(=O)[O-].[Cs+],,,,,,
687,160688,"1,2-Heptanoylphosphatidylcholine",CCCCCCC(=O)OC[C@@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCC,,,,,,
688,160689,"2-[[(2S)-2,3-di(heptanoyloxy)propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium",CCCCCCC(=O)OC[C@@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCC,,,,,,
689,160690,"5-Amino-3-(1-methyl-2-phenylethyl)-2,3-dihydro-1,2,3-oxadiazol-2-ium chloride",CC(CC1=CC=CC=C1)N2C=C(O[NH2+]2)N.[Cl-],,,,,,
690,160691,3-(1-phenylpropan-2-yl)-2H-oxadiazol-5-amine,CC(CC1=CC=CC=C1)N2C=C(ON2)N,,,,,,
691,160692,"alpha,alpha-Diphenylsuccinimide",C1C(=O)NC(=O)C1(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
692,160693,Formamidine acetate,CC(=O)O.C(=N)N,,,,,,
693,160694,"[4-(1,2-Dicarboxyethylidene)-2,2,6,6-tetramethylpiperidin-1-yl]oxidanyl",CC1(CC(=C(CC(=O)O)C(=O)O)CC(N1[O])(C)C)C,,,,,,
694,160695,Silver(1+) stearate,CCCCCCCCCCCCCCCCCC(=O)[O-].[Ag+],,,,,,
695,160696,Xylocytidine,C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@H]([C@H](O2)CO)O)O,,,,,,
696,160697,CID 160697,C(CO)CS(=O)(=O)[O-].[Na+],,,,,,
697,160698,CID 160698,C1=C2C(=CC(=C1O)O)OC3=CC(=O)C=C(C3=C2O)O,,,,,,
698,160699,CID 160699,COC1=CC(=O)C2=C(C1=O)C(=C(C(=C2O)OC)OC)O,,,,,,
699,160700,6-Pyridoxyllysine,CC1=NC=C(C(=C1O)CNCCCC[C@@H](C(=O)O)N)CO,,,,,,
700,160701,"2,2-Dichloro-1,1-bis(4-chlorophenyl)ethanol",C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)(C(Cl)Cl)O)Cl,,,,,,
701,160702,"3-[(4S,7R,7aR)-3,7-dimethyl-2,4,5,6,7,7a-hexahydro-1H-inden-4-yl]-2-methylprop-2-enoic acid",C[C@@H]1CC[C@H](C2=C(CC[C@H]12)C)C=C(C)C(=O)O,,,,,,
702,160703,Amidinomycin,C1C[C@@H](C[C@@H]1C(=O)NCCC(=N)N)N,,,,,,
703,160704,"Docosanoic acid, calcium salt",CCCCCCCCCCCCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCCCCCCCCCCCC(=O)[O-].[Ca+2],,,,,,
704,160705,4'-Demethyldeoxypodophyllotoxin,COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@@H](CC4=CC5=C(C=C24)OCO5)COC3=O,,,,,,
705,160706,Aldosterone 18-glucuronide,C[C@]12CCC(=O)C=C1CCC3C2[C@H]4CC5(C3CC[C@@H]5C(=O)CO)C(O4)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O,,,,,,
706,160707,"3,7-Dimethyl-7-ethoxyoctanal",CCOC(C)(C)CCCC(C)CC=O,,,,,,
707,160708,CID 160708,COC1=C(C=C(C=C1)N(O)O)N=NC2=C(C=C3C=CC(=NC4=CC=CC=C4)C=C3C2=O)S(=O)(=O)[O-].[Na+],,,,,,
708,160709,CID 160709,COC1=C(C=C(C=C1)N(O)O)N=NC2=C(C=C3C=CC(=NC4=CC=CC=C4)C=C3C2=O)S(=O)(=O)O,,,,,,
709,160710,Cnidilide,CCCC[C@H]1[C@H]2CCC=C[C@H]2C(=O)O1,,,,,,
710,160711,Hemiphloin,C1[C@H](OC2=C(C1=O)C(=C(C(=C2)O)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)C4=CC=C(C=C4)O,,,,,,
711,160712,Nordamnacanthal,C1=CC=C2C(=C1)C(=O)C3=CC(=C(C(=C3C2=O)O)C=O)O,,,,,,
712,160713,2-(Diethylamino)ethyl alpha-cyclopentyl-alpha-hydroxythiophen-2-acetate hydrochloride,CCN(CC)CCOC(=O)C(C1CCCC1)(C2=CC=CS2)O.Cl,,,,,,
713,160714,2-(Diethylamino)ethyl 2-cyclopentyl-2-hydroxy-2-thiophen-2-ylacetate,CCN(CC)CCOC(=O)C(C1CCCC1)(C2=CC=CS2)O,,,,,,
714,160715,CID 160715,CCCC(=O)N=NC(=N)C1=CC=C(O1)N(O)O,,,,,,
715,160716,7-Hydroxynalidixic acid,CCN1C=C(C(=O)C2=C1N=C(C=C2)CO)C(=O)O,,,,,,
716,160717,Questin,CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3OC)O,,,,,,
717,160718,Streptothricin E,C1[C@H]([C@@H]2[C@@H](C(=O)N1)N=C(N2)N[C@H]3[C@@H]([C@@H]([C@H]([C@H](O3)CO)OC(=O)N)O)NC(=O)C[C@H](CCCNC(=O)C[C@H](CCCN)N)N)O,,,,,,
718,160719,CID 160719,CCC(=O)N=NC(=N)C1=CC=C(O1)N(O)O,,,,,,
719,160720,CID 160720,CC(=O)N=NC(=N)C1=CC=C(O1)N(O)O,,,,,,
720,160721,"Acetic acid, scandium(3+) salt",CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].[Sc+3],,,,,,
721,160722,2'-Chloro-biphenyl-4-carboxylic acid,C1=CC=C(C(=C1)C2=CC=C(C=C2)C(=O)O)Cl,,,,,,
722,160723,"2,4-Diamino-6,7-diisopropylpteridine",CC(C)C1=NC2=C(N=C(N=C2N=C1C(C)C)N)N,,,,,,
723,160724,"2,3-Dimethyl-5-(3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl)benzene-1,4-diol",CC1=C(C=C(C(=C1C)O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)O,,,,,,
724,160725,1-(4-Chlorophenyl)-3-((4-methylphenyl)sulfonyl)urea,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2=CC=C(C=C2)Cl,,,,,,
725,160726,"Disodium 1-(((1,1'-biphenyl)-4-ylcarbonyl)amino)anthracene-9,10-diyl disulphate",C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)NC3=CC=CC4=C(C5=CC=CC=C5C(=C43)OS(=O)(=O)[O-])OS(=O)(=O)[O-].[Na+].[Na+],,,,,,
726,160727,[1-[(4-Phenylbenzoyl)amino]-10-sulfooxyanthracen-9-yl] hydrogen sulfate,C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)NC3=CC=CC4=C(C5=CC=CC=C5C(=C43)OS(=O)(=O)O)OS(=O)(=O)O,,,,,,
727,160728,S-(2-Cyanoethyl)cysteine,C(CSC[C@@H](C(=O)O)N)C#N,,,,,,
728,160729,N-[4-[(6-methoxypyrimidin-4-yl)sulfamoyl]phenyl]acetamide,CC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC2=CC(=NC=N2)OC,,,,,,
729,160730,(5-Nitrofuran-2-yl)methyl nitrate,C1=C(OC(=C1)[N+](=O)[O-])CO[N+](=O)[O-],,,,,,
730,160731,"Ammonium 2-(2-(2-(aminosulphonyl)-1,1,2,2-tetrafluoroethoxy)-1,1,2,3,3,3-hexafluoropropoxy)-2,3,3,3-tetrafluoropropionate",C(=O)(C(C(F)(F)F)(OC(C(C(F)(F)F)(OC(C(F)(F)S(=O)(=O)N)(F)F)F)(F)F)F)[O-].[NH4+],,,,,,
731,160732,"2,3,3,3-Tetrafluoro-2-[1,1,2,3,3,3-hexafluoro-2-(1,1,2,2-tetrafluoro-2-sulfamoylethoxy)propoxy]propanoic acid",C(=O)(C(C(F)(F)F)(OC(C(C(F)(F)F)(OC(C(F)(F)S(=O)(=O)N)(F)F)F)(F)F)F)O,,,,,,
732,160733,Benzo-tepa,C1CN1P(=O)(NC(=O)C2=CC=CC=C2)N3CC3,,,,,,
733,160734,Ammonium perfluorononanoate,C(=O)(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)[O-].[NH4+],,,,,,
734,160735,CID 160735,CCC[SnH](CCC)CCC.CC(=C)C(=O)O,,,,,,
735,160736,2-Methylthiazolidine-4-carboxylic acid,CC1NC(CS1)C(=O)O,,,,,,
736,160737,"3-[(4S,7R,7aR)-3,7-dimethyl-2,4,5,6,7,7a-hexahydro-1H-inden-4-yl]-2-methylprop-2-enal",C[C@@H]1CC[C@H](C2=C(CC[C@H]12)C)C=C(C)C=O,,,,,,
737,160738,12alpha-Hydroxy-3-oxo-5beta-cholan-24-oic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CC[C@H]4[C@@]3(CCC(=O)C4)C)O)C,,,,,,
738,160739,9-Xylosyladenine,C1=NC(=C2C(=N1)N(C=N2)C3[C@@H]([C@H]([C@H](O3)CO)O)O)N,,,,,,
739,160740,"2,7-Naphthalenedisulfonic acid, 3-[[4-(acetylamino)phenyl]azo]-4,5-dihydroxy-, disodium salt",CC(=O)NC1=CC=C(C=C1)N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)[O-])S(=O)(=O)[O-])O)O.[Na+].[Na+],,,,,,
740,160741,"3-[(4-Acetamidophenyl)diazenyl]-4,5-dihydroxynaphthalene-2,7-disulfonic acid",CC(=O)NC1=CC=C(C=C1)N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)O)S(=O)(=O)O)O)O,,,,,,
741,160742,1-Methyl-2-(p-fluorophenyl)-5-nitroimidazole,CN1C(=CN=C1C2=CC=C(C=C2)F)[N+](=O)[O-],,,,,,
742,160743,N(4)-Acetylsulfisoxazole,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)NC(=O)C,,,,,,
743,160744,Histidyl-phenylalanyl-arginyl-tryptophan,C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC3=CC=C(C=C3)C(=O)[C@H](CC4=CN=CN4)N)N,,,,,,
744,160745,2-Hydroxy-3-nitrobiphenyl,C1=CC=C(C=C1)C2=C(C(=CC=C2)[N+](=O)[O-])O,,,,,,
745,160746,Tevenel,C1=CC(=CC=C1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)S(=O)(=O)N,,,,,,
746,160747,"4,4'-Bis(4-methylimidazolin-2-yl)terephthalanilide 2HCl",CC1CN=C(N1)C2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)C5=NCC(N5)C.Cl.Cl,,,,,,
747,160748,"1-N,4-N-bis[4-(5-methyl-4,5-dihydro-1H-imidazol-2-yl)phenyl]benzene-1,4-dicarboxamide",CC1CN=C(N1)C2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)C5=NCC(N5)C,,,,,,
748,160749,Isocytisoside,COC1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C(=C3O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O,,,,,,
749,160750,Pentan-3-yl methanesulfonate,CCC(CC)OS(=O)(=O)C,,,,,,
750,160751,8-Azidoadenosine,C1=NC(=C2C(=N1)N(C(=N2)N=[N+]=[N-])[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,,,,,,
751,160752,CID 160752,CNC1=NC2=C(C=C(C=C2)Cl)C(=NC1)C3=CC=CC=C3,,,,,,
752,160753,Testololactone,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC(=O)O4)C,,,,,,
753,160754,5-Hydroxy-4-oxonorvaline,C([C@@H](C(=O)O)N)C(=O)CO,,,"['Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)']",,,
754,160755,Desmethylnortriptyline,C1CC2=CC=CC=C2C(=CCCN)C3=CC=CC=C31,,,,,['Demethylnortriptyline is a known human metabolite of nortriptyline.'],
755,160756,6-Formyl-7-methoxycoumarin,COC1=C(C=C2C=CC(=O)OC2=C1)C=O,,,,,,
756,160757,"1,2-Ethanediol, 1,2-bis(4-methoxyphenyl)-",COC1=CC=C(C=C1)C(C(C2=CC=C(C=C2)OC)O)O,,,,,,
757,160758,CID 160758,[Li+].CCCCCCCCCCCCCCCCCCCCCC(=O)[O-],,,,,,
758,160759,"1-[2,4-dihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one",C1=CC(=CC=C1C=CC(=O)C2=C(C=C(C=C2O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)O,,,,,,
759,160760,"[(3S,6aR,6aR,6bR,8aS,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,6a,7,8,9,12,12a,13,14,14a-tetradecahydro-1H-picen-3-yl] acetate",C[C@H]1[C@@H]2[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C(C5CC[C@]4([C@@]3(CC[C@]2(CC=C1C)C)C)C)(C)C)OC(=O)C)C,,,,,,
760,160761,p-Methylbenzyl tosylate,CC1=CC=C(C=C1)COS(=O)(=O)C2=CC=C(C=C2)C,,,,,,
761,160762,"Estra-4,9,11-triene-3,17-dione",C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CCC2=O,,,,,,
762,160763,Night blue,CCN(CC)C1=CC=C(C=C1)C(=C2C=CC(=[NH+]C3=CC=C(C=C3)C)C4=CC=CC=C24)C5=CC=C(C=C5)N(CC)CC.[Cl-],,,,,,
763,160764,"4-[[4-(diethylamino)phenyl]-[4-(4-methylphenyl)iminonaphthalen-1-ylidene]methyl]-N,N-diethylaniline",CCN(CC)C1=CC=C(C=C1)C(=C2C=CC(=NC3=CC=C(C=C3)C)C4=CC=CC=C24)C5=CC=C(C=C5)N(CC)CC,,,,,,
764,160765,Sulfobetaine,C[S+](C)CC(=O)[O-],,,,,,
765,160766,(Carboxymethyl)(dimethyl)sulfonium,C[S+](C)CC(=O)O,,,,,,
766,160767,Isoflavanone,C1C(C(=O)C2=CC=CC=C2O1)C3=CC=CC=C3,,,,,,
767,160768,3-(Dimethylamino)-l-alanine,CN(C)C[C@@H](C(=O)O)N,,,,,,
768,160769,"6,7-Cyclopentanochrysene",C1CC2=CC3=C(C=CC4=CC=CC=C43)C5=CC=CC1=C25,,,,,,
769,160770,"Ochratoxin A-O-methyl, methyl ester",C[C@@H]1CC2=C(C=C(C(=C2C(=O)O1)OC)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)OC)Cl,,,,,,
770,160771,"(2S,5S,8S,9S)-2-Methyl-6-methylidene-9-propan-2-yl-11-oxatricyclo[6.2.1.01,5]undecan-8-ol",C[C@H]1CC[C@@H]2C13C[C@H]([C@@](O3)(CC2=C)O)C(C)C,,,,,,
771,160772,Ammonium bis(2-ethylhexyl) phosphate,CCCCC(CC)COP(=O)([O-])OCC(CC)CCCC.[NH4+],,,,,,
772,160773,N(4)-Acetylsulfadoxine,CC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC=N2)OC)OC,,,,,,
773,160774,4-Methoxytriamterene,COC1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N,,,,,,
774,160775,Copper heptanoate,CCCCCCC(=O)[O-].CCCCCCC(=O)[O-].[Cu+2],,,,,,
775,160776,"4-[(7-Chloroquinolin-4-yl)amino]-2,6-bis(pyrrolidin-1-ylmethyl)phenol",C1CCN(C1)CC2=CC(=CC(=C2O)CN3CCCC3)NC4=C5C=CC(=CC5=NC=C4)Cl,,,,,,
776,160777,CID 160777,C1=CC=C(C(=C1)N2C=C(O[NH2+]2)[O-])Cl,,,,,,
777,160778,CID 160778,C1=CC=C(C(=C1)N2C=C(ON2)O)Cl,,,,,,
778,160779,"4-Methoxy-N,6-dimethyl-1,3,5-triazin-2-amine",CC1=NC(=NC(=N1)OC)NC,,,,,,
779,160780,"N,N'-(3,3'-Dichloro[1,1'-biphenyl]-4,4'-diyl)bis[4-[(2-chlorophenyl)azo]-3-hydroxynaphthalene-2-carboxamide]",C1=CC=C2C(=C1)C=C(C(=C2N=NC3=CC=CC=C3Cl)O)C(=O)NC4=C(C=C(C=C4)C5=CC(=C(C=C5)NC(=O)C6=CC7=CC=CC=C7C(=C6O)N=NC8=CC=CC=C8Cl)Cl)Cl,,,,,,
780,160781,CID 160781,CCCCCCCCCCCCCCCCCCCCCC(=O)[O-].[Na+],,,,,,
781,160782,Ethyl 2-hydroxyquinoline-4-carboxylate,CCOC(=O)C1=CC(=O)NC2=CC=CC=C21,,,,,,
782,160783,2-Hydroxyethylthioacetate,C(CSCC(=O)O)O,,,,,,
783,160784,Succinylmonocholine,C[N+](C)(C)CCOC(=O)CCC(=O)O,,,,,,
784,160785,Undecenovanillylamide,COC1=C(C=CC(=C1)CNC(=O)CCCCCCCCC=C)O,,,,,,
785,160786,"9,10-Methylenehexadecanoic acid",CCCCCCC1CC1CCCCCCCC(=O)O,,,,,,
786,160787,"9H-Pyrido(3,4-b)indolium, 2-methyl-, iodide",CN1C=CC2C3=CC=CC=C3[NH2+]C2=C1.[I-],,,,,,
787,160788,Dihydrosterculic acid,CCCCCCCCC1CC1CCCCCCCC(=O)O,,,,,,
788,160789,"16-Hydroxyandrost-4-ene-3,17-dione",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC(C4=O)O)C,,,,,,
789,160790,CID 160790,C1C2C(N2P(N3C4C3COC4)N5C6C5COC6)CO1,,,,,,
790,160791,"3,4,4-Trichlorobut-3-en-2-one",CC(=O)C(=C(Cl)Cl)Cl,,,,,,
791,160792,CID 160792,C1CN=C(SC(=N1)S)S,,,,,,
792,160793,1-Chlorophthalazine,C1=CC=C2C(=C1)C=NN=C2Cl,,,,,,
793,160794,"17,20,21-Trihydroxypregn-4-en-3-one",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@]4(C(CO)O)O)C,,,,,,
794,160795,"2,2'-Dimethyl-3,3'-dinitroazoxybenzene",CC1=C(C=CC=C1[N+](=O)[O-])N=[N+](C2=C(C(=CC=C2)[N+](=O)[O-])C)[O-],,,,,,
795,160796,Clobenzorex hydrochloride,CC(CC1=CC=CC=C1)NCC2=CC=CC=C2Cl.Cl,,,,,,
796,160797,CID 160797,CC1=C(C2=C(C=C1)N=C(S2)C3=CC=C(C=C3)NN=C4C=CC(=O)C(=NNC5=CC=CC=C5)C4=O)S(=O)(=O)[O-].[Na+],,,,,,
797,160798,"2-(4-{2-[4,6-Dioxo-5-(2-phenylhydrazinylidene)cyclohex-2-en-1-ylidene]hydrazinyl}phenyl)-6-methyl-1,3-benzothiazole-7-sulfonic acid",CC1=C(C2=C(C=C1)N=C(S2)C3=CC=C(C=C3)NN=C4C=CC(=O)C(=NNC5=CC=CC=C5)C4=O)S(=O)(=O)O,,,,,,
798,160799,Cedrelanol,CC1=C[C@H]2[C@@H](CC[C@]([C@@H]2CC1)(C)O)C(C)C,,,,,,
799,160800,Berberine chloride dihydrate,COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC.O.O.[Cl-],,,,,,
800,160801,"Arsonic acid, methyl-, disodium salt, hexahydrate",C[As](=O)([O-])[O-].O.O.O.O.O.O.[Na+].[Na+],,,,,,
801,160802,CID 160802,C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[O-])[O-])NC(=NC2=O)N.[Mn+2],,,,,,
802,160803,Maesopsin,C1=CC(=CC=C1CC2(C(=O)C3=C(C=C(C=C3O2)O)O)O)O,,,,,,
803,160804,CID 160804,CC=C(C)C(=O)O[C@@H]1CCN2[C@@H]1C(=CC2)CO,,,,,,
804,160805,CID 160805,CC(C)O.C(CO)N(CCO)CCO.[GeH4],,,,,,
805,160806,Tantalum(5+) ethanolate,CC[O-].CC[O-].CC[O-].CC[O-].CC[O-].[Ta+5],,,,,,
806,160807,p-Hydroxyamphetamine hydrochloride,CC(CC1=CC=C(C=C1)O)N.Cl,,,,,,
807,160808,CID 160808,C(CC(=O)[O-])[C@@H](C(=O)O)N.O.[Na+],,,,,,
808,160809,Histapyrrodine hydrochloride,C1CCN(C1)CCN(CC2=CC=CC=C2)C3=CC=CC=C3.Cl,,,,,,
809,160810,"Phosphonic acid, methylenebis-, tetrasodium salt",C(P(=O)([O-])[O-])P(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
810,160811,Isopropylidenediphosphonic acid,CC(C)(P(=O)(O)O)P(=O)(O)O,,,,,,
811,160812,Manganese butyrate,CCCC(=O)[O-].CCCC(=O)[O-].[Mn+2],,,,,,
812,160813,"1,1,1,3,3,4,4,4-Octafluoro-2-(trifluoromethyl)-2-butanol",C(C(C(F)(F)F)(F)F)(C(F)(F)F)(C(F)(F)F)O,,,,,,
813,160814,"Pyrene-4,5-dione",C1=CC2=C3C(=C1)C(=O)C(=O)C4=CC=CC(=C43)C=C2,,,,,,
814,160815,CID 160815,C1=CC=C(C=C1)S(=O)(=O)C2=CC=CC=C2N=NC3=C(C=CC4=CC(=CC(=C43)O)S(=O)(=O)[O-])N.[Na+],,,,,,
815,160816,6-Amino-4-hydroxy-5-((2-(phenylsulphonyl)phenyl)azo)naphthalene-2-sulphonic acid,C1=CC=C(C=C1)S(=O)(=O)C2=CC=CC=C2N=NC3=C(C=CC4=CC(=CC(=C43)O)S(=O)(=O)O)N,,,,,,
816,160817,1-Hydroxy-2-methylanthraquinone,CC1=C(C2=C(C=C1)C(=O)C3=CC=CC=C3C2=O)O,,,,,,
817,160818,"N,N-Bis(2-hydroxyethyl)-2-naphthylamine",C1=CC=C2C=C(C=CC2=C1)N(CCO)CCO,,,,,,
818,160819,CID 160819,CC1=NN(C(=O)C1N=NC2=CC=C(C=C2)S(=O)(=O)[O-])C3=CC=CC=C3.[Na+],,,,,,
819,160820,"4-[[(4,5-Dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol)-4-yl]azo]benzenesulfonic acid",CC1=NN(C(=O)C1N=NC2=CC=C(C=C2)S(=O)(=O)O)C3=CC=CC=C3,,,,,,
820,160821,CID 160821,CCN(C1=CC=CC=C1)S(=O)(=O)C2=C(C=CC(=C2)NC(=O)C)N=NC3=C(C=CC4=CC(=CC(=C43)O)S(=O)(=O)[O-])N.[Na+],,,,,,
821,160822,5-[[4-Acetamido-2-[ethyl(phenyl)sulfamoyl]phenyl]diazenyl]-6-amino-4-hydroxynaphthalene-2-sulfonic acid,CCN(C1=CC=CC=C1)S(=O)(=O)C2=C(C=CC(=C2)NC(=O)C)N=NC3=C(C=CC4=CC(=CC(=C43)O)S(=O)(=O)O)N,,,,,,
822,160823,"Ethanediamide, N,N'-bis[5-(benzoylamino)-9,10-dihydro-9,10-dioxo-1-anthracenyl]-",C1=CC=C(C=C1)C(=O)NC2=CC=CC3=C2C(=O)C4=C(C3=O)C(=CC=C4)NC(=O)C(=O)NC5=CC=CC6=C5C(=O)C7=C(C6=O)C(=CC=C7)NC(=O)C8=CC=CC=C8,,,,,,
823,160824,"2,5-Dimethylbenzene-1,4-diamine",CC1=CC(=C(C=C1N)C)N,,,,,,
824,160825,CID 160825,C1=CC=C2C(=C1)C=CC=C2N=NC3=CC4=C(C=C3)C=C(C=C4)S(=O)(=O)[O-].[Na+],,,,,,
825,160826,6-(1-Naphthylazo)naphthalene-2-sulphonic acid,C1=CC=C2C(=C1)C=CC=C2N=NC3=CC4=C(C=C3)C=C(C=C4)S(=O)(=O)O,,,,,,
826,160827,"Benzenesulfonic acid, 4,4'-((1,4-diamino-9,10-dihydro-9,10-dioxo-2,3-anthracenediyl)bis(oxy))bis-, disodium salt",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C(=C3N)OC4=CC=C(C=C4)S(=O)(=O)[O-])OC5=CC=C(C=C5)S(=O)(=O)[O-])N.[Na+].[Na+],,,,,,
827,160828,"4,4'-[(1,4-Diamino-9,10-dioxo-9,10-dihydroanthracene-2,3-diyl)bis(oxy)]di(benzene-1-sulfonic acid)",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C(=C3N)OC4=CC=C(C=C4)S(=O)(=O)O)OC5=CC=C(C=C5)S(=O)(=O)O)N,,,,,,
828,160829,CID 160829,C1=CC=C2C(=C1)C(=CC=C2O)N=NC3=CC=C(C4=CC=CC=C43)S(=O)(=O)[O-].[Na+],,,,,,
829,160830,C.I. Acid Green 8,CCN(CC)C1=CC=C(C=C1)C(=C2C=CC(=[N+](CC)CC)C=C2)C3=CC(=C(C=C3S(=O)(=O)[O-])S(=O)(=O)[O-])NC4=C(C=C(C=C4)[N+](=O)[O-])[N+](=O)[O-].[Na+],,,,,,
830,160831,"N-[4-[[4-(Diethylamino)phenyl][5-[(2,4-dinitrophenyl)amino]-2-sulfonato-4-sulfophenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-ethylethanaminium",CCN(CC)C1=CC=C(C=C1)C(=C2C=CC(=[N+](CC)CC)C=C2)C3=CC(=C(C=C3S(=O)(=O)O)S(=O)(=O)O)NC4=C(C=C(C=C4)[N+](=O)[O-])[N+](=O)[O-],,,,,,
831,160832,"Disodium 3-[(5-chloro-2-phenoxyphenyl)azo]-4-hydroxy-5-[[(p-tolyl)sulphonyl]amino]naphthalene-2,7-disulphonate",CC1=CC=C(C=C1)S(=O)(=O)NC2=C3C(=CC(=C2)S(=O)(=O)[O-])C=C(C(=C3O)N=NC4=C(C=CC(=C4)Cl)OC5=CC=CC=C5)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
832,160833,"3-[2-(5-Chloro-2-phenoxyphenyl)diazenyl]-4-hydroxy-5-[[(4-methylphenyl)sulfonyl]amino]-2,7-naphthalenedisulfonic acid",CC1=CC=C(C=C1)S(=O)(=O)NC2=C3C(=CC(=C2)S(=O)(=O)O)C=C(C(=C3O)N=NC4=C(C=CC(=C4)Cl)OC5=CC=CC=C5)S(=O)(=O)O,,,,,,
833,160834,"Trisodium 5-amino-3-((4'-((6-amino-1-hydroxy-3-sulphonato-2-naphthyl)azo)-3,3'-dimethyl(1,1'-biphenyl)-4-yl)azo)-4-hydroxynaphthalene-2,7-disulphonate",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C=C4C=C(C=CC4=C3O)N)S(=O)(=O)[O-])C)N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)[O-])S(=O)(=O)[O-])N)O.[Na+].[Na+].[Na+],,,,,,
834,160835,"5-Amino-3-((4'-((6-amino-1-hydroxy-3-sulfo-2-naphthyl)diazenyl)-3,3'-dimethyl[biphenyl]-4-yl)diazenyl)-4-hydroxy-2,7-naphthalenedisulfonic acid",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C=C4C=C(C=CC4=C3O)N)S(=O)(=O)O)C)N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)O)S(=O)(=O)O)N)O,,,,,,
835,160836,Direct Yellow 34,CC1=CC(=C(C=C1N=NC2=CC3=C(C=CC=C3S(=O)(=O)[O-])C(=C2)S(=O)(=O)[O-])OC)NC(=O)NC4=C(C=C(C(=C4)C)N=NC5=CC6=C(C=CC=C6S(=O)(=O)[O-])C(=C5)S(=O)(=O)[O-])OC.[Na+].[Na+].[Na+].[Na+],,,,,,
836,160837,"1,5-Naphthalenedisulfonic acid, 3,3'-[carbonylbis[imino(5-methoxy-2-methyl-4,1-phenylene)azo]]bis-",CC1=CC(=C(C=C1N=NC2=CC3=C(C=CC=C3S(=O)(=O)O)C(=C2)S(=O)(=O)O)OC)NC(=O)NC4=C(C=C(C(=C4)C)N=NC5=CC6=C(C=CC=C6S(=O)(=O)O)C(=C5)S(=O)(=O)O)OC,,,,,,
837,160838,"Disodium 3,3'-[cyclohexylidenebis[(2-methoxy-4,1-phenylene)azo]]bis(4,6-dihydroxynaphthalene-2-sulphonate)",COC1=C(C=CC(=C1)C2(CCCCC2)C3=CC(=C(C=C3)N=NC4=C(C=C5C=CC(=CC5=C4O)O)S(=O)(=O)[O-])OC)N=NC6=C(C=C7C=CC(=CC7=C6O)O)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
838,160839,"3,3'-(Cyclohexylidenebis((2-methoxy-4,1-phenylene)azo))bis(4,6-dihydroxynaphthalene-2-sulphonic) acid",COC1=C(C=CC(=C1)C2(CCCCC2)C3=CC(=C(C=C3)N=NC4=C(C=C5C=CC(=CC5=C4O)O)S(=O)(=O)O)OC)N=NC6=C(C=C7C=CC(=CC7=C6O)O)S(=O)(=O)O,,,,,,
839,160840,Disodium 5-((4-nitro-2-sulphonatophenyl)azo)salicylate,C1=CC(=C(C=C1N=NC2=C(C=C(C=C2)[N+](=O)[O-])S(=O)(=O)[O-])C(=O)O)[O-].[Na+].[Na+],,,,,,
840,160841,2-Hydroxy-5-[(4-nitro-2-sulfophenyl)diazenyl]benzoic acid,C1=CC(=C(C=C1N=NC2=C(C=C(C=C2)[N+](=O)[O-])S(=O)(=O)O)C(=O)O)O,,,,,,
841,160842,CID 160842,C1=CC(=CC=C1C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)[O-])N=NC4=CC(=C(C=C4)O)C(=O)[O-].[Na+].[Na+],,,,,,
842,160843,Chrysamine G,C1=CC(=CC=C1C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O)N=NC4=CC(=C(C=C4)O)C(=O)O,,,,,,
843,160844,"Sodium 4-{[4-(dibenzylamino)phenyl][4-(dibenzyliminio)cyclohexa-2,5-dien-1-ylidene]methyl}benzene-1,3-disulfonate",C1=CC=C(C=C1)CN(CC2=CC=CC=C2)C3=CC=C(C=C3)C(=C4C=CC(=[N+](CC5=CC=CC=C5)CC6=CC=CC=C6)C=C4)C7=C(C=C(C=C7)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+],,,,,,
844,160845,"N,N-Dibenzyl-4-{[4-(dibenzylamino)phenyl](2,4-disulfophenyl)methylidene}cyclohexa-2,5-dien-1-iminium",C1=CC=C(C=C1)CN(CC2=CC=CC=C2)C3=CC=C(C=C3)C(=C4C=CC(=[N+](CC5=CC=CC=C5)CC6=CC=CC=C6)C=C4)C7=C(C=C(C=C7)S(=O)(=O)O)S(=O)(=O)O,,,,,,
845,160846,"Phosphonic acid, ethyl-, ethyl 2,4,5-trichlorophenyl ester",CCOP(=O)(CC)OC1=CC(=C(C=C1Cl)Cl)Cl,,,,,,
846,160847,"C.I. Direct brown 52, trisodium salt",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)[O-])S(=O)(=O)[O-])N=NC5=C(C=C(C=C5)N)N)O)C)N=NC6=CC(=C(C=C6)O)C(=O)[O-].[Na+].[Na+].[Na+],,,,,,
847,160848,"5-{[4'-({8-[(2,4-Diaminophenyl)diazenyl]-1-hydroxy-3,6-disulfonaphthalen-2-yl}diazenyl)-3,3'-dimethyl[1,1'-biphenyl]-4-yl]diazenyl}-2-hydroxybenzoic acid",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)O)S(=O)(=O)O)N=NC5=C(C=C(C=C5)N)N)O)C)N=NC6=CC(=C(C=C6)O)C(=O)O,,,,,,
848,160849,"Methanaminium, N-(4-((3-(bis((3-sulfophenyl)methyl)amino)phenyl)(4-(dimethylamino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-N-methyl-, inner salt, sodium salt",CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC(=CC=C3)N(CC4=CC(=CC=C4)S(=O)(=O)[O-])CC5=CC(=CC=C5)S(=O)(=O)[O-].[Na+],,,,,,
849,160850,"[4-[[3-[Bis[(3-sulfophenyl)methyl]amino]phenyl]-[4-(dimethylamino)phenyl]methylidene]cyclohexa-2,5-dien-1-ylidene]-dimethylazanium",CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC(=CC=C3)N(CC4=CC(=CC=C4)S(=O)(=O)O)CC5=CC(=CC=C5)S(=O)(=O)O,,,,,,
850,160851,"2-Naphthalenesulfonic acid, 3,3'-(cyclohexylidenebis((2-methyl-4,1-phenylene)azo))bis(4,6-dihydroxy-, disodium salt",CC1=C(C=CC(=C1)C2(CCCCC2)C3=CC(=C(C=C3)N=NC4=C(C=C5C=CC(=CC5=C4O)O)S(=O)(=O)[O-])C)N=NC6=C(C=C7C=CC(=CC7=C6O)O)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
851,160852,"3-[[4-[1-[4-[(1,7-Dihydroxy-3-sulfonaphthalen-2-yl)diazenyl]-3-methylphenyl]cyclohexyl]-2-methylphenyl]diazenyl]-4,6-dihydroxynaphthalene-2-sulfonic acid",CC1=C(C=CC(=C1)C2(CCCCC2)C3=CC(=C(C=C3)N=NC4=C(C=C5C=CC(=CC5=C4O)O)S(=O)(=O)O)C)N=NC6=C(C=C7C=CC(=CC7=C6O)O)S(=O)(=O)O,,,,,,
852,160853,N(2)-methylharmine,CC1=C2C(=C3C=CC(=CC3=N2)OC)C=CN1C,,,,,,
853,160854,Manganese octanoate,CCCCCCCC(=O)[O-].CCCCCCCC(=O)[O-].[Mn+2],,,,,,
854,160855,"(R)-2,3-Bis((9Z,12Z)-octadeca-9,12-dienoyloxy)propyl (2-(trimethylammonio)ethyl) phosphate",CCCCCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCC=CCCCCC,,,,,,
855,160856,"1,3-Dioxolane, 2,2'-(1,3-propanediyl)bis-",C1COC(O1)CCCC2OCCO2,,,,,,
856,160857,"Disodium 8-[[3,3'-dimethoxy-4'-[[4-[[(p-tolyl)sulphonyl]oxy]phenyl]azo][1,1'-biphenyl]-4-yl]azo]-7-hydroxynaphthalene-1,3-disulphonate",CC1=CC=C(C=C1)S(=O)(=O)OC2=CC=C(C=C2)N=NC3=C(C=C(C=C3)C4=CC(=C(C=C4)N=NC5=C(C=CC6=CC(=CC(=C65)S(=O)(=O)[O-])S(=O)(=O)[O-])O)OC)OC.[Na+].[Na+],,,,,,
857,160858,"8-((3,3'-Dimethoxy-4'-((4-(((4-methylphenyl)sulfonyl)oxy)phenyl)diazenyl)[biphenyl]-4-yl)diazenyl)-7-hydroxy-1,3-naphthalenedisulfonic acid",CC1=CC=C(C=C1)S(=O)(=O)OC2=CC=C(C=C2)N=NC3=C(C=C(C=C3)C4=CC(=C(C=C4)N=NC5=C(C=CC6=CC(=CC(=C65)S(=O)(=O)O)S(=O)(=O)O)O)OC)OC,,,,,,
858,160859,CID 160859,C1=CC(=CC=C1NN=C2C(=O)C(=CC(=NN=C3C=C(C=C(C3=O)[N+](=O)O)N(O)O)C2=O)N=NC4=C5C(=CC(=C4)S(=O)(=O)[O-])C=C(C=C5[O-])S(=O)(=O)[O-])[N+](=O)[O-].[Na+].[Na+],,,,,,
859,160860,CID 160860,CCOC1=C(C=C(C=C1)NC2=CC=C(C=C2)C(=C3C=CC(=NC4=CC(=C(C=C4)OCC)S(=O)(=O)O)C=C3)C5=C(N(C6=CC=CC=C65)C)C7=CC=CC=C7)S(=O)(=O)[O-].[Na+],,,,,,
860,160861,"2-Ethoxy-5-[(4-{[4-(4-ethoxy-3-sulfoanilino)phenyl](1-methyl-2-phenyl-1H-indol-3-yl)methylidene}cyclohexa-2,5-dien-1-ylidene)amino]benzene-1-sulfonic acid",CCOC1=C(C=C(C=C1)NC2=CC=C(C=C2)C(=C3C=CC(=NC4=CC(=C(C=C4)OCC)S(=O)(=O)O)C=C3)C5=C(N(C6=CC=CC=C65)C)C7=CC=CC=C7)S(=O)(=O)O,,,,,,
861,160862,"Naphth[2,3-c]acridine-5,8,14(13H)-trione, 10-chloro-7-[(6,11-dihydro-6,11-dioxo-2-phenylnaphtho[2,3-g]quinazolin-4-yl)amino]-",C1=CC=C(C=C1)C2=NC3=CC4=C(C=C3C(=N2)NC5=C6C(=C7C(=C5)C(=O)C8=CC=CC=C8C7=O)NC9=C(C6=O)C=C(C=C9)Cl)C(=O)C1=CC=CC=C1C4=O,,,,,,
862,160863,"(2R,3R,4R)-hexane-1,2,3,4,6-pentol",C(CO)[C@H]([C@H]([C@@H](CO)O)O)O,,,,,,
863,160864,Prooxen,CN(C)CCC=C1C2=CC=CC=C2OC3=CC=CC=C31.Cl,,,,,,
864,160865,"N,N-dimethyl-3-xanthen-9-ylidenepropan-1-amine",CN(C)CCC=C1C2=CC=CC=C2OC3=CC=CC=C31,,,,,,
865,160866,7-Oxabicyclo[4.1.0]hept-2-ene,C1CC2C(O2)C=C1,,,,,,
866,160867,CID 160867,C[C@@]12CC[C@]3(CCC(CC3[C@H]1CC[C@H]4[C@]2(CCC5[C@@]4(CCC(=O)C5(C)C)C)C)(C)C)C(=O)O,,,,,,
867,160868,Oxiran-2-ylmethyl 4-methylbenzenesulfonate,CC1=CC=C(C=C1)S(=O)(=O)OCC2CO2,,,,,,
868,160869,"1-[2,4-Dihydroxy-6-methoxy-3-(3-methyl-2-buten-1-yl)phenyl]-3-(4-hydroxyphenyl)-2-propen-1-one",CC(=CCC1=C(C(=C(C=C1O)OC)C(=O)C=CC2=CC=C(C=C2)O)O)C,,,,,,
869,160870,Oxazepam glucuronide,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O,,,,,['Oxazepam glucuronide is a known human metabolite of Oxazepam.'],
870,160871,"Glycine, N-(N-L-gamma-glutamyl-S-(phenylmethyl)-L-cysteinyl)-",C1=CC=C(C=C1)CSC[C@@H](C(=O)N(CC(=O)O)C(=O)CC[C@@H](C(=O)O)N)N,,,,,,
871,160872,"(1S,2R,9R)-11-but-3-enyl-7,11-diazatricyclo[7.3.1.02,7]tridec-5-en-4-one",C=CCCN1C[C@H]2C[C@@H](C1)[C@H]3CC(=O)C=CN3C2,,,,,,
872,160873,"D-Xylose, 4-O-beta-D-xylopyranosyl-",C1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@H](CO)[C@@H]([C@H](C=O)O)O)O)O)O,,,,,,
873,160874,"3-[(3S,5R,8R,9S,10R,13R,17R)-14-hydroxy-10-(hydroxymethyl)-13-methyl-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3CC[C@]5(C4(CC[C@@H]5C6=CC(=O)OC6)O)C)CO)O)O)O,,,,,,
874,160875,Asimilobine,COC1=C(C=C2CCN[C@H]3C2=C1C4=CC=CC=C4C3)O,,,,,,
875,160876,Epiberberine,COC1=C(C=C2C(=C1)CC[N+]3=C2C=C4C=CC5=C(C4=C3)OCO5)OC,,,,,,
876,160877,Salicifoline,C[N+](C)(C)CCC1=CC(=C(C=C1)OC)O,,,,,,
877,160878,"4-(3,7-Dimethylnona-2,4,6,8-tetraenylidene)-3,5,5-trimethylcyclohex-2-en-1-ol",CC1=CC(CC(C1=CC=C(C)C=CC=C(C)C=C)(C)C)O,,,,,,
878,160879,"[(4aS,7S,7aS)-7-methyl-1-[(2S,3R,4R,6R)-3,4,5,5,6-pentahydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-7-yl] acetate",CC(=O)O[C@]1(CC[C@@H]2[C@@H]1C(OC=C2)O[C@@H]3[C@@H]([C@H](C([C@](O3)(CO)O)(O)O)O)O)C,,,,,,
879,160880,"n-(2-Hydroxyethyl)-n,n-dimethyl-2,3-bis(octadecanoyloxy)propan-1-aminium acetate",CCCCCCCCCCCCCCCCCC(=O)OCC(C[N+](C)(C)CCO)OC(=O)CCCCCCCCCCCCCCCCC.CC(=O)[O-],,,,,,
880,160881,"4-Benzylidene-2,6-di-tert-butylcyclohexa-2,5-dien-1-one",CC(C)(C)C1=CC(=CC2=CC=CC=C2)C=C(C1=O)C(C)(C)C,,,,,,
881,160882,"Benzenesulfonic acid, 4-methyl-, copper(2+) salt",CC1=CC=C(C=C1)S(=O)(=O)[O-].CC1=CC=C(C=C1)S(=O)(=O)[O-].[Cu+2],,,,,,
882,160883,Butylscopolamine,CCCC[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4)C,['Used to treat abdmoninal cramping and pain.'],['Scopolamine butylbromide is a muscarinic antagonist which acts to prevent acetylcholine-stimulated contraction of smooth muscle in the gastrointestinal tract.'],"['Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)', 'Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)']","['Scopolamine butylbromide has extremely low oral bioavailability with only 0.25-0.82% reaching systemic circulation. Peak plasma concentration is reached 0.25-2 hours. Scopolamine butylbromide does not cross the blood brain barrier.', ""Mainly eliminated in the feces (69.7%) with very little in the urine (4.4%). Only 2.8% is eliminated via the bile owing to scopolamine butylbromide's poor absorption."", 'The volume of distribution is 128 liters.', 'Total clearace is 1.2 liters per minute.', 'After intravenous administration (100 mg as infusion), the plasma concentration of hyoscine butylbromide declines rapidly and the elimination half-life ranges between 1 and 5 hours. The total clearance is 1.2 L/min, of which 50% is excreted as unchanged drug through the kidneys . ... Elimination following oral administration is primarily via fecal excretion with a minor urinary component. /Hyoscine butylbromide/', 'Oral hyoscine butylbromide is poorly absorbed (8%) and has a low systemic bioavailability; blood levels are difficult to detect at therapeutic doses (e.g., 30-60 mg). ... Plasma levels were detectable only after a single oral dose of 500 mg, and the maximum plasma concentration observed was 5 ng/mL. The amount of drug recovered in urine after oral administration of the 500 mg dose was 0.16%. The bioavailability of oral hyoscine butylbromide (100 or 500 mg), based on urinary excretion data, was generally < 1%. The volume of distribution is 128 L. As a quaternary ammonium derivative, hyoscine butylbromide does not pass across the blood-brain barrier or enter the CNS. /Hyoscine butylbromide/', 'Following single IV administration of (14)C-Buscopan (0.4 mg/kg, side chain labeled) in 3 horses, the major route of elimination of total radioactivity was via urine and feces almost equally. The bulk of the radioactivity (>96%) that represents all 14C-labeled moieties derived from the (14)C-Buscopan dose was eliminated (urine and feces) within the first 48 hours post-dosing. The elimination half-life of total plasma (14)C was estimated to be approximately 6 hours. Therefore, the elimination half-life of the parent drug in plasma is equal to or shorter than 6 hours. The main radioactive component in the urine, which co-chromatographed with Buscopan using thin layer chromatography, accounted for approximately 85% of the detected radioactivity. /N-butylscopolammonium bromide/', 'In contrast with hyoscine, quaternary ammonium compounds such as hyoscine butylbromide should not be systemically absorbed. Limited systemic absorption may improve the adverse events profile compared with the parent compound hyoscine. /hyoscine butylbromide/']","['Metabolism occurs mainly through hydrolysis of the ester bond. The metabolites are not considered to be significantly active.', 'The main metabolic pathway is hydrolytic cleavage of the ester bond. The metabolites that are excreted in the kidneys bind barely to muscarinic receptors and are not considered to contribute to the effect of hyoscine butylbromide. /Hyoscine butylbromide/']","['The half life of elimination is 1-5 hours.', 'After intravenous administration (100 mg as infusion), the plasma concentration of hyoscine butylbromide declines rapidly and the elimination half-life ranges between 1 and 5 hours. ...  /Hyoscine butylbromide/', 'Following single IV administration of (14)C-Buscopan (0.4 mg/kg, side chain labeled) in 3 horses, ... the elimination half-life of total plasma (14)C was estimated to be approximately 6 hours. Therefore, the elimination half-life of the parent drug in plasma is equal to or shorter than 6 hours. ... /N-butylscopolammonium bromide/']"
883,160884,3-Benzoyl-5-ethyl-5-isoamylbarbituric acid,CCC1(C(=O)NC(=O)N(C1=O)C(=O)C2=CC=CC=C2)CCC(C)C,,,,,,
884,160885,Iodoindoxyl phosphate,C1=CC2=C(C=C1I)C(=CN2)OP(=O)(O)O,,,,,,
885,160886,1D-myo-inositol 5-phosphate,[C@H]1([C@H](C([C@H]([C@@H](C1O)O)O)OP(=O)(O)O)O)O,,,,,,
886,160887,Tetrangomycin,CC1(CC2=C(C(=O)C1)C3=C(C=C2)C(=O)C4=C(C3=O)C=CC=C4O)O,,,,,,
887,160888,"1H-Dibenzo(a,d)cycloheptene, 2,3,4,4a,5,10,11,11a-octahydro-",C1CCC2CC3=CC=CC=C3CCC2C1,,,,,,
888,160889,CID 160889,C(C[O-])O.[Na+],,,,,,
889,160890,"1,3-Propanediaminium, N,N,N,N',N'-pentamethyl-N'-octadecyl-, dichloride",CCCCCCCCCCCCCCCCCC[N+](C)(C)CCC[N+](C)(C)C.[Cl-].[Cl-],,,,,,
890,160891,"N,N,N,N',N'-Pentamethyl-N'-octadecyl-1,3-propanediaminium",CCCCCCCCCCCCCCCCCC[N+](C)(C)CCC[N+](C)(C)C,,,,,,
891,160892,Phencyclidine methiodide,C[N+]1(CCCCC1)C2(CCCCC2)C3=CC=CC=C3.[I-],,,,,,
892,160893,1-Methyl-1-(1-phenylcyclohexyl)piperidinium,C[N+]1(CCCCC1)C2(CCCCC2)C3=CC=CC=C3,,,,,,
893,160894,Cerous octanoate,CCCCCCCC(=O)[O-].CCCCCCCC(=O)[O-].CCCCCCCC(=O)[O-].[Ce+3],,,,,,
894,160895,Phentolacin,CC1=CC=C(C=C1)C(C2=CC=CC=C2)C(=O)C3C(=O)C4=CC=CC=C4C3=O,,,,,,
895,160896,5-Chloro-4-oxo-L-norvaline,C([C@@H](C(=O)O)N)C(=O)CCl,,,,,,
896,160897,2-Hydroxyphenylacetaldehyde,C1=CC=C(C(=C1)CC=O)O,,,,,,
897,160898,Dyfoxon,CCOP(=O)(CC)OC1=CC=CC=C1,,,,,,
898,160899,"Phosphonic acid, [nitrilotris(methylene)]tris-, trisodium salt",C(N(CP(=O)(O)[O-])CP(=O)([O-])[O-])P(=O)(O)O.[Na+].[Na+].[Na+],,,,,,
899,160900,Dibutylamine Oleate,CCCCCCCCC=CCCCCCCCC(=O)O.CCCCNCCCC,,,,,,
900,160901,Tin stearate,CCCCCCCCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCCCCCCCC(=O)[O-].[Sn+4],,,,,,
901,160902,"(7R,8R,9S,10R,13S,14S)-17-ethynyl-17-hydroxy-7,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one",C[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CCC([C@]4(CC3)C)(C#C)O)C,,,,,,
902,160903,4-Benzylpiperazine-1-carboximidamide,C1CN(CCN1CC2=CC=CC=C2)C(=N)N,,,,,,
903,160904,Silver nitrite,N(=O)[O-].[Ag+],,,,,,
904,160905,"1,2,4,5-Tetrahydrotestolactone",C[C@]12CCC(=O)C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC(=O)O4)C,,,,,,
905,160906,(+)-Carnitine hydrochloride,C[N+](C)(C)C[C@H](CC(=O)O)O.[Cl-],,,,,,
906,160907,"(2S)-3-carboxy-2-hydroxy-N,N,N-trimethylpropan-1-aminium",C[N+](C)(C)C[C@H](CC(=O)O)O,,,,,,
907,160908,Cotarnine chloride,C[N+]1=CC2=C(C3=C(C=C2CC1)OCO3)OC.[Cl-],,,,,,
908,160909,Cotarninium,C[N+]1=CC2=C(C3=C(C=C2CC1)OCO3)OC,,,,,,
909,160910,Tin bis(sulphate),[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Sn+4],,,,,,
910,160911,Bismuth nitrate pentahydrate,[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].O.O.O.O.O.[Bi+3],,,,,,
911,160912,Triethanolamine monoborate,B(O)(O)O.C(CO)N(CCO)CCO,,,,,,
912,160913,Glycinamide ribonucleotide,C([C@@H]1[C@H]([C@H]([C@@H](O1)NC(=O)CN)O)O)OP(=O)(O)O,,,,,,
913,160914,Protokosin,CC1=C(C(=C(C(=C1OC)C(=O)C(C)C)O)CC2=C(C(=C(C(=C2O)C(=O)C(C)C)O)CC3=C(C(=C(C(=C3O)C)OC)C(=O)C(C)C)OC)O)O,,,,,,
914,160915,Ammonium manganese(3+) diphosphate,[NH4+].[O-]P(=O)([O-])OP(=O)([O-])[O-].[Mn+3],,,,,,
915,160916,Sodium sulfite heptahydrate,O.O.O.O.O.O.O.[O-]S(=O)[O-].[Na+].[Na+],,,,,,
916,160917,Magnesium thiosulfate,[O-]S(=O)(=S)[O-].[Mg+2],,,,,,
917,160918,"8-((7-Amino-1-hydroxy-3-sulpho-2-naphthyl)azo)-5-((4-(phenylazo)-7-sulpho-1-naphthyl)azo)naphthalene-2-sulphonic acid, sodium salt",C1=CC=C(C=C1)N=NC2=C3C=CC(=CC3=C(C=C2)N=NC4=C5C=CC(=CC5=C(C=C4)N=NC6=C(C=C7C=CC(=CC7=C6O)N)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
918,160919,8-[(7-Amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-5-[[4-(phenylazo)-7-sulfo-1-naphthyl]azo]-2-naphthalenesulfonic acid,C1=CC=C(C=C1)N=NC2=C3C=CC(=CC3=C(C=C2)N=NC4=C5C=CC(=CC5=C(C=C4)N=NC6=C(C=C7C=CC(=CC7=C6O)N)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
919,160920,Linatine,C1C[C@@H](N(C1)NC(=O)CC[C@@H](C(=O)O)N)C(=O)O,,,,,,
920,160921,Nevadensin,COC1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C(=C3O2)OC)O)OC)O,,,,,,
921,160922,Barium myristate,CCCCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCCCC(=O)[O-].[Ba+2],,,,,,
922,160923,Copper(2+) selenite,[O-][Se](=O)[O-].[Cu+2],,,,,,
923,160924,"Benz(a)anthracene-5,6-dione, 7,12-dimethyl-",CC1=C2C3=CC=CC=C3C(=O)C(=O)C2=C(C4=CC=CC=C14)C,,,,,,
924,160925,N-[(4-Amino-2-methylpyrimidin-5-yl)methyl]-N-[5-hydroxy-3-(oxolan-2-ylmethyldisulfanyl)pent-2-en-2-yl]formamide;hydrochloride,CC1=NC=C(C(=N1)N)CN(C=O)C(=C(CCO)SSCC2CCCO2)C.Cl,,,,,,
925,160926,Desacetyl-1-isotenulin,C[C@@H]1C[C@H]2[C@@H]([C@H](C(=O)O2)C)[C@H]([C@]3([C@@H]1C=CC3=O)C)O,,,,,,
926,160927,8-Hydroxyquinoline oxalate,C1=CC2=C(C(=C1)O)N=CC=C2.C(=O)(C(=O)O)O,,,,,,
927,160928,1-(p-(Phenylazo)phenyl)piperidine,C1CCN(CC1)C2=CC=C(C=C2)N=NC3=CC=CC=C3,,,,,,
928,160929,"Disodium 4,10-dibromodibenzo(def,mno)chrysene-6,12-diyl bis(sulphate)",C1=CC2=C3C(=C1)C(=C4C=C(C5=C6C4=C3C(=C(C6=CC=C5)OS(=O)(=O)[O-])C=C2Br)Br)OS(=O)(=O)[O-].[Na+].[Na+],,,,,,
929,160930,"4,10-Dibromonaphtho[7,8,1,2,3-nopqr]tetraphene-6,12-diyl bis(hydrogen sulfate)",C1=CC2=C3C(=C1)C(=C4C=C(C5=C6C4=C3C(=C(C6=CC=C5)OS(=O)(=O)O)C=C2Br)Br)OS(=O)(=O)O,,,,,,
930,160931,Potassium manganate,[O-][Mn](=O)(=O)[O-].[K+].[K+],,,,,,
931,160932,Manganate,[O-][Mn](=O)(=O)[O-],,,,,,
932,160933,"1,3-Diacetylchloramphenicol",CC(=O)OC[C@H]([C@@H](C1=CC=C(C=C1)[N+](=O)[O-])OC(=O)C)NC(=O)C(Cl)Cl,,,,,,
933,160934,CID 160934,C1=CC=C2C(=C1)C(=CC=C2N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)[O-])N=NC5=CC=CC(=C5O)C(=O)[O-].[Na+].[Na+],,,,,,
934,160935,3-[4-(7-Amino-3-sulfo-1-hydroxy-2-naphthalenylazo)-1-naphthalenylazo]-2-hydroxybenzoic acid,C1=CC=C2C(=C1)C(=CC=C2N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)O)N=NC5=CC=CC(=C5O)C(=O)O,,,,,,
935,160936,2-Deoxy-2-[(1-hydroxyethylidene)amino]-6-O-sulfohexose,CC(=O)N[C@@H](C=O)[C@H]([C@@H]([C@@H](COS(=O)(=O)O)O)O)O,,,,,,
936,160937,"Peroxymonosulfuric acid, dipotassium salt",[O-]S1(OOOO1)[O-].[K+].[K+],,,,,,
937,160938,"5,5-Dihydroxytetraoxathiolane",OS1(OOOO1)O,,,,,,
938,160939,Thorium sulfate,[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Th+4],,,,,,
939,160940,Glafenic acid,C1=CC=C(C(=C1)C(=O)O)NC2=C3C=CC(=CC3=NC=C2)Cl,,,,,,
940,160941,"2-(3,7-Dimethylocta-2,6-dien-1-yl)benzene-1,4-diol",CC(=CCCC(=CCC1=C(C=CC(=C1)O)O)C)C,,,,,,
941,160942,S-(Carboxymethyl)cysteinyl-N-gamma-glutamylglycine,C(CC(=O)N(CC(=O)O)C(=O)[C@H](CSCC(=O)O)N)[C@@H](C(=O)O)N,,,,,,
942,160943,"Benzoyl-1,4-dipyrrolidinone",C1CC(=O)N(C1)C(=O)C2=CC=C(C=C2)C(=O)N3CCCC3=O,,,,,,
943,160944,Septonex,CCCCCCCCCCCCCCC(C(=O)OCC)[N+](C)(C)C.[Br-],,,,,,
944,160945,1-(Ethoxycarbonyl)pentadecyltrimethylaminium,CCCCCCCCCCCCCCC(C(=O)OCC)[N+](C)(C)C,,,,,,
945,160946,1-Cyclopropyl-1-nitrosourea,C1CC1N(C(=O)N)N=O,,,,,,
946,160947,(3-Lauramidopropyl)trimethylammonium methyl sulfate,CCCCCCCCCCCC(=O)NCCC[N+](C)(C)C.COS(=O)(=O)[O-],,,,,,
947,160948,"N-[3-(Lauroylamino)propyl]-N,N,N-trimethylaminium",CCCCCCCCCCCC(=O)NCCC[N+](C)(C)C,,,,,,
948,160949,4-Nitro-1H-benzimidazole,C1=CC2=C(C(=C1)[N+](=O)[O-])N=CN2,,,,,,
949,160950,Dehydrocorydaline chloride,CC1=C2C=CC(=C(C2=C[N+]3=C1C4=CC(=C(C=C4CC3)OC)OC)OC)OC.[Cl-],,,,,,
950,160951,Gratioside,C[C@]1(CC[C@H](O1)C(C)(C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)[C@H]3CC[C@@]4([C@@]3(CC(=O)[C@@]5([C@H]4CC=C6[C@H]5CC[C@@H](C6(C)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C)C)C,,,,,,
951,160952,CID 160952,CC1=C(C2=C(C=C1)C(=O)C3=C(C2=O)C=C4[C@@H]([C@H](C5=C(C4=C3O)C(=O)C6=C(NC(=CC6=C5)C)O)O)OC)O,,,,,,
952,160953,Nogalarene,CC1=C(C2=CC3=C(C(=C2C=C1)O)C(=O)C4=C(C=C5C(=C4C3=O)O[C@H]6[C@H]([C@@H]([C@H]([C@@]5(O6)C)O)N(C)C)O)O)C(=O)OC,,,,,,
953,160954,CID 160954,[NH3+][O-],,,,,,
954,160955,Aminooxidanide,N[O-],,,,,,
955,160956,Molybdatesilicate,O[Si](=O)O.[O-][Mo](=O)(=O)[O-],,,,,,
956,160957,Iron(3+) sulfide,[S-2].[S-2].[S-2].[Fe+3].[Fe+3],,,,,,
957,160958,CID 160958,B.B.[O-2].[K+].[K+],,,,,,
958,160959,manganese(II)oxide,[O-2].[Mn+2],,,,,,
959,160960,Titanium(4+);tetrachloride,[Cl-].[Cl-].[Cl-].[Cl-].[Ti+4],,,,,,
960,160961,Satin white pigment,[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Al+3].[Al+3].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2],,,,,,
961,160962,Tricopper tetrahydroxide sulphate,[OH-].[OH-].[OH-].[OH-].[O-]S(=O)(=O)[O-].[Cu+2].[Cu+2].[Cu+2],,,,,,
962,160963,Thallium hydroxide,[OH-].[Tl+],,,,,,
963,160964,Tin dihydroxide,[OH-].[OH-].[OH-].[OH-].[Sn+4],,,,,,
964,160965,Sodium zirconium oxide silicate (Na2ZrO(SiO4)),[O-2].[O-][Si]([O-])([O-])[O-].[Na+].[Na+].[Zr+4],,,,,,
965,160966,Indium sulfide (In2S3),[S-2].[S-2].[S-2].[In+3].[In+3],,,,,,
966,160967,Potassium niobium trioxide,[O-2].[O-2].[O-2].[K+].[Nb+5],,,,,,
967,160968,Lithium titanium oxide (Li2TiO3),[Li+].[Li+].[O-2].[O-2].[O-2].[Ti+4],,,,,,
968,160969,Azanylidynesilane,N#[SiH],,,,,,
969,160970,Sodium titanium oxide (Na2TiO3),[O-2].[O-2].[O-2].[Na+].[Na+].[Ti+4],,,,,,
970,160971,Silicon phosphate (Si3(PO4)4),[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[Si+4].[Si+4].[Si+4],,,,,,
971,160972,CID 160972,[P-]=[P-].[Zn+2],,,,,,
972,160973,CID 160973,[P-]=[P-],,,,,,
973,160974,Titanium monosulfide,[S-2].[S-2].[Ti+4],,,,,,
974,160975,"Silicic acid, aluminum magnesium sodium salt",[O-][Si](=O)[O-].[O-][Si](=O)[O-].[O-][Si](=O)[O-].[Na+].[Mg+2].[Al+3],,,,,,
975,160976,Bismuth sulfide,[S-2].[S-2].[S-2].[Bi+3].[Bi+3],,,,,,
976,160977,Bismuth oxide (BiO2),[O-2].[O-2].[O-2].[Bi+3].[Bi+3],,,,,,
977,160978,"Benzoic acid, 2-hydroxy-, disodium salt",C1=CC=C(C(=C1)C(=O)[O-])[O-].[Na+].[Na+],,,,,,
978,160979,But-2-enedioate;lead(2+),C(=CC(=O)[O-])C(=O)[O-].[Pb+2],,,,,,
979,160980,CID 160980,[O-]P(=O)[O-].[Na+].[Na+],,,,,,
980,160981,Copper(1+) sodium cyanide(1:1:2),[C-]#N.[C-]#N.[Na+].[Cu+],,,,,,
981,160982,Disodium uranium tetraoxide,[O-2].[O-2].[O-2].[O-2].[Na+].[Na+].[U],,,,,,
982,160983,"Hydroxylamine, O-acetyl-N-(methylcarbamoyl)-N-phenyl-",CC(=O)ON(C1=CC=CC=C1)C(=O)NC,,,,,,
983,160984,2-Phenylbenzo[f]chromen-3-one,C1=CC=C(C=C1)C2=CC3=C(C=CC4=CC=CC=C43)OC2=O,,,,,,
984,160985,CID 160985,[Li+].[O-]I(=O)=O,,,,,,
985,160986,Zirconium phosphate,[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[Zr+4].[Zr+4].[Zr+4],,,,,,
986,160987,Molybdenum zinc oxide,[O-2].[O-2].[O-2].[O-2].[Zn+2].[Mo],,,,,,
987,160988,Fluoroboron,BF,,,,,,
988,160989,"Aluminate(3-), hexafluoro-, potassium (1:3), (OC-6-11)-",[F-].[F-].[F-].[F-].[F-].[F-].[Al+3].[K+].[K+].[K+],,,,,,
989,160990,"Palladium, diamminedichloro-, cis-",N.N.[Cl-].[Cl-].[Pd+2],,,,,,
990,160991,Copper tellurite,O[Te](=O)O.[Cu+2],,,,,,
991,160992,Sulfuric acid-d2,[2H]OS(=O)(=O)O[2H],,,,,,
992,160993,"Selenious acid, cadmium salt (1:1)",O[Se](=O)O.[Cd],,,,,,
993,160994,Tetraammineplatinum tetrachloroplatinate,N.N.N.N.[Cl-].[Cl-].[Cl-].[Cl-].[Pt+2].[Pt+2],,,,,,
994,160995,Platin B salt,[NH4+].N.[Cl-].[Cl-].[Cl-].[Pt+2],,,,,,
995,160996,Trilithium hexafluoroaluminate,[Li+].[Li+].[Li+].[F-].[F-].[F-].[F-].[F-].[F-].[Al+3],,,,,,
996,160997,CID 160997,NS(=O)(=O)[O-].[K+],,,,,,
997,160998,"Boric acid (H3BO3), sodium salt",B([O-])([O-])[O-].[Na+],,,,,,
998,160999,Phosphoramidothioic acid,NP(=S)(O)O,,,,,,
999,161000,"Phosphoric acid, cadmium salt",OP(=O)(O)O.OP(=O)(O)O.OP(=O)(O)O.[Cd].[Cd],,,,,,
1000,161001,Ammonium sodium sulphate,[NH4+].[O-]S(=O)(=O)[O-].[Na+],,,,,,
1001,161002,"Oxo(29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)vanadium",C1=CC=C2C(=C1)C3=NC4=C5C=CC=CC5=C([N-]4)N=C6C7=CC=CC=C7C(=N6)N=C8C9=CC=CC=C9C(=N8)N=C2[N-]3.O=[V+2],,,,,,
1002,161003,Pyridoxylideneglutamate,CC1=NC=C(C(=C1O)C=N[C@@H](CCC(=O)O)C(=O)O)CO,,,,,,
1003,161004,Zinc hematoporphyrin,[H+].[H+].CC1=C(C2=CC3=C(C(=C([N-]3)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C1[N-]2)C)C(C)O)C)C(C)O)C)CCC(=O)[O-])CCC(=O)[O-].[Zn+2],,,,,,
1004,161005,Iodoindigane,[InH2]I,,,,,,
1005,161006,Mercury monofluoride,[F-].[F-].[Hg+2],,,,,,
1006,161007,Holmium-166,[166Ho],,,,,,
1007,161008,Terbium-160,[160Tb],,,,,,
1008,161009,Thulium-170,[170Tm],,,,,,
1009,161010,CID 161010,[127TeH2],,,,,,
1010,161011,CID 161011,[225RaH2],,,,,,
1011,161012,CID 161012,[114InH3],,,,,,
1012,161013,Tantalum-182,[182Ta],,,,,,
1013,161014,CID 161014,[72GaH3],,,,,,
1014,161015,Cadmium disulphamate,NS(=O)(=O)O.NS(=O)(=O)O.[Cd],,,,,,
1015,161016,Chromium(III) hexa-urea chloride,C(=O)(N)N.C(=O)(N)N.C(=O)(N)N.C(=O)(N)N.C(=O)(N)N.C(=O)(N)N.[Cl-].[Cl-].[Cl-].[Cr+3],,,,,,
1016,161017,Tris(ethylenediamine)rhodium trichloride,C(CN)N.C(CN)N.C(CN)N.[Cl-].[Cl-].[Cl-].[Rh+3],,,,,,
1017,161018,Ytterbium-175,[175Yb],,,,,,
1018,161019,CID 161019,[H-].[H-].[H-].[B+3].C1CCOC1,,,,,,
1019,161020,"Cobaltate(3-), hexakis(cyano-kappaC)-, zinc (2:3), (OC-6-11)-",[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[Co+3].[Co+3].[Co+3].[Zn+2].[Zn+2],,,,,,
1020,161021,"Europium(III)tris[1,1,1-trifluoro-4-oxo-4-(2-thienyl)-2-butene-2-olate]",C1=CSC(=C1)C(=CC(=O)C(F)(F)F)[O-].C1=CSC(=C1)C(=CC(=O)C(F)(F)F)[O-].C1=CSC(=C1)C(=CC(=O)C(F)(F)F)[O-].[Eu+3],,,,,,
1021,161022,"1-(2-Thienyl)-3-hydroxy-4,4,4-trifluoro-2-butene-1-one",C1=CSC(=C1)C(=CC(=O)C(F)(F)F)O,,,,,,
1022,161023,4-Hydroxyamino-3-methylpyridine 1-oxide,CC1=CN(C=CC1=NO)O,,,,,,
1023,161024,Molybdenum-93,[93Mo],,,,,,
1024,161025,Cerium-143,[143Ce],,,,,,
1025,161026,Osmium-191,[191Os],,,,,,
1026,161027,"3,3'-Dimethyloxacarbocyanine iodide",CN1C2=CC=CC=C2OC1=CC=CC3=[N+](C4=CC=CC=C4O3)C.[I-],,,,,,
1027,161028,3-Methyl-2-[3-[3-methylbenzoxazol-2(3H)-ylidene]-1-propenyl]benzoxazol-3-ium,CN1C2=CC=CC=C2OC1=CC=CC3=[N+](C4=CC=CC=C4O3)C,,,,,,
1028,161029,Iodine-126,[126IH],,,,,,
1029,161030,CID 161030,CCO.CCO.CCO.CCO.[GeH4],,,,,,
1030,161031,"1,1'-(Tetramethylenedioxy)bis(3-chloro-2-propanol)",C(CCOCC(CCl)O)COCC(CCl)O,,,,,,
1031,161032,Diallyl sulfoxide,C=CCS(=O)CC=C,,,,,,
1032,161033,CID 161033,[115InH3],,,,,,
1033,161034,"N-(6-chloro-1-phenyl-2,3-dihydroquinolin-4-ylidene)hydroxylamine",C1CN(C2=C(C1=NO)C=C(C=C2)Cl)C3=CC=CC=C3,,,,,,
1034,161035,CID 161035,C1=CC(=C(C=C1Cl)Cl)OCC(=O)[O-].[K+],,,,,,
1035,161036,Sweroside,C=C[C@@H]1[C@@H]2CCOC(=O)C2=CO[C@H]1O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
1036,161037,trans-Diamminediiodopalladium,N.N.[Pd+2].[I-].[I-],,,,,,
1037,161038,"Ferrate(3-), hexakis(cyano-kappaC)-, ammonium (1:3), (OC-6-11)-",[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[NH4+].[NH4+].[NH4+].[Fe+3],,,,,,
1038,161039,CID 161039,[132TeH2],,,,,,
1039,161040,Platinum(2+) potassium ethanedioate--water (1/2/2/2),C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].O.O.[K+].[K+].[Pt+2],,,,,,
1040,161041,"2-((4-((2-Chloro-4-nitrophenyl)azo)phenyl)ethylamino)-N,N,N-trimethylethanaminium methyl sulfate",CCN(CC[N+](C)(C)C)C1=CC=C(C=C1)N=NC2=C(C=C(C=C2)[N+](=O)[O-])Cl.COS(=O)(=O)[O-],,,,,,
1041,161042,"3-[[9,10-Dihydro-4-(methylamino)-9,10-dioxo-1-anthryl]aminopropyl]trimethylammonium methyl sulphate",CNC1=C2C(=C(C=C1)NCCC[N+](C)(C)C)C(=O)C3=CC=CC=C3C2=O.COS(=O)(=O)[O-],,,,,,
1042,161043,"Trimethyl-[3-[[4-(methylamino)-9,10-dioxoanthracen-1-yl]amino]propyl]azanium",CNC1=C2C(=C(C=C1)NCCC[N+](C)(C)C)C(=O)C3=CC=CC=C3C2=O,,,,,,
1043,161044,Tripotassium tetra(cyano-C)cuprate(3-),[C-]#N.[C-]#N.[C-]#N.[C-]#N.[K+].[K+].[K+].[Cu+],,,,,,
1044,161045,16-Hydroxyprogesterone,CC(=O)[C@H]1C(C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O,,,,,,
1045,161046,Lutetium-177,[177Lu],,,,,,
1046,161047,trans-Dibromotetrakis(pyridine)rhodium bromide,C1=CC=NC=C1.C1=CC=NC=C1.C1=CC=NC=C1.C1=CC=NC=C1.[Br-].[Br-].[Br-].[Rh+3],,,,,,
1047,161048,"3-(Phosphonooxy)propane-1,2-diyl dioctadec-9-enoate",CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)O)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
1048,161049,Gadolinium-153,[153Gd],,,,,,
1049,161050,Tripotassium hexathiocyanatochromate,C(#N)[S-].C(#N)[S-].C(#N)[S-].C(#N)[S-].C(#N)[S-].C(#N)[S-].[K+].[K+].[K+].[Cu+],,,,,,
1050,161051,"[(1S,2S,3S,7R,10R,11S,12S)-3,10,11-triacetyloxy-1,5-dimethyl-4-oxospiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-2-yl]methyl acetate",CC1=C[C@@H]2[C@]([C@@H](C1=O)OC(=O)C)([C@]3([C@@H]([C@H](C([C@@]34CO4)O2)OC(=O)C)OC(=O)C)C)COC(=O)C,,,,,,
1051,161052,Verazine,C[C@H]1CCC(=NC1)[C@@H](C)[C@H]2CC[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4(CC[C@@H](C5)O)C)C,,,,,,
1052,161053,Iron(3+);3-oxo-1-phenylbut-1-en-1-olate,CC(=O)C=C(C1=CC=CC=C1)[O-].CC(=O)C=C(C1=CC=CC=C1)[O-].CC(=O)C=C(C1=CC=CC=C1)[O-].[Fe+3],,,,,,
1053,161054,Vanadium-48,[48V],,,,,,
1054,161055,"Cadmium, isotope of mass 113",[113Cd],,,,,,
1055,161056,Tetrachloropalladate ion (PdCl42-),[Cl-].[Cl-].[Cl-].[Cl-].[Pd+2],,,,,,
1056,161057,Unii-99LY10G7K9,[H+].[H+].CCC1=C(C2=CC3=NC(=CC4=C(C(=C([N-]4)C=C5C(=C(C(=CC1=N2)[N-]5)C)CCC(=O)[O-])CCC(=O)[O-])C)C(=C3C)CC)C.[Zn+2],,,,,,
1057,161058,"2,8-Diethyl-3,7,12,18-tetramethyl-21H,23H-porphyrin-13,17-dipropanoic acid",CCC1=C(C2=CC3=C(C(=C(N3)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C1N2)C)CCC(=O)O)CCC(=O)O)C)CC)C)C,,,,,,
1058,161059,"tris(2,2'-bipyridyl)cobalt(III)",C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[Co+3],,,,,,
1059,161060,CID 161060,[125TeH2],,,,,,
1060,161061,CID 161061,[10BeH2],,,,,,
1061,161062,Rhenium-187,[187Re],,,,,,
1062,161063,Scandium-47,[47Sc],,,,,,
1063,161064,Magnesium Disodium EDTA,C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Mg+2],,,"['Substances that bind to and sequester CALCIUM ions. (See all compounds classified as Calcium Chelating Agents.)', 'Substances used in the processing or storage of foods or animal feed including ANTIOXIDANTS; FOOD PRESERVATIVES; FOOD COLORING AGENTS; FLAVORING AGENTS; ANTI-INFECTIVE AGENTS; EXCIPIENTS and other similarly used substances. Many of the same substances are used as PHARMACEUTIC AIDS. (See all compounds classified as Food Additives.)', 'Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)']",,,
1064,161065,CID 161065,CC1=C2C=CC(=O)C(=C2OC(=C1)O)CN(CCCl)CCCl,,,,,,
1065,161066,Ferric ferricyanide,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[Fe+3].[Fe+3],,,,,,
1066,161067,Potassium ferrocyanide trihyrate,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.O.O.O.[K+].[K+].[K+].[K+].[Fe+2],,,,,,
1067,161068,CID 161068,O[Si](=O)O.[MgH2].[CaH2],,,,,,
1068,161069,CID 161069,CC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C2)C4=NC5=C(N4)C(=O)N=C(N5)N,,,,,,
1069,161070,Dipotassium tetrakis(thiocyanato-S)palladate(2-),C(#N)[S-].C(#N)[S-].C(#N)[S-].C(#N)[S-].[K+].[K+].[Pd+2],,,,,,
1070,161071,"1,3-Butadiene, 2-chloro-, dimer",C=CC(=C)Cl.C=CC(=C)Cl,,,,,,
1071,161072,CID 161072,[CH+3],,,,,,
1072,161073,CID 161073,[CH2+2],,,,,,
1073,161074,Iron tribenzoate,C1=CC=C(C=C1)C(=O)[O-].C1=CC=C(C=C1)C(=O)[O-].C1=CC=C(C=C1)C(=O)[O-].[Fe+3],,,,,,
1074,161075,CID 161075,C1[C@@H]([C@H](OC1N2C=NC3=C2NC(=NC3=O)N)COP(=O)(O)O)O.N,,,,,,
1075,161076,2-Amino-3-chlorobutanoic acid,CC(C(C(=O)O)N)Cl,,,,,,
1076,161077,Norakin,C1CCN(CC1)CCC(C2C3CC4C2C4C3)(C5=CC=CC=C5)O.Cl,,,,,,
1077,161078,Triperiden free base,C1CCN(CC1)CCC(C2C3CC4C2C4C3)(C5=CC=CC=C5)O,,,,,,
1078,161079,CID 161079,[125SnH2],,,,,,
1079,161080,"Benzo(a)heptalen-9(5H)-one, 7-benzamido-6,7-dihydro-10-hydroxy-1,2,3-trimethoxy-",COC1=C(C(=C2C(=C1)CC[C@@H](C3=CC(=O)C(=CC=C32)O)NC(=O)C4=CC=CC=C4)OC)OC,,,,,,
1080,161081,Trisodium diphosphate,OP(=O)([O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+],,,,,,
1081,161082,"Cuprate(4-), (3-(2-(8-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-1-(hydroxy-kappaO)-3,6-disulfo-2-naphthalenyl)diazenyl-kappaN1)-4-(hydroxy-kappaO)-1,5-naphthalenedisulfonato(6-))-, sodium (1:1)",C1=CC2=C(C=C(C(=C2C(=C1)S(=O)(=O)[O-])[O-])N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)[O-])S(=O)(=O)[O-])NC5=NC(=NC(=N5)N)Cl)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Cu+2],,,,,,
1082,161083,"5-(4-Amino-6-chloro-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(1-hydroxy-4,8-disulfo-2-naphthalenylazo)naphthalene-2,7-disulfonic acid",C1=CC2=C(C=C(C(=C2C(=C1)S(=O)(=O)O)O)N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)O)S(=O)(=O)O)NC5=NC(=NC(=N5)N)Cl)O)S(=O)(=O)O,,,,,,
1083,161084,CID 161084,OP(=O)(O)OP(=O)(O)O.OP(=O)(O)OP(=O)(O)O.OP(=O)(O)OP(=O)(O)O.[AlH3].[AlH3].[AlH3].[AlH3],,,,,,
1084,161085,Pyrimethamine isethionate,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl.C(CS(=O)(=O)O)O,,,,,,
1085,161086,(2S)-2-amino-6-(phosphonoamino)hexanoic acid,C(CCNP(=O)(O)O)C[C@@H](C(=O)O)N,,,,,,
1086,161087,Garcinia biflavonoid 1,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)C3=C(C=C(C=C3O2)O)O)C4=C5C(=C(C=C4O)O)C(=O)[C@@H]([C@H](O5)C6=CC=C(C=C6)O)O)O,,,,,,
1087,161088,CID 161088,CCC1=C(C2=NC1=CC3=C(C4=C(C(C(=C5C(=C(C(=CC6=NC(=C2)C(=C6C)C=C)[N-]5)C)CCC(=O)OCC=C(C)CCCC(C)CCCC(C)CCCC(C)C)C4=N3)C(=O)OC)[O-])C)C.[Mg+2],,,,,,
1088,161089,CID 161089,CCC1=C(C2=NC1=CC3=C(C4=C(C(C(=C5C(=C(C(=N5)C=C6C(=C(C(=C2)N6)C=C)C)C)CCC(=O)OCC=C(C)CCCC(C)CCCC(C)CCCC(C)C)C4=N3)C(=O)OC)O)C)C,,,,,,
1089,161090,Diisopropoxy(2-oxo-5-oxa-3-heptene-4-yloxy) aluminum,CCOC(=O)C=C(C)[O-].CC(C)[O-].CC(C)[O-].[Al+3],,,,,,
1090,161091,2-Phenylquinolin-4-ol,C1=CC=C(C=C1)C2=CC(=O)C3=CC=CC=C3N2,,,,,,
1091,161092,Titanium lactate,CC(C(=O)[O-])O.CC(C(=O)[O-])O.CC(C(=O)[O-])O.CC(C(=O)[O-])O.[Ti+4],,,,,,
1092,161093,"1,2-Ethanediamine, phosphate",C(CN)N.OP(=O)(O)O,,,,,,
1093,161094,Hafnium-181,[181Hf],,,,,,
1094,161095,CID 161095,[131CsH],,,,,,
1095,161096,"s-Triazine, 2,4-bis(1-aziridinyl)-6-methoxy-",COC1=NC(=NC(=N1)N2CC2)N3CC3,,,,,,
1096,161097,Tungsten-185,[185W],,,,,,
1097,161098,Dicyanoaurate ion,[C-]#N.[C-]#N.[Au+],,,,,,
1098,161099,"5-[[4-(diethylamino)phenyl]azo]-1,4-dimethyl-1H-1,2,4-triazolium trichlorozincate(1-)",CCN(CC)C1=CC=C(C=C1)N=NC2[NH+](N=CN2C)C.Cl[Zn-](Cl)Cl,,,,,,
1099,161100,"4-[(2,4-dimethyl-3H-1,2,4-triazol-3-yl)diazenyl]-N,N-diethylaniline",CCN(CC)C1=CC=C(C=C1)N=NC2N(C=NN2C)C,,,,,,
1100,161101,Trichlorozinc(1-),Cl[Zn-](Cl)Cl,,,,,,
1101,161102,"Rhodate(3-), hexachloro-, trisodium, (OC-6-11)-",[Na+].[Na+].[Na+].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Rh+3],,,,,,
1102,161103,Praseodymium-143,[143Pr],,,,,,
1103,161104,Cloperastine hydrochloride,C1CCN(CC1)CCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl,,,,,,
1104,161105,Rhenium-186,[186Re],,,,,,
1105,161106,"2-{[4-(Dimethylamino)phenyl]diazenyl}-6-methoxy-3-methyl-1,3-benzothiazol-3-ium methyl sulfate",C[N+]1=C(SC2=C1C=CC(=C2)OC)N=NC3=CC=C(C=C3)N(C)C.COS(=O)(=O)[O-],,,,,,
1106,161107,Potassium ruthenium cyanide,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[K+].[K+].[K+].[K+].[Ru+2],,,,,,
1107,161108,Bis(4-phenoxyphenyl)diazene 1-oxide,C1=CC=C(C=C1)OC2=CC=C(C=C2)N=[N+](C3=CC=C(C=C3)OC4=CC=CC=C4)[O-],,,,,,
1108,161109,20-Hydroxypregn-4-en-3-one,CC([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O,,,,,,
1109,161110,"1,1-Cyclopropanediol",C1CC1(O)O,,,,,,
1110,161111,"N-Decyl-N,N-dimethyl-3-ammonio-1-propanesulfonate",CCCCCCCCCC[N+](C)(C)CCCS(=O)(=O)[O-],,,,,,
1111,161112,"3-(Decyldimethylammonio)propanesulfonate inner salt, 97%",CCCCCCCCCC[N+](C)(C)CCCS(=O)(=O)O,,,,,,
1112,161113,CID 161113,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC(=NC3=O)N)COP(=O)(O)OC4C[C@@H](O[C@@H]4CO)N5C=NC6=C5NC(=NC6=O)N)O,,,,,,
1113,161114,"1h-Isoindole-1,3(2h)-dione, 2-[(4-methylphenyl)thio]-",CC1=CC=C(C=C1)SN2C(=O)C3=CC=CC=C3C2=O,,,,,,
1114,161115,"methyl (9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17R)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate",CC[C@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,,,,,,
1115,161116,Lysergide tartrate,CCN(CC)C(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O,,,,,,
1116,161117,"(6aR)-N,N-diethyl-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide",CCN(CC)C(=O)C1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C,,,,,,
1117,161118,"7-Oxabicyclo[4.1.0]hept-3-ene-2,5-dione",C1=CC(=O)C2C(C1=O)O2,,,,,,
1118,161119,Trisodium tetra(cyano-C)cuprate(3-),[C-]#N.[C-]#N.[C-]#N.[C-]#N.[Na+].[Na+].[Na+].[Cu+],,,,,,
1119,161120,Ginkgolide C,CC1C(=O)OC2C1(C34C(=O)OC5C3(C2O)C6(C(C5O)C(C)(C)C)C(C(=O)OC6O4)O)O,,,,,,
1120,161121,N-Nitroso-N-phenylhydroxylamine aluminum salt,C1=CC=C(C=C1)N(N=O)[O-].C1=CC=C(C=C1)N(N=O)[O-].C1=CC=C(C=C1)N(N=O)[O-].[Al+3],,,,,,
1121,161122,"Benzenamine,N-hydroxy-N-nitroso-, ammonium salt (1:1)",C1=CC=C(C=C1)N(N=O)[O-],,,,,"['O-Alkylation of N-nitroso-N-phenylhydroxylamine ammonium salt (cupferron) was studied for the synthesis of novel nitric oxide (NO) releasing agents. The alkylation occurred regioselectively at the terminal oxygen, leading to a single product N-(alkyloxy)-N\'-phenyldiimide N\'-oxide as indicated by NMR and X-ray analysis. The O-alkyl derivatives exhibited significantly improved stability compared to their parent compound, cupferron. It was demonstrated that the cupferron O-alkyl derivatives could function as photoreleasing NO donor compounds. N-(N""-acetylphenylalanylmethylenyloxy)-N\'-phenyldiimide N\'-oxide), which linked the cupferron portion with an amino acid via an acetal moiety, was synthesized as an model NO prodrug where controlled NO release would occur either by increasing pH or by a protease-catalyzed hydrolysis.']",
1122,161123,Iron(3+);methyl 6-[3-[5-[[4-[5-[[4-[5-[acetyl(oxido)amino]pentylamino]-4-oxobutanoyl]-oxidoamino]pentylamino]-4-oxobutanoyl]-oxidoamino]pentylcarbamoyl]-5-hydroxyanilino]-4-amino-5-hydroxy-5-(hydroxymethyl)-6-methyl-2-oxopiperidine-3-carboximidate,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)C1=CC(=CC(=C1)O)NC2(C(C(C(C(=O)N2)C(=N)OC)N)(CO)O)C)[O-])[O-])[O-].[Fe+3],,,,,,
1123,161124,Methyl 6-[3-[5-[[4-[5-[[4-[5-[acetyl(oxido)amino]pentylamino]-4-oxobutanoyl]-oxidoamino]pentylamino]-4-oxobutanoyl]-oxidoamino]pentylcarbamoyl]-5-hydroxyanilino]-4-amino-5-hydroxy-5-(hydroxymethyl)-6-methyl-2-oxopiperidine-3-carboximidate,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)C1=CC(=CC(=C1)O)NC2(C(C(C(C(=O)N2)C(=N)OC)N)(CO)O)C)[O-])[O-])[O-],,,,,,
1124,161125,Neodymium pyrocatechin disulfonate,[H+].C1=C(C=C(C(=C1[O-])[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].C1=C(C=C(C(=C1[O-])[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Nd+3],,,,,,
1125,161126,"3,4-Dihydroxymethamphetamine",CC(CC1=CC(=C(C=C1)O)O)NC,,,,,"['N-Methyl-3,4dihydroxyamphetamine is a known human metabolite of N-methyl-3,4methylenedioxyamphetamine.']",
1126,161127,"Benzenesulfonic acid, 4-methyl-, compd. with N,N-diethylethanamine (1:1)",CCN(CC)CC.CC1=CC=C(C=C1)S(=O)(=O)O,,,,,,
1127,161128,CID 161128,[73AsH3],,,,,,
1128,161129,"trioxido-1kappa(2)O,2kappaO-dinitrate(N--N)(2-)",N(=O)N([O-])[O-],,,,,,
1129,161130,Aluminum chlorate,[O-]Cl(=O)=O.[O-]Cl(=O)=O.[O-]Cl(=O)=O.[Al+3],,,,,,
1130,161131,"(1s,5r)-1-Methyl-9-azabicyclo[3.3.1]nonan-3-one",C[C@@]12CCC[C@@H](N1)CC(=O)C2,,,,,,
1131,161132,Chlorodiethylenetriaminoplatinum,C(CNCCN)N.[Cl-].[Pt+2],,,,,,
1132,161133,CID 161133,[B-](CC)(CC)(CC)CC.[Na+],,,,,,
1133,161134,Tetraethylboron anion,[B-](CC)(CC)(CC)CC,,,,,,
1134,161135,Bis((2-hydroxyethyl)ammonium) sulphite,C(CO)N.C(CO)N.OS(=O)O,,,,,,
1135,161136,CID 161136,OS(=O)(=O)[O-].[Rb+],,,,,,
1136,161137,"Rhodium, trichlorotris(pyridine)-, sesquihydrate",C1=CC=NC=C1.C1=CC=NC=C1.C1=CC=NC=C1.[Cl-].[Cl-].[Cl-].[Rh],,,,,,
1137,161138,CID 161138,CC(C)C(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H](C(O1)N2C=NC3=C2NC(=NC3=O)N)O)OP(=O)(O)O)O,,,,,,
1138,161139,"Chromium, tetrachloro-mu-hydroxy(mu-(tetradecanoato-kappaO:kappaO'))di-",CCCCCCCCCCCCCC(=O)[O-].[OH-].[Cl-].[Cl-].[Cl-].[Cl-].[Cr+3].[Cr+3],,,,,,
1139,161140,Dimethialium,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)C,,,,,,
1140,161141,"cobalt(3+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate;hydrogen sulfite",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.OS(=O)[O-].[Co+3],,,,,,
1141,161142,Platinum-191,[191Pt],,,,,,
1142,161143,Tungsten-181,[181W],,,,,,
1143,161144,Phosphorus-33,[33PH3],,,,,,
1144,161145,"Iridate(3-), hexachloro-, triammonium, (OC-6-11)-",[NH4+].[NH4+].[NH4+].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Ir+3],,,,,,
1145,161146,Ruthenium-97,[97Ru],,,,,,
1146,161147,Technetium-97,[97Tc],,,,,,
1147,161148,Silver-111,[111Ag],,,,,,
1148,161149,Promethium-149,[149Pm],,,,,,
1149,161150,Lead dilaurate,CCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCC(=O)[O-].[Pb+2],,,,,,
1150,161151,CID 161151,[206BiH3],,,,,,
1151,161152,CID 161152,[H-].[Na+],,,,,,
1152,161153,Erbium-169,[169Er],,,,,,
1153,161154,Norketobemidone,CCC(=O)C1(CCNCC1)C2=CC(=CC=C2)O,,,,,['Norketobemidone is a known human metabolite of ketobemidone.'],
1154,161155,CID 161155,O[Si](O)(O)O.[NaH],,,,,,
1155,161156,"Phosphorodithioic acid, O,O-bis(2-ethylhexyl) ester, antimony(3+) salt",CCCCC(CC)COP(=S)(OCC(CC)CCCC)[S-].CCCCC(CC)COP(=S)(OCC(CC)CCCC)[S-].CCCCC(CC)COP(=S)(OCC(CC)CCCC)[S-].[Sb+3],,,,,,
1156,161157,"Titanium 2,2',2''-nitrilotrisethanolate",C(C[O-])N(CC[O-])CC[O-].[OH-].[Ti+4],,,,,,
1157,161158,Stizolobic acid,C1=C(C=C(OC1=O)C(=O)O)C[C@@H](C(=O)O)N,,,,,,
1158,161159,"1,3'-Diethyl-4,2'-quinolylthiacyanineiodide",CCN1C2=CC=CC=C2SC1=CC3=CC=[N+](C4=CC=CC=C34)CC.[I-],,,,,,
1159,161160,"Benzothiazolium, 3-ethyl-2-[(1-ethyl-4(1H)-quinolinylidene)methyl]-",CCN1C2=CC=CC=C2SC1=CC3=CC=[N+](C4=CC=CC=C34)CC,,,,,,
1160,161161,"3,4,5-Trihydroxyphenylalanine",C1=C(C=C(C(=C1O)O)O)C[C@@H](C(=O)O)N,,,,,,
1161,161162,CID 161162,O=[Cr](=O)=O.[Cl-].[K+],,,,,,
1162,161163,CID 161163,OP(O)O.[PbH2],,,,,,
1163,161164,Cobalt dilactate,CC(C(=O)[O-])O.CC(C(=O)[O-])O.[Co+2],,,,,,
1164,161165,Kynurenine sulfate,C1=CC=C(C(=C1)C(=O)C[C@@H](C(=O)O)N)N.OS(=O)(=O)O,,,,,,
1165,161166,L-kynurenine,C1=CC=C(C(=C1)C(=O)C[C@@H](C(=O)O)N)N,,,,,,
1166,161167,8-(4-Benzenesulfonylamino)quinoline,C1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC3=C2N=CC=C3,,,,,,
1167,161168,CID 161168,CC1=CC=C(C=C1)S(=O)(=O)[O-].[K+],,,,,,
1168,161169,"C.I. Direct Blue 76, tetrasodium salt",C1=CC(=C(C=C1C2=CC(=C(C=C2)N=NC3=C(C4=C(C=C3)C(=CC(=C4N)S(=O)(=O)[O-])S(=O)(=O)[O-])[O-])[O-])[O-])N=NC5=C(C6=C(C=C5)C(=CC(=C6N)S(=O)(=O)[O-])S(=O)(=O)[O-])[O-].[Na+].[Na+].[Na+].[Na+].[Cu+2].[Cu+2],,,,,,
1169,161170,"4-Amino-6-[[4-[4-[(8-amino-1-hydroxy-5,7-disulfonaphthalen-2-yl)diazenyl]-3-hydroxyphenyl]-2-hydroxyphenyl]diazenyl]-5-hydroxynaphthalene-1,3-disulfonic acid",C1=CC(=C(C=C1C2=CC(=C(C=C2)N=NC3=C(C4=C(C=C3)C(=CC(=C4N)S(=O)(=O)O)S(=O)(=O)O)O)O)O)N=NC5=C(C6=C(C=C5)C(=CC(=C6N)S(=O)(=O)O)S(=O)(=O)O)O,,,,,,
1170,161171,Ephedroxane,C[C@H]1[C@H](OC(=O)N1C)C2=CC=CC=C2,,,,,,
1171,161172,"5,7-Dimethoxy-4'-hydroxyflavone",COC1=CC2=C(C(=C1)OC)C(=O)C=C(O2)C3=CC=C(C=C3)O,,,,,,
1172,161173,(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid,C[C@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N,,,,,,
1173,161174,3-Chloro-4-(2-amino-3-chlorophenyl)pyrrole,C1=CC(=C(C(=C1)Cl)N)C2=CNC=C2Cl,,,,,,
1174,161175,"2,3-Dihydroxybenzoylglycine",C1=CC(=C(C(=C1)O)O)C(=O)NCC(=O)O,,,,,,
1175,161176,12-Hydroxyrotenone,CC(=C)[C@H]1CC2=C(O1)C=CC3=C2O[C@H]4COC5=CC(=C(C=C5[C@]4(C3=O)O)OC)OC,,,,,,
1176,161177,Podophyllotoxin glucoside,COC1=CC(=CC(=C1OC)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](C4=CC5=C(C=C24)OCO5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O,,,,,,
1177,161178,Androst-16-ene,C[C@]12CC[C@H]3[C@H]([C@@H]1CC=C2)CCC4[C@@]3(CCCC4)C,,,,,,
1178,161179,"Cuprate(2-), bis(3-(hydroxy-kappaO)-4-(phenylazo)-2-naphthalenecarboxylato(2-)-kappaO)-, dihydrogen",[H+].[H+].C1=CC=C(C=C1)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)[O-])[O-].C1=CC=C(C=C1)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)[O-])[O-].[Cu+2],,,,,,
1179,161180,CID 161180,C1CCN(C1)C(=NN=CC2=CC=CC=N2)S,,,,,,
1180,161181,Zinc phenanthroline complex,C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1.[Zn+2],,,,,,
1181,161182,"2H-Naphtho[1,2-d]triazole-5-sulfonic acid, 2-[4-[2-[4-[[2-methyl-4-(7-sulfo-2H-naphtho[1,2-d]triazol-2-yl)phenyl]azo]-2-sulfophenyl]ethenyl]-3-sulfophenyl]-, tetrasodium salt",CC1=C(C=CC(=C1)N2N=C3C=CC4=C(C3=N2)C=CC(=C4)S(=O)(=O)[O-])N=NC5=CC(=C(C=C5)C=CC6=C(C=C(C=C6)N7N=C8C=C(C9=CC=CC=C9C8=N7)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
1182,161183,"2-{4-[2-(4-{[2-Methyl-4-(7-sulfo-2H-naphtho[1,2-d][1,2,3]triazol-2-yl)phenyl]diazenyl}-2-sulfophenyl)ethenyl]-3-sulfophenyl}-2H-naphtho[1,2-d][1,2,3]triazole-5-sulfonic acid",CC1=C(C=CC(=C1)N2N=C3C=CC4=C(C3=N2)C=CC(=C4)S(=O)(=O)O)N=NC5=CC(=C(C=C5)C=CC6=C(C=C(C=C6)N7N=C8C=C(C9=CC=CC=C9C8=N7)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
1183,161184,"(2S,3S,4S,5R,6R)-6-[3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O)C)C,,,,,,
1184,161185,"Butanedioic acid, sulfo-, 1,4-didecyl ester, calcium salt",CCCCCCCCCCOC(=O)CC(C(=O)OCCCCCCCCCC)S(=O)(=O)[O-].CCCCCCCCCCOC(=O)CC(C(=O)OCCCCCCCCCC)S(=O)(=O)[O-].[Ca+2],,,,,,
1185,161186,3-Chloro-2-methylpropanoic acid,CC(CCl)C(=O)O,,,,,,
1186,161187,S-Adenosyl-2-methylmethionine,CC(CC[S+](C)C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O)(C(=O)[O-])N,,,,,,
1187,161188,"(3-amino-3-carboxybutyl)-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-methylsulfanium",CC(CC[S+](C)C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O)(C(=O)O)N,,,,,,
1188,161189,"2-(3,4-Dichlorophenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile",CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)Cl)Cl,,,,,,
1189,161190,"Pyridinium, 3,3'-(1,4-phenylenebis(carbonylimino-4,1-phenylenecarbonylimino))bis(1-ethyl-, salt with 4-methylbenzenesulfonic acid (1:1)",CC[N+]1=CC=CC(=C1)C(=O)NC2=CC=C(C=C2)C(=O)NC3=CC=CC(=C3)C(=O)NC4=CC=C(C=C4)C(=O)NC5=C[N+](=CC=C5)CC.CC1=CC=C(C=C1)S(=O)(=O)[O-].CC1=CC=C(C=C1)S(=O)(=O)[O-],,,,,,
1190,161191,1-ethyl-N-[4-[[3-[[4-[(1-ethylpyridin-1-ium-3-yl)carbamoyl]phenyl]carbamoyl]phenyl]carbamoyl]phenyl]pyridin-1-ium-3-carboxamide,CC[N+]1=CC=CC(=C1)C(=O)NC2=CC=C(C=C2)C(=O)NC3=CC=CC(=C3)C(=O)NC4=CC=C(C=C4)C(=O)NC5=C[N+](=CC=C5)CC,,,,,,
1191,161192,Pereniporin B,C[C@]12CCCC([C@@H]1[C@@H](C=C3[C@@]2(COC3=O)O)O)(C)C,,,,,,
1192,161193,CID 161193,C[C@H]([C@@H](C1=CC=CC=C1)O)NCCC(=O)C2=CC(=CC=C2)OC.Cl,,,,,,
1193,161194,"3-[[(1R,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-(3-methoxyphenyl)propan-1-one",C[C@H]([C@@H](C1=CC=CC=C1)O)NCCC(=O)C2=CC(=CC=C2)OC,,,,,,
1194,161195,2-Benzoylbenzaldehyde,C1=CC=C(C=C1)C(=O)C2=CC=CC=C2C=O,,,,,,
1195,161196,N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-5-iodo-2-methoxybenzamide,COC1=C(C=C(C=C1)I)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,,,,,,
1196,161197,gamma-Glutamylaspartic acid,C(CC(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C(=O)O)N,,,,,,
1197,161198,CID 161198,O.O.O.O.O.O.O.O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.[AlH3].[AlH3],,,,,,
1198,161199,2-[3-(8-Azabicyclo[3.2.1]octan-3-yl)phenyl]-3-hydroxypropanoic acid,C1CC2CC(CC1N2)C3=CC(=CC=C3)C(CO)C(=O)O,,,,,,
1199,161200,"5H-Dibenz(b,f)azepine-5-propanaminium, 10,11-dihydro-N,N,N-trimethyl-",C[N+](C)(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,,,,,,
1200,161201,Pentaamminechloroplatinum(3+) trichloride,N.N.N.N.N.[Cl-].[Cl-].[Cl-].[Cl-].[Pt+4],,,,,,
1201,161202,CID 161202,[H+].[B+3].[OH-].[F-].[F-].[F-],,,,,,
1202,161203,"Benzenesulfonamide, N-bromo-, sodium salt",C1=CC=C(C=C1)S(=O)(=O)NBr.[Na+],,,,,,
1203,161204,N-bromobenzenesulfonamide,C1=CC=C(C=C1)S(=O)(=O)NBr,,,,,,
1204,161205,"Palladate(2-), tetrachloro-, dihydrogen, (SP-4-1)-",[H+].[H+].[Cl-].[Cl-].[Cl-].[Cl-].[Pd+2],,,,,,
1205,161206,"2,5-Cyclohexadiene-1,4-dione, 2-(1,5-dimethyl-4-hexenyl)-3,6-dihydroxy-5-methyl-, (R)-",CC1=C(C(=O)C(=C(C1=O)O)[C@H](C)CCC=C(C)C)O,,,,,,
1206,161207,CID 161207,CC(C(=O)[O-])Cl.[Na+],,,,,,
1207,161208,PZ-Peptide,CC(C)C[C@@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)OCC3=CC=C(C=C3)N=NC4=CC=CC=C4,,,,,,
1208,161209,2-Hydroxyheptanal,CCCCCC(C=O)O,,,,,,
1209,161210,Metyrapol,CC(C)(C1=CN=CC=C1)C(C2=CN=CC=C2)O,,,,,,
1210,161211,"1,3-Dichloropropan-2-yl methanesulfonate",CS(=O)(=O)OC(CCl)CCl,,,,,,
1211,161212,CID 161212,CCCCCCCCCCC(=O)[O-].[Na+],,,,,,
1212,161213,4-Oxopent-2-en-2-olate,CC(=CC(=O)C)[O-],,,,,,
1213,161214,CID 161214,CSC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C2NC=NC3=O)O)O,,,,,,
1214,161215,Brucine N-oxide hydrate,COC1=C(C=C2C(=C1)[C@]34CC[N+]5([C@H]3C[C@@H]6C7C4N2C(=O)CC7OCC=C6C5)[O-])OC,,,,,,
1215,161216,4'-Hydroxydiazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=C(C=C3)O,,,,,,
1216,161217,CID 161217,C(CCCC(=O)O)CCCC(=O)[O-].[Na+],,,,,,
1217,161218,Aristolochic acid d,COC1=CC(=CC2=C3C(=C(C=C12)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)O)O,,,,,,
1218,161219,N-[2-(4-Hydroxyphenyl)ethyl]triimidodicarbonic diamide,C1=CC(=CC=C1CCN(C(=N)N)C(=N)N)O,,,,,,
1219,161220,Quinol sulfate,C1=CC(=CC=C1O)OS(=O)(=O)O,,,,,,
1220,161221,"Titanate(2-), hexafluoro-, dihydrogen, (OC-6-11)-",[H+].[H+].[F-].[F-].[F-].[F-].[F-].[F-].[Ti+4],,,,,,
1221,161222,Dicyclohexano-30-crown-10,C1CCC2C(C1)OCCOCCOCCOCCOC3CCCCC3OCCOCCOCCOCCO2,,,,,,
1222,161223,Pglcua,CCCCCCCCCCCCCCCCO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)C(=O)O)O)O)O,,,,,,
1223,161224,"Octanoic acid, compd. with 1-octanamine (1:1)",CCCCCCCCN.CCCCCCCC(=O)O,,,,,,
1224,161225,Udp galactosamine,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)O[C@@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)N)O)O,,,,,,
1225,161226,4-Oxopent-2-en-2-olate;titanium(4+),CC(=CC(=O)C)[O-].CC(=CC(=O)C)[O-].CC(=CC(=O)C)[O-].CC(=CC(=O)C)[O-].[Ti+4],,,,,,
1226,161227,2-Keto-3-deoxygluconate,C([C@@H]([C@@H](CO)O)O)C(=O)C(=O)O,,,,,,
1227,161228,Nonanoic acid diethanolamine salt,CCCCCCCCC(=O)O.C(CO)NCCO,,,,,,
1228,161229,HMBOA D-glucoside,COC1=CC2=C(C=C1)NC(=O)C(O2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
1229,161230,Amminetrichloroplatinum(1-),N.[Cl-].[Cl-].[Cl-].[Pt+2],,,,,,
1230,161231,Palladium-107,[107Pd],,,,,,
1231,161232,CID 161232,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=C(N=C3S)N)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,,,,,,
1232,161233,Nicotinic acid riboside,C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)[O-],,,,,,
1233,161234,D-ribosylnicotinic acid,C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)O,,,,,,
1234,161235,CID 161235,CC1=CC(=C(C=C1Cl)S(=O)(=O)O)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)O)O.[BaH2],,,,,,
1235,161236,(4-Carboxybutyl)triphenylphosphonium bromide,C1=CC=C(C=C1)[P+](CCCCC(=O)O)(C2=CC=CC=C2)C3=CC=CC=C3.[Br-],,,,,,
1236,161237,5-(Triphenylphosphonio)valerate,C1=CC=C(C=C1)[P+](CCCCC(=O)O)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
1237,161238,CID 161238,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=C(C2=O)C=CC=C3O)O,,,,,,
1238,161239,4-Oxopent-2-en-2-olate;propan-2-olate;titanium(4+),CC(C)[O-].CC(C)[O-].CC(=CC(=O)C)[O-].CC(=CC(=O)C)[O-].[Ti+4],,,,,,
1239,161240,N(6)-[(indol-3-yl)acetyl]-L-lysine,C1=CC=C2C(=C1)C(=CN2)CC(=O)NCCCC[C@@H](C(=O)O)N,,,,,,
1240,161241,"Phosphonic acid, azidomethyl-, diethyl ester",CCOP(=O)(CN=[N+]=[N-])OCC,,,,,,
1241,161242,"Phosphonic acid, azidomethyl-, ethyl methyl ester",CCOP(=O)(CN=[N+]=[N-])OC,,,,,,
1242,161243,Chelirubine,C[N+]1=CC2=C3C(=CC(=C2C4=C1C5=CC6=C(C=C5C=C4)OCO6)OC)OCO3,,,,,,
1243,161244,"3a,3'a(1H,1'H):7',3''a(1''H)-Terpyrrolo[2,3-b]indole, 2,2',2'',3,3',3'',8,8',8'',8a,8'a,8''a-dodecahydro-1,1',1''-trimethyl-",CN1CCC2(C1NC3=CC=CC=C32)C4=C5C(=CC=C4)C6(CCN(C6N5)C)C78CCN(C7NC9=CC=CC=C89)C,,,,,,
1244,161245,Fenproporex hydrochloride,CC(CC1=CC=CC=C1)NCCC#N.Cl,,,,,,
1245,161246,Salicylamide glucuronide,C1=CC=C(C(=C1)C(=O)N)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O,,,,,,
1246,161247,"Benzene, [3-[(trichloromethyl)sulfinyl]-1,2-propadienyl]-",C1=CC=C(C=C1)C=C=CS(=O)C(Cl)(Cl)Cl,,,,,,
1247,161248,3-Doxylcholestane,C[C@H](CCCC(C)C)[C@H]1CCC2[C@@]1(CCC3C2CC[C@@H]4[C@@]3(CCC5(C4)N(C(CO5)(C)C)[O])C)C,,,,,,
1248,161249,"Quinolinium, 6,6'-(p,p'-biphenylylenebis(carbonylimino))bis(1-ethyl-, ditosylate",CC[N+]1=CC=CC2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C4=CC=C(C=C4)C(=O)NC5=CC6=C(C=C5)[N+](=CC=C6)CC.CC1=CC=C(C=C1)S(=O)(=O)[O-].CC1=CC=C(C=C1)S(=O)(=O)[O-],,,,,,
1249,161250,N-(1-ethylquinolin-1-ium-6-yl)-4-[4-[(1-ethylquinolin-1-ium-6-yl)carbamoyl]phenyl]benzamide,CC[N+]1=CC=CC2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C4=CC=C(C=C4)C(=O)NC5=CC6=C(C=C5)[N+](=CC=C6)CC,,,,,,
1250,161251,4-Carbethoxyhexafluorobutyryl chloride,CCOC(=O)C(C(C(C(=O)Cl)(F)F)(F)F)(F)F,,,,,,
1251,161252,Lithium picrate,[Li+].C1=C(C=C(C(=C1[N+](=O)[O-])[O-])[N+](=O)[O-])[N+](=O)[O-],,,,,,
1252,161253,"Carbonic acid, bismuth salt",C(=O)([O-])[O-].C(=O)([O-])[O-].C(=O)([O-])[O-].[Bi+3].[Bi+3],,,,,,
1253,161254,Einecs 242-520-2,[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[Mn+2],,,,,,
1254,161255,Leucodopachrome,C1[C@H](NC2=CC(=C(C=C21)O)O)C(=O)O,,,,,,
1255,161256,"Propanedinitrile, (bis(ethylthio)methylene)-",CCSC(=C(C#N)C#N)SCC,,,,,,
1256,161257,Penicillamine cysteine disulfide,CC(C)([C@H](C(=O)O)N)SSC[C@@H](C(=O)O)N,,,,,,
1257,161258,Dttp alphas,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=S)(O)OP(=O)(O)OP(=O)(O)O)O,,,['Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)'],,,
1258,161259,Garcinia biflavonoid 2,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)C3=C(C=C(C=C3O2)O)O)C4=C5C(=C(C=C4O)O)C(=O)[C@@H]([C@H](O5)C6=CC(=C(C=C6)O)O)O)O,,,,,,
1259,161260,Cycloguanide phenylsulfone,CC1(N=C(N=C(N1C2=CC=C(C=C2)S(=O)(=O)C3=CC=C(C=C3)N4C(=NC(=NC4(C)C)N)N)N)N)C.Cl.Cl,,,,,,
1260,161261,"1-[4-[4-(4,6-Diamino-2,2-dimethyl-1,3,5-triazin-1-yl)phenyl]sulfonylphenyl]-6,6-dimethyl-1,3,5-triazine-2,4-diamine",CC1(N=C(N=C(N1C2=CC=C(C=C2)S(=O)(=O)C3=CC=C(C=C3)N4C(=NC(=NC4(C)C)N)N)N)N)C,,,,,,
1261,161262,2-Hydroxymandelic acid,C1=CC=C(C(=C1)C(C(=O)[O-])O)O,,,,,,
1262,161263,2-Hydroxy-2-(2-hydroxyphenyl)acetic acid,C1=CC=C(C(=C1)C(C(=O)O)O)O,,,,,,
1263,161264,"(1R,3S,4S,7S,11S,12R)-4-Hydroxy-1,4-dimethyl-12-(6-methylhept-5-en-2-yl)-6-oxotricyclo[9.3.0.03,7]tetradec-8-ene-8-carbaldehyde",CC(CCC=C(C)C)[C@H]1CC[C@]2([C@H]1CC=C([C@@H]3[C@H](C2)[C@@](CC3=O)(C)O)C=O)C,,,,,,
1264,161265,CID 161265,CC1=CC=C(C=C1)S(=O)(=O)[O-].CC1=CC=C(C=C1)S(=O)(=O)[O-].C[N+]1=CC=CC(=C1)NC(=O)C2=CC=C(C=C2)NC(=O)C=CC3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)C(=O)NC5=C[N+](=CC=C5)C,,,,,,
1265,161266,CID 161266,C[N+]1=CC=CC(=C1)NC(=O)C2=CC=C(C=C2)NC(=O)C=CC3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)C(=O)NC5=C[N+](=CC=C5)C,,,,,,
1266,161267,4-Carboxyphenylglycylaminoacetonitrile,C1=CC(=CC=C1C(=O)O)NCC(=O)NCC#N,,,,,,
1267,161268,methyl 2-(4-chloro-1H-indol-3-yl)acetate,COC(=O)CC1=CNC2=C1C(=CC=C2)Cl,,,,,,
1268,161269,CID 161269,O[Si](O)(O)O.O[Si](O)(O)O.[MgH2].[MgH2].[MgH2].[Fe],,,,,,
1269,161270,CID 161270,C1=CC(=O)C=C2C1=CC(=C(O2)O)C#N,,,,,,
1270,161271,Salvigenin,COC1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC)OC)O,,,,,,
1271,161272,"Adenosine, thymidylyl-(3'-5')-2'-deoxy-",CC1=CN(C(=O)NC1=O)[C@@H]2C[C@@H]([C@H](O2)OP(=O)(O)OC[C@@H]3[C@H](C[C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)CO,,,,,,
1272,161273,"13,14-Dihydro-PGE1",CCCCC[C@@H](CC[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O,,,,,,
1273,161274,"5alpha-Androstane-3beta,7alpha,17beta-triol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@@H](C[C@@H]4[C@@]3(CC[C@@H](C4)O)C)O,,,,,,
1274,161275,CID 161275,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)S)O)O)N,,,,,,
1275,161276,Secologanin,COC(=O)C1=CO[C@H]([C@@H]([C@@H]1CC=O)C=C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
1276,161277,[Acetyl-(1-oxidoquinolin-1-ium-4-yl)amino] acetate,CC(=O)N(C1=CC=[N+](C2=CC=CC=C21)[O-])OC(=O)C,,,,,,
1277,161278,CID 161278,CC=C1CN([C@@H]1C(=O)O)C(=O)[C@H]([C@@H]2[C@H]([C@H]([C@@H](O2)N3C=C(C(=O)NC3=O)CO)O)O)NC(=O)[C@H]([C@@H]([C@H](COC(=O)N)O)O)N,,,,,,
1278,161279,"L-Methionine, N-(N-(N-L-seryl-L-tyrosyl)-L-seryl)-",CSCC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C1=CC=C(C=C1)O)C(=O)[C@@H](CO)N)N,,,,,,
1279,161280,CID 161280,C1NC(=CC=N1)N,,,,,,
1280,161281,Cerium(III) chloride hydrate,O.Cl[Ce](Cl)Cl,,,,,,
1281,161282,Cerium trichloride,Cl[Ce](Cl)Cl,,,,,,
1282,161283,N-Desmethylpheniramine,CNCCC(C1=CC=CC=C1)C2=CC=CC=N2,,,,,,
1283,161284,3-Phenyl-3-pyridin-2-ylpropan-1-amine,C1=CC=C(C=C1)C(CCN)C2=CC=CC=N2,,,,,,
1284,161285,"(2S,3R,5R,9R,10R,13R,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R)-2,3,6,7-tetrahydroxy-6-methylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one",C[C@]12CC[C@H]3C(=CC(=O)[C@H]4[C@@]3(C[C@@H]([C@@H](C4)O)O)C)C1(CC[C@@H]2[C@](C)([C@@H](CCC(C)(CO)O)O)O)O,,,,,,
1285,161286,"Androst-7-ene-6,17-dione, 2,3,14-trihydroxy-, (2beta,3beta,5beta)-",C[C@]12CC[C@H]3C(=CC(=O)[C@H]4[C@@]3(C[C@@H]([C@@H](C4)O)O)C)C1(CCC2=O)O,,,,,,
1286,161287,"[2-(2,6-Dichlorophenyl)ethyl]hydrazine",C1=CC(=C(C(=C1)Cl)CCNN)Cl,,,,,,
1287,161288,"N,N,N'-Triphenyl-p-phenylenediamine",C1=CC=C(C=C1)NC2=CC=C(C=C2)N(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
1288,161289,"Cholesta-5,7,22-trien-3b-ol",C[C@H](C=CCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=CC=C4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
1289,161290,Phenestrol,CCC(C1=CC=C(C=C1)OC(=O)CC2=CC=C(C=C2)N(CCCl)CCCl)C(CC)C3=CC=C(C=C3)OC(=O)CC4=CC=C(C=C4)N(CCCl)CCCl,,,,,,
1290,161291,"4-Methyl-5-phenyl-1,3,4-thiadiazol-4-ium-2-thiolate",C[N+]1=C(SC(=N1)[S-])C2=CC=CC=C2,,,,,,
1291,161292,CID 161292,C[N+]1=C(SC(=N1)S)C2=CC=CC=C2,,,,,,
1292,161293,"(2R,3R,4S,5S,6R)-2-[[(10R,13R,17R)-17-[(2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol",CC[C@H](C=C[C@@H](C)[C@H]1CCC2[C@@]1(CCC3C2CC=C4[C@@]3(CCC(C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)C)C(C)C,,,,,,
1293,161294,Peimisine,C[C@H]1C[C@@H]2[C@H]([C@H]([C@]3(O2)CC[C@H]4[C@@H]5CC(=O)[C@H]6C[C@H](CC[C@@]6([C@H]5CC4=C3C)C)O)C)NC1,,,,,,
1294,161295,methyl 3-[5-[(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-2-[[5-[(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-3-(3-methoxy-3-oxopropyl)-4-methyl-1H-pyrrol-2-yl]methyl]-4-methyl-1H-pyrrol-3-yl]propanoate,CC1=C(NC(=C1CCC(=O)OC)CC2=C(C(=C(N2)C=C3C(=C(C(=O)N3)C)C=C)C)CCC(=O)OC)C=C4C(=C(C(=O)N4)C=C)C,,,,,,
1295,161296,CID 161296,C(CS(=O)(=O)[O-])OCC(CS)S.[Na+],,,,,,
1296,161297,"2-[2,3-Bis(sulfanyl)propoxy]ethanesulfonic acid",C(CS(=O)(=O)O)OCC(CS)S,,,,,,
1297,161298,(+)-Maackiain,C1[C@H]2[C@@H](C3=C(O1)C=C(C=C3)O)OC4=CC5=C(C=C24)OCO5,,,,,,
1298,161299,"2,6-Diethylcyclohexanamine",CCC1CCCC(C1N)CC,,,,,,
1299,161300,Isoleurosine,CC[C@@H]1C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,,,,,,
1300,161301,Dihydrogriesenin,CC12CCC3=CCC4C(CC3(O1)CO2)OC(=O)C4=C,,,,,,
1301,161302,6-Demethylgriseofulvin,CC1CC(=O)C=C(C12C(=O)C3=C(C=C(C(=C3O2)Cl)O)OC)OC,,,,,,
1302,161303,"Octanoic acid, chromium salt",CCCCCCCC(=O)[O-].CCCCCCCC(=O)[O-].CCCCCCCC(=O)[O-].[Cr+3],,,,,,
1303,161304,"3,6-Bis(dimethylamino)-10-methylacridinium chloride",C[N+]1=C2C=C(C=CC2=CC3=C1C=C(C=C3)N(C)C)N(C)C.[Cl-],,,,,,
1304,161305,CID 161305,C1=C(C=C(C(=C1[O-])Cl)Cl)Cl.[Na+],,,,,,
1305,161306,2-Hydroxy-6-tridecylbenzoic acid,CCCCCCCCCCCCCC1=C(C(=CC=C1)O)C(=O)O,,,,,,
1306,161307,"Ethanol, 2,2'-iminobis-, sulfate (2:1) (salt)",C(CO)NCCO.C(CO)NCCO.OS(=O)(=O)O,,,,,,
1307,161308,[4-[4-(4-Octanoyloxyphenyl)hexan-3-yl]phenyl] octanoate,CCCCCCCC(=O)OC1=CC=C(C=C1)C(CC)C(CC)C2=CC=C(C=C2)OC(=O)CCCCCCC,,,,,,
1308,161309,beta-Ergocryptine,CC[C@H](C)[C@@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=CNC7=CC=CC(=C67)C5=C4)C)O,,,,,,
1309,161310,5-Hydroxyemodin,CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C(=C(C=C3O)O)O,,,,,,
1310,161311,"2-Pentanol, 4-methyl-, hydrogen phosphorodithioate, lead(2+) salt",CC(C)CC(C)OP(=S)(OC(C)CC(C)C)S.CC(C)CC(C)OP(=S)(OC(C)CC(C)C)S.[Pb+2],,,,,,
1311,161312,Dihydrostreptose,CC(C(CO)(C(C=O)O)O)O,,,,,,
1312,161313,Anabasamine,CN1CCCCC1C2=CN=C(C=C2)C3=CN=CC=C3,,,,,,
1313,161314,Crotepoxide,CC(=O)O[C@@H]1[C@@H]2[C@@H](O2)[C@@H]3[C@]([C@H]1OC(=O)C)(O3)COC(=O)C4=CC=CC=C4,,,,,,
1314,161315,Acetylaranotin,CC(=O)OC1C=COC=C2C1N3C(=O)C45CC6=COC=CC(C6N4C(=O)C3(C2)SS5)OC(=O)C,,,,,,
1315,161316,Einecs 243-855-7,[H+].CC1=NN(C(=C1N=NC2=C(C=CC(=C2)S(=O)(=O)C)[O-])[O-])C3=CC(=CC=C3)Cl.CC1=NN(C(=C1N=NC2=C(C=CC(=C2)S(=O)(=O)C)[O-])[O-])C3=CC(=CC=C3)Cl.CC(C)C1=CC2=C(C=C1)[C@]3(CCC[C@@]([C@@H]3CC2)(C)CN)C.[Co+3],,,,,,
1316,161317,1-(3-Chlorophenyl)-4-[2-[2-hydroxy-5-(methylsulfonyl)phenyl]diazenyl]-3-methyl-1H-pyrazol-5-ol,CC1=C(C(=O)N(N1)C2=CC(=CC=C2)Cl)N=NC3=C(C=CC(=C3)S(=O)(=O)C)O,,,,,,
1317,161318,Copper octanoate,CCCCCCCC(=O)[O-].CCCCCCCC(=O)[O-].[Cu+2],,,,,,
1318,161319,N(4)-Methoxycytosine,CONC1=CC=NC(=O)N1,,,,,,
1319,161320,CID 161320,CCOC(=O)CN1C(=C(O)OCC)C(=O)C2=CC=CC=C2S1(=O)=O,,,,,,
1320,161321,3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1-amine,CNCCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,,,,,,
1321,161322,Didesmethylchlorpheniramine,C1=CC=NC(=C1)C(CCN)C2=CC=C(C=C2)Cl,,,,,,
1322,161323,"(6aR,10aR)-3-hexyl-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol",CCCCCCC1=CC(=C2[C@@H]3CC(=CC[C@H]3C(OC2=C1)(C)C)C)O,,,,,,
1323,161324,cis-Ammine(dimethylsulfinyl)dichloroplatinum (II),CS(=O)C.N.[Cl-].[Cl-].[Pt+2],,,,,,
1324,161325,"Pyridinium, 4,4'-(terephthaloylbis(imino-p-phenyleneimino))bis(1-methyl-, di-p-toluenesulfonate",CC1=CC=C(C=C1)S(=O)(=O)[O-].CC1=CC=C(C=C1)S(=O)(=O)[O-].C[N+]1=CC=C(C=C1)NC2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)NC5=C[N+](=CC=C5)C,,,,,,
1325,161326,"4-N-[4-[(1-methylpyridin-1-ium-3-yl)amino]phenyl]-1-N-[4-[(1-methylpyridin-1-ium-4-yl)amino]phenyl]benzene-1,4-dicarboxamide",C[N+]1=CC=C(C=C1)NC2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)NC5=C[N+](=CC=C5)C,,,,,,
1326,161327,CID 161327,CC1=CC=C(C=C1)S(=O)(=O)[O-].CC1=CC=C(C=C1)S(=O)(=O)[O-].C[N+]1=CC=C(C=C1)NC2=CC=C(C=C2)NC(=O)C=CC3=CC=C(C=C3)C=CC(=O)NC4=CC=C(C=C4)NC5=C[N+](=CC=C5)C,,,,,,
1327,161328,CID 161328,C[N+]1=CC=C(C=C1)NC2=CC=C(C=C2)NC(=O)C=CC3=CC=C(C=C3)C=CC(=O)NC4=CC=C(C=C4)NC5=C[N+](=CC=C5)C,,,,,,
1328,161329,"Pyridinium, 2,2'-(terephthaloylbis(imino-p-phenyleneimino))bis(1-methyl-, di-p-toluenesulfonate",CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CN1C=CC=CC1=NC2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)N=C5C=CC=CN5C,,,,,,
1329,161330,"1-N,4-N-bis[4-[(1-methylpyridin-2-ylidene)amino]phenyl]benzene-1,4-dicarboxamide",CN1C=CC=CC1=NC2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)N=C5C=CC=CN5C,,,,,,
1330,161331,"(2S,3S,4S,5R,6R)-6-[[(4S,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid",CN1CC[C@]23[C@@H]4[C@@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O,,,,,,
1331,161332,Norphalloin,CCCC1C(=O)NC(C(=O)NC(C(=O)NC2CSC3=C(CC(C(=O)N1)NC(=O)C(NC(=O)C4CC(CN4C2=O)O)C)C5=CC=CC=C5N3)C(C)O)C,,,,,,
1332,161333,Methoxyacetate,COCC(=O)[O-],,,"['Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)']",,,
1333,161334,"4-N-[4-[[2-(diaminomethylidene)hydrazinyl]methylideneamino]phenyl]-1-N-[4-[(1-methylpyridin-1-ium-3-yl)carbamoyl]phenyl]benzene-1,4-dicarboxamide;iodide;hydroiodide",C[N+]1=CC=CC(=C1)NC(=O)C2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)N=CNN=C(N)N.I.[I-],,,,,,
1334,161335,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-imidazol-1-ylphosphinic acid",C1=CN(C=N1)P(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)O,,,,,,
1335,161336,Strictosidine,COC(=O)C1=CO[C@H]([C@@H]([C@@H]1C[C@H]2C3=C(CCN2)C4=CC=CC=C4N3)C=C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O,,,,,,
1336,161337,2-Methylthio-N-6-isopentenyladenosine,CC(=CCNC1=C2C(=NC(=N1)SC)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)C,,,,,,
1337,161338,"L-Lysine, mono-1,2-dithiolane-3-pentanoate",C1CSSC1CCCCC(=O)O.C(CCN)C[C@@H](C(=O)O)N,,,,,,
1338,161339,"1H-Indene-1,3(2H)-dione, 2-ethyl-2-(methylamino)-",CCC1(C(=O)C2=CC=CC=C2C1=O)NC,,,,,,
1339,161340,CID 161340,C1=CC=C(C(=C1)C(=O)[O-])O.[Cu+2],,,,,,
1340,161341,N-[4-(benzoylamino)phenyl]-3-hydroxy-4-[[2-methoxy-5-[[[3-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]azo]naphthalene-2-carboxamide,COC1=C(C=C(C=C1)C(=O)NC2=CC=CC(=C2)C(F)(F)F)N=NC3=C(C(=CC4=CC=CC=C43)C(=O)NC5=CC=C(C=C5)NC(=O)C6=CC=CC=C6)O,,,,,,
1341,161342,"Ethanol, 2-(methylamino)-, compd. with sulfur dioxide",CNCCO.O=S=O,,,,,,
1342,161343,"7H-Dibenzo(a,g)carbazole, 9-chloro-",C1=CC=C2C(=C1)C=CC3=C2C4=C(N3)C5=C(C=CC(=C5)Cl)C=C4,,,,,,
1343,161344,"Pyridine-3-carboxylic acid--methyl 10,11-dimethoxy-19-methyl-16,17-didehydro-18-oxayohimban-16-carboxylate (1/1)",C[C@H]1[C@@H]2CN3CCC4=C([C@@H]3C[C@@H]2C(=CO1)C(=O)OC)NC5=CC(=C(C=C45)OC)OC.C1=CC(=CN=C1)C(=O)O,,,,,,
1344,161345,Isoreserpiline,C[C@H]1[C@@H]2CN3CCC4=C([C@@H]3C[C@@H]2C(=CO1)C(=O)OC)NC5=CC(=C(C=C45)OC)OC,,,,,,
1345,161346,CID 161346,CC1=C(C=CC(=C1)N=NC2=CC=C(C=C2)O)N=NC3=CC=C(C=C3)OCCOS(=O)(=O)[O-].[Na+],,,,,,
1346,161347,P-[[3-methyl-4-[[4-[2-(sulphooxy)ethoxy]phenyl]azo]phenyl]azo]phenol,CC1=C(C=CC(=C1)N=NC2=CC=C(C=C2)O)N=NC3=CC=C(C=C3)OCCOS(=O)(=O)O,,,,,,
1347,161348,"Sulfuric acid, monododecyl ester, compd. with 1-amino-2-propanol (1:1)",CCCCCCCCCCCCOS(=O)(=O)O.CC(CN)O,,,,,,
1348,161349,meANA,CCC(C)C1C(=O)NCC(=O)NC2CS(=O)C3=C(CC(C(=O)NCC(=O)N1)NC(=O)C(NC(=O)C4CC(CN4C(=O)C(NC2=O)CC(=O)N)O)C(C)C(CO)O)C5=C(N3)C=C(C=C5)OC,,,,,,
1349,161350,Cobalt mesoporphyrin,[H+].[H+].CCC1=C(C2=NC1=CC3=C(C(=C([N-]3)C=C4C(=C(C(=CC5=NC(=C2)C(=C5C)CC)[N-]4)C)CCC(=O)[O-])CCC(=O)[O-])C)C.[Co+2],,,,,,
1350,161351,1-Octylimidazole,CCCCCCCCN1C=CN=C1,,,,,,
1351,161352,Ceanothic acid,CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@H]4[C@]([C@@]3(CC2)C)(CC[C@@H]5[C@@]4([C@H]([C@@H](C5(C)C)O)C(=O)O)C)C)C(=O)O,,,,,,
1352,161353,Niobium(2+) ethanedioate,C(=O)(C(=O)[O-])[O-].[Nb+2],,,,,,
1353,161354,"Rhodium(2+), pentaamminechloro-, (OC-6-22)-, sulfate (1:1)",N.N.N.N.N.[O-]S(=O)(=O)[O-].[Cl-].[Rh+3],,,,,,
1354,161355,Dhurrin,C1=CC(=CC=C1[C@@H](C#N)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O,,,,,,
1355,161356,"Phosphorothioic acid, O-(1,2-dihydro-1,6-dimethyl-2-oxo-4-pyridinyl) O,O-dimethyl ester",CC1=CC(=CC(=O)N1C)OP(=S)(OC)OC,,,,,,
1356,161357,"Phosphorothioic acid, O-(1,2-dihydro-1,6-dimethyl-2-oxo-4-pyridinyl) O,O-diethyl ester",CCOP(=S)(OCC)OC1=CC(=O)N(C(=C1)C)C,,,,,,
1357,161358,"beta-(2,4-Dihydroxypyrimidin-1-yl)alanine",C1=CN(C(=O)NC1=O)CCC(=O)ON,,,,,,
1358,161359,Baeocystin,CNCCC1=CNC2=C1C(=CC=C2)OP(=O)(O)O,,,,,,
1359,161360,CID 161360,CC(=CCC1=CC2=CC=C(OC2=CC1=O)O)C,,,,,,
1360,161361,7-Hydroxyactinomycin D,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=CC(=O)C(=C4C3=NC5=C(O4)C(=C(C(=C5C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)O)C)C,,,,,,
1361,161362,Agrimonolide,COC1=CC=C(C=C1)CC[C@H]2CC3=C(C(=CC(=C3)O)O)C(=O)O2,,,,,,
1362,161363,"Dodecanamide, N-(4-((4-aminophenyl)sulfonyl)phenyl)-",CCCCCCCCCCCC(=O)NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(C=C2)N,,,,,,
1363,161364,CID 161364,CCOC(=O)C1=CC=CC=C1C2=C3C=C(C(=O)C(=C3OC4=C(C(=C(C=C24)Br)[O-])Br)Br)Br.[Na+],,,,,,
1364,161365,Ethanimidoselenoic acid,CC(=N)[SeH],,,,,,
1365,161366,"3-(Hydroxymethyl)-5,5-diphenylimidazolidine-2,4-dione",C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)CO)C3=CC=CC=C3,,,,,,
1366,161367,Nepetalactone cis-trans-form,C[C@H]1CC[C@H]2[C@@H]1C(=O)OC=C2C,,,,,,
1367,161368,1D-myo-inositol 6-phosphate,[C@@H]1([C@H](C([C@H]([C@@H](C1O)O)O)OP(=O)(O)O)O)O,,,,,,
1368,161369,"2,4,6,8,10-Pentaoxadodecan-12-oyl fluoride, 1,1,1,3,3,5,5,7,7,9,9,11,11-tridecafluoro-",C(=O)(C(OC(OC(OC(OC(OC(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)F,,,,,,
1369,161370,"2-Isopropylaminomethyl-6-methyl-7-nitro-1,2,3,4-tetrahydroquinoline",CC1=CC2=C(C=C1[N+](=O)[O-])NC(CC2)CNC(C)C,,,,,,
1370,161371,"8,9-Dihydroxy-7-methylbenzo(b)quinolizinium, bromide",CC1=C(C(=CC2=CC3=CC=CC=[N+]3C=C12)O)O.[Br-],,,,,,
1371,161372,"7-Methylbenzo[b]quinolizin-5-ium-8,9-diol",CC1=C(C(=CC2=CC3=CC=CC=[N+]3C=C12)O)O,,,,,,
1372,161373,"Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one, 3',6'-diethoxy-",CCOC1=CC2=C(C=C1)C3(C4=C(O2)C=C(C=C4)OCC)C5=CC=CC=C5C(=O)O3,,,,,,
1373,161374,(2R)-2-hydroxy-3-[3-(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)phenyl]propanoic acid,CN1C2CCC1CC(C2)C3=CC=CC(=C3)C[C@H](C(=O)O)O,,,,,,
1374,161375,Nitrostanolone,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4O[N+](=O)[O-])C,,,,,,
1375,161376,5-methyl-dCTP,CC1=CN(C(=O)N=C1N)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,,,,,,
1376,161377,CID 161377,CCC1=C(C2=CC3=C(C(=C(N3)C=C4[C@H]([C@@H](C(=N4)C(=C(O)O)C5=NC(=CC1=N2)C(=C5C(=O)O)C)CCC(=O)O)C)C)C=C)C,,,,,,
1377,161378,CID 161378,C1NCN=C(N1)S,,,,,,
1378,161379,"Phenanthro(3,4-d)-1,3-dioxole-5-ethanamine, N,N-dimethyl-",CN(C)CCC1=CC2=C(C3=C1C=CC4=CC=CC=C43)OCO2,,,,,,
1379,161380,CID 161380,CS(=O)(=O)CCCC(C=NOS(=O)(=O)O)[C@@]1([C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)S.[K+],,,,,,
1380,161381,CID 161381,CS(=O)(=O)CCCC(C=NOS(=O)(=O)O)[C@@]1([C@@H]([C@H]([C@@H](C(O1)CO)O)O)O)S,,,,,,
1381,161382,2-(Furan-2-yl)-3-(5-nitrothiophen-2-yl)prop-2-enamide,C1=COC(=C1)C(=CC2=CC=C(S2)[N+](=O)[O-])C(=O)N,,,,,,
1382,161383,CID 161383,C1=NC2=C(N1CCCl)C(=O)N=C(N2)N,,,,,,
1383,161384,"S-(2-(Bis(1-methylethyl)amino)ethyl) O,O-bis(1-methylethyl) phosphorothioate",CC(C)N(CCSP(=O)(OC(C)C)OC(C)C)C(C)C,,,,,,
1384,161385,Versiconol,C1=C(C=C(C2=C1C(=O)C3=CC(=C(C(=C3C2=O)O)[C@H](CCO)CO)O)O)O,,,,,,
1385,161386,"4,11,18,25,27,28-Hexahydroxy-7,22-dimethylheptacyclo[13.11.1.12,14.03,12.05,10.017,26.019,24]octacosa-3(12),4,7,10,17(26),18,21,24-octaene-6,9,13,16,20,23-hexone",CC1=CC(=O)C2=C(C3=C(C4C5C(C(C(C4O)C3=O)C(=O)C6=C5C(=C7C(=C6O)C(=O)C=C(C7=O)C)O)O)C(=C2C1=O)O)O,,,,,,
1386,161387,"Kaura-9(11),16-dien-18-oic acid",C[C@@]12CCC[C@@]([C@H]1CCC34C2=CCC(C3)C(=C)C4)(C)C(=O)O,,,,,,
1387,161388,"(4aR,5R,6aR,6aS,6bR,9R,10R,11S,12aR,14bR)-5,10,11-trihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid",C[C@@]12CCC3[C@@]([C@H]1CC=C4[C@]2(C[C@H]([C@@]5([C@@H]4CC(CC5)(C)C)C(=O)O)O)C)(C[C@@H]([C@@H]([C@@]3(C)CO)O)O)C,,,,,,
1388,161389,Dactylarin,C[C@@]1(CC2=C(C[C@H]1O)C(=O)C3=C(C2=O)C=C(C=C3O)OC)O,,,,,,
1389,161390,16-Hydroxykauran-18-oic acid,C[C@@]12CCC[C@@]([C@H]1CC[C@]34[C@H]2CC[C@@H](C3)[C@](C4)(C)O)(C)C(=O)O,,,,,,
1390,161391,"1,3,4,14b-Tetrahydro-2,7-dimethyl-2H-dibenzo(b,f)pyrazino(1,2-d)(1,4)oxazepine",CC1=CC2=C(C=C1)OC3=CC=CC=C3C4N2CCN(C4)C,,,,,,
1391,161392,"N-[3-[2-(5-nitrofuran-2-yl)ethenyl]-1,2,4-oxadiazol-5-yl]acetamide",CC(=O)NC1=NC(=NO1)C=CC2=CC=C(O2)[N+](=O)[O-],,,,,,
1392,161393,S-Butyl O-(1-methylethyl) methyl thiophosphonate,CCC(C)OP(=S)(C)OC(C)C,,,,,,
1393,161394,5-[2-(Tert-butylamino)-1-hydroxyethyl]-2-hydroxybenzamide,CC(C)(C)NCC(C1=CC(=C(C=C1)O)C(=O)N)O,,,,,,
1394,161395,"N(2)-Acetyl-N(6)-(2,4-dinitrophenyl)lysine",CC(=O)N[C@@H](CCCCNC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-])C(=O)O,,,,,,
1395,161396,Morpholine stearate,CCCCCCCCCCCCCCCCCC(=O)O.C1COCCN1,,,,,,
1396,161397,Ethion dioxon,CCOP(=O)(OCC)SCSP(=O)(OCC)OCC,,,,,,
1397,161398,"1,6-Dimethyl-2-oxo-1,2-dihydropyridin-4-yl dimethyl phosphate",CC1=CC(=CC(=O)N1C)OP(=O)(OC)OC,,,,,,
1398,161399,"Phosphoric acid, diethyl 1-ethyl-1,2-dihydro-6-methyl-2-oxo-4-pyridinyl ester",CCN1C(=CC(=CC1=O)OP(=O)(OCC)OCC)C,,,,,,
1399,161400,"(OC-6-22)-Dichlorobis(1,10-phenanthroline-N(sup 1),N(sup 10))rhodium chloride",C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1.C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1.[Cl-].[Cl-].[Cl-].[Rh+3],,,,,,
1400,161401,CID 161401,COC1=CC=CC2=C1OC3=CC(=C(C(=O)C3=C2O)OC)OC,,,,,,
1401,161402,"Platinum(II), bis(ethylammine)dichloro-, cis-",CCN.CCN.[Cl-].[Cl-].[Pt+2],,,,,,
1402,161403,CID 161403,CCCCCCCC(C=CCCCC(C)O)C1=CC=CC=C1C(=O)O,,,,,,
1403,161404,Molybdenum zinc oxide (Mo2Zn3O9),[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Zn+2].[Zn+2].[Zn+2].[Mo].[Mo],,,,,,
1404,161405,Octanoic acid triethanolamine salt,CCCCCCCC(=O)O.C(CO)N(CCO)CCO,,,,,,
1405,161406,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Hydrochloride",CN1CCC(=CC1)C2=CC=CC=C2.Cl,,,,,,
1406,161407,Dipotassium ruthenium(4+) hexachloride,[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[K+].[K+].[Ru+4],,,,,,
1407,161408,CID 161408,C1=NC2=C(N1CCCCO)NC(=NC2=O)N,,,,,,
1408,161409,Columbianetin acetate,CC(=O)OC(C)(C)[C@@H]1CC2=C(O1)C=CC3=C2OC(=O)C=C3,,,,,,
1409,161410,Diazole Orange O,[H+].C1=CC=C(C(=C1)[N+]#N)[N+](=O)[O-].C1=CC=C(C(=C1)[N+]#N)[N+](=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Cl-].[Cl-].[Zn+2],,,,,,
1410,161411,"Zinc chloride, compd. with 2,5-dichlorobenzenediazonium sulfate (1:2:2)",[H+].C1=CC(=C(C=C1Cl)[N+]#N)Cl.C1=CC(=C(C=C1Cl)[N+]#N)Cl.[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Cl-].[Cl-].[Zn+2],,,,,,
1411,161412,Diazole Red K,[H+].COC1=C(C=C(C=C1)[N+](=O)[O-])[N+]#N.COC1=C(C=C(C=C1)[N+](=O)[O-])[N+]#N.[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Cl-].[Cl-].[Zn+2],,,,,,
1412,161413,Lunularic acid,C1=CC(=C(C(=C1)O)C(=O)O)CCC2=CC=C(C=C2)O,,,,,,
1413,161414,N-methylmethanamine;sulfate,CNC.[O-]S(=O)(=O)[O-],,,,,,
1414,161415,2'-Deoxyadenylyl-(3'-5')-2'-deoxyadenosine,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)N)CO)OP(=O)(O)OC[C@@H]4[C@H](CC(O4)N5C=NC6=C(N=CN=C65)N)O,,,,,,
1415,161416,"Ethanol, 2,2'-iminobis-, 2-hydroxy-1,2,3-propanetricarboxylate (salt)",C(CO)NCCO.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,,,,,,
1416,161417,Nuttalline,C1CCN2CC3CC(C2C1)CN4C3CC(CC4=O)O,,,,,,
1417,161418,"Benzothiazolium, 2-[[4-(dimethylamino)phenyl]azo]-3-ethyl-6-methoxy-, trichlorozincate(1-)",CC[N+]1=C(SC2=C1C=CC(=C2)OC)N=NC3=CC=C(C=C3)N(C)C.Cl[Zn-](Cl)Cl,,,,,,
1418,161419,2-[p-(Dimethylamino)phenylazo]-3-ethyl-6-methoxybenzothiazol-3-ium,CC[N+]1=C(SC2=C1C=CC(=C2)OC)N=NC3=CC=C(C=C3)N(C)C,,,,,,
1419,161420,Barium palmitate,CCCCCCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCCCCCC(=O)[O-].[Ba+2],,,,,,
1420,161421,"Inositol 1,2-bisphosphate",[C@H]1([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)OP(=O)(O)O)OP(=O)(O)O)O)O)O,,,,,,
1421,161422,"1H-1,2,4-Triazolium, 5-((4-(diethylamino)phenyl)azo)-1,4-dimethyl-, methyl sulfate",CCN(CC)C1=CC=C(C=C1)N=NC2N(C=NN2C)C.COS(=O)(=O)O,,,,,,
1422,161423,"2-Naphthalenesulfonic acid, 7-((4-chloro-6-((3-sulfophenyl)amino)-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-((2-sulfophenyl)azo)-, trisodium salt",C1=CC=C(C(=C1)N=NC2=C(C=C3C=C(C=CC3=C2O)NC4=NC(=NC(=N4)NC5=CC(=CC=C5)S(=O)(=O)[O-])Cl)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
1423,161424,"7-{[4-Chloro-6-(3-sulfoanilino)-1,3,5-triazin-2-yl]amino}-4-oxo-3-[2-(2-sulfophenyl)hydrazinylidene]-3,4-dihydronaphthalene-2-sulfonic acid",C1=CC=C(C(=C1)N=NC2=C(C=C3C=C(C=CC3=C2O)NC4=NC(=NC(=N4)NC5=CC(=CC=C5)S(=O)(=O)O)Cl)S(=O)(=O)O)S(=O)(=O)O,,,,,,
1424,161425,CID 161425,CCC(=NN=C(N)S)C1=CC=C(S1)Br,,,,,,
1425,161426,8-Bromo-2'-amp,C1=NC(=C2C(=N1)N(C(=N2)Br)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)OP(=O)(O)O)N,,,,,,
1426,161427,CID 161427,O.O.O.O.O.O.O.[SbH3].[SbH3],,,,,,
1427,161428,"Pyridinium, 3,3'-((2,3-dimethylterephthaloyl)bis(imino-p-phenylenecarbonylimino))bis(1-methyl-, di-p-toluenesulfonate",CC1=CC=C(C=C1)S(=O)(=O)[O-].CC1=CC=C(C=C1)S(=O)(=O)[O-].CC1=C(C=CC(=C1C)C(=O)NC2=CC=C(C=C2)C(=O)NC3=C[N+](=CC=C3)C)C(=O)NC4=CC=C(C=C4)C(=O)NC5=C[N+](=CC=C5)C,,,,,,
1428,161429,"2,3-dimethyl-1-N,4-N-bis[4-[(1-methylpyridin-1-ium-3-yl)carbamoyl]phenyl]benzene-1,4-dicarboxamide",CC1=C(C=CC(=C1C)C(=O)NC2=CC=C(C=C2)C(=O)NC3=C[N+](=CC=C3)C)C(=O)NC4=CC=C(C=C4)C(=O)NC5=C[N+](=CC=C5)C,,,,,,
1429,161430,Mnthcc,CC1C2=C(CC(N1N=O)C(=O)O)C3=CC=CC=C3N2,,,,,,
1430,161431,"Methanesulfinic acid, nitrilotris-, trisodium salt",C(N(CS(=O)[O-])CS(=O)[O-])S(=O)[O-].[Na+].[Na+].[Na+],,,,,,
1431,161432,Nitrilotrimethanesulfinic acid,C(N(CS(=O)O)CS(=O)O)S(=O)O,,,,,,
1432,161433,Solvat Brown BR,C1=CC=C2C(=C1)C(=C3C=CC4=C(C3=C2OS(=O)(=O)[O-])N=C5C4=C6C7=C(C8=C(C9=CC=CC=C9C(=C8C=C7)OS(=O)(=O)[O-])OS(=O)(=O)[O-])N=C6C1=C(C2=CC=CC=C2C(=C15)OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,,,,,
1433,161434,"(7,14,27,33,40-Pentasulfooxy-17,30-diazaundecacyclo[27.15.0.02,18.03,16.06,15.08,13.019,28.021,26.031,44.032,41.034,39]tetratetraconta-1,3(16),4,6,8,10,12,14,17,19,21,23,25,27,29,31(44),32,34,36,38,40,42-docosaen-20-yl) hydrogen sulfate",C1=CC=C2C(=C1)C(=C3C=CC4=C(C3=C2OS(=O)(=O)O)N=C5C4=C6C7=C(C8=C(C9=CC=CC=C9C(=C8C=C7)OS(=O)(=O)O)OS(=O)(=O)O)N=C6C1=C(C2=CC=CC=C2C(=C15)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O,,,,,,
1434,161435,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[4,6-bis[(4-chlorophenyl)amino]-1,3,5-triazin-2-yl]amino]-, sodium salt (1:2)",C1=CC(=CC=C1NC2=NC(=NC(=N2)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC=C(C=C6)Cl)NC7=CC=C(C=C7)Cl)S(=O)(=O)[O-])S(=O)(=O)[O-])NC8=CC=C(C=C8)Cl)Cl.[Na+].[Na+],,,,,,
1435,161436,"5-[[4,6-Bis(4-chloroanilino)-1,3,5-triazin-2-yl]amino]-2-[2-[4-[[4,6-bis(4-chloroanilino)-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]benzenesulfonic acid",C1=CC(=CC=C1NC2=NC(=NC(=N2)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC=C(C=C6)Cl)NC7=CC=C(C=C7)Cl)S(=O)(=O)O)S(=O)(=O)O)NC8=CC=C(C=C8)Cl)Cl,,,,,,
1436,161437,"2-[(3R,6S)-6,10-dimethylspiro[4.5]dec-9-en-3-yl]propan-2-ol",C[C@H]1CCC=C(C12CC[C@H](C2)C(C)(C)O)C,,,,,,
1437,161438,"(2R)-N-[(2S,3S,4S,6R)-6-[[(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]-3-hydroxy-2-methyloxan-4-yl]-2-amino-4-methylpentanamide",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)[C@@H](CC(C)C)N)O,,,,,,
1438,161439,"2,3,6-Trimethoxy-17-methyl-5,6,8,14-tetradehydromorphinan-7-one",CN1CC[C@]23C=C(C(=O)C=C2C1CC4=CC(=C(C=C34)OC)OC)OC,,,,,,
1439,161440,Pyridinium toluene-4-sulphonate,CC1=CC=C(C=C1)S(=O)(=O)O.C1=CC=NC=C1,,,,,,
1440,161441,Anhydroevoxine,CC1(C(O1)COC2=C(C3=C(C=C2)C(=C4C=COC4=N3)OC)OC)C,,,,,,
1441,161442,Arbusculin B,CC1=C2[C@@H]3[C@@H](CC[C@]2(CCC1)C)C(=C)C(=O)O3,,,,,,
1442,161443,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[4-(4-sulfophenyl)-2H-1,2,3-triazol-2-yl]-, tetrasodium salt",C1=CC(=CC=C1C2=NN(N=C2)C3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)N5N=CC(=N5)C6=CC=C(C=C6)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
1443,161444,5-[4-(4-Sulfophenyl)triazol-2-yl]-2-[2-[2-sulfo-4-[4-(4-sulfophenyl)triazol-2-yl]phenyl]ethenyl]benzenesulfonic acid,C1=CC(=CC=C1C2=NN(N=C2)C3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)N5N=CC(=N5)C6=CC=C(C=C6)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
1444,161445,Einecs 246-146-0,CC(=O)NC1=CC=CC2=C1C(=C(C=C2)[O-])N=NC3=C(C=CC(=C3)S(=O)(=O)N)[O-].CC(=O)NC1=CC=CC2=C1C(=C(C=C2)[O-])N=NC3=C(C=CC(=C3)S(=O)(=O)N)[O-].[Na+].[Cr+3],,,,,,
1445,161446,"Benzenesulfinic acid, zinc salt",C1=CC=C(C=C1)S(=O)[O-].C1=CC=C(C=C1)S(=O)[O-].[Zn+2],,,,,,
1446,161447,"silver;4-amino-N-(1,3-thiazol-2-yl)benzenesulfonamide",C1=CC(=CC=C1N)S(=O)(=O)NC2=NC=CS2.[Ag+],,,,,,
1447,161448,1-Methyl-4-(o-methyl-alpha-phenylbenzyl)piperazine dihydrochloride,CC1=CC=CC=C1C(C2=CC=CC=C2)N3CCN(CC3)C.Cl.Cl,,,,,,
1448,161449,1-Methyl-4-[(2-methylphenyl)-phenylmethyl]piperazine,CC1=CC=CC=C1C(C2=CC=CC=C2)N3CCN(CC3)C,,,,,,
1449,161450,"Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-(1,1-dimethylethyl)-",CC(C)(C)N1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,,,,,,
1450,161451,CID 161451,C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=CC=C(C=C4)NC(=O)CCl)S(=O)(=O)[O-])N.[Na+],,,,,,
1451,161452,"1-Amino-4-[4-(2-chloroacetamido)anilino]-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=CC=C(C=C4)NC(=O)CCl)S(=O)(=O)O)N,,,,,,
1452,161453,Tectol,CC1(C=CC2=C(O1)C3=CC=CC=C3C(=C2C4=C(C5=CC=CC=C5C6=C4C=CC(O6)(C)C)O)O)C,,,,,,
1453,161454,(+)-Hardwickiic Acid,C[C@H]1CC[C@]2([C@H]([C@]1(C)CCC3=COC=C3)CCC=C2C(=O)O)C,,,,,,
1454,161455,1-Bicyclo[2.2.1]hept-2-ylethanamine,CC(C1CC2CCC1C2)N,,,,,,
1455,161456,Pyropheophorbide a,CCC1=C(C2=NC1=CC3=C(C4=C(CC(=C5[C@H]([C@@H](C(=CC6=NC(=C2)C(=C6C)C=C)N5)C)CCC(=O)O)C4=N3)O)C)C,,,,,,
1456,161457,CID 161457,CC(=O)CC(C1=CC=C(C=C1)O)C2=C(OC3=CC=CC=C3C2=O)O,,,,,,
1457,161458,CID 161458,C(CN(N=O)O)C(C(=O)O)N,,,,,,
1458,161459,Dioxouranium(2+);dicarbonate,C(=O)([O-])[O-].C(=O)([O-])[O-].O=[U+2]=O,,,,,,
1459,161460,3'-Fucosyllactose,C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)O[C@H]2[C@H]([C@H](O[C@H]([C@@H]2O)O[C@@H]3[C@H](OC([C@@H]([C@H]3O)O)O)CO)CO)O)O)O)O,,,,,,
1460,161461,Adepren,CN1CCC(=N)C2=CC=CC=C21.I,,,,,,
1461,161462,"1-Methyl-2,3-dihydroquinolin-4-imine",CN1CCC(=N)C2=CC=CC=C21,,,,,,
1462,161463,Chloroethylene bisthiocyanate,C(C(SC#N)Cl)SC#N,,,,,,
1463,161464,Leonurine,COC1=CC(=CC(=C1O)OC)C(=O)OCCCCN=C(N)N,,,,,,
1464,161465,CID 161465,C1=C(C(=O)C=C2C1=C(C3=C(O2)C(=C(C=C3O)O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O,,,,,,
1465,161466,N6-Carbamoyl-L-threonyladenosine,C[C@H]([C@@H](C(=O)O)NC(=O)NC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
1466,161467,2-Chloro-4-oxohex-2-enedioic acid,C(C(=O)C=C(C(=O)O)Cl)C(=O)O,,,,,,
1467,161468,tetranor-PGEM,C1[C@H]([C@@H]([C@H](C1=O)CCC(=O)O)CCC(=O)CCCCC(=O)O)O,,,,,,
1468,161469,Aluminum;butan-2-olate;4-ethoxy-4-oxobut-2-en-2-olate,CCC(C)[O-].CCC(C)[O-].CCOC(=O)C=C(C)[O-].[Al+3],,,,,,
1469,161470,6-Fluoro-9-beta-d-ribofuranosylpurine,C1=NC2=C(C(=N1)F)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
1470,161471,"Docosanoic acid, compd. with 2,2',2''-nitrilotris[ethanol] (1:1)",CCCCCCCCCCCCCCCCCCCCCC(=O)O.C(CO)N(CCO)CCO,,,,,,
1471,161472,Nthcc,C1C(N(CC2=C1C3=CC=CC=C3N2)N=O)C(=O)O,,,,,,
1472,161473,Maptmp,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)OP(=O)(O)OC3=CC=C(C=C3)N,,,,,,
1473,161474,CID 161474,[CH2]CCC[O-].[CH2]CCC[O-].[CH2]CCC[O-].[CH2]CCC[O-].[GeH4],,,,,,
1474,161475,4-Hydroxybutylradical,[CH2]CCCO,,,,,,
1475,161476,"1-Methylpiperidine-2,6-dione",CN1C(=O)CCCC1=O,,,,,,
1476,161477,Lymphostim,CC(=C)C(=O)O.C=CC(=O)N,,,,,,
1477,161478,"1-Butene, polymer with ethene",CCC=C.C=C,,,,,,
1478,161479,"6-(4-methoxyphenyl)-N-(2-methylpropyl)hexa-2,4-dienamide",CC(C)CNC(=O)C=CC=CCC1=CC=C(C=C1)OC,,,,,,
1479,161480,"1-Butene, polymer with sulfur dioxide",CCC=C.O=S=O,,,,,,
1480,161481,CID 161481,C[C@H]1CCC=C([C@H](C=C[C@@](C=CC(=O)O[C@@H]1C)(C)O)OC)C,,,,,,
1481,161482,"2-[10,15,20-Tris(2-hydroxyphenyl)-21,24-dihydroporphyrin-5-yl]phenol",C1=CC=C(C(=C1)C2=C3C=CC(=C(C4=CC=C(N4)C(=C5C=CC(=N5)C(=C6C=CC2=N6)C7=CC=CC=C7O)C8=CC=CC=C8O)C9=CC=CC=C9O)N3)O,,,,,,
1482,161483,CID 161483,C1=CN=CC=C1C(=O)NN=C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O)O,,,,,,
1483,161484,"2-(4-Methyl-2,6-dinitroanilino)-N-methylpropionamide",CC1=CC(=C(C(=C1)[N+](=O)[O-])NC(C)C(=O)NC)[N+](=O)[O-],,,,,,
1484,161485,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-amino-6-[(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]-, disodium salt",C1=CC(=C(C=C1NC2=NC(=NC(=N2)NCCO)N)S(=O)(=O)[O-])C=CC3=C(C=C(C=C3)NC4=NC(=NC(=N4)NCCO)N)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
1485,161486,"5-[[4-Amino-6-(2-hydroxyethylamino)-1,3,5-triazin-2-yl]amino]-2-[2-[4-[[4-amino-6-(2-hydroxyethylamino)-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]benzenesulfonic acid",C1=CC(=C(C=C1NC2=NC(=NC(=N2)NCCO)N)S(=O)(=O)O)C=CC3=C(C=C(C=C3)NC4=NC(=NC(=N4)NCCO)N)S(=O)(=O)O,,,,,,
1486,161487,Menisperine,C[N+]1(CCC2=CC(=C(C3=C2[C@@H]1CC4=C3C(=C(C=C4)OC)O)OC)OC)C,,,,,,
1487,161488,Gentisuric acid,C1=CC(=C(C=C1O)C(=O)NCC(=O)O)O,,,,,,
1488,161489,"Ethene, tetrafluoro-, telomer with pentafluoroiodoethane",C(=C(F)F)(F)F.C(C(F)(F)I)(F)(F)F,,,,,,
1489,161490,Phenylarsonous acid,C1=CC=C(C=C1)[As](O)O,,,,,,
1490,161491,Methylarsonous acid,C[As](O)O,,,,,,
1491,161492,"Thiazolo(3,2-a)perimidine",C1=CC2=C3C(=C1)N=C4N(C3=CC=C2)C=CS4,,,,,,
1492,161493,Purpurin 18,CCC1=C(C2=NC1=CC3=C(C4=C(N3)C(=C5[C@H]([C@@H](C(=CC6=NC(=C2)C(=C6C)C=C)N5)C)CCC(=O)O)C(=O)OC4=O)C)C,,,,,,
1493,161494,Histidinehydroxamic acid,C1=C(NC=N1)CC(C(=O)NO)N,,,,,,
1494,161495,3-Hydroxy-15-methylhexadecanoic acid,CC(C)CCCCCCCCCCCC(CC(=O)O)O,,,,,,
1495,161496,Bruceine B,CC1=C(C(=O)C[C@]2([C@H]1C[C@@H]3[C@]45[C@@H]2[C@H]([C@@H]([C@]([C@@H]4[C@H](C(=O)O3)OC(=O)C)(OC5)C(=O)OC)O)O)C)O,,,,,,
1496,161497,Hydroxypropylglutamine,C(CN[C@@H](CCC(=O)N)C(=O)O)CO,,,,,,
1497,161498,Pvpeb,CC[N+]1=CC=C(C=C1)C=C.[Br-],,,,,,
1498,161499,1-Ethyl-4-vinylpyridinium,CC[N+]1=CC=C(C=C1)C=C,,,,,,
1499,161500,5-Aminoimidazole ribonucleotide,C1=C(N(C=N1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)N,,,,,,
1500,161501,"2-Propenoic acid, 2-methyl-, ethyl ester, polymer with methyl 2-methyl-2-propenoate",CCOC(=O)C(=C)C.CC(=C)C(=O)OC,,,,,,
1501,161502,"Pyrimido[5,4-e]-1,2,4-triazine-5,7(6H,8H)-dione, 3,6,8-trimethyl-",CC1=NC2=C(N=N1)N(C(=O)N(C2=O)C)C,,,,,,
1502,161503,1-(3-Methoxypropoxy)butane,CCCCOCCCOC,,,,,,
1503,161504,"(3R,5R,8R,9R,10S,13S,14S)-17-ethynyl-13-methyl-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol",C[C@]12CC[C@@H]3[C@H]4CC[C@H](C[C@H]4CC[C@H]3[C@@H]1CCC2(C#C)O)O,,,,,,
1504,161505,"[(3R,4S,6S,8R,13S,16S,17R,18S)-11-ethyl-8,9-dihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-13-yl]methyl 2-(2,5-dioxopyrrolidin-1-yl)benzoate",CCN1C[C@@]2(CC[C@@H](C34[C@@H]2[C@@H](C(C31)([C@]5(C[C@@H](C6CC4[C@@H]5[C@H]6OC)OC)O)O)OC)OC)COC(=O)C7=CC=CC=C7N8C(=O)CCC8=O,,,,,,
1505,161506,Putreanine,C(CCNCCC(=O)O)CN,,,,,,
1506,161507,"Hexanedioic acid, polymer with 1,2-ethanediol and 1,1'-methylenebis(4-isocyanatobenzene)",C1=CC(=CC=C1CC2=CC=C(C=C2)N=C=O)N=C=O.C(CCC(=O)O)CC(=O)O.C(CO)O,,,,,,
1507,161508,Americium trinitrate,[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Am],,,,,,
1508,161509,"Butanedioic acid, methylene-, polymer with 2-propenoic acid",C=CC(=O)O.C=C(CC(=O)O)C(=O)O,,,,,,
1509,161510,CID 161510,C1C(NC2=C(N1)NC(=NC2=O)N)C(C(CO)O)O,,,,,,
1510,161511,"Benzothiazolium, 2-((4-(butyl(2-cyanoethyl)amino)phenyl)azo)-6-methoxy-3-methyl-, methyl sulfate",CCCCN(CCC#N)C1=CC=C(C=C1)N=NC2=[N+](C3=C(S2)C=C(C=C3)OC)C.COS(=O)(=O)[O-],,,,,,
1511,161512,"2-[(e)-{4-[Butyl(2-cyanoethyl)amino]phenyl}diazenyl]-6-methoxy-3-methyl-1,3-benzothiazol-3-ium",CCCCN(CCC#N)C1=CC=C(C=C1)N=NC2=[N+](C3=C(S2)C=C(C=C3)OC)C,,,,,,
1512,161513,(2-Hydroxypropyl)ammonium dihydrogen orthoborate,B(O)(O)O.CC(CN)O,,,,,,
1513,161514,"4,4'-Bismaleimidodiphenylmethane, polymer with 4,4'-diaminodiphenylmethane",C1=CC(=CC=C1CC2=CC=C(C=C2)N)N.C1=CC(=CC=C1CC2=CC=C(C=C2)N3C(=O)C=CC3=O)N4C(=O)C=CC4=O,,,,,,
1514,161515,Denudatine,CCN1CC2(CCCC34[C@@H]2C[C@@H]([C@H]31)[C@]56[C@H]4[C@H]([C@H](CC5)C(=C)[C@H]6O)O)C,,,,,,
1515,161516,N-Acetyl-S-(carboxymethyl)-L-cysteine,CC(=O)N[C@@H](CSCC(=O)O)C(=O)O,,,,,,
1516,161517,2-Methylthio-n6-(4-hydroxy-3-methylbut-2-enyl)adenosine,CC(=CCNC1=C2C(=NC(=N1)SC)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)CO,,,,,,
1517,161518,"2-bromo-N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(=C(C(=C32)OC)OC)OC)NC(=O)CBr,,,,,,
1518,161519,"Trachyloban-18-oic acid, (4beta)-",C[C@]12CCC[C@@H]([C@@H]1CCC34[C@H]2C[C@@H]5[C@H](C3)[C@]5(C4)C)C(=O)OC,,,,,,
1519,161520,"4-(7-Methyl-1,2,3,5,8,8a-hexahydroindolizin-6-yl)phenol",CC1=C(CN2CCCC2C1)C3=CC=C(C=C3)O,,,,,,
1520,161521,Pandex,C1=CC(=CC=C1CC2=CC=C(C=C2)N=C=O)N=C=O.C(CCC(=O)O)CC(=O)O.C(CCO)CO,,,,,,
1521,161522,N-(Trifluoroacetyl)daunorubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)C(F)(F)F)O,,,,,,
1522,161523,Gold tert-dodecanethiolate,CCCCCCCCCC(C)(C)[S-].[Au+],,,,,,
1523,161524,"2,5-Furandione, polymer with 2-methyl-1-propene",CC(=C)C.C1=CC(=O)OC1=O,,,,,,
1524,161525,"3-(3,5-Dihydroxyphenyl)propanoic acid",C1=C(C=C(C=C1O)O)CCC(=O)O,,,,,,
1525,161526,CID 161526,C1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=CC(=O)C4=C(C=C(OC4=C3)C5=CC=C(C=C5)O)O)CO)O)O)O)(CO)O,,,,,,
1526,161527,Maprounic acid,C[C@]12CC[C@@H](C([C@@H]1CC[C@@]3([C@@H]2CC[C@@]4(C3=CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)O)C)C)(C)C)O,,,,,,
1527,161528,Ethyl oct-3-enoate,CCCCC=CCC(=O)OCC,,,,,,
1528,161529,"2H-Azepin-2-one, hexahydro-, polymer with oxirane",C1CCC(=O)NCC1.C1CO1,,,,,,
1529,161530,"Hexanedioic acid, polymer with 1,4-butanediol and 1,2-ethanediol",C(CCC(=O)O)CC(=O)O.C(CCO)CO.C(CO)O,,,,,,
1530,161531,"[(3S,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl] [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate",CC(=O)N[C@H]1[C@H]([C@@H]([C@H](OC1OP(=O)(O)OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC(=O)NC3=O)O)O)CO)O)O,,,,,,
1531,161532,Nocardamine,C1CCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CC1)O)O)O,,,,,,
1532,161533,Aristolochene,C[C@@H]1CCCC2=CC[C@H](C[C@@]12C)C(=C)C,,,,,,
1533,161534,Decafluorobis(trifluoromethyl)cyclohexane,C1(C(C(C(C(C1(F)F)(F)F)(F)F)(F)F)(F)F)(C(F)(F)F)C(F)(F)F,,,,,,
1534,161535,"(4R,5R,6S)-4-[(1R)-1,2-dimethoxyethyl]-2-(furan-2-yl)-5-methoxy-6-(methoxymethyl)-1,3-dioxane",COC[C@H]1[C@H]([C@H](OC(O1)C2=CC=CO2)[C@@H](COC)OC)OC,,,,,,
1535,161536,Bis(4-chlorophenyl)(5-pyrimidinyl)methanol,C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)(C3=CN=CN=C3)O)Cl,,,,,,
1536,161537,CID 161537,CCCCC(CC)COC(=O)C[S-].CCCC[SnH]=S,,,,,,
1537,161538,Paucin,C[C@@H]1C[C@@H]2[C@H](C[C@]3([C@H]1[C@H](CC3=O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)COC(=O)C)O)O)O)C)C(=C)C(=O)O2,,,,,,
1538,161539,CID 161539,C=COS(=O)(=O)[O-].[K+],,,,,,
1539,161540,2-[[4-[Ethyl(2-hydroxyethyl)amino]phenyl]azo]-6-methoxy-3-methylbenzothiazolium chloride,CCN(CCO)C1=CC=C(C=C1)N=NC2=[N+](C3=C(S2)C=C(C=C3)OC)C.[Cl-],,,,,,
1540,161541,CID 161541,CC(C)CCCCCCOS(=O)(=O)[O-].[Na+],,,,,,
1541,161542,7-Methyloctyl hydrogen sulfate,CC(C)CCCCCCOS(=O)(=O)O,,,,,,
1542,161543,4-Methyl-1-homopiperazinedithiocarboxylic acid,CN1CCCN(CC1)C(=S)S,,,,,,
1543,161544,Oxysophocarpine,C1C[C@H]2CN3[C@H](CC=CC3=O)[C@@H]4[C@H]2[N+](C1)(CCC4)[O-],,,,,,
1544,161545,"5-(Pyridin-2-yl)-3,4-dihydro-2h-pyrrole-2-carboxylic acid",C1CC(=NC1C(=O)O)C2=CC=CC=N2,,,,,,
1545,161546,"2-Propenoic acid, 2-methyl-, polymer with methyl 2-methyl-2-propenoate and methyl 2-propenoate",CC(=C)C(=O)O.CC(=C)C(=O)OC.COC(=O)C=C,,,,,,
1546,161547,"2-Propenoic acid, methyl ester, polymer with 1,2-ethanediamine",COC(=O)C=C.C(CN)N,,,,,,
1547,161548,Paladon 65,CC(=C)C(=O)OC.CC(=C)C(=O)OCCCCOC(=O)C(=C)C,,,,,,
1548,161549,CID 161549,C1NC(=NCN1CCO)S,,,,,,
1549,161550,"7H-Furo(2,3-f)(1)benzopyran-7-one, 4,9-dimethyl-",CC1=CC2=C(C(=CC(=O)O2)C)C3=C1C=CO3,,,,,,
1550,161551,3-(2-Iodoacetamido)-PROXYL,CC1(CC(C(N1[O])(C)C)NC(=O)CI)C,,,,,,
1551,161552,"Phosphoric acid, chromium(3+) salt (3:1)",[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[Cr+3],,,,,,
1552,161553,"Phosphonium, tetrakis(hydroxymethyl)-, chloride, polymer with urea",C(O)[P+](CO)(CO)CO.C(=O)(N)N.[Cl-],,,,,,
1553,161554,Sucrose phosphate,C([C@@H]1[C@H]([C@@H]([C@@](O1)(CO)[C@]2([C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)OP(=O)(O)O)O)O)O,,,,,,
1554,161555,"3-[(3S,5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-3-[(2R,4S,5S,6S)-3-hydroxy-4-methoxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyoxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one",C[C@H]1[C@@H]([C@H](C([C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3CC[C@]5([C@@]4(CC[C@@H]5C6=CC(=O)OC6)O)C)C)O)OC)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O)O,,,,,,
1555,161556,"Formaldehyde, polymer with phenol, 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate",C=O.C1=CC=C(C=C1)O.C1=CC2=C(C=CC(=C2[O-])[N+]#N)C(=C1)S(=O)(=O)O,,,,,,
1556,161557,Dihydromyricetin,C1=C(C=C(C(=C1O)O)O)[C@@H]2[C@H](C(=O)C3=C(C=C(C=C3O2)O)O)O,,,,,,
1557,161558,"alpha-D-Glucopyranoside, beta-D-fructofuranosyl, monotetradecanoate",CCCCCCCCCCCCCC(=O)O[C@@]1([C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)[C@@]2([C@H]([C@@H]([C@H](O2)CO)O)O)CO,,,,,,
1558,161559,Diisotridecyl phthalate,CC(C)CCCCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCCCCC(C)C,,,,,,
1559,161560,CID 161560,CCOC(C=CC=CC)OCC,,,,,,
1560,161561,10-Diethylaminopropionyl-3-trifluoromethyl phenothiazine hydrochloride,CCN(CC)CCC(=O)N1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F.Cl,,,,,,
1561,161562,Fluacizine,CCN(CC)CCC(=O)N1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F,,,,,,
1562,161563,"1-[(1,3-Dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)ethylidene]-1,2,3,4-tetrahydro-6-methoxyquinolinium chloride",CC1(C2=CC=CC=C2N(C1=CC=[N+]3CCCC4=C3C=CC(=C4)OC)C)C.[Cl-],,,,,,
1563,161564,"2-[2-[(3,4-Dihydro-6-methoxy-2H-quinolin)-1-yl]ethenyl]-1,3,3-trimethyl-3H-indolium",CC1(C2=CC=CC=C2N(C1=CC=[N+]3CCCC4=C3C=CC(=C4)OC)C)C,,,,,,
1564,161565,CID 161565,C1=CC=C(C=C1)NC2=NC(=NC(=N2)N(CCC(=O)N)CCO)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC=CC=C6)N(CCC(=O)N)CCO)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
1565,161566,"3-(4-Hydroxy-3-methoxyphenyl)propane-1,2-diol",COC1=C(C=CC(=C1)CC(CO)O)O,,,,,,
1566,161567,CID 161567,C1=CC=C(C(=C1)C(C2C(=O)NC(=NC2=O)S)C3C(=O)NC(=NC3=O)S)O,,,,,,
1567,161568,Phenylphosphonic acid isobutyl 2-propynyl ester,CC(C)COP(=O)(C1=CC=CC=C1)OCC#C,,,,,,
1568,161569,"5-Amino-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile",CC(C)C(CCCN)(C#N)C1=CC(=C(C=C1)OC)OC,,,,,"['5-Amino-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile is a known human metabolite of D-617, D-702, and Norverapamil.']",
1569,161570,Edulinine,CC(C)([C@@H](CC1=C(C2=CC=CC=C2N(C1=O)C)OC)O)O,,,,,,
1570,161571,Ammonium borate,B([O-])([O-])[O-].[NH4+].[NH4+].[NH4+],,,,,,
1571,161572,"(8-Acetyloxy-4,9-dimethyl-14-methylidene-13-oxo-5,12-dioxatricyclo[9.3.0.04,6]tetradec-9-en-2-yl) 2-methylprop-2-enoate",CC1=CC2C(C(CC3(C(O3)CC1OC(=O)C)C)OC(=O)C(=C)C)C(=C)C(=O)O2,,,,,,
1572,161573,Frullanolide,CC1=C2[C@H]3[C@@H](CC[C@]2(CCC1)C)C(=C)C(=O)O3,,,,,,
1573,161574,Eprozinol dihydrochloride,COC(CN1CCN(CC1)CCC(C2=CC=CC=C2)O)C3=CC=CC=C3.Cl.Cl,,,,,,
1574,161575,CID 161575,C1=NC2=C(C(=N1)S)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O,,,,,,
1575,161576,CID 161576,C1[C@H](C(=O)C(=CC1=C(O)O)O)O,,,,,,
1576,161577,"Cobaltate(2-), tetrakis(thiocyanato-kappaN)-, mercury(2+) (1:1), (T-4)-",C(#N)[S-].C(#N)[S-].C(#N)[S-].C(#N)[S-].[Co+2].[Hg+2],,,,,,
1577,161578,CID 161578,C1=CC(=C(C=C1C2=CC(=C3C(=CC(=O)C(=C3O2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)O)O,,,,,,
1578,161579,3-Hydroxy-2-formylbenzothiophene,C1=CC=C2C(=C1)C(=C(S2)C=O)O,,,,,,
1579,161580,"2-Aminoethanethiol;2,3-dihydroxybutanedioate",C(CS)N.C(C(C(=O)[O-])O)(C(=O)[O-])O,,,,,,
1580,161581,Hexapotassium [nitrilotris(methylene)]trisphosphonate,C(N(CP(=O)([O-])[O-])CP(=O)([O-])[O-])P(=O)([O-])[O-].[K+].[K+].[K+].[K+].[K+].[K+],,,,,,
1581,161582,N-diaminophosphorylbenzamide,C1=CC=C(C=C1)C(=O)NP(=O)(N)N,,,,,,
1582,161583,N(4)-Methyl-5-azacytidine,CNC1=NC(=O)N(C=N1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
1583,161584,"N(4),N(4)-Dimethyl-5-azacytidine",CN(C)C1=NC(=O)N(C=N1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
1584,161585,Titanium ethylacetoacetate,CCOC(=O)C=C(C)[O-].CCOC(=O)C=C(C)[O-].CC(C)[O-].CC(C)[O-].[Ti+4],,,,,,
1585,161586,Nitroxinil eglumine,CCNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.C1=C(C=C(C(=C1[N+](=O)[O-])O)I)C#N,,,,,,
1586,161587,"3,3',5,5'-Tetrabromobiphenyl-2,2',4,4'-tetrol",C1=C(C(=C(C(=C1Br)O)Br)O)C2=CC(=C(C(=C2O)Br)O)Br,,,,,,
1587,161588,"3-Pentanone, 1-hydroxy-2-methyl-",CCC(=O)C(C)CO,,,,,,
1588,161589,CID 161589,CC1=CCC[C@@]([C@H]2C[C@@H]([C@H](CC(=CCC1)C)OC(=O)C)C(=C)C(=O)O2)(C)O,,,,,,
1589,161590,CID 161590,CN1C=[N+](C2=C1C(=O)N=C(N2)N)[C@@H]3C[C@@H]([C@H](O3)CO)O,,,,,,
1590,161591,Chaetocin,CN1C(=O)C23CC4(C(N2C(=O)C1(SS3)CO)NC5=CC=CC=C54)C67CC89C(=O)N(C(C(=O)N8C6NC1=CC=CC=C71)(SS9)CO)C,,,,,,
1591,161592,"5-Thyminil-5,6-dihydrothymine",CC1(CNC(=O)NC1=O)CC2=CNC(=O)NC2=O,,,,,,
1592,161593,5-(4-Nitrophenyl)furan-2-carboxylic acid,C1=CC(=CC=C1C2=CC=C(O2)C(=O)O)[N+](=O)[O-],,,,,,
1593,161594,4-Hydroxysulfinpyrazone,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=C(C=C3)O)CCS(=O)C4=CC=CC=C4,,,,,['4-Hydroxysulfinpyrazone is a known human metabolite of sulfinpyrazone_sulfide.'],
1594,161595,Magnesium;2-aminobutanedioate;hydron;chloride,[H+].C(C(C(=O)[O-])N)C(=O)[O-].[Mg+2].[Cl-],,,,,,
1595,161596,"2-Propenoic acid, homopolymer, ammonium salt",C=CC(=O)[O-].[NH4+],,,,,,
1596,161597,Methylselenic acid,C[Se](=O)O,,,,,,
1597,161598,"Benzamide, 3-(((2,4-bis(1,1-dimethylpropyl)phenoxy)acetyl)amino)-N-(4,5-dihydro-4-((4-methoxyphenyl)azo)-5-oxo-1-(2,4,6-trichlorophenyl)-1H-pyrazol-3-yl)-",CCC(C)(C)C1=CC(=C(C=C1)OCC(=O)NC2=CC=CC(=C2)C(=O)NC3=NN(C(=O)C3N=NC4=CC=C(C=C4)OC)C5=C(C=C(C=C5Cl)Cl)Cl)C(C)(C)CC,,,,,,
1598,161599,"[2-[Ethyl[3-methyl-4-[(3-phenyl-1,2,4-thiadiazol-5-yl)azo]phenyl]amino]ethyl]trimethylammonium methyl sulphate",CCN(CC[N+](C)(C)C)C1=CC(=C(C=C1)N=NC2=NC(=NS2)C3=CC=CC=C3)C.COS(=O)(=O)[O-],,,,,,
1599,161600,"(2-(N-Ethyl-4-((3-phenyl-1,2,4-thiadiazol-5-yl)azo)-m-toluidino)ethyl)trimethylammonium",CCN(CC[N+](C)(C)C)C1=CC(=C(C=C1)N=NC2=NC(=NS2)C3=CC=CC=C3)C,,,,,,
1600,161601,"Benzenamine, 4,4'-methylenebis-, polymer with (chloromethyl)oxirane",C1C(O1)CCl.C1=CC(=CC=C1CC2=CC=C(C=C2)N)N,,,,,,
1601,161602,Isoaminile citrate,CC(C)C(CC(C)N(C)C)(C#N)C1=CC=CC=C1.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,,,"['Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)']",,,
1602,161603,"1,3,5-Trimethyl-1H-pyrazol-4-amine",CC1=C(C(=NN1C)C)N,,,,,,
1603,161604,1-Methyl-2-(naphthalen-2-yl)aziridine,CN1CC1C2=CC3=CC=CC=C3C=C2,,,,,,
1604,161605,2'-O-methyladenosine 5'-monophosphate,CO[C@@H]1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O,,,,,,
1605,161606,9-Ribosylzeatin,CC(=CCNC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)CO,,,,,,
1606,161607,Hexamethylene diisocyanate trimer,C(CCCN=C=O)CCN=C=O.C(CCCN=C=O)CCN=C=O.C(CCCN=C=O)CCN=C=O,,,,,,
1607,161608,"Trisodium 3-[[4-[[[[2-methoxy-4-[(3-sulphonatophenyl)azo]phenyl]amino]carbonyl]amino]-o-tolyl]azo]naphthalene-1,5-disulphonate",CC1=C(C=CC(=C1)NC(=O)NC2=C(C=C(C=C2)N=NC3=CC(=CC=C3)S(=O)(=O)[O-])OC)N=NC4=CC5=C(C=CC=C5S(=O)(=O)[O-])C(=C4)S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
1608,161609,"3-({4-[({2-Methoxy-4-[(3-sulfophenyl)diazenyl]phenyl}carbamoyl)amino]-2-methylphenyl}diazenyl)naphthalene-1,5-disulfonic acid",CC1=C(C=CC(=C1)NC(=O)NC2=C(C=C(C=C2)N=NC3=CC(=CC=C3)S(=O)(=O)O)OC)N=NC4=CC5=C(C=CC=C5S(=O)(=O)O)C(=C4)S(=O)(=O)O,,,,,,
1609,161610,"2-Naphthalenesulfonic acid, 7,7'-(carbonyldiimino)bis(4-hydroxy-3-(2-(6-sulfo-2-naphthalenyl)diazenyl)-, sodium salt (1:4)",C1=CC2=C(C=C(C=C2)N=NC3=C(C=C4C=C(C=CC4=C3O)NC(=O)NC5=CC6=C(C=C(C(=C6C=C5)S(=O)(=O)[O-])N=NC7=CC8=C(C=C7)C(=CC=C8)S(=O)(=O)[O-])O)S(=O)(=O)[O-])C(=C1)S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
1610,161611,4-Hydroxy-7-[[8-hydroxy-5-sulfo-6-[(5-sulfonaphthalen-2-yl)diazenyl]naphthalen-2-yl]carbamoylamino]-3-[(8-sulfonaphthalen-2-yl)diazenyl]naphthalene-2-sulfonic acid,C1=CC2=C(C=C(C=C2)N=NC3=C(C=C4C=C(C=CC4=C3O)NC(=O)NC5=CC6=C(C=C(C(=C6C=C5)S(=O)(=O)O)N=NC7=CC8=C(C=C7)C(=CC=C8)S(=O)(=O)O)O)S(=O)(=O)O)C(=C1)S(=O)(=O)O,,,,,,
1611,161612,"2-Naphthalenesulfonic acid, 7,7'-(carbonyldiimino)bis(4-hydroxy-3-(2-(2-methyl-4-sulfophenyl)diazenyl)-, sodium salt (1:4)",CC1=CC(=C(C=C1)N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=C(C=C(C(=C5C=C4)S(=O)(=O)[O-])N=NC6=CC(=CC(=C6)C)S(=O)(=O)[O-])O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
1612,161613,4-Hydroxy-7-[[8-hydroxy-6-[(3-methyl-5-sulfophenyl)diazenyl]-5-sulfonaphthalen-2-yl]carbamoylamino]-3-[(4-methyl-2-sulfophenyl)diazenyl]naphthalene-2-sulfonic acid,CC1=CC(=C(C=C1)N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=C(C=C(C(=C5C=C4)S(=O)(=O)O)N=NC6=CC(=CC(=C6)C)S(=O)(=O)O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
1613,161614,"1-Chloro-2,2,2-trifluoroethyl radical",[CH](C(F)(F)F)Cl,,,,,,
1614,161615,"1H-Imidazole-1-ethanol, 2-heptadecyl-4,5-dihydro-, acetate (1:1)",CCCCCCCCCCCCCCCCCC1=NCCN1CCO.CC(=O)O,,,,,,
1615,161616,Acetyl aleuritolic acid,CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@@H]5CC(CC[C@@]5(CC=C4[C@@]3(CC[C@H]2C1(C)C)C)C(=O)O)(C)C)C)C,,,,,,
1616,161617,CID 161617,CC1(CC[C@@H]([C@]23[C@@H]1[C@@H]([C@]([C@]45[C@H]2CC[C@H](C4O)C(=C)[C@H]5O)(OC3)O)O)O)C,,,,,,
1617,161618,O-Methyl-demethyl gamma-amanitin,CCC(C)C1C(=O)NCC(=O)NC2CS(=O)C3=C(CC(C(=O)NCC(=O)N1)NC(=O)C(NC(=O)C4CC(CN4C(=O)C(NC2=O)CC(=O)N)O)C(C)CO)C5=C(N3)C=C(C=C5)OC,,,,,,
1618,161619,Syringopicroside,C[C@@H]1[C@@H]2[C@H](CC1=O)C(=CO[C@H]2O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C(=O)OCCC4=CC=C(C=C4)O,,,,,,
1619,161620,CID 161620,CC1=C[C@H](CC([C@H]1C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(C(=O)[C@H](CC2(C)C)O)C)C)C)(C)C)O,,,,,,
1620,161621,"1,6-Di-O-methane-sulphonyl-2,3,4,5-dianhydro-L-iditol",CS(=O)(=O)OC[C@H]1[C@@H](O1)[C@H]2[C@@H](O2)COS(=O)(=O)C,,,,,,
1621,161622,Lactoxylidide,CC1=C(C(=CC=C1)C)NC(=O)C(C)O,,,,,,
1622,161623,CID 161623,CC(=C(C(=O)NC1=CC=CC=C1)N=O)N[O-].CC(=C(C(=O)NC1=CC=CC=C1)N=O)N[O-].[Ni+2],,,,,,
1623,161624,CID 161624,CC(=C(C(=O)NC1=CC=CC=C1)N=O)N[O-],,,,,,
1624,161625,2-[3-(Furan-2-yl)prop-2-enoylamino]acetic acid,C1=COC(=C1)C=CC(=O)NCC(=O)O,,,,,,
1625,161626,Pyrromethane cofactor,C1=C(C(=C(N1)CC2=C(C(=C(N2)CN)CC(=O)O)CCC(=O)O)CC(=O)O)CCC(=O)O,,,,,,
1626,161627,"Ethanol, 2,2',2''-nitrilotris-, sulfite (salt)",C(CO)N(CCO)CCO.OS(=O)O,,,,,,
1627,161628,"2,2',2''-Nitrilotriethanol citrate",C(CO)N(CCO)CCO.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,,,,,,
1628,161629,"2-Propenoic acid, 2-methyl-, 2-hydroxyethyl ester, polymer with 2-methoxyethyl 2-methyl-2-propenoate",CC(=C)C(=O)OCCO.CC(=C)C(=O)OCCOC,,,,,,
1629,161630,"2-Propenoic acid, 2-methyl-, methyl ester, polymer with butyl 2-propenoate and 2-propenamide",CCCCOC(=O)C=C.CC(=C)C(=O)OC.C=CC(=O)N,,,,,,
1630,161631,CID 161631,C[C@H](C(=O)NC(C(C)C)C(=O)NCC(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]5CCCN5C(=O)C(C(C)C)NC(=O)C6CCC(=O)N6,,,,,,
1631,161632,"(2S,5R,6R)-6-[[(2R)-Carboxy-3-thienylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid disodium salt",CC1([C@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CSC=C3)C(=O)[O-])C(=O)[O-])C.[Na+].[Na+],,,,,,
1632,161633,"(2R,5R,6R)-6-[(2-carboxy-2-thiophen-3-ylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",CC1([C@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CSC=C3)C(=O)O)C(=O)O)C,,,,,,
1633,161634,"methyl 2-[(2S,3R,12bS)-3-ethyl-8-hydroxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate",CC[C@H]1CN2CCC3=C([C@@H]2C[C@@H]1C(=COC)C(=O)OC)NC4=C3C(=CC=C4)O,,,,,,
1634,161635,Ergoptin,CC[C@@]1(C(=O)N2[C@@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=CNC7=CC=CC(=C67)C5=C4)C,,,,,,
1635,161636,"1,5-Dimethyl-3-((2-methyl-1H-indol-3-yl)azo)-2-phenyl-1H-pyrazolium methyl sulphate",CC1C=C(N([NH+]1C)C2=CC=CC=C2)N=NC3=C(NC4=CC=CC=C43)C.COS(=O)(=O)[O-],,,,,,
1636,161637,"(2,3-dimethyl-1-phenyl-3H-pyrazol-5-yl)-(2-methyl-1H-indol-3-yl)diazene",CC1C=C(N(N1C)C2=CC=CC=C2)N=NC3=C(NC4=CC=CC=C43)C,,,,,,
1637,161638,N-(5-Pyrrolidinopent-3-ynyl)succinimide,C1CCN(C1)CC#CCCN2C(=O)CCC2=O,,,,,,
1638,161639,"1-(7-(4-Ethyl-5-methyl-2H-1,2,3-triazol-2-yl)-2-oxo-2H-1-benzopyran-3-yl)-4-methyl-1H-1,2,4-triazolium methyl sulphate",CCC1=NN(N=C1C)C2=CC3=C(C=C2)C=C(C(=O)O3)[NH+]4CN(C=N4)C.COS(=O)(=O)[O-],,,,,,
1639,161640,"7-(4-ethyl-5-methyltriazol-2-yl)-3-(4-methyl-3H-1,2,4-triazol-2-yl)chromen-2-one",CCC1=NN(N=C1C)C2=CC3=C(C=C2)C=C(C(=O)O3)N4CN(C=N4)C,,,,,,
1640,161641,2-Oxopropane sulfonate,CC(=O)CS(=O)(=O)[O-],,,,,,
1641,161642,Acetyl-methanesulfonic acid,CC(=O)CS(=O)(=O)O,,,,,,
1642,161643,Copper;5-hydroxy-2-(hydroxyiminomethyl)phenolate,C1=CC(=C(C=C1O)[O-])C=NO.C1=CC(=C(C=C1O)[O-])C=NO.[Cu+2],,,,,,
1643,161644,Ammonium glycinate,C(C(=O)[O-])N.[NH4+],,,"['Substances used for their pharmacological actions on glycinergic systems. Glycinergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function. (See all compounds classified as Glycine Agents.)']",,,
1644,161645,"aluminum;(4aS,6aS,6bR,12aS,14bS)-10-acetyloxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylate",CC(=O)OC1CC[C@]2(C(C1(C)C)CC[C@@]3(C2C(=O)C=C4[C@]3(CC[C@@]5([C@@H]4CC(CC5)(C)C(=O)[O-])C)C)C)C.CC(=O)OC1CC[C@]2(C(C1(C)C)CC[C@@]3(C2C(=O)C=C4[C@]3(CC[C@@]5([C@@H]4CC(CC5)(C)C(=O)[O-])C)C)C)C.CC(=O)OC1CC[C@]2(C(C1(C)C)CC[C@@]3(C2C(=O)C=C4[C@]3(CC[C@@]5([C@@H]4CC(CC5)(C)C(=O)[O-])C)C)C)C.[Al+3],,,,,,
1645,161646,"(4aS,6aS,6bR,12aS,14bS)-10-acetyloxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid",CC(=O)OC1CC[C@]2(C(C1(C)C)CC[C@@]3(C2C(=O)C=C4[C@]3(CC[C@@]5([C@@H]4CC(CC5)(C)C(=O)O)C)C)C)C,,,,,,
1646,161647,6-Hydroxyuridine-5'-phosphate,C1=C(N(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)O,,,,,,
1647,161648,CID 161648,C(C(=O)[O-])S.[Ca+2],,,,,,
1648,161649,beta-Methylstreptozotocin,CN(C(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC)CO)O)O)N=O,,,,,,
1649,161650,alpha-Methylstreptozotocin,CN(C(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1OC)CO)O)O)N=O,,,,,,
1650,161651,"Ethanol, 2-amino-, phosphate (salt)",C(CO)N.OP(=O)(O)O,,,,,,
1651,161652,Lithium arsenic(+5) cation hexafluoride,[Li+].[F-].[F-].[F-].[F-].[F-].[F-].[As+5],,,,,,
1652,161653,"(2S,3S)-3,4-Epoxy-2-hydroxybutyl methanesulfonate",CS(=O)(=O)OC[C@@H]([C@@H]1CO1)O,,,,,,
1653,161654,Acrylic acid-allyl pentaerythritol copolymer,C=CCOCC(COCC=C)(COCC=C)COCC=C.C=CC(=O)O,,,,,,
1654,161655,2-(9-Oxoxanthen-2-yl)propionic Acid,CC(C1=CC2=C(C=C1)OC3=CC=CC=C3C2=O)C(=O)O,,,,,,
1655,161656,Pan copolymer,CC(=C)CS(=O)(=O)O.C=CC#N,,,,,,
1656,161657,CID 161657,C1=CC2=C(C=C(OC2=CC1=O)C(=O)O)O,,,,,,
1657,161658,"(2S,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal",C([C@H]([C@H]([C@@H]([C@@H](C=O)O)O)O)O)O,,,,,,
1658,161659,"s-Triazine-2,4-diol, 6-(2,5-dichlorophenyl)-",C1=CC(=C(C=C1Cl)C2=NC(=O)NC(=O)N2)Cl,,,,,,
1659,161660,"6-Deoxy-3-c-methyl-2,3,4-tri-o-methylhexopyranose",CC1C(C(C(C(O1)O)OC)(C)OC)OC,,,,,,
1660,161661,"Methyl 6-nor-9,10-dihydrolysergate",COC(=O)[C@@H]1CC2[C@@H](CC3=CNC4=CC=CC2=C34)NC1,,,,,,
1661,161662,"Bis(2,5-dioxopyrrolidin-1-yl) succinate",C1CC(=O)N(C1=O)OC(=O)CCC(=O)ON2C(=O)CCC2=O,,,,,,
1662,161663,Ammonium bis(2-(N-ethyl(heptadecafluorooctane)sulphonylamino)ethyl) phosphate,CCN(CCOP(=O)([O-])OCCN(CC)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F.[NH4+],,,,,,
1663,161664,Methacrol 2138F,CCCCCCCCCCOC(=O)C(=C)C.CC(C)N(CCOC(=O)C(=C)C)C(C)C,,,,,,
1664,161665,Corydalmine,COC1=C(C=C2[C@@H]3CC4=C(CN3CCC2=C1)C(=C(C=C4)O)OC)OC,,,,,,
1665,161666,Oxygen(2-);vanadium;pentahydroxide,[OH-].[OH-].[OH-].[OH-].[OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[V].[V].[V],,,,,,
1666,161667,CID 161667,CCCCOC(=O)C=CC(=O)OCCCC.CC(=C)C(=O)OCC1CO1.CC(=O)OC=C.C=CC(=O)O,,,,,,
1667,161668,"3-Methyl-1,13b-dihydro-4h-[1,2,4]triazino[4,3-f]phenanthridine",CC1=NNC2C3=CC=CC=C3C4=CC=CC=C4N2C1,,,,,,
1668,161669,"Propanediamine, N-octadecyl-, diacetate",CCCCCCCCCCCCCCCCCCNC(CC)N.CC(=O)O.CC(=O)O,,,,,,
1669,161670,"1-N'-octadecylpropane-1,1-diamine",CCCCCCCCCCCCCCCCCCNC(CC)N,,,,,,
1670,161671,Withanolide D,CC1=C(C(=O)O[C@H](C1)[C@@](C)([C@H]2CC[C@@H]3[C@@]2(CC[C@H]4[C@H]3C[C@@H]5[C@]6([C@@]4(C(=O)C=C[C@@H]6O)C)O5)C)O)C,,,,,,
1671,161672,"N-(5-((4-(2,4-Bis(1,1-dimethylpropyl)phenoxy)-1-oxobutyl)amino)-2-chlorophenyl)-4,4-dimethyl-3-oxo-2-(4-((4-(phenylmethoxy)phenyl)sulphonyl)phenoxy)valeramide",CCC(C)(C)C1=CC(=C(C=C1)OCCCC(=O)NC2=CC(=C(C=C2)Cl)NC(=O)C(C(=O)C(C)(C)C)OC3=CC=C(C=C3)S(=O)(=O)C4=CC=C(C=C4)OCC5=CC=CC=C5)C(C)(C)CC,,,,,,
1672,161673,CID 161673,CCCCC(CC)C(=O)O.CCCCC(CC)C(=O)O.O.[AlH3],,,,,,
1673,161674,"Oxytocin, N-acetyl-2-O-methyl-tyr-",CC[C@H](C)C1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)OC)NC(=O)C)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,,,,,,
1674,161675,"Octahydro-4,7-methano-1H-indenemethyl acetate",CC(=O)OCC1CCC2C1C3CCC2C3,,,,,,
1675,161676,"Octahydro-4,7-methano-1H-indenecarbaldehyde",C1CC2CC1C3C2C(CC3)C=O,,,,,,
1676,161677,"9,10-Anthracenedione, 1,5-diamino-2,6-dibromo-4,8-dihydroxy-",C1=C(C2=C(C(=C1Br)N)C(=O)C3=C(C2=O)C(=C(C=C3O)Br)N)O,,,,,,
1677,161678,Dibromoethylbenzene,C1=CC=C(C=C1)CC(Br)Br,,,,,,
1678,161679,Isooctyl hydrogen phthalate,CC(C)CCCCCOC(=O)C1=CC=CC=C1C(=O)O,,,,,,
1679,161680,"Bicyclo[3.1.1]hept-2-ene, 2-(chloromethyl)-6,6-dimethyl-",CC1(C2CC=C(C1C2)CCl)C,,,,,,
1680,161681,(1-{[2-(Diethylamino)ethyl]amino}-9-oxo-9h-thioxanthen-4-yl)methyl methanesulfonate,CCN(CC)CCNC1=C2C(=C(C=C1)COS(=O)(=O)C)SC3=CC=CC=C3C2=O,,,,,,
1681,161682,"Hydrazine, (2-bromophenethyl)-",C1=CC=C(C(=C1)CCNN)Br,,,,,,
1682,161683,Cedr-8-en-10-one,C[C@@H]1CC[C@@H]2C13C[C@H](C2(C)C)C(=CC3=O)C,,,,,,
1683,161684,"2-(6,6-Dimethylbicyclo(3.1.1)hept-2-en-2-yl)ethyl phenylacetate",CC1(C2CC=C(C1C2)CCOC(=O)CC3=CC=CC=C3)C,,,,,,
1684,161685,"(S)-2-Amino-5-guanidinopentanoic acid thiazolidine-2,4-dicarboxylic acid (1:1)",C1C(NC(S1)C(=O)O)C(=O)O.C(C[C@@H](C(=O)O)N)CN=C(N)N,,,,,,
1685,161686,Sapindoside B,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H](CO[C@H]2O[C@H]3CC[C@]4([C@H]([C@]3(C)CO)CC[C@@]5([C@@H]4CC=C6[C@]5(CC[C@@]7([C@H]6CC(CC7)(C)C)C(=O)O)C)C)C)O)O)O)O[C@H]8[C@@H]([C@H]([C@@H](CO8)O)O)O)O,,,,,,
1686,161687,4-[(2-Chloro-4-nitrophenyl)azo]-N-ethyl-N-(2-phenoxyethyl)aniline,CCN(CCOC1=CC=CC=C1)C2=CC=C(C=C2)N=NC3=C(C=C(C=C3)[N+](=O)[O-])Cl,,,,,,
1687,161688,"2-[2,4-Bis(tert-pentyl)phenoxy]-N-(3,5-dichloro-2-hydroxy-P-tolyl)butyramide",CCC(C(=O)NC1=CC(=C(C(=C1O)Cl)C)Cl)OC2=C(C=C(C=C2)C(C)(C)CC)C(C)(C)CC,,,,,,
1688,161689,"2,2'-(3,7,12,16-Tetramethyloctadeca-3,7,11,15-tetraene-1,18-diyl)bis(3,3-dimethyloxirane)",CC(=CCCC=C(C)CCC=C(C)CCC1C(O1)(C)C)CCC=C(C)CCC2C(O2)(C)C,,,,,,
1689,161690,CID 161690,CC1=C(C(C[C@@H](C1)O)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C#CC2=C(C[C@H](CC2(C)C)O)C)C)C,,,,,,
1690,161691,"1,3-Isobenzofurandione, hexahydro-, polymer with (chloromethyl)oxirane",C1CCC2C(C1)C(=O)OC2=O.C1C(O1)CCl,,,,,,
1691,161692,Mecambridine,COC1=C(C(=C2C[C@H]3C4=C(C5=C(C=C4CCN3CC2=C1)OCO5)OC)CO)OC,,,,,,
1692,161693,"1,3-Diazetidin-2-one, 1,3-bis(4-((4-isocyanatophenyl)methyl)phenyl)-4-((4-((4-isocyanatophenyl)methyl)phenyl)imino)-",C1=CC(=CC=C1CC2=CC=C(C=C2)N=C3N(C(=O)N3C4=CC=C(C=C4)CC5=CC=C(C=C5)N=C=O)C6=CC=C(C=C6)CC7=CC=C(C=C7)N=C=O)N=C=O,,,,,,
1693,161694,"3,5,14-Trihydroxycholest-7-en-6-one",C[C@H](CCCC(C)C)[C@H]1CCC2([C@@]1(CC[C@H]3C2=CC(=O)[C@]4([C@@]3(CC[C@@H](C4)O)C)O)C)O,,,,,,
1694,161695,"Aurate(1-), tetrachloro-, ammonium, (SP-4-1)-",[NH4+].[Cl-].[Cl-].[Cl-].[Cl-].[Au+3],,,,,,
1695,161696,CID 161696,CC(C)CC1=CC=C(C=C1)C(C)C(=O)[O-].[Na+],,,,,,
1696,161697,disodium 2-heptadecyl-1-[(sulphonatophenyl)methyl]-1H-benzimidazolesulphonate,CCCCCCCCCCCCCCCCCOS(=O)(=O)C1=NC2=CC=CC=C2N1CC3=CC=CC=C3S(=O)(=O)[O-].CCCCCCCCCCCCCCCCCOS(=O)(=O)C1=NC2=CC=CC=C2N1CC3=CC=CC=C3S(=O)(=O)[O-].[Na+].[Na+],,,,,,
1697,161698,2-[(2-Heptadecoxysulfonylbenzimidazol-1-yl)methyl]benzenesulfonic acid,CCCCCCCCCCCCCCCCCOS(=O)(=O)C1=NC2=CC=CC=C2N1CC3=CC=CC=C3S(=O)(=O)O,,,,,,
1698,161699,Lyoniol-A,CC(=O)O[C@@H]1[C@H]([C@]2([C@@H]([C@H]3[C@@H](C2(C)C)O3)[C@]([C@H]4[C@]15C[C@@H](CC4)[C@](C5)(C)O)(C)O)O)O,,,,,,
1699,161700,4-tert-Butyl-3-methylanisole,CC1=C(C=CC(=C1)OC)C(C)(C)C,,,,,,
1700,161701,"cis-Dichlorobis(1,10-phenanthroline)chromium(1+) chloride dihydrate",C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1.C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1.[Cl-].[Cl-].[Cl-].[Cr+3],,,,,,
1701,161702,N-(2-Aminoethyl)-N'-(2-(1-piperazinyl)ethyl)ethylenediamine,C1CN(CCN1)CCNCCNCCN,,,,,,
1702,161703,"N1-(2-(4-(2-aminoethyl)piperazin-1-yl)ethyl)ethane-1,2-diamine",C1CN(CCN1CCN)CCNCCN,,,,,,
1703,161704,"(1s,5r,6s)-5-Hydroxy-3-(1-hydroxy-3-methylbut-2-en-1-yl)-7-oxabicyclo[4.1.0]hept-3-en-2-one",CC(=CC(C1=C[C@H]([C@H]2[C@@H](C1=O)O2)O)O)C,,,,,,
1704,161705,"Phosphorodithioic acid, O,O-diethyl S-[2-(methylthio)-1-propenyl] ester",CCOP(=S)(OCC)SC=C(C)SC,,,,,,
1705,161706,"4-Amino-4,6-dideoxy-D-mannose",C[C@H]([C@H]([C@@H]([C@@H](C=O)O)O)N)O,,,,,,
1706,161707,1-(2-Cyanoethyl)-2-[4-(diethylamino)phenyl]benz[cd]indolium chloride,CCN(CC)C1=CC=C(C=C1)C2=[N+](C3=CC=CC4=C3C2=CC=C4)CCC#N.[Cl-],,,,,,
1707,161708,1-(2-Cyanoethyl)-2-[4-(diethylamino)phenyl]benz[cd]indol-1-ium,CCN(CC)C1=CC=C(C=C1)C2=[N+](C3=CC=CC4=C3C2=CC=C4)CCC#N,,,,,,
1708,161709,"Benzene-1,4-disulfonic acid",C1=CC(=CC=C1S(=O)(=O)O)S(=O)(=O)O,,,,,,
1709,161710,"Propanenitrile, 3-[methyl[4-[(4-nitrophenyl)azo]phenyl]amino]-",CN(CCC#N)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
1710,161711,Maleic anhydride 1-tetradecene polymer,CCCCCCCCCCCCC=C.C1=CC(=O)OC1=O,,,,,,
1711,161712,2-Amino-4-sulfinobutanoic acid,C(CS(=O)O)C(C(=O)O)N,,,,,,
1712,161713,"1,3-Dipropyl-7-methylxanthine",CCCN1C2=C(C(=O)N(C1=O)CCC)N(C=N2)C,,,,,,
1713,161714,CID 161714,CC(C)(C)CCCCCC(=O)[O-].[Na+],,,,,,
1714,161715,"(12R)-1,5,9-trimethyl-12-prop-1-en-2-ylcyclotetradeca-1,5,9-triene",CC1=CCCC(=CC[C@@H](CCC(=CCC1)C)C(=C)C)C,,,,,,
1715,161716,2-Isopropyl-1-methoxy-4-methylbenzene,CC1=CC(=C(C=C1)OC)C(C)C,,,,,,
1716,161717,"Cholest-7-en-6-one, 3,14,22,25-tetrahydroxy-, (3beta,5beta,22R)-",C[C@@H]([C@H]1CCC2([C@@]1(CC[C@H]3C2=CC(=O)[C@H]4[C@@]3(CC[C@@H](C4)O)C)C)O)[C@@H](CCC(C)(C)O)O,,,,,,
1717,161718,2-Aminotridecane undecylenate,CCCCCCCCCCCC(C)N.C=CCCCCCCCCC(=O)O,,,,,,
1718,161719,"1,5-Diaminodibromo-4,8-dihydroxyanthraquinone",C1=CC(=C2C(=C1N)C(=O)C3=C(C2=O)C(=C(C(=C3O)Br)Br)N)O,,,,,,
1719,161720,alpha-(Trichloromethyl)benzyl propionate,CCC(=O)OC(C1=CC=CC=C1)C(Cl)(Cl)Cl,,,,,,
1720,161721,Pinusolide,C[C@]12CCC[C@]([C@@H]1CCC(=C)[C@@H]2CCC3=CCOC3=O)(C)C(=O)OC,,,,,,
1721,161722,CID 161722,CC1=C[C@H]2[C@H](C2(C)C)[C@H](CC(=CCC1)C)OC(=O)C=CC3=CC=CC=C3,,,,,,
1722,161723,"Chromate(1-), bis(1-((5-chloro-2-(hydroxy-kappaO)phenyl)azo-kappaN1)-2-naphthalenolato(2-)-kappaO)-, hydrogen",[H+].C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=CC(=C3)Cl)[O-])[O-].C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=CC(=C3)Cl)[O-])[O-].[Cr+3],,,,,,
1723,161724,CID 161724,C1=COC2=CC(=O)C=C(C2=C1O)O,,,,,,
1724,161725,"Benzoic acid, 2-[[3-[[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)amino]carbonyl]-2-hydroxy-1-naphthalenyl]azo]-, butyl ester",CCCCOC(=O)C1=CC=CC=C1N=NC2=C(C(=CC3=CC=CC=C32)C(=O)NC4=CC5=C(C=C4)NC(=O)N5)O,,,,,,
1725,161726,"(2,2-Dibromovinyl)benzene",C1=CC=C(C=C1)C=C(Br)Br,,,,,,
1726,161727,CID 161727,C[Si](O)(O)[O-].[K+],,,,,,
1727,161728,Dimethylethylamine-N-oxide,CC[N+](C)(C)[O-],,,,,,
1728,161729,Tris(2-bromopropyl)phosphate,CC(COP(=O)(OCC(C)Br)OCC(C)Br)Br,,,,,,
1729,161730,"4-hydroxy-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-diazinan-2-one",C1CN(C(=O)NC1O)[C@H]2C[C@@H]([C@H](O2)CO)O,,,,,,
1730,161731,"Benzenesulfonic acid, 4-[4-[2-(3-ethyl-2(3H)-benzothiazolylidene)-1-methylethylidene]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]-",CCN1C2=CC=CC=C2SC1=CC(=C3C(=NN(C3=O)C4=CC=C(C=C4)S(=O)(=O)O)C)C,,,,,,
1731,161732,4-Methylbenzenediazonium sulfate,CC1=CC=C(C=C1)[N+]#N.[O-]S(=O)(=O)[O-],,,,,,
1732,161733,N(6)-Benzyl cyclic amp,C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)NCC5=CC=CC=C5)O)OP(=O)(O1)O,,,,,,
1733,161734,Piquerol A,CC(=C)[C@@H]1[C@@H](C=C[C@@H](C1=C)O)O,,,,,,
1734,161735,CID 161735,CCN1CC2(CCC(C34C2CC(C31)C5(CC(C6CC4C5C6O)OC)O)OC)CO,,,,,,
1735,161736,"2-Hydroxy-N-methyl-N,N-bis[2-(octadecanoyloxy)ethyl]ethan-1-aminium [dihydroxy(methoxy)-lambda~4~-sulfanyl]oxidanide",CCCCCCCCCCCCCCCCCC(=O)OCC[N+](C)(CCO)CCOC(=O)CCCCCCCCCCCCCCCCC.COS(O)(O)[O-],,,,,,
1736,161737,N-(2-Hydroxyethyl)-N-methyl-2-[(1-oxooctadecyl)oxy]-N-[2-[(1-oxooctadecyl)oxy]ethyl]ethanaminium,CCCCCCCCCCCCCCCCCC(=O)OCC[N+](C)(CCO)CCOC(=O)CCCCCCCCCCCCCCCCC,,,,,,
1737,161738,Trihydroxy(methoxy)-lambda4-sulfane,COS(O)(O)O,,,,,,
1738,161739,Lupeol palmitate,CCCCCCCCCCCCCCCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@@H]4[C@H]5[C@@H](CC[C@@]5(CC[C@]4([C@@]3(CC[C@H]2C1(C)C)C)C)C)C(=C)C)C,,,,,,
1739,161740,CID 161740,CC(=O)C1=CC(=NC2=NC(=NC(=N2)NC3=CC(=C(C4=C(C5=CC=CC=C5C(=C34)O)O)N)C(=O)C)C6=CC=CC=C6)C7=C(C1=N)C(=O)C8=CC=CC=C8C7=O,,,,,,
1740,161741,Ancistrocladine,C[C@H]1CC2=C(C(=CC(=C2[C@@H](N1)C)OC)O)C3=C4C=CC=C(C4=C(C=C3C)OC)OC,,,,,,
1741,161742,Disodium glutarate,C(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+],,,,,,
1742,161743,"Hexanedioic acid, polymer with 1,4-butanediol, 1,1'-methylenebis(4-isocyanatobenzene) and 2,2'-(1,4-phenylenebis(oxy))bis(ethanol)",C1=CC(=CC=C1CC2=CC=C(C=C2)N=C=O)N=C=O.C1=CC(=CC=C1OCCO)OCCO.C(CCC(=O)O)CC(=O)O.C(CCO)CO,,,,,,
1743,161744,"1-Octadecanaminium, N-hexadecyl-N,N-dimethyl-, chloride",CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCC.[Cl-],,,,,,
1744,161745,Dimethylpalmitylstearylammonium,CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCC,,,,,,
1745,161746,Minimycin,C1=C(C(=O)NC(=O)O1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
1746,161747,Cochlioquinone A,CC[C@H](C)[C@H]([C@@H](C)C1=CC(=O)C2=C(C1=O)O[C@@]3(CC[C@@H]4[C@@]([C@H]3[C@@H]2O)(CC[C@@H](O4)C(C)(C)O)C)C)OC(=O)C,,,,,,
1747,161748,Myricanone,COC1=C2C=C(CCCCC(=O)CCC3=CC2=C(C=C3)O)C(=C1OC)O,,,,,,
1748,161749,Tylophorinidine,COC1=CC2=C(C=C1)C3=C(CN4CCC[C@H]4[C@H]3O)C5=CC(=C(C=C52)O)OC,,,,,,
1749,161750,"Benzoic acid, 3,3'-oxybis(2-amino-",C1=CC(=C(C(=C1)OC2=CC=CC(=C2N)C(=O)O)N)C(=O)O,,,,,,
1750,161751,Rhonite,CCSC(=O)NC1CCCCC1,,,,,,
1751,161752,Cadmium lauroyl sarcosinate,CCCCCCCCCCCC(=O)N(C)CC(=O)[O-].CCCCCCCCCCCC(=O)N(C)CC(=O)[O-].[Cd+2],,,,,,
1752,161753,2-Amino-3-sulfidopropanoate;carbanide;hydron;mercury(2+),[H+].[CH3-].C(C(C(=O)[O-])N)[S-].[Hg+2],,,,,,
1753,161754,"Benzenesulfonic acid, compd. with C.I. Basic Yellow 2",CC1=C(C(=C(C=C1)C(=N)C2=C(C(=C(C=C2)C)C)N)N)C.C1=CC=C(C=C1)S(=O)(=O)[O-],,,,,,
1754,161755,"2,2'-Carbonimidoylbis(5,6-dimethylaniline)",CC1=C(C(=C(C=C1)C(=N)C2=C(C(=C(C=C2)C)C)N)N)C,,,,,,
1755,161756,"2,2-Bis(4-ethoxyphenyl)-3,3-dimethyloxetane",CCOC1=CC=C(C=C1)C2(C(CO2)(C)C)C3=CC=C(C=C3)OCC,,,,,,
1756,161757,"1,10-Bis(carboxymethylthio)decane",C(CCCCCSCC(=O)O)CCCCSCC(=O)O,,,,,,
1757,161758,CID 161758,CN(C1CCCCC1)S(=O)(=O)C2=CC=CC=C2N=NC3=C(C=CC4=CC(=CC(=C43)O)S(=O)(=O)[O-])N.[Na+],,,,,,
1758,161759,Tectilon Red 2B,CN(C1CCCCC1)S(=O)(=O)C2=CC=CC=C2N=NC3=C(C=CC4=CC(=CC(=C43)O)S(=O)(=O)O)N,,,,,,
1759,161760,"3-(4-Amino-phenyl)-pyrrolidine-2,5-dione",C1C(C(=O)NC1=O)C2=CC=C(C=C2)N,,,,,,
1760,161761,"5,6-Benzo-2,2,4,4-tetramethyl-1,2,3,4-tetrahydro-gamma-carboline-oxyl",CC1(CC2=C(C3=C(N2)C=CC4=CC=CC=C43)C(N1[O])(C)C)C,,,,,,
1761,161762,"(6R)-6-but-1-enylcyclohepta-1,4-diene",CCC=C[C@H]1CC=CCC=C1,,,,,,
1762,161763,"2,4,9-Trimethylallopsoralen",CC1=CC2=C(C(=CC(=O)O2)C)C3=C1C=C(O3)C,,,,,,
1763,161764,"Disodium 2-(4,5-diiodo-6-oxido-3-oxoxanthen-9-yl)benzoate",C1=CC=C2C(=C1)C(=O)OC23C4=C(C(=C(C=C4)[O-])I)OC5=C3C=CC(=C5I)[O-].[Na+].[Na+],,,,,,
1764,161765,Ervatamine,CC[C@@H]1CN(C[C@@]2([C@H]1CC(=O)C3=C(C2)C4=CC=CC=C4N3)C(=O)OC)C,,,,,,
1765,161766,CID 161766,CC([C-]1CC=CC=C1)SC(C)[C-]2CC=CC=C2.[Fe+2],,,,,,
1766,161767,CID 161767,CC(C1CC=CC=C1)SC(C)C2CC=CC=C2,,,,,,
1767,161768,"Hydrogen bis(2,4-dihydro-4-((2-hydroxy-4-nitrophenyl)azo)-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-))chromate(1-)",[H+].CC1=NN(C(=C1N=NC2=C(C=C(C=C2)[N+](=O)[O-])[O-])[O-])C3=CC=CC=C3.CC1=NN(C(=O)C1=NN=C2C=CC(=CC2=O)N([O-])[O-])C3=CC=CC=C3.[Cr],,,,,,
1768,161769,CID 161769,CC1=NN(C(=O)C1=NN=C2C=CC(=CC2=O)N(O)O)C3=CC=CC=C3,,,,,,
1769,161770,"4-[[4-(Dioxidoamino)-6-oxocyclohexa-2,4-dien-1-ylidene]hydrazinylidene]-5-methyl-2-phenylpyrazol-3-one",CC1=NN(C(=O)C1=NN=C2C=CC(=CC2=O)N([O-])[O-])C3=CC=CC=C3,,,,,,
1770,161771,3-(Fluorocarbamoylamino)propanoic acid,C(CNC(=O)NF)C(=O)O,,,,,,
1771,161772,Carboxymethanesulfinyl-acetic acid,C(C(=O)O)S(=O)CC(=O)O,,,,,,
1772,161773,Cyclobutyldithymidine dimers,C[C@@]12[C@@H]([C@H]3[C@@]1(C(=O)NC(=O)N3[C@H]4C[C@@H]([C@H](O4)CO)O)C)N(C(=O)NC2=O)[C@H]5C[C@@H]([C@H](O5)CO)O,,,,,,
1773,161774,"2,3-Dihydro-N-methyl-1H-phenalen-2-amine",CNC1CC2=CC=CC3=C2C(=CC=C3)C1,,,,,,
1774,161775,"(1R,2R,6S,7S,8R,10S,11S,12R,14S,16R,18R)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-16-prop-1-en-2-yl-14-trideca-1,3-dienyl-9,13,15,19-tetraoxahexacyclo[12.4.1.01,11.02,6.08,10.012,16]nonadec-3-en-5-one",CCCCCCCCCC=CC=C[C@]12O[C@@H]3[C@@H]4[C@H]5[C@](O5)([C@H]([C@]6([C@H]([C@@]4(O1)[C@@H](C[C@@]3(O2)C(=C)C)C)C=C(C6=O)C)O)O)CO,,,,,,
1775,161776,2-(6-Methylergolin-8-yl)ethanimidic acid,CN1C[C@@H](CC2[C@H]1CC3=CNC4=CC=CC2=C34)CC(=O)N,,,,,,
1776,161777,Tertatolol hydrochloride,CC(C)(C)NCC(COC1=CC=CC2=C1SCCC2)O.Cl,,,"['Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)', 'Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)']",,,
1777,161778,4-(2-Hydroxyethylamino)-2-(5-nitro-2-furyl)thienopyrimidine,C1=CSC2=C1N=C(N=C2NCCO)C3=CC=C(O3)[N+](=O)[O-],,,,,,
1778,161779,Myricanol,COC1=C2C=C(CCCC[C@H](CCC3=CC2=C(C=C3)O)O)C(=C1OC)O,,,,,,
1779,161780,Sodium aurotiosulfate,O.O.[O-]S(=O)(=S)[O-].[O-]S(=O)(=S)[O-].[Na+].[Na+].[Na+].[Au+],,,['Drugs that are used to treat RHEUMATOID ARTHRITIS. (See all compounds classified as Antirheumatic Agents.)'],,,
1780,161781,Tyrosine-4-azobenzenearsonate,C1=CC(=CC=C1N=NC2=C(C=CC(=C2)C[C@@H](C(=O)O)N)O)[As](=O)(O)O,,,,,,
1781,161782,Copper(II)-glycyl-L-serine,C(C(C(=O)[O-])N)O.C(C(=O)[O-])N.[Cu+2],,,,,,
1782,161783,"2,3-Dimethoxy-7,8,9,10,10a,11-hexahydro-13h-pyrido[1',2':3,4]imidazo[2,1-b]quinazolin-13-one",COC1=C(C=C2C(=C1)C(=O)N3CC4CCCCN4C3=N2)OC,,,,,,
1783,161784,Abieslactone,CC1=C[C@H](OC1=O)C[C@@H](C)[C@H]2CC[C@@]3([C@@]2(CC[C@@H]4C3=CC[C@@H]5[C@@]4(CC[C@H](C5(C)C)OC)C)C)C,,,,,,
1784,161785,"4,4'-Sulfonylbis(N,N-dimethylbenzenamine)",CN(C)C1=CC=C(C=C1)S(=O)(=O)C2=CC=C(C=C2)N(C)C,,,,,,
1785,161786,"[2,15,17,30-Tetrahydroxy-28-[(6-hydroxy-2-methyloxan-3-yl)amino]-11-methoxy-3,7,12,14,16,23-hexamethyl-6,21,24-trioxo-8,31-dioxa-25-azapentacyclo[24.3.1.14,7.05,29.018,20]hentriaconta-1(30),2,4,9,22,26,28-heptaen-13-yl] acetate",CC1C(C=COC2(C(=O)C3=C(O2)C(=C(C4=C(C(=CC(=C43)NC5CCC(OC5C)O)NC(=O)C(=CC(=O)C6CC6C(C(C(C(C1OC(=O)C)C)O)C)O)C)O)O)C)C)OC,,,,,,
1786,161787,CID 161787,[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[SbH3],,,,,,
1787,161788,Einecs 251-737-1,C1=CC=C2C(=C1)C=CC(=C2OS(=O)(=O)C3=CC=CC4=C3C=CC(=C4[O-])[N+]#N)CC5=C(C6=CC=CC=C6C=C5)OS(=O)(=O)C7=CC=CC8=C7C=CC(=C8[O-])[N+]#N,,,,,,
1788,161789,5-[2-[[1-(6-Diazonio-5-hydroxynaphthalen-1-yl)sulfonyloxynaphthalen-2-yl]methyl]naphthalen-1-yl]oxysulfonyl-1-hydroxynaphthalene-2-diazonium,C1=CC=C2C(=C1)C=CC(=C2OS(=O)(=O)C3=CC=CC4=C3C=CC(=C4O)[N+]#N)CC5=C(C6=CC=CC=C6C=C5)OS(=O)(=O)C7=CC=CC8=C7C=CC(=C8O)[N+]#N,,,,,,
1789,161790,"Glycinamide, L-gamma-glutamyl-L-cysteinyl-N-(3-((4-aminobutyl)amino)propyl)-",C(CCNCCCNCC(=O)N(C(=O)CC[C@@H](C(=O)O)N)C(=O)[C@H](CS)N)CN,,,,,,
1790,161791,CID 161791,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O.C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)N.C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)NC(=NC2=O)N,,,,,,
1791,161792,Iron methanearsonate,C[As](=O)([O-])[O-].[Fe+3],,,,,,
1792,161793,"3-(Bis(3,3-diphenylpropyl)amino)propan-1-ol hydrochloride",C1=CC=C(C=C1)C(CCN(CCCO)CCC(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4.Cl,,,,,,
1793,161794,"1-Propanol, 3-(bis(3,3-diphenylpropyl)amino)-",C1=CC=C(C=C1)C(CCN(CCCO)CCC(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
1794,161795,CID 161795,CC[C@@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)Cl)C)C)C(C)C,,,,,,
1795,161796,"(2,3-Dihydroxypropyl)trimethylammonium chloride",C[N+](C)(C)CC(CO)O.[Cl-],,,,,,
1796,161797,"1-Propanaminium, 2,3-dihydroxy-N,N,N-trimethyl-",C[N+](C)(C)CC(CO)O,,,,,,
1797,161798,Protopanaxtriol,CC(=CCC[C@@](C)([C@H]1CC[C@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O)C)O)C)O)C,,,,,,
1798,161799,"2,3-Bis(acetoxymethyl)-1-methylpyrrole",CC(=O)OCC1=C(N(C=C1)C)COC(=O)C,,,,,,
1799,161800,Glycyrrhetic Acid 3-O-Glucuronide,C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O)C)(C)C(=O)O,,,,,,
1800,161801,6-Bromo-2-(4-(diethylamino)phenyl)-1-ethylbenz(cd)indolium chloride,CC[N+]1=C(C2=CC=CC3=C(C=CC1=C32)Br)C4=CC=C(C=C4)N(CC)CC.[Cl-],,,,,,
1801,161802,3-(Aminomethyl)pyridyl salicylate,C1=CC=C(C(=C1)C(=O)O)O.C1=CC(=CN=C1)CN,,,,,,
1802,161803,Fipexide hydrochloride,C1CN(CCN1CC2=CC3=C(C=C2)OCO3)C(=O)COC4=CC=C(C=C4)Cl.Cl,,,,,,
1803,161804,CID 161804,CC1=CC=C2C3=C4C(=C(O2)O)C(=O)C5=CC=CC(=O)C5=C4OC(=C13)O,,,,,,
1804,161805,"1H-Pyrrolizine-7-carboxaldehyde, 2,3-dihydro-1-hydroxy-",C1CN2C=CC(=C2C1O)C=O,,,,,,
1805,161806,Me-Uridine,COC1=NC(=O)N(C=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
1806,161807,"3beta,6alpha-Dihydroxy-5alpha-cholest-9(11)-en-23-one",C[C@H](CC(=O)CC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC=C3[C@H]2C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4)O)C)O)C,,,,,,
1807,161808,CID 161808,CC(=O)C=C(C1=CC=CC=C1)[O-].CC(=O)C=C(C1=CC=CC=C1)[O-].[Cl-].[Cl-].[Mo+4],,,,,,
1808,161809,"(Nitrilotris(methylene))trisphosphonic acid, ammonium salt",C(N(CP(=O)([O-])[O-])CP(=O)([O-])[O-])P(=O)([O-])[O-].[NH4+],,,,,,
1809,161810,"1,2,4-Thiadiazole-3,5-diamine",C1(=NSC(=N1)N)N,,,,,,
1810,161811,Uniblue A,C=CS(=O)(=O)C1=CC=CC(=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)O,,,['Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)'],,,
1811,161812,N-Methyl-2-(4-methylphenyl)succinimide,CC1=CC=C(C=C1)C2CC(=O)N(C2=O)C,,,,,,
1812,161813,Dihydroilludin M,CC1=C2[C@H](C(C=C2[C@H]([C@](C13CC3)(C)O)O)(C)C)O,,,,,,
1813,161814,"L-Prolinamide, 5-oxo-L-prolyl-1-methyl-L-histidyl-",CN1C=C(N=C1)C[C@@H](C(=O)N2CCC[C@H]2C(=O)NC(=O)[C@@H]3CCC(=O)N3)N,,,,,,
1814,161815,"(4S,5R)-4-hydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one",C1[C@@H]([C@H](OC1=O)CO)O,,,,,,
1815,161816,Hydroxysitosterol,CC[C@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C=C4[C@@]3(CC[C@@H](C4)O)C)O)C)C(C)C,,,,,,
1816,161817,"6-Chloro-4-((4-((2-cyanoethyl)ethylamino)phenyl)azo)-1,3-dimethyl-1H-benzimidazolium chloride",CCN(CCC#N)C1=CC=C(C=C1)N=NC2=C3C(=CC(=C2)Cl)N(C=[N+]3C)C.[Cl-],,,,,,
1817,161818,"6-Chloro-4-[[4-[(2-cyanoethyl)ethylamino]phenyl]azo]-1,3-dimethyl-1H-benzimidazol-3-ium",CCN(CCC#N)C1=CC=C(C=C1)N=NC2=C3C(=CC(=C2)Cl)N(C=[N+]3C)C,,,,,,
1818,161819,1-Ipomeanol,CC(=O)CCC(C1=COC=C1)O,,,,,,
1819,161820,Silver diammine fluoride,N.N.[F-].[Ag+],,,,,,
1820,161821,Polyvinyl acetate phthalate,CC(=O)OC=C.C1=CC=C(C(=C1)C(=O)O)C(=O)O,,,,,,
1821,161822,"4-{[6-{3-[(3-Carboxypropanoyl)oxy]-5,7-dihydroxy-4-oxo-3,4-dihydro-2H-1-benzopyran-2-yl}-3-(4-hydroxy-3-methoxyphenyl)-2,3-dihydro-1,4-benzodioxin-2-yl]methoxy}-4-oxobutanoic acid",COC1=C(C=CC(=C1)[C@@H]2C(OC3=C(O2)C=C(C=C3)[C@@H]4C(C(=O)C5=C(C=C(C=C5O4)O)O)OC(=O)CCC(=O)O)COC(=O)CCC(=O)O)O,,,,,,
1822,161823,Madecassoside,CC1CCC2(CCC3(C(=CCC4C3(CC(C5C4(CC(C(C5(C)CO)O)O)C)O)C)C2C1C)C)C(=O)OC6C(C(C(C(O6)COC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)O)O)O)O)O)O)O)O,,,,,,
1823,161824,3-Hydroxylidocaine,CCN(CC)CC(=O)NC1=C(C=CC(=C1C)O)C,,,,,['3-Hydroxylidocaine has known human metabolites that include 3-Hydroxymonoethyl glycinexylidide.'],
1824,161825,5-Hydroxypyrazine-2-carboxylic acid,C1=C(N=CC(=O)N1)C(=O)O,,,,,,
1825,161826,1-Methyl-3-acetoxyxanthine,CC(=O)ON1C2=C(C(=O)N(C1=O)C)NC=N2,,,,,,
1826,161827,3-Acetoxy-8-azaxanthine,CC(=O)ON1C2=NNN=C2C(=O)NC1=O,,,,,,
1827,161828,alpha-D-glucopyranosyl-(1->4)-alpha-D-glucopyranosyl-(1->4)-alpha-D-glucopyranosyl-(1->4)-alpha-D-glucopyranosyl-(1->4)-alpha-D-glucopyranosyl-(1->4)-D-glucose,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@H]([C@@H](CO)O)[C@@H]([C@H](C=O)O)O)CO)CO)CO)CO)O)O)O)O,,,,,,
1828,161829,"2,6-Bis(tert-butyl)-4-(1-methyl-1-phenylethyl)phenol",CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C(C)(C)C2=CC=CC=C2,,,,,,
1829,161830,"4,5-dibromo-1H-pyrrole-2-carboxylic acid",C1=C(NC(=C1Br)Br)C(=O)O,,,,,,
1830,161831,"N-[3-(2-amino-1H-imidazol-5-yl)prop-2-enyl]-4,5-dibromo-1H-pyrrole-2-carboxamide",C1=C(NC(=C1Br)Br)C(=O)NCC=CC2=CN=C(N2)N,,,,,,
1831,161832,Einecs 252-134-6,CC1=NN(C(=C1N=NC2=C(C=CC(=C2)S(=O)(=O)N)[O-])[O-])C3=CC=CC=C3.CC1=NN(C(=C1N=NC2=C(C=CC(=C2)S(=O)(=O)N)[O-])[O-])C3=CC=CC=C3.[Na+].[Co+3],,,,,,
1832,161833,CID 161833,CCCC(=O)O.C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C3NC=NC4=O)O)OP(=O)(O1)O,,,,,,
1833,161834,CID 161834,C1[C@@H]2[C@H]([C@H](C(O2)N3C=NC4=C3NC=NC4=O)O)OP(=O)(O1)O,,,,,,
1834,161835,"2-[3-[N-[(4,5-diphenyl-1,3-oxazol-2-yl)amino]-C-methylcarbonimidoyl]-N-(2-hydroxyethyl)anilino]ethanol",CC(=NNC1=NC(=C(O1)C2=CC=CC=C2)C3=CC=CC=C3)C4=CC(=CC=C4)N(CCO)CCO,,,,,,
1835,161836,CID 161836,[B+3].CCCCCCCCN(C)C.[Cl-].[Cl-].[Cl-],,,,,,
1836,161837,Aluminum calcium phosphate,[O-]P(=O)([O-])[O-].[Al+3].[Ca+2],,,,,,
1837,161838,"Sulphuric acid, gallium salt",[O-]S(=O)(=O)[O-].[Ga+3],,,,,,
1838,161839,Pyroglutamyl-phenylalanyl-prolinamide,C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H]3CCC(=O)N3)C(=O)N,,,,,,
1839,161840,Diethylcarbamazine N-oxide,CCN(CC)C(=O)N1CC[N+](CC1)(C)[O-],,,,,,
1840,161841,CID 161841,CCOC(=O)NC(=NC1=NN=CS1)S,,,,,,
1841,161842,"4-Piperidinamine, 2,2,6,6-tetramethyl-N-(2,2,6,6-tetramethyl-4-piperidinyl)-",CC1(CC(CC(N1)(C)C)N2C(CC(CC2(C)C)N)(C)C)C,,,,,,
1842,161843,3-Fluoromalic acid,[C@H]([C@H](C(=O)O)F)(C(=O)O)O,,,,,,
1843,161844,Jolethin,CCCCCC(C(CC(C(CCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCC(C(CC(C(CC(C(C)I)I)I)I)I)I)I)I)I)I,,,,,,
1844,161845,"2-[[2-(10,11,13,14,16,17-Hexaiodooctadecanoyloxy)-3-(9,10,12,13-tetraiodooctadecanoyloxy)propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium",CCCCCC(C(CC(C(CCCCCCCC(=O)OCC(COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCC(C(CC(C(CC(C(C)I)I)I)I)I)I)I)I)I)I,,,,,,
1845,161846,CID 161846,CC(=O)C1=CC(=CC(=C1O)C[N+](C)(C)CCOC2=CC=CC=C2)Cl.C1=CC=C2C=C(C(=CC2=C1)C(=O)[O-])O,,,,,,
1846,161847,(3-Acetyl-5-chloro-2-hydroxyphenyl)methyl-dimethyl-(2-phenoxyethyl)azanium,CC(=O)C1=CC(=CC(=C1O)C[N+](C)(C)CCOC2=CC=CC=C2)Cl,,,,,,
1847,161848,Indopine,C1CN(CCC1CCC2=CNC3=CC=CC=C32)CCC4=CC=CC=C4,,,,,,
1848,161849,Lodiperone,C1CN(CCN1CCC2=C(NC(=O)O2)C3=CC=C(C=C3)F)C4=CC(=CC(=C4)Cl)Cl,,,,,,
1849,161850,"4,5-Dihydroxy-1-methylpiperidine-2-carboxylic acid",CN1CC(C(CC1C(=O)O)O)O,,,,,,
1850,161851,Dansylethylenediamine,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NCCN,,,,,,
1851,161852,3-(4-Hydroxyphenoxy)benzoic acid,C1=CC(=CC(=C1)OC2=CC=C(C=C2)O)C(=O)O,,,,,,
1852,161853,N-Chloroglycine,C(C(=O)O)NCl,,,,,,
1853,161854,Bufetolol hydrochloride,CC(C)(C)NCC(COC1=CC=CC=C1OCC2CCCO2)O.Cl,,,"['Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)']",,,
1854,161855,2-(4-((4-Ethoxyphenyl)methylamino)phenyl)-1-ethylbenz(cd)indolium chloride,CC[N+]1=C(C2=CC=CC3=C2C1=CC=C3)C4=CC=C(C=C4)N(C)C5=CC=C(C=C5)OCC.[Cl-],,,,,,
1855,161856,2-[4-[(4-Ethoxyphenyl)(methyl)amino]phenyl]-1-ethylbenz[cd]indol-1-ium,CC[N+]1=C(C2=CC=CC3=C2C1=CC=C3)C4=CC=C(C=C4)N(C)C5=CC=C(C=C5)OCC,,,,,,
1856,161857,Dethiophalloidin,CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2CC(CC2C(=O)N1)O)C)C(C)O)C)CC(C)(CO)O)CC3=CNC4=CC=CC=C43,,,,,,
1857,161858,"5-Nonadecylbenzene-1,3-diol",CCCCCCCCCCCCCCCCCCCC1=CC(=CC(=C1)O)O,,,,,,
1858,161859,4-Methylpentan-2-yl but-2-enoate,CC=CC(=O)OC(C)CC(C)C,,,,,,
1859,161860,2'-Hydroxyflavone,C1=CC=C(C(=C1)C2=CC(=O)C3=CC=CC=C3O2)O,,,,,['2p-Hydroxyflavone has known human metabolites that include Flavone 2p-O-glucuronide.'],
1860,161861,4-(2-(Dimethylamino)ethyl)-2-methoxyphenol,CN(C)CCC1=CC(=C(C=C1)O)OC,,,,,,
1861,161862,4-(4-Cyclohexylphenyl)-4-oxobutanoic acid,C1CCC(CC1)C2=CC=C(C=C2)C(=O)CCC(=O)O,,,,,,
1862,161863,CID 161863,CC(=O)O[C@@H]1[C@H](C2=C([C@H]([C@@]1(C)OC(=O)C)OC(=O)C)C(=C3C2=C(C4=CC=CC(=O)C4=C3O)[O-])[N+]#N)O,,,,,,
1863,161864,CID 161864,CC(=O)O[C@@H]1[C@H](C2=C([C@H]([C@@]1(C)OC(=O)C)OC(=O)C)C(=C3C2=C(C4=CC=CC(=O)C4=C3O)O)[N+]#N)O,,,,,,
1864,161865,CID 161865,CC(=O)O[C@@H]1[C@H](C2=C([C@H]([C@@]1(C)O)OC(=O)C)C(=C3C2=C(C4=CC=CC(=O)C4=C3O)[O-])[N+]#N)O,,,,,,
1865,161866,CID 161866,CC(=O)O[C@@H]1[C@H](C2=C([C@H]([C@@]1(C)O)OC(=O)C)C(=C3C2=C(C4=CC=CC(=O)C4=C3O)O)[N+]#N)O,,,,,,
1866,161867,Curium trinitrate,[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Cm],,,,,,
1867,161868,"[3,6-Bis(trifluoromethyl)phenanthren-9-yl]-piperidin-2-ylmethanol;hydrochloride",C1CCNC(C1)C(C2=C3C=CC(=CC3=C4C=C(C=CC4=C2)C(F)(F)F)C(F)(F)F)O.Cl,,,,,,
1868,161869,"alpha-(2-Piperidyl)-3,6-bis(trifluoromethyl)-9-phenanthrenemethanol",C1CCNC(C1)C(C2=C3C=CC(=CC3=C4C=C(C=CC4=C2)C(F)(F)F)C(F)(F)F)O,,,,,,
1869,161870,CID 161870,[Li+].CC1=C(C2=C(C=C1)N=C(S2)C3=CC=C(C=C3)N=NC4C(=O)NC(=O)NC4=O)S(=O)(=O)[O-],,,,,,
1870,161871,Fukiic acid,C1=CC(=C(C=C1C[C@@]([C@@H](C(=O)O)O)(C(=O)O)O)O)O,,,,,,
1871,161872,((Phenylmethoxy)methoxy)methanol,C1=CC=C(C=C1)COCOCO,,,,,,
1872,161873,CID 161873,C1=CC=C(C=C1)CN=C(S)SC[C@@H](C(=O)O)N,,,,,,
1873,161874,Muramic lactam,C[C@@H]1C(=O)N[C@H]([C@@H](O1)[C@@H](C(CO)O)O)C=O,,,,,,
1874,161875,2-Dodecylcyclobutanone,CCCCCCCCCCCCC1CCC1=O,,,,,,
1875,161876,CID 161876,C1C=CC=C1.C1=CC=C(C(=C1)C(=C2C=CC=C2)O)C(=O)[O-].[Na+].[Fe+2],,,,,,
1876,161877,"2-[Cyclopenta-2,4-dien-1-ylidene(hydroxy)methyl]benzoic acid",C1=CC=C(C(=C1)C(=C2C=CC=C2)O)C(=O)O,,,,,,
1877,161878,"6-Chloro-3-[[ethoxy(methyl)phosphinothioyl]sulfanylmethyl]-[1,3]oxazolo[4,5-b]pyridin-2-one",CCOP(=S)(C)SCN1C2=C(C=C(C=N2)Cl)OC1=O,,,,,,
1878,161879,CID 161879,COC1=C(C=C(C=C1)C2=C(C(=C3C(=CC(=C(C3=O)OC)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O2)O)OC)O,,,,,,
1879,161880,4-Nitrophenyl-beta-D-mannopyranoside,C1=CC(=CC=C1[N+](=O)[O-])O[C@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
1880,161881,"9H-Xanthene-4-acetic acid, 9-oxo-",C1=CC=C2C(=C1)C(=O)C3=CC=CC(=C3O2)CC(=O)O,,,,,,
1881,161882,"Dihexylenetriaminepentakismethylenephosphonic acid, sodium salt",C(CCCN(CP(=O)(O)O)CP(=O)(O)O)CCN(CCCCCCN(CP(=O)(O)O)CP(=O)(O)O)CP(=O)(O)O.[Na+],,,,,,
1882,161883,9-Fluorenylmethyl carbazate,C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NN,,,,,,
1883,161884,Ethyl adenosine-5'-carboxylate,CCOC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O,,,,,,
1884,161885,"7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxooct-1-enyl)cyclopentyl]hept-5-enoic acid",CCCCCC(=O)C=C[C@H]1[C@@H](C[C@@H]([C@@H]1CC=CCCCC(=O)O)O)O,,,,,,
1885,161886,"7-(Diethylamino)-3-(1,3-dimethylbenzimidazol-3-ium-2-yl)chromen-2-one; methyl sulfate",CCN(CC)C1=CC2=C(C=C1)C=C(C(=O)O2)C3=[N+](C4=CC=CC=C4N3C)C.COS(=O)(=O)[O-],,,,,,
1886,161887,"1,3-Dimethyl-2-[7-(diethylamino)-2-oxo-2H-1-benzopyran-3-yl]-3H-benzimidazol-1-ium",CCN(CC)C1=CC2=C(C=C1)C=C(C(=O)O2)C3=[N+](C4=CC=CC=C4N3C)C,,,,,,
1887,161888,CID 161888,C1=CC=C2C(=C1)C=C(C(=C2N=NC3=C(C=C(C=C3)Cl)[N+](=O)O)O)C(=O)N=C4C=CC(=NC(=O)C5=CC6=CC=CC=C6C(=C5[O-])N=NC7=C(C=C(C=C7)Cl)N(O)O)C(=C4)Cl,,,,,,
1888,161889,CID 161889,C1=CC=C2C(=C1)C=C(C(=C2N=NC3=C(C=C(C=C3)Cl)[N+](=O)O)O)C(=O)N=C4C=CC(=NC(=O)C5=CC6=CC=CC=C6C(=C5O)N=NC7=C(C=C(C=C7)Cl)N(O)O)C(=C4)Cl,,,,,,
1889,161890,(s)-2-Amino-4-methoxybut-3-enoic acid,COC=C[C@@H](C(=O)O)N,,,,,,
1890,161891,Pterosin I,CC1=CC2=C(C(=C1CCOC)C)C(=O)C(C2)(C)C,,,,,,
1891,161892,Distamycin A/5,CN1C=C(C=C1C(=O)NC2=CN(C(=C2)C(=O)NC3=CN(C(=C3)C(=O)NC4=CN(C(=C4)C(=O)NC5=CN(C(=C5)C(=O)NCCC(=N)N)C)C)C)C)NC=O,,,,,,
1892,161893,"5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-",CC(=O)C1(CCC2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)O,,,,,,
1893,161894,"Phosphinic acid, bis(1-aziridinyl)-, 1-methylethyl ester",CC(C)OP(=O)(N1CC1)N2CC2,,,,,,
1894,161895,5-Nitrothiophene-3-carboxamide,C1=C(SC=C1C(=O)N)[N+](=O)[O-],,,,,,
1895,161896,N-(2-Hydroxyethyl)-N-methyl-N'-phenylurea,CN(CCO)C(=O)NC1=CC=CC=C1,,,,,,
1896,161897,"(S)-7-Amino-6,7-dihydro-1,2,3,10-tetramethoxybenzo(a)heptalen-9(5H)-one",COC1=CC=C2C(=CC1=O)C(CCC3=CC(=C(C(=C32)OC)OC)OC)N.COC1=CC=C2C(=CC1=O)C(CCC3=CC(=C(C(=C32)OC)OC)OC)N.C(C(C(=O)O)O)(C(=O)O)O,,,,,,
1897,161898,Trimethylcolchicinic acid methyl ether,COC1=CC=C2C(=CC1=O)C(CCC3=CC(=C(C(=C32)OC)OC)OC)N,,,,,,
1898,161899,Dehydroaporheine,CN1CCC2=CC3=C(C4=C2C1=CC5=CC=CC=C54)OCO3,,,,,,
1899,161900,"(9S,10R)-4,17-dimethyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene",CC1=CC2=C(C[C@H]3[C@H]4C2(CCCC4)CCN3C)C=C1,,,,,,
1900,161901,Calcium beta-alaninate,C(CN)C(=O)[O-].C(CN)C(=O)[O-].[Ca+2],,,,,,
1901,161902,"(1,1'-biphenyl)-4,4'-dimethanol, |A,|A'-bis((4-methyl-1-piperidinyl)methyl)-, dihydrobromide",CC1CCN(CC1)CC(C2=CC=C(C=C2)C3=CC=C(C=C3)C(CN4CCC(CC4)C)O)O.Br.Br,,,,,,
1902,161903,1-[4-[4-[1-Hydroxy-2-(4-methylpiperidin-1-yl)ethyl]phenyl]phenyl]-2-(4-methylpiperidin-1-yl)ethanol,CC1CCN(CC1)CC(C2=CC=C(C=C2)C3=CC=C(C=C3)C(CN4CCC(CC4)C)O)O,,,,,,
1903,161904,Platinum(2+);prop-2-enylbenzene,C=CCC1=CC=C[C-]=C1.C=CCC1=CC=C[C-]=C1.[Pt+2],,,,,,
1904,161905,Diisopropylamine salicylate,CC(C)NC(C)C.C1=CC=C(C(=C1)C(=O)O)O,,,,,,
1905,161906,n-Hexyl-delta-9-thc,CCCCCCC1=CC(=C2[C@@H]3C=C(CC[C@H]3C(OC2=C1)(C)C)C)O,,,,,,
1906,161907,CID 161907,CCOC(=CC(=O)C)[O-].CCOC(=CC(=O)C)[O-].C(C[O-])C[O-].[Ti+4],,,,,,
1907,161908,Lead bis(dipentyldithiocarbamate),CCCCCN(CCCCC)C(=S)[S-].CCCCCN(CCCCC)C(=S)[S-].[Pb+2],,,,,,
1908,161909,"(2R)-2-[(2S,3S,6R)-6-[(2R,3S)-3-[(5S,6R)-6-[[(2R,3S,5R,6R)-6-[[(5R)-5-[(2R,3R,5S)-5-[(2R,5R,6S)-6-ethyl-5-hydroxy-5-methyloxan-2-yl]-2-hydroxy-3,5-dimethyloxolan-2-yl]-5-methyloxolan-2-yl]-hydroxymethyl]-6-hydroxy-3,5-dimethyloxan-2-yl]methyl]-6-hydroxy-5-methyloxan-2-yl]-2-hydroxybutyl]-3-methyloxan-2-yl]propanoic acid",CC[C@H]1[C@](CC[C@@H](O1)[C@@]2(C[C@H]([C@@](O2)([C@]3(CCC(O3)C([C@]4([C@@H](C[C@@H]([C@H](O4)C[C@@]5([C@H](CCC(O5)[C@@H](C)[C@@H](C[C@H]6CC[C@@H]([C@H](O6)[C@@H](C)C(=O)O)C)O)C)O)C)C)O)O)C)O)C)C)(C)O,,,,,,
1909,161910,Morphine 6-hemisuccinate,CN1CC[C@]23[C@@H]4C1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)OC(=O)CCC(=O)O,,,,,,
1910,161911,Pentachlorophenyl propyl ether,CCCOC1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl,,,,,,
1911,161912,4-[2-(Tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol;sulfate,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.[O-]S(=O)(=O)[O-],,,,,,
1912,161913,Chloropalladic acid,[H+].[H+].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Pd],,,,,,
1913,161914,"cis-1,1'-(3,3-Dichloro-1,2-cyclopropanediyl)bis(benzene)",C1=CC=C(C=C1)[C@H]2[C@H](C2(Cl)Cl)C3=CC=CC=C3,,,,,,
1914,161915,Tosylmethyl isocyanide,CC1=CC=C(C=C1)S(=O)(=O)C[N+]#[C-],,,,,,
1915,161916,CID 161916,CC(=NNC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-])OCC=O,,,,,,
1916,161917,Methyl 1-(N-cyclohexylbenzimidoyl)-5-methyl-3-pyrazolecarboxylate,CC1=CC(=NN1C(=NC2CCCCC2)C3=CC=CC=C3)C(=O)OC,,,,,,
1917,161918,1-(N-(4-Methoxyphenyl)benzimidoyl)-5-methyl-3-pyrazolecarboxylate,CC1=CC(=NN1C(=NC2=CC=C(C=C2)OC)C3=CC=CC=C3)C(=O)OC,,,,,,
1918,161919,Titanium(4+) 2-(bis(2-hydroxyethyl)amino)ethanolate propan-2-olate (1:2:2),CC(C)[O-].CC(C)[O-].C(CO)N(CCO)CC[O-].C(CO)N(CCO)CC[O-].[Ti+4],,,,,,
1919,161920,"Benzenesulfonic acid, 5-chloro-2-((1-(2-chlorophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl)azo)-",CC1=NN(C(=O)C1N=NC2=C(C=C(C=C2)Cl)S(=O)(=O)O)C3=CC=CC=C3Cl,,,,,,
1920,161921,2-Ethylhexanoic anhydride,CCCCC(CC)C(=O)OC(=O)C(CC)CCCC,,,,,,
1921,161922,"3-[4-(3-Methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]propane-1,2-diol",COC1CC2=CC=CC=C2C(C1C3=CC=CC=C3)C4=CC=C(C=C4)OCC(CO)O,,,,,,
1922,161923,"1,6-Dinitrophenazine",C1=CC2=C(C(=C1)[N+](=O)[O-])N=C3C=CC=C(C3=N2)[N+](=O)[O-],,,,,,
1923,161924,Dihydroguaiaretic acid,CC(CC1=CC(=C(C=C1)O)OC)C(C)CC2=CC(=C(C=C2)O)OC,,,,,,
1924,161925,"Benzenemethanamine, 4-((2-chloroethyl)methylamino)-",CN(CCCl)C1=CC=C(C=C1)CN,,,,,,
1925,161926,"1-Propanol,2,3-dibromo-, 1,1'-(hydrogen phosphate)",C(C(CBr)Br)O.OP(=O)([O-])[O-].[Mg+2],,,,,,
1926,161927,"Ethanol, 2,2'-[oxybis(methylenesulfonyl)]bis-",C(CS(=O)(=O)COCS(=O)(=O)CCO)O,,,,,,
1927,161928,"6-(4-Aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2h)-one",CC1CC(=O)NN=C1C2=CC=C(C=C2)N,,,,,,
1928,161929,"3,5,5-Trimethylhexanoyl chloride",CC(CC(=O)Cl)CC(C)(C)C,,,,,,
1929,161930,Icilin,C1C=C(NC(=O)N1C2=CC=CC=C2O)C3=CC(=CC=C3)[N+](=O)[O-],,,"['A class of drugs that stimulate sodium influx through cell membrane channels. (See all compounds classified as Sodium Channel Agonists.)', 'Agents that increase calcium influx into calcium channels of excitable tissues. This causes vasoconstriction in VASCULAR SMOOTH MUSCLE and/or CARDIAC MUSCLE cells as well as stimulation of insulin release from pancreatic islets. Therefore, tissue-selective calcium agonists have the potential to combat cardiac failure and endocrinological disorders. They have been used primarily in experimental studies in cell and tissue culture. (See all compounds classified as Calcium Channel Agonists.)']",,,
1930,161931,"10H-Phenoxazine-3,7-diamine, 10-benzoyl-N,N,N',N'-tetraethyl-",CCN(CC)C1=CC2=C(C=C1)N(C3=C(O2)C=C(C=C3)N(CC)CC)C(=O)C4=CC=CC=C4,,,,,,
1931,161932,"6-(Diiodomethyl)-6-[2-[6-(diiodomethyl)-2,5-dioxabicyclo[2.1.1]hexan-6-yl]ethyl]-2,5-dioxabicyclo[2.1.1]hexane;pyrrolidin-1-ium",C1CC[NH2+]C1.C1C2C(C(O1)O2)(CCC3(C4COC3O4)C(I)I)C(I)I,,,,,,
1932,161933,"6-(Diiodomethyl)-6-[2-[6-(diiodomethyl)-2,5-dioxabicyclo[2.1.1]hexan-6-yl]ethyl]-2,5-dioxabicyclo[2.1.1]hexane",C1C2C(C(O1)O2)(CCC3(C4COC3O4)C(I)I)C(I)I,,,,,,
1933,161934,2-O-Methylthymidine,CC1=CN(C(=NC1=O)OC)[C@H]2C[C@@H]([C@H](O2)CO)O,,,,,,
1934,161935,CID 161935,C[C@@]1([C@@H]2C[C@@H]3[C@H](C(=O)C(=C(NCN4CCC[C@H]4C(=O)O)O)C(=O)[C@@]3(C(=O)C2=C(C5=C1C=CC=C5O)O)O)N(C)C)O,,,,,,
1935,161936,1-Ethynyl-2-(1-methylpropyl)cyclohexyl acetate,CCC(C)C1CCCCC1(C#C)OC(=O)C,,,,,,
1936,161937,Capsidiol,C[C@@H]1[C@@H](C[C@H](C2=CC[C@H](C[C@]12C)C(=C)C)O)O,,,,,,
1937,161938,Chlorophosphorane,PCl,,,,,,
1938,161939,Calcium magnesium oxide,[O-2].[O-2].[Mg+2].[Ca+2],,,,,,
1939,161940,"4-hydroxy-9-[4-hydroxy-2-(hydroxymethyl)-10-oxo-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9H-anthracen-9-yl]-10-oxo-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9H-anthracene-2-carboxylic acid",C1=CC2=C(C(=C1)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C(=O)C4=C(C2C5C6=C(C(=CC=C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C(=O)C8=C5C=C(C=C8O)C(=O)O)C=C(C=C4O)CO,,,,,,
1940,161941,"2-Propenoic acid, 2-ethyl-2-(hydroxymethyl)-1,3-propanediyl ester",CCC(CO)(COC(=O)C=C)COC(=O)C=C,,,,,,
1941,161942,Sangor,C1=CC(=C(C=C1Cl)Cl)OCC(=O)[O-].C1(=C(C(=NC(=C1Cl)Cl)C(=O)[O-])Cl)N,,,,,,
1942,161943,CID 161943,C1=C(C(=NC(=C1Cl)Cl)[O-])Cl.[Na+],,,,,,
1943,161944,"4H-1-Benzopyran-2-carboxylic acid, 6,8-diethyl-5-hydroxy-4-oxo-",CCC1=CC(=C2C(=C1O)C(=O)C=C(O2)C(=O)O)CC,,,,,,
1944,161945,"Benzenesulfonic acid, (1-methylethyl)-, ammonium salt",CC(C)C1=CC=CC=C1S(=O)(=O)[O-].[NH4+],,,,,,
1945,161946,o-Cumenesulfonic acid,CC(C)C1=CC=CC=C1S(=O)(=O)O,,,,,,
1946,161947,CID 161947,C(CS)[O-].[Na+],,,,,,
1947,161948,Etheno-adenosine monophosphate,C1=CN2C=NC3=C(C2=N1)N=CN3[C@H]4[C@@H]([C@@H]([C@H](O4)COP(=O)(O)O)O)O,,,,,,
1948,161949,1-Methoxy-1-methylcyclododecane,CC1(CCCCCCCCCCC1)OC,,,,,,
1949,161950,3-Hydroxyacetaminophen,CC(=O)NC1=CC(=C(C=C1)O)O,,,,,['3-Hydroxyacetaminophen is a known human metabolite of acetaminophen.'],
1950,161951,CID 161951,COC1=CC=C(C=C1)[SeH],,,,,,
1951,161952,7-Deoxyadriamycinol aglycone,COC1=CC=CC2=C1C(=O)C3=C(C4=C(C[C@](CC4)([C@H](CO)O)O)C(=C3C2=O)O)O,,,,,,
1952,161953,Jolkinolide A,CC1=C2[C@@H]3[C@]4(O3)CC[C@H]5[C@]([C@@H]4C=C2OC1=O)(CCCC5(C)C)C,,,,,,
1953,161954,Jolkinolide B,CC1=C2[C@@H]3[C@]4(O3)CC[C@H]5[C@]([C@@H]4[C@@H]6[C@]2(O6)OC1=O)(CCCC5(C)C)C,,,,,,
1954,161955,Palmitoyl glutamic acid,CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
1955,161956,4-(Bis(2-chloroethyl)amino)phenyl beta-D-glucopyranosiduronic acid,C1=CC(=CC=C1N(CCCl)CCCl)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O,,,,,,
1956,161957,S-((2-Chloroethyl)carbamoyl)glutathione,C(CC(=O)N[C@@H](CSC(=O)NCCCl)C(=O)NCC(=O)O)[C@@H](C(=O)O)N,,,,,,
1957,161958,"4-Chloro-3,5-dinitrobenzenesulfonate",C1=C(C=C(C(=C1[N+](=O)[O-])Cl)[N+](=O)[O-])S(=O)(=O)[O-],,,,,,
1958,161959,"1-Pentanone, 1-(4-aminophenyl)-",CCCCC(=O)C1=CC=C(C=C1)N,,,,,,
1959,161960,5-Methyl-3-butyltetrahydropyran-4-yl acetate,CCCCC1COCC(C1OC(=O)C)C,,,,,,
1960,161961,(2S)-2-[[(2S)-2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoyl]-[(2S)-pyrrolidine-2-carbonyl]amino]-3-(4-fluorophenyl)propanoic acid,C1C[C@H](NC1)C(=O)N([C@@H](CC2=CC=C(C=C2)F)C(=O)O)C(=O)[C@H](CC3=CC(=CC=C3)N(CCCl)CCCl)N,,,,,,
1961,161962,CID 161962,CCCCOCCOCC[O-].[Na+],,,,,,
1962,161963,"1,2-Dichloro-4-(methylsulfonyl)benzene",CS(=O)(=O)C1=CC(=C(C=C1)Cl)Cl,,,,,,
1963,161964,"6-Methyl-2-(3-methyl-1-oxobutyl)-1-oxa-5-azaspiro(2.5)oct-6-ene-4,8-dione",CC1=CC(=O)C2([C@@H](O2)C(=O)CC(C)C)C(=O)N1,,,,,,
1964,161965,N-Hydroxyphentermine,CC(C)(CC1=CC=CC=C1)NO,,,,,,
1965,161966,CID 161966,C1=CC(=C(N=C1)S)C(=O)O,,,,,,
1966,161967,Trifenofos,CCCSP(=O)(OCC)OC1=C(C=C(C=C1Cl)Cl)Cl,,,,,,
1967,161968,"3-Ethyl-3-(4-nitrophenyl)piperidine-2,6-dione",CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)[N+](=O)[O-],,,,,,
1968,161969,"2-[3-Chloro-4-(4-chlorobenzoyl)phenyl]-1,2,4-triazine-3,5(2h,4h)-dione",C1=CC(=CC=C1C(=O)C2=C(C=C(C=C2)N3C(=O)NC(=O)C=N3)Cl)Cl,,,,,,
1969,161970,H-Lys-Trp-Lys-OH,C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCCN)N,,,,,,
1970,161971,"Cyclohexanebutanoic acid, cobalt(2+) salt",C1CCC(CC1)CCCC(=O)[O-].C1CCC(CC1)CCCC(=O)[O-].[Co+2],,,,,,
1971,161972,6-Bromoandrostenedione,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)C[C@H](C4=CC(=O)CC[C@]34C)Br,,,,,,
1972,161973,Dodecylnaphthalene,CCCCCCCCCCCCC1=CC=CC2=CC=CC=C21,,,,,,
1973,161974,CID 161974,C[C@]12C[C@@H](C3=C([C@@H]1C[C@H]4[C@@]5([C@@]26[C@@H](O6)[C@H]7[C@@]([C@H]5O)(O7)C)O4)COC3=O)O,,,,,,
1974,161975,(+)-Validoxylamine-A,C1C(C(C(C(C1NC2C=C(C(C(C2O)O)O)CO)O)O)O)CO,,,,,,
1975,161976,"N,N-Bis(2-hydroxypropyl)-p-toluidine",CC1=CC=C(C=C1)N(CC(C)O)CC(C)O,,,,,,
1976,161977,"10-Ethylidene-2-oxa-6-azatricyclo[5.3.0.01,3]dec-8-ene",CC=C1C=CC2C13C(O3)CCN2,,,,,,
1977,161978,CID 161978,C[C@H]1C=CC=C(C(=O)N=C2C(=CNN3CCN(CC3)C)C(=C4C5=C(C[C@@](C5=O)(OC=C[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)O)C)OC)C)C(=C(C4=C2O)O)C)O)C.[Na+],,,,,,
1978,161979,CID 161979,C[C@H]1C=CC=C(C(=O)N=C2C(=CNN3CCN(CC3)C)C(=C4C5=C(C[C@@](C5=O)(OC=C[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)O)C)OC)C)C(=C(C4=C2O)O)C)O)C,,,,,,
1979,161980,Diammineplatinum(II) malonate,C(C(=O)[O-])C(=O)[O-].N.N.[Pt+2],,,,,,
1980,161981,"Chromate(1-), bis(4-(hydroxy-kappaO)-3-((2-(hydroxy-kappaO)-1-naphthalenyl)azo-kappaN1)benzenesulfonamidato(2-))-, hydrogen",[H+].CC1=C(C=C(C=C1)S(=O)(=O)N)N=NC2=C(C=CC3=CC=CC=C32)C.C[O-].C[O-].C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=CC(=C3)S(=O)(=O)N)[O-])[O-].[Cr+3],,,,,,
1981,161982,4-Methyl-3-[(2-methylnaphthalen-1-yl)diazenyl]benzenesulfonamide,CC1=C(C=C(C=C1)S(=O)(=O)N)N=NC2=C(C=CC3=CC=CC=C32)C,,,,,,
1982,161983,"Ethanol, 2-((3-((7-chloro-2-methoxybenzo(b)-1,5-naphthyridin-10-yl)amino)propyl)amino)-, dihydrochloride, hemihydrate",COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCNCCO.Cl.Cl,,,,,,
1983,161984,"2-[3-[(7-Chloro-2-methoxybenzo[b][1,5]naphthyridin-10-yl)amino]propylamino]ethanol",COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCNCCO,,,,,,
1984,161985,ICR 371 dihydrochloride,CCCCOC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCNCCCl.Cl.Cl,,,,,,
1985,161986,"N-(2-Butoxy-7-chlorobenzo(b)-1,5-naphthyridin-10-yl)-N'-(2-chloroethyl)-1,3-propanediamine",CCCCOC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCNCCCl,,,,,,
1986,161987,Icr 292OH,CCN(CCCNC1=C2C=CC=CC2=NC3=CC4=CC=CC=C4C=C31)CCO.Cl.Cl,,,,,,
1987,161988,2-[3-(Benzo[b]acridin-12-ylamino)propyl-ethylamino]ethanol,CCN(CCCNC1=C2C=CC=CC2=NC3=CC4=CC=CC=C4C=C31)CCO,,,,,,
1988,161989,"methyl (6S)-5-ethylidene-4-[2-oxo-2-[[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[2-(4-hydroxyphenyl)ethoxy]oxan-2-yl]methoxy]ethyl]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate",CC=C1[C@@H](OC=C(C1CC(=O)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OCCC3=CC=C(C=C3)O)O)O)O)C(=O)OC)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
1989,161990,"1,3-Propanediamine, N'-benzo(b)(1,10)phenanthrolin-7-yl-N-(2-chloroethyl)-N-ethyl-, dihydrochloride",CCN(CCCNC1=C2C=CC3=C(C2=NC4=CC=CC=C41)N=CC=C3)CCCl.Cl.Cl,,,,,,
1990,161991,"N-benzo[b][1,10]phenanthrolin-7-yl-N'-(2-chloroethyl)-N'-ethylpropane-1,3-diamine",CCN(CCCNC1=C2C=CC3=C(C2=NC4=CC=CC=C41)N=CC=C3)CCCl,,,,,,
1991,161992,5-Hydroxyflufenamic acid,C1=CC(=CC(=C1)NC2=C(C=C(C=C2)O)C(=O)O)C(F)(F)F,,,,,,
1992,161993,3-Propylbicyclo[2.2.1]hept-5-ene-2-carbaldehyde,CCCC1C2CC(C1C=O)C=C2,,,,,,
1993,161994,"2,3,3-Trichloro-1-butene",CC(C(=C)Cl)(Cl)Cl,,,,,,
1994,161995,Potassium ferrite,[O-2].[O-2].[K+].[Fe+3],,,,,,
1995,161996,"L-Cysteine, S-(2,5-dihydroxyphenyl)-",C1=CC(=C(C=C1O)SC[C@@H](C(=O)O)N)O,,,,,,
1996,161997,5-(1-Hydroxyethyl)uracil,CC(C1=CNC(=O)NC1=O)O,,,,,,
1997,161998,8-Nonenal,C=CCCCCCCC=O,,,,,,
1998,161999,8-Aminohexylamino cAMP,CCCCCN(CC1=NC2=C(N=CN=C2N1[C@H]3[C@@H]([C@H]4[C@H](O3)COP(=O)(O4)O)O)N)N,,,,,,
1999,162000,"Nonanediol, diacetate",CCCCCCCCC(OC(=O)C)OC(=O)C,,,,,,
2000,162001,2-Chloro-4-(trifluoromethyl)aniline,C1=CC(=C(C=C1C(F)(F)F)Cl)N,,,,,,
2001,162002,Cedrol formate,C[C@@H]1CC[C@@H]2[C@]13CC[C@@]([C@H](C3)C2(C)C)(C)OC=O,,,,,,
2002,162003,"4-(4-Ethoxyphenylimino)-2,5-cyclohexadiene-1-one",CCOC1=CC=C(C=C1)N=C2C=CC(=O)C=C2,,,,,,
2003,162004,CID 162004,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)OP(=O)([O-])OP(=O)(O)O)F,,,,,,
2004,162005,3'-Fluorothymidine-5'-triphosphate,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)F,,,,,,
2005,162006,CID 162006,CC1=CC2=C(C=C1)OC3=CC=CC=C3C4N2CCN(C4)C.C(=CC(=O)[O-])C(=O)[O-],,,,,,
2006,162007,"2-Chloro-N-(chloromethyl)-N-(2,6-diethylphenyl)acetamide",CCC1=C(C(=CC=C1)CC)N(CCl)C(=O)CCl,,,,,,
2007,162008,"Pyridinium, 1,1'-oxydimethylenebis(4-tert-butyl-, dichloride",CC(C)(C)C1=CC=[N+](C=C1)COCC2=CC=[N+](C=C2)C(C)(C)C.[Cl-].[Cl-],,,,,,
2008,162009,1-Tert-butyl-4-[(4-tert-butylpyridin-1-ium-1-yl)methoxymethyl]pyridin-1-ium,CC(C)(C)C1=CC=[N+](C=C1)COCC2=CC=[N+](C=C2)C(C)(C)C,,,,,,
2009,162010,Viramidine hydrochloride,C1=NC(=NN1C2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=N)N.Cl,,,,,,
2010,162011,"1-[(3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboximidamide",C1=NC(=NN1C2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=N)N,,,,,,
2011,162012,"4,4,15,15-Tetraethoxy-3,16-dioxa-8,9,10,11-tetrathia-4,15-disilaoctadecane",CCO[Si](CCCSSSSCCC[Si](OCC)(OCC)OCC)(OCC)OCC,,,,,,
2012,162013,n-Acetyl-s-(2-chlorobenzyl)-l-cysteine,CC(=O)N[C@@H](CSCC1=CC=CC=C1Cl)C(=O)O,,,,,,
2013,162014,Indanazoline hydrochloride,C1CC2=C(C1)C(=CC=C2)NC3=NCCN3.Cl,,,,,,
2014,162015,Indium formate,C(=O)[O-].C(=O)[O-].C(=O)[O-].[In+3],,,,,,
2015,162016,"4-Pentenoic acid, 2-acetyl-5,5-dichloro-4-methyl-, ethyl ester",CCOC(=O)C(CC(=C(Cl)Cl)C)C(=O)C,,,,,,
2016,162017,CID 162017,C[NH2+]C1=CC=C(C=C1)C2=C3C=CC(=N3)C(=C4C=CN(C=C4)C)C5=NC(=C(C6=CC=C([N-]6)C(=C7C=CC2=N7)C8=CC=[N+](C=C8)C)C9=CC=[N+](C=C9)C)C=C5.[Zn+2],,,,,,
2017,162018,CID 162018,CNC1=CC=C(C=C1)C2=C3C=CC(=N3)C(=C4C=CC(=N4)C(=C5C=CC(=N5)C(=C6C=CN(C=C6)C)C7=CC=C2N7)C8=CC=[N+](C=C8)C)C9=CC=[N+](C=C9)C,,,,,,
2018,162019,1-Octanesulfonyl fluoride,CCCCCCCCS(=O)(=O)F,,,,,,
2019,162020,"8-Dodecen-1-ol, (8Z)-",CCCC=CCCCCCCCO,,,,,,
2020,162021,Butylhydrazine oxalate,CCCCNN.C(=O)(C(=O)O)O,,,,,,
2021,162022,CID 162022,C1=CC=C(C=C1)NC2=NC(=O)C3=C(N2)N=CN3,,,,,,
2022,162023,CID 162023,CC1=C(C=C(C=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)[O-])S(=O)(=O)NCCO.[Na+],,,,,,
2023,162024,"1-Amino-4-[3-[(2-hydroxyethyl)sulfamoyl]-4-methylanilino]-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid",CC1=C(C=C(C=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)O)S(=O)(=O)NCCO,,,,,,
2024,162025,CID 162025,C1C(=O)NC(=O)N=C1NNC2=CC=C(C=C2)O,,,,,,
2025,162026,3-[[4-[(2-Chloro-4-nitrophenyl)azo]phenyl]ethylamino]propiononitrile,CCN(CCC#N)C1=CC=C(C=C1)N=NC2=C(C=C(C=C2)[N+](=O)[O-])Cl,,,,,,
2026,162027,"1,6-Octadiene, 3-(1-ethoxyethoxy)-3,7-dimethyl-",CCOC(C)OC(C)(CCC=C(C)C)C=C,,,,,,
2027,162028,CID 162028,CC1=C(C=CC(=C1)[C@H](CN)O)O.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O,,,,,,
2028,162029,4-[(1R)-2-amino-1-hydroxyethyl]-2-methylphenol,CC1=C(C=CC(=C1)[C@H](CN)O)O,,,,,,
2029,162030,"Cyclopentanone, 3-(2-oxopropyl)-2-pentyl-",CCCCCC1C(CCC1=O)CC(=O)C,,,,,,
2030,162031,13-[(2-O-Hexopyranosylhexopyranosyl)oxy]kaur-16-en-18-oic acid,C[C@]12CCC[C@@]([C@@H]1CC[C@@]34[C@@H]2CC[C@@](C3)(C(=C)C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)(C)C(=O)O,,,,,,
2031,162032,Haaapbmi,C1=CC(=CC=C1N)NC2=CC(=NC3=CC=C(C=C3)N)C(=O)C=C2O,,,,,,
2032,162033,(4s)-2-Oxoimidazolidine-4-carboxylic acid,C1[C@H](NC(=O)N1)C(=O)O,,,,,,
2033,162034,"1,1'-Biphenyl;methanol",CO.C1=CC=C(C=C1)C2=CC=CC=C2,,,,,,
2034,162035,"1-Benzyl-3-(2,3-dihydroxypropoxy)indazole",C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=N2)OCC(CO)O,,,,,,
2035,162036,"[3-Chloro-4-(2,3-dihydroxypropoxy)phenyl]acetic acid",C1=CC(=C(C=C1CC(=O)O)Cl)OCC(CO)O,,,,,,
2036,162037,CID 162037,CC=C(C)C(=O)OC1C2COC(=O)C2CC3=C(C4=CC5=C(C=C14)OCO5)C(=C(C(=C3)C)C)OC,,,,,,
2037,162038,CID 162038,CCN(CC)CCSC(=NO)C1=CC=C(C=C1)Br.Cl,,,,,,
2038,162039,CID 162039,CCN(CC)CCSC(=NO)C1=CC=C(C=C1)Br,,,,,,
2039,162040,Ethylmalonatodiammine platinum(II),CCC(C(=O)[O-])C(=O)[O-].N.N.[Pt+2],,,,,,
2040,162041,"Phorbol 13,20-diacetate",C[C@@H]1[C@H]([C@@]2([C@@H](C2(C)C)[C@H]3[C@]1([C@@H]4C=C(C(=O)[C@]4(CC(=C3)COC(=O)C)O)C)O)OC(=O)C)O,,,,,,
2041,162042,2-Phenyl-4-amino-5-imidazolecarboxamide,C1=CC=C(C=C1)C2=NC(=C(N2)C(=O)N)N,,,,,,
2042,162043,"Acetamide, N-[2-[(2,6-dicyano-4-nitrophenyl)azo]-5-(diethylamino)phenyl]-",CCN(CC)C1=CC(=C(C=C1)N=NC2=C(C=C(C=C2C#N)[N+](=O)[O-])C#N)NC(=O)C,,,,,,
2043,162044,(1R)-1-[2-[[(2S)-1-hydroxybutan-2-yl]amino]ethylamino]butan-1-ol;[2-(pyridine-4-carbonyl)hydrazinyl]methanesulfonate,CCC[C@H](NCCN[C@@H](CC)CO)O.C1=CN=CC=C1C(=O)NNCS(=O)(=O)[O-],,,,,,
2044,162045,(1R)-1-[2-[[(2S)-1-hydroxybutan-2-yl]amino]ethylamino]butan-1-ol,CCC[C@H](NCCN[C@@H](CC)CO)O,,,,,,
2045,162046,"1,2,2,6,6-Pentamethyl-1-azoniabicyclo[2.2.2]octane iodide",CC1(CC2CC[N+]1(C(C2)(C)C)C)C.[I-],,,,,,
2046,162047,"1,2,2,6,6-Pentamethyl-1-azoniabicyclo[2.2.2]octane",CC1(CC2CC[N+]1(C(C2)(C)C)C)C,,,,,,
2047,162048,Isostearyl isostearate,CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C,,,,,,
2048,162049,"1,2-Dichloro-1-methoxyethane",COC(CCl)Cl,,,,,,
2049,162050,"7-[(1R,2S)-2-[(3R)-3-hydroxy-4,4-dimethyloct-1-enyl]-5-oxocyclopent-3-en-1-yl]heptanoic acid",CCCCC(C)(C)[C@@H](C=C[C@H]1C=CC(=O)[C@@H]1CCCCCCC(=O)O)O,,,,,,
2050,162051,"Cyclohexanecarbonyl chloride, 1-amino-, hydrochloride",C1CCC(CC1)(C(=O)Cl)N.Cl,,,,,,
2051,162052,"Cyclohexanecarbonylchloride, 1-amino-",C1CCC(CC1)(C(=O)Cl)N,,,,,,
2052,162053,"7-Methoxy-3,7-dimethyloctan-2-ol",CC(CCCC(C)(C)OC)C(C)O,,,,,,
2053,162054,7-Acetamidoclonazepam,CC(=O)NC1=CC2=C(C=C1)NC(=O)CN=C2C3=CC=CC=C3Cl,,,,,,
2054,162055,2-(4-nitro-1H-pyrazol-1-yl)ethanol,C1=C(C=NN1CCO)[N+](=O)[O-],,,,,,
2055,162056,Phenaridine,CCC(=O)N(C1CC(N(CC1C)CCC2=CC=CC=C2)C)C3=CC=CC=C3,,,,,,
2056,162057,"Benzenesulfonic acid, 3,3'-([1,1'-biphenyl]-4,4'-diyldi-2,1-ethenediyl)bis[6-chloro-, disodium salt",C1=CC(=CC=C1C=CC2=CC(=C(C=C2)Cl)S(=O)(=O)[O-])C3=CC=C(C=C3)C=CC4=CC(=C(C=C4)Cl)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
2057,162058,"3,3'-[[1,1'-Biphenyl]-4,4'-diyldi(ethene-2,1-diyl)]bis(6-chlorobenzene-1-sulfonic acid)",C1=CC(=CC=C1C=CC2=CC(=C(C=C2)Cl)S(=O)(=O)O)C3=CC=C(C=C3)C=CC4=CC(=C(C=C4)Cl)S(=O)(=O)O,,,,,,
2058,162059,"4-Amino-2,6-dichlorophenol hydrochloride",C1=C(C=C(C(=C1Cl)O)Cl)N.Cl,,,,,,
2059,162060,"Cyclopentanone, 2-(1-hydroxypentyl)-",CCCCC(C1CCCC1=O)O,,,,,,
2060,162061,(Methoxymethoxy)cyclododecane,COCOC1CCCCCCCCCCC1,,,,,,
2061,162062,"3-[2-(2-Anilinoethenyl)-4,5-dihydro-1,3-thiazol-3-ium-3-yl]propane-1-sulfonate",C1CSC(=[N+]1CCCS(=O)(=O)[O-])C=CNC2=CC=CC=C2,,,,,,
2062,162063,"Thiazolium, 4,5-dihydro-2-[2-(phenylamino)ethenyl]-3-(3-sulfopropyl)-, inner salt",C1CSC(=[N+]1CCCS(=O)(=O)O)C=CNC2=CC=CC=C2,,,,,,
2063,162064,"Phenol, 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitro-",C1=CC(=C(C=C1C(F)(F)F)Cl)OC2=CC(=C(C=C2)[N+](=O)[O-])O,,,,,,
2064,162065,"1,2-Ethanediamine, N-(phenylmethyl)-N'-(3-(trimethoxysilyl)propyl)-, monohydrochloride",CO[Si](CCCNCCNCC1=CC=CC=C1)(OC)OC.Cl,,,,,,
2065,162066,"1,2-Ethanediamine, N-(phenylmethyl)-N'-[3-(trimethoxysilyl)propyl]-",CO[Si](CCCNCCNCC1=CC=CC=C1)(OC)OC,,,,,,
2066,162067,"Benzene, 2-(1,1-dimethylethyl)-1-methoxy-4-methyl-",CC1=CC(=C(C=C1)OC)C(C)(C)C,,,,,,
2067,162068,CID 162068,CCC1=C(C(=C(C=C1)C(=N)C2=C(C(=C(C=C2)CC)CC)NO[N+](=O)[O-])NO[N+](=O)[O-])CC,,,,,,
2068,162069,4-Acetamido-2-aminobenzoic acid,CC(=O)NC1=CC(=C(C=C1)C(=O)O)N,,,,,,
2069,162070,2-Methylbutyl acrylate,CCC(C)COC(=O)C=C,,,,,,
2070,162071,(2-(Acryloyloxy)ethyl)trimethylammonium chloride,C[N+](C)(C)CCOC(=O)C=C.[Cl-],,,,,,
2071,162072,2-(3-Oxazolidinyl)ethyl methacrylate,CC(=C)C(=O)OCCN1CCOC1,,,,,,
2072,162073,Dimethylaminoethyl acrylate benzyl chloride,C[N+](C)(CCOC(=O)C=C)CC1=CC=CC=C1.[Cl-],,,,,,
2073,162074,"N-[2-(Acryloyloxy)ethyl]-N,N-dimethylbenzenemethanaminium",C[N+](C)(CCOC(=O)C=C)CC1=CC=CC=C1,,,,,,
2074,162075,[4-[4-(4-Hydroxyphenyl)hex-3-en-3-yl]phenyl] dihydrogen phosphate,CCC(=C(CC)C1=CC=C(C=C1)OP(=O)(O)O)C2=CC=C(C=C2)O,,,,,,
2075,162076,"2H-Indol-2-one, 1,3-dihydro-3,3-bis(4-hydroxy-3-methylphenyl)-",CC1=C(C=CC(=C1)C2(C3=CC=CC=C3NC2=O)C4=CC(=C(C=C4)O)C)O,,,,,,
2076,162077,"1-N,3-N-bis[4-[(1-methylpyridin-1-ium-3-yl)carbamoyl]phenyl]benzene-1,3-dicarboxamide",C[N+]1=CC=CC(=C1)NC(=O)C2=CC=C(C=C2)NC(=O)C3=CC(=CC=C3)C(=O)NC4=CC=C(C=C4)C(=O)NC5=C[N+](=CC=C5)C,,,,,,
2077,162078,"2-Propenoic acid, eicosyl ester",CCCCCCCCCCCCCCCCCCCCOC(=O)C=C,,,,,,
2078,162079,CID 162079,CC1C(N(C2=CC=CC=[N+]12)N=NN3C4=CC=CC=[N+]4C(=C3C5CCCCC5)C)C6CCCCC6.[Br-].[Br-],,,,,,
2079,162080,CID 162080,CC1C(N(C2=CC=CC=[N+]12)N=NN3C4=CC=CC=[N+]4C(=C3C5CCCCC5)C)C6CCCCC6,,,,,,
2080,162081,"N-Acetyl-1,6-diaminohexane",CC(=O)NCCCCCCN,,,,,,
2081,162082,Pentenomycin I,C1=CC(=O)[C@@]([C@H]1O)(CO)O,,,,,,
2082,162083,Pentaacetyl geniposide,CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@H]2[C@H]3[C@H](CC=C3COC(=O)C)C(=CO2)C(=O)OC)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
2083,162084,Medicagenic acid 3-O-beta-D-glucopyranoside,C[C@@]12CCC3[C@@]([C@H]1CC=C4[C@]2(CC[C@@]5([C@@H]4CC(CC5)(C)C)C(=O)O)C)(C[C@@H]([C@@H](C3(C)C(=O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O)C,,,,,,
2084,162085,"2-Propenoic acid, 2-[methyl[(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)sulfonyl]amino]ethyl ester",CN(CCOC(=O)C=C)S(=O)(=O)CCC(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
2085,162086,4-Hydroxyglutethimide,CCC1(C(CC(=O)NC1=O)O)C2=CC=CC=C2,,,,,,
2086,162087,Cain's quinolinium,C[N+]1=CC=C(C=C1)NC2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)NC4=C5C=C(C=CC5=[N+](C=C4)C)N.[Br-].[Br-],,,,,,
2087,162088,Neptunium nitrate,C.[N+](=O)(O)[O-],,,,,,
2088,162089,Diaquoethylenediamineplatinum(II),C(C[NH-])[NH-].O.O.[Pt+2],,,,,,
2089,162090,5-(2-Chloro-4-(trifluoromethyl)phenoxy)-2-nitrophenyl acetate,CC(=O)OC1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)[N+](=O)[O-],,,,,,
2090,162091,CID 162091,CC1=CC(=O)C=C([C@@H]([C@@H]2[C@@H]([C@H](C1)OC(=O)C(=C)C)C(=C)C(=O)O2)O)C,,,,,,
2091,162092,"15-Aza-24-methylene-8,14-cholestadiene-3beta-ol",CC(C)C(=C)CCC(C)C1CCN=C2[C@@]1(CCC3=C2CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
2092,162093,"Acetamide, N,N'-(ethenylmethylsilylene)bis[N-methyl-",CC(=O)N(C)[Si](C)(C=C)N(C)C(=O)C,,,,,,
2093,162094,"3,4-Dihydroisonoracronycine",CC1(CCC2=C(O1)C=C3C(=C2O)C(=O)C4=CC=CC=C4N3C)C,,,,,,
2094,162095,1-Chloroethyl ethyl carbonate,CCOC(=O)OC(C)Cl,,,,,,
2095,162096,"(8R)-8,12-dimethyl-4-methylidene-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one",C[C@@H]1CCC2C(=C)C(=O)OC23C1CCC4(C3O4)C,,,,,,
2096,162097,Vinyl neodecanoate,CC(C)(C)CCCCCC(=O)OC=C,,,,,,
2097,162098,TI(Bzac)2-F2,CC(=O)CC(=O)C1CCCCC1.CC(=O)CC(=O)C1CCCCC1.[F-].[F-].[Ti+4],,,,,,
2098,162099,"1-Cyclohexylbutane-1,3-dione",CC(=O)CC(=O)C1CCCCC1,,,,,,
2099,162100,Sodium tungsten hydroxide oxide phosphate,[OH-].[O-2].[O-]P(=O)([O-])[O-].[Na+].[W],,,,,,
2100,162101,CID 162101,CN1C=CC(=C2C3=NC(=C(C4=NC(=C(C5=NC(=C(C6=CC=C2N6)C7=CC=NC=C7)C=C5)C8=CC=[N+](C=C8)C)C=C4)C9=CC=[N+](C=C9)C)C=C3)C=C1.[Co+3],,,,,,
2101,162102,CID 162102,CN1C=CC(=C2C3=NC(=C(C4=NC(=C(C5=NC(=C(C6=CC=C2N6)C7=CC=NC=C7)C=C5)C8=CC=[N+](C=C8)C)C=C4)C9=CC=[N+](C=C9)C)C=C3)C=C1,,,,,,
2102,162103,"Formic acid, compd. with 2,2'-oxybis[N,N-dimethylethanamine] (1:1)",CN(C)CCOCCN(C)C.C(=O)O,,,,,,
2103,162104,Trehalulose,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)OCC(=O)[C@H]([C@@H]([C@@H](CO)O)O)O)O)O)O)O,,,,,,
2104,162105,3-(4-Hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde,CC(C)(CCCC1=CCCC(C1)C=O)O,,,,,,
2105,162106,CID 162106,C1=NC(=C2C(=N1)N(C=N2)C3C(C([C@H](O3)COP(=O)(O)OOP(=O)OOP(=O)O)O)O)N.C(CS)N,,,,,,
2106,162107,CID 162107,C1=NC(=C2C(=N1)N(C=N2)C3C(C([C@H](O3)COP(=O)(O)OOP(=O)OOP(=O)O)O)O)N,,,,,,
2107,162108,CID 162108,COC1=C(C=CC(=C1)C2C(OC3=C(O2)C=CC(=C3)C4=CC(=C5C(=CC(=O)C=C5O4)O)O)CO)O,,,,,,
2108,162109,2-[[[2-[(2-Aminoethyl)amino]ethyl]amino]methyl]phenol,C1=CC=C(C(=C1)CNCCNCCN)O,,,,,,
2109,162110,Weedmaster,CNC.CNC.COC1=C(C=CC(=C1C(=O)O)Cl)Cl.C1=CC(=C(C=C1Cl)Cl)OCC(=O)O,,,,,,
2110,162111,"(3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-((3,4,5-trimethoxybenzoyl)oxy)yohimban-16-carboxylic acid methyl ester, mixt. with 2,3-dihydro-1,4-phthalazinedione dihydrazone sulfate (1:1)",CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC.C1=CC=C2C(=C1)C(=NN=C2NN)NN.OS(=O)(=O)O,,,,,,
2111,162112,Propotox M,CC(C)OC1=CC=CC=C1OC(=O)NC.COC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC)C(Cl)(Cl)Cl,,,,,,
2112,162113,Cannabielsoin,CCCCCC1=CC(=C2[C@H]3[C@@H](CC[C@]([C@H]3OC2=C1)(C)O)C(=C)C)O,,,,,,
2113,162114,"Sodium;2-hydroxypropane-1,2,3-tricarboxylate;iron(3+)",C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Fe+3],,,,,,
2114,162115,5-Hydroxy Dantrolene,C1=CC(=CC=C1C2=CC=C(O2)C=NN3C(C(=O)NC3=O)O)[N+](=O)[O-],,,,,,
2115,162116,Bilharcid,[H+].[H+].C1CNCCN1.C(C(C(=O)[O-])[O-])(C(=O)[O-])[O-].C(C(C(=O)[O-])[O-])(C(=O)[O-])[O-].[Sb+3].[Sb+3],,,,,,
2116,162117,Dimehypo,CN(C)C(CSS(=O)(=O)[O-])CSS(=O)(=O)[O-].[Na+].[Na+],,,"['Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)']",,,
2117,162118,CID 162118,CCC(NC1=NC(=O)C2=C(N1)N(C=N2)[C@H]3[C@@H]([C@H]4[C@H](O3)COP(=O)(O4)O)O)O,,,,,,
2118,162119,CID 162119,CC(=CCC[C@](C)([C@@H]1CC[C@@]2([C@H]1[C@@H](CC3C2C[C@H](C4[C@]3(CCC(C4(C)C)O)C)O[C@@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)CO)O)O)O[C@@H]6[C@@H]([C@@H]([C@H]([C@@H](O6)CO)O)O)O)O)C)O)C,,,,,,
2119,162120,CID 162120,C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)O[C@@H]2[C@@H]([C@H]([C@@H](O[C@@H]2O[C@@H]3CC4C(C[C@H](C5[C@]4(CCC5[C@@](C)(CCC=C(C)C)O)C)O)[C@]6(C3C(C(CC6)O)(C)C)C)CO)O)O)O)O)O,,,,,,
2120,162121,"1,4-Benzenedisulfonic acid, 2,2'-[1,2-ethenediylbis[(3-sulfo-4,1-phenylene)imino[6-(4-morpholinyl)-1,3,5-triazine-4,2-diyl]imino]]bis-, hexasodium salt",C1COCCN1C2=NC(=NC(=N2)NC3=C(C=CC(=C3)S(=O)(=O)[O-])S(=O)(=O)[O-])NC4=CC(=C(C=C4)C=CC5=C(C=C(C=C5)NC6=NC(=NC(=N6)N7CCOCC7)NC8=C(C=CC(=C8)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,,,,,
2121,162122,"2-[[4-[4-[2-[4-[[4-(2,5-Disulfoanilino)-6-morpholin-4-yl-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]-3-sulfoanilino]-6-morpholin-4-yl-1,3,5-triazin-2-yl]amino]benzene-1,4-disulfonic acid",C1COCCN1C2=NC(=NC(=N2)NC3=C(C=CC(=C3)S(=O)(=O)O)S(=O)(=O)O)NC4=CC(=C(C=C4)C=CC5=C(C=C(C=C5)NC6=NC(=NC(=N6)N7CCOCC7)NC8=C(C=CC(=C8)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
2122,162123,1-(4-Chlorophenyl)-n-hydroxy-2-methylpropan-2-amine,CC(C)(CC1=CC=C(C=C1)Cl)NO,,,,,,
2123,162124,CID 162124,CCCCOCC[O-].[Na+],,,,,,
2124,162125,Fenagon,CCCCOC(=O)COC(=O)COC1=C(C=C(C=C1)Cl)Cl,,,,,,
2125,162126,1-O-Hexadecyl-sn-glycero-3-phosphocholine,CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)O,,,,,,
2126,162127,2-[[(2R)-3-hexadecoxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCCOC[C@H](COP(=O)(O)OCC[N+](C)(C)C)O,,,['Biologically active substances whose activities affect or play a role in the functioning of the immune system. (See all compounds classified as Immunologic Factors.)'],,,
2127,162128,CID 162128,CC(=CCC[C@@](C)(C1CC[C@]2(C1[C@H](CC3C2CCC4[C@@]3(CCC(C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C,,,,,,
2128,162129,1-(3-Cyclohexen-1-ylcarbonyl)piperidine,C1CCN(CC1)C(=O)C2CCC=CC2,,,,,,
2129,162130,"1H-1,2,4-Triazolium, dimethyl-3-((4-(methyl(phenylmethyl)amino)phenyl)azo)-, trichlorozincate(1-)",CC1=NC(=N[NH+]1C)N=NC2=CC=C(C=C2)N(C)CC3=CC=CC=C3.Cl[Zn-](Cl)Cl,,,,,,
2130,162131,"N-benzyl-4-[(1,5-dimethyl-1,2,4-triazol-3-yl)diazenyl]-N-methylaniline",CC1=NC(=NN1C)N=NC2=CC=C(C=C2)N(C)CC3=CC=CC=C3,,,,,,
2131,162132,Dihydromyristicin,CCCC1=CC2=C(C(=C1)OC)OCO2,,,,,,
2132,162133,Capriblue GN,CN(C)C1=CC2=C(C=C1)N=C3C=CC(=[N+](C)C)C=C3O2,,,,,,
2133,162134,Dioctylisopentylphosphine oxide,CCCCCCCCP(=O)(CCCCCCCC)CCC(C)C,,,,,,
2134,162135,Patrinoside,CC(C)CC(=O)O[C@H]1[C@H]2[C@H](C[C@@H]([C@@H]2CO)O)C(=CO1)CO[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
2135,162136,Fenbendazole sulfone,COC(=O)NC1=NC2=C(N1)C=C(C=C2)S(=O)(=O)C3=CC=CC=C3,,,,,,
2136,162137,Brovanexine,CC(=O)OC1=C(C=C(C=C1)C(=O)NC2=C(C=C(C=C2Br)Br)CN(C)C3CCCCC3)OC,,,,,,
2137,162138,3-Dihydrocadambine,COC(=O)C1=CO[C@H]([C@H]2[C@@H]1C[C@H]3C4=C(CCN3C[C@H]2O)C5=CC=CC=C5N4)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O,,,,,,
2138,162139,"Acetic acid, (4-chlorophenoxy)-, 2-hydroxy-3-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)propyl ester",CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(COC(=O)COC3=CC=C(C=C3)Cl)O,,,,,,
2139,162140,"1-(3-chlorophenyl)-2-methoxy-N,N-dimethylimidazole-4-carboxamide",CN(C)C(=O)C1=CN(C(=N1)OC)C2=CC(=CC=C2)Cl,,,,,,
2140,162141,CID 162141,CCO[C@@]12C=C(C[C@@H]([C@@H]3[C@@H]([C@@H](O1)C(=C2)C)OC(=O)C3=C)OC(=O)C(=C)C)C,,,,,,
2141,162142,CID 162142,CC[C@@H]1[C@]2(C([C@@](O1)([C@H]([C@@H](O2)C=CC=CC=CC3=C(C(=CC(=O)O3)OC)C)O)C)OC(=O)C)C,,,,,,
2142,162143,"3-Chloro-4-(2-chloro-4-(3,5-dioxo-4,5-dihydro-1,2,4-triazin-2(3H)-yl)-6-methylphenoxy)-N-ethyl-N-methylbenzenesulfonamide",CCN(C)S(=O)(=O)C1=CC(=C(C=C1)OC2=C(C=C(C=C2C)N3C(=O)NC(=O)C=N3)Cl)Cl,,,,,,
2143,162144,"4-[1-(4-Chlorophenyl)-4,5-dihydro-1h-1,2,3-triazol-5-yl]pyridine",C1C(N(N=N1)C2=CC=C(C=C2)Cl)C3=CC=NC=C3,,,,,,
2144,162145,CID 162145,CC[C@@H](C1[C@@H](C[C@](O1)(C)[C@@]2([C@@H](C[C@@](O2)(CC)[C@H](CC)O)C)O)C)C(=O)[C@H](C)[C@H](C(C)[C@H]3[C@@H](C[C@H]([C@@H](O3)CC(=O)OO)C)C)O,,,,,,
2145,162146,Verruculotoxin,C1CCN2C[C@@H](NC(=O)[C@@H]2C1)CC3=CC=CC=C3,,,,,,
2146,162147,Aloperine,C1CCN2C[C@H]3C[C@@H]([C@H]2C1)C=C4[C@H]3NCCC4,,,,,,
2147,162148,"2-(sec-Butyl)-4,5-dihydrothiazole",CCC(C)C1=NCCS1,,,,,,
2148,162149,4-Benzoyl-1-indancarboxylic acid,C1CC2=C(C1C(=O)O)C=CC=C2C(=O)C3=CC=CC=C3,,,,,,
2149,162150,4-(4-Methylbenzoyl)-1-indancarboxylic acid,CC1=CC=C(C=C1)C(=O)C2=CC=CC3=C2CCC3C(=O)O,,,,,,
2150,162151,"Imidodisulfuric acid, trisodium salt",N(S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
2151,162152,Sulfosulfamic acid,N(S(=O)(=O)O)S(=O)(=O)O,,,,,,
2152,162153,1-Ethyl-1-hexadecylpiperidinium bromide,CCCCCCCCCCCCCCCC[N+]1(CCCCC1)CC.[Br-],,,,,,
2153,162154,1-Ethyl-1-hexadecylpiperidin-1-ium,CCCCCCCCCCCCCCCC[N+]1(CCCCC1)CC,,,,,,
2154,162155,"1,3-Dioxolane, 4,4'-(oxybis(methylene))bis-",C1C(OCO1)COCC2COCO2,,,,,,
2155,162156,3-Phenoxybenzyltriethylammonium,CC[N+](CC)(CC)CC1=CC(=CC=C1)OC2=CC=CC=C2.[Cl-],,,,,,
2156,162157,m-Phenoxybenzyltriethylaminium,CC[N+](CC)(CC)CC1=CC(=CC=C1)OC2=CC=CC=C2,,,,,,
2157,162158,"2-(3-Methoxyphenyl)-5H-s-triazolo(5,1-a)isoindole",COC1=CC=CC(=C1)C2=NN3CC4=CC=CC=C4C3=N2,,,,,,
2158,162159,"Chromate(1-), bis(1-((2-hydroxy-5-nitrophenyl)azo)-2-naphthalenolato(2-))-, sodium",C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=CC(=C3)[N+](=O)[O-])[O-])[O-].C1=CC=C2C(=C1)C=CC(=O)C2=NN=C3C=C(C=CC3=O)N([O-])[O-].[Na+].[Cr+3],,,,,,
2159,162160,"1-[[3-(Dioxidoamino)-6-oxocyclohexa-2,4-dien-1-ylidene]hydrazinylidene]naphthalen-2-one",C1=CC=C2C(=C1)C=CC(=O)C2=NN=C3C=C(C=CC3=O)N([O-])[O-],,,,,,
2160,162161,1-Methylquinoxalinium-4-toluene sulfonate,CC1=CC=C(C=C1)S(=O)(=O)[O-].C[N+]1=CC=NC2=CC=CC=C21,,,,,,
2161,162162,1-Methylquinoxalin-1-ium,C[N+]1=CC=NC2=CC=CC=C21,,,,,,
2162,162163,Centhaquine,CC1=CC(=CC=C1)N2CCN(CC2)CCC3=NC4=CC=CC=C4C=C3,,,,,,
2163,162164,"N,N-diethyl-2-[phenyl(3-tricyclo[2.2.1.02,6]heptanylidene)methoxy]ethanamine;hydrochloride",CCN(CC)CCOC(=C1C2CC3C1C3C2)C4=CC=CC=C4.Cl,,,,,,
2164,162165,"N,N-Diethyl-2-{[(E)-phenyl(tricyclo[2.2.1.0~2,6~]heptan-3-ylidene)methyl]oxy}ethan-1-amine",CCN(CC)CCOC(=C1C2CC3C1C3C2)C4=CC=CC=C4,,,,,,
2165,162166,"[(4S,5R,6R,9S,10R,12R,14R)-4-Benzoyloxy-5,6-dihydroxy-3,11,11,14-tetramethyl-15-oxo-7-tetracyclo[7.5.1.01,5.010,12]pentadeca-2,7-dienyl]methyl benzoate",C[C@@H]1C[C@@H]2[C@@H](C2(C)C)[C@@H]3C=C([C@H]([C@@]4(C1(C3=O)C=C([C@@H]4OC(=O)C5=CC=CC=C5)C)O)O)COC(=O)C6=CC=CC=C6,,,,,,
2166,162167,Ammonium antimony tungsten oxide,[NH4+].[O-2].[O-2].[O-2].[O-2].[O-2].[Sb+3].[W],,,"['Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)', 'Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)']",,,
2167,162168,Ethyl 2-(4-chlorophenyl)-5-ethoxy-4-oxazoleacetate,CCOC1=C(N=C(O1)C2=CC=C(C=C2)Cl)CC(=O)OCC,,,,,,
2168,162169,CID 162169,COCC1=CCC(=CC1)C=NO,,,,,,
2169,162170,Desethylpiperacillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)NC(=O)N4CC(=O)NC(=O)C4)C(=O)O)C,,,,,,
2170,162171,4-Phenyl-4-piperidinocyclohexanol,C1CCN(CC1)C2(CCC(CC2)O)C3=CC=CC=C3,,,,,['C-PPC/t-PPC is a known human metabolite of phencyclidine.'],
2171,162172,Noralfentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCNCC2)COC,,,,,['Noralfentanil is a known human metabolite of alfentanil.'],
2172,162173,CID 162173,C1CCC(CC1)C=CC=CC=CC(=O)NC2=C[C@]([C@H]3[C@@H](C2=O)O3)(C=CC=CC=CC(=O)NC4=C(CCC4=O)O)O,,,,,,
2173,162174,Chiridquitoxin,C12C3C(C4C(C1(C(C(O3)(O4)O)O)NC(=NC2O)N)O)(C(C(C(=O)O)N)O)O,,,,,,
2174,162175,"7-[(1R,2R,3R)-3-Hydroxy-2-[(3S,4S)-3-hydroxy-8-methoxy-4-methyloct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid",C[C@@H](CCCCOC)[C@@H](C=C[C@H]1[C@@H](CC(=O)[C@@H]1CC=CCCCC(=O)O)O)O,,,,,,
2175,162176,CID 162176,CC1=CC=CC=C1OP(=S)(OC2=CC=CC=C2C)[S-].[Na+],,,,,,
2176,162177,"O,O-Bis(methylphenyl) hydrogen dithiophosphate",CC1=CC=CC=C1OP(=S)(OC2=CC=CC=C2C)S,,,,,,
2177,162178,2-(Diethylamino)ethanol;octadec-9-enyl hydrogen sulfate,CCCCCCCCC=CCCCCCCCCOS(=O)(=O)O.CCN(CC)CCO,,,,,,
2178,162179,Dimepranol acedoben,CC(CN(C)C)O.CC(=O)NC1=CC=C(C=C1)C(=O)O,,,,,,
2179,162180,Desmethylcitalopram,CNCCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,,,,,"['Desmethylcitalopram has known human metabolites that include N,N-Didesmethylcitalopram.']",
2180,162181,O-Demethylmetoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCO)O,,,,,,
2181,162182,"1-Amino-3,7,8-trichlorodibenzo-p-dioxin",C1=C(C=C2C(=C1N)OC3=CC(=C(C=C3O2)Cl)Cl)Cl,,,,,,
2182,162183,CID 162183,C([C@@H]([C@@H]1C(=O)C(=C(O1)O)O)O)Br,,,,,,
2183,162184,"1,4-Dioxaspiro[4.5]decane-2-methanol, 9-methyl-6-(1-methylethyl)-",CC1CCC(C2(C1)OCC(O2)CO)C(C)C,,,,,,
2184,162185,N-(2'-Pyrrolidinoethyl)diphenylacetamide hydrochloride,C1CCN(C1)CCNC(=O)C(C2=CC=CC=C2)C3=CC=CC=C3.Cl,,,,,,
2185,162186,"2,2-diphenyl-N-(2-pyrrolidin-1-ylethyl)acetamide",C1CCN(C1)CCNC(=O)C(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
2186,162187,CID 162187,CN1C[C@@]2([C@@H](C[C@@H](C34[C@@H]2[C@H](C(C31)[C@@]5([C@@H]6[C@H]4CC([C@@H]6OC(=O)C7CCCCC7)([C@H]([C@@H]5O)OC)O)O)OC)OC)O)OC,,,,,,
2187,162188,N-(4-chlorophenyl)-2-phenyl-N-piperidin-4-ylacetamide,C1CNCCC1N(C2=CC=C(C=C2)Cl)C(=O)CC3=CC=CC=C3,,,,,,
2188,162189,CID 162189,CNC1=C(C(=CC=C1)NC(=O)C(=O)[O-])C#N.[Na+],,,,,,
2189,162190,WY-41195 free acid,CNC1=C(C(=CC=C1)NC(=O)C(=O)O)C#N,,,,,,
2190,162191,"[5,9,10,12-Tetrahydroxy-1,13-dimethyl-6,11-dioxo-3,4,6,7,8,9,10,11-octahydro-1H-7,10-(epoxymethano)anthra[2,3-c]pyran-3-yl]acetic acid",CC1C2=C(CC(O1)CC(=O)O)C(=C3C(=C2O)C(=O)C4=C(C3=O)C5CC(C4(C(O5)C)O)O)O,,,,,,
2191,162192,CID 162192,CC(=NC1=CC(=C(C=C1)O)N)C2=C(OC(=C(C2=O)C(=O)C)O)O.Cl,,,,,,
2192,162193,CID 162193,CC(=NC1=CC(=C(C=C1)O)N)C2=C(OC(=C(C2=O)C(=O)C)O)O,,,,,,
2193,162194,CID 162194,CC1=CC[C@H](C(=C[C@@H]2[C@@H]([C@@H](C1)OC(=O)C(=CCO)CO)C(=C)C(=O)O2)C)OC(=O)C,,,,,,
2194,162195,Amminedichloro(cyclopentylamine)platinum(0),C1CCC(C1)N.N.[Cl-].[Cl-].[Pt+2],,,,,,
2195,162196,"2-Naphthalenesulfonic acid, 7-amino-4-hydroxy-3-((4-((4-sulfophenyl)azo)phenyl)azo)-, compd. with 2,2',2''-nitrilotris(ethanol) (1:2)",C1=CC(=CC=C1N=NC2=CC=C(C=C2)S(=O)(=O)O)N=NC3=C(C=C4C=C(C=CC4=C3O)N)S(=O)(=O)O.C(CO)N(CCO)CCO.C(CO)N(CCO)CCO,,,,,,
2196,162197,"beta-Alanine, N-dodecyl-, compd. with 2,2'-iminobis[ethanol] (1:1)",CCCCCCCCCCCCNCCC(=O)O.C(CO)NCCO,,,,,,
2197,162198,"Acetic acid, oxo((7-oxo-1,3,5-cycloheptatrien-1-yl)amino)-, ethyl ester",CCOC(=O)C(=O)NC1=CC=CC=CC1=O,,,,,,
2198,162199,"Poly(difluoromethylene), alpha-fluoro-omega-(2-((2-methyl-1-oxo-2-propenyl)oxy)ethyl)-",CC(=C)C(=O)OCCC(F)(F)F,,,,,,
2199,162200,"1-Decene, polymer with 1-octene",CCCCCCCCC=C.CCCCCCC=C,,,,,,
2200,162201,Furprofen,CC(C1=CC=C(C=C1)C(=O)C2=CC=CO2)C(=O)O,,,,,,
2201,162202,2-Methoxyphenyl 2-(4-tert-butylphenyl)propanoate,CC(C1=CC=C(C=C1)C(C)(C)C)C(=O)OC2=CC=CC=C2OC,,,,,,
2202,162203,2-(2-Aminoethylthiomethyl)-5-dimethylaminomethylfuran,CN(C)CC1=CC=C(O1)CSCCN,,,,,,
2203,162204,(3-(Acetylhydroxyamino)propyl)phosphonic acid,CC(=O)N(CCCP(=O)(O)O)O,,,,,,
2204,162205,CID 162205,CC[C@H]1CC[C@@H]2[C@@H]1C=C[C@@H]([C@H]2C(=O)C3=CC=CN3)C=CC=C(CC)[C@H]4[C@H](CCC(O4)[C@@H](C)C(=O)O)C,,,,,,
2205,162206,"Benzothiazolium, 2-[[4-[ethyl(2-hydroxyethyl)amino]phenyl]azo]-6-methoxy-3-methyl-, sulfate (2:1) (salt)",CCN(CCO)C1=CC=C(C=C1)N=NC2=[N+](C3=C(S2)C=C(C=C3)OC)C.CCN(CCO)C1=CC=C(C=C1)N=NC2=[N+](C3=C(S2)C=C(C=C3)OC)C.[O-]S(=O)(=O)[O-],,,,,,
2206,162207,CID 162207,C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)NC2=NC(=C3C(=CN=C3N2)C#N)OC)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)OC)O)O,,,,,,
2207,162208,"2-Propenoic acid, butyl ester, telomer with 1,4-diethenylbenzene, 1-dodecanethiol and ethenylbenzene",CCCCCCCCCCCCS.CCCCOC(=O)C=C.C=CC1=CC=CC=C1.C=CC1=CC=C(C=C1)C=C,,,,,,
2208,162209,Pisiferic acid,CC(C)C1=C(C=C2C(=C1)CC[C@@H]3[C@@]2(CCCC3(C)C)C(=O)O)O,,,,,,
2209,162210,"Isononanoic acid, compd. with 2,2',2''-nitrilotris(ethanol) (1:1)",CC(C)CCCCCC(=O)O.C(CO)N(CCO)CCO,,,,,,
2210,162211,2-Aminophenol;sulfate,C1=CC=C(C(=C1)N)O.C1=CC=C(C(=C1)N)O.[O-]S(=O)(=O)[O-],,,,,,
2211,162212,Nickel chlorate,[O-]Cl(=O)=O.[O-]Cl(=O)=O.[Ni+2],,,,,,
2212,162213,"1,2,3,4,5,6,7,8-Octahydro-7-isopropylidene-1,4-dimethyl-,-epoxyazulene",CC1CCC2=C1CC3(CCC2C)C(O3)(C)C,,,,,,
2213,162214,"2-Propanone, reaction products with diphenylamine",CC(=O)C.C1CCC(CC1)NC2CCCCC2,,,,,,
2214,162215,"Sulfuric acid, mono-C8-30-alkyl esters, compds. with triethanolamine",C(CO)N(CCO)CCO.[O-]S(=O)(=O)[O-],,,,,,
2215,162216,Ammonium diisopropylnaphthalenesulphonate,CC(C)C1=CC2=CC=CC=C2C(=C1C(C)C)S(=O)(=O)[O-].[NH4+],,,,,,
2216,162217,"2,3-Di(propan-2-yl)naphthalene-1-sulfonic acid",CC(C)C1=CC2=CC=CC=C2C(=C1C(C)C)S(=O)(=O)O,,,,,,
2217,162218,"Acetaldehyde, reaction products with formaldehyde, by-products from",CC=O.C=O,,,,,,
2218,162219,CID 162219,CCCCCCCC=CCCCCCCC(=O)O.CCOS(=O)(=O)OCC.C(CNCCN)N,,,,,,
2219,162220,(2-Hydroxyethyl)ammonium dihydrogen orthoborate,B(O)(O)O.C(CO)N,,,,,,
2220,162221,"Octadec-9-enoic acid;propane-1,2-diol",CCCCCCCCC=CCCCCCCCC(=O)O.CC(CO)O,,,,,,
2221,162222,"Phenol, 4-methyl-, reaction products with dicyclopentadiene and isobutylene",CC1=CC=C(C=C1)O.CC(=C)C.C1C=CC2C1C3CC2C=C3,,,,,,
2222,162223,Dipotassium isooctyl phosphate,CC(C)CCCCCOP(=O)([O-])[O-].[K+].[K+],,,,,,
2223,162224,"Isooctadecanoic acid, reaction products with tetraethylenepentamine",CCCCCCCCCCCCCCCCCC(=O)O.C(CNCCNCCNCCN)N,,,,,,
2224,162225,"Octadecanoic acid, reaction products with 2-((2-aminoethyl)amino)ethanol",CCCCCCCCCCCCCCCCCC(=O)O.C(CNCCO)N,,,,,,
2225,162226,"1-(p-Hydroxyphenyl)-2,3-diisocyano-4-(p-methoxyphenyl)-buta-1,3-diene",COC1=CC=C(C=C1)C=C(C(=CC2=CC=C(C=C2)O)[N+]#[C-])[N+]#[C-],,,,,,
2226,162227,CID 162227,CC1(C2=CC=CC=C2N(C3=CC=CC=C31)CCCCNC)C,,,,,,
2227,162228,"N'-[(3,4-Dimethoxyphenyl)methylidene]pyridine-4-carbohydrazide",COC1=C(C=C(C=C1)C=NNC(=O)C2=CC=NC=C2)OC,,,,,,
2228,162229,Verilopam,COC1=C(C=C2CCN(CCC2=C1)CCC3=CC=C(C=C3)N)OC,,,,,,
2229,162230,2-morpholin-4-ylethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate;hydrochloride,CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)OCCN3CCOCC3)O.Cl,,,,,,
2230,162231,Amoxecaine,CCN(CC)CCN(CC)CCOC(=O)C1=CC=C(C=C1)N,,,,,,
2231,162232,"Benzeneethanaminium, 4-((4-(ethyl(2-hydroxy-3-(trimethylammonio)propyl)amino)-2-methylphenyl)azo)-N,N,N-trimethyl-beta-oxo-, bis(tetrafluoroborate(1-))",[B-](F)(F)(F)F.[B-](F)(F)(F)F.CCN(CC(C[N+](C)(C)C)O)C1=CC(=C(C=C1)N=NC2=CC=C(C=C2)C(=O)C[N+](C)(C)C)C,,,,,,
2232,162233,"3-{Ethyl[3-methyl-4-({4-[(trimethylazaniumyl)acetyl]phenyl}diazenyl)phenyl]amino}-2-hydroxy-N,N,N-trimethylpropan-1-aminium",CCN(CC(C[N+](C)(C)C)O)C1=CC(=C(C=C1)N=NC2=CC=C(C=C2)C(=O)C[N+](C)(C)C)C,,,,,,
2233,162234,"Adenosine cyclic 3',5'-(hydrogen phosphate) 2'-(hydrogen succinate)",C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)OC(=O)CCC(=O)O)OP(=O)(O1)O,,,,,,
2234,162235,"2-Naphthalenecarboxamide, 4-[[4-(aminocarbonyl)phenyl]azo]-3-hydroxy-N-(2-methoxyphenyl)-",COC1=CC=CC=C1NC(=O)C2=CC3=CC=CC=C3C(=C2O)N=NC4=CC=C(C=C4)C(=O)N,,,,,,
2235,162236,1-[2-[[4-[(2-Chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]pyridinium chloride,CCN(CC[N+]1=CC=CC=C1)C2=CC=C(C=C2)N=NC3=C(C=C(C=C3)[N+](=O)[O-])Cl.[Cl-],,,,,,
2236,162237,1-[2-[[4-(2-Chloro-4-nitrophenylazo)phenyl]ethylamino]ethyl]pyridinium,CCN(CC[N+]1=CC=CC=C1)C2=CC=C(C=C2)N=NC3=C(C=C(C=C3)[N+](=O)[O-])Cl,,,,,,
2237,162238,Dihexadecyl=phosphonate,CCCCCCCCCCCCCCCCOP(=O)OCCCCCCCCCCCCCCCC,,,,,,
2238,162239,Propyl 2-methylbutyrate,CCCOC(=O)C(C)CC,,,,,,
2239,162240,CID 162240,CC1=NN(C(=O)C1N=NC2=C(C=CC(=C2)S(=O)(=O)[O-])Cl)C3=CC=C(C=C3)Cl.[Na+],,,,,,
2240,162241,"4-Chloro-3-[[[1-(4-chlorophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol]-4-yl]azo]benzenesulfonic acid",CC1=NN(C(=O)C1N=NC2=C(C=CC(=C2)S(=O)(=O)O)Cl)C3=CC=C(C=C3)Cl,,,,,,
2241,162242,7-Hydroxyamoxapine,C1CN(CCN1)C2=NC3=C(C=C(C=C3)O)OC4=C2C=C(C=C4)Cl,,,,,,
2242,162243,25-Azacoprostane,C[C@H](CCCN(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CCCC4)C)C,,,,,,
2243,162244,alpha-Hydroxyalprazolam,C1C2=NN=C(N2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4)CO,,,,,,
2244,162245,"12,13-Epoxytrichothec-9-ene",CC1=C[C@@H]2[C@](CC1)([C@]3(CC[C@H]([C@@]34CO4)O2)C)C,,,,,,
2245,162246,Rphdhd,CCCCCCCC(CC(=O)O)OC(=O)CC(CCCCCCC)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O,,,,,,
2246,162247,"1,4-Dimethylputrescine",C[C@H](CC[C@@H](C)N)N,,,,,,
2247,162248,2-(1-Methylpropyl)-1-vinylcyclohexyl acetate,CCC(C)C1CCCCC1(C=C)OC(=O)C,,,,,,
2248,162249,Methyl 2-hexyl-3-oxocyclopentanecarboxylate,CCCCCCC1C(CCC1=O)C(=O)OC,,,,,,
2249,162250,Dithiothreitol tetraacetate,CC(=O)O[C@H](CSC(=O)C)[C@H](CSC(=O)C)OC(=O)C,,,,,,
2250,162251,Calcium titanium oxide (CaTiO3),[O-2].[O-2].[O-2].[Ca+2].[Ti+4],,,,,,
2251,162252,CID 162252,[BeH2].[Ni],,,,,,
2252,162253,"Oxirane, methyl-, polymer with oxirane, monooctadecanoate",CCCCCCCCCCCCCCCCCC(=O)[O-].CC1CO1.C1CO1,,,,,,
2253,162254,"alpha-D-Glucopyranoside, beta-D-fructofuranosyl, dodecanoate",CCCCCCCCCCCC(=O)O.C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)CO)O)O)CO)O)O)O)O,,,,,,
2254,162255,Direct violet 48,CNS(=O)(=O)C1=CC(=C(C=C1)[O-])N=NC2=C(C=C3C=C(C=CC3=C2[O-])NC4=CC5=CC(=C(C(=C5C=C4)[O-])N=NC6=C(C=CC(=C6)S(=O)(=O)NC)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Cu+2].[Cu+2],,,,,,
2255,162256,"7,7'-Azanediylbis(4-hydroxy-3-{[2-hydroxy-5-(methylsulfamoyl)phenyl]diazenyl}naphthalene-2-sulfonic acid)",CNS(=O)(=O)C1=CC(=C(C=C1)O)N=NC2=C(C=C3C=C(C=CC3=C2O)NC4=CC5=CC(=C(C(=C5C=C4)O)N=NC6=C(C=CC(=C6)S(=O)(=O)NC)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
2256,162257,"Butanedioic acid, sulfo-, 4-isodecyl ester, disodium salt",CC(C)CCCCCCCO.C(C(C(=O)O)S(=O)(=O)O)C(=O)O.[Na+].[Na+],,,,,,
2257,162258,sec-Butyl Peroxide,CCC(C)OOC(C)CC,,,,,,
2258,162259,"Benz(a)anthracene, 6-fluoro-12-methyl-",CC1=C2C3=CC=CC=C3C=C(C2=CC4=CC=CC=C14)F,,,,,,
2259,162260,"Acetamide, N-[4-hydroxy-3-(methylthio)phenyl]-",CC(=O)NC1=CC(=C(C=C1)O)SC,,,,,,
2260,162261,"Benzenesulfonic acid, dodecyl-, compd. with 2-amino-2-methyl-1-propanol (1:1)",CCCCCCCCCCCCC1=CC=CC=C1S(=O)(=O)O.CC(C)(CO)N,,,,,,
2261,162262,Etheno adenosine triphosphate,C1=CN2C=NC3=C(C2=N1)N=CN3C4[C@@H]([C@@H]([C@H](O4)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O,,,,,,
2262,162263,Dipotassium trisulphide,[S-2].[K+].[K+],,,,,,
2263,162264,"2-Butenoic acid, 3-methyl-, phenylmethyl ester",CC(=CC(=O)OCC1=CC=CC=C1)C,,,,,,
2264,162265,Norpseudoephedrine,C[C@H]([C@@H](C1=CC=CC=C1)O)N,,,['Agents that are used to suppress appetite. (See all compounds classified as Appetite Depressants.)'],"['Phenylpropanolamine is well absorbed orally, and the peak blood concentration is attained within one to two hours. ... The drug is principally excreted unchanged; the major route of excretion is renal. Since phenylpropanolamine is a weak base, elimination is enhanced in acid urine.', 'Phenylpropanolamine is readily absorbed from the GI tract. Nasal decongestion reportedly occurs within 15-30 minutes after oral administration of 25 mg of phenylpropanolamine hydrochloride and appears to persist for 3 hours. Plasma concentrations of the drug required for a therapeutic effect are not known. In one study, peak plasma concentrations of 100 ng/mL were reached in 1-2 hours and concentrations remained greater than 60 ng/ml for 6 hours following oral administration of 50 mg of phenylpropanolamine hydrochloride to fasting adults. Following administration of 150 mg of an extended-release preparation of the drug, peak plasma concentrations of 300 ng/mL occurred after 3.5 hours and phenylpropanolamine concentrations remained greater than 180 ng/mL for 12 hours. /Phenylpropanolamine hydrochloride/', 'Animal studies indicate that phenylpropanolamine is distributed into various tissues and fluids, including /cerebrospinal fluid/ and brain. /Phenylpropanolamine hydrochloride/', 'The bioavailability and pharmacokinetics of phenylpropanolamine hydrochloride from a controlled release caplet and solution were studied in 12 male subjects, aged 18 to 36 yr, who received either a 75 mg caplet once daily or a 25 mg solution 3 times daily for 4 days. Maximum plasma concentrations, time to maximum concentration, and areas under the concentration-time curves are reported for both caplet and solution. The mean first order absorption rate constant, elimination half-life and lag time for the drug from the caplet were 0.488 ngxhr/mL, 5.84 hr, and 0.394 hr, respectively, and 2.87 ngxhr/mL, 3.73 hr, and 0.325 hr, respectively, from the solution. The smaller apparent mean first order absorption rate constant and longer elimination half-life from the caplet is due to the slow release of drug, thereby slowing its absorption and producing sustained plasma drug concentrations.', 'For more Absorption, Distribution and Excretion (Complete) data for PHENYLPROPANOLAMINE (6 total), please visit the HSDB record page.']","['Like other phenylisopropanolamines, small amounts of the drug are slowly metabolized in the liver to an active hydroxylated metabolite. About 80-90% of a dose of phenylpropanolamine is excreted unchanged in the urine within 24 hours. /Phenylpropanolamine hydrochloride/']","['The half-life ranges from 2.7 to 3.4 hrs. /Phenylpropanolamine hydrochloride/', 'Phenylpropanolamine reportedly has a half-life of 3-4 hours. /Phenylpropanolamine hydrochloride/', 'The bioavailability and pharmacokinetics of phenylpropanolamine hydrochloride (PPA HCl) from a controlled-release (CR) caplet and solution was studied in 12 male subjects, who  received either a 75 mg PPA HCl CR caplet once daily or a 25 mg PPA HCl solution given three times a day. All subjects received the medication for 4 consecutive days. ... The mean elimination half-life  for PPA HCl from the CR caplet was  5.84 hr and 3.73 hr, for the solution. ...']"
2265,162266,CID 162266,C1OC2=C(O1)C=C(C=C2)C(O)S(=O)(=O)[O-].[Na+],,,,,,
2266,162267,2-Methyldodecanal,CCCCCCCCCCC(C)C=O,,,,,,
2267,162268,5-Cyclohexadecen-1-one,C1CCCCCC(=O)CCCC=CCCCC1,,,,,,
2268,162269,"3-[(6aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]-1,1-diethylurea;but-2-enedioic acid",CCN(CC)C(=O)NC1CC2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)C.C(=CC(=O)O)C(=O)O,,,,,,
2269,162270,"3-[(6aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]-1,1-diethylurea",CCN(CC)C(=O)NC1CC2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)C,,,,,,
2270,162271,"2,9-Dimethyl-beta-carbolinium",CN1C2=CC=CC=C2C3=C1C=[N+](C=C3)C,,,,,,
2271,162272,Asterone,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC=C3[C@H]2C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4)O)C)O)C,,,,,,
2272,162273,"Carbonochloridothioic acid, S-(phenylmethyl) ester",C1=CC=C(C=C1)CSC(=O)Cl,,,,,,
2273,162274,Mycestericin C,CCCCCCC(=O)CCCCCCCCC[C@H]([C@@H]([C@@](CO)(C(=O)O)N)O)O,,,,,,
2274,162275,Methyl 2-[(phenylmethylene)amino]benzoate,COC(=O)C1=CC=CC=C1N=CC2=CC=CC=C2,,,,,,
2275,162276,"5-Acetyl-1,3,6,8-tetrahydroxyanthraquinone",CC(=O)C1=C(C=C(C2=C1C(=O)C3=C(C2=O)C(=CC(=C3)O)O)O)O,,,,,,
2276,162277,CID 162277,CC1(CC2=C3C(=NOS3ON2)C1)C,,,,,,
2277,162278,"2,4,5-Trimethyl-4-phenyl-1,3-dioxane",CC1COC(OC1(C)C2=CC=CC=C2)C,,,,,,
2278,162279,Methyl methacrylate butyl acrylate styrene glycidyl methacrylate polymer,CCCCOC(=O)C=C.CC(=C)C(=O)OC.CC(=C)C(=O)OCC1CO1.C=CC1=CC=CC=C1,,,,,,
2279,162280,"1-Propen-1-ol, 2-phenyl-, acetate, (1E)-",CC(=COC(=O)C)C1=CC=CC=C1,,,,,,
2280,162281,"Acetamide, N-[2-[(2-chloro-4,6-dinitrophenyl)azo]-5-[(2-cyanoethyl)amino]-4-methoxyphenyl]-",CC(=O)NC1=CC(=C(C=C1N=NC2=C(C=C(C=C2Cl)[N+](=O)[O-])[N+](=O)[O-])OC)NCCC#N,,,,,,
2281,162282,Polylysine,C(CCN)C[CH+]C(=O)[NH-],,,,,,
2282,162283,"3-(((Heptadecafluorooctyl)sulfonyl)amino)-N,N,N-trimethyl-1-propanaminium chloride",C[N+](C)(C)CCCNS(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F.[Cl-],,,,,,
2283,162284,"2-[3-(4-methylphenyl)-2,4-dioxo-1,3-thiazolidin-5-yl]-N-(1-phenylethylideneamino)acetamide",CC1=CC=C(C=C1)N2C(=O)C(SC2=O)CC(=O)NN=C(C)C3=CC=CC=C3,,,,,,
2284,162285,"Bicyclo(3.1.1)hept-2-ene-2-butanal, 6,6-dimethyl-",CC1(C2CC=C(C1C2)CCCC=O)C,,,,,,
2285,162286,5-Chloro-2-hydroxynicotinic acid,C1=C(C(=O)NC=C1Cl)C(=O)O,,,,,,
2286,162287,Desacetylcephapirin,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)CSC3=CC=NC=C3)C(=O)O)CO,,,,,,
2287,162288,"6-[3-(1,3-Benzothiazol-2-yl)-5-(2-phenylethenyl)tetrazol-3-ium-2-yl]-2,3-dihydrophthalazine-1,4-dione;chloride",C1=CC=C(C=C1)C=CC2=NN([N+](=N2)C3=NC4=CC=CC=C4S3)C5=CC6=C(C=C5)C(=O)NNC6=O.[Cl-],,,,,,
2288,162289,"6-[3-(1,3-Benzothiazol-2-yl)-5-(2-phenylethenyl)tetrazol-3-ium-2-yl]-2,3-dihydrophthalazine-1,4-dione",C1=CC=C(C=C1)C=CC2=NN([N+](=N2)C3=NC4=CC=CC=C4S3)C5=CC6=C(C=C5)C(=O)NNC6=O,,,,,,
2289,162290,Decamethoxine,CC1CCC(C(C1)OC(=O)C[N+](C)(C)CCCCCCCCCC[N+](C)(C)CC(=O)OC2CC(CCC2C(C)C)C)C(C)C.[Cl-].[Cl-],,,"['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)', 'Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)']",,,
2290,162291,10-[Dimethyl-[2-(5-methyl-2-propan-2-ylcyclohexyl)oxy-2-oxoethyl]azaniumyl]decyl-dimethyl-[2-(5-methyl-2-propan-2-ylcyclohexyl)oxy-2-oxoethyl]azanium,CC1CCC(C(C1)OC(=O)C[N+](C)(C)CCCCCCCCCC[N+](C)(C)CC(=O)OC2CC(CCC2C(C)C)C)C(C)C,,,"['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)', 'Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)']",,,
2291,162292,1-(4-Methylthiazol-5-yl)ethanone,CC1=C(SC=N1)C(=O)C,,,,,,
2292,162293,"5-Ethyl-2,4-dimethylthiazole",CCC1=C(N=C(S1)C)C,,,,,,
2293,162294,"1,5-Dimethylhex-5-enyl acetate",CC(CCCC(=C)C)OC(=O)C,,,,,,
2294,162295,(2S)-2-[[(2S)-3-[3-[bis(2-chloroethyl)amino]phenyl]-2-[[(2S)-pyrrolidine-2-carbonyl]amino]propanoyl]amino]pentanoic acid,CCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC(=CC=C1)N(CCCl)CCCl)NC(=O)[C@@H]2CCCN2,,,,,,
2295,162296,Einecs 253-859-0,CC1(CC2C1C(=C)CCC(C(=C)CC2)O)C,,,,,,
2296,162297,"Cyclododecoxazole, 4,5,6,7,8,9,10,11,12,13-decahydro-",C1CCCCCC2=C(CCCC1)N=CO2,,,,,,
2297,162298,"(1alpha,3abeta,4alpha,7alpha,8abeta)-Hexahydro-1,4,10,10-tetramethyl-1H,4H,3a,8a-epoxy-4,7-methanoazulene",C[C@H]1CC[C@@]23[C@@]1(O2)C[C@@H]4CC[C@]3(C4(C)C)C,,,,,,
2298,162299,"Octanoic acid, compd. with morpholine (1:1)",CCCCCCCC(=O)O.C1COCCN1,,,,,,
2299,162300,1-((3-Aminophenyl)amino)-3-phenoxypropan-2-ol,C1=CC=C(C=C1)OCC(CNC2=CC=CC(=C2)N)O,,,,,,
2300,162301,CID 162301,CC1CO1.CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O.C(=CC(=O)O)C(=O)O,,,,,,
2301,162302,(+)-Penbutolol,CC(C)(C)NC[C@H](COC1=CC=CC=C1C2CCCC2)O,,,,,,
2302,162303,Bis(2-hydroxyethyl)dimethylammonium chloride,C[N+](C)(CCO)CCO.[Cl-],,,,,,
2303,162304,Dimethyldiethanolammonium,C[N+](C)(CCO)CCO,,,,,,
2304,162305,Aloenin,CC1=CC(=CC(=C1C2=CC(=CC(=O)O2)OC)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O,,,,,,
2305,162306,"1,3-Dichloro-5-(methylsulfinyl)benzene",CS(=O)C1=CC(=CC(=C1)Cl)Cl,,,,,,
2306,162307,2-Hydroxyamylthiobenzthiazole,CCCC(CSC1=NC2=CC=CC=C2S1)O,,,,,,
2307,162308,CID 162308,CCNCC.C1=CC=C2C(=C1)N=C(S2)S,,,,,,
2308,162309,"4-(4,8-Dimethylnona-3,7-dienyl)pyridine",CC(=CCCC(=CCCC1=CC=NC=C1)C)C,,,,,,
2309,162310,"4-(5,9-Dimethyldeca-4,8-dien-2-yl)pyridine",CC(CC=C(C)CCC=C(C)C)C1=CC=NC=C1,,,,,,
2310,162311,Bis(4-dimethylaminodithiobenzil)nickel,CN(C)C1=CC=C(C=C1)C(=C(C2=CC=CC=C2)[S-])[S-].CN(C)C1=CC=C(C=C1)C(=C(C2=CC=CC=C2)[S-])[S-].[Ni],,,,,,
2311,162312,"1-[4-(Dimethylamino)phenyl]-2-phenylethene-1,2-dithiol",CN(C)C1=CC=C(C=C1)C(=C(C2=CC=CC=C2)S)S,,,,,,
2312,162313,"Hexanedioic acid, dianhydride with acetic acid",CC(=O)OC(=O)CCCCC(=O)OC(=O)C,,,,,,
2313,162314,"Hexanoic acid, 2-ethyl-, compd. with 2,2',2''-nitrilotris[ethanol] (1:1)",CCCCC(CC)C(=O)O.C(CO)N(CCO)CCO,,,,,,
2314,162315,CID 162315,C1CCC(CC1)CCCC(=O)O.C1CCC(CC1)CCCC(=O)O.O.[AlH3],,,,,,
2315,162316,CID 162316,CCC1=C(NC=N1)CSCCNC(=NC)S,,,,,,
2316,162317,"N-Nitroso-5H-dibenz(b,f)azepine",C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2N=O,,,,,,
2317,162318,"2,5-Diethoxy-4-((4-methylphenyl)thio)benzenediazonium tetrachlorozincate (2:1)",CCOC1=CC(=C(C=C1[N+]#N)OCC)SC2=CC=C(C=C2)C.CCOC1=CC(=C(C=C1[N+]#N)OCC)SC2=CC=C(C=C2)C.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
2318,162319,"1H-Pyrazol-3-amine, 4-[[4-(ethylsulfonyl)-2-nitrophenyl]azo]-5-methyl-1-phenyl-",CCS(=O)(=O)C1=CC(=C(C=C1)N=NC2=C(N(N=C2N)C3=CC=CC=C3)C)[N+](=O)[O-],,,,,,
2319,162320,"6-(2-(2-Methyl-1H-imidazol-1-yl)ethyl)-1,3,5-triazine-2,4-diamine",CC1=NC=CN1CCC2=NC(=NC(=N2)N)N,,,,,,
2320,162321,Nortilidine,CCOC(=O)[C@]1(CCC=C[C@@H]1NC)C2=CC=CC=C2,,,,,,
2321,162322,"Zinc(2+), tetraammine-, (T-4)-, carbonate (1:1)",C(=O)([O-])[O-].N.N.N.N.[Zn+2],,,,,,
2322,162323,"Tetraammonium tetrahydrogen (hexane-1,6-diylbis(nitrilobis(methylene)))tetrakisphosphonate",C(CCCN(CP(=O)(O)O)CP(=O)(O)O)CCN(CP(=O)(O)O)CP(=O)(O)O.N.N.N.N,,,,,,
2323,162324,Tmsl S-oxide,C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@]45CCC(=O)O5)C)S(=O)C,,,,,,
2324,162325,7alpha-Thiomethylspironolactone,C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@]45CCC(=O)O5)C)SC,,,,,,
2325,162326,"Ethanaminium, N,N,N-trimethyl-2-((methyl(1,2,2-trimethylpropoxy)phosphinyl)thio)-",CC(C(C)(C)C)OP(=O)(C)SCC[N+](C)(C)C,,,,,,
2326,162327,N-(2-Chloroethyl)-N-methyl-9H-fluoren-9-amine,CN(CCCl)C1C2=CC=CC=C2C3=CC=CC=C13,,,,,,
2327,162328,cis-Dipyrrolidinedichloroplatinum (II),C1CCNC1.C1CCNC1.[Cl-].[Cl-].[Pt+2],,,,,,
2328,162329,"2-Naphthalenesulfonic acid, 7,7'-(carbonyldiimino)bis(4-hydroxy-3-((2-methyl-4-sulfophenyl)azo)-, compd. with 2,2',2''-nitrilotris(ethanol) (1:4)",CC1=C(C=CC(=C1)S(=O)(=O)O)N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=CC(=C(C(=C5C=C4)O)N=NC6=C(C=C(C=C6)S(=O)(=O)O)C)S(=O)(=O)O)S(=O)(=O)O.C(CO)N(CCO)CCO.C(CO)N(CCO)CCO.C(CO)N(CCO)CCO.C(CO)N(CCO)CCO,,,,,,
2329,162330,"2-Naphthalenesulfonic acid, 7,7'-(carbonyldiimino)bis(4-hydroxy-3-((2-methyl-4-sulfophenyl)azo)-, sodium salt, compd. with 2,2',2''-nitrilotris(ethanol)",CC1=C(C=CC(=C1)S(=O)(=O)O)N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=CC(=C(C(=C5C=C4)O)N=NC6=C(C=C(C=C6)S(=O)(=O)O)C)S(=O)(=O)O)S(=O)(=O)O,,,,,,
2330,162331,Isoverrucarol,CC1=C[C@@H]2[C@](CC1)([C@]3(C[C@H]([C@H]([C@@]34CO4)O2)O)C)CO,,,,,,
2331,162332,"3-[3-[2-Hydroxyethyl(dimethyl)azaniumyl]propyl-(1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluorohexylsulfonyl)amino]propane-1-sulfonate",C[N+](C)(CCCN(CCCS(=O)(=O)[O-])S(=O)(=O)C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)CCO,,,,,,
2332,162333,"1-Propanaminium, N-(2-hydroxyethyl)-N,N-dimethyl-3-[(3-sulfopropyl)[(tridecafluorohexyl)sulfonyl]amino]-, inner salt",C[N+](C)(CCCN(CCCS(=O)(=O)O)S(=O)(=O)C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)CCO,,,,,,
2333,162334,"Pyrrolidine, 1-(1-oxooctyl)-2-(3-pyridinyl)-, (S)-",CCCCCCCC(=O)N1CCC[C@H]1C2=CN=CC=C2,,,,,,
2334,162335,"1,6-Hexanediamine, N,N'-bis(2-(4-bromobutoxy)ethyl)-",C(CCCNCCOCCCCBr)CCNCCOCCCCBr,,,,,,
2335,162336,"Nonanedioic acid, dilithium salt",[Li+].[Li+].C(CCCC(=O)[O-])CCCC(=O)[O-],,,,,,
2336,162337,"Benz(c)acridine, 7-((3-((2-chloroethyl)amino)propyl)amino)-, dihydrochloride, sesquihydrate",C1=CC=C2C(=C1)C=CC3=C(C4=CC=CC=C4N=C32)NCCCNCCCl.Cl.Cl,,,,,,
2337,162338,"1,3-Propanediamine, N-benz[c]acridin-7-yl-N'-(2-chloroethyl)-",C1=CC=C2C(=C1)C=CC3=C(C4=CC=CC=C4N=C32)NCCCNCCCl,,,,,,
2338,162339,"Ethanol, 2-((3-((benz(c)acridin-7-yl)amino)propyl)amino)-, dihydrochloride, hemihydrate",C1=CC=C2C(=C1)C=CC3=C(C4=CC=CC=C4N=C32)NCCCNCCO.Cl.Cl,,,,,,
2339,162340,2-[3-(Benzo[c]acridin-7-ylamino)propylamino]ethanol,C1=CC=C2C(=C1)C=CC3=C(C4=CC=CC=C4N=C32)NCCCNCCO,,,,,,
2340,162341,"7-((3-((2-Chloroethyl)amino)propyl)amino)benzo(b)(1,8)phenanthroline dihydrochloride hydrate",C1=CC=C2C(=C1)C(=C3C=CC4=C(C3=N2)C=CN=C4)NCCCNCCCl.Cl.Cl,,,,,,
2341,162342,"N'-benzo[b][1,8]phenanthrolin-7-yl-N-(2-chloroethyl)propane-1,3-diamine",C1=CC=C2C(=C1)C(=C3C=CC4=C(C3=N2)C=CN=C4)NCCCNCCCl,,,,,,
2342,162343,"1H-Indolium, 1-[(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)ethylidene]-2,3-dihydro-5-methoxy-2,3,3-trimethyl-, chloride",CC1C(C2=C([N+]1=CC=C3C(C4=CC=CC=C4N3C)(C)C)C=CC(=C2)OC)(C)C.[Cl-],,,,,,
2343,162344,"2-[2-[(2,3-Dihydro-5-methoxy-2,3,3-trimethyl-1H-indol)-1-yl]ethenyl]-1,3,3-trimethyl-3H-indolium",CC1C(C2=C([N+]1=CC=C3C(C4=CC=CC=C4N3C)(C)C)C=CC(=C2)OC)(C)C,,,,,,
2344,162345,"3H-Indolium, 1,3,3-trimethyl-2-[(methyl-2-naphthalenylhydrazono)methyl]-, chloride",CC1(C2=CC=CC=C2[N+](=C1C=NN(C)C3=CC4=CC=CC=C4C=C3)C)C.[Cl-],,,,,,
2345,162346,"1,3,3-Trimethyl-2-[2-methyl-2-(2-naphthyl)hydrazonomethyl]-3H-indole-1-ium",CC1(C2=CC=CC=C2[N+](=C1C=NN(C)C3=CC4=CC=CC=C4C=C3)C)C,,,,,,
2346,162347,"2-(4-Methoxyphenyl)methylhydrazonomethyl-1,3,3-trimethyl-3H-indolium chloride",CC1(C2=CC=CC=C2[N+](=C1C=NNCC3=CC=C(C=C3)OC)C)C.[Cl-],,,,,,
2347,162348,"2-[[2-(4-Methoxyphenyl)methylhydrazono]methyl]-1,3,3-trimethyl-3H-indolium",CC1(C2=CC=CC=C2[N+](=C1C=NNCC3=CC=C(C=C3)OC)C)C,,,,,,
2348,162349,Dihydrobunolol,CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2O)O,,,,,,
2349,162350,Isovitexin,C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C=C(C(=C3O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O,,,,,,
2350,162351,Tulipalin B,C=C1[C@@H](COC1=O)O,,,,,,
2351,162352,Ecgonine methyl ester hydrochloride,CN1[C@H]2CC[C@@H]1[C@H]([C@H](C2)O)C(=O)OC.Cl,,,,,,
2352,162353,CID 162353,CN1[C@H]2CCC1C([C@H](C2)O)C(=O)OC,,,,,,
2353,162354,3-Hydroxypent-4-enoic acid,C=CC(CC(=O)O)O,,,,,,
2354,162355,CID 162355,CC12CC(C3CC1(C3(C(=O)O2)COC(=O)C4=CC=CC=C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O,,,,,,
2355,162356,"1-Ethyl-4-hydrazino-lH-pyrazolo-(3,4-b)-pyridine-5-carboxylic acid ethyl ester hydrochloride",CCN1C2=NC=C(C(=C2C=N1)NN)C(=O)OCC.Cl,,,,,,
2356,162357,"1-Ethyl-4-hydrazino-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid ethyl ester",CCN1C2=NC=C(C(=C2C=N1)NN)C(=O)OCC,,,,,,
2357,162358,5-(2-aminoethyl)-1H-imidazol-2-amine,C1=C(NC(=N1)N)CCN,,,,,,
2358,162359,"2,4-Dimethyl-6-propylcyclohex-3-ene-1-carbaldehyde",CCCC1CC(=CC(C1C=O)C)C,,,,,,
2359,162360,CID 162360,COC(=O)N=C(NC1=C(C=CC(=C1)C(=O)C2=CC=CC=C2)N)S,,,,,,
2360,162361,"2,5-Dibromohexane-3,4-dione",CC(C(=O)C(=O)C(C)Br)Br,,,,,,
2361,162362,2-Thiopheneacetyl chloride,C1=CSC(=C1)CC(=O)Cl,,,,,,
2362,162363,"Cyclopentanone, 2-heptylidene-",CCCCCCC=C1CCCC1=O,,,,,,
2363,162364,CID 162364,CCC(=CC1=[N+](C2=C(O1)C=CC(=C2)Cl)CCCS(=O)(=O)[O-])C=C3N(C4=C(O3)C=CC(=C4)Cl)CCCS(=O)(=O)O.CCN(CC)CC,,,,,,
2364,162365,2-[2-[3-(3-Sulfopropyl)-5-chlorobenzoxazole-2(3H)-ylidenemethyl]-1-butenyl]-3-(3-sulfonatopropyl)-5-chlorobenzoxazole-3-ium,CCC(=CC1=[N+](C2=C(O1)C=CC(=C2)Cl)CCCS(=O)(=O)O)C=C3N(C4=C(O3)C=CC(=C4)Cl)CCCS(=O)(=O)O,,,,,,
2365,162366,Iminoctadine triacetate,CC(=O)O.CC(=O)O.CC(=O)O.C(CCCCN=C(N)N)CCCNCCCCCCCCN=C(N)N,,,,,,
2366,162367,"[3-(4-Chlorophenyl)-3-hydroxy-2,3-dihydro[1,3]thiazolo[3,2-a]benzimidazol-2-yl]acetic acid",C1=CC=C2C(=C1)N=C3N2C(C(S3)CC(=O)O)(C4=CC=C(C=C4)Cl)O,,,,,,
2367,162368,2-(Perfluorododecyl)ethanol,C(CO)C(C(C(C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
2368,162369,CID 162369,[OH-].[O-]S(=O)(=O)[O-].[AlH3].[Cl-],,,,,,
2369,162370,CID 162370,CC1=CC=C(C=C1)S(=O)(=O)O.CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].CC1(CC(=O)CC(N1)(C)C)C.[Na+],,,,,,
2370,162371,Paraquat dichloride mixt. with simazine,CCNC1=NC(=NC(=N1)Cl)NCC.C[N+]1=CC=C(C=C1)C2=CC=[N+](C=C2)C.[Cl-].[Cl-],,,,,,
2371,162372,Tungsten oxide (W2O5),[O-2].[O-2].[O-2].[W],,,,,,
2372,162373,"2-Butenedioic acid (2E)-, polymer with alpha,alpha'-[(1-methylethylidene)di-4,1-phenylene]bis[omega-hydroxypoly[oxy(methyl-1,2-ethanediyl)]]",CC(C)(C1=CC=C(C=C1)OCCCO)C2=CC=C(C=C2)OCCCO.C(=CC(=O)O)C(=O)O,,,,,,
2373,162374,CID 162374,CC(C)(CO)CO.CC(C)(C1=CC=C(C=C1)OCCCO)C2=CC=C(C=C2)OCCCO.C(=CC(=O)O)C(=O)O,,,,,,
2374,162375,Osmium zinc iodide,[Zn+2].[I-].[I-].[I-].[I-].[I-].[I-].[Os+4],,,['Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)'],,,
2375,162376,Einecs 254-445-2,CCCCCCCO.CP(=O)(O)O,,,,,,
2376,162377,Hydron;pyridine;tribromide,[H+].C1=CC=NC=C1.[Br-].[Br-].[Br-],,,,,,
2377,162378,CID 162378,C1=CC(=C(C=C1Cl)Cl)OCCOP(=O)OCCOC2=C(C=C(C=C2)Cl)Cl.C1=CC(=C(C=C1Cl)Cl)OCCOP(OCCOC2=C(C=C(C=C2)Cl)Cl)OCCOC3=C(C=C(C=C3)Cl)Cl,,,,,,
2378,162379,CID 162379,C1=CC(=C(C=C1Cl)Cl)OCCOP(=O)OCCOC2=C(C=C(C=C2)Cl)Cl,,,,,,
2379,162380,Reslin,CCCCOCCOCCOCC1=CC2=C(C=C1CCC)OCO2.CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=COC(=C2)CC3=CC=CC=C3)C,,,,,,
2380,162381,Bioresmethrin,CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=COC(=C2)CC3=CC=CC=C3)C,,,"['Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)']",,['Bioresmethrin has known human metabolites that include BFA.'],
2381,162382,Vantal,CNC(=O)CSP(=S)(OC)OC.C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(Cl)(Cl)Cl)Cl,,,,,,
2382,162383,"L-Cysteine, N-acetyl-S-(1,4-dihydro-3-methyl-1,4-dioxo-2-naphthalenyl)-",CC1=C(C(=O)C2=CC=CC=C2C1=O)SC[C@@H](C(=O)O)NC(=O)C,,,,,,
2383,162384,Tetradecenic acid,CCCCCCCCCCCC=CC(=O)O,,,,,,
2384,162385,"Chromate(1-), bis(2-((4,5-dihydro-3-methyl-5-(oxo-kappaO)-1-phenyl-1H-pyrazol-4-yl)azo-kappaN1)benzoato(2-)-kappaO)-, hydrogen, compd. with 3-((2-ethylhexyl)oxy)-1-propanamine (1:1)",[H+].CCCCC(CC)COCCCN.CC1=NN(C(=C1N=NC2=CC=CC=C2C(=O)[O-])[O-])C3=CC=CC=C3.CC1=NN(C(=C1N=NC2=CC=CC=C2C(=O)[O-])[O-])C3=CC=CC=C3.[Cr+3],,,,,,
2385,162386,o-(5-Hydroxy-3-methyl-1-phenyl-4-pyrazolylazo)benzoic acid,CC1=C(C(=O)N(N1)C2=CC=CC=C2)N=NC3=CC=CC=C3C(=O)O,,,,,,
2386,162387,1H-Benzimidazole-2-pentanamine,C1=CC=C2C(=C1)NC(=N2)CCCCCN,,,,,,
2387,162388,2-[2-(2-Ethoxyethoxy)ethoxy]ethyl methacrylate,CCOCCOCCOCCOC(=O)C(=C)C,,,,,,
2388,162389,delta(8)-Thc-11-oic acid,CCCCCC1=CC(=C2[C@@H]3CC(=CC[C@H]3C(OC2=C1)(C)C)C(=O)O)O,,,,,,
2389,162390,2-((2-Aminoethyl)(2-((2-hydroxyethyl)amino)ethyl)amino)ethanol,C(CN(CCNCCO)CCO)N,,,,,,
2390,162391,"2-(3,7,11,15-Tetramethylhexadeca-2,6,10,14-tetraenyl)benzene-1,4-diol",CC(=CCCC(=CCCC(=CCCC(=CCC1=C(C=CC(=C1)O)O)C)C)C)C,,,,,,
2391,162392,9-Decenal,C=CCCCCCCCC=O,,,,,,
2392,162393,"2-Methyl-3-(3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl)naphthalene-1,4-diol",CC1=C(C2=CC=CC=C2C(=C1CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)O)O,,,,,,
2393,162394,Menaquinol 6,CC1=C(C2=CC=CC=C2C(=C1CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)O)O,,,,,,
2394,162395,"Bicyclo(3.1.1)heptan-3-ol, 6,6-dimethyl-2-methylene-, acetate, (1R,3R,5R)-",CC(=O)O[C@@H]1C[C@H]2C[C@@H](C1=C)C2(C)C,,,,,,
2395,162396,{7-[(4-Nitrobenzoyl)oxy]hexahydro-1h-pyrrolizin-1-yl}methyl 4-nitrobenzoate,C1CN2CCC(C2C1COC(=O)C3=CC=C(C=C3)[N+](=O)[O-])OC(=O)C4=CC=C(C=C4)[N+](=O)[O-],,,,,,
2396,162397,"Cyclohexene, 4-(1-chloro-1-methylethyl)-1-methyl-",CC1=CCC(CC1)C(C)(C)Cl,,,,,,
2397,162398,"Magnesium, butyl(1-methylpropyl)-",CCC[CH2-].CC[CH-]C.[Mg+2],,,,,,
2398,162399,Acetylarsenocholine,CC(=O)OCC[As+](C)(C)C,,,,,,
2399,162400,Aba-nat,CC(=O)N[C@@H](CC1=CC(=C(C=C1)O)N=NC2=CC=C(C=C2)[As](=O)(O)O)C(=O)O,,,,,,
2400,162401,Degalactotigonin,C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O[C@H]9[C@@H]([C@H]([C@@H](CO9)O)O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)C)C)C)OC1,,,,,,
2401,162402,"{4-[(Bromoacetyl)oxy]-2,2,6,6-tetramethylpiperidin-1-yl}oxidanyl",CC1(CC(CC(N1[O])(C)C)OC(=O)CBr)C,,,,,,
2402,162403,4-Bromo-3-hydroxyanthranilic acid,C1=CC(=C(C(=C1C(=O)O)N)O)Br,,,,,,
2403,162404,Thorium(III) hydride,[HH].[HH].[HH].[Th],,,,,,
2404,162405,Monoiodoamphenicol,C1=CC(=CC=C1[C@H]([C@@H](CO)NC(=O)CI)O)[N+](=O)[O-],,,,,,
2405,162406,Erythrulose,C(C(C(=O)CO)O)O,,,,,,
2406,162407,2-tert-Butyl-4(5)-phenyl-5(4)-(3-pyridyl)imidazole,CC(C)(C)C1=NC(=C(N1)C2=CC=CC=C2)C3=CN=CC=C3,,,,,,
2407,162408,N-(Octadec-9-en-1-yl)octadec-9-en-1-amine,CCCCCCCCC=CCCCCCCCCNCCCCCCCCC=CCCCCCCCC,,,,,,
2408,162409,Methyl cyclopentylideneacetate,COC(=O)C=C1CCCC1,,,,,,
2409,162410,(4-Formyl-5-hydroxy-6-methylpyridin-3-yl)methyl hydrogen sulfate,CC1=NC=C(C(=C1O)C=O)COS(=O)(=O)O,,,,,,
2410,162411,"Pregnan-20-one, 3,17-dihydroxy-",CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4[C@@]3(CCC(C4)O)C)C)O,,,,,,
2411,162412,Phaseollinisoflavan,CC1(C=CC2=C(O1)C=CC(=C2O)[C@H]3CC4=C(C=C(C=C4)O)OC3)C,,,,,,
2412,162413,Isononyl acetate,CC(C)CCCCCCOC(=O)C,,,,,,
2413,162414,"1-(4-Chlorophenoxy)-3-[4-(3,4-dimethoxyphenyl)piperazin-1-yl]propan-2-ol",COC1=C(C=C(C=C1)N2CCN(CC2)CC(COC3=CC=C(C=C3)Cl)O)OC,,,,,,
2414,162415,"Carbonic acid, 2-[(1-amino-9,10-dihydro-4-hydroxy-9,10-dioxo-2-anthracenyl)oxy]ethyl ethyl ester",CCOC(=O)OCCOC1=C(C2=C(C(=C1)O)C(=O)C3=CC=CC=C3C2=O)N,,,,,,
2415,162416,Isooctyl stearate,CCCCCCCCCCCCCCCCCC(=O)OCCCCCC(C)C,,,,,,
2416,162417,"Dichloro(4,5-dimethyl-o-phenylenediamine)platinum(II)",CC1=CC(=C(C=C1C)N)N.[Cl-].[Cl-].[Pt+2],,,,,,
2417,162418,"4,8-Dimethylnon-7-en-2-ol",CC(CCC=C(C)C)CC(C)O,,,,,,
2418,162419,"5'-O-(4,4'-Dimethoxytrityl)thymidine",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)O,,,,,,
2419,162420,"N,N'-(2,5-Dichloro-1,4-phenylene)bis[4-[(2,5-dichlorophenyl)azo]-3-hydroxynaphthalene-2-carboxamide]",C1=CC=C2C(=C1)C=C(C(=C2N=NC3=C(C=CC(=C3)Cl)Cl)O)C(=O)NC4=CC(=C(C=C4Cl)NC(=O)C5=CC6=CC=CC=C6C(=C5O)N=NC7=C(C=CC(=C7)Cl)Cl)Cl,,,,,,
2420,162421,"2',3'-Dideoxyformycin A",C1C[C@@H](O[C@@H]1CO)C2=C3C(=NN2)C(=NC=N3)N,,,,,,
2421,162422,"Propanenitrile, 3-[[2-(benzoyloxy)ethyl][4-[(4-nitrophenyl)azo]phenyl]amino]-",C1=CC=C(C=C1)C(=O)OCCN(CCC#N)C2=CC=C(C=C2)N=NC3=CC=C(C=C3)[N+](=O)[O-],,,,,,
2422,162423,2-tert-Butylcyclohexyl propionate,CCC(=O)OC1CCCCC1C(C)(C)C,,,,,,
2423,162424,"4-(2H-1,3-benzodioxol-5-yl)butan-2-amine",CC(CCC1=CC2=C(C=C1)OCO2)N,,,,,,
2424,162425,4-(N-Maleimido)benzyltrimethylammonium,C[N+](C)(C)CC1=CC=C(C=C1)N2C(=O)C=CC2=O,,,,,,
2425,162426,Mequitazine sulfoxide,C1CN2CCC1C(C2)CN3C4=CC=CC=C4S(=O)C5=CC=CC=C53,,,,,,
2426,162427,"2-[2,5-dichloro-4-(6,11-dioxo-3H-naphtho[2,3-e]benzimidazol-2-yl)phenyl]-3H-naphtho[3,2-e]benzimidazole-6,11-dione",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C4=C(C=C3)NC(=N4)C5=CC(=C(C=C5Cl)C6=NC7=C(N6)C=CC8=C7C(=O)C9=CC=CC=C9C8=O)Cl,,,,,,
2427,162428,Solanid-5-en-3-yl 6-deoxyhexopyranosyl-(1->2)hexopyranosyl-(1->3)hexopyranoside--hydrogen chloride (1/1),CC1CCC2C(C3C(N2C1)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)O)OC8C(C(C(C(O8)CO)O)O)OC9C(C(C(C(O9)C)O)O)O)O)C)C)C.Cl,,,,,,
2428,162429,"2-[2-[3,5-Dihydroxy-2-(hydroxymethyl)-6-[(10,14,16,20-tetramethyl-22-azahexacyclo[12.10.0.02,11.05,10.015,23.017,22]tetracos-4-en-7-yl)oxy]oxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol",CC1CCC2C(C3C(N2C1)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)O)OC8C(C(C(C(O8)CO)O)O)OC9C(C(C(C(O9)C)O)O)O)O)C)C)C,,,,,,
2429,162430,ZINC;2-amino-4-methylsulfanylbutanoate,CSCCC(C(=O)[O-])N.CSCCC(C(=O)[O-])N.[Zn+2],,,,,,
2430,162431,Vouacapan,C[C@]12CCCC([C@@H]1[C@H]([C@@H]([C@@H]3[C@@H]2CC4=C([C@H]3C(=O)O)C=CO4)O)O)(C)C,,,,,,
2431,162432,CID 162432,CCCCC[C@@H](C=C[C@H]1[C@@H](C[C@@H]([C@@H]1CC=CCCCC(=O)O)O)O)OC,,,,,,
2432,162433,"7-Benzothiazolesulfonic acid, 6-methyl-2-(4-((2-oxo-1-(((4-sulfo-1-naphthalenyl)amino)carbonyl)propyl)azo)-3-sulfophenyl)-, trisodium salt",CC1=C(C2=C(C=C1)N=C(S2)C3=CC(=C(C=C3)N=NC(C(=O)C)C(=O)NC4=CC=C(C5=CC=CC=C54)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
2433,162434,"2-[4-({1,3-Dioxo-1-[(4-sulfonaphthalen-1-yl)amino]butan-2-yl}diazenyl)-3-sulfophenyl]-6-methyl-1,3-benzothiazole-7-sulfonic acid",CC1=C(C2=C(C=C1)N=C(S2)C3=CC(=C(C=C3)N=NC(C(=O)C)C(=O)NC4=CC=C(C5=CC=CC=C54)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
2434,162435,Americium-241 citrate,C(C(=O)O)C(CC(=O)O)(C(=O)O)O.[241Am],,,,,,
2435,162436,Tetradec-9-en-1-amine,CCCCC=CCCCCCCCCN,,,,,,
2436,162437,"1H-Pyrrolo(1,2-c)imidazole-1,3(2H)-dione, tetrahydro-, (S)-",C1C[C@H]2C(=O)NC(=O)N2C1,,,,,,
2437,162438,"Ammonium Bicarbonate, FCC",C(=O)([O-])[O-].C(=O)([O-])[O-].C(=O)([O-])[O-].[NH4+].[NH4+].[Zn+2].[Zn+2],,,,,,
2438,162439,"1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-5-(2-(methylamino)ethyl)-, monohydrochloride",CNCCN1C2=CC=CC=C2SC(C(C1=O)O)C3=CC=C(C=C3)OC.Cl,,,,,,
2439,162440,O-Desacetyl-N-desmethyl Diltiazem,CNCCN1C2=CC=CC=C2SC(C(C1=O)O)C3=CC=C(C=C3)OC,,,,,,
2440,162441,(Bis((trifluoromethyl)sulfonyl)methyl)benzene,C1=CC=C(C=C1)C(S(=O)(=O)C(F)(F)F)S(=O)(=O)C(F)(F)F,,,,,,
2441,162442,Propyl-3-hydroxypropylnitrosamine,CCCN(CCCO)N=O,,,,,,
2442,162443,16-Methylcyprenorphine,C[C@H]1C[C@]23[C@@H]4[C@]5(C=C[C@@]2(C[C@@H]5C(C)(C)O)C(N1CC6CC6)CC7=C3C(=C(C=C7)O)O4)OC,,,,,,
2443,162444,CID 162444,CC(C)[C@]1(CC2=CC(=O)CC[C@@]2(C3C1C4CC[C@]([C@]4(CC3)C)(CCC(=O)O)O)C)C(=O)[O-].[K+],,,,,,
2444,162445,"(7S,10R,13S,17R)-17-(2-carboxyethyl)-17-hydroxy-10,13-dimethyl-3-oxo-7-propan-2-yl-1,2,6,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthrene-7-carboxylic acid",CC(C)[C@]1(CC2=CC(=O)CC[C@@]2(C3C1C4CC[C@]([C@]4(CC3)C)(CCC(=O)O)O)C)C(=O)O,,,,,,
2445,162446,Deisopropylngaione,CC(=O)C[C@]1(CC[C@H](O1)C2=COC=C2)C,,,,,,
2446,162447,CID 162447,C[C@@H]([C@]1(CC[C@]2([C@@]1([C@@H](C[C@H]3C2(CC=C4[C@@]3(CC[C@@H](C4)O)C)O)OC(=O)C=CC5=CC=CC=C5)C)O)O)OC(=O)C6=CN=CC=C6,,,,,,
2447,162448,"4-methoxy-N-[2-(1,3,3-trimethylindol-1-ium-2-yl)ethenyl]aniline;sulfate",CC1(C2=CC=CC=C2[N+](=C1C=CNC3=CC=C(C=C3)OC)C)C.CC1(C2=CC=CC=C2[N+](=C1C=CNC3=CC=C(C=C3)OC)C)C.[O-]S(=O)(=O)[O-],,,,,,
2448,162449,S-(2-Hydroxy-5-nitrobenzyl)-6-thioguanosine,C1=CC(=C(C=C1[N+](=O)[O-])CSC2=NC(=NC3=C2N=CN3[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N)O,,,,,,
2449,162450,"2',3'-Dideoxy-3'-fluorouridine",C1[C@@H]([C@H](O[C@H]1N2C=CC(=O)NC2=O)CO)F,,,,,,
2450,162451,"1,8-Dimethylfluoren-9-one",CC1=C2C(=CC=C1)C3=CC=CC(=C3C2=O)C,,,,,,
2451,162452,"1,2,3,4,4a,5,6,7-Octahydro-2,5,5-trimethyl-2-naphthol",CC1(CCC=C2C1CCC(C2)(C)O)C,,,,,,
2452,162453,"Disodium 7,7'-(carbonyldiimino)bis(3-((4-(acetylamino)phenyl)azo)-4-hydroxynaphthalene-2-sulphonate)",CC(=O)NC1=CC=C(C=C1)N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=CC(=C(C(=C5C=C4)O)N=NC6=CC=C(C=C6)NC(=O)C)S(=O)(=O)O)S(=O)(=O)O.[Na+].[Na+],,,,,,
2453,162454,3-[(E)-(4-acetamidophenyl)azo]-7-[[6-[(E)-(4-acetamidophenyl)azo]-5-hydroxy-7-sulfo-2-naphthyl]carbamoylamino]-4-hydroxy-naphthalene-2-sulfonic acid,CC(=O)NC1=CC=C(C=C1)N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=CC(=C(C(=C5C=C4)O)N=NC6=CC=C(C=C6)NC(=O)C)S(=O)(=O)O)S(=O)(=O)O,,,,,,
2454,162455,"4-Hydroxy-3-undecylnaphthalene-1,2-dione",CCCCCCCCCCCC1=C(C2=CC=CC=C2C(=O)C1=O)O,,,,,,
2455,162456,"1,4-Benzenedisulfonic acid, 2,2'-[1,2-ethenediylbis[(3-sulfo-4,1-phenylene)imino(6-phenoxy-1,3,5-triazine-4,2-diyl)imino]]bis-, hexasodium salt",C1=CC=C(C=C1)OC2=NC(=NC(=N2)NC3=C(C=CC(=C3)S(=O)(=O)[O-])S(=O)(=O)[O-])NC4=CC(=C(C=C4)C=CC5=C(C=C(C=C5)NC6=NC(=NC(=N6)OC7=CC=CC=C7)NC8=C(C=CC(=C8)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,,,,,
2456,162457,"2-[[4-[4-[2-[4-[[4-(2,5-Disulfoanilino)-6-phenoxy-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]-3-sulfoanilino]-6-phenoxy-1,3,5-triazin-2-yl]amino]benzene-1,4-disulfonic acid",C1=CC=C(C=C1)OC2=NC(=NC(=N2)NC3=C(C=CC(=C3)S(=O)(=O)O)S(=O)(=O)O)NC4=CC(=C(C=C4)C=CC5=C(C=C(C=C5)NC6=NC(=NC(=N6)OC7=CC=CC=C7)NC8=C(C=CC(=C8)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
2457,162458,Methyl N-formylanthranilate,COC(=O)C1=CC=CC=C1NC=O,,,,,,
2458,162459,"C.I. Solvent Green 1, acetate salt",CC(=O)[O-].CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=CC=C3,,,,,,
2459,162460,"2-((4-(2,2-Dicyanovinyl)-3-methylphenyl)ethylamino)ethyl methyl terephthalate",CCN(CCOC(=O)C1=CC=C(C=C1)C(=O)OC)C2=CC(=C(C=C2)C=C(C#N)C#N)C,,,,,,
2460,162461,4-methoxy-2-methyl-N-phenylaniline,CC1=C(C=CC(=C1)OC)NC2=CC=CC=C2,,,,,,
2461,162462,cis-(Oxalatodiammine)platinum(II),C(=O)(C(=O)[O-])[O-].N.N.[Pt+2],,,,,,
2462,162463,"3-((4-((5,6-Dichlorobenzothiazol-2-yl)azo)phenyl)methylamino)propiononitrile",CN(CCC#N)C1=CC=C(C=C1)N=NC2=NC3=CC(=C(C=C3S2)Cl)Cl,,,,,,
2463,162464,Cirsilineol,COC1=C(C=CC(=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC)OC)O)O,,,,,,
2464,162465,"[1,1'-Biphenyl]-4-carbonitrile, 4'-(hexyloxy)-",CCCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C#N,,,,,,
2465,162466,"Benzo(3,4)furo(3',4':6,7)cycloocta(1,2-f)(1,3)benzodioxol-3(1H)-one, 3a,4,14,14a-tetrahydro-14-hydroxy-6,7,8-trimethoxy-, stereoisomer",COC1=C(C(=C2C(=C1)CC3C(COC3=O)C(C4=CC5=C(C=C42)OCO5)O)OC)OC,,,,,,
2466,162467,"(2S,3R,5R,9R,10R,11R,13R,17S)-2,3,11,14-tetrahydroxy-10,13-dimethyl-17-[(2R,3R)-2,3,6-trihydroxy-6-methylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one",C[C@]12C[C@H]([C@H]3C(=CC(=O)[C@H]4[C@@]3(C[C@@H]([C@@H](C4)O)O)C)C1(CC[C@@H]2[C@](C)([C@@H](CCC(C)(C)O)O)O)O)O,,,,,,
2467,162468,"2-Propenamide, 2-methyl-N-[4-(phenylamino)phenyl]-",CC(=C)C(=O)NC1=CC=C(C=C1)NC2=CC=CC=C2,,,,,,
2468,162469,"2-[(6aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]acetamide;2,3-dihydroxybutanedioate",CN1CC(CC2[C@H]1CC3=CNC4=CC=CC2=C34)CC(=O)N.C(C(C(=O)[O-])O)(C(=O)[O-])O,,,,,,
2469,162470,"2-[(6aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]acetamide",CN1CC(CC2[C@H]1CC3=CNC4=CC=CC2=C34)CC(=O)N,,,,,,
2470,162471,"Platinum, diamminebis(nitrato-kappaO)-, (SP-4-2)-",N.N.[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Pt+2],,,,,,
2471,162472,CID 162472,CCCCCCCCCCCCOC(=O)C(CC(=O)NCCO)S(=O)(=O)[O-].[Na+],,,,,,
2472,162473,"1-(Dodecyloxy)-4-[(2-hydroxyethyl)amino]-1,4-dioxobutane-2-sulfonic acid",CCCCCCCCCCCCOC(=O)C(CC(=O)NCCO)S(=O)(=O)O,,,,,,
2473,162474,"Acetamide, N,N'-[1,2-ethanediylbis(imino-2,1-ethanediyl)]bis[2-cyano-, hydrochloride",C(CNCCNC(=O)CC#N)NCCNC(=O)CC#N.Cl,,,,,,
2474,162475,"N,N'-[1,2-Ethanediylbis(imino-2,1-ethanediyl)]bis(2-cyanoacetamide)",C(CNCCNC(=O)CC#N)NCCNC(=O)CC#N,,,,,,
2475,162476,"1-(3,4-Epoxy-4-methylpentyl)-1-methylallyl acetate",CC(=O)OC(C)(CCC1C(O1)(C)C)C=C,,,,,,
2476,162477,"myo-Inositol 1,2,3-trisphosphate",[C@H]1([C@H](C([C@H]([C@@H](C1O)O)OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)O,,,,,,
2477,162478,CID 162478,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@H](C(=O)[O-])N)I)I)O.[Na+],,,,,,
2478,162479,"3,7-Dimethylocten-2-ol",CC(C)CCCC(C)C(=C)O,,,,,,
2479,162480,Diethylene glycol dihexanoate,CCCCCC(=O)OCCOCCOC(=O)CCCCC,,,,,,
2480,162481,"Octahydro-7-methyl-1,4-methanonaphthalen-6(2H)-one",CC1CC2C3CCC(C3)C2CC1=O,,,,,,
2481,162482,CID 162482,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)[O-])S(=O)(=O)N)Cl.[Na+],,,,,,
2482,162483,"Chromate(1-), bis(2-((4,5-dihydro-3-methyl-5-(oxo-kappaO)-1-phenyl-1H-pyrazol-4-yl)azo-kappaN1)benzoato(2-)-kappaO)-, sodium",CC1=NN(C(=C1N=NC2=CC=CC=C2C(=O)[O-])[O-])C3=CC=CC=C3.CC1=NN(C(=C1N=NC2=CC=CC=C2C(=O)[O-])[O-])C3=CC=CC=C3.[Na+].[Cr+3],,,,,,
2483,162484,CID 162484,CC1=CC2=CC3=CC(=CC(=O)C3=C(C2=C(O1)O)O)OC,,,,,,
2484,162485,"(2R,3R)-2-(3,4-dimethoxyphenyl)-7-methoxy-3-methyl-5-prop-1-enyl-2,3-dihydro-1-benzofuran",CC=CC1=CC2=C(C(=C1)OC)O[C@H]([C@@H]2C)C3=CC(=C(C=C3)OC)OC,,,,,,
2485,162486,"(19,20,22,23,25-Pentaacetyloxy-26-hydroxy-3,15,26-trimethyl-6,16-dioxo-2,5,17-trioxa-11-azapentacyclo[16.7.1.01,21.03,24.07,12]hexacosa-7(12),8,10-trien-21-yl)methyl acetate",CC1CCC2=C(C=CC=N2)C(=O)OCC3(C4C(C(C5(C(C(C(C(C5(C4OC(=O)C)O3)(C)O)OC1=O)OC(=O)C)OC(=O)C)COC(=O)C)OC(=O)C)OC(=O)C)C,,,,,,
2486,162487,CID 162487,CCCCCCCCN(CCCCCCCC)C(=S)[S-].[Na+],,,,,,
2487,162488,Dioctylcarbamodithioic acid,CCCCCCCCN(CCCCCCCC)C(=S)S,,,,,,
2488,162489,"Propanoic acid, 2-(4-dibenzofuranyloxy)-2-methyl-, ethyl ester",CCOC(=O)C(C)(C)OC1=CC=CC2=C1OC3=CC=CC=C23,,,,,,
2489,162490,O-(2-Hydroxyethyl)choline iodide,C[N+](C)(C)CCOCCO.[I-],,,,,,
2490,162491,O-(2-Hydroxyethyl)choline,C[N+](C)(C)CCOCCO,,,,,,
2491,162492,"8-(2,2-Dimethoxyethoxy)-2,6-dimethyloct-2-ene",CC(CCC=C(C)C)CCOCC(OC)OC,,,,,,
2492,162493,(2-Phenylethoxy)acetaldehyde,C1=CC=C(C=C1)CCOCC=O,,,,,,
2493,162494,"1-Hydroxy-2-[(1-hydroxy-4-imino-5,5-dimethylimidazol-2-yl)diazenyl]-5,5-dimethylimidazol-4-imine",CC1(C(=N)N=C(N1O)N=NC2=NC(=N)C(N2O)(C)C)C,,,,,,
2494,162495,"Cyclo(O-methyltyrosine-L-isoleucine-L-pipecolic acid-2-amino-8-oxo-9,10-epoxydecanoic acid)",CC[C@H](C)C1C(=O)N2CCCC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](C(=O)N1)CC3=CC=C(C=C3)OC)CCCCCC(=O)C4CO4,,,,,,
2495,162496,Cain quinolinium,CC[N+]1=CC=C(C=C1)NC2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)NC4=C5C=C(C=CC5=[N+](C=C4)CC)N.[Br-].[Br-],,,,,,
2496,162497,4-[(6-amino-1-ethylquinolin-1-ium-4-yl)amino]-N-[4-[(1-ethylpyridin-1-ium-4-yl)amino]phenyl]benzamide,CC[N+]1=CC=C(C=C1)NC2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)NC4=C5C=C(C=CC5=[N+](C=C4)CC)N,,,,,,
2497,162498,Dihydrotestosterone glucuronide,C[C@]12CCC3C(C1CC[C@H]2O[C@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)C(=O)O)O)O)O)CCC5[C@@]3(CCC(=O)C5)C,,,,,,
2498,162499,CID 162499,CC(=O)C(=C(NC1=CC=CC=C1OC)O)N=O,,,,,,
2499,162500,2-Penten-1-yl acetate,CCC=CCOC(=O)C,,,,,,
2500,162501,3'-Deoxy-3'-aminothymidine monophosphate,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)O)N,,,,,,
2501,162502,"(6S,7S,8R,10R,13S,14S,17R)-6-hydroxy-10,13-dimethyl-7-methylsulfanylspiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,5'-oxolane]-2',3-dione",C[C@]12CCC3[C@H]([C@@H]1CC[C@@]24CCC(=O)O4)[C@@H]([C@H](C5=CC(=O)CC[C@]35C)O)SC,,,,,,
2502,162503,"Phosphonic acid, (1-hydroxyethylidene)bis-, compd. with 2-aminoethanol",CC(O)(P(=O)(O)O)P(=O)(O)O.C(CO)N,,,,,,
2503,162504,Dodecyl decanoate,CCCCCCCCCCCCOC(=O)CCCCCCCCC,,,,,,
2504,162505,Hexyl palmitate,CCCCCCCCCCCCCCCC(=O)OCCCCCC,,,,,,
2505,162506,Hexadecyl docosanoate,CCCCCCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC,,,,,,
2506,162507,Ammonium 3-oxo-3h-phenoxazin-7-olate,C1=CC2=C(C=C1[O-])OC3=CC(=O)C=CC3=N2.[NH4+],,,,,,
2507,162508,"1,2:5,6-Dianhydro-d-glucitol",C1[C@@H](O1)[C@H]([C@@H]([C@@H]2CO2)O)O,,,,,,
2508,162509,CID 162509,CN1C(=C2C=C(C(=O)C3=CC=CC(=C32)C1=O)N=NC4=C(C=C(C=C4)[N+](=O)[O-])OC)O,,,,,,
2509,162510,CID 162510,CCN1C(=C2C=C(C(=O)C3=CC=CC(=C32)C1=O)N=NC4=C(C=C(C=C4)[N+](=O)[O-])OC)O,,,,,,
2510,162511,"Ethanone, 1-(3,3-dimethylbicyclo[2.2.1]hept-5-en-2-yl)-",CC(=O)C1C2CC(C1(C)C)C=C2,,,,,,
2511,162512,"1-(3,3-Dimethylbicyclo[2.2.1]hept-2-yl)ethan-1-one",CC(=O)C1C2CCC(C2)C1(C)C,,,,,,
2512,162513,CID 162513,CC(C)CCCCCOC(=O)CC[S-].CC(C)CCCCCOC(=O)CC[S-].C[Sn]C,,,,,,
2513,162514,Dibutyrylapomorphine,CCCC(=O)OC1=C(C2=C(C[C@@H]3C4=C(CCN3C)C=CC=C42)C=C1)OC(=O)CCC,,,,,,
2514,162515,"D-Glucose, polymer with 1,2-ethanediol and (2,2,2-trichloroethyl)oxirane",C1C(O1)CC(Cl)(Cl)Cl.C(CO)O.C([C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O)O,,,,,,
2515,162516,"Propanoic acid, 2-[[4-(4-chlorophenyl)-2-thiazolyl]oxy]-",CC(C(=O)O)OC1=NC(=CS1)C2=CC=C(C=C2)Cl,,,,,,
2516,162517,"2-Pyrrolidinecarbonitrile, 1-methyl-5-(3-pyridinyl)-",CN1C(CCC1C2=CN=CC=C2)C#N,,,,,,
2517,162518,N-(quinolin-5-yl)acetamide,CC(=O)NC1=CC=CC2=C1C=CC=N2,,,,,,
2518,162519,"[1,1'-Biphenyl]-4-ol, 3-(1,1-dimethylethyl)-",CC(C)(C)C1=C(C=CC(=C1)C2=CC=CC=C2)O,,,,,,
2519,162520,"[1,1'-Biphenyl]-4-ol, 3,4'-bis(1,1-dimethylethyl)-",CC(C)(C)C1=CC=C(C=C1)C2=CC(=C(C=C2)O)C(C)(C)C,,,,,,
2520,162521,CID 162521,C=CC=O.OS(=O)[O-].[Na+],,,,,,
2521,162522,2-Ketodoxapram,CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4=O,,,,,,
2522,162523,N(5)-Hydroxy-L-arginine,C(C[C@@H](C(=O)O)N)CN(C(=N)N)O,,,,,,
2523,162524,"D-Gluconic acid, compd. with 2,2',2''-nitrilotris[ethanol] (1:1)",C(CO)N(CCO)CCO.C([C@H]([C@H]([C@@H]([C@H](C(=O)O)O)O)O)O)O,,,,,,
2524,162525,Ammonium valerate,CCCCC(=O)[O-].[NH4+],,,,,,
2525,162526,"1H-Benz[f]indene-1,3(2H)-dione, 2-(3-hydroxy-2-quinolinyl)-",C1=CC=C2C=C3C(=CC2=C1)C(=O)C(C3=O)C4=NC5=CC=CC=C5C=C4O,,,,,,
2526,162527,"2,2'-((4-((3,5-Dinitro-2-thienyl)azo)phenyl)imino)bisethyl diacetate",CC(=O)OCCN(CCOC(=O)C)C1=CC=C(C=C1)N=NC2=C(C=C(S2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
2527,162528,N-(4-ethylphenyl)-1-phenylmethanimine oxide,CCC1=CC=C(C=C1)[N+](=CC2=CC=CC=C2)[O-],,,,,,
2528,162529,1-Undecen-3-one,CCCCCCCCC(=O)C=C,,,,,,
2529,162530,Florenal,C1=CC=C2C(=C1)C3=C(C2=O)C=C(C=C3)C(=O)C=O,,,,,,
2530,162531,4-Fluorochalcone oxide,C1=CC=C(C=C1)C(=O)C2C(O2)C3=CC=C(C=C3)F,,,,,,
2531,162532,"Acetamide, N-[2-[(2-bromo-4,6-dinitrophenyl)azo]-4-methoxy-5-[(phenylmethyl)-2-propenylamino]phenyl]-",CC(=O)NC1=CC(=C(C=C1N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])[N+](=O)[O-])OC)N(CC=C)CC3=CC=CC=C3,,,,,,
2532,162533,"1-(2,2-Dimethoxyethyl)-4-methylbenzene",CC1=CC=C(C=C1)CC(OC)OC,,,,,,
2533,162534,1-(p-Dodecylanilino)anthraquinone,CCCCCCCCCCCCC1=CC=C(C=C1)NC2=CC=CC3=C2C(=O)C4=CC=CC=C4C3=O,,,,,,
2534,162535,5-Hydroxymethyl-3-(p-methoxyphenyl)-2-oxazolidinone,COC1=CC=C(C=C1)N2CC(OC2=O)CO,,,,,,
2535,162536,"[(3S,5S,10S,13S,17R)-17-hydroxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate",CC(=O)O[C@H]1C[C@@H]2CCC3C([C@]2(CC1[N+]4(CCCCC4)C)C)CC[C@]5(C3CC([C@@H]5O)[N+]6(CCCCC6)C)C,,,,,,
2536,162537,"Ethanol, 2-[[2-chloro-4-[(4-nitrophenyl)azo]phenyl]amino]-",C1=CC(=CC=C1N=NC2=CC(=C(C=C2)NCCO)Cl)[N+](=O)[O-],,,,,,
2537,162538,"1H-Indene-5-carboxamide, 2,3-dihydro-2-(3-hydroxy-2(1H)-quinolinylidene)-N,N-dimethyl-1,3-dioxo-",CN(C)C(=O)C1=CC2=C(C=C1)C(=O)C(=C2O)C3=NC4=CC=CC=C4C=C3O,,,,,,
2538,162539,Silver tert-dodecanethiolate,CCCCCCCCCC(C)(C)[S-].[Ag+],,,,,,
2539,162540,"3,6-Bis(2-diethylaminoethoxy)acridine trihydrochloride",CCN(CC)CCOC1=CC2=C(C=C1)C=C3C=CC(=CC3=N2)OCCN(CC)CC.Cl.Cl.Cl,,,,,,
2540,162541,"3,6-Bis(2-(diethylamino)ethoxy)acridine",CCN(CC)CCOC1=CC2=C(C=C1)C=C3C=CC(=CC3=N2)OCCN(CC)CC,,,,,,
2541,162542,Benzimidazol-2-one,C1=CC2=NC(=O)N=C2C=C1,,,,,,
2542,162543,CID 162543,CCCCCCCCC=CCCCCCCCC(=O)O.CCCCCCCCC=CCCCCCCCC(=O)O.C[Sn]C.C[Sn]C.O,,,,,,
2543,162544,CID 162544,C1=CC=C(C=C1)NN=C2C(=CC3=C(C2=O)C(=N)C(=NNC4=CC=C(C=C4)C(=O)NC5=CC=C(C=C5)N=NC6=C(C=C(C=C6)O)N)C(=C3)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
2544,162545,CID 162545,C1=CC=C(C=C1)NN=C2C(=CC3=C(C2=O)C(=N)C(=NNC4=CC=C(C=C4)C(=O)NC5=CC=C(C=C5)N=NC6=C(C=C(C=C6)O)N)C(=C3)S(=O)(=O)O)S(=O)(=O)O,,,,,,
2545,162546,"Butanedioic acid, sulfo-, 1-[1-methyl-2-[(1-oxo-9-octadecenyl)amino]ethyl] ester, disodium salt",CCCCCCCCC=CCCCCCCCC(=O)NCC(C)OC(=O)C(CC(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
2546,162547,4-{[1-(Octadec-9-enoylamino)propan-2-yl]oxy}-4-oxo-3-sulfobutanoic acid,CCCCCCCCC=CCCCCCCCC(=O)NCC(C)OC(=O)C(CC(=O)O)S(=O)(=O)O,,,,,,
2547,162548,Zopiclone N-oxide,C[N+]1(CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl)[O-],,,,,['N-oxide-zopiclone is a known human metabolite of Zoplicone and eszopiclone.'],
2548,162549,"2-Propenoic acid, 1,2,2,6,6-pentamethyl-4-piperidinyl ester",CC1(CC(CC(N1C)(C)C)OC(=O)C=C)C,,,,,,
2549,162550,"2,6,10,14,19,23,27,31-Octamethyldotriacontane",CC(C)CCCC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)CCCC(C)C,,,,,,
2550,162551,Iodonium thiophene,C1=CSC(=C1)[I+]C2=CC=CS2,,,,,,
2551,162552,8-Hydroxydebrisoquin,C1CN(CC2=C1C=CC=C2O)C(=N)N,,,,,,
2552,162553,CID 162553,C1=CC=NC(=C1)C=NNC2=CC=CC=N2.[Cl-].[Cl-].[Cu+2],,,,,,
2553,162554,4-[Bis(2-chloroethyl)amino]phenyl dihydrogen phosphate,C1=CC(=CC=C1N(CCCl)CCCl)OP(=O)(O)O,,,,,,
2554,162555,Iodo(triphenylphosphino)copper,C1=CC=C(C=C1)P(C2=CC=CC=C2)C3=CC=CC=C3.[Cu+].[I-],,,,,,
2555,162556,Cromanidin,CC1=C(C(=C(C2=C1OC(CC2)(C)C)C)OCCN=C(N)N)C,,,,,,
2556,162557,CID 162557,CC=C1C[N+]2([C@H]3C[C@H]1[C@H](C2CC4=C3NC5=C4C=C(C=C5)O)CO)C,,,,,,
2557,162558,Desmethylazelastine,C1CC(CCNC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,,,,,,
2558,162559,"(1R,9R,10S,13S,14R,16S,18R)-15-[3-(diethylamino)-2-hydroxypropyl]-13-ethyl-8-methyl-8-aza-15-azoniahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol",CC[C@@H]1[C@H]([N+]2([C@H]3CC1C4[C@@H]2C[C@@]5([C@H]3N(C6=CC=CC=C65)C)[C@@H]4O)CC(CN(CC)CC)O)O,,,,,,
2559,162560,Di-para-toluoylisoproterenol,CC1=CC=C(C=C1)C(=O)OC2=C(C=C(C=C2)C(CNC(C)C)O)OC(=O)C3=CC=C(C=C3)C,,,,,,
2560,162561,(Au(Dppe)2)Cl,C1=CC=C(C=C1)P(CCP(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4.C1=CC=C(C=C1)P(CCP(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4.[Au+],,,,,,
2561,162562,Vasoactive intestinal peptide (22-28),CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(C=C1)O)N,,,,,,
2562,162563,Tetracyanonickelate,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[Ni+2],,,,,,
2563,162564,"2-Propenoic acid, 2-[[(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)sulfonyl]methylamino]ethyl ester",CN(CCOC(=O)C=C)S(=O)(=O)CCC(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
2564,162565,2-Chloro-ATP,C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)Cl)N,,,,,,
2565,162566,2-Methyloct-2-enal,CCCCCC=C(C)C=O,,,,,,
2566,162567,Scytalone,C1[C@H](CC(=O)C2=C1C=C(C=C2O)O)O,,,,,,
2567,162568,CID 162568,C1=CC=C2C(=C1)N=C(S2)SCCCS(=O)(=O)[O-].[Na+],,,,,,
2568,162569,"1-Propanesulfonic acid, 3-(2-benzothiazolylthio)-",C1=CC=C2C(=C1)N=C(S2)SCCCS(=O)(=O)O,,,,,,
2569,162570,"Cyclohexanecarboxylic acid, 1-phenyl-, 1-azabicyclo(2.2.2)oct-3-yl ester, hydrochloride",C1CCC(CC1)(C2=CC=CC=C2)C(=O)OC3CN4CCC3CC4.Cl,,,,,,
2570,162571,1-Azabicyclo[2.2.2]octan-3-yl 1-phenylcyclohexane-1-carboxylate,C1CCC(CC1)(C2=CC=CC=C2)C(=O)OC3CN4CCC3CC4,,,,,,
2571,162572,"2-Imidazolidinone, 4,5-dihydroxy-1-(hydroxymethyl)-3-octadecyl-",CCCCCCCCCCCCCCCCCCN1C(C(N(C1=O)CO)O)O,,,,,,
2572,162573,Poly(d(C-T)),CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)OC3C[C@@H](O[C@@H]3COP(=O)(O)O)N4C=CC(=NC4=O)N)O,,,,,,
2573,162574,Triethanolamine palmitate,CCCCCCCCCCCCCCCC(=O)O.C(CO)N(CCO)CCO,,,,,,
2574,162575,"1-Ethyl-1,2-dihydro-6-hydroxy-4-methyl-5-[(2-nitrophenyl)azo]-2-oxonicotinonitrile",CCN1C(=C(C(=C(C1=O)N=NC2=CC=CC=C2[N+](=O)[O-])C)C#N)O,,,,,,
2575,162576,"2-(2-Methoxyethoxy)ethyl 4-[(5-cyano-1-ethyl-1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridin-3-yl)azo]benzoate",CCN1C(=C(C(=C(C1=O)N=NC2=CC=C(C=C2)C(=O)OCCOCCOC)C)C#N)O,,,,,,
2576,162577,"2-Naphthalenol, 1-[(4-methoxy-2-nitrophenyl)azo]-",COC1=CC(=C(C=C1)N=NC2=C(C=CC3=CC=CC=C32)O)[N+](=O)[O-],,,,,,
2577,162578,"Phenol, 4,4'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[2-methyl-",CC1=C(C=CC(=C1)N=NC2=C(C=C(C=C2)C3=CC(=C(C=C3)N=NC4=CC(=C(C=C4)O)C)Cl)Cl)O,,,,,,
2578,162579,Kayahope,CCCSC1=C(C=CC(=C1)OC2=CC=C(C=C2)[N+](=O)[O-])Cl,,,,,,
2579,162580,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-[bis(2-hydroxypropyl)amino]-6-[(4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-, dipotassium disodium salt",CC(CN(CC(C)O)C1=NC(=NC(=N1)NC2=CC(=C(C=C2)C=CC3=C(C=C(C=C3)NC4=NC(=NC(=N4)NC5=CC=C(C=C5)S(=O)(=O)[O-])N(CC(C)O)CC(C)O)S(=O)(=O)[O-])S(=O)(=O)[O-])NC6=CC=C(C=C6)S(=O)(=O)[O-])O.[Na+].[Na+].[K+].[K+],,,,,,
2580,162581,Prorenoate,C[C@]12CCC(=O)C=C1[C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@]5([C@H]4CC[C@]5(CCC(=O)O)O)C,,,,,,
2581,162582,"Cyclopentanol, 1-((1,1-dimethylethyl)azo)-, (E)-",CC(C)(C)N=NC1(CCCC1)O,,,,,,
2582,162583,"1(3H)-Isobenzofuranone, 3,3-bis(1-butyl-2-methyl-1H-indol-3-yl)-",CCCCN1C(=C(C2=CC=CC=C21)C3(C4=CC=CC=C4C(=O)O3)C5=C(N(C6=CC=CC=C65)CCCC)C)C,,,,,,
2583,162584,"1(3H)-Isobenzofuranone, 3,3-bis(2-methyl-1-octyl-1H-indol-3-yl)-",CCCCCCCCN1C(=C(C2=CC=CC=C21)C3(C4=CC=CC=C4C(=O)O3)C5=C(N(C6=CC=CC=C65)CCCCCCCC)C)C,,,,,,
2584,162585,"(8,20-Dihydro-8,20-diphenyl-5,24:12,17-diimino-7,10:22,19-dinitrilodibenz(f,p)(1,2,4,9,11,12,14,19)octaazacycloicosinato(2-)-N25,N26,N27,N28)iron",C1=CC=C(C=C1)N2C3=NC(=N2)N=C4C5=CC=CC=C5C(=NC6=NC(=NN6C7=CC=CC=C7)N=C8C9=CC=CC=C9C(=N3)[N-]8)[N-]4.[Fe+2],,,,,,
2585,162586,"4,18-Diphenyl-2,4,5,7,16,18,19,21,29,30,31,32-dodecazaheptacyclo[20.6.1.13,6.18,15.117,20.09,14.023,28]dotriaconta-1,3(32),6,8(31),9,11,13,15,17(30),20,22(29),23,25,27-tetradecaene",C1=CC=C(C=C1)N2C3=NC(=NC4=NC(=NC5=NC(=NC6=NC(=N3)C7=CC=CC=C76)NN5C8=CC=CC=C8)C9=CC=CC=C94)N2,,,,,,
2586,162587,"N,N-Diethylglycyl-N-(2,6-dimethylphenyl)glycinamide",CCN(CC)CC(=O)NC(=O)CNC1=C(C=CC=C1C)C,,,,,,
2587,162588,"1,4-Naphthalenedione, 2-(bromomethyl)-3-methyl-",CC1=C(C(=O)C2=CC=CC=C2C1=O)CBr,,,,,,
2588,162589,"2H-Pyran-2-one, 4-methyl-6-(1-methylethyl)-",CC1=CC(=O)OC(=C1)C(C)C,,,,,,
2589,162590,2-Acetylaminoquinoline,CC(=O)NC1=NC2=CC=CC=C2C=C1,,,,,,
2590,162591,"7-[(3,7-Dimethylocta-2,6-dienyl)oxy]-4-methyl-2-benzopyrone",CC1=CC(=O)OC2=C1C=CC(=C2)OCC=C(C)CCC=C(C)C,,,,,,
2591,162592,3-(Acetyloxy)-17-hydroxy-16-(1-methylpiperidin-1-ium-1-yl)-2-(piperidin-1-yl)androstane bromide,CC(=O)O[C@H]1C[C@@H]2CCC3C([C@]2(C[C@@H]1N4CCCCC4)C)CC[C@]5(C3C[C@@H]([C@@H]5O)[N+]6(CCCCC6)C)C.[Br-],,,,,,
2592,162593,"[(2S,3S,5S,10S,13S,16S,17R)-17-hydroxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate",CC(=O)O[C@H]1C[C@@H]2CCC3C([C@]2(C[C@@H]1N4CCCCC4)C)CC[C@]5(C3C[C@@H]([C@@H]5O)[N+]6(CCCCC6)C)C,,,,,,
2593,162594,CID 162594,C1=NC2=C(N=CN(C2=N1)CCO)N,,,,,,
2594,162595,Methyl 2-[(2-methylpentylidene)amino]benzoate,CCCC(C)C=NC1=CC=CC=C1C(=O)OC,,,,,,
2595,162596,3-(2-Carboxyethyl)cytosine,C1=C(N(C(=O)N=C1)CCC(=O)O)N,,,,,,
2596,162597,(2-((3-Methyl-2-butenyl)oxy)ethyl)benzene,CC(=CCOCCC1=CC=CC=C1)C,,,,,,
2597,162598,Neopybuthrin,CCCCOCCOCCOCC1=CC2=C(C=C1CCC)OCO2.CC1=C(C(=O)CC1OC(=O)C2C(C2(C)C)C=C(C)C)CC=C.CC(=C[C@H]1[C@@](C1(C)C)(C2=COC(=C2)CC3=CC=CC=C3)C(=O)OC)C,,,,,,
2598,162599,"methyl (1R,3R)-1-(5-benzylfuran-3-yl)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate",CC(=C[C@H]1[C@@](C1(C)C)(C2=COC(=C2)CC3=CC=CC=C3)C(=O)OC)C,,,,,,
2599,162600,"N-((2,4-Dichlorophenoxy)acetyl)-L-tryptophan",C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)COC3=C(C=C(C=C3)Cl)Cl,,,,,,
2600,162601,"1-Piperidinyloxy, 4-((2-hydroxyethyl)dimethylammonio)-2,2,6,6-tetramethyl-",CC1(CC(CC(N1[O])(C)C)[N+](C)(C)CCO)C,,,,,,
2601,162602,Dopamine quinone,C1=CC(=O)C(=O)C=C1CCN,,,,,,
2602,162603,"D-Glucopyranose, pentakis(3,4,5-trihydroxybenzoate)",C1=C(C=C(C(=C1O)O)O)C(=O)OC[C@@H]2[C@H]([C@@H]([C@H](C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C(=C5)O)O)O)OC(=O)C6=CC(=C(C(=C6)O)O)O,,,,,,
2603,162604,O(6)-n-Butyldeoxyguanosine,CCCCOC1=NC(=NC2=C1N=CN2[C@H]3C[C@@H]([C@H](O3)CO)O)N,,,,,,
2604,162605,"6-(2-(2-Undecyl-1H-imidazol-1-yl)ethyl)-1,3,5-triazine-2,4-diamine",CCCCCCCCCCCC1=NC=CN1CCC2=NC(=NC(=N2)N)N,,,,,,
2605,162606,3-(4-Chlorophenyl)-1-(4-chlorophenylcarbamoyl)-2-pyrazoline,C1CN(N=C1C2=CC=C(C=C2)Cl)C(=O)NC3=CC=C(C=C3)Cl,,,,,,
2606,162607,8-Bromo-1-octanol,C(CCCCBr)CCCO,,,,,,
2607,162608,"[4,9-Dimethyl-14-methylidene-2-(2-methylprop-2-enoyloxy)-13-oxo-5,12-dioxatricyclo[9.3.0.04,6]tetradec-9-en-8-yl] 2-methylprop-2-enoate",CC1=CC2C(C(CC3(C(O3)CC1OC(=O)C(=C)C)C)OC(=O)C(=C)C)C(=C)C(=O)O2,,,,,,
2608,162609,"N-((2,4-Dichlorophenoxy)acetyl)-L-methionine",CSCC[C@@H](C(=O)O)NC(=O)COC1=C(C=C(C=C1)Cl)Cl,,,,,,
2609,162610,"Ethanediamide, N,N'-bis(cyclohexylthio)-N,N'-diphenyl-",C1CCC(CC1)SN(C2=CC=CC=C2)C(=O)C(=O)N(C3=CC=CC=C3)SC4CCCCC4,,,,,,
2610,162611,"2,7-Naphthalenedisulfonic acid, 3-hydroxy-4-[(4-sulfophenyl)azo]-, trisodium salt",C1=CC(=CC=C1N=NC2=C3C=CC(=CC3=CC(=C2O)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
2611,162612,"3-Oxo-4-[2-(4-sulfophenyl)hydrazinylidene]-3,4-dihydronaphthalene-2,7-disulfonic acid",C1=CC(=CC=C1N=NC2=C3C=CC(=CC3=CC(=C2O)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
2612,162613,"Benzoic acid, 3-amino-, ethyl ester, hydrochloride",CCOC(=O)C1=CC(=CC=C1)N.Cl,,,"['Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. (See all compounds classified as Anesthetics.)']",,,
2613,162614,"Benzenesulfonic acid, hydroxy-, polymer with formaldehyde",C=O.C1=CC=C(C(=C1)O)S(=O)(=O)O,,,,,,
2614,162615,"(2R,3S)-2-[(3,4-dihydroxyphenyl)methyl]-3-[3-(3,4-dihydroxyphenyl)prop-2-enoyloxy]-2-hydroxybutanedioic acid",C1=CC(=C(C=C1C[C@@]([C@@H](C(=O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O)(C(=O)O)O)O)O,,,,,,
2615,162616,Norpropyphenazone,CC1=C(C(=O)N(N1)C2=CC=CC=C2)C(C)C,,,,,,
2616,162617,2-Propylimidazole,CCCC1=NC=CN1,,,,,,
2617,162618,CID 162618,CC(C(C1=CC=CC=C1)O)N.CN(C)CCCC1=CC=CC=N1.C1=CC(=CC=C1OC(=O)C=CC(=O)O)Cl.Cl,,,,,,
2618,162619,8-Methyl-1-tetralone,CC1=C2C(=CC=C1)CCCC2=O,,,,,,
2619,162620,6-Methyl-1-tetralone,CC1=CC2=C(C=C1)C(=O)CCC2,,,,,,
2620,162621,CID 162621,C1=CC=C2C(=C1)C(=NC2=O)NC3=CC(=C(C=C3Cl)NC4=NC(=O)C5=CC=CC=C54)Cl,,,,,,
2621,162622,"5-[(2R,3R)-7-Methoxy-3-methyl-5-prop-1-enyl-2,3-dihydro-1-benzofuran-2-yl]-1,3-benzodioxole",CC=CC1=CC2=C(C(=C1)OC)O[C@H]([C@@H]2C)C3=CC4=C(C=C3)OCO4,,,,,,
2622,162623,"Titanium, bis((hydroxy-kappaO)acetato-kappaO)((hydroxy-kappaO)acetato(2-)-kappaO)-",C(C[O-])[O-].C(C(=O)[O-])O.C(C(=O)[O-])[O-].[Ti+4],,,,,,
2623,162624,"Benzenamine, 2-methyl-5-nitro-, monohydrochloride",CC1=C(C=C(C=C1)[N+](=O)[O-])N.Cl,,,,,,
2624,162625,"4-[10,15,20-Tris(4-hydroxyphenyl)-21,24-dihydroporphyrin-5-yl]phenol",C1=CC(=CC=C1C2=C3C=CC(=C(C4=CC=C(N4)C(=C5C=CC(=N5)C(=C6C=CC2=N6)C7=CC=C(C=C7)O)C8=CC=C(C=C8)O)C9=CC=C(C=C9)O)N3)O,,,,,,
2625,162626,2-Methylbutyl salicylate,CCC(C)COC(=O)C1=CC=CC=C1O,,,,,,
2626,162627,2-Methylbutyl butyrate,CCCC(=O)OCC(C)CC,,,,,,
2627,162628,Tri(2-Ethylhexanoyl)borate,B(OC(=O)C(CC)CCCC)(OC(=O)C(CC)CCCC)OC(=O)C(CC)CCCC,,,,,,
2628,162629,FDGal,C([C@H]([C@@H]([C@@H]([C@H](C=O)F)O)O)O)O,,,"['Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) (See all compounds classified as Radiopharmaceuticals.)']",,,
2629,162630,"Chromate(1-), bis(2-(3-chlorophenyl)-2,4-dihydro-4-((2-(hydroxy-kappaO)-5-(methylsulfonyl)phenyl)azo-kappaN1)-5-methyl-3H-pyrazol-3-onato(2-)-kappaO3)-, sodium",CC1=NN(C(=C1N=NC2=C(C=CC(=C2)S(=O)(=O)C)[O-])[O-])C3=CC(=CC=C3)Cl.CC1=NN(C(=C1N=NC2=C(C=CC(=C2)S(=O)(=O)C)[O-])[O-])C3=CC(=CC=C3)Cl.[Na+].[Cr+3],,,,,,
2630,162631,Benzamidomethyl benzylpenicillinate,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)OCNC(=O)C4=CC=CC=C4)C,,,,,,
2631,162632,Substance P (5-11),CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)N,,,,,,
2632,162633,CID 162633,C1=C(C=C(C=C1C(=O)[O-])S(=O)(=O)O)C(=O)O.C(CCCN)CCN.[Na+],,,,,,
2633,162634,1-(1H-Indol-4-yloxy)-3-(isopropylamino)propan-2-ol hydrochloride,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O.Cl,,,,,,
2634,162635,"2-Propenoic acid, 2-methyl-, 1,1'-((1-methyl-1,2-ethanediyl)bis(oxy(methyl-2,1-ethanediyl))) ester",CC(COCC(C)OC(=O)C(=C)C)OCC(C)OC(=O)C(=C)C,,,,,,
2635,162636,2-Amino-1H-benzo[d]imidazol-5-ol,C1=CC2=C(C=C1O)NC(=N2)N,,,,,,
2636,162637,Disodium tartrate,[C@@H]([C@H](C(=O)[O-])O)(C(=O)[O-])O.[Na+].[Na+],"['It acts as an emulsifier and pH control agent in food products,. In the laboratory, it is used while performing the Karl Fischer equation, which is used to determine the water content of various substances,.']",,,,,
2637,162638,CID 162638,CC(=O)OC1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C)C#C.C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC,,,,,,
2638,162639,"(8R,9S,13S,14S)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC,,,,,,
2639,162640,"[(8R,9S,10R,13S,14S)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate",CC(=O)OC1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C)C#C,,,,,,
2640,162641,Bis-(4-methylumbelliferyl)phosphate,CC1=CC(=O)OC2=C1C=CC(=C2)OP(=O)(O)OC3=CC4=C(C=C3)C(=CC(=O)O4)C,,,,,,
2641,162642,"Benzenesulfonamide, 4-amino-N-(5-hydroxy-4,6-dimethyl-2-pyrimidinyl)-",CC1=C(C(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C)O,,,,,,
2642,162643,6-Hydroxymethylsulfadimidine,CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)CO,,,,,,
2643,162644,Momilactone A,C[C@]1(CC[C@@H]2C(=C[C@@H]3[C@@H]4[C@@]2(CCC(=O)[C@@]4(C(=O)O3)C)C)C1)C=C,,,,,,
2644,162645,"4-Chloro-2-methylbenzenediazonium 1,5-naphthalenedisulphonate",CC1=C(C=CC(=C1)Cl)[N+]#N.C1=CC2=C(C=CC=C2S(=O)(=O)[O-])C(=C1)S(=O)(=O)[O-],,,,,,
2645,162646,Bis(2-hydroxyethyl)ammonium hexadecyl sulphate,CCCCCCCCCCCCCCCCOS(=O)(=O)O.C(CO)NCCO,,,,,,
2646,162647,Steviol acetate,CC(=O)O[C@@]12CC[C@H]3[C@@]4(CCC[C@@](C4CC[C@]3(C1)CC2=C)(C)C(=O)O)C,,,,,,
2647,162648,Ethamon DS,CC[N+](C)(CC)CN1CCN(C1=O)C[N+](C)(C2=CC=CC=C2)C3=CC=CC=C3.[O-]S(=O)(=O)[O-],,,,,,
2648,162649,Diethyl-methyl-[[3-[[methyl(diphenyl)azaniumyl]methyl]-2-oxoimidazolidin-1-yl]methyl]azanium,CC[N+](C)(CC)CN1CCN(C1=O)C[N+](C)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
2649,162650,"2,2-Dimethoxyacetaldehyde",COC(C=O)OC,,,,,,
2650,162651,Titanium oxide,[O-2].[O-2].[Ti+4],,,,"['Electron microscopy visualization and light microscopic investigations of three different application forms of titanium dioxide proved that neither surface characteristics, particle size nor shape of the micronized titanium dioxide result in any dermal absorption of this substance: Micronized titanium dioxide is solely deposited on the outermost surface of the stratum corneum and cannot be detected in deeper stratum corneum layers, the human epidermis and dermis.', 'There is increasing concern over the local and systemic side effects of TiO(2) and ZnO coated nanoparticles widely used in sun blockers. To determine the localization and possible skin penetration of TiO(2) and ZnO nanoparticles, dispersed in 3 sunscreen formulations, under realistic in vivo conditions in normal and altered skin. Nuclear microscopy techniques provided spatially resolved quantitative analysis of Ti and Zn nanoparticle distributions in transversal cryosections of skin obtained by biopsy with no further treatment. A test hydrophobic formulation containing coated 20-nm TiO(2) nanoparticles and 2 commercial sunscreen formulations containing TiO(2) alone or in combination with ZnO were tried, taking into account realistic use conditions by consumers and compared with the recommended standard condition for the sun protection factor test. The protocols consisted of an open test. Following a 2-hour exposure period of normal human skin to TiO(2)- and ZnO-containing sunscreens, detectable amounts of these physical blockers were only present at the skin surface and in the uppermost stratum corneum regions. Layers deeper than the stratum corneum were devoid of TiO(2) or exogenous ZnO, even after 48 hr of exposure to the sunscreen, under occlusion. Deposition of TiO(2) and ZnO nanoparticles in the openings of the pilosebaceous follicles was also observed, suggesting a preferential fixation area. Penetration of nanoparticles into viable skin tissue could not be detected. TiO(2) or ZnO nanoparticles are absent or their levels are too low to be tested under the stratum corneum in human viable epidermal layers. Therefore, significant penetration towards the underlying keratinocytes is unlikely.', 'The in vivo kinetics of nanoparticles is an essential to understand the hazard of nanoparticles. Here, the absorption, distribution, and excretion patterns of titanium dioxide (TiO2) and zinc oxide (ZnO) nanoparticles following oral administration were evaluated. Nanoparticles were orally administered to rats for 13 weeks (7 days/week). Samples of blood, tissues (liver, kidneys, spleen, and brain), urine, and feces were obtained at necropsy. The level of Ti or Zn in each sample was measured using inductively coupled plasma-mass spectrometry. TiO2 nanoparticles had extremely low absorption, while ZnO nanoparticles had higher absorption and a clear dose-response curve. Tissue distribution data showed that TiO2 nanoparticles were not significantly increased in sampled organs, even in the group receiving the highest dose (1041.5 mg/kg body weight). In contrast, Zn concentrations in the liver and kidney were significantly increased compared with the vehicle control. ZnO nanoparticles in the spleen and brain were minimally increased. Ti concentrations were not significantly increased in the urine, while Zn levels were significantly increased in the urine, again with a clear dose-response curve. Very high concentrations of Ti were detected in the feces, while much less Zn was detected in the feces. Compared with TiO2 nanoparticles, ZnO nanoparticles demonstrated higher absorption and more extensive organ distribution when administered orally. The higher absorption of ZnO than TiO2 nanoparticles might be due to the higher dissolution rate in acidic gastric fluid, although more thorough studies are needed.']",,
2651,162652,3-Nitrophthalonitrile,C1=CC(=C(C(=C1)[N+](=O)[O-])C#N)C#N,,,,,,
2652,162653,"Hydrochloric acid, compd. with 2-methyl-1,3-butadiene (1:1)",CC(=C)C=C.Cl,,,,,,
2653,162654,S-Benzyl dibutylthiocarbamate,CCCCN(CCCC)C(=O)SCC1=CC=CC=C1,,,,,,
2654,162655,CID 162655,C[C@H]1C[C@]23C(=O)[C@@H]([C@@H]([C@@H]4[C@@H](C4(C)C)[C@@H]([C@@H](C(=C[C@@]2([C@H]1OC(=O)C)O3)C)OC(=O)C)OC(=O)C)OC(=O)C)C,,,,,,
2655,162656,Phenylalanylproline,C1C[C@H](N(C1)C(=O)[C@@H](CC2=CC=CC=C2)N)C(=O)O,,,,,,
2656,162657,N-Butyl-N-(2-carboxyethyl)nitrosamine,CCCCN(CCC(=O)OC)N=O,,,,,,
2657,162658,"16-Azido-3-methoxyestra-1,3,5(10)-trien-17-one",C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H](C2=O)N=[N+]=[N-])CCC4=C3C=CC(=C4)OC,,,,,,
2658,162659,CID 162659,C[C@H]1C=CC=C(C(=O)N=C2C(=CN(N3CCN(CC3)C)O)C(=C4C(=C2O)C(=C(C5=C4C(=O)[C@](O5)(OC=C[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C,,,,,,
2659,162660,"2-Piperidinecarboxamide, 1-butyl-N-(4-hydroxy-2,6-dimethylphenyl)-",CCCCN1CCCCC1C(=O)NC2=C(C=C(C=C2C)O)C,,,,,,
2660,162661,CID 162661,COC1=C(C=CC(=C1)C(CO)O)O.[C@@H]1([C@@H]([C@H](O[C@H]([C@@H]1O)O)C(=O)O)O)O,,,,,,
2661,162662,"7-{[(4-Nitrobenzoyl)oxy]methyl}-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 4-nitrobenzoate",C1CN2CC=C(C2C1OC(=O)C3=CC=C(C=C3)[N+](=O)[O-])COC(=O)C4=CC=C(C=C4)[N+](=O)[O-],,,,,,
2662,162663,"(1R,9S,10S)-10-hydroxy-4,5,12,13-tetramethoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2,4,6,12-tetraen-11-one",CN1CC[C@]23CC(=C(C(=O)[C@]2([C@@H]1CC4=CC(=C(C=C34)OC)OC)O)OC)OC,,,,,,
2663,162664,"3alpha,17,20-Trihydroxy-11-oxopregnan-21-oic acid",C[C@]12CC[C@H](C[C@H]1CC[C@@H]3[C@@H]2C(=O)C[C@]4([C@H]3CC[C@@]4([C@H](C(=O)O)O)O)C)O,,,,,,
2664,162665,Cortolic acid,C[C@]12CC[C@H](C[C@H]1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4([C@@H](C(=O)O)O)O)C)O)O,,,,,,
2665,162666,Calurin,CC(=O)OC1=CC=CC=C1C(=O)O.C(=O)(N)N,,,"['Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)']",,,
2666,162667,"Methyl 3,4-diphenyl-2-furoate",COC(=O)C1=C(C(=CO1)C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
2667,162668,Zinc (2-ethylhexyl) acid phosphate,CCCCC(CC)CO.OP(=O)([O-])[O-].[Zn+2],,,,,,
2668,162669,Cyclodrine,CCN(CC)CCOC(=O)C(C1=CC=CC=C1)C2(CCCC2)O,,,,,,
2669,162670,Phleomycin A2,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,,,,,,
2670,162671,CID 162671,C1=CC=C(C=C1)NN=C2C(=CC3=C(C2=O)C(=N)C(=NNC4=CC=C(C=C4)S(=O)(=O)C5=CC=C(C=C5)N=NC6=C(C=C(C=C6)N)N)C(=C3)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
2671,162672,CID 162672,C1=CC=C(C=C1)NN=C2C(=CC3=C(C2=O)C(=N)C(=NNC4=CC=C(C=C4)S(=O)(=O)C5=CC=C(C=C5)N=NC6=C(C=C(C=C6)N)N)C(=C3)S(=O)(=O)O)S(=O)(=O)O,,,,,,
2672,162673,"2-Anthracenesulfonic acid, 9,10-dimethoxy-",COC1=C2C=CC(=CC2=C(C3=CC=CC=C31)OC)S(=O)(=O)O,,,,,,
2673,162674,"Platinum(II), diaqua(1,2-ethanediammine-N,N')-, (SP-4-2)-, dinitrate",C(CN)N.[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].O.O.[Pt+2],,,,,,
2674,162675,Hydrogen bis(1-((2-hydroxy-5-nitrophenyl)azo)-2-naphtholato(2-))chromate(1-),[H+].C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=CC(=C3)[N+](=O)[O-])[O-])[O-].C1=CC=C2C(=C1)C=CC(=O)C2=NN=C3C=C(C=CC3=O)N([O-])[O-].[Cr+3],,,,,,
2675,162676,Einecs 257-854-4,CC(C)(C1=CC=C(C=C1)OS(=O)(=O)C2=CC=CC(=C2)N=NC3=C(C=CC4=CC(=CC(=C43)O)S(=O)(=O)O)N)C5=CC=C(C=C5)OS(=O)(=O)C6=CC=CC(=C6)N=NC7=C(C=CC8=CC(=CC(=C87)O)S(=O)(=O)O)N.[Na+].[Na+],,,,,,
2676,162677,6-Amino-5-[[3-[4-[2-[4-[3-[(2-amino-8-hydroxy-6-sulfonaphthalen-1-yl)diazenyl]phenyl]sulfonyloxyphenyl]propan-2-yl]phenoxy]sulfonylphenyl]diazenyl]-4-hydroxynaphthalene-2-sulfonic acid,CC(C)(C1=CC=C(C=C1)OS(=O)(=O)C2=CC=CC(=C2)N=NC3=C(C=CC4=CC(=CC(=C43)O)S(=O)(=O)O)N)C5=CC=C(C=C5)OS(=O)(=O)C6=CC=CC(=C6)N=NC7=C(C=CC8=CC(=CC(=C87)O)S(=O)(=O)O)N,,,,,,
2677,162678,N-Desmethylcimetidine,CC1=C(N=CN1)CSCCN=C(N)NC#N,,,,,,
2678,162679,Seryl-adenylate,C1=NC(=C2C(=N1)N(C=N2)C3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OC(=O)[C@H](CO)N)O)O)N,,,,,,
2679,162680,Dipotassium azelate,C(CCCC(=O)[O-])CCCC(=O)[O-].[K+].[K+],,,"['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)', 'Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)']",,,
2680,162681,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(tritritiomethyl)pyrimidine-2,4-dione",[3H]C([3H])([3H])C1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)O,,,,,,
2681,162682,"1H-Pyrazol-4-aminium, 2,3-dihydro-3-oxo-N,N,N,1,5-pentamethyl-2-phenyl-, iodide",CC1=C(C(=O)N(N1C)C2=CC=CC=C2)[N+](C)(C)C.[I-],,,,,,
2682,162683,"Trimethyl[(1-phenyl-2,3-dimethyl-5-oxo-2,5-dihydro-1H-pyrazol)-4-yl]aminium",CC1=C(C(=O)N(N1C)C2=CC=CC=C2)[N+](C)(C)C,,,,,,
2683,162684,"5,5a-Dihydroxy-4-(hydroxymethyl)-1,1,7,9-tetramethyl-11-oxo-1a,2,5,5a,6,9,10,10a-octahydro-1H-2,8a-methanocyclopenta[a]cyclopropa[e][10]annulen-6-yl hexadecanoate",CCCCCCCCCCCCCCCC(=O)O[C@H]1C(=CC23[C@@]1([C@@H](C(=C[C@@H](C2=O)C4C(C4(C)C)C[C@H]3C)CO)O)O)C,,,,,,
2684,162685,N-Stearoyl GABA,CCCCCCCCCCCCCCCCCC(=O)NCCCC(=O)O,,,,,,
2685,162686,"2-Hydroxy-2',6'-diethylacetanilide",CCC1=C(C(=CC=C1)CC)NC(=O)CO,,,,,,
2686,162687,"Chromate(2-), (3-((4,5-dihydro-3-methyl-5-(oxo-kappaO)-1-phenyl-1H-pyrazol-4-yl)azo-kappaN)-4-(hydroxy-kappaO)benzenesulfonato(3-))(1-((2-(hydroxy-kappaO)-5-(phenylazo)phenyl)azo-kappaN1)-2-naphthalenolato(2-)-kappaO)-, disodium",CC1=NN(C(=C1N=NC2=C(C=CC(=C2)S(=O)(=O)[O-])[O-])[O-])C3=CC=CC=C3.C1=CC=C(C=C1)N=NC2=CC(=C(C=C2)[O-])N=NC3=C(C=CC4=CC=CC=C43)[O-].[Na+].[Na+].[Cr+3],,,,,,
2687,162688,4-hydroxy-3-[(5-methyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)diazenyl]benzenesulfonic acid,CC1=C(C(=O)N(N1)C2=CC=CC=C2)N=NC3=C(C=CC(=C3)S(=O)(=O)O)O,,,,,,
2688,162689,1-[2-[2-Hydroxy-5-(2-phenyldiazenyl)phenyl]diazenyl]-2-naphthalenol,C1=CC=C(C=C1)N=NC2=CC(=C(C=C2)O)N=NC3=C(C=CC4=CC=CC=C43)O,,,,,,
2689,162690,Borjatriol,C[C@]12CCCC([C@@H]1C[C@@H]([C@@]3([C@@H]2CC[C@](O3)(C)[C@@H](CO)O)C)O)(C)C,,,,,,
2690,162691,"[5-[[6-[(6-Acetamido-3-aminohexanoyl)amino]-3-aminohexanoyl]amino]-4-hydroxy-2-(hydroxymethyl)-6-[(7-hydroxy-4-oxo-1,3a,5,6,7,7a-hexahydroimidazo[4,5-c]pyridin-2-yl)amino]oxan-3-yl] carbamate",CC(=O)NCCCC(CC(=O)NCCCC(CC(=O)NC1C(C(C(OC1NC2=NC3C(N2)C(CNC3=O)O)CO)OC(=O)N)O)N)N,,,,,,
2691,162692,"6,7-Dihydroxy-1-methyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid",CC1C2=CC(=C(C=C2CC(N1)C(=O)O)O)O,,,,,,
2692,162693,Amobarbital mixture with Glutethimide,CCC1(CCC(=O)NC1=O)C2=CC=CC=C2.CCC1(C(=O)NC(=O)NC1=O)CCC(C)C,,,,,,
2693,162694,Monodansylthiacadaverine,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NCCSCCN,,,,,,
2694,162695,"LHRH, Lys(6)-",CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,,,,,,
2695,162696,(Sulfobromophthalein)glutathione conjugate,C1=CC(=C(C=C1C2(C3=C(C(=C(C(=C3Br)Br)Br)Br)C(=O)O2)C4=CC(=C(C=C4)O)S(=O)(=O)[O-])S(=O)(=O)[O-])O.C(CC(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C(=O)O)N.[Na+].[Na+],,,,,,
2696,162697,"1,3-Propanediamine, N-(2,3-dihydro-1H-inden-2-yl)-N'-ethyl-N-phenyl-",CCNCCCN(C1CC2=CC=CC=C2C1)C3=CC=CC=C3,,,,,['Desethylaprindine is a known human metabolite of Aprindine.'],
2697,162698,Argopsin,CC1=C2C(=C(C(=C1Cl)O)C=O)OC3=C(C(=C(C(=C3OC2=O)C)OC)Cl)C,,,,,,
2698,162699,Psoberan,COC1=C2C=CC(=O)OC2=CC3=C1C=CO3.C1=CC(=O)OC2=CC3=C(C=CO3)C=C21,,,,,,
2699,162700,"Benzo(g)(1)benzothiopyrano(4,3-b)indole, 2-fluoro-",C1=CC=C2C(=C1)C=CC3=C2N=C4C3=CSC5=C4C=C(C=C5)F,,,,,,
2700,162701,"Benzo(e)(1)benzothiopyrano(4,3-b)indole, 2-fluoro-",C1=CC=C2C(=C1)C=CC3=C2C4=CSC5=C(C4=N3)C=C(C=C5)F,,,,,,
2701,162702,"Benzo(g)(1)benzothiopyrano(4,3-b)indole, 3-fluoro-",C1=CC=C2C(=C1)C=CC3=C2N=C4C3=CSC5=C4C=CC(=C5)F,,,,,,
2702,162703,"Benzo(e)(1)benzothiopyrano(4,3-b)indole, 3-fluoro-",C1=CC=C2C(=C1)C=CC3=C2C4=CSC5=C(C4=N3)C=CC(=C5)F,,,,,,
2703,162704,"Benzo(g)(1)benzothiopyrano(4,3-b)indole, 4-fluoro-",C1=CC=C2C(=C1)C=CC3=C2N=C4C3=CSC5=C4C=CC=C5F,,,,,,
2704,162705,"Benzo(e)(1)benzothiopyrano(4,3-b)indole, 4-fluoro-",C1=CC=C2C(=C1)C=CC3=C2C4=CSC5=C(C4=N3)C=CC=C5F,,,,,,
2705,162706,"4-Trifluoromethyl-6H-benzo(e)(1)benzothiopyrano(4,3-b)indole",C1C2=C(C3=C(S1)C(=CC=C3)C(F)(F)F)NC4=C2C5=CC=CC=C5C=C4,,,,,,
2706,162707,delta9-Tetrahydrocannabinol hemisuccinate,CCCCCC1=CC2=C([C@@H]3C=C(CC[C@H]3C(O2)(C)C)C)C(=C1)OC(=O)CCC(=O)O,,,,,,
2707,162708,"(1r,8r,9s,10r,14s)-13-Ethyl-17-ethynyl-17-hydroxy-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl acetate(non-preferred name)",CCC12CC[C@H]3[C@H]([C@@H]1CCC2(C#C)O)CCC4=CC(=O)C[C@H]([C@H]34)OC(=O)C,,,,,,
2708,162709,"[(5S,8R,9S,10S,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] N,N-bis(2-chloroethyl)carbamate",C[C@]12CCC(=O)C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4OC(=O)N(CCCl)CCCl)C,,,,,,
2709,162710,"Chromate(3-), bis(3-(hydroxy-kappaO)-4-((2-(hydroxy-kappaO)-1-naphthalenyl)azo-kappaN1)-7-nitro-1-naphthalenesulfonato(3-))-, trihydrogen",[H+].[H+].[H+].C1=CC=C2C(=C1)C=CC(=C2N=NC3=C4C=CC(=CC4=C(C=C3[O-])S(=O)(=O)[O-])[N+](=O)[O-])[O-].C1=CC=C2C(=C1)C=CC(=O)C2=NN=C3C4=C(C=C(C=C4)N([O-])[O-])C(=CC3=O)S(=O)(=O)[O-].[Cr+3],,,,,,
2710,162711,Bccho,C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC(=O)N4)C)OC(=O)CC5=CC=C(C=C5)N(CCCl)CCCl,,,,,,
2711,162712,Fenbendazoleamine,C1=CC=C(C=C1)SC2=CC3=C(C=C2)N=C(N3)N,,,,,,
2712,162713,Methyltrichloroplatinate(2-),[CH3-].[Cl-].[Cl-].[Cl-].[Pt+2],,,,,,
2713,162714,"5,10-Dihydromirex",C12C3(C(C4(C1(C5(C4(C3(C2(C5(Cl)Cl)Cl)Cl)Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
2714,162715,"(1S,9R,11S,22R)-9,11-dihydroxy-22-methyl-6,23-dioxa-26-thia-2,17,27-triazatricyclo[17.5.2.14,7]heptacosa-4,7(27),12,14,19-pentaene-3,18,24-trione",C[C@@H]1CC=C2C(=O)NCC=CC=C[C@H](C[C@H](CC3=NC(=CO3)C(=O)N[C@H](CS2)C(=O)O1)O)O,,,,,,
2715,162716,CID 162716,CC1=CCCC(C1C=CC(=CC=CC(=CCOC(=O)C)C)C)(C)C,,,,,,
2716,162717,"(1S,15R)-8-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,12-tetraen-15-ol;pyridin-4-amine;hydrobromide;hydrochloride",CN1CC[C@@]23C[C@@H](CC=C2OC4=CC(=CC(=C34)C1)OC)O.C1=CN=CC=C1N.Cl.Br,,,,,,
2717,162718,"(1S,15R)-8-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,12-tetraen-15-ol",CN1CC[C@@]23C[C@@H](CC=C2OC4=CC(=CC(=C34)C1)OC)O,,,,,,
2718,162719,alpha-Ethylstreptozotocin,CCO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)NC(=O)N(C)N=O,,,,,,
2719,162720,beta-Propylstreptozotocin,CCCO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)NC(=O)N(C)N=O,,,,,,
2720,162721,alpha-Butylstreptozotocin,CCCCO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)NC(=O)N(C)N=O,,,,,,
2721,162722,beta-Butylstreptozotocin,CCCCO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)NC(=O)N(C)N=O,,,,,,
2722,162723,"2,6-Dichloro-n-[2,6-dinitro-4-(trifluoromethyl)phenyl]-4-nitroaniline",C1=C(C=C(C(=C1[N+](=O)[O-])NC2=C(C=C(C=C2Cl)[N+](=O)[O-])Cl)[N+](=O)[O-])C(F)(F)F,,,,,,
2723,162724,CID 162724,C1CCC(CC1)[SnH](C2CCCCC2)C3=CC=CC=C3.O,,,,,,
2724,162725,CID 162725,C1CCC(CC1)[SnH](C2CCCCC2)C3=CC=CC=C3,,,,,,
2725,162726,CID 162726,C1=C(C(=CC(=C1Cl)Cl)Cl)S(=O)(=O)[O-].[Na+],,,,,,
2726,162727,"3-Hydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,8a,9,12,12a,12b,13,14,14a-decahydropicen-2(6bh)-one",CC1=CCC2(CCC3(C4=CC=C5C(=C(C(=O)C=C5C4(CCC3(C2C1)C)C)O)C)C)C,,,,,,
2727,162728,Copper-glycyl-glycyl-histidine,C1=C(NC=N1)CC(C(=O)[O-])N=C(CN=C(CN)[O-])[O-].[Cu+2],,,,,,
2728,162729,Oxoprenolol glucuronide,CC(C)NCC(COC1=CC=CC=C1OCC=C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O,,,,,['Oxprenolol glucuronide is a known human metabolite of Oxoprenolol.'],
2729,162730,"2',4'-Difluorobiphenyl-4-acetic acid",C1=CC(=CC=C1CC(=O)O)C2=C(C=C(C=C2)F)F,,,,,,
2730,162731,CID 162731,CCOCC[O-].CCOCC[O-].CCOC(=CC(=O)C)[O-].[Al+3],,,,,,
2731,162732,CID 162732,CC(=O)OC1=CC=CC=C1C(=O)O.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.C(=O)(O)[O-].[Na+],,,,,,
2732,162733,Aspirin softam,CC(=O)OC1=CC=CC=C1C(=O)O.C(C(=O)[O-])N.C(=O)([O-])[O-].[OH-].[OH-].[Mg+2].[Al+3],,,,,,
2733,162734,"p,p'-Diaminoquaterphenyl",C1=CC(=CC=C1C2=CC=C(C=C2)C3=CC=C(C=C3)N)C4=CC=C(C=C4)N,,,,,,
2734,162735,"N,N,N',N'-Tetraethyldiaminoquaterphenyl",CCN(CC)C1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C4=CC=C(C=C4)N(CC)CC,,,,,,
2735,162736,"(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol;sulfate",C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)O)N.[O-]S(=O)(=O)[O-],,,,,,
2736,162737,CID 162737,C1[C@H]([C@H](C([C@@H]([C@@H]1N)O[C@@H]2[C@@H](C([C@H]([C@@H](O2)CN)O)O)N)O[C@@H]3[C@@H]([C@H]([C@@H](O3)CO)O)O)O)N,,,,,,
2737,162738,2-(2-Hydroxyethylamino)ethanol benzoate,C1=CC=C(C=C1)C(=O)[O-].C(CO)NCCO,,,,,,
2738,162739,Aristolactam BII,COC1=C(C2=C3C(=C1)C(=O)NC3=CC4=CC=CC=C42)OC,,,,,,
2739,162740,"ethyl (1R,2S)-2-amino-1-phenylcyclohex-3-ene-1-carboxylate",CCOC(=O)[C@]1(CCC=C[C@@H]1N)C2=CC=CC=C2,,,,,,
2740,162741,"(2R,3S,4R,5R,6S)-2-(hydroxymethyl)-6-[(2R)-6-methyl-2-[(6R,10R,12S,13R,14R,17S)-3,6,12-trihydroxy-4,4,10,14,17-pentamethyl-2,3,5,6,7,8,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol",CC(=CCC[C@](C)([C@]1(CC[C@]2([C@H]1[C@H](CC3C2C[C@H](C4[C@@]3(CCC(C4(C)C)O)C)O)O)C)C)O[C@H]5[C@@H]([C@@H]([C@@H]([C@H](O5)CO)O)O)O)C,,,,,,
2741,162742,Berlocombin,CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N.COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,,,,,,
2742,162743,Cloranolol hydrochloride,CC(C)(C)NCC(COC1=C(C=CC(=C1)Cl)Cl)O.Cl,,,"['Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)', 'Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)']",,,
2743,162744,3-Deazauridine 5'-triphosphate,C1C(=O)C=CN(C1=O)[C@@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O,,,,,,
2744,162745,Chlorohyssopifolin E,CC(CO)(C(=O)OC1CC(=C)C2CC(C(C2C3C1C(=C)C(=O)O3)(CCl)O)O)O,,,,,,
2745,162746,3-Phenyl-1-pyridin-3-ylprop-2-en-1-ol,C1=CC=C(C=C1)C=CC(C2=CN=CC=C2)O,,,,,,
2746,162747,"2,7,7-Trimethylbicyclo[3.1.1]hept-2-en-6-yl acetate",CC1=CCC2C(C1C2(C)C)OC(=O)C,,,,,,
2747,162748,"Piperidine, 4-(5-chloro-2-benzofuranyl)-1-methyl-, hydrochloride",CN1CCC(CC1)C2=CC3=C(O2)C=CC(=C3)Cl.Cl,,,,,,
2748,162749,Sercloremine,CN1CCC(CC1)C2=CC3=C(O2)C=CC(=C3)Cl,,,,,,
2749,162750,"1-(5-Chloro-2-hydroxyphenyl)-5-trifluoromethyl-1,3-dihydro-2-benzimidazol-2-one",[Ti].[Ti].[Ti].[V].[V].[V].[Mo].[Mo].[Mo].[Mo].[W].[W].[W].[W].[W].[W].[W].[W].[W].[W],,,,,,
2750,162751,"(2S)-2-amino-2-[(4S,5R)-3-chloro-4-hydroxy-4,5-dihydro-1,2-oxazol-5-yl]acetic acid",[C@@H]1([C@H](ON=C1Cl)[C@@H](C(=O)O)N)O,,,,,,
2751,162752,Pyromellitic acid 2-phenyl-2-imidazoline salt (1:2),C1CN=C(N1)C2=CC=CC=C2.C1CN=C(N1)C2=CC=CC=C2.C1=C(C(=CC(=C1C(=O)O)C(=O)O)C(=O)O)C(=O)O,,,,,,
2752,162753,"5-N,5-N,13-N,13-N-tetramethyl-2-iodoniatricyclo[8.4.0.03,8]tetradeca-1(10),3(8),4,6,11,13-hexaene-5,13-diamine;formate",CN(C)C1=CC2=C(CC3=C([I+]2)C=C(C=C3)N(C)C)C=C1.C(=O)[O-],,,,,,
2753,162754,"methyl 2-[(8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoacetate",C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)C(=O)OC)CCC4=CC(=O)C=C[C@]34C)O,,,,,,
2754,162755,"3-amino-N-[2-(3,4-dihydroxyphenyl)ethyl]propanamide",C1=CC(=C(C=C1CCNC(=O)CCN)O)O,,,,,,
2755,162756,CID 162756,CC1C2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O,,,,,,
2756,162757,N-isobutyleicosadienamide,CCCCCCCCCCCCCCCC=CC=CC(=O)NCC(C)C,,,,,,
2757,162758,CID 162758,CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C=C(C=C3)N)N)C)NN=C4C(=CC5=C(C4=N)C(=O)C(=NNC6=CC=CC=C6)C(=C5)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
2758,162759,CID 162759,CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C=C(C=C3)N)N)C)NN=C4C(=CC5=C(C4=N)C(=O)C(=NNC6=CC=CC=C6)C(=C5)S(=O)(=O)O)S(=O)(=O)O,,,,,,
2759,162760,Cyclosidimine,C1CCC(CC1)C(=O)NC2=C[N+](=NO2)N3CCOCC3.Cl.[Cl-],,,,,,
2760,162761,"Acetic acid, ((trimethylstannyl)thio)-, isooctyl ester",CC(C)CCCCCOC(=O)CS[Sn](C)(C)C,,,,,,
2761,162762,Citrulline malate,C(C[C@@H](C(=O)O)N)CNC(=O)N.C(C(C(=O)O)O)C(=O)O,,,,,,
2762,162763,cyclo[N(Me)Ala-Leu-D-N(Me)Phe-Gly],C[C@H]1C(=O)N[C@H](C(=O)N([C@@H](C(=O)NCC(=O)N1C)CC2=CC=CC=C2)C)CC(C)C,,,,,,
2763,162764,CID 162764,C1=CC(=CC=C1C=CC2=CC=C(O2)[N+](=O)[O-])C(=O)[O-].[Na+],,,,,,
2764,162765,Methyl 4-aminobenzenecarbodithioate,CSC(=S)C1=CC=C(C=C1)N,,,,,,
2765,162766,Mefenamic acid diethylaminoethyl ester,CCN(CC)CCOC(=O)C1=CC=CC=C1NC2=CC=CC(=C2C)C.Cl,,,,,,
2766,162767,"Diethylaminoethyl 2-[(2,3-dimethylphenyl)amino]benzoate",CCN(CC)CCOC(=O)C1=CC=CC=C1NC2=CC=CC(=C2C)C,,,,,,
2767,162768,"N-(4,6-dimethylpyrimidin-2-yl)-4-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]benzenesulfonamide",CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C,,,,,,
2768,162769,Brinerdine,C[C@@H]1CCC[C@@H](N1NC(=O)C2=CC(=C(C=C2)Cl)S(=O)(=O)N)C.CC(C)[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C.CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC.CS(=O)(=O)[O-],,,,,,
2769,162770,"4-(3,5-Dichloroanilino)-4-oxobut-2-enoic acid",C1=C(C=C(C=C1Cl)Cl)NC(=O)C=CC(=O)O,,,,,,
2770,162771,Trimethyl-beta-cyclodextrin,COC[C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3OC)OC)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4OC)OC)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5OC)OC)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6OC)OC)O[C@@H]7[C@H](O[C@@H]([C@@H]([C@H]7OC)OC)O[C@@H]8[C@H](O[C@H](O2)[C@@H]([C@H]8OC)OC)COC)COC)COC)COC)COC)COC)OC)OC,,,,,,
2771,162772,CID 162772,CCC(=CC[C@@H]1[C@@H](C[C@@H]([C@@H](O1)CC=CC#C)Cl)Br)Br,,,,,,
2772,162773,CID 162773,C[C@@H]1[C@H]([C@]2([C@H]3[C@H]4[C@@]1([C@@H]5C=C(C(=O)[C@]5([C@@H]([C@@]6([C@H]4O6)CO)O)O)C)O[C@](O3)(O2)C7=CC=CC=C7)C(=C)C)OC(=O)C=CC8=CC=CC=C8,,,,,,
2773,162774,"Stannane, (((diethylamino)thioxomethyl)thio)tris(phenylmethyl)-",CCN(CC)C(=S)S[Sn](CC1=CC=CC=C1)(CC2=CC=CC=C2)CC3=CC=CC=C3,,,,,,
2774,162775,Dichromium copper diiron heptaoxide,[O-2].[O-2].[O-2].[O-2].[Cr+3].[Fe+3].[Cu+2],,,,,,
2775,162776,"(6R,7R)-7-[[2-amino-2-(1,3-benzodioxol-5-yl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)C(C3=CC4=C(C=C3)OCO4)N)SC1)C(=O)O,,,,,,
2776,162777,"(3z)-3-Imino-8,9-dimethoxy-5,6-dihydro[1,3]thiazolo[4,3-a]isoquinoline-1-carbonitrile",COC1=C(C=C2C(=C1)CCN3C2=C(SC3=N)C#N)OC,,,,,,
2777,162778,CID 162778,COC(=O)CCCOCC[C@H]1[C@H](C[C@H]([C@@H]1C=CC(CCC2=CC=CC=C2)O)O)O,,,,,,
2778,162779,"2-Propenoic acid, 2-methyl-, butyl ester, polymer with ethenylbenzene, methyl 2-methyl-2-propenoate and oxiranylmethyl 2-methyl-2-propenoate",CCCCOC(=O)C(=C)C.CC(=C)C(=O)OC.CC(=C)C(=O)OCC1CO1.C=CC1=CC=CC=C1,,,,,,
2779,162780,Pannarin,CC1=CC(=C(C2=C1OC3=C(C(=C(C(=C3C(=O)O2)C)Cl)O)C=O)C)OC,,,,,,
2780,162781,"Coenzyme A, sodium salt",CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H](C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCS)O.[Na+],,,,,,
2781,162782,"[[(2R,3S,4R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-(2-sulfanylethylamino)propyl]amino]butyl] hydrogen phosphate",CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H](C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCS)O,,,,,,
2782,162783,Pentizidone,CC(=CC(=O)C)N[C@@H]1CONC1=O,,,,,,
2783,162784,"4-(8-Amino-1,2,3,4-tetrahydro-2-methyl-4-isoquinolinyl)phenol",CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=C(C=C3)O,,,,,,
2784,162785,CID 162785,CCCN(CC(=O)[O-])S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F.[K+],,,,,,
2785,162786,N-Propyl-N-(heptadecafluorooctylsulfonyl)glycine,CCCN(CC(=O)O)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
2786,162787,CID 162787,C#CCS(=O)(=O)[O-].[Na+],,,,,,
2787,162788,2-Propyne-1-sulfonic acid,C#CCS(=O)(=O)O,,,,,,
2788,162789,AM Toxin II,C[C@H]1C(=O)O[C@H](C(=O)N[C@H](C(=O)NC(=C)C(=O)N1)CCCC2=CC=CC=C2)C(C)C,,,,,,
2789,162790,Coleon O,CC1CC12C(C(=O)C3=C(C2=O)C(C(C4C3(CCC(=C4C)C)C)O)OC(=O)C)O,,,,,,
2790,162791,Potassium titanium fluoride,[F-].[F-].[F-].[F-].[F-].[K+].[Ti+4],,,,,,
2791,162792,Ethyl 4-(2-(t-butylcarbonyloxy)butoxy)benzoate,CCC(COC1=CC=C(C=C1)C(=O)OCC)OC(=O)C(C)(C)C,,,,,,
2792,162793,N-((5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)valine,C[C@@H]1CC2=C(C=C(C(=C2C(=O)O1)O)C(=O)N[C@@H](C(C)C)C(=O)O)Cl,,,,,,
2793,162794,CID 162794,C1C[C@H]([C@@H]2[C@@]34[C@@H]1[C@H](CC5=C3C(=C(C=C5)O)O2)N(CC4)CC6CC6)N=[N+]=[N-],,,,,,
2794,162795,2-(2-Chloro-6-methylphenylamino)-2-imidazoline nitrate,CC1=C(C(=CC=C1)Cl)NC2=NCCN2.[N+](=O)(O)[O-],,,,,,
2795,162796,"N-(2-chloro-6-methylphenyl)-4,5-dihydro-1H-imidazol-2-amine",CC1=C(C(=CC=C1)Cl)NC2=NCCN2,,,,,,
2796,162797,1-Propyl-3-methyl-7-(5-hydroxyhexyl)xanthine,CCCN1C(=O)C2=C(N=CN2CCCCC(C)O)N(C1=O)C,,,,,,
2797,162798,4-(2-(Diethylamino)ethoxy)-alpha-ethyl-alpha-phenylbenzenemethanol,CCC(C1=CC=CC=C1)(C2=CC=C(C=C2)OCCN(CC)CC)O,,,,,,
2798,162799,Chinotilin,C1=CC=C2C(=C1)C=CC=[N+]2CCOC(=O)CCC(=O)OCC[N+]3=CC=CC4=CC=CC=C43.[I-].[I-],,,,,,
2799,162800,Bis(2-quinolin-1-ium-1-ylethyl) butanedioate,C1=CC=C2C(=C1)C=CC=[N+]2CCOC(=O)CCC(=O)OCC[N+]3=CC=CC4=CC=CC=C43,,,,,,
2800,162801,"Ethanol, 2-amino-, sulfate (salt)",C(CO)N.OS(=O)(=O)O,,,,,,
2801,162802,"Hexamethylenediamine tetra(methylene phosphonic acid), sodium salt",C(CCCN(CP(=O)(O)O)CP(=O)(O)O)CCN(CP(=O)(O)O)CP(=O)(O)O.[Na+],,,,,,
2802,162803,"Chromate(2-), (2,4-dihydro-4-((2-hydroxy-5-nitrophenyl)azo)-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-2-hydroxy-5-nitrobenzenesulfonato(3-))-, disodium",CC1=NN(C(=C1N=NC2=C(C=CC(=C2)[N+](=O)[O-])[O-])[O-])C3=CC=CC=C3.CC1=NN(C(=O)C1=NN=C2C=C(C=C(C2=O)S(=O)(=O)[O-])N([O-])[O-])C3=CC=CC=C3.[Na+].[Na+].[Cr+3],,,,,,
2803,162804,Vinylglyoxylate,C=CC(=O)C(=O)O,,,,,,
2804,162805,Methylenecyclopropyl acetyl-coa,CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H](C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCSC(=O)CC4CC4=C)O,,,,,,
2805,162806,"(Ethylenebis(nitrilobis(methylene)))tetrakisphosphonic acid, ammonium salt",C(CN(CP(=O)(O)O)CP(=O)(O)O)N(CP(=O)(O)O)CP(=O)(O)O.N,,,,,,
2806,162807,Glyceollin,CC1(C=CC2=C(O1)C=CC3=C2OC[C@@]4([C@H]3OC5=C4C=CC(=C5)O)O)C,,,,,,
2807,162808,"Chromate(2-), (3-((4,5-dihydro-3-methyl-5-(oxo-kappaO)-1-phenyl-1H-pyrazol-4-yl)azo-kappaN1)-2-(hydroxy-kappaO)-5-nitrobenzenesulfonato(3-))(3-((4,5-dihydro-3-methyl-5-(oxo-kappaO)-1-phenyl-1H-pyrazol-4-yl)azo-kappaN1)-4-(hydroxy-kappaO)-N-phenylbenzenesulfonamidato(2-))-, disodium",CC1=NN(C(=C1N=NC2=C(C=CC(=C2)S(=O)(=O)NC3=CC=CC=C3)[O-])[O-])C4=CC=CC=C4.CC1=NN(C(=C1N=NC2=C(C(=CC(=C2)[N+](=O)[O-])S(=O)(=O)[O-])[O-])[O-])C3=CC=CC=C3.[Na+].[Na+].[Cr+3],,,,,,
2808,162809,5-Hydroxy-4-(2-hydroxy-5-anilinosulfonylphenylazo)-3-methyl-1-phenyl-1H-pyrazole,CC1=C(C(=O)N(N1)C2=CC=CC=C2)N=NC3=C(C=CC(=C3)S(=O)(=O)NC4=CC=CC=C4)O,,,,,,
2809,162810,Aluminum zirconium chloride hydroxide,[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Zr+4].[Zr+4],,,,,,
2810,162811,N-Nitrosodesipramine,CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)N=O,,,,,,
2811,162812,Desacetylmetipranolol,CC1=CC(=C(C(=C1O)C)C)OCC(CNC(C)C)O,,,,,,
2812,162813,Sodium bis(1-((2-hydroxy-3-nitro-5-tert-pentylphenyl)azo)-2-naphtholato(2-))chromate(1-),CCC(C)(C)C1=CC(=C(C(=C1)[N+](=O)[O-])[O-])N=NC2=C(C=CC3=CC=CC=C32)[O-].CCC(C)(C)C1=CC(=NN=C2C(=O)C=CC3=CC=CC=C32)C(=O)C(=C1)N([O-])[O-].[Na+].[Cr+3],,,,,,
2813,162814,CID 162814,CCC(C)(C)C1=CC(=NN=C2C(=O)C=CC3=CC=CC=C32)C(=O)C(=C1)N(O)O,,,,,,
2814,162815,"1-[[5-(Dioxidoamino)-3-(2-methylbutan-2-yl)-6-oxocyclohexa-2,4-dien-1-ylidene]hydrazinylidene]naphthalen-2-one",CCC(C)(C)C1=CC(=NN=C2C(=O)C=CC3=CC=CC=C32)C(=O)C(=C1)N([O-])[O-],,,,,,
2815,162816,Heptaminol 5'-adenylate,CC(CCCC(C)(C)O)N.C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)N,,,,,,
2816,162817,8-Hydroxymianserin,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2C=CC(=C4)O,,,,,['8-Hydroxymianserin is a known human metabolite of Mianserine.'],
2817,162818,4-((1-Methylethyl)amino)-1-(1-naphthalenyloxy)-2-butanol,CC(C)NCCC(COC1=CC=CC2=CC=CC=C21)O,,,,,,
2818,162819,"1-(2,3-Dichlorophenoxy)-4-((1-methylethyl)amino)-2-butanol",CC(C)NCCC(COC1=C(C(=CC=C1)Cl)Cl)O,,,,,,
2819,162820,Cotyledoside,CC1C(C2(C(C(O1)OC3CC4CC5C6(O5)C(C4(CC3O2)C)CCC7(C6(CCC7C8=COC(=O)C=C8)O)C)O)OC)O,,,,,,
2820,162821,Mepifiline,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(=O)O.CN(C)CCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2,,,,,,
2821,162822,"2-Octadecanone, 3-hydroxy-",CCCCCCCCCCCCCCCC(C(=O)C)O,,,,,,
2822,162823,8-O-Acetyl shanzhiside methyl ester,CC(=O)O[C@]1(C[C@H]([C@H]2[C@@H]1[C@@H](OC=C2C(=O)OC)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)C,,,,,,
2823,162824,Resiniferonol,C[C@@H]1C[C@]([C@@H]([C@H]2[C@]1([C@@H]3C=C(C(=O)[C@]3(CC(=C2)CO)O)C)O)O)(C(=C)C)O,,,,,,
2824,162825,Lincospectin,C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)NC)O)O.C[C@H]([C@H]([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)SC)O)O)O)NC(=O)[C@@H]2C[C@H](CN2C)C(C)C)O.OS(=O)(=O)O,,,,,,
2825,162826,CID 162826,C[C@H]([C@H]([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)SC)O)O)O)NC(=O)[C@@H]2CC(CN2C)C(C)C)O,,,,,,
2826,162827,"1-(4-(3-Chlorophenyl)-1-(3-(4-methyl-1-piperazinyl)propyl)-4-piperidinyl)-1-pentanone, trihydrochloride",CCCCC(=O)C1(CCN(CC1)CCCN2CCN(CC2)C)C3=CC(=CC=C3)Cl.Cl.Cl.Cl,,,,,,
2827,162828,1-[4-(3-Chlorophenyl)-1-[3-(4-methylpiperazin-1-yl)propyl]piperidin-4-yl]pentan-1-one,CCCCC(=O)C1(CCN(CC1)CCCN2CCN(CC2)C)C3=CC(=CC=C3)Cl,,,,,,
2828,162829,"Trisodium 5-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(1-sulphonato-2-naphthyl)azo]naphthalene-2,7-disulphonate",C1=CC=C2C(=C1)C=CC(=C2S(=O)(=O)[O-])N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)[O-])S(=O)(=O)[O-])NC5=NC(=NC(=N5)Cl)Cl)O.[Na+].[Na+].[Na+],,,,,,
2829,162830,CID 162830,C1=CC(=CC(=C1)OS(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)NC(=O)C2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)C(=O)[O-].[K+],,,,,,
2830,162831,"2,3,4,5-Tetrachloro-6-[[[3-[[(1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctyl)sulfonyl]oxy]phenyl]amino]carbonyl]benzoic acid",C1=CC(=CC(=C1)OS(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)NC(=O)C2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)C(=O)O,,,,,,
2831,162832,"1,6-Dihydro-1-methyl-2-pyridinecarboxaldehyde oxime",CN1CC=CC=C1C=NO,,,,,,
2832,162833,p-Acrylamidobenzoic acid 2-(diethylamino)ethyl ester,CCN(CC)CCOC(=O)C1=CC=C(C=C1)NC(=O)C=C,,,,,,
2833,162834,CID 162834,CN1CC(=O)N=C1NC(=O)NC2=CC(=CC=C2)Cl,,,,,,
2834,162835,Dehydronorketamine,C1CC(C(=O)C=C1)(C2=CC=CC=C2Cl)N,,,,,,
2835,162836,1'-Hydroxybufuralol,CC(C1=CC=CC2=C1OC(=C2)C(CNC(C)(C)C)O)O,,,,,,
2836,162837,"[4-(Hydroxymethyl)-8-methyl-12-methylidene-13-oxo-3,14-dioxatricyclo[9.3.0.02,4]tetradec-7-en-10-yl] 4-hydroxy-2-methylbut-2-enoate",CC1=CCCC2(C(O2)C3C(C(C1)OC(=O)C(=CCO)C)C(=C)C(=O)O3)CO,,,,,,
2837,162838,"2,4-Dinitro-N-(2,4,6-tribromophenyl)-6-(trifluoromethyl)aniline",C1=C(C=C(C(=C1C(F)(F)F)NC2=C(C=C(C=C2Br)Br)Br)[N+](=O)[O-])[N+](=O)[O-],,,,,,
2838,162839,Clopyralid-olamine,C1=CC(=NC(=C1Cl)C(=O)O)Cl.C(CO)N,,,,,,
2839,162840,AM Toxin III,CC1C(=O)OC(C(=O)NC(C(=O)NC(=C)C(=O)N1)CCCC2=CC=C(C=C2)O)C(C)C,,,,,,
2840,162841,Piperazine sultosylate,CC1=CC=C(C=C1)S(=O)(=O)OC2=CC(=C(C=C2)O)S(=O)(=O)O.C1CNCCN1,,,,,,
2841,162842,"Cuprate(3-), (4-amino-6-((6-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-2-(hydroxy-kappaO)-4-sulfo-1-naphthalenyl)azo-kappaN1)-5-(hydroxy-kappaO)-1,3-naphthalenedisulfonato(5-))-, trisodium",C1=CC2=C(C(=CC(=C2C=C1NC3=NC(=NC(=N3)N)Cl)S(=O)(=O)[O-])[O-])N=NC4=C(C5=C(C=C4)C(=CC(=C5N)S(=O)(=O)[O-])S(=O)(=O)[O-])[O-].[Na+].[Na+].[Na+].[Cu+2],,,,,,
2842,162843,"4-Amino-6-({6-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-2-hydroxy-4-sulfonaphthalen-1-yl}diazenyl)-5-hydroxynaphthalene-1,3-disulfonic acid",C1=CC2=C(C(=CC(=C2C=C1NC3=NC(=NC(=N3)N)Cl)S(=O)(=O)O)O)N=NC4=C(C5=C(C=C4)C(=CC(=C5N)S(=O)(=O)O)S(=O)(=O)O)O,,,,,,
2843,162844,CID 162844,C1[C@@H]2N(C1=O)[C@H](C(=CCO)O2)C(=O)[O-].[Na+],,,,,,
2844,162845,1-[2-Ethoxy-2-(pyridin-3-yl)ethyl]-4-(2-methoxyphenyl)piperazine,CCOC(CN1CCN(CC1)C2=CC=CC=C2OC)C3=CN=CC=C3,,,,,,
2845,162846,1-(2-Chloro-4-hydroxyphenyl)-tert-butylaminoethanol,CC(C)(C)NCC(C1=C(C=C(C=C1)O)Cl)O,,,,,,
2846,162847,"Benzenesulfonic acid, 4-dodecyl-, compd. with 2-aminoethanol (1:1)",CCCCCCCCCCCCC1=CC=C(C=C1)S(=O)(=O)O.C(CO)N,,,,,,
2847,162848,Benphthalate,COC(=O)C1=CC=CC=C1C(=O)OC.C1CCN(CC1)C(=O)C2=CC=CC=C2,,,,,,
2848,162849,Tris(acetonitrile)trichlororhodium,CC#N.CC#N.CC#N.[Cl-].[Cl-].[Cl-].[Rh+3],,,,,,
2849,162850,Roussin's Red Salt,N#[O+].N#[O+].N#[O+].N#[O+].[S-2].[S-2].[Fe].[Fe],,,,,,
2850,162851,"(2S)-5-amino-2-(3,4-dihydroxyanilino)-5-oxopentanoic acid",C1=CC(=C(C=C1N[C@@H](CCC(=O)N)C(=O)O)O)O,,,,,,
2851,162852,"Cobaltate(1-), bis(4-(hydroxy-kappaO)-3-((2-(hydroxy-kappaO)-1-naphthalenyl)azo-kappaN1)benzenesulfonamidato(2-))-, sodium",C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=CC(=C3)S(=O)(=O)N)[O-])[O-].C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=CC(=C3)S(=O)(=O)N)[O-])[O-].[Na+].[Co+3],,,,,,
2852,162853,"Benzene, dodecylnitro-",CCCCCCCCCCCCC1=CC=CC=C1[N+](=O)[O-],,,,,,
2853,162854,CID 162854,CC(C)(CS(=O)(=O)C1=CC=C(C=C1)N2CCC(=N2)C3=CC=C(C=C3)Cl)S(=O)(=O)[O-].[Na+],,,,,,
2854,162855,"1-{4-[3-(4-Chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]benzene-1-sulfonyl}-2-methylpropane-2-sulfonic acid",CC(C)(CS(=O)(=O)C1=CC=C(C=C1)N2CCC(=N2)C3=CC=C(C=C3)Cl)S(=O)(=O)O,,,,,,
2855,162856,"Ammonium O,O-bis(methylphenyl) dithiophosphate",CC1=CC=CC=C1OP(=S)(OC2=CC=CC=C2C)[S-].[NH4+],,,,,,
2856,162857,"L-Cysteine, N-acetyl-S-(2-((1-methylethyl)phenylamino)-2-oxoethyl)-",CC(C)N(C1=CC=CC=C1)C(=O)CSC[C@@H](C(=O)O)NC(=O)C,,,,,,
2857,162858,"1,4-Dinitrobut-2-ene",C(C=CC[N+](=O)[O-])[N+](=O)[O-],,,,,,
2858,162859,Platycodin D,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H](CO[C@H]2OC(=O)[C@]34CCC(C[C@H]3C5=CC[C@H]6[C@]([C@@]5(C[C@H]4O)C)(CC[C@@H]7[C@@]6(C[C@@H]([C@@H](C7(CO)CO)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)C)C)(C)C)O)O)O)O)O[C@H]9[C@@H]([C@H]([C@@H](CO9)O)O[C@H]1[C@@H]([C@](CO1)(CO)O)O)O,,,,,,
2859,162860,"2-Propanone, mixt. with 1,1,2-trichloro-1,2,2-trifluoroethane",CC(=O)C.C(C(F)(Cl)Cl)(F)(F)Cl,,,,,,
2860,162861,C.I. Pigment Blue 19,CC1=C(C=CC(=C1)C(=C2C=CC(=NC3=CC=CC=C3S(=O)(=O)O)C=C2)C4=CC=C(C=C4)NC5=CC=CC=C5)N,,,,,,
2861,162862,"(2S,3R,4S,5S,6R)-2-[(1S,2S,3R,4S,6R)-3-[(2R,3R,6S)-6-(aminomethyl)-3-azanyl-oxan-2-yl]oxy-4,6-bis(azanyl)-2-oxidanyl-cyclohexyl]oxy-4-azanyl-6-(hydroxymethyl)oxane-3,5-diol sulfate",C1C[C@H]([C@H](O[C@@H]1CN)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N)N)N.[O-]S(=O)(=O)[O-],,,['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)'],,,
2862,162863,CID 162863,C1C[C@H]([C@H](O[C@@H]1CN)O[C@@H]2[C@H](C[C@H]([C@@H](C2O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N)N)N,,,,,,
2863,162864,"(3S,4S,5S,8S,9S,10R,13R,14S,17R)-4,10,13-trimethyl-17-[(2R,5R)-4,5,6-trimethylhept-3-en-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol",C[C@H]1[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@]2(CC[C@@H]1O)C)C)[C@H](C)C=C(C)[C@H](C)C(C)C,,,,,,
2864,162865,CID 162865,C[C@@H]1C=CC(=O)NCC=CC(=C[C@H](C[C@H](CC2=NC(=CO2)C(=O)N[C@@H](C(=O)O[C@@H]1C(C)C)C)O)O)C,,,,,,
2865,162866,Neodecanoic acid diethanolamine salt,CC(C)(C)CCCCCC(=O)O.C(CO)NCCO,,,,,,
2866,162867,"1-(4-methoxyphenyl)-N-[(1,3,3-trimethylindol-1-ium-2-yl)methylideneamino]methanamine;acetate",CC(=O)[O-].CC1(C2=CC=CC=C2[N+](=C1C=NNCC3=CC=C(C=C3)OC)C)C,,,,,,
2867,162868,Secoxyloganin,COC(=O)C1=CO[C@H]([C@@H]([C@@H]1CC(=O)O)C=C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
2868,162869,"5-(4-Dimethylaminobenzyl)imidazolidine-2,4-dione",CN(C)C1=CC=C(C=C1)CC2C(=O)NC(=O)N2,,,,,,
2869,162870,"2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole hydrochloride",C1CNCC2=C1C3=CC=CC=C3N2.Cl,,,,,,
2870,162871,"1H-Pyrido(3,4-b)indol-1-one, 2,3,4,9-tetrahydro-2-methyl-",CN1CCC2=C(C1=O)NC3=CC=CC=C23,,,,,,
2871,162872,"alpha-5,9-Dimethyl-2-(2-methyl-3-furylmethyl)-2'-hydroxy-6,7-benzomorphan",C[C@H]1[C@H]2CC3=C([C@@]1(CCN2CC4=C(OC=C4)C)C)C=C(C=C3)O,,,,,,
2872,162873,1-[3-(4-Chlorophenyl)propyl]piperazine,C1CN(CCN1)CCCC2=CC=C(C=C2)Cl,,,,,,
2873,162874,2-(2-Hydroxyethylamino)ethanol;sulfate,C(CO)NCCO.[O-]S(=O)(=O)[O-],,,,,,
2874,162875,CID 162875,C[C@@]1(CC[C@@H]2C(=C1)CC[C@@H]3[C@@]2(CCC(C3(C)C)OC4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C)[C@H](CO)O,,,,,,
2875,162876,Erigeroside,C1=COC=C(C1=O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
2876,162877,"(2,15,17,32-Tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,33-dioxa-27-thia-24,29-diazapentacyclo[23.6.1.14,7.05,31.026,30]tritriaconta-1(31),2,4,9,19,21,25(32),26(30),28-nonaen-13-yl) acetate",CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2SC=N5)O)C,,,,,,
2877,162878,Narcissiflorine,C[C@]12CC[C@@H](C([C@@H]1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)O)C)C)(C)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O[C@H]7[C@@H]([C@H]([C@@H](O7)CO)O)O)O)O,,,,,,
2878,162879,Hydroxymethyl cimetidine,CN=C(NCCSCC1=C(N=CN1)CO)NC#N,,,,,,
2879,162880,"Benzenesulfonic acid, hydroxydinonyl-, monoammonium salt",CCCCCCCCCC1=C(C=CC(=C1CCCCCCCCC)S(=O)(=O)[O-])O.[NH4+],,,,,,
2880,162881,"Benzenesulfonic acid, hydroxydinonyl-",CCCCCCCCCC1=C(C=CC(=C1CCCCCCCCC)S(=O)(=O)O)O,,,,,,
2881,162882,Dimethyl 6-ethoxy-2-ethyl-4-pyrimidinyl phosphate,CCC1=NC(=CC(=N1)OP(=O)(OC)OC)OCC,,,,,,
2882,162883,Eudistomin N,C1=CC2=C(C=C1Br)C3=C(N2)C=NC=C3,,,,,,
2883,162884,1-Butyl-4-phenyl-4-isonicotinoylaminomethylpiperidine,CCCCN1CCC(CC1)(CNC(=O)C2=CC=NC=C2)C3=CC=CC=C3,,,,,,
2884,162885,S-(Cyanomethyl) O-ethyl carbonodithioate,CCOC(=S)SCC#N,,,,,,
2885,162886,10-Bromocarbamazepine,C1=CC=C2C(=C1)C=C(C3=CC=CC=C3N2C(=O)N)Br,,,,,,
2886,162887,1-[2-[[4-[(2-Chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]pyridinium acetate,CCN(CC[N+]1=CC=CC=C1)C2=CC=C(C=C2)N=NC3=C(C=C(C=C3)[N+](=O)[O-])Cl.CC(=O)[O-],,,,,,
2887,162888,"6-[6-[6-[(12,14-Dihydroxy-10,13-dimethyl-17-pyridazin-4-yl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl)oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyloxane-3,4-diol",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CN=NC=C8)O)C)O)C)C)C)O)O,,,,,,
2888,162889,"Phosphorothioic acid, O-ethyl O-(4-((methylsulfonyl)oxy)phenyl) S-propyl ester",CCCSP(=O)(OCC)OC1=CC=C(C=C1)OS(=O)(=O)C,,,,,,
2889,162890,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,17,17,18,18,18-Tritriacontafluorooctadecyl methacrylate",CC(=C)C(=O)OCCC(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
2890,162891,8-Chlororugulovasine B,CC1=C[C@@]2([C@@H](CC3=CNC4=C(C=CC2=C34)Cl)NC)OC1=O,,,,,,
2891,162892,N-Desmethylzopiclone,C1CN(CCN1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,,,,,['N-desmethyl-zopiclone is a known human metabolite of eszopiclone.'],
2892,162893,beta-D-Glucopyranosyl-4-nitrophenyltriazene,C1=CC(=CC=C1NN=NCC2C(C(C(C(O2)CO)O)O)O)[N+](=O)[O-],,,,,,
2893,162894,2-(Dihydroxymethyl)-2-hydroxy-2H-pyran-3(6H)-one,C1C=CC(=O)C(O1)(C(O)O)O,,,,,,
2894,162895,"1-(2,3-Dihydro-1,4-benzodioxin-6-yl)-4-(3-phenylpyrrolidin-1-yl)butan-1-one hydrochloride(1:1)",C1CN(CC1C2=CC=CC=C2)CCCC(=O)C3=CC4=C(C=C3)OCCO4.Cl,,,,,,
2895,162896,"1-(2,3-Dihydro-1,4-benzodioxin-6-yl)-4-(3-phenylpyrrolidin-1-yl)butan-1-one",C1CN(CC1C2=CC=CC=C2)CCCC(=O)C3=CC4=C(C=C3)OCCO4,,,,,,
2896,162897,"Phosphoric acid, bis(2-ethylhexyl) ester, compd. with 2,2',2''-nitrilotris[ethanol] (1:1)",CCCCC(CC)COP(=O)(O)OCC(CC)CCCC.C(CO)N(CCO)CCO,,,,,,
2897,162898,"11H-3,11a-(Iminomethano)(1,2,4)dithiazino(4,3-b)(1,2)benzoxazine-4,12(3H)-dione, 9-chloro-8-hydroxy-11-methoxy-",CON1[C@@H]2C(=O)NC3(C1=O)[C@H](C4=CC(=C(C=C4O3)O)Cl)SS2,,,,,,
2898,162899,Spinacine,C1[C@H](NCC2=C1N=CN2)C(=O)O,,,,,,
2899,162900,CID 162900,CC(=CCCCC[C@@H](C=C[C@H]1[C@@H](CC(=O)[C@@H]1CC=CCCCC(=O)O)O)O)C,,,,,,
2900,162901,Aluminum gluconate,C([C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O)O.C([C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O)O.C([C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O)O.[Al+3],,,,,,
2901,162902,"11,17-Dihydroxy-17-methyl-3-oxo-androsta-1,4-diene-2-carboxylic acid, decyl ester",CCCCCCCCCCOC(=O)C1=C[C@@]2([C@@H]3[C@@H](CCC2=CC1=O)[C@@H]4CC[C@@]([C@]4(C[C@@H]3O)C)(C)O)C,,,,,,
2902,162903,13-Octadecenyl acetate,CCCCC=CCCCCCCCCCCCCOC(=O)C,,,,,,
2903,162904,"3-(3-Fluorophenyl)-1-methylpyrrolidine-2,5-dione",CN1C(=O)CC(C1=O)C2=CC(=CC=C2)F,,,,,,
2904,162905,"Acetamide, N-(ethoxymethyl)-N-(2-ethyl-6-methylphenyl)-2-hydroxy-",CCC1=CC=CC(=C1N(COCC)C(=O)CO)C,,,,,,
2905,162906,"3-(1,1'-Biphenyl-4-yl)butanenitrile",CC(CC#N)C1=CC=C(C=C1)C2=CC=CC=C2,,,,,,
2906,162907,13-(Hexopyranosyloxy)kaur-16-en-18-oic acid,CC12CCCC(C1CCC34C2CCC(C3)(C(=C)C4)OC5C(C(C(C(O5)CO)O)O)O)(C)C(=O)O,,,,,,
2907,162908,Pyrenedecanoic acid,C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)CCCCCCCCCC(=O)O,,,,,,
2908,162909,CID 162909,CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C.C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C(N)O)C(=O)[C@]3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)N(C)C)O.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C,,,,,,
2909,162910,"2-Methyl-9-phenyl-2,3,4,4a-tetrahydro-1H-indeno[2,1-c]pyridine",CN1CCC2C(=C(C3=CC=CC=C23)C4=CC=CC=C4)C1,,,,,,
2910,162911,CID 162911,CC(=CCCC(=C[C@@H](CC(=CCCC(=CCO)C)C)O)C)C,,,,,,
2911,162912,"(3-((4-((2,4-Dimethylphenyl)amino)-9,10-dihydro-9,10-dioxo-1-anthryl)amino)propyl)trimethylammonium methyl sulphate",CC1=CC(=C(C=C1)NC2=C3C(=C(C=C2)NCCC[N+](C)(C)C)C(=O)C4=CC=CC=C4C3=O)C.COS(=O)(=O)[O-],,,,,,
2912,162913,"3-{[4-(2,4-Dimethylanilino)-9,10-dioxo-9,10-dihydroanthracen-1-yl]amino}-N,N,N-trimethylpropan-1-aminium",CC1=CC(=C(C=C1)NC2=C3C(=C(C=C2)NCCC[N+](C)(C)C)C(=O)C4=CC=CC=C4C3=O)C,,,,,,
2913,162914,"Benzene, 1,1'-(1-methylethylidene)bis[3,5-dibromo-4-[2-(2,4,6-tribromophenoxy)ethoxy]-",CC(C)(C1=CC(=C(C(=C1)Br)OCCOC2=C(C=C(C=C2Br)Br)Br)Br)C3=CC(=C(C(=C3)Br)OCCOC4=C(C=C(C=C4Br)Br)Br)Br,,,,,,
2914,162915,Mab-N-sulfate,CN(C1=CC=C(C=C1)N=NC2=CC=CC=C2)OS(=O)(=O)O,,,,,,
2915,162916,"(2S)-3-hydroxypropane-1,2-diyl didecanoate",CCCCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCCCC,,,,,,
2916,162917,Cephapirin lactone,C1C2=C(C(=O)O1)N3[C@@H]([C@@H](C3=O)NC(=O)CSC4=CC=NC=C4)SC2,,,,,,
2917,162918,"5-(8-Amino-1,2,3,4-tetrahydro-2-methyl-4-isoquinolinyl)-2-methoxyphenol",CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC(=C(C=C3)OC)O,,,,,,
2918,162919,"2,2-Bis(trifluoromethyl)-4,5-dichloro-4,5-difluoro-1,3-dioxolane",C1(C(OC(O1)(C(F)(F)F)C(F)(F)F)(F)Cl)(F)Cl,,,,,,
2919,162920,Desmethylnaproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O,,,,,,
2920,162921,1-(1-Phenyl-4-hydroxycyclohexyl)-4-hydroxypiperidine,C1CC(CCC1O)(C2=CC=CC=C2)N3CCC(CC3)O,,,,,,
2921,162922,"2-(3-(1,1-Dimethylethyl))-5-methoxyphenyloxazolo(4,5-b)pyridine",CC(C)(C)C1=CC(=CC(=C1)C2=NC3=C(O2)C=CC=N3)OC,,,,,,
2922,162923,2-Amino-5-bromo-2'-chlorobenzophenone,C1=CC=C(C(=C1)C(=O)C2=C(C=CC(=C2)Br)N)Cl,,,,,,
2923,162924,3-(4-Methoxybenzylamino)-4-hydroxy-alpha-(tert-butylaminomethyl)benzyl alcohol hydrochloride,CC(C)(C)NCC(C1=CC(=C(C=C1)O)NCC2=CC=C(C=C2)OC)O.Cl,,,,,,
2924,162925,"alpha-[[(1,1-Dimethylethyl)amino]methyl]-4-hydroxy-3-[[(4-methoxyphenyl)methyl]amino]benzenemethanol",CC(C)(C)NCC(C1=CC(=C(C=C1)O)NCC2=CC=C(C=C2)OC)O,,,,,,
2925,162926,5-(2-Hydroxyphenyl)-5-phenylhydantoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3O,,,,,,
2926,162927,CID 162927,CN1C(=CC(=O)C(=C1O)C(=N)C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
2927,162928,"2-Phenyl-5H-imidazo[2,1-a]isoindole",C1C2=CC=CC=C2C3=NC(=CN31)C4=CC=CC=C4,,,,,,
2928,162929,Barium 2-((2-hydroxy-3-(((4-sulphonatophenyl)amino)carbonyl)-1-naphthyl)azo)benzenesulphonate,C1=CC=C2C(=C1)C=C(C(=C2N=NC3=CC=CC=C3S(=O)(=O)[O-])O)C(=O)NC4=CC=C(C=C4)S(=O)(=O)[O-].[Ba+2],,,,,,
2929,162930,o-[2-Hydroxy-3-[(p-sulfophenyl)carbamoyl]-1-naphthylazo]benzenesulfonic acid,C1=CC=C2C(=C1)C=C(C(=C2N=NC3=CC=CC=C3S(=O)(=O)O)O)C(=O)NC4=CC=C(C=C4)S(=O)(=O)O,,,,,,
2930,162931,Glumitan,C1=CC2=C(C=C1O)C(=CN2)CCNC(=O)[C@H](CCC(=O)O)N,,,,,,
2931,162932,Ethynodiol testosterone ester,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC(=O)O[C@H]4CC[C@@H]5C6CC[C@]7(C(C6CCC5=C4)CC[C@]7(C#C)O)C)CCC8=CC(=O)CC[C@]38C,,,,,,
2932,162933,"3,9-Dihydroxypterocarpan",C1[C@@H]2[C@H](C3=C(O1)C=C(C=C3)O)OC4=C2C=CC(=C4)O,,,,,,
2933,162934,Dimethyl cathate,COC1=CC(=CC(=C1OCC2=C(C=NC=C2)C(=O)OC)OC)C(=O)OC,,,,,,
2934,162935,"3-Bromo-4,5-dihydroxybenzoic acid",C1=C(C=C(C(=C1O)O)Br)C(=O)O,,,,,,
2935,162936,Cannabispiran,COC1=CC2=C(C(=C1)O)C3(CCC(=O)CC3)CC2,,,,,,
2936,162937,N-ethylcyclohexanamine hydrochloride,CCNC1CCCCC1.Cl,,,,,,
2937,162938,7-Hydroxyflumequine,CC1CC(C2=CC(=CC3=C2N1C=C(C3=O)C(=O)O)F)O,,,,,,
2938,162939,Cortisol-21-palmitate,CCCCCCCCCCCCCCCC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C)O,,,,,,
2939,162940,CID 162940,CC1(CCC2=C(O1)C=CC(=C2)C=C(C(=CC3=CC=C(C=C3)O)[N+]#[C-])[N+]#[C-])C,,,,,,
2940,162941,Isopropyl titanium triisostearate,CC(C)CCCCCCCCCCCCCCC(=O)O.CC(C)CCCCCCCCCCCCCCC(=O)O.CC(C)CCCCCCCCCCCCCCC(=O)O.CC(C)O.[Ti],,,,,,
2941,162942,CID 162942,C1C(C(C(C1O)C=CC(COC2=CC=CC=C2)O)CC=C=CCCC(=O)O)O,,,,,,
2942,162943,"Octadeca-9,12,15-trien-6-ynoic acid",CCC=CCC=CCC=CCC#CCCCCC(=O)O,,,,,,
2943,162944,(2S)-N-[2-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]acetyl]pyrrolidine-2-carboxamide,CC(C)C[C@H](C(=O)NCC(=O)NC(=O)[C@@H]1CCCN1)NC,,,,,,
2944,162945,Microhelenin A,CC1CC2C(CC34C1C(CC3=O)OC4)C(=C)C(=O)O2,,,,,,
2945,162946,"1H-Imidazole-4,5-dicarboxamide, 1-ethyl-",CCN1C=NC(=C1C(=O)N)C(=O)N,,,,,,
2946,162947,Pentaerythritol tetrabehenate,CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC,,,,,,
2947,162948,4-(2-(Ethylamino)ethyl)-2-methyl-5-((methylthio)methyl)-3-pyridinol,CCNCCC1=C(C(=NC=C1CSC)C)O,,,,,,
2948,162949,CID 162949,CC1=CC(=NC=C1)NC(=C2C(=O)C3=C(C4=CC=CC=C4C=C3)S(=O)(=O)N2C)O,,,,,,
2949,162950,Metaclazepam hydrochloride,CN1C(CN=C(C2=C1C=CC(=C2)Br)C3=CC=CC=C3Cl)COC.Cl,,,,,,
2950,162951,Hydroxytriamterene sulfate,C1=CC(=CC=C1C2=NC3=C(N=C(N=C3N=C2N)N)N)OS(=O)(=O)O,,,,,['Hydroxytriamterene sulfate is a known human metabolite of 4p-Hydroxytriamterene.'],
2951,162952,Gingerdione,CCCCCC(=O)CC(=O)CCC1=CC(=C(C=C1)O)OC,,,,,,
2952,162953,"Chromate(3-), bis(4-((4,5-dihydro-3-methyl-5-(oxo-kappaO)-1-phenyl-1H-pyrazol-4-yl)azo-kappaN1)-3-(hydroxy-kappaO)-1-naphthalenesulfonato(3-))-, trisodium",CC1=NN(C(=C1N=NC2=C(C=C(C3=CC=CC=C32)S(=O)(=O)[O-])[O-])[O-])C4=CC=CC=C4.CC1=NN(C(=C1N=NC2=C(C=C(C3=CC=CC=C32)S(=O)(=O)[O-])[O-])[O-])C4=CC=CC=C4.[Na+].[Na+].[Na+].[Cr+3],,,,,,
2953,162954,(2S)-2-amino-3-phenyl-N-[(2S)-1-phenylpropan-2-yl]propanamide,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CC=CC=C2)N,,,,,,
2954,162955,Tixocortol,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CS)O)C)O,['Tixocortol is indicated for the treatment of rhinitis as a nasal suspension or aerosol. It is also used in the form of lozenges for the treatment of pharyngitis and in the form of enemas or rectal solution for the treatment of ulcerative colitis. Tixocortol can be used orally in a suspension or powder for the treatment of inflammatory conditions. It is also the substance used for the screening of contact allergies to class A steroids.'],"['Tixocortol presents the characteristic of local action which reduces significantly the side effects of systemic glucocorticoids. Reports have demonstrated that gastrointestinal administration of tixocortol generates a decrease in abdominal pain, bleeding, and frequency of stools which resulted in an amelioration in the malabsorption laboratory tests. All the effects were independent of suppression of the pituitary-adrenal axis, which was shown by the absence of significant depression of cortisol. Administration of tixocortol as a nasal spray has been shown to respect nasal drainage by the ciliary beats of the pituitary mucosa. The actions of tixocortol have no effect on leukocyte count, blood glucose level, sodium urinary excretion, and immunosupressive activity on lymphocytes.']",,"['The absorption of tixocortol is the same as in other steroids including hydrocortisone. Oral administration of tixocortol presents a 10-20% bioavailability with a significantly lower plasma Cmax than cortisol. The fast metabolism, larger volume of distribution and low bioavailability donates tixocortol with the absence of systemic activity.', 'Tixocortol has a rapid elimination after continuous metabolism. Urine analysis of oral administration of tixocortol demonstrate a complete lack of unchanged drug.', 'Studies have shown that oral or intravenous administration of tixocortol presents a significantly larger volume of distribution compared to cortisol of 21.7 L/kg.', 'Studies have shown that oral or intravenous administration of tixocortol presents a significantly larger clearance rate compared to cortisol of 33.3 L h/kg.']","['Tixocortol is rapidly modified within red blood cells and it is immediately metabolized by a first-pass liver metabolism. The metabolites of tixocortol are mainly represented by the formation of sulfo- and glucurono-conjugates which are later hydrolyzed from the conjugate forming neutral steroids. The metabolic transformations are the reduction of the 3-keto and delta 4 system, reduction of the C-20 carbonyl group, oxidation of the C-11 alcohol and cleavage of the side chain at C-17. The specific metabolic pathways of the C-21 thiol ester function were its transformation into methylthio, methylsulfonyl and methylsulfonyl derivatives and reductive cleavage of the C-21-S bond leading to 21-methyl structures. None of the metabolites have affinity for glucocorticoid receptors. This and the extensive metabolism explains the exclusive local activities of tixocortol.']",['Tixocortol presents a shorter half-life than cortisol.']
2955,162956,Amipurimycin,C1CC(C(C1)N)C(=O)NC(C2CC(C(C(O2)N3C=NC4=CN=C(N=C43)N)O)(C(CO)O)O)C(=O)O,,,,,,
2956,162957,"2',4',4-Trihydroxy-6'-methoxychalcone",COC1=CC(=CC(=C1C(=O)C=CC2=CC=C(C=C2)O)O)O,,,,,,
2957,162958,"Benzoic acid, 2,4-dihydroxy-6-tridecyl-",CCCCCCCCCCCCCC1=C(C(=CC(=C1)O)O)C(=O)O,,,,,,
2958,162959,"4-(8-Amino-1,2,3,4-tetrahydro-2-methyl-4-isoquinolinyl)-2-methoxyphenol",CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC(=C(C=C3)O)OC,,,,,,
2959,162960,Pentigetide,C1C[C@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,,,,,,
2960,162961,"Benzenesulfonic acid, 4-(4,5-dihydro-4-((2-methoxy-5-methyl-4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)azo)-3-methyl-5-oxo-1H-pyrazol-1-yl)-, sodium salt",CC1=CC(=C(C=C1S(=O)(=O)CCOS(=O)(=O)[O-])OC)N=NC2C(=NN(C2=O)C3=CC=C(C=C3)S(=O)(=O)[O-])C.[Na+].[Na+],,,,,,
2961,162962,"Benzenesulfonic acid, 4-(4-((2,5-dimethoxy-4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)azo)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)-, sodium salt",CC1=NN(C(=O)C1N=NC2=CC(=C(C=C2OC)S(=O)(=O)CCOS(=O)(=O)[O-])OC)C3=CC=C(C=C3)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
2962,162963,"2-Naphthalenesulfonic acid, 5-((4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)azo)-8-(phenylazo)-, disodium salt",CCN(CC1=CC(=CC=C1)S(=O)(=O)[O-])C2=CC=C(C=C2)N=NC3=C4C=CC(=CC4=C(C=C3)N=NC5=CC=CC=C5)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
2963,162964,5-[(4-{Ethyl[(3-sulfophenyl)methyl]amino}phenyl)diazenyl]-8-(phenyldiazenyl)naphthalene-2-sulfonic acid,CCN(CC1=CC(=CC=C1)S(=O)(=O)O)C2=CC=C(C=C2)N=NC3=C4C=CC(=CC4=C(C=C3)N=NC5=CC=CC=C5)S(=O)(=O)O,,,,,,
2964,162965,"2-Naphthalenesulfonic acid, 8-((4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)azo)-5-(phenylazo)-, disodium salt",CCN(CC1=CC(=CC=C1)S(=O)(=O)[O-])C2=CC=C(C=C2)N=NC3=C4C=C(C=CC4=C(C=C3)N=NC5=CC=CC=C5)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
2965,162966,8-[(4-{Ethyl[(3-sulfophenyl)methyl]amino}phenyl)diazenyl]-5-(phenyldiazenyl)naphthalene-2-sulfonic acid,CCN(CC1=CC(=CC=C1)S(=O)(=O)O)C2=CC=C(C=C2)N=NC3=C4C=C(C=CC4=C(C=C3)N=NC5=CC=CC=C5)S(=O)(=O)O,,,,,,
2966,162967,Monol,C[C@H](CCCO)[C@H]1CC[C@]2([C@H]1CC[C@@]3([C@@H]2CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CCCC5(C)C)C)C)C)C,,,,,,
2967,162968,"Sulfuric acid, dimethyl ester, compd. with N-methyl-N-[4-[(1-methyl-1H-1,2,4-triazol-5-yl)azo]phenyl]benzenemethanamine (1:1)",CN1C(=NC=N1)N=NC2=CC=C(C=C2)N(C)CC3=CC=CC=C3.COS(=O)(=O)OC,,,,,,
2968,162969,"N-Methyl-N-[4-(1-methyl-1H-1,2,4-triazole-5-ylazo)phenyl]benzenemethanamine",CN1C(=NC=N1)N=NC2=CC=C(C=C2)N(C)CC3=CC=CC=C3,,,,,,
2969,162970,"3-[(3R,5R,8R,9S,10S,13R,17R)-14-hydroxy-3,10,13-trimethyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4,5,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one",C[C@]1(CC[C@]2([C@@H](C1)CC[C@@H]3[C@@H]2CC[C@]4(C3(CC[C@@H]4C5=CC(=O)OC5)O)C)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O,,,,,,
2970,162971,"(6S)-4-methoxy-6-[[4-[2-methoxy-5-[[(1S)-5,6,7-trimethoxy-2,2-dimethyl-3,4-dihydro-1H-isoquinolin-2-ium-1-yl]methyl]phenoxy]phenyl]methyl]-7-methyl-8,9-dihydro-6H-[1,3]dioxolo[4,5-f]isoquinoline",CN1CCC2=C3C(=C(C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)C[C@H]6C7=CC(=C(C(=C7CC[N+]6(C)C)OC)OC)OC)OC)OC)OCO3,,,,,,
2971,162972,Cyanofenphos oxon,CCOP(=O)(C1=CC=CC=C1)OC2=CC=C(C=C2)C#N,,,,,,
2972,162973,Dimenformon prolongatum,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)OC(=O)C5=CC=CC=C5.C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC4=CC=CC=C4)CCC5=C3C=CC(=C5)O,,,,,,
2973,162974,CID 162974,C[C@]12CCC3C([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)OC(=O)C5=CC=CC=C5,,,,,,
2974,162975,CID 162975,C[C@]12CC[C@H]3C(C1CC[C@@H]2OC(=O)CCC4=CC=CC=C4)CCC5=C3C=CC(=C5)O,,,,,,
2975,162976,Didemethylcitalopram,C1C2=C(C=CC(=C2)C#N)C(O1)(CCCN)C3=CC=C(C=C3)F,,,,,"['N,N-Didesmethylcitalopram is a known human metabolite of Desmethylescitalopram and desmethylcitalopram.']",
2976,162977,"3,3-Diphenyl-L-alanine",C1=CC=C(C=C1)C(C2=CC=CC=C2)[C@@H](C(=O)O)N,,,,,,
2977,162978,CID 162978,CC(=O)NC1=CC=C(C=C1)C=NN=C(N)S.C1=CN=CC=C1C(=O)NN,,,,,,
2978,162979,"alpha-(3,4,5,6-Tetrahydrophthalimido)-glutarimide",C1CCC2=C(C1)C(=O)N(C2=O)C3CCC(=O)NC3=O,,,,,,
2979,162980,N-Acetylamrinone,CC(=O)NC1=CC(=CNC1=O)C2=CC=NC=C2,,,,,,
2980,162981,CID 162981,CCCCC[C@@H](C=C[C@H]1[C@@H](C[C@@H]2C1C[C@@H](O2)CCCCC(=O)O)O)O,,,,,,
2981,162982,"3-Pyrrolidinol, 1-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-, monohydrochloride",C1CN(CC1O)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F.Cl,,,,,,
2982,162983,10-[3-(3-Hydroxy-1-pyrrolidinyl)propyl]-2-trifluoromethyl-10H-phenothiazine,C1CN(CC1O)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F,,,,,,
2983,162984,2-[[4-Amino-2-(2-aminopropanoylamino)-4-oxobutanoyl]amino]-5-phosphonopent-3-enoic acid,CC(C(=O)NC(CC(=O)N)C(=O)NC(C=CCP(=O)(O)O)C(=O)O)N,,,,,,
2984,162985,2-[[2-(2-Aminopropanoylamino)-3-carboxypropanoyl]amino]-5-phosphonopent-3-enoic acid,CC(C(=O)NC(CC(=O)O)C(=O)NC(C=CCP(=O)(O)O)C(=O)O)N,,,,,,
2985,162986,"5-(6-Methoxy-1,3-benzodioxol-5-yl)-1-piperidin-1-ylpent-2-en-1-one",COC1=CC2=C(C=C1CCC=CC(=O)N3CCCCC3)OCO2,,,,,,
2986,162987,6-Methoxyindan-1-acetic acid,COC1=CC2=C(CCC2CC(=O)O)C=C1,,,,,,
2987,162988,"5,6-Dimethoxyindan-1-acetic acid",COC1=C(C=C2C(CCC2=C1)CC(=O)O)OC,,,,,,
2988,162989,CID 162989,C[C@H]1CCCC=C[C@@H]2CC(=O)C[C@H]2[C@@H](C=CC(=O)O1)O,,,,,,
2989,162990,"Butanamide, 2-[2,4-bis(1,1-dimethylpropyl)phenoxy]-N-[4-[4,5-dihydro-5-oxo-4-[(1-phenyl-1H-tetrazol-5-yl)thio]-3-(1-pyrrolidinyl)-1H-pyrazol-1-yl]phenyl]-, monohydrochloride",CCC(C(=O)NC1=CC=C(C=C1)N2C(=O)C(C(=N2)N3CCCC3)SC4=NN=NN4C5=CC=CC=C5)OC6=C(C=C(C=C6)C(C)(C)CC)C(C)(C)CC.Cl,,,,,,
2990,162991,"2-(2,4-Bis(1,1-dimethylpropyl)phenoxy)-N-(4-(4,5-dihydro-5-oxo-4-((1-phenyl-1H-tetrazol-5-yl)thio)-3-(1-pyrrolidinyl)-1H-pyrazol-1-yl)phenyl)butanamide",CCC(C(=O)NC1=CC=C(C=C1)N2C(=O)C(C(=N2)N3CCCC3)SC4=NN=NN4C5=CC=CC=C5)OC6=C(C=C(C=C6)C(C)(C)CC)C(C)(C)CC,,,,,,
2991,162992,Xylachlor,CC1=C(C(=CC=C1)N(C(C)C)C(=O)CCl)C,,,,,,
2992,162993,"Naphtho[2,3-d]thiazole-3(2H)-propanesulfonic acid, 2-[4-(1-heptyl-3-phenyl-5-oxo-2-thioxo-4-imidazolidinylidene)-2-butenylidene]-alpha-methyl-, compd. with N,N-diethylethanamine (1:1)",CCCCCCCN1C(=O)C(=CC=CC=C2N(C3=CC4=CC=CC=C4C=C3S2)CCC(C)S(=O)(=O)O)N(C1=S)C5=CC=CC=C5.CCN(CC)CC,,,,,,
2993,162994,"4-{2-[4-(1-Heptyl-5-oxo-3-phenyl-2-sulfanylideneimidazolidin-4-ylidene)but-2-en-1-ylidene]naphtho[2,3-d][1,3]thiazol-3(2H)-yl}butane-2-sulfonic acid",CCCCCCCN1C(=O)C(=CC=CC=C2N(C3=CC4=CC=CC=C4C=C3S2)CCC(C)S(=O)(=O)O)N(C1=S)C5=CC=CC=C5,,,,,,
2994,162995,"3-[5-chloro-2-[2-[[5-phenyl-3-(3-sulfobutyl)-1,3-benzoxazol-3-ium-2-yl]methylidene]butylidene]-1,3-benzoxazol-3-yl]propane-1-sulfonate;N,N-diethylethanamine",CCC(=CC1=[N+](C2=C(O1)C=CC(=C2)C3=CC=CC=C3)CCC(C)S(=O)(=O)O)C=C4N(C5=C(O4)C=CC(=C5)Cl)CCCS(=O)(=O)[O-].CCN(CC)CC,,,,,,
2995,162996,2-[3-[3-(3-Sulfobutyl)-5-phenylbenzoxazole-2(3H)-ylidene]-2-ethyl-1-propenyl]-5-chloro-3-(3-sulfonatopropyl)benzoxazolium,CCC(=CC1=[N+](C2=C(O1)C=CC(=C2)C3=CC=CC=C3)CCC(C)S(=O)(=O)O)C=C4N(C5=C(O4)C=CC(=C5)Cl)CCCS(=O)(=O)O,,,,,,
2996,162997,"8-Chloro-6-(2-chlorophenyl)-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide",C1C2=C(N=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4Cl)C(=O)N,,,,,,
2997,162998,Oxmetidine hydrochloride,CC1=C(N=CN1)CSCCNC2=NC=C(C(=O)N2)CC3=CC4=C(C=C3)OCO4.Cl.Cl,,,"['Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. (See all compounds classified as Histamine H2 Antagonists.)', 'Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)']",,,
2998,162999,"Dipotassium 3,3'-sulphonylbis(benzenesulphonate)",C1=CC(=CC(=C1)S(=O)(=O)[O-])S(=O)(=O)C2=CC(=CC=C2)S(=O)(=O)[O-].[K+].[K+],,,,,,
2999,163000,"Benzenesulfonic acid, 3,3'-sulfonylbis-, disodium salt",C1=CC(=CC(=C1)S(=O)(=O)O)S(=O)(=O)C2=CC(=CC=C2)S(=O)(=O)O,,,,,,
3000,163001,Malabaricone B,C1=CC(=C(C(=C1)O)C(=O)CCCCCCCCC2=CC=C(C=C2)O)O,,,,,,
3001,163002,"[(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6R)-6-[[(4R,5S,6S,7R,9R,15R,16R)-4-acetyloxy-16-ethyl-15-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-5,9,13-trimethyl-2,10-dioxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate",CC[C@@H]1[C@H](C=C(C=CC(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)OC(=O)C)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)OC)OC,,,,,,
3002,163003,"(3S,8R)-7-ethylidene-5-methyl-5,12-diazatetracyclo[9.7.0.03,8.013,18]octadeca-1(11),13,15,17-tetraen-10-one",CC=C1CN(C[C@@H]2[C@H]1CC(=O)C3=C(C2)C4=CC=CC=C4N3)C,,,,,,
3003,163004,"[1-Amino-2-(2,6-dichlorophenyl)ethylidene]urea;hydrochloride",C1=CC(=C(C(=C1)Cl)CC(=NC(=O)N)N)Cl.Cl,,,,,,
3004,163005,"N-Carbamoyl-2-(2,6-dichlorophenyl)acetamidine",C1=CC(=C(C(=C1)Cl)CC(=NC(=O)N)N)Cl,,,,,,
3005,163006,"Naphthalenesulfonic acid, diisononyl-, compd. with 1,2-ethanediamine (2:1)",CC(C)CCCCCCC1=CC2=CC=CC=C2C(=C1CCCCCCC(C)C)S(=O)(=O)O.CC(C)CCCCCCC1=CC2=CC=CC=C2C(=C1CCCCCCC(C)C)S(=O)(=O)O.C(CN)N,,,,,,
3006,163007,"2,3-Bis(7-methyloctyl)naphthalene-1-sulfonic acid",CC(C)CCCCCCC1=CC2=CC=CC=C2C(=C1CCCCCCC(C)C)S(=O)(=O)O,,,,,,
3007,163008,CID 163008,CC1=NN=C(S1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)CN4C=C(C(=O)C(=C4)Cl)Cl)SC2)C(=O)[O-].[Na+],,,,,,
3008,163009,"9-[2-(Hydroxymethyl)-6,6-dimethylcyclohexen-1-yl]-3,7-dimethylnona-2,4,6,8-tetraenoic acid",CC(=CC=CC(=CC(=O)O)C)C=CC1=C(CCCC1(C)C)CO,,,,,,
3009,163010,"Naphthalenesulfonic acid, diisononyl-, ammonium salt",CC(C)CCCCCCC1=CC2=CC=CC=C2C(=C1CCCCCCC(C)C)S(=O)(=O)[O-].[NH4+],,,,,,
3010,163011,Lead bis(diisononylnaphthalenesulphonate),CC(C)CCCCCCC1=CC2=CC=CC=C2C(=C1CCCCCCC(C)C)S(=O)(=O)[O-].CC(C)CCCCCCC1=CC2=CC=CC=C2C(=C1CCCCCCC(C)C)S(=O)(=O)[O-].[Pb+2],,,,,,
3011,163012,"Silane, trimethyl(1-oxohexyl)-",CCCCCC(=O)[Si](C)(C)C,,,,,,
3012,163013,"2,3-Dihydro-2-(1-methylethenyl)-5-benzofurancarboxaldehyde",CC(=C)[C@@H]1CC2=C(O1)C=CC(=C2)C=O,,,,,,
3013,163014,"8,16-Pyranthrenedione, dibromo-6,14-dichloro-",C1=CC=C2C(=C1)C3=CC4=C(C=C5C6=C4C7=C3C(=CC(=C7C=C6C8=C(C5=O)C(=C(C=C8)Br)Br)Cl)C2=O)Cl,,,,,,
3014,163015,Vespakinin-X,CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@@H]5CCCN5C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)N,,,,,,
3015,163016,Cycloneosamandaridine,C[C@]12CCN3CC[C@H]1[C@@]3(C[C@@H]4[C@@H]2CC[C@]5([C@H]4C[C@H]6[C@@H]5CC(=O)O6)C)O,,,,,,
3016,163017,Dihydrocyclosporin D,CCCC[C@@H](C)[C@H](C1C(=O)N[C@H](C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C(C)C)O,,,,,,
3017,163018,CID 163018,C1C=[N+](C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O.C1=NC(=O)C2=C(N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O.C(CCN)C[C@@H](C(=O)O)N,,,,,,
3018,163019,CID 163019,C1C=[N+](C(=O)N=C1N)[C@H]2C(C([C@H](O2)COP(=O)(O)O)O)O,,,,,,
3019,163020,5-(5-(4-Chlorophenyl-2-furanyl))dihydro-2(3H)-furanone,C1CC(=O)OC1C2=CC=C(O2)C3=CC=C(C=C3)Cl,,,,,,
3020,163021,"Propanoic acid, 3-(1-(difluoro((trifluoroethenyl)oxy)methyl)-1,2,2,2-tetrafluoroethoxy)-2,2,3,3-tetrafluoro-, methyl ester, polymer with tetrafluoroethene",COC(=O)C(C(OC(C(OC(=C(F)F)F)(F)F)(C(F)(F)F)F)(F)F)(F)F.C(=C(F)F)(F)F,,,,,,
3021,163022,"(9S,10R)-17-methyl-17-prop-2-enyl-17-azoniatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol;iodide",C[N+]1(CCC23CCCC[C@H]2[C@@H]1CC4=C3C=C(C=C4)O)CC=C.[I-],,,,,,
3022,163023,"(9S,10R)-17-methyl-17-prop-2-enyl-17-azoniatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol",C[N+]1(CCC23CCCC[C@H]2[C@@H]1CC4=C3C=C(C=C4)O)CC=C,,,,,,
3023,163024,"Silicic acid, aluminum silver salt",[O-][Si](=O)[O-].[O-][Si](=O)[O-].[Al+3].[Ag+],,,,,,
3024,163025,Einecs 264-591-9,[H+].[H+].[H+].CC1=NN(C(=C1N=NC2=CC=CC=C2C(=O)[O-])[O-])C3=CC=C(C=C3)S(=O)(=O)[O-].CC1=NN(C(=C1N=NC2=CC=CC=C2C(=O)[O-])[O-])C3=CC=C(C=C3)S(=O)(=O)[O-].C1CCC(CC1)NC2CCCCC2.C1CCC(CC1)NC2CCCCC2.[Cr+3],,,,,,
3025,163026,2-[[5-Hydroxy-3-methyl-1-(4-sulfophenyl)-1H-pyrazol-4-yl]azo]benzoic acid,CC1=C(C(=O)N(N1)C2=CC=C(C=C2)S(=O)(=O)O)N=NC3=CC=CC=C3C(=O)O,,,,,,
3026,163027,"1-(2,3-Dihydro-1-benzothiophen-5-yl)-2-(4-phenylbutylamino)propan-1-ol hydrochloride",CC(C(C1=CC2=C(C=C1)SCC2)O)NCCCCC3=CC=CC=C3.Cl,,,,,,
3027,163028,"1-(2,3-Dihydro-1-benzothiophen-5-yl)-2-(4-phenylbutylamino)propan-1-ol",CC(C(C1=CC2=C(C=C1)SCC2)O)NCCCCC3=CC=CC=C3,,,,,,
3028,163029,"2,2-Dihydroxybutanedioic acid--methyl 14-hydroxy-14,15-dihydroeburnamenine-14-carboxylate (1/1)",CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4[C@](C2)(C(=O)OC)O.C(C(=O)O)C(C(=O)O)(O)O,,,,,,
3029,163030,"Butanedioic acid, 2,2-dihydroxy-",C(C(=O)O)C(C(=O)O)(O)O,,,,,,
3030,163031,Petaline,C[N+]1(CCC2=C([C@H]1CC3=CC=C(C=C3)OC)C(=C(C=C2)OC)O)C.[Cl-],,,,,,
3031,163032,"(1R)-7-methoxy-1-[(4-methoxyphenyl)methyl]-2,2-dimethyl-3,4-dihydro-1H-isoquinolin-2-ium-8-ol",C[N+]1(CCC2=C([C@H]1CC3=CC=C(C=C3)OC)C(=C(C=C2)OC)O)C,,,,,,
3032,163033,3-(1-Carboxyethoxycarbonyl)pentadec-4-enoic acid,CCCCCCCCCCC=CC(CC(=O)O)C(=O)OC(C)C(=O)O,,,,,,
3033,163034,"1,2-Benzisothiazol-5-amine, 3-methoxy-",COC1=NSC2=C1C=C(C=C2)N,,,,,,
3034,163035,Disodium butyl phosphate,CCCCOP(=O)([O-])[O-].[Na+].[Na+],,,,,,
3035,163036,Triazolo-benzophenone,CC1=NN=C(N1C2=C(C=C(C=C2)Cl)C(=O)C3=CC=CC=C3Cl)CNC(=O)CN,,,,,,
3036,163037,"2-Octanol, hydrogen sulfate, sodium salt",CCCCCCC(C)OS(=O)(=O)O.[Na+],,,,,,
3037,163038,Octan-2-yl hydrogen sulfate,CCCCCCC(C)OS(=O)(=O)O,,,,,,
3038,163039,Baumycin B1,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)OC(CC(C)O)OC(C)C(=O)O,,,,,,
3039,163040,Aucubigenin,C1=CO[C@H]([C@H]2[C@@H]1[C@@H](C=C2CO)O)O,,,,,,
3040,163041,"3-[2-[[3-[(3-Ethyl-1,3-benzothiazol-2-ylidene)methyl]-5,5-dimethylcyclohex-2-en-1-ylidene]methyl]-1,3-benzothiazol-3-ium-3-yl]propane-1-sulfonate",CCN1C2=CC=CC=C2SC1=CC3=CC(=CC4=[N+](C5=CC=CC=C5S4)CCCS(=O)(=O)[O-])CC(C3)(C)C,,,,,,
3041,163042,"Benzothiazolium, 2-[[5,5-dimethyl-3-[[3-(3-sulfopropyl)-2(3H)-benzothiazolylidene]methyl]-2-cyclohexen-1-ylidene]methyl]-3-ethyl-, inner salt",CCN1C2=CC=CC=C2SC1=CC3=CC(=CC4=[N+](C5=CC=CC=C5S4)CCCS(=O)(=O)O)CC(C3)(C)C,,,,,,
3042,163043,Acetagastrodine,CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)OC2=CC=C(C=C2)CO)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
3043,163044,(2-Hydroxyethyl)(2-((2-hydroxyethyl)(stearoyl)amino)ethyl)-(2-((2-hydroxyethyl)(2-(stearoyloxy)ethyl)amino)ethyl)methylammonium methyl sulphate,CCCCCCCCCCCCCCCCCC(=O)N(CC[N+](C)(CCN(CCO)CCOC(=O)CCCCCCCCCCCCCCCCC)CCO)CCO.COS(=O)(=O)[O-],,,,,,
3044,163045,N-(2-Hydroxyethyl)-2-[(2-hydroxyethyl)(1-oxooctadecyl)amino]-N-[2-[(2-hydroxyethyl)[2-[(1-oxooctadecyl)oxy]ethyl]amino]ethyl]-N-methylethanaminium,CCCCCCCCCCCCCCCCCC(=O)N(CC[N+](C)(CCN(CCO)CCOC(=O)CCCCCCCCCCCCCCCCC)CCO)CCO,,,,,,
3045,163046,Trifluoroacetyladriamycin-14-octanoate,CCCCCCCC(=O)OCC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)C)O)NC(=O)C(F)(F)F)O,,,,,,
3046,163047,"Benzoic acid, 4-(2-((1-methyl-5-nitro-1H-imidazol-2-yl)thio)ethoxy)-, sodium salt",CN1C(=CN=C1SCCOC2=CC=C(C=C2)C(=O)[O-])[N+](=O)[O-].[Na+],,,,,,
3047,163048,4-[2-(1-Methyl-5-nitroimidazol-2-yl)sulfanylethoxy]benzoic acid,CN1C(=CN=C1SCCOC2=CC=C(C=C2)C(=O)O)[N+](=O)[O-],,,,,,
3048,163049,N-Methyltropanyl benzilate,CN1[C@H]2CC[C@@H]1[C@@H](CC2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O,,,,,,
3049,163050,"(+)-2-alpha-Nortropan-2-ol, diphenylglycolate",C1CC2CCC([C@@H]1N2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O,,,,,,
3050,163051,Xylotubercidin,C1=CN(C2=NC=NC(=C21)N)[C@H]3[C@@H]([C@H]([C@H](O3)CO)O)O,,,,,,
3051,163052,"Benzamide, 4-chloro-N-(2-(4-morpholinyl)ethyl)-, N-oxide",C1COCC[N+]1(CCNC(=O)C2=CC=C(C=C2)Cl)[O-],,,,,,
3052,163053,"Chromate(1-), bis(2,4-dihydro-4-((2-(hydroxy-kappaO)-4-nitrophenyl)azo-kappaN1)-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)-kappaO3)-, sodium",CC1=NN(C(=C1N=NC2=C(C=C(C=C2)[N+](=O)[O-])[O-])[O-])C3=CC=CC=C3.CC1=NN(C(=O)C1=NN=C2C=CC(=CC2=O)N([O-])[O-])C3=CC=CC=C3.[Na+].[Cr+3],,,,,,
3053,163054,"Decanoic acid, compd. with 2,2'-iminobis[ethanol] (1:1)",CCCCCCCCCC(=O)O.C(CO)NCCO,,,,,,
3054,163055,"Cobaltate(1-), bis(1-(2-(2-(hydroxy-kappaO)-4-nitrophenyl)diazenyl-kappaN1)-2-naphthalenolato(2-)-kappaO)-, sodium (1:1)",C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=C(C=C3)[N+](=O)[O-])[O-])[O-].C1=CC=C2C(=C1)C=CC(=O)C2=NN=C3C=CC(=CC3=O)N([O-])[O-].[Na+].[Co+3],,,,,,
3055,163056,"1-[[4-(Dioxidoamino)-6-oxocyclohexa-2,4-dien-1-ylidene]hydrazinylidene]naphthalen-2-one",C1=CC=C2C(=C1)C=CC(=O)C2=NN=C3C=CC(=CC3=O)N([O-])[O-],,,,,,
3056,163057,"Chromate(1-), bis(1-((2-hydroxy-4-nitrophenyl)azo)-2-naphthalenolato(2-))-, sodium",C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=C(C=C3)[N+](=O)[O-])[O-])[O-].C1=CC=C2C(=C1)C=CC(=O)C2=NN=C3C=CC(=CC3=O)N([O-])[O-].[Na+].[Cr+3],,,,,,
3057,163058,3-(Diethylamino)-7-((o-tolyl)amino)phenoxazin-5-ium tetrachlorozincate (2:1),CC[N+](=C1C=CC2=NC3=C(C=C(C=C3)NC4=CC=CC=C4C)OC2=C1)CC.CC[N+](=C1C=CC2=NC3=C(C=C(C=C3)NC4=CC=CC=C4C)OC2=C1)CC.[Cl-].[Cl-].[Cl-].[Cl-].[Zn],,,,,,
3058,163059,3-Diethyliminio-7-o-tolylamino-3H-phenoxazine,CC[N+](=C1C=CC2=NC3=C(C=C(C=C3)NC4=CC=CC=C4C)OC2=C1)CC,,,,,,
3059,163060,Diethanolamine borate,B(O)(O)O.C(CO)NCCO,,,,,,
3060,163061,CID 163061,CCCCCCCC=CCCCC1CC(=O)OC1=O.C1=CC2=NNN=C2C=C1,,,,,,
3061,163062,"3-Dodec-4-enyloxolane-2,5-dione",CCCCCCCC=CCCCC1CC(=O)OC1=O,,,,,,
3062,163063,beta-Cyclodextrin-benzaldehyde,C1=CC=C(C=C1)C=O.C([C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](O[C@@H]([C@@H]([C@H]7O)O)O[C@@H]8[C@H](O[C@H](O2)[C@@H]([C@H]8O)O)CO)CO)CO)CO)CO)CO)O)O)O,,,,,,
3063,163064,"Ethanesulfonamide, N-(2,6-dimethyl-4-(((methylamino)carbonyl)oxy)phenyl)-",CCS(=O)(=O)NC1=C(C=C(C=C1C)OC(=O)NC)C,,,,,,
3064,163065,"4,10,16,22-Tetramethyl-3,9,15,21-tetrakis(2-methylpropyl)-6,12,18,24-tetra(propan-2-yl)-1,7,13,19-tetraoxa-4,10,16,22-tetrazacyclotetracosane-2,5,8,11,14,17,20,23-octone",CC(C)CC1C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N1C)C(C)C)CC(C)C)C)C(C)C)CC(C)C)C)C(C)C)CC(C)C)C)C(C)C,,,,,,
3065,163066,Captopril disulphide,C[C@H](CSSCC(C)C(=O)N1CCC[C@H]1C(=O)O)C(=O)N2CCC[C@H]2C(=O)O,,,,,,
3066,163067,Schisantherin D,C[C@H]1CC2=CC3=C(C(=C2C4=C(C5=C(C=C4[C@@H]([C@@]1(C)O)OC(=O)C6=CC=CC=C6)OCO5)OC)OC)OCO3,,,,,,
3067,163068,"7-Benzothiazolesulfonic acid, 2-(4-((hexahydro-2,4,6-trioxo-5-pyrimidinyl)azo)phenyl)-6-methyl-, compd. with 2,2',2''-nitrilotris(ethanol) (1:1)",CC1=C(C2=C(C=C1)N=C(S2)C3=CC=C(C=C3)N=NC4C(=O)NC(=O)NC4=O)S(=O)(=O)O.C(CO)N(CCO)CCO,,,,,,
3068,163069,"Ethanaminium, N-(2-hydroxyethyl)-N-[2-[(2-hydroxyethyl)[2-[(2-hydroxyethyl)[2-[(1-oxooctadecyl)oxy]ethyl]amino]ethyl]amino]ethyl]-2-[(2-hydroxyethyl)(1-oxooctadecyl)amino]-N-methyl-, methyl sulfate (salt)",CCCCCCCCCCCCCCCCCC(=O)N(CC[N+](C)(CCN(CCN(CCO)CCOC(=O)CCCCCCCCCCCCCCCCC)CCO)CCO)CCO.COS(=O)(=O)[O-],,,,,,
3069,163070,N-(2-Hydroxyethyl)-N-[2-[(2-hydroxyethyl)[2-[(2-hydroxyethyl)[2-[(1-oxooctadecyl)oxy]ethyl]amino]ethyl]amino]ethyl]-2-[(2-hydroxyethyl)(1-oxooctadecyl)amino]-N-methylethanaminium,CCCCCCCCCCCCCCCCCC(=O)N(CC[N+](C)(CCN(CCN(CCO)CCOC(=O)CCCCCCCCCCCCCCCCC)CCO)CCO)CCO,,,,,,
3070,163071,Tris(bis(2-hydroxyethyl)ammonium) citrate,C(CO)NCCO.C(CO)NCCO.C(CO)NCCO.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,,,,,,
3071,163072,"1,3-Benzenediol, 2,4-bis[(4-dodecylphenyl)azo]-",CCCCCCCCCCCCC1=CC=C(C=C1)NN=C2C=CC(=O)C(=NNC3=CC=C(C=C3)CCCCCCCCCCCC)C2=O,,,,,,
3072,163073,Diethanolamine myristyl sulfate,CCCCCCCCCCCCCCOS(=O)(=O)O.C(CO)NCCO,,,,,,
3073,163074,"2-Propenoic acid, 2-methyl-, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,17,17,18,18,19,19,20,20,20-heptatriacontafluoroeicosyl ester",CC(=C)C(=O)OCCC(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
3074,163075,"Methyl 6-(4-chloro-3-methoxyphenyl)-2-(methoxymethylidene)-3-methylhexa-3,5-dienoate",CC(=CC=CC1=CC(=C(C=C1)Cl)OC)C(=COC)C(=O)OC,,,,,,
3075,163076,Dipivaloylisoproterenol,CC(C)NCC(C1=CC(=C(C=C1)OC(=O)C(C)(C)C)OC(=O)C(C)(C)C)O,,,,,,
3076,163077,"(2-Ethyl-2,4,4-trimethyl-1,3-oxazolidin-3-yl)oxidanyl",CCC1(N(C(CO1)(C)C)[O])C,,,,,,
3077,163078,Unii-gxo6938TH1,CC1=C[C@@H]2[C@](C[C@@H]1OC(=O)C)([C@]3([C@@H]([C@H]([C@H]([C@@]34CO4)O2)O)OC(=O)C)C)CO,,,,,,
3078,163079,CID 163079,CC[C@H](C)[C@@H]1[C@H]([C@H](C[C@@]2(O1)C[C@@H]3C[C@H](O2)CC=C([C@H]([C@H](C=CC=C4CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)C)O)C,,,,,,
3079,163080,"Chromium, pentahydroxy(tetradecanoato)di-",CCCCCCCCCCCCCC(=O)[O-].[OH-].[OH-].[OH-].[OH-].[OH-].[Cr+3].[Cr+3],,,,,,
3080,163081,"[(6R)-6-hydroxy-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-16-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-5-oxohept-3-en-2-yl] acetate",CC(=O)OC(C)(C)C=CC(=O)[C@@](C)([C@H]1[C@@H](C[C@@]2([C@@]1(CC(=O)[C@@]3([C@H]2CC=C4[C@H]3C[C@@H](C(=O)C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)C)C)O)O,,,,,,
3081,163082,Cyclohexyl-[1-[[2-(hydroxyiminomethyl)pyridin-1-ium-1-yl]methoxymethyl]pyridin-1-ium-3-yl]methanone;diiodide,C1CCC(CC1)C(=O)C2=C[N+](=CC=C2)COC[N+]3=CC=CC=C3C=NO.[I-].[I-],,,,,,
3082,163083,1-[[[3-(Cyclohexylcarbonyl)pyridinio]methoxy]methyl]-2-[(hydroxyimino)methyl]pyridinium,C1CCC(CC1)C(=O)C2=C[N+](=CC=C2)COC[N+]3=CC=CC=C3C=NO,,,,,,
3083,163084,(S)-2-(3-tert-Butylamino-2-hydroxypropoxy)-3-cyanopyridine,CC(C)(C)NC[C@@H](COC1=C(C=CC=N1)C#N)O,,,,,,
3084,163085,17-Hydroxycyproterone acetate,CC(=O)[C@]1(C[C@H]([C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)[C@@H]5C[C@@H]5[C@]34C)Cl)C)O)OC(=O)C,,,,,,
3085,163086,"Glycine, N-((hydroxyphenoxyphosphinyl)methyl)-, methyl ester",COC(=O)CNCP(=O)(O)OC1=CC=CC=C1,,,,,,
3086,163087,"2-A-7,8,8-Ttmidz",CC1([C@@H]2CCC1(C3=NN(C=C23)N)C)C,,,,,,
3087,163088,Trimethyl(((1-oxoallyl)amino)methyl)ammonium methyl sulphate,C[N+](C)(C)CNC(=O)C=C.COS(=O)(=O)[O-],,,,,,
3088,163089,"N,N,N-Trimethyl-alpha-[(1-oxo-2-propenyl)amino]methanaminium",C[N+](C)(C)CNC(=O)C=C,,,,,,
3089,163090,3'-Deoxykanamycin C,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CO)O)N)N,,,,,,
3090,163091,Asenapine,CN1C[C@H]2[C@H](C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24,['Sycrest is indicated for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults.'],,"['Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)']","['Asenapine is administered sublingually because of the low bioavailability (less than 2%) and extensive first-pass metabolism observed following oral administration.', 'Sublingual tablets of the drug are rapidly absorbed in the sublingual, supralingual, and buccal mucosa following sublingual administration, with peak plasma concentrations occurring within 0.5-1.5 hours.', 'The absolute bioavailability of sublingual asenapine (5 mg) is 35%. Steady-state plasma concentrations are reached within 3 days with twice-daily sublingual administration.', 'Following a single 5-mg dose of asenapine, the mean Cmax was approximately 4 ng/mL and was observed at a mean tmax of 1 hour.', 'For more Absorption, Distribution and Excretion (Complete) data for Asenapine (16 total), please visit the HSDB record page.']","['About 50% of the circulating species in plasma have been identified. The predominant species was asenapine N+-glucuronide; others included N-desmethylasenapine, N-desmethylasenapine N-carbamoyl glucuronide, and unchanged asenapine in smaller amounts. Asenapine activity is primarily due to the parent drug.', 'The metabolism and excretion of asenapine [(3aRS,12bRS)-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]-oxepino [4,5-c]pyrrole (2Z)-2-butenedioate (1:1)] were studied after sublingual administration of (14)C-asenapine to healthy male volunteers. ... Metabolic profiles were determined in plasma, urine, and feces using high-performance liquid chromatography with radioactivity detection. Approximately 50% of drug-related material in human plasma was identified or quantified. The remaining circulating radioactivity corresponded to at least 15 very polar, minor peaks (mostly phase II products). Overall, >70% of circulating radioactivity was associated with conjugated metabolites. Major metabolic routes were direct glucuronidation and N-demethylation. The principal circulating metabolite was asenapine N(+)-glucuronide; other circulating metabolites were N-desmethylasenapine-N-carbamoyl-glucuronide, N-desmethylasenapine, and asenapine 11-O-sulfate. In addition to the parent compound, asenapine, the principal excretory metabolite was asenapine N(+)-glucuronide. Other excretory metabolites were N-desmethylasenapine-N-carbamoylglucuronide, 11-hydroxyasenapine followed by conjugation, 10,11-dihydroxy-N-desmethylasenapine, 10,11-dihydroxyasenapine followed by conjugation (several combinations of these routes were found) and N-formylasenapine in combination with several hydroxylations, and most probably asenapine N-oxide in combination with 10,11-hydroxylations followed by conjugations. In conclusion, asenapine was extensively and rapidly metabolized, resulting in several regio-isomeric hydroxylated and conjugated metabolites.']","['Following an initial more rapid distribution phase, the mean terminal half-life is approximately 24 hrs.']"
3091,163092,"n-Methyl-2,4-dinitro-6-(trifluoromethyl)-n-[3-(trifluoromethyl)phenyl]aniline",CN(C1=CC=CC(=C1)C(F)(F)F)C2=C(C=C(C=C2[N+](=O)[O-])[N+](=O)[O-])C(F)(F)F,,,,,,
3092,163093,Isaxonine phosphate,CC(C)NC1=NC=CC=N1.OP(=O)(O)O,,,,,,
3093,163094,CID 163094,CC=C(C)C(=O)O[C@@]12C[C@H]([C@]3([C@H]([C@@H]1C2(C)C)C=C(C[C@]4([C@H]3C=C(C4=O)C)O)CO)O)C,,,,,,
3094,163095,Dihydrocitrinone,C[C@@H]1[C@H](OC(=O)C2=C(C(=C(C(=C12)C)O)C(=O)O)O)C,,,,,,
3095,163096,"Ethyl 4-butoxy-5-fluoro-2,6-dioxohexahydropyrimidine-5-carboxylate",CCCCOC1C(C(=O)NC(=O)N1)(C(=O)OCC)F,,,,,,
3096,163097,Vidarabine 5'-valerate,CCCCC(=O)OC[C@@H]1[C@H]([C@@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O,,,,,,
3097,163098,"Benzo[h]quinoline-5,6-dione",C1=CC=C2C(=C1)C3=C(C=CC=N3)C(=O)C2=O,,,,,,
3098,163099,"Antibiotic A 204A, 6,27-didemethoxy-, (1'S)-",C[C@H]1C[C@H]([C@@](OC1[C@H]2CC[C@@H](O2)[C@@H]3CCC(O3)[C@@]4([C@@H]([C@H](C5(O4)[C@@H]([C@@H](C[C@H](O5)C[C@H]6[C@H]([C@H]([C@H]([C@H](O6)[C@@H](C)C(=O)OO)C)O[C@@H]7CC[C@@H]([C@H](O7)C)OC)C)OC)C)C)OC)C)(C)O)C,,,,,,
3099,163100,Ethylenediamine tetrabromophthalate,C(CN)N.C1(=C(C(=C(C(=C1Br)Br)Br)Br)C(=O)O)C(=O)O.C1(=C(C(=C(C(=C1Br)Br)Br)Br)C(=O)O)C(=O)O,,,,,,
3100,163101,"1H-Isoindole-1,3(2H)-dione, 2,2'-(1,6-hexanediyl)bis[4,5,6,7-tetrachloro-",C(CCCN1C(=O)C2=C(C1=O)C(=C(C(=C2Cl)Cl)Cl)Cl)CCN3C(=O)C4=C(C3=O)C(=C(C(=C4Cl)Cl)Cl)Cl,,,,,,
3101,163102,CID 163102,[Li+].[Li+].C1=CC(=CC=C1N=NC2=CC(=C(C=C2)C=CC3=C(C=C(C=C3)N=NC4=CC=C(C=C4)O)S(=O)(=O)[O-])S(=O)(=O)[O-])O.[Na+].[Na+],,,,,,
3102,163103,Technetium Tc 99m (Sn)methylenediphosphonate,C(P(=O)(O)O)P(=O)(O)O.[99Tc+4].[99Tc+4].[Sn+2],,,,,,
3103,163104,CID 163104,CCCCCCCCCCCCO.CCCC=CCCCCCCCOC(=O)C,,,,,,
3104,163105,Technetium imidodiphosphate,N=P([O-])([O-])OP(=O)([O-])[O-].[Tc+4],,,,,,
3105,163106,Dihydroxyphosphinimyl dihydrogen phosphate,N=P(O)(O)OP(=O)(O)O,,,,,,
3106,163107,Aluminum magnesium chloride hydroxide(2:2:5:5),[OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Mg+2].[Al+3].[Al+3].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-],,,,,,
3107,163108,CID 163108,[Cu].[Cu].[Cu].[Ag].[Ag].[Ag].[Ag].[SnH2].[SnH2].[SnH2],,,,,,
3108,163109,CID 163109,C1=CC=C2C(=C1)C(=CC3=NN(N=C23)C4=CC(=C(C=C4)C=CC5=C(C=C(C=C5)N=[N+](C6=CC(=C(C=C6)S(=O)(=O)[O-])C=CC7=C(C=C(C=C7)N8N=C9C=C(C1=CC=CC=C1C9=N8)S(=O)(=O)[O-])S(=O)(=O)[O-])[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,,,,,
3109,163110,CID 163110,C1=CC=C2C(=C1)C(=CC3=NN(N=C23)C4=CC(=C(C=C4)C=CC5=C(C=C(C=C5)N=[N+](C6=CC(=C(C=C6)S(=O)(=O)O)C=CC7=C(C=C(C=C7)N8N=C9C=C(C1=CC=CC=C1C9=N8)S(=O)(=O)O)S(=O)(=O)O)[O-])S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3110,163111,CID 163111,C(=O)(O)[O-].[OH-].[OH-].[OH-].[O-2].[Na+].[Mg+2].[Al+3].[SiH4],,,,,,
3111,163112,Technetium N-(methylamino)methylene diphosphonate,CNC(P(=O)(O)O)P(=O)(O)O.[99Tc],,,,,,
3112,163113,CID 163113,CC(=O)NC1=CC(=CC=C1)N=NC2=CC(=C(C=C2OC)N=NC3=C(C=CC4=CC(=CC(=C43)O)S(=O)(=O)[O-])N)OC.[Na+],,,,,,
3113,163114,"5-({4-[2-(3-Acetamidophenyl)hydrazinyl]-2,5-dimethoxyphenyl}diazenyl)-6-imino-4-oxo-4,6-dihydronaphthalene-2-sulfonic acid",CC(=O)NC1=CC(=CC=C1)N=NC2=CC(=C(C=C2OC)N=NC3=C(C=CC4=CC(=CC(=C43)O)S(=O)(=O)O)N)OC,,,,,,
3114,163115,CID 163115,C[C@]1(CC(=C)[C@H](C[C@H]1Br)C=CCl)Cl,,,,,,
3115,163116,Desmethylranitidine,CNCC1=CC=C(O1)CSCCNC(=C[N+](=O)[O-])NC,,,,,,
3116,163117,"2-(6-Methoxy-1,3-benzoxazol-2-yl)-1,3-dimethyl-1h-3,1-benzimidazol-3-ium methyl sulfate",CN1C2=CC=CC=C2[N+](=C1C3=NC4=C(O3)C=C(C=C4)OC)C.COS(=O)(=O)[O-],,,,,,
3117,163118,"2-(6-Methoxybenzoxazol-2-yl)-1,3-dimethyl-1H-benzimidazol-3-ium",CN1C2=CC=CC=C2[N+](=C1C3=NC4=C(O3)C=C(C=C4)OC)C,,,,,,
3118,163119,N-Methyljervine methiodide,C[C@H]1C[C@@H]2[C@H]([C@H]([C@]3(O2)CC[C@H]4[C@@H]5CC=C6C[C@H](CC[C@@H]6[C@H]5C(=O)C4=C3C)O)C)[N+](C1)(C)C.[I-],,,,,,
3119,163120,CID 163120,C[C@H]1C[C@@H]2[C@H](C([C@]3(O2)CC[C@H]4[C@@H]5CC=C6C[C@H](CC[C@@H]6C5C(=O)C4=C3C)O)C)[N+](C1)(C)C,,,,,,
3120,163121,"Pyrimidine, 2-((2,4-dinitrophenyl)thio)-",C1=CN=C(N=C1)SC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
3121,163122,(2S-(2R*(R*(R*))))-N-(2-(4-(Aminocarbonyl)-3-thiazolidinyl)-1-(1H-imidazol-4-ylmethyl)-2-oxoethyl)-6-oxopiperidine-2-carboxamide,C1C[C@H](NC(=O)C1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CSC[C@@H]3C(=O)N,,,"['Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)']",,,
3122,163123,CID 163123,[OH-].[O-]P(=O)([O-])[O-].[AlH3],,,,,,
3123,163124,CID 163124,CCCCCCCCCCCC12OC3C4C5C(O5)(C(C6(C(C4(O1)C(CC3(O2)C(=C)C)C)C=C(C6=O)C)O)O)CO,,,,,,
3124,163125,"6-Hydroxy-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3-yl propanoate",CCC(=O)OC1=C2C3=C(CC4[C@H]5[C@]3(CCN4C)[C@@H](O2)[C@H](C=C5)O)C=C1,,,,,,
3125,163126,"3-Hydroxy-17-methyl-7,8-didehydro-4,5-epoxymorphinan-6-yl propanoate",CCC(=O)O[C@H]1C=C[C@H]2C3CC4=C5[C@]2([C@H]1OC5=C(C=C4)O)CCN3C,,,,,,
3126,163127,CID 163127,COC1=C(C=C(C=C1)C=C[C@@]2(CCC[C@@H]3[C@H]2CCN3)O)OC.COC1=C(C=C(C=C1)C=C[C@@]2(CCC[C@@H]3[C@H]2CCN3)O)OC.C(=CC(=O)[O-])C(=O)[O-],,,,,,
3127,163128,CID 163128,COC1=C(C=C(C=C1)C=C[C@@]2(CCC[C@@H]3[C@H]2CCN3)O)OC,,,,,,
3128,163129,"D-Gluconic acid, compd. with 2,2'-iminobis[ethanol] (1:1)",C(CO)NCCO.C([C@H]([C@H]([C@@H]([C@H](C(=O)O)O)O)O)O)O,,,,,,
3129,163130,Tralocythrin,CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C(C(Cl)(Cl)Br)Br)C,,,,,,
3130,163131,"N-(N(sup 2)-((6,7-Dimethoxy-2-naphthalenyl)sulfonyl)-L-arginyl)-N-(2-methoxyethyl)glycine",COCCN(CC(=O)O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)C1=CC2=CC(=C(C=C2C=C1)OC)OC,,,,,,
3131,163132,Meglumine papaveroline 6'-sulfonate,CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.C1=CC(=C(C=C1CC2=NC=CC3=CC(=C(C=C32)O)OS(=O)(=O)O)O)O,,,,,,
3132,163133,"[1-[(3,4-Dihydroxyphenyl)methyl]-7-hydroxyisoquinolin-6-yl] hydrogen sulfate",C1=CC(=C(C=C1CC2=NC=CC3=CC(=C(C=C32)O)OS(=O)(=O)O)O)O,,,,,,
3133,163134,"Chromate(1-), bis(2-chloro-4-(2-(4,5-dihydro-3-methyl-5-(oxo-kappaO)-1-phenyl-1H-pyrazol-4-yl)diazenyl-kappaN1)-5-(hydroxy-kappaO)benzenesulfonamidato(2-))-, sodium (1:1)",CC1=NN(C(=C1N=NC2=CC(=C(C=C2[O-])S(=O)(=O)N)Cl)[O-])C3=CC=CC=C3.CC1=NN(C(=C1N=NC2=CC(=C(C=C2[O-])S(=O)(=O)N)Cl)[O-])C3=CC=CC=C3.[Na+].[Cr+3],,,,,,
3134,163135,"Benzenesulfonamide, 2-chloro-4-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-hydroxy-",CC1=C(C(=O)N(N1)C2=CC=CC=C2)N=NC3=CC(=C(C=C3O)S(=O)(=O)N)Cl,,,,,,
3135,163136,Fokaptame,CCN(CC)P(=O)(N1C2=CC=CC=C2SC1=S)N(CC)CC,,,,,,
3136,163137,CID 163137,COC1=CC=CC(=C1)C=NOCC(CN2CCN(CC2)C3=CC=CC=C3OC)O.Cl.Cl,,,,,,
3137,163138,Peradoxime,COC1=CC=CC(=C1)C=NOCC(CN2CCN(CC2)C3=CC=CC=C3OC)O,,,,,,
3138,163139,"Chromium, (3-((4,5-dihydro-3-methyl-5-(oxo-kappaO)-1-phenyl-1H-pyrazol-4-yl)azo-kappaN1)-2-(hydroxy-kappaO)-5-nitrobenzenesulfonato(3-))-",CC1=NN(C(=C1N=NC2=C(C(=CC(=C2)[N+](=O)[O-])S(=O)(=O)[O-])[O-])[O-])C3=CC=CC=C3.[Cr+3],,,,,,
3139,163140,"Chromate(1-), bis(2,4-dihydro-4-(2-(2-(hydroxy-kappaO)-5-nitrophenyl)diazenyl-kappaN1)-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)-kappaO3)-, sodium (1:1)",CC1=NN(C(=C1N=NC2=C(C=CC(=C2)[N+](=O)[O-])[O-])[O-])C3=CC=CC=C3.CC1=NN(C(=O)C1=NN=C2C=C(C=CC2=O)N([O-])[O-])C3=CC=CC=C3.[Na+].[Cr+3],,,,,,
3140,163141,Croton factor F2,CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@H]([C@@]2([C@@H]3C=C(C(=O)[C@H]3CC(=C[C@H]2[C@H]4[C@@]1([C@]4(C)CO)OC(=O)C)CO)C)O)C,,,,,,
3141,163142,3-Phenoxy-N-methylmorphinan,CN1CC[C@]23CCCC[C@H]2C1CC4=C3C=C(C=C4)OC5=CC=CC=C5,,,,,,
3142,163143,Normorphine 3-glucuronide,C1CNC2CC3=C4[C@@]15[C@H]2C=CC(C5OC4=C(C=C3)OC6C(C(C(C(O6)C(=O)O)O)O)O)O,,,,,,
3143,163144,CID 163144,C1(C(C(C(C(C1(F)F)(F)F)(F)F)(F)F)(F)F)(C(C(F)(F)F)(F)F)S(=O)(=O)[O-].[K+],,,,,,
3144,163145,Perfluoro-1-(perfluoroethyl)cyclohexanesulfonic acid,C1(C(C(C(C(C1(F)F)(F)F)(F)F)(F)F)(F)F)(C(C(F)(F)F)(F)F)S(=O)(=O)O,,,,,,
3145,163146,"Octadecanamide, N-(2-hydroxyethyl)-N-[2-[(1-oxooctadecyl)amino]ethyl]-, monoacetate (salt)",CCCCCCCCCCCCCCCCCC(=O)NCCN(CCO)C(=O)CCCCCCCCCCCCCCCCC.CC(=O)O,,,,,,
3146,163147,"[5-(2,2-Dimethyl-6-methylidenecyclohexyl)-3-formylpenta-1,3-dienyl] acetate",CC(=O)OC=CC(=CCC1C(=C)CCCC1(C)C)C=O,,,,,,
3147,163148,"Benzenamine, 4,4'-[(9-butyl-9H-carbazol-3-yl)methylene]bis[N-methyl-N-phenyl-",CCCCN1C2=C(C=C(C=C2)C(C3=CC=C(C=C3)N(C)C4=CC=CC=C4)C5=CC=C(C=C5)N(C)C6=CC=CC=C6)C7=CC=CC=C71,,,,,,
3148,163149,"2,5-Furandione, dihydro-, monopolyisobutenyl derivs., reaction products with triethanolamine",C1CC(=O)OC1=O.C(CO)N(CCO)CCO,,,,,,
3149,163150,CID 163150,CC(=CCCC(=CC=CC(=O)CCC=C)C)C,,,,,,
3150,163151,Isononanoic acid monoethanolamine salt,CC(C)CCCCCC(=O)O.C(CO)N,,,,,,
3151,163152,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4,6-bis[[2-(2-hydroxyethoxy)ethyl]amino]-1,3,5-triazin-2-yl]amino]-, disodium salt",C1=CC(=C(C=C1NC2=NC(=NC(=N2)NCCOCCO)NCCOCCO)S(=O)(=O)[O-])C=CC3=C(C=C(C=C3)NC4=NC(=NC(=N4)NCCOCCO)NCCOCCO)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
3152,163153,"2,2'-(Ethene-1,2-diyl)bis{5-[(4,6-bis{[2-(2-hydroxyethoxy)ethyl]amino}-1,3,5-triazin-2-yl)amino]benzene-1-sulfonic acid}",C1=CC(=C(C=C1NC2=NC(=NC(=N2)NCCOCCO)NCCOCCO)S(=O)(=O)O)C=CC3=C(C=C(C=C3)NC4=NC(=NC(=N4)NCCOCCO)NCCOCCO)S(=O)(=O)O,,,,,,
3153,163154,"5-[[4-Anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]-2-[2-[4-[[4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]benzenesulfonic acid;2-[bis(2-hydroxyethyl)amino]ethanol",C1=CC=C(C=C1)NC2=NC(=NC(=N2)N(CCO)CCO)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC=CC=C6)N(CCO)CCO)S(=O)(=O)O)S(=O)(=O)O.C(CO)N(CCO)CCO.C(CO)N(CCO)CCO,,,,,,
3154,163155,Rhodium(III) phosphate,[O-]P(=O)([O-])[O-].[Rh+3],,,,,,
3155,163156,"2-Naphthalenesulfonic acid, 6-amino-5-((4-((3-chlorobenzoyl)amino)-2-sulfophenyl)azo)-4-hydroxy-, disodium salt",C1=CC(=CC(=C1)Cl)C(=O)NC2=CC(=C(C=C2)N=NC3=C(C=CC4=CC(=CC(=C43)O)S(=O)(=O)[O-])N)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
3156,163157,6-Amino-5-[[4-[(3-chlorobenzoyl)amino]-2-sulfophenyl]diazenyl]-4-hydroxynaphthalene-2-sulfonic acid,C1=CC(=CC(=C1)Cl)C(=O)NC2=CC(=C(C=C2)N=NC3=C(C=CC4=CC(=CC(=C43)O)S(=O)(=O)O)N)S(=O)(=O)O,,,,,,
3157,163158,Acetaminophen and codeine phosphate,CC(=O)NC1=CC=C(C=C1)O.CN1CC[C@]23[C@@H]4C1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O.OP(=O)(O)O,,,,,,
3158,163159,"(4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol",CN1CC[C@]23[C@@H]4C1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O,,,,,,
3159,163160,CID 163160,CC1=CC(=C(C=C1)O)N=NC2=CC=C(C=C2)NC3=NC(=NC(=N3)OC)N(C)CCS(=O)(=O)[O-].[Na+],,,,,,
3160,163161,"2-[(4-Methoxy-6-{4-[2-(3-methyl-6-oxocyclohexa-2,4-dien-1-ylidene)hydrazinyl]anilino}-1,3,5-triazin-2-yl)(methyl)amino]ethane-1-sulfonic acid",CC1=CC(=C(C=C1)O)N=NC2=CC=C(C=C2)NC3=NC(=NC(=N3)OC)N(C)CCS(=O)(=O)O,,,,,,
3161,163162,CID 163162,CC1=CC=C(C=C1)S(=O)(=O)OC2=CC=C(C=C2)N=NC3C(=NN(C3=O)C4=CC(=C(C=C4Cl)S(=O)(=O)[O-])Cl)C.[Na+],,,,,,
3162,163163,"2,5-Dichloro-4-[3-methyl-4-({4-[(4-methylbenzene-1-sulfonyl)oxy]phenyl}diazenyl)-5-oxo-4,5-dihydro-1H-pyrazol-1-yl]benzene-1-sulfonic acid",CC1=CC=C(C=C1)S(=O)(=O)OC2=CC=C(C=C2)N=NC3C(=NN(C3=O)C4=CC(=C(C=C4Cl)S(=O)(=O)O)Cl)C,,,,,,
3163,163164,CID 163164,CCCCCCCCC1=CC=CC=C1OCCOCCOCCS(=O)(=O)[O-].[Na+],,,,,,
3164,163165,2-{2-[2-(2-Octylphenoxy)ethoxy]ethoxy}ethane-1-sulfonic acid,CCCCCCCCC1=CC=CC=C1OCCOCCOCCS(=O)(=O)O,,,,,,
3165,163166,"Trilithium 5-amino-4-hydroxy-3-((4'-((1-hydroxy-4-sulphonato-2-naphthyl)azo)-3,3'-dimethoxy(1,1'-biphenyl)-4-yl)azo)naphthalene-2,7-disulphonate",[Li+].[Li+].[Li+].COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)[O-])S(=O)(=O)[O-])N)O)OC)N=NC5=C(C6=CC=CC=C6C(=C5)S(=O)(=O)[O-])O,,,,,,
3166,163167,"5-Amino-4-hydroxy-3-[[4'-[(1-hydroxy-4-sulfo-2-naphthalenyl)azo]-3,3'-dimethoxy[1,1'-biphenyl]-4-yl]azo]-2,7-naphthalenedisulfonic acid",COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)O)S(=O)(=O)O)N)O)OC)N=NC5=C(C6=CC=CC=C6C(=C5)S(=O)(=O)O)O,,,,,,
3167,163168,"Phosphonic acid, (hexamethylenebis(nitrilodimethylene))tetra-, hexaammonium salt",C(CCCN(CP(=O)(O)O)CP(=O)(O)O)CCN(CP(=O)(O)O)CP(=O)(O)O.N.N.N.N.N.N,,,,,,
3168,163169,"1-Heptanesulfonamide, N,N',N''-(phosphinylidynetris(oxy-2,1-ethanediyl))tris(N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-",CCN(CCOP(=O)(OCCN(CC)S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)OCCN(CC)S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
3169,163170,Ammonium bis(2-(ethyl((pentadecafluoroheptyl)sulphonyl)amino)ethyl) phosphate,CCN(CCOP(=O)([O-])OCCN(CC)S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F.[NH4+],,,,,,
3170,163171,Bis[2-[ethyl[(pentadecafluoroheptyl)sulphonyl]amino]ethyl] hydrogen phosphate,CCN(CCOP(=O)(O)OCCN(CC)S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
3171,163172,1-[Bis(2-hydroxypropyl)amino]propan-2-ol;octadec-9-enoic acid,CCCCCCCCC=CCCCCCCCC(=O)O.CC(CN(CC(C)O)CC(C)O)O,,,,,,
3172,163173,"Cuprate(4-), (mu-((6,6'-((3,3'-di(hydroxy-kappaO)(1,1'-biphenyl)-4,4'-diyl)bis((2,1-diazenediyl-kappaN1)(4,5-dihydro-3-methyl-5-(oxo-kappaO)-1H-pyrazole-4,1-diyl)))bis(1,3-naphthalenedisulfonato))(8-)))di-, sodium (1:4)",CC1=NN(C(=C1N=NC2=C(C=C(C=C2)C3=CC(=C(C=C3)N=NC4=C(N(N=C4C)C5=CC6=CC(=CC(=C6C=C5)S(=O)(=O)[O-])S(=O)(=O)[O-])[O-])[O-])[O-])[O-])C7=CC8=CC(=CC(=C8C=C7)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Cu+2].[Cu+2],,,,,,
3173,163174,"6-[4-[[4-[4-[[2-(5,7-disulfonaphthalen-2-yl)-5-methyl-3-oxo-1H-pyrazol-4-yl]diazenyl]-3-hydroxyphenyl]-2-hydroxyphenyl]diazenyl]-5-methyl-3-oxo-1H-pyrazol-2-yl]naphthalene-1,3-disulfonic acid",CC1=C(C(=O)N(N1)C2=CC3=CC(=CC(=C3C=C2)S(=O)(=O)O)S(=O)(=O)O)N=NC4=C(C=C(C=C4)C5=CC(=C(C=C5)N=NC6=C(NN(C6=O)C7=CC8=CC(=CC(=C8C=C7)S(=O)(=O)O)S(=O)(=O)O)C)O)O,,,,,,
3174,163175,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-[2-(2-hydroxyethoxy)ethoxy]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-, disodium salt",C1=CC=C(C=C1)NC2=NC(=NC(=N2)OCCOCCO)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC=CC=C6)OCCOCCO)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
3175,163176,"2,2'-(Ethene-1,2-diyl)bis[5-({4-anilino-6-[2-(2-hydroxyethoxy)ethoxy]-1,3,5-triazin-2-yl}amino)benzene-1-sulfonic acid]",C1=CC=C(C=C1)NC2=NC(=NC(=N2)OCCOCCO)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC=CC=C6)OCCOCCO)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3176,163177,CID 163177,C1=CC(=CC(=C1)S(=O)(=O)O)NC2=NC(=NC(=N2)N(CCO)CCO)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC(=CC=C6)S(=O)(=O)[O-])N(CCO)CCO)S(=O)(=O)[O-])S(=O)(=O)O.C(CO)N(CCO)CCO.C(CO)N(CCO)CCO.[Na+].[Na+],,,,,,
3177,163178,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-(4-phenyl-2H-1,2,3-triazol-2-yl)-, potassium sodium salt",C1=CC=C(C=C1)C2=NN(N=C2)C3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)N5N=CC(=N5)C6=CC=CC=C6)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[K+],,,,,,
3178,163179,Copper neodecanoate,CC(C)(C)CCCCCC(=O)[O-].CC(C)(C)CCCCCC(=O)[O-].[Cu+2],,,,,,
3179,163180,"Benzenesulfonic acid, dodecyl-, compd. with 4,4-dimethyloxazolidine (1:1)",CCCCCCCCCCCCC1=CC=CC=C1S(=O)(=O)O.CC1(COCN1)C,,,,,,
3180,163181,"Benzoic acid, 3-methyl-, cadmium salt",CC1=CC(=CC=C1)C(=O)[O-].CC1=CC(=CC=C1)C(=O)[O-].[Cd+2],,,,,,
3181,163182,Zinc m-toluate,CC1=CC(=CC=C1)C(=O)[O-].CC1=CC(=CC=C1)C(=O)[O-].[Zn+2],,,,,,
3182,163183,"Hexanedioic acid, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol, octadecanoate",CCCCCCCCCCCCCCCCCC(=O)O.C(CCC(=O)O)CC(=O)O.C(C(CO)(CO)CO)O,,,,,,
3183,163184,"Nonanedioic acid, reaction products with triethanolamine",C(CCCC(=O)O)CCCC(=O)O.C(CO)N(CCO)CCO,,,,,,
3184,163185,"Nonanedioic acid, reaction products with diethanolamine",C(CCCC(=O)O)CCCC(=O)O.C(CO)NCCO,,,,,,
3185,163186,CID 163186,[H+].C1=CC=C(C=C1)C(=NNC2=CC(=CC(=NC3=NC(=NC(=NC4=C(C=C(C(=C4)S(=O)(=O)[O-])N=C5[N-]C(=NC(=NC6=CC(=CC=C6)S(=O)(=O)[O-])[N-]5)Cl)S(=O)(=O)[O-])[N-]3)Cl)C2=O)S(=O)(=O)[O-])NNC7=C(C=C(C=C7)S(=O)(=O)[O-])C(=O)O.[Na+].[Na+].[Na+].[Na+].[Na+].[Cu+2],,,,,,
3186,163187,CID 163187,C1=CC=C(C=C1)C(=NNC2=CC(=CC(=C2O)NC3=NC(=NC(=N3)Cl)NC4=C(C=C(C(=C4)S(=O)(=O)O)NC5=NC(=NC(=N5)NC6=CC(=CC=C6)S(=O)(=O)O)Cl)S(=O)(=O)O)S(=O)(=O)O)N=NC7=C(C=C(C=C7)S(=O)(=O)O)C(=O)O,,,,,,
3187,163188,2-Amino-2-methylpropan-1-ol;octadec-9-enoic acid,CCCCCCCCC=CCCCCCCCC(=O)O.CC(C)(CO)N,,,,,,
3188,163189,"Acetic acid, hydroxy-, compd. with 2-aminoethanol (1:1)",C(CO)N.C(C(=O)O)O,,,,,,
3189,163190,"Octadecanoic acid, compd. with 1-dodecylpiperidine (1:1)",CCCCCCCCCCCCCCCCCC(=O)O.CCCCCCCCCCCCN1CCCCC1,,,,,,
3190,163191,Epichlorohydrin triethanolamine,C1C(O1)CCl.C(CO)N(CCO)CCO,,,,,,
3191,163192,"Phosphonic acid, [[(phosphonomethyl)imino]bis[2,1-ethanediylnitrilobis(methylene)]]tetrakis-, heptasodium salt",C(CN(CP(=O)(O)O)CP(=O)(O)O)N(CCN(CP(=O)(O)O)CP(=O)(O)O)CP(=O)(O)O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,,,,,
3192,163193,CID 163193,C1(C(C(C(C(C1(F)F)(F)F)(F)F)(F)F)(C(F)(F)F)S(=O)(=O)[O-])(C(F)(F)F)F.[K+],,,,,,
3193,163194,"2,2,3,3,4,4,5,5,6-Nonafluoro-1,6-bis(trifluoromethyl)cyclohexane-1-sulfonic acid",C1(C(C(C(C(C1(F)F)(F)F)(F)F)(F)F)(C(F)(F)F)S(=O)(=O)O)(C(F)(F)F)F,,,,,,
3194,163195,CID 163195,C1(C(C(C(C(C1(F)F)(F)F)(F)F)(F)F)(F)F)(C(F)(F)F)S(=O)(=O)[O-].[K+],,,,,,
3195,163196,1-Perfluoromethylcyclohexane-1-sulfonic acid,C1(C(C(C(C(C1(F)F)(F)F)(F)F)(F)F)(F)F)(C(F)(F)F)S(=O)(=O)O,,,,,,
3196,163197,"Naphthalenesulfonic acid, di-C5-6-alkyl derivs., compds. with cyclohexylamine",C1CCC(CC1)N.C1=CC=C2C(=C1)C=CC=C2S(=O)(=O)O,,,,,,
3197,163198,"Naphthalenesulfonic acid, di-C5-6-alkyl derivs., compds. with butylamine",CCCCN.C1=CC=C2C(=C1)C=CC=C2S(=O)(=O)O,,,,,,
3198,163199,Diethanolamine bisulfate,C(CO)NCCO.OS(=O)(=O)O,,,,,,
3199,163200,"Tetrapotassium tetrahydrogen (ethane-1,2-diylbis(nitrilobis(methylene)))tetrakisphosphonate",C(CN(CP(=O)(O)O)CP(=O)(O)O)N(CP(=O)(O)O)CP(=O)(O)O.[K+].[K+].[K+].[K+],,,,,,
3200,163201,"Phosphoric acid, 2-ethylhexyl ester, triethanolamine salt",CCCCC(CC)CO.C(CO)N(CCO)CCO.OP(=O)(O)O,,,,,,
3201,163202,"2-Naphthalenesulfonic acid, 7-amino-4-hydroxy-3-[[4-[(4-sulfophenyl)azo]phenyl]azo]-, compd. with 2,2'-iminobis[ethanol] (1:2)",C1=CC(=CC=C1N=NC2=CC=C(C=C2)S(=O)(=O)O)N=NC3=C(C=C4C=C(C=CC4=C3O)N)S(=O)(=O)O.C(CO)NCCO.C(CO)NCCO,,,,,,
3202,163203,Chromium fluorosilicate,[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[Si+4].[Si+4].[Si+4].[Cr+3].[Cr+3],,,,,,
3203,163204,Einecs 269-448-4,C1=CC2=C(C=C1S(=O)(=O)[O-])C3=NC4=NC(=NC5=C6C=CC(=CC6=C([N-]5)N=C7C8=C(C=C(C=C8)S(=O)(=O)[O-])C(=N7)N=C2[N-]3)S(=O)(=O)[O-])C9=C4C=CC(=C9)S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Cu+2],,,,,,
3204,163205,"Phenol, 3-amino-, sulfate (2:1) (salt)",C1=CC(=CC(=C1)O)N.C1=CC(=CC(=C1)O)N.OS(=O)(=O)O,,,,,,
3205,163206,"2-Propanol, 1-amino-, benzoate (salt)",CC(CN)O.C1=CC=C(C=C1)C(=O)O,,,,,,
3206,163207,"1-Butanesulfonic acid, 1,1,2,2,3,3,4,4,4-nonafluoro-, ammonium salt",C(C(C(F)(F)S(=O)(=O)[O-])(F)F)(C(F)(F)F)(F)F.[NH4+],,,,,,
3207,163208,CID 163208,CCCCOCCOCCC(=O)[O-].[Na+],,,,,,
3208,163209,"Octanoic acid, 2,2-dimethyl-, compd. with 2,2'-iminobis[ethanol] (1:1)",CCCCCCC(C)(C)C(=O)O.C(CO)NCCO,,,,,,
3209,163210,"Zirconate(2-), bis(carbonato(2-)-kappaO)dihydroxy-, diammonium, (T-4)-",C(=O)([O-])[O-].C(=O)([O-])[O-].[NH4+].[NH4+].[OH-].[OH-].[Zr+4],,,,,,
3210,163211,"Chromate(2-), (2,4-dihydro-4-((2-(hydroxy-kappaO)-5-methyl-3-nitrophenyl)azo-kappaN1)-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)-kappaO3)(3-((4,5-dihydro-3-methyl-5-(oxo-kappaO)-1-phenyl-1H-pyrazol-4-yl)azo-kappaN1)-4-(hydroxy-kappaO)-5-nitrobenzenesulfonato(3-))-, disodium",CC1=CC(=C(C(=C1)[N+](=O)[O-])[O-])N=NC2=C(N(N=C2C)C3=CC=CC=C3)[O-].CC1=NN(C(=O)C1=NN=C2C=C(C=C(C2=O)N([O-])[O-])S(=O)(=O)[O-])C3=CC=CC=C3.[Cr+3],,,,,,
3211,163212,CID 163212,CC1=CC(=NN=C2C(=NN(C2=O)C3=CC=CC=C3)C)C(=O)C(=C1)N(O)O,,,,,,
3212,163213,"5-(Dioxidoamino)-3-[(3-methyl-5-oxo-1-phenylpyrazol-4-ylidene)hydrazinylidene]-4-oxocyclohexa-1,5-diene-1-sulfonic acid",CC1=NN(C(=O)C1=NN=C2C=C(C=C(C2=O)N([O-])[O-])S(=O)(=O)O)C3=CC=CC=C3,,,,,,
3213,163214,H-Lys-OH.Unk-N(Me)4Abz-Glu-OH,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O.C(CCN)C[C@@H](C(=O)O)N,,,,,,
3214,163215,Carbonylbis((1H-benzimidazol-1-ylcarbonyl)benzoic) acid,C1=CC=C(C(=C1)C(=O)N2C=NC3=CC=CC=C32)C(=O)OC(=O)OC(=O)C4=CC=CC=C4C(=O)N5C=NC6=CC=CC=C65,,,,,,
3215,163216,Manganese bis(dimethylhexanoate),CCCCC(C)(C)C(=O)[O-].CCCCC(C)(C)C(=O)[O-].[Mn+2],,,,,,
3216,163217,"2,2-Dimethylhexanoic acid",CCCCC(C)(C)C(=O)O,,,,,,
3217,163218,Pentapotassium pentahydrogen ((bis(2-(bis(phosphonatomethyl)amino)ethyl)amino)methyl)phosphonate,C(CN(CP(=O)(O)[O-])CP(=O)(O)[O-])N(CCN(CP(=O)(O)[O-])CP(=O)(O)[O-])CP(=O)(O)[O-].[K+].[K+].[K+].[K+].[K+],,,,,,
3218,163219,"Distillates (coal), solvent-refining (SRC), recycle",C1C(O1)CCl.C(C#CCO)O,,,,,,
3219,163220,"Butanal, reaction products with butylamine",CCCCN.CCCC=O,,,,,,
3220,163221,"Butanal, reaction products with aniline",CCCC=O.C1=CC=C(C=C1)N,,,,,,
3221,163222,"Phosphoric acid, reaction products with aluminum hydroxide and boric acid (H3BO3)",B(O)(O)O.[OH-].[OH-].[OH-].OP(=O)(O)O.[Al+3],,,,,,
3222,163223,"Benzenesulfonic acid, C10-13-alkyl derivs., compds. with triethanolamine",C1=CC=C(C=C1)S(=O)(=O)O.C(CO)N(CCO)CCO,,,,,,
3223,163224,"2-Furancarboxaldehyde, reaction products with heptanal, hydrogenated",CCCCCCC=O.C1=COC(=C1)C=O,,,,,,
3224,163225,"Formaldehyde, reaction products with o-toluidine",CC1=CC=CC=C1N.C=O,,,,,,
3225,163226,"1,2-Ethanediamine, N-(2-aminoethyl)-, reaction products with bisphenol A diglycidyl ether homopolymer",CC(C)(C1=CC=C(C=C1)OCC2CO2)C3=CC=C(C=C3)OCC4CO4.C(CNCCN)N,,,,,,
3226,163227,"Octadecanoic acid, reaction products with diethylenetriamine",CCCCCCCCCCCCCCCCCC(=O)O.C(CNCCN)N,,,,,,
3227,163228,"Octadecanoic acid, reaction products with 2-((2-aminoethyl)amino)ethanol and urea",CCCCCCCCCCCCCCCCCC(=O)O.C(CNCCO)N.C(=O)(N)N,,,,,,
3228,163229,"Octadecanamide, N-(2-((2-hydroxyethyl)amino)ethyl)-, reaction products with urea",CCCCCCCCCCCCCCCCCC(=O)NCCNCCO.C(=O)(N)N,,,,,,
3229,163230,CID 163230,CC(C)CCCCCCCCCCCCCCC(=O)[O-].[K+],,,,,,
3230,163231,Einecs 270-370-8,C1=C2C(=CC(=C1Br)Br)C3=NC2=NC4=C5C(=C([N-]4)N=C6C7=CC(=C(C(=C7C(=N6)[N-]C8=NC(=N3)C9=CC(=C(C(=C98)Cl)Br)Br)Br)Br)Br)C=C(C(=C5Cl)Br)Br.[Cu+2],,,,,,
3231,163232,CID 163232,C1=C2C(=CC(=C1Br)Br)C3=NC2=NC4=C5C=C(C(=C(C5=C(N4)NC6=NC(=NC7=NC(=N3)C8=C(C(=C(C=C87)Br)Br)Cl)C9=CC(=C(C(=C96)Br)Br)Br)Cl)Br)Br,,,,,,
3232,163233,CID 163233,CCCCCCCCCCC=CC1CC(=O)OC1=O.CCCCCCCCC=CCCCCCCCC(=O)O.C(CNCCNCCN)N,,,,,,
3233,163234,"Chromate(2-), (3-(hydroxy-kappaO)-4-((2-(hydroxy-kappaO)-1-naphthalenyl)azo-kappaN1)-7-nitro-1-naphthalenesulfonato(3-))(1-((2-(hydroxy-kappaO)-4-nitrophenyl)azo-kappaN1)-2-naphthalenolato(2-)-kappaO)-, sodium hydrogen",[H+].C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=C(C=C3)[N+](=O)[O-])[O-])[O-].C1=CC=C2C(=C1)C=CC(=O)C2=NN=C3C4=C(C=C(C=C4)N([O-])[O-])C(=CC3=O)S(=O)(=O)[O-].[Na+].[Cr+3],,,,,,
3234,163235,"Chromate(2-), (2,4-dihydro-4-((2-(hydroxy-kappaO)-5-nitrophenyl)azo-kappaN1)-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)-kappaO3)(3-(hydroxy-kappaO)-4-((2-(hydroxy-kappaO)-1-naphthalenyl)azo-kappaN1)-7-nitro-1-naphthalenesulfonato(3-))-, sodium hydrogen",[H+].CC1=NN(C(=C1N=NC2=C(C=CC(=C2)[N+](=O)[O-])[O-])[O-])C3=CC=CC=C3.C1=CC=C2C(=C1)C=CC(=O)C2=NN=C3C4=C(C=C(C=C4)N([O-])[O-])C(=CC3=O)S(=O)(=O)[O-].[Na+].[Cr+3],,,,,,
3235,163236,Isobutyl beta-2-furylacrylate,CC(C)COC(=O)C=CC1=CC=CO1,,,,,,
3236,163237,"Boric acid (H3BO3), reaction products with ethanolamine and triethanolamine",B(O)(O)O.C(CO)N.C(CO)N(CCO)CCO,,,,,,
3237,163238,CID 163238,CCCCCCCCCCC=CC1CC(=O)OC1=O.CC(CN)O,,,,,,
3238,163239,"Hexanoic acid, 2-ethyl-, reaction products with diethanolamine",CCCCC(CC)C(=O)O.C(CO)NCCO,,,,,,
3239,163240,CID 163240,CCCCCC=CCC=CCCCCCCCC(=O)O.CCCCCC=CCC=CCCCCCCCC(=O)O.C(CNCCNCCN)N,,,,,,
3240,163241,Trisodium bis(4-hydroxy-3-((2-hydroxy-4-nitrophenyl)azo)naphthalene-1-sulphonato(3-))chromate(3-),C1=CC=C2C(=C1)C(=CC(=C2[O-])N=NC3=C(C=C(C=C3)[N+](=O)[O-])[O-])S(=O)(=O)[O-].C1=CC=C2C(=C1)C(=CC(=NN=C3C=CC(=CC3=O)N([O-])[O-])C2=O)S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Cr+3],,,,,,
3241,163242,"3-[[4-(Dioxidoamino)-6-oxocyclohexa-2,4-dien-1-ylidene]hydrazinylidene]-4-oxonaphthalene-1-sulfonic acid",C1=CC=C2C(=C1)C(=CC(=NN=C3C=CC(=CC3=O)N([O-])[O-])C2=O)S(=O)(=O)O,,,,,,
3242,163243,Acid Blue 317,C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=C(C=C3)[N+](=O)[O-])[O-])[O-].C1=CC=C2C(=C1)C(=CC(=NN=C3C=CC(=CC3=O)N([O-])[O-])C2=O)S(=O)(=O)[O-].[Na+].[Na+].[Cr+3],,,,,,
3243,163244,"2-Ethylhexanol, phosphate, potassium salt",CCCCC(CC)CO.OP(=O)([O-])[O-].[K+].[K+],,,,,,
3244,163245,"1,3-Naphthalenedisulfonic acid, 7-hydroxy-8-((4-(phenylazo)phenyl)azo)-, compd. with 2-ethyl-N-(2-ethylhexyl)-1-hexanamine (1:2)",CCCCC(CC)CNCC(CC)CCCC.CCCCC(CC)CNCC(CC)CCCC.C1=CC=C(C=C1)N=NC2=CC=C(C=C2)N=NC3=C(C=CC4=CC(=CC(=C43)S(=O)(=O)O)S(=O)(=O)O)O,,,,,,
3245,163246,"Benzenamine, 4,4'-carbonimidoylbis[N,N-dimethyl-, compd. with molybdenum phosphorus hydroxide oxide (1:1)",CN(C)C1=CC=C(C=C1)C(=N)C2=CC=C(C=C2)N(C)C.[OH-].[O-2].P.[Mo],,,,,,
3246,163247,"Chromate(2-), (3-(hydroxy-kappaO)-4-(2-(2-(hydroxy-kappaO)-1-naphthalenyl)diazenyl-kappaN1)-7-nitro-1-naphthalenesulfonato(3-))(1-(2-(2-(hydroxy-kappaO)-5-nitrophenyl)diazenyl-kappaN1)-2-naphthalenolato(2-)-kappaO)-, sodium hydrogen (1:1:1)",[H+].C1=CC=C2C(=C1)C=CC(=C2N=NC3=C4C=CC(=CC4=C(C=C3[O-])S(=O)(=O)[O-])[N+](=O)[O-])[O-].C1=CC=C2C(=C1)C=CC(=O)C2=NN=C3C=C(C=CC3=O)N([O-])[O-].[Na+].[Cr+3],,,,,,
3247,163248,Heptanoic acid diethanolamine salt,CCCCCCC(=O)O.C(CO)NCCO,,,,,,
3248,163249,"Ethanamine, N-ethyl-N-hydroxy-, reaction products with hexamethylcyclotrisiloxane, silica and 1,1,1-trimethyl-N-(trimethylsilyl)silanamine",CCN(CC)O.C[Si]1(O[Si](O[Si](O1)(C)C)(C)C)C.C[Si](C)(C)N[Si](C)(C)C.O=[Si]=O,,,,,,
3249,163250,"Silane, trimethoxymethyl-, hydrolysis products with silica",CO[Si](C)(OC)OC.O=[Si]=O,,,,,,
3250,163251,"Octanal, 7-hydroxy-3,7-dimethyl-, reaction products with 3-methyl-1H-indole",CC1=CNC2=CC=CC=C12.CC(CCCC(C)(C)O)CC=O,,,,,,
3251,163252,"Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, reaction products with 2,4,6,8-tetraethenyl-2,4,6,8-tetramethylcyclotetrasiloxane",[H+].[H+].C[Si]1(O[Si](O[Si](O[Si](O1)(C)C=C)(C)C=C)(C)C=C)C=C.[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Pt+4],,,,,,
3252,163253,CID 163253,CC[O-].CC(C)[O-].CC(=CC(=O)C)[O-].CC(=CC(=O)C)[O-].[Ti+4],,,,,,
3253,163254,CID 163254,CCCCCCCCCCCCCCCCCC1=NCCN1CCO.C(C(=O)O)Cl.[OH-].[Na+],,,,,,
3254,163255,CID 163255,CCCCCCCC1=NCCN1CCO.C(C(=O)O)Cl.[OH-].[Na+],,,,,,
3255,163256,"Phenol, 4,4'-(1-methylethylidene)bis-, reaction products with diethylenetriamine",CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O.C(CNCCN)N,,,,,,
3256,163257,CID 163257,CCCCCCCC1=NCCN1CCO.C(C(CCl)O)S(=O)(=O)[O-].[Na+],,,,,,
3257,163258,CID 163258,CCCCC(CC)CN.COC(=O)C=C.[OH-].[Na+],,,,,,
3258,163259,"3-Pentanone, 1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-, reaction products with 2-propyn-1-ol",CCC(=O)CCC1C(=CCCC1(C)C)C.C#CCO,,,,,,
3259,163260,"Ethanol, 2-amino-, reaction products with ammonia, by-products from",C(CO)N.N,,,,,,
3260,163261,Mono((acetyloxy)methyl)octanol acetate,CCCCCCCC(COC(=O)C)OC(=O)C,,,,,,
3261,163262,Einecs 272-261-0,C[C@]12CCCC([C@@H]1CC[C@@]([C@@H]2CC[C@](C)(C=C)O)(C)O)(C)C.[O-][Cr](=O)(=O)O[Cr](=O)(=O)[O-].[Na+].[Na+],,,,,,
3262,163263,Sclareol,C[C@]12CCCC([C@@H]1CC[C@@]([C@@H]2CC[C@](C)(C=C)O)(C)O)(C)C,,,,,,
3263,163264,"Boric acid (H3BO3), compd. with 2-aminoethanol (1:3)",B(O)(O)O.C(CO)N.C(CO)N.C(CO)N,,,,,,
3264,163265,"3,7-Dimethylocta-2,6-dienal;propan-2-one",CC(=CCCC(=CC=O)C)C.CC(=O)C,,,,,,
3265,163266,"Nonanedioic acid, compd. with 2,2'-iminobis(ethanol)",C(CCCC=O)CCCC(=O)O.C(CO)NCCO,,,,,,
3266,163267,"Formic acid, reaction products with boron trifluoride and (1S,3aR,4S,8aS)-decahydro-4,8,8-trimethyl-9-methylene-1,4-methanoazulene",B(F)(F)F.C[C@]12CCCC([C@H]3[C@H]1CC[C@@H]3C2=C)(C)C.C(=O)O,,,,,,
3267,163268,CID 163268,C[C@]12CCCC([C@H]3[C@H]1CCC3C2=C)(C)C,,,,,,
3268,163269,"2-Butyne-1,4-diol, reaction products with epichlorohydrin and sodium sulfite",C1C(O1)CCl.C(C#CCO)O.[O-]S(=O)[O-].[Na+].[Na+],,,,,,
3269,163270,"1-Propanaminium, 3-chloro-2-hydroxy-N,N,N-trimethyl-, chloride, reaction products with tetraethylenepentamine",C[N+](C)(C)CC(CCl)O.C(CNCCNCCNCCN)N.[Cl-],,,,,,
3270,163271,Einecs 272-586-8,CCN(CC(=O)[O-])S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F.CC(C)CO.CC(C)CO.O.O.[OH-].[Cl-].[Cl-].[Cl-].[Cl-].[Cr+3].[Cr+3],,,,,,
3271,163272,Einecs 272-587-3,CCN(CC(=O)[O-])S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F.CC(C)O.CC(C)O.O.O.[OH-].[Cl-].[Cl-].[Cl-].[Cl-].[Cr+3].[Cr+3],,,,,,
3272,163273,Einecs 272-588-9,CCN(CC(=O)[O-])S(=O)(=O)C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F.CC(C)O.CC(C)O.O.O.[OH-].[Cl-].[Cl-].[Cl-].[Cl-].[Cr+3].[Cr+3],,,,,,
3273,163274,Einecs 272-589-4,CCN(CC(=O)[O-])S(=O)(=O)C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F.CC(C)O.CC(C)O.O.O.[OH-].[Cl-].[Cl-].[Cl-].[Cl-].[Cr+3].[Cr+3],,,,,,
3274,163275,"1,4-Benzenedisulfonic acid, 2-(2-(4-(2-(4-((4,6-dichloro-1,3,5-triazin-2-yl)amino)-5-sulfo-1-naphthalenyl)diazenyl)-2,5-dimethylphenyl)diazenyl)-, sodium salt (1:3)",CC1=CC(=C(C=C1N=NC2=C(C=CC(=C2)S(=O)(=O)[O-])S(=O)(=O)[O-])C)N=NC3=C4C=CC=C(C4=C(C=C3)NC5=NC(=NC(=N5)Cl)Cl)S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
3275,163276,"2-((4-((4-((4,6-Dichloro-1,3,5-triazin-2-yl)amino)-5-sulpho-1-naphthyl)azo)-2,5-dimethylphenyl)azo)benzene-1,4-disulphonic acid",CC1=CC(=C(C=C1N=NC2=C(C=CC(=C2)S(=O)(=O)O)S(=O)(=O)O)C)N=NC3=C4C=CC=C(C4=C(C=C3)NC5=NC(=NC(=N5)Cl)Cl)S(=O)(=O)O,,,,,,
3276,163277,Einecs 272-646-3,CCN(CC(=O)[O-])S(=O)(=O)C(C(C(C(F)(F)F)(F)F)(F)F)(F)F.CC(C)O.CC(C)O.O.O.[OH-].[Cl-].[Cl-].[Cl-].[Cl-].[Cr+3].[Cr+3],,,,,,
3277,163278,"1,4-Dimethyl-7-(propan-2-yl)-1,2,3,4,5,6,7,8-octahydroazulene",CC1CCC(CC2=C1CCC2C)C(C)C,,,,,,
3278,163279,"Benzenemethanamine, N-(dimethylphenyl)-, hydrochloride",CC1=C(C(=CC=C1)NCC2=CC=CC=C2)C.Cl,,,,,,
3279,163280,"N-benzyl-2,3-dimethylaniline",CC1=C(C(=CC=C1)NCC2=CC=CC=C2)C,,,,,,
3280,163281,"Octanal, 7-hydroxy-3,7-dimethyl-, reaction products with 1H-indole",CC(CCCC(C)(C)O)CC=O.C1=CC=C2C(=C1)C=CN2,,,,,,
3281,163282,"Ethanol, 2,2'-oxybis-, reaction products with ammonia, fractionation forecuts",C(COCCO)O.N,,,,,,
3282,163283,"Sulfuric acid, mono-C10-16-alkyl esters, compds. with isopropanolamine",CC(CN)O.OS(=O)(=O)O,,,,,,
3283,163284,"Benzenemethanol, 3,5-bis(1,1-dimethylethyl)-4-hydroxy-, reaction products with 1,3,5-trimethylbenzene",CC1=CC(=CC(=C1)C)C.CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)CO,,,,,,
3284,163285,"Cuprate(4-), (2-((((3-((4-fluoro-6-((3-sulfophenyl)amino)-1,3,5-triazin-2-yl)amino)-2-(hydroxy-kappaO)-5-sulfophenyl)azo-kappaN2)phenylmethyl)azo-kappaN1)-4-sulfobenzoato(6-)-kappaO)-, tetrasodium",C1=CC=C(C=C1)[C-](N=NC2=CC(=CC(=C2[O-])NC3=NC(=NC(=N3)NC4=CC(=CC=C4)S(=O)(=O)[O-])F)S(=O)(=O)[O-])N=NC5=C(C=CC(=C5)S(=O)(=O)[O-])C(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Cu+2],,,,,,
3285,163286,"2-({[2-(3-{[4-Fluoro-6-(3-sulfoanilino)-1,3,5-triazin-2-yl]amino}-2-hydroxy-5-sulfophenyl)hydrazinylidene](phenyl)methyl}diazenyl)-4-sulfobenzoic acid",C1=CC=C(C=C1)C(=NNC2=CC(=CC(=C2O)NC3=NC(=NC(=N3)NC4=CC(=CC=C4)S(=O)(=O)O)F)S(=O)(=O)O)N=NC5=C(C=CC(=C5)S(=O)(=O)O)C(=O)O,,,,,,
3286,163287,CID 163287,CCCCC(CC)CN=C(C(=NNC1=C(C=CC(=C1)S(=O)(=O)N)[O-])C(=O)C)[O-].C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C(=CC(=C3)[N+](=O)[O-])[N+](=O)[O-])[O-])[N-]C4=CC=C(C=C4)S(=O)(=O)[O-].[K+].[K+].[Co+3],,,,,,
3287,163288,CID 163288,CCCCC(CC)CNC(=O)C(=NNC1=C(C=CC(=C1)S(=O)(=O)N)O)C(=O)C,,,,,,
3288,163289,CID 163289,C1=CC=C2C(=C1)C=CC(=NC3=CC=C(C=C3)S(=O)(=O)O)C2=NN=C4C=C(C=C(C4=O)[N+](=O)[O-])N(O)O,,,,,,
3289,163290,(Butylstannylidyne)tris(thioethylene) tripalmitate,CCCCCCCCCCCCCCCC(=O)OCCS[Sn](CCCC)(SCCOC(=O)CCCCCCCCCCCCCCC)SCCOC(=O)CCCCCCCCCCCCCCC,,,,,,
3290,163291,(Methylstannylidyne)tris(thioethylene) tripalmitate,CCCCCCCCCCCCCCCC(=O)OCCS[Sn](C)(SCCOC(=O)CCCCCCCCCCCCCCC)SCCOC(=O)CCCCCCCCCCCCCCC,,,,,,
3291,163292,Frenolicin B,CCC[C@@H]1C2=C([C@@H]3[C@H](O1)CC(=O)O3)C(=O)C4=C(C2=O)C(=CC=C4)O,,,,,,
3292,163293,"1H-Imidazolium, 2-((4-(dimethylamino)phenyl)azo)-1,3-dimethyl-, (T-4)-tetrachlorozincate(2-) (2:1)",CN1C=C[N+](=C1N=NC2=CC=C(C=C2)N(C)C)C.CN1C=C[N+](=C1N=NC2=CC=C(C=C2)N(C)C)C.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
3293,163294,CID 163294,CCC(=O)C.CC(=CCCC(=CC=O)C)C.CO,,,,,,
3294,163295,"Silanamine, 1,1,1-trimethyl-N-(trimethylsilyl)-, reaction products with ammonia, octamethylcyclotetrasiloxane and silica",C[Si]1(O[Si](O[Si](O[Si](O1)(C)C)(C)C)(C)C)C.C[Si](C)(C)N[Si](C)(C)C.N.O=[Si]=O,,,,,,
3295,163296,Tipranavir disodium,CCC[C@]1(CC(=C(C(=O)O1)[C@H](CC)C2=CC(=CC=C2)[N-]S(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)[O-])CCC4=CC=CC=C4.[Na+].[Na+],,,['Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)'],,,
3296,163297,CID 163297,C1=CC(=CC=C1C(=O)[O-])NCCCN2C=NC3=C2NC=NC3=O.[K+],,,,,,
3297,163298,CID 163298,C1=CC(=CC=C1C(=O)O)NCCCN2C=NC3=C2NC=NC3=O,,,,,,
3298,163299,CID 163299,CCN(CCCCCC(C)(C)F)CCC[C@@H](C1=CC=C(C=C1)NS(=O)(=O)C)O.CCN(CCCCCC(C)(C)F)CCC[C@@H](C1=CC=C(C=C1)NS(=O)(=O)C)O.C(=CC(=O)O)C(=O)O,,,,,,
3299,163300,Trecetilide,CCN(CCCCCC(C)(C)F)CCC[C@@H](C1=CC=C(C=C1)NS(=O)(=O)C)O,,,,,,
3300,163301,Amifloxacin mesylate,CNN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O.CS(=O)(=O)O,,,,,,
3301,163302,CID 163302,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](CCOC(=O)[C@@H](C)C(C)C)CN1C=NC2=C1NC(=NC2=O)N,,,,,,
3302,163303,CID 163303,C[S+](CCCCN=C=S)O,,,,,,
3303,163304,Nitrafudam,C1=CC=C(C(=C1)C2=CC=C(O2)C(=N)N)[N+](=O)[O-],,,,,,
3304,163305,Nitramisole hydrochloride,C1CSC2=NC(CN21)C3=CC(=CC=C3)[N+](=O)[O-].Cl,,,,,,
3305,163306,Nitramisole,C1CSC2=NC(CN21)C3=CC(=CC=C3)[N+](=O)[O-],,,,,,
3306,163307,Talmetoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N3C(=O)C4=CC=CC=C4C3=O,,,,,,
3307,163308,Tametraline,CN[C@@H]1CC[C@H](C2=CC=CC=C12)C3=CC=CC=C3,,,,,,
3308,163309,Tefazoline,C1CCC2=C(C1)C=CC=C2CC3=NCCN3,,,,,,
3309,163310,Tefenperate,CC(=O)OC(CC1=CC=CC=C1Cl)(CC2=CC=CC=C2Cl)C(=O)OCCN3C(CCCC3(C)C)(C)C,,,,,,
3310,163311,"Isohypophosphoric acid, (((1S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy)methyl)-",C1=CN(C(=O)N=C1N)C[C@@H](CO)OCP(=O)(O)OP(=O)(O)O,,,,,,
3311,163312,Tetriprofen,CC(C1=CC=C(C=C1)C2=CCCCC2)C(=O)O,,,,,,
3312,163313,Ibuverine,CC(C)COC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,,,,,,
3313,163314,Idropranolol,CC(C)NCC(COC1=CC=CC2=C1C=CCC2)O,,,,,,
3314,163315,Imafen hydrochloride,C1CN2C(CN=C2N1)C3=CC=CC=C3.Cl,,,,,,
3315,163316,Deximafen,C1CN2C(CN=C2N1)C3=CC=CC=C3,,,,,,
3316,163317,Iminophenimide,CCC1(C(=O)NC(=O)CN1)C2=CC=CC=C2,,,,,,
3317,163318,Impromidine hydrochloride,CC1=C(N=CN1)CSCCNC(=NCCCC2=CN=CN2)N.Cl.Cl.Cl,,,['Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically. (See all compounds classified as Histamine Agonists.)'],,,
3318,163319,Imuracetam,C1CC(=O)N(C1)CNC(=O)NCN2CCCC2=O,,,,,,
3319,163320,2-(4-Acetoxyphenyl)-3-ethyl-1-methyl-6-indenyl acetat,CCC1=C(C(C2=C1C=CC(=C2)OC(=O)C)C)C3=CC=C(C=C3)OC(=O)C,,,,,,
3320,163321,Nicofibrate hydrochloride,CC(C)(C(=O)OCC1=CN=CC=C1)OC2=CC=C(C=C2)Cl.Cl,,,,,,
3321,163322,"Tetranicotinic acid 1-(3-methoxycarbonyl-2-methylfuran-5-yl)butane-1,2,3,4-tetryl ester",CC1=C(C=C(O1)C(C(C(COC(=O)C2=CN=CC=C2)OC(=O)C3=CN=CC=C3)OC(=O)C4=CN=CC=C4)OC(=O)C5=CN=CC=C5)C(=O)OC,,,,,,
3322,163323,1-(1H-Imidazol-1-yl)oct-1-en-3-yl pyridine-3-carboxylate,CCCCCC(C=CN1C=CN=C1)OC(=O)C2=CN=CC=C2,,,,,,
3323,163324,CID 163324,CCOC(=NC)N=C(NC1=CC=CC=C1)S,,,,,,
3324,163325,4-Hydroxybut-2-enal,C(C=CC=O)O,,,,,,
3325,163326,Nabazenil,CCCCCC(C)C(C)C1=CC2=C(C3=C(CCC(C3)C)C(O2)(C)C)C(=C1)OC(=O)CCCN4CCCCCC4,,,,,,
3326,163327,CID 163327,CC(=O)C(=C([N-]C1=CC=CC=C1)[O-])[N-]N=C2C=CC(=CC2=O)[N+](=O)O.CC(=O)C(=NN=C1C=CC(=CC1=O)N([O-])[O-])C(=O)NC2=CC=CC=C2.[Na+].[Co+3],,,,,,
3327,163328,CID 163328,CC(=O)C(=NNC1=C(C=C(C=C1)[N+](=O)O)O)C(=O)NC2=CC=CC=C2,,,,,,
3328,163329,CID 163329,CC(=O)C(=NN=C1C=CC(=CC1=O)N([O-])[O-])C(=O)NC2=CC=CC=C2,,,,,,
3329,163330,"3-Hydroxyestra-1(10),2,4-trien-17-yl pentanoate--17-oxoandrost-5-en-3-yl heptanoate (1/1)",CCCCCCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CCC4=O)C)C.CCCCC(=O)O[C@H]1CCC2[C@@]1(CCC3C2CCC4=C3C=CC(=C4)O)C,,,,,,
3330,163331,Prasterone enanthate,CCCCCCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CCC4=O)C)C,,,,,,
3331,163332,"pentanoic acid [(13S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] ester",CCCCC(=O)O[C@H]1CCC2[C@@]1(CCC3C2CCC4=C3C=CC(=C4)O)C,,,,,,
3332,163333,"N-(Methylsulfonyl)phenanthrene 9,10-imine",CS(=O)(=O)N1C2C1C3=CC=CC=C3C4=CC=CC=C24,,,,,,
3333,163334,"[8,8-Dimethyl-9-(2-methylbut-2-enoyloxy)-2-oxo-9,10-dihydropyrano[2,3-f]chromen-10-yl] 2-methylbut-2-enoate",CC=C(C)C(=O)OC1C(C(OC2=C1C3=C(C=C2)C=CC(=O)O3)(C)C)OC(=O)C(=CC)C,,,,,,
3334,163335,"Astato-2-methyl-1,4-naphthoquinol diphosphate",CC1=CC(=C2C=C(C=CC2=C1OP(=O)(O)O)[211At])OP(=O)(O)O,,,,,,
3335,163336,4-Methyl-3-decene-5-ol,CCCCCC(C(=CCC)C)O,,,,,,
3336,163337,1-Pyrenebutyryl-coa,CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCSC(=O)CCCC4=C5C=CC6=CC=CC7=C6C5=C(C=C7)C=C4)O,,,,,,
3337,163338,Schizandrer A,C[C@H]1CC2=CC3=C(C(=C2C4=C(C(=C(C=C4[C@H]([C@]1(C)O)OC(=O)C5=CC=CC=C5)OC)OC)OC)OC)OCO3,,,,,,
3338,163339,[2-[[4-[(2-Chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl](2-hydroxypropyl)dimethylammonium acetate,CCN(CC[N+](C)(C)CC(C)O)C1=CC=C(C=C1)N=NC2=C(C=C(C=C2)[N+](=O)[O-])Cl.CC(=O)[O-],,,,,,
3339,163340,Naphthocyanidine,CC1=C(C2=C(C(N3C(C4CC5C(C3C2N6C5OCC6)N4C)C#N)CO)C(=O)C1=O)O,,,,,,
3340,163341,Nourseimycin,C[C@@H](C(=O)OC(=O)[C@H](C1CC(N(C1=O)O)O)N)N,,,,,,
3341,163342,CID 163342,C1=CC(=CC(=C1)O)O.C1=CC(=O)C(=N)C=C1N(O)O.C1=C(C=C(C(=O)C1=N)S(=O)(=O)[O-])N(O)O.[NaH].[Na+].[Fe],,,,,,
3342,163343,CID 163343,C1=CC(=CC(=C1)O)O.C1=CC(=C(C(=C1)S(=O)(=O)[O-])O)N.C1=CC(=CC=C1N)[N+](=O)[O-].[NaH].[Na+].[Fe],,,,,,
3343,163344,Aminohydroxybenzenesulfonic acid,C1=CC(=C(C(=C1)S(=O)(=O)O)O)N,,,,,,
3344,163345,"4-Heptenal, 2,5,6-trimethyl-",CC(C)C(=CCC(C)C=O)C,,,,,,
3345,163346,Oxymorphonazine,CN1CCC23C4C(=NN=C5CCC6(C7CC8=C9C6(C5OC9=C(C=C8)O)CCN7C)O)CCC2(C1CC1=C3C(=C(C=C1)O)O4)O,,,,,,
3346,163347,CID 163347,C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)O[C@@H]2[C@H]([C@@H](O[C@@H](C2O)OCCC3=CC(=C(C=C3)O)O)CO[C@@H]4[C@@H]([C@@H]([C@H]([C@@H](O4)CO)O)O)O)OC(=O)C=CC5=CC(=C(C=C5)O)O)O)O)O,,,,,,
3347,163348,"Chromate(1-), (2-((4,5-dihydro-3-methyl-1-(2-methyl-4-sulfophenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-sulfobenzoato(4-))-, sodium",CC1=CC(=CC(=C1)S(=O)(=O)[O-])N2C(=C(C(=N2)C)N=NC3=C(C=CC(=C3)S(=O)(=O)[O-])C(=O)[O-])[O-].[Na+].[Cr+3],,,,,,
3348,163349,2-[[5-methyl-2-(3-methyl-5-sulfophenyl)-3-oxo-1H-pyrazol-4-yl]diazenyl]-4-sulfobenzoic acid,CC1=CC(=CC(=C1)S(=O)(=O)O)N2C(=O)C(=C(N2)C)N=NC3=C(C=CC(=C3)S(=O)(=O)O)C(=O)O,,,,,,
3349,163350,Chromium(3+) sodium 5-chloro-3-{[3-methyl-5-oxido-1-(3-sulfonatophenyl)-1h-pyrazol-4-yl]diazenyl}-2-oxidobenzenesulfonate(1:1:1),CC1=NN(C(=C1N=NC2=C(C(=CC(=C2)Cl)S(=O)(=O)[O-])[O-])[O-])C3=CC(=CC=C3)S(=O)(=O)[O-].[Na+].[Cr+3],,,,,,
3350,163351,"[(2R,3S,4S,5R)-3,4-dihydroxy-6-methoxy-5-octadec-9-enoyloxyoxan-2-yl]methyl octadec-9-enoate",CCCCCCCCC=CCCCCCCCC(=O)OC[C@@H]1[C@H]([C@@H]([C@H](C(O1)OC)OC(=O)CCCCCCCC=CCCCCCCCC)O)O,,,,,,
3351,163352,CID 163352,CC=C(C(=O)NC(CO)C(=O)O)NC(=O)C1CCCN1C(=O)C2CCCCN2C(=O)C(C(C)N)NC(=O)C(C(C)CCN=C(N)N)N,,,,,,
3352,163353,1-DC-DG-E,C1[C@@H]([C@H](O[C@H]1N2C=CC(=N)N(C2=O)CCN3C(=O)C4=C(N=C3N)N(C=N4)[C@H]5C[C@@H]([C@H](O5)CO)O)CO)O,,,,,,
3353,163354,"Cuprate(4-), [mu-[7-(benzoylamino)-3-[[3,3'-di(hydroxy-kappaO)-4'-[[1-(hydroxy-kappaO)-4,8-disulfo-2-naphthalenyl]azo-kappaN1][1,1'-biphenyl]-4-yl]azo-kappaN1]-4-(hydroxy-kappaO)-1,5-naphthalenedisulfonato(8-)]]di-, tetrasodium",C1=CC=C(C=C1)C(=O)NC2=CC3=C(C=C(C(=C3C(=C2)S(=O)(=O)[O-])[O-])N=NC4=C(C=C(C=C4)C5=CC(=C(C=C5)N=NC6=CC(=C7C=CC=C(C7=C6[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])[O-])[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Cu+2].[Cu+2],,,,,,
3354,163355,"7-Benzamido-4-hydroxy-3-[[2-hydroxy-4-[3-hydroxy-4-[(1-hydroxy-4,8-disulfonaphthalen-2-yl)diazenyl]phenyl]phenyl]diazenyl]naphthalene-1,5-disulfonic acid",C1=CC=C(C=C1)C(=O)NC2=CC3=C(C=C(C(=C3C(=C2)S(=O)(=O)O)O)N=NC4=C(C=C(C=C4)C5=CC(=C(C=C5)N=NC6=CC(=C7C=CC=C(C7=C6O)S(=O)(=O)O)S(=O)(=O)O)O)O)S(=O)(=O)O,,,,,,
3355,163356,CID 163356,C1=CC(=NN=C2C=CC(=O)C(=C2)C(=O)[O-])C=CC1=NC3=C(C=C(C=C3)N(O)[O-])S(=O)(=O)[O-].C1=CC(=CC=C1[N-]C2=C(C=C(C=C2)[N+](=O)O)S(=O)(=O)[O-])[N-]N=C3C=CC(=O)C(=C3)C(=O)[O-].[Na+].[Na+].[Na+].[Cr+3],,,,,,
3356,163357,CID 163357,C1=CC(=CC=C1NC2=C(C=C(C=C2)[N+](=O)O)S(=O)(=O)O)N=NC3=CC(=C(C=C3)O)C(=O)O,,,,,,
3357,163358,CID 163358,C1=CC(=NN=C2C=CC(=O)C(=C2)C(=O)[O-])C=CC1=NC3=C(C=C(C=C3)N(O)O)S(=O)(=O)O,,,,,,
3358,163359,CID 163359,[B+3].C1=CC=[C-]C=C1.C1=CC=[C-]C=C1.[OH-].[OH-],,,,,,
3359,163360,Clrch2NHP(pU)6,CN(CCCl)C1=CC=C(C=C1)CNP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC(=O)NC3=O)O)OP(=O)(O)OC[C@@H]4[C@H]([C@H]([C@@H](O4)N5C=CC(=O)NC5=O)O)OP(=O)(O)OC[C@@H]6[C@H]([C@H]([C@@H](O6)N7C=CC(=O)NC7=O)O)OP(=O)(O)OC[C@@H]8[C@H]([C@H]([C@@H](O8)N9C=CC(=O)NC9=O)O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=CC(=O)NC1=O)O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=CC(=O)NC1=O)O)O,,,,,,
3360,163361,"5-[(3,4-Dichlorophenyl)azo]-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxonicotinonitrile",CC1=C(C(=O)N(C(=C1C#N)O)C)N=NC2=CC(=C(C=C2)Cl)Cl,,,,,,
3361,163362,"1-Naphthalenesulfonic acid, 2-[(2-hydroxy-6-sulfo-1-naphthalenyl)azo]-, calcium salt (1:1)",C1=CC=C2C(=C1)C=CC(=C2S(=O)(=O)[O-])N=NC3=C(C=CC4=C3C=CC(=C4)S(=O)(=O)[O-])O.[Ca+2],,,,,,
3362,163363,2-[(2-Hydroxy-6-sulfo-1-naphthalenyl)azo]-1-naphthalenesulfonic acid,C1=CC=C2C(=C1)C=CC(=C2S(=O)(=O)O)N=NC3=C(C=CC4=C3C=CC(=C4)S(=O)(=O)O)O,,,,,,
3363,163364,"1,4-Benzenedisulfonic acid, 2-((4-((4-(((2,3-dichloro-6-quinoxalinyl)carbonyl)amino)-5-sulfo-1-naphthalenyl)azo)-7-sulfo-1-naphthalenyl)azo)-, lithium sodium salt",[Li+].[Li+].C1=CC2=C(C=CC(=C2C(=C1)S(=O)(=O)[O-])NC(=O)C3=CC4=C(C=C3)N=C(C(=N4)Cl)Cl)N=NC5=C6C=CC(=CC6=C(C=C5)N=NC7=C(C=CC(=C7)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
3364,163365,"2-{[4-({4-[(2,3-Dichloroquinoxaline-6-carbonyl)amino]-5-sulfonaphthalen-1-yl}diazenyl)-7-sulfonaphthalen-1-yl]diazenyl}benzene-1,4-disulfonic acid",C1=CC2=C(C=CC(=C2C(=C1)S(=O)(=O)O)NC(=O)C3=CC4=C(C=C3)N=C(C(=N4)Cl)Cl)N=NC5=C6C=CC(=CC6=C(C=C5)N=NC7=C(C=CC(=C7)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3365,163366,"2-Anthracenesulfonic acid, 1-amino-4-[[4-[[[(2,3-dichloro-6-quinoxalinyl)carbonyl]methylamino]methyl]-2-sulfophenyl]amino]-9,10-dihydro-9,10-dioxo-, disodium salt",CN(CC1=CC(=C(C=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)[O-])S(=O)(=O)[O-])C(=O)C5=CC6=C(C=C5)N=C(C(=N6)Cl)Cl.[Na+].[Na+],,,,,,
3366,163367,"1-Amino-4-(4-{[(2,3-dichloroquinoxaline-6-carbonyl)(methyl)amino]methyl}-2-sulfoanilino)-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid",CN(CC1=CC(=C(C=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)O)S(=O)(=O)O)C(=O)C5=CC6=C(C=C5)N=C(C(=N6)Cl)Cl,,,,,,
3367,163368,"1,7-Naphthalenedisulfonic acid, 4-(benzoylamino)-6-((5-(((5-chloro-2,6-difluoro-4-pyrimidinyl)amino)methyl)-1-sulfo-2-naphthalenyl)azo)-5-hydroxy-, lithium sodium salt",[Li+].C1=CC=C(C=C1)C(=O)NC2=C3C(=C(C=C2)S(=O)(=O)[O-])C=C(C(=C3O)N=NC4=C(C5=CC=CC(=C5C=C4)CNC6=C(C(=NC(=N6)F)F)Cl)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
3368,163369,"4-Benzamido-6-((5-(((5-chloro-2,6-difluoropyrimidin-4-yl)amino)methyl)-1-sulfonaphthalen-2-yl)diazenyl)-5-hydroxynaphthalene-1,7-disulfonic acid",C1=CC=C(C=C1)C(=O)NC2=C3C(=C(C=C2)S(=O)(=O)O)C=C(C(=C3O)N=NC4=C(C5=CC=CC(=C5C=C4)CNC6=C(C(=NC(=N6)F)F)Cl)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3369,163370,"5-(Benzoylamino)-3-((5-(((5-chloro-2,6-difluoro-4-pyrimidinyl)amino)methyl)-1-sulpho-2-naphthyl)azo)-4-hydroxynaphthalene-2,7-disulphonic acid, lithium sodium salt",[Li+].C1=CC=C(C=C1)C(=O)NC2=C3C(=CC(=C2)S(=O)(=O)[O-])C=C(C(=C3O)N=NC4=C(C5=CC=CC(=C5C=C4)CNC6=C(C(=NC(=N6)F)F)Cl)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
3370,163371,"5-(Benzoylamino)-3-[[5-[[(5-chloro-2,6-difluoro-4-pyrimidinyl)amino]methyl]-1-sulpho-2-naphthyl]azo]-4-hydroxynaphthalene-2,7-disulphonic acid",C1=CC=C(C=C1)C(=O)NC2=C3C(=CC(=C2)S(=O)(=O)O)C=C(C(=C3O)N=NC4=C(C5=CC=CC(=C5C=C4)CNC6=C(C(=NC(=N6)F)F)Cl)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3371,163372,"5-[(5-Chloro-2-fluoro-6-methyl-4-pyrimidinyl)amino]-4-hydroxy-3-[(2-sulphophenyl)azo]naphthalene-2,7-disulphonic acid, sodium salt",CC1=C(C(=NC(=N1)F)NC2=C3C(=CC(=C2)S(=O)(=O)[O-])C=C(C(=C3O)N=NC4=CC=CC=C4S(=O)(=O)[O-])S(=O)(=O)[O-])Cl.[Na+].[Na+].[Na+],,,,,,
3372,163373,"5-[(5-Chloro-2-fluoro-6-methyl-4-pyrimidinyl)amino]-4-hydroxy-3-[(2-sulfophenyl)azo]-2,7-naphthalenedisulfonic acid",CC1=C(C(=NC(=N1)F)NC2=C3C(=CC(=C2)S(=O)(=O)O)C=C(C(=C3O)N=NC4=CC=CC=C4S(=O)(=O)O)S(=O)(=O)O)Cl,,,,,,
3373,163374,"2,7-Naphthalenedisulfonic acid, 5-((5-chloro-2-fluoro-6-methyl-4-pyrimidinyl)amino)-4-hydroxy-3-((4-methyl-2-sulfophenyl)azo)-, sodium salt",CC1=CC(=C(C=C1)N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)[O-])S(=O)(=O)[O-])NC4=NC(=NC(=C4Cl)C)F)O)S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
3374,163375,"5-[(5-Chloro-2-fluoro-6-methyl-4-pyrimidinyl)amino]-4-hydroxy-3-[(4-methyl-2-sulfophenyl)azo]-2,7-naphthalenedisulfonic acid",CC1=CC(=C(C=C1)N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)O)S(=O)(=O)O)NC4=NC(=NC(=C4Cl)C)F)O)S(=O)(=O)O,,,,,,
3375,163376,CID 163376,C1=CC(=C(C=C1N2N=C3C=C(C4=C(C3=N2)C(=CC(=C4)NC5=C(C(=NC(=N5)F)F)Cl)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])N=NC6=C(NC(=O)C=C6C(=O)O)O.[Na+].[Na+].[Na+],,,,,,
3376,163377,"5-[2-[4-[7-[(5-Chloro-2,6-Difluoro-4-Pyrimidinyl)Amino]-5,9-Disulfo-2H-Naphtho[1,2-d]Triazol-2-Yl]-2-Sulfophenyl]Diazenyl]-1,2-Dihydro-6-Hydroxy-2-Oxo-4-Pyridinecarboxylic Acid",C1=CC(=C(C=C1N2N=C3C=C(C4=C(C3=N2)C(=CC(=C4)NC5=C(C(=NC(=N5)F)F)Cl)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)N=NC6=C(NC(=O)C=C6C(=O)O)O,,,,,,
3377,163378,CID 163378,CC=C(C)[C@@H]1[C@@]2([C@H]3C=C[C@H]4C[C@H](CC[C@@H]4[C@]3(C(O1)(O2)[C@]5(C(=O)C(=C)OC5=O)OC(=O)C)C)C(=O)O)C,,,,,,
3378,163379,CID 163379,C1=CC=C(C=C1)C(=O)NN=CC2=CC=CC=C2[O-].O.[Cu+2],,,,,,
3379,163380,CID 163380,[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Cu].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[Ag].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2].[SnH2],,,,,,
3380,163381,Einecs 280-649-6,CC1=C(C(=C(C=C1)S(=O)(=O)N)C)N2C(=C(C(=N2)C)N=NC3=C(C(=CC(=C3)Cl)[N+](=O)[O-])[O-])[O-].CC1=C(C(=C(C=C1)S(=O)(=O)N)C)N2C(=O)C(=NN=C3C=C(C=C(C3=O)N([O-])[O-])Cl)C(=N2)C.[Na+].[Cr+3],,,,,,
3381,163382,CID 163382,CC1=C(C(=C(C=C1)S(=O)(=O)N)C)N2C(=O)C(=NN=C3C=C(C=C(C3=O)N(O)O)Cl)C(=N2)C,,,,,,
3382,163383,"3-[4-[[3-Chloro-5-(dioxidoamino)-6-oxocyclohexa-2,4-dien-1-ylidene]hydrazinylidene]-3-methyl-5-oxopyrazol-1-yl]-2,4-dimethylbenzenesulfonamide",CC1=C(C(=C(C=C1)S(=O)(=O)N)C)N2C(=O)C(=NN=C3C=C(C=C(C3=O)N([O-])[O-])Cl)C(=N2)C,,,,,,
3383,163384,CID 163384,[Li+].[Li+].CN(CCO)CCO.C1=CC(=C(C=C1C=CC2=C(C=C(C=C2)N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)[O-])S(=O)(=O)[O-])N)O)S(=O)(=O)[O-])S(=O)(=O)[O-])N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)[O-])S(=O)(=O)[O-])N)O.[Na+].[Na+].[Na+].[Na+],,,,,,
3384,163385,CID 163385,C1=CC(=C(C=C1C=CC2=C(C=C(C=C2)N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)O)S(=O)(=O)O)N)O)S(=O)(=O)O)S(=O)(=O)O)N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)O)S(=O)(=O)O)N)O,,,,,,
3385,163386,CID 163386,[Li+].CN(CCO)CCO.C1=CC(=C(C=C1C=CC2=C(C=C(C=C2)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])N=NC5=C(C=C6C=CC(=CC6=C5O)N)S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
3386,163387,CID 163387,C1=CC(=C(C=C1C=CC2=C(C=C(C=C2)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)N=NC5=C(C=C6C=CC(=CC6=C5O)N)S(=O)(=O)O,,,,,,
3387,163388,CID 163388,[Li+].[Li+].CN(CCO)CCO.C1=CC(=C(C=C1C=CC2=C(C=C(C=C2)N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)[O-])S(=O)(=O)[O-])N)O)S(=O)(=O)[O-])S(=O)(=O)[O-])N=NC5=C(C=C6C=CC(=CC6=C5O)N)S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
3388,163389,CID 163389,C1=CC(=C(C=C1C=CC2=C(C=C(C=C2)N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)O)S(=O)(=O)O)N)O)S(=O)(=O)O)S(=O)(=O)O)N=NC5=C(C=C6C=CC(=CC6=C5O)N)S(=O)(=O)O,,,,,,
3389,163390,CID 163390,[Li+].CC1=CC(=CC(=C1O)C(=O)O)N=NC2=CC(=C(C=C2)C=CC3=CC(=C(C=C3)N=NC4=CC(=C(C(=C4)C)O)C(=O)O)S(=O)(=O)[O-])S(=O)(=O)[O-].CN(CCO)CCO.[Na+],,,,,,
3390,163391,CID 163391,CC1=CC(=CC(=C1O)C(=O)O)N=NC2=CC(=C(C=C2)C=CC3=CC(=C(C=C3)N=NC4=CC(=C(C(=C4)C)O)C(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3391,163392,"Methanaminium, N-(4-((4-(dimethylamino)phenyl)(4-(phenylamino)-1-naphthalenyl)methylene)-2,5-cyclohexadien-1-ylidene)-N-methyl-, acetate",CC(=O)[O-].CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[NH+]C3=CC=CC=C3)C4=CC=CC=C24)C5=CC=C(C=C5)N(C)C,,,,,,
3392,163393,CID 163393,CC(=O)C(=C([N-]C1=CC=CC=C1)O)[N-]N=C2C=C(C=CC2=O)S(=O)(=O)N.CC(=O)C(=NNC1=C(C=CC(=C1)S(=O)(=O)N)[O-])C(=NC2=CC=CC=C2)[O-].[Na+].[Cr+3],,,,,,
3393,163394,Ferensimycin A,CCC(C1C(CC(O1)(C)C2(C(CC(O2)(CC)C(C)O)C)O)C)C(=O)C(C)C(C(C)C3C(CC(C(O3)(C(C)C(=O)O)O)C)C)O,,,,,,
3394,163395,Ferensimycin B,CC[C@H]([C@@H]1[C@H](C[C@@](O1)(C)[C@]2([C@@H](C[C@](O2)(CC)[C@H](CC)O)C)O)C)C(=O)[C@@H](C)[C@H]([C@H](C)[C@@H]3[C@H](C[C@H]([C@@](O3)([C@H](C)C(=O)O)O)C)C)O,,,,,,
3395,163396,CID 163396,[B+3].[B+3].[C-]#N.[C-]#N.C1=CC=[C-]C=C1.C1=CC=[C-]C=C1.C1=CC=[C-]C=C1.C1=CC=[C-]C=C1.C1=CC=[C-]C=C1.C1=CC=[C-]C=C1.C(CCC#N)CC#N.C(CCC#N)CC#N.[Ni+2],,,,,,
3396,163397,CID 163397,CC1=C(C=CC(=C1)S(=O)(=O)[O-])N=NC2=C(C(=CC3=CC=CC=C32)C(=O)[O-])O.[Mn+2],,,,,,
3397,163398,"4-[2-(2-Methyl-4-sulfophenyl)hydrazinylidene]-3-oxo-3,4-dihydronaphthalene-2-carboxylic acid",CC1=C(C=CC(=C1)S(=O)(=O)O)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)O)O,,,,,,
3398,163399,CID 163399,CCCCCCCCC=CCCCCCCCC(=O)O.CNC1=CC=CC=C1.CN(C)C1=CC=CC=C1.C=O,,,,,,
3399,163400,"3-(1-Ethoxyethoxy)-3,7-dimethyloct-1-ene",CCOC(C)OC(C)(CCCC(C)C)C=C,,,,,,
3400,163401,"5-Thiazoleethanol, 2,5-dihydro-4-methyl-",CC1=NCSC1CCO,,,,,,
3401,163402,"3-[(2R)-2-[(2R,3R,4R,5S)-5-ethoxy-4-hydroxy-3-methoxyoxolan-2-yl]-2-methoxyethyl]-1-methyl-1-nitrosourea",CCO[C@@H]1[C@@H]([C@H]([C@H](O1)[C@@H](CNC(=O)N(C)N=O)OC)OC)O,,,,,,
3402,163403,Pt2AmCl4,C(CCCN(CCN)CCN)CCN(CCN)CCN.[Cl-].[Cl-].[Cl-].[Cl-].[Pt+2].[Pt+2],,,,,,
3403,163404,"N,N,N',N'-tetrakis(2-aminoethyl)hexane-1,6-diamine",C(CCCN(CCN)CCN)CCN(CCN)CCN,,,,,,
3404,163405,1-(4-benzhydrylpiperidin-1-yl)-N-octylmethanimine;but-2-enedioic acid,CCCCCCCCN=CN1CCC(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3.C(=CC(=O)O)C(=O)O,,,,,,
3405,163406,"Ethanesulfonic acid, 1,1',1''-nitrilotris-, tripotassium salt",CC(N(C(C)S(=O)(=O)[O-])C(C)S(=O)(=O)[O-])S(=O)(=O)[O-].[K+].[K+].[K+],,,,,,
3406,163407,"1,1',1''-Nitrilotri(ethane-1-sulfonic acid)",CC(N(C(C)S(=O)(=O)O)C(C)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3407,163408,"4,4'-Carbonimidoylbis[N,N-dimethylaniline] nitrate",CN(C)C1=CC=C(C=C1)C(=N)C2=CC=C(C=C2)N(C)C.[N+](=O)(O)[O-],,,,,,
3408,163409,Isobutyl non-2-ynoate,CCCCCCC#CC(=O)OCC(C)C,,,,,,
3409,163410,"(4S,8R,9R,12S,13S,14S,16R)-14-Hydroxy-9-methoxy-7,7-dimethyl-17-methylidene-3,10-dioxapentacyclo[14.2.1.01,13.04,12.08,12]nonadecane-2,18-dione",CC1(CC[C@H]2[C@]3([C@@H]1[C@@H](OC3)OC)[C@@H]4[C@H](C[C@H]5CC4(C(=O)C5=C)C(=O)O2)O)C,,,,,,
3410,163411,"[(1'R,3'S,6S,7S,9R)-3'-acetyloxy-7-hydroxy-6',6'-dimethyl-10-methylidene-2,11-dioxospiro[3-oxatricyclo[7.2.1.01,6]dodecane-5,2'-cyclohexane]-1'-yl]methyl acetate",CC(=O)OC[C@@H]1C(CC[C@@H](C12COC(=O)C34[C@H]2[C@H](C[C@@H](C3)C(=C)C4=O)O)OC(=O)C)(C)C,,,,,,
3411,163412,"Sodium;[4-(6-aminopurin-9-yl)-2',4',6'-trinitrospiro[3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxole-2,1'-cyclohexane]-6-yl]methyl phosphono hydrogen phosphate",C1C(CC(C2(C1[N+](=O)[O-])OC3C(OC(C3O2)N4C=NC5=C(N=CN=C54)N)COP(=O)(O)OP(=O)(O)O)[N+](=O)[O-])[N+](=O)[O-].[Na+],,,,,,
3412,163413,"[4-(6-Aminopurin-9-yl)-2',4',6'-trinitrospiro[3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxole-2,1'-cyclohexane]-6-yl]methyl phosphono hydrogen phosphate",C1C(CC(C2(C1[N+](=O)[O-])OC3C(OC(C3O2)N4C=NC5=C(N=CN=C54)N)COP(=O)(O)OP(=O)(O)O)[N+](=O)[O-])[N+](=O)[O-],,,,,,
3413,163414,"N,2-dimethyl-N-phenylbutanamide",CCC(C)C(=O)N(C)C1=CC=CC=C1,,,,,,
3414,163415,"5-(Phenylazo)toluene-2,4-diamine monoacetate",CC1=CC(=C(C=C1N)N)N=NC2=CC=CC=C2.CC(=O)O,,,,,,
3415,163416,"1,5-Pentanediol, 2,4-bis(dimethoxymethyl)-2,4-bis(hydroxymethyl)-",COC(C(CC(CO)(CO)C(OC)OC)(CO)CO)OC,,,,,,
3416,163417,"1,5,8-Trimethylbicyclo[3.2.1]octan-8-ol",CC12CCCC(C1(C)O)(CC2)C,,,,,,
3417,163418,"8-Ethyl-1,5-dimethylbicyclo[3.2.1]octan-8-ol",CCC1(C2(CCCC1(CC2)C)C)O,,,,,,
3418,163419,Calcium 4-((4-ethoxy-2-sulphonatophenyl)azo)-3-hydroxy-2-naphthoate,CCOC1=CC(=C(C=C1)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)O)O)S(=O)(=O)[O-].[Ca+2],,,,,,
3419,163420,4-[(4-Ethoxy-2-sulfophenyl)azo]-3-hydroxy-2-naphthalenecarboxylic acid,CCOC1=CC(=C(C=C1)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)O)O)S(=O)(=O)O,,,,,,
3420,163421,CID 163421,CC[C@H]1[C@H]([C@@H](CC(=CC=C[C@@H](C(OC(=O)C(=CC(=C[C@H]([C@H]1O)C)C)OC)[C@@H](C)[C@H]([C@H](C)[C@]2(C[C@H]([C@@H]([C@H](O2)C=CC)C)OC(=O)C=CC(=O)NC3=C(CCC3=O)O)O)O)OC)C)C)O,,,,,,
3421,163422,"3H-Indolium, 1-methyl-3-[(3-methyl-2(3H)-thiazolylidene)hydrazono]-2-phenyl-, acetate",CC(=O)[O-].CN1C2=CC=CC=C2C(=C1C3=CC=CC=C3)N=NC4=[N+](C=CS4)C,,,,,,
3422,163423,"Chromate(1-), bis(4-((4,5-dihydro-3-methyl-5-(oxo-kappaO)-1-phenyl-1H-pyrazol-4-yl)azo-kappaN1)-5-(hydroxy-kappaO)-2-methylbenzenesulfonamidato(2-))-, sodium",CC1=CC(=C(C=C1S(=O)(=O)N)[O-])N=NC2=C(N(N=C2C)C3=CC=CC=C3)[O-].CC1=CC(=C(C=C1S(=O)(=O)N)[O-])N=NC2=C(N(N=C2C)C3=CC=CC=C3)[O-].[Na+].[Cr+3],,,,,,
3423,163424,5-hydroxy-2-methyl-4-[(5-methyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)diazenyl]benzenesulfonamide,CC1=CC(=C(C=C1S(=O)(=O)N)O)N=NC2=C(NN(C2=O)C3=CC=CC=C3)C,,,,,,
3424,163425,CID 163425,C1=CC(=CC=C1NS(=O)(=O)C2=CC=C(C=C2)NN=C3C(=CC4=C(C3=O)C(=N)C(=NNC5=CC=C(C=C5)[N+](=O)[O-])C(=C4)S(=O)(=O)[O-])S(=O)(=O)[O-])N=NC6=C(C=C(C=C6)O)O.[K+].[K+],,,,,,
3425,163426,CID 163426,C1=CC(=CC=C1NS(=O)(=O)C2=CC=C(C=C2)NN=C3C(=CC4=C(C3=O)C(=N)C(=NNC5=CC=C(C=C5)[N+](=O)[O-])C(=C4)S(=O)(=O)O)S(=O)(=O)O)N=NC6=C(C=C(C=C6)O)O,,,,,,
3426,163427,CID 163427,C1=CC(=C(C=C1[N+](=O)[O-])S(=O)(=O)[O-])N=NC2=CC(=NN=C3C=C(C=C(C3=O)S(=O)(=O)[O-])N(O)[O-])C(=O)C=C2[O-].[Na+].[Fe+3],,,,,,
3427,163428,CID 163428,C1=CC(=C(C=C1[N+](=O)[O-])S(=O)(=O)O)N=NC2=CC(=NN=C3C=C(C=C(C3=O)S(=O)(=O)O)N(O)O)C(=O)C=C2[O-],,,,,,
3428,163429,"Cobaltate(1-), bis(4-(hydroxy-kappaO)-3-(2-(2-(hydroxy-kappaO)-1-naphthalenyl)diazenyl-kappaN1)benzenesulfonamidato(2-))-, hydrogen, compd. with 3-((2-ethylhexyl)oxy)-1-propanamine (1:1:1)",[H+].CCCCC(CC)COCCCN.C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=CC(=C3)S(=O)(=O)N)[O-])[O-].C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=CC(=C3)S(=O)(=O)N)[O-])[O-].[Co+3],,,,,,
3429,163430,CID 163430,[H+].[H+].[H+].CCCCC(CC)COCCCN.CC(=O)C(=C([N-]C1=CC=CC=C1)[O-])[N-]N=C2C=C(C=C(C2=O)S(=O)(=O)[O-])[N+](=O)O.CC(=O)C(=NN=C1C=C(C=C(C1=O)S(=O)(=O)[O-])N([O-])[O-])C(=O)NC2=CC=CC=C2.[Cr+3],,,,,,
3430,163431,CID 163431,CC(=O)C(=NNC1=C(C(=CC(=C1)[N+](=O)O)S(=O)(=O)O)O)C(=O)NC2=CC=CC=C2,,,,,,
3431,163432,"Benzenesulfonic acid, 2,5-dichloro-4-((2-(dibutylamino)-4-methyl-6-((2-(4-sulfophenyl)ethyl)amino)-5-pyrimidinyl)azo)-, sodium salt",CCCCN(CCCC)C1=NC(=C(C(=N1)NCCC2=CC=C(C=C2)S(=O)(=O)[O-])N=NC3=CC(=C(C=C3Cl)S(=O)(=O)[O-])Cl)C.[Na+].[Na+],,,,,,
3432,163433,"Benzenesulfonic acid, 2,5-dichloro-4-[[2-(dibutylamino)-4-methyl-6-[[2-(4-sulfophenyl)ethyl]amino]-5-pyrimidinyl]azo]-",CCCCN(CCCC)C1=NC(=C(C(=N1)NCCC2=CC=C(C=C2)S(=O)(=O)O)N=NC3=CC(=C(C=C3Cl)S(=O)(=O)O)Cl)C,,,,,,
3433,163434,Einecs 284-939-3,CC1=NN(C(=C1N=NC2=C(C=CC(=C2)S(=O)(=O)N)[O-])[O-])C3=CC=CC=C3.CC1=NN(C(=O)C1=NN=C2C=C(C=CC2=O)N([O-])[O-])C3=CC=CC=C3.[Na+].[Co+3],,,,,,
3434,163435,[4-[Bis[4-(dimethylamino)phenyl]methylidene]naphthalen-1-ylidene]-phenylazanium;octadec-9-enoate,CCCCCCCCC=CCCCCCCCC(=O)[O-].CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[NH+]C3=CC=CC=C3)C4=CC=CC=C24)C5=CC=C(C=C5)N(C)C,,,,,,
3435,163436,"Phenoxazin-5-ium, 3-(ethylamino)-2-methyl-7-((2-methylphenyl)amino)-, chloride",CC[NH+]=C1C=C2C(=NC3=C(O2)C=C(C=C3)NC4=CC=CC=C4C)C=C1C.[Cl-],,,,,,
3436,163437,3-(Ethylimino)-2-methyl-N-(o-tolyl)-3H-phenoxazin-7-amine,CCN=C1C=C2C(=NC3=C(O2)C=C(C=C3)NC4=CC=CC=C4C)C=C1C,,,,,,
3437,163438,"2,7-Naphthalenedisulfonic acid, 3-hydroxy-4-((4-((4-((2-hydroxy-6-sulfo-1-naphthalenyl)azo)-2-methylphenyl)methyl)-3-methylphenyl)azo)-, sodium salt",CC1=C(C=CC(=C1)N=NC2=C(C=CC3=C2C=CC(=C3)S(=O)(=O)[O-])O)CC4=C(C=C(C=C4)N=NC5=C6C=CC(=CC6=CC(=C5O)S(=O)(=O)[O-])S(=O)(=O)[O-])C.[Na+].[Na+].[Na+],,,,,,
3438,163439,"2,7-Naphthalenedisulfonic acid, 3-hydroxy-4-[[4-[[4-[(2-hydroxy-6-sulfo-1-naphthalenyl)azo]-2-methylphenyl]methyl]-3-methylphenyl]azo]-",CC1=C(C=CC(=C1)N=NC2=C(C=CC3=C2C=CC(=C3)S(=O)(=O)O)O)CC4=C(C=C(C=C4)N=NC5=C6C=CC(=CC6=CC(=C5O)S(=O)(=O)O)S(=O)(=O)O)C,,,,,,
3439,163440,N-(2-Ethylhexyl)-2-nitroaniline,CCCCC(CC)CNC1=CC=CC=C1[N+](=O)[O-],,,,,,
3440,163441,CID 163441,[Li+].[Li+].COC1=CC(=NN(C2=CC(=C(C=C2)N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)[O-])S(=O)(=O)[O-])O)O)OC)O)C=CC1=NN=C5C(=CC6=C(C5=O)C(=CC(=C6)S(=O)(=O)[O-])O)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
3441,163442,"Butanedioic acid, polyisobutenyl derivs., reaction products with tetraethylenepentamine, zinc salts",C(CC(=O)O)C(=O)O.C(CNCCNCCNCCN)N.[Zn],,,,,,
3442,163443,"Propanoic acid, 2-hydroxy-, compd. with 1-[[4-[3-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]phenyl]sulfonyl]-N,N-dimethyl-2-propanamine (1:1)",CC(CS(=O)(=O)C1=CC=C(C=C1)N2CCC(=N2)C3=CC=C(C=C3)Cl)N(C)C.CC(C(=O)O)O,,,,,,
3443,163444,"2-((4-(3-(4-Chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl)phenyl)sulphonyl)-N,N-dimethyl-1-methylethylamine",CC(CS(=O)(=O)C1=CC=C(C=C1)N2CCC(=N2)C3=CC=C(C=C3)Cl)N(C)C,,,,,,
3444,163445,"Xanthylium, 9-(2-carboxyphenyl)-3,6-bis(diethylamino)-, salt with mono-C10-14-alkylbenzenesulfonic acid (1:1)",CCN(CC)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](CC)CC)C=C3O2)C4=CC=CC=C4C(=O)O.C1=CC=C(C=C1)S(=O)(=O)O,,,,,,
3445,163446,Cloperastine fendizoate,C1CCN(CC1)CCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.C1=CC=C(C=C1)C2=C(C=CC(=C2)C(=O)C3=CC=CC=C3C(=O)O)O,,,,,,
3446,163447,Fendizoic acid,C1=CC=C(C=C1)C2=C(C=CC(=C2)C(=O)C3=CC=CC=C3C(=O)O)O,,,,,,
3447,163448,CID 163448,CCCCC(CC)CNC(=O)C=CC(=O)O.C(CO)N(CCO)CCO,,,,,,
3448,163449,"Disodium 3,3'-(iminobis(4,1-phenyleneazo))bis(5-(benzoylamino)-4-hydroxynaphthalene-2,7-disulphonate)",C1=CC=C(C=C1)C(=O)NC2=C3C(=CC(=C2)S(=O)(=O)[O-])C=C(C(=C3O)N=NC4=CC=C(C=C4)NC5=CC=C(C=C5)N=NC6=C(C7=C(C=C(C=C7C=C6S(=O)(=O)[O-])S(=O)(=O)[O-])NC(=O)C8=CC=CC=C8)O)S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
3449,163450,"2,7-Naphthalenedisulfonic acid, 3,3'-(iminobis(4,1-phenyleneazo))bis(5-(benzoylamino)-4-hydroxy-",C1=CC=C(C=C1)C(=O)NC2=C3C(=CC(=C2)S(=O)(=O)O)C=C(C(=C3O)N=NC4=CC=C(C=C4)NC5=CC=C(C=C5)N=NC6=C(C7=C(C=C(C=C7C=C6S(=O)(=O)O)S(=O)(=O)O)NC(=O)C8=CC=CC=C8)O)S(=O)(=O)O,,,,,,
3450,163451,CID 163451,C1=CC(=CC=C1N=NC2=CC(=C(C=C2O)O)N=NC3=C(C=C(C=C3)CC4=CC(=C(C=C4)N=NC5=C(C=C(C(=C5)N=NC6=CC=C(C=C6)S(=O)(=O)[O-])O)O)C(=O)[O-])C(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
3451,163452,"Benzoic acid, 3,3'-methylenebis[6-[[2,4-dihydroxy-5-[(4-sulfophenyl)azo]phenyl]azo]-",C1=CC(=CC=C1N=NC2=CC(=C(C=C2O)O)N=NC3=C(C=C(C=C3)CC4=CC(=C(C=C4)N=NC5=C(C=C(C(=C5)N=NC6=CC=C(C=C6)S(=O)(=O)O)O)O)C(=O)O)C(=O)O)S(=O)(=O)O,,,,,,
3452,163453,"15-(3-ethylidene-2,4,6,7,12,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl)-2,4a,5,5a,7,8,13a,15a,15b,16-decahydro4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinoline",CC=C1CN2CCC3=C(C2CC1C4=CN5C6C7C4OCC=C8C7CC9C6(CCN9C8)C1=CC=CC=C15)NC1=CC=CC=C31,,,,,,
3453,163454,"7-((5-Chloro-2,6-difluoro-4-pyrimidinyl)amino)-4-hydroxy-3-((4-methoxy-2-sulphophenyl)azo)naphthalene-2-sulphonic acid, sodium salt",COC1=CC(=C(C=C1)N=NC2=C(C=C3C=C(C=CC3=C2O)NC4=C(C(=NC(=N4)F)F)Cl)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
3454,163455,"7-[(5-Chloro-2,6-difluoro-4-pyrimidinyl)amino]-4-hydroxy-3-[(4-methoxy-2-sulfophenyl)azo]2-naphthalenesulfonic acid",COC1=CC(=C(C=C1)N=NC2=C(C=C3C=C(C=CC3=C2O)NC4=C(C(=NC(=N4)F)F)Cl)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3455,163456,"2,2'-Methylenebis(6-(o-isocyanatobenzyl)phenyl) diisocyanate",C1=CC=C(C(=C1)CC2=C(C(=CC=C2)CC3=CC=CC(=C3N=C=O)CC4=CC=CC=C4N=C=O)N=C=O)N=C=O,,,,,,
3456,163457,"3-Pyridinecarbonitrile, 5-[[2-chloro-4-(phenylazo)phenyl]azo]-2,6-bis[(3-methoxypropyl)amino]-4-methyl-",CC1=C(C(=NC(=C1N=NC2=C(C=C(C=C2)N=NC3=CC=CC=C3)Cl)NCCCOC)NCCCOC)C#N,,,,,,
3457,163458,"Benzenesulfonamide, 4-[(1-amino-9,10-dihydro-4-hydroxy-9,10-dioxo-2-anthracenyl)thio]-N-(3-ethoxypropyl)-",CCOCCCNS(=O)(=O)C1=CC=C(C=C1)SC2=C(C3=C(C(=C2)O)C(=O)C4=CC=CC=C4C3=O)N,,,,,,
3458,163459,CID 163459,C1=C(C=C(C(=C1[N-]N=C2C=C(C(=CC2=O)[O-])CC3=CC(=NN=C4C=C(C=C(C4=O)N(O)[O-])S(=O)(=O)[O-])C(=O)C=C3[O-])[O-])S(=O)(=O)[O-])[N+](=O)O.[Fe+3].[Fe+3],,,,,,
3459,163460,CID 163460,C1=C(C=C(C(=C1NN=C2C=C(C(=CC2=O)O)CC3=CC(=NN=C4C=C(C=C(C4=O)N(O)O)S(=O)(=O)O)C(=O)C=C3[O-])O)S(=O)(=O)O)[N+](=O)O,,,,,,
3460,163461,"(3R,4S,6R)-3-Ethyl-6-[(S)-hydroxy-(6-methoxyquinolin-4-yl)methyl]-1-azabicyclo[2.2.2]octan-3-ol",CC[C@@]1(CN2CC[C@H]1C[C@@H]2[C@H](C3=C4C=C(C=CC4=NC=C3)OC)O)O,,,,,,
3461,163462,"1,3,5-Triazine-2,4,6-triamine, N,N'''-1,6-hexanediylbis[N',N''-di-2-propenyl-N-(2,2,6,6-tetramethyl-4-piperidinyl)-",CC1(CC(CC(N1)(C)C)N(CCCCCCN(C2CC(NC(C2)(C)C)(C)C)C3=NC(=NC(=N3)NCC=C)NCC=C)C4=NC(=NC(=N4)NCC=C)NCC=C)C,,,,,,
3462,163463,Licorice acid,C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O)O)O)C)(C)C(=O)O.[Zn],,,,,,
3463,163464,Einecs 287-251-1,[H+].CC1=NN(C(=C1N=NC2=C(C(=CC(=C2)Cl)S(=O)(=O)[O-])[O-])[O-])C3=CC=CC=C3.[OH-].[Cr+3],,,,,,
3464,163465,"Chromate(1-), (3-(2-(4,5-dihydro-3-methyl-5-(oxo-kappaO)-1-phenyl-1H-pyrazol-4-yl)diazenyl-kappaN1)-2-(hydroxy-kappaO)-5-nitrobenzenesulfonato(3-))hydroxy-, hydrogen (1:1)",[H+].CC1=NN(C(=C1N=NC2=C(C(=CC(=C2)[N+](=O)[O-])S(=O)(=O)[O-])[O-])[O-])C3=CC=CC=C3.[OH-].[Cr+3],,,,,,
3465,163466,"Chromate(1-), (3-(2-(4,5-dihydro-3-methyl-5-(oxo-kappaO)-1-phenyl-1H-pyrazol-4-yl)diazenyl-kappaN1)-2-(hydroxy-kappaO)-5-nitrobenzenesulfonato(3-))hydroxy-, (T-4)-, hydrogen, compd. with 3-((2-ethylhexyl)oxy)-1-propanamine (1:1:1)",[H+].CCCCC(CC)COCCCN.CC1=NN(C(=C1N=NC2=C(C(=CC(=C2)[N+](=O)[O-])S(=O)(=O)[O-])[O-])[O-])C3=CC=CC=C3.[OH-].[Cr+3],,,,,,
3466,163467,"Chromate(1-), (5-((5-chloro-2-(hydroxy-kappaO)phenyl)azo-kappaN1)-6-(hydroxy-kappaO)-2-naphthalenesulfonato(3-))hydroxy-, sodium",C1=CC2=C(C=CC(=C2N=NC3=C(C=CC(=C3)Cl)[O-])[O-])C=C1S(=O)(=O)[O-].[OH-].[Na+].[Cr+3],,,,,,
3467,163468,5-[(5-Chloro-2-hydroxyphenyl)azo]-6-hydroxy-2-naphthalenesulfonic acid,C1=CC2=C(C=CC(=C2N=NC3=C(C=CC(=C3)Cl)O)O)C=C1S(=O)(=O)O,,,,,,
3468,163469,"Methanesulfonamide, N-(2-(4-hydrazinophenyl)ethyl)-, monohydrochloride",CS(=O)(=O)NCCC1=CC=C(C=C1)NN.Cl,,,,,,
3469,163470,Sogmab,C1=CC(=CC=C1NCSC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)N=NC2=CC=C(C=C2)OS(=O)(=O)O,,,,,,
3470,163471,"Phosphoramidodithioic acid, ethylformyl-, O-ethyl S-(1-methylpropyl) ester",CCC(C)SP(=S)(N(CC)C=O)OCC,,,,,,
3471,163472,"2-Anthracenesulfonic acid, 1-amino-4-((4-((3-((2-chloroethyl)sulfonyl)benzoyl)methylamino)-2-sulfophenyl)amino)-9,10-dihydro-9,10-dioxo-, sodium salt",CN(C1=CC(=C(C=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)[O-])S(=O)(=O)[O-])C(=O)C5=CC(=CC=C5)S(=O)(=O)CCCl.[Na+].[Na+],,,,,,
3472,163473,"2-Naphthalenesulfonic acid, 6-amino-4-hydroxy-5-((2-sulfo-4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)azo)-, sodium salt",C1=CC(=C(C2=C(C=C(C=C21)S(=O)(=O)[O-])O)N=NC3=C(C=C(C=C3)S(=O)(=O)CCOS(=O)(=O)[O-])S(=O)(=O)[O-])N.[Na+].[Na+].[Na+],,,,,,
3473,163474,6-Amino-4-hydroxy-5-((2-sulpho-4-((2-(sulphooxy)ethyl)sulphonyl)phenyl)azo)naphthalene-2-sulphonic acid,C1=CC(=C(C2=C(C=C(C=C21)S(=O)(=O)O)O)N=NC3=C(C=C(C=C3)S(=O)(=O)CCOS(=O)(=O)O)S(=O)(=O)O)N,,,,,,
3474,163475,"1-Naphthalenesulfonic acid, 6-amino-5-((2-sulfo-4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)azo)-, sodium salt",C1=CC2=C(C=CC(=C2N=NC3=C(C=C(C=C3)S(=O)(=O)CCOS(=O)(=O)[O-])S(=O)(=O)[O-])N)C(=C1)S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
3475,163476,"2,7-Naphthalenedisulfonic acid, 5-((4-(bis(2-((2-chloroethyl)sulfonyl)ethyl)amino)-6-chloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-((2-sulfophenyl)azo)-, potassium sodium salt",C1=CC=C(C(=C1)N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)[O-])S(=O)(=O)[O-])NC4=NC(=NC(=N4)Cl)N(CCS(=O)(=O)CCCl)CCS(=O)(=O)CCCl)O)S(=O)(=O)[O-].[Na+].[Na+].[K+],,,,,,
3476,163477,"5-[[4-[Bis[2-[(2-chloroethyl)sulfonyl]ethyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[(2-sulfophenyl)azo]-2,7-naphthalenedisulfonic acid",C1=CC=C(C(=C1)N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)O)S(=O)(=O)O)NC4=NC(=NC(=N4)Cl)N(CCS(=O)(=O)CCCl)CCS(=O)(=O)CCCl)O)S(=O)(=O)O,,,,,,
3477,163478,"1,5-Naphthalenedisulfonic acid, 2-((8-((4-(bis(2-((2-chloroethyl)sulfonyl)ethyl)amino)-6-chloro-1,3,5-triazin-2-yl)amino)-1-hydroxy-3,6-disulfo-2-naphthalenyl)azo)-, sodium salt",C1=CC2=C(C=CC(=C2S(=O)(=O)[O-])N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)[O-])S(=O)(=O)[O-])NC5=NC(=NC(=N5)Cl)N(CCS(=O)(=O)CCCl)CCS(=O)(=O)CCCl)O)C(=C1)S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
3478,163479,"1,5-Naphthalenedisulfonic acid, 2-[[8-[[4-[bis[2-[(2-chloroethyl)sulfonyl]ethyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfo-2-naphthalenyl]azo]-",C1=CC2=C(C=CC(=C2S(=O)(=O)O)N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)O)S(=O)(=O)O)NC5=NC(=NC(=N5)Cl)N(CCS(=O)(=O)CCCl)CCS(=O)(=O)CCCl)O)C(=C1)S(=O)(=O)O,,,,,,
3479,163480,"1,7-Naphthalenedisulfonic acid, 4-(benzoylamino)-5-hydroxy-6-((4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)azo)-, sodium salt",C1=CC=C(C=C1)C(=O)NC2=C3C(=C(C=C2)S(=O)(=O)[O-])C=C(C(=C3O)N=NC4=CC=C(C=C4)S(=O)(=O)CCOS(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
3480,163481,"2,7-Naphthalenedisulfonic acid, 5-(acetylamino)-4-hydroxy-3-((8-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthalenyl)azo)-, sodium salt",CC(=O)NC1=C2C(=CC(=C1)S(=O)(=O)[O-])C=C(C(=C2O)N=NC3=CC4=C(C=CC=C4S(=O)(=O)CCOS(=O)(=O)[O-])C=C3)S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
3481,163482,"Methanaminium, N-(4-((4-(dimethylamino)phenyl)(4-(phenylamino)-1-naphthalenyl)methylene)-2,5-cyclohexadien-1-ylidene)-N-methyl-, salt with C10-14-alkylbenzenesulfonic acid (1:1)",CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[NH+]C3=CC=CC=C3)C4=CC=CC=C24)C5=CC=C(C=C5)N(C)C.C1=CC=C(C=C1)S(=O)(=O)O,,,,,,
3482,163483,"2,7-Naphthalenedisulfonic acid, 5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthalenyl)azo)-, sodium salt",C1=CC=C(C=C1)C(=O)NC2=C3C(=CC(=C2)S(=O)(=O)[O-])C=C(C(=C3O)N=NC4=C(C5=C(C=C4)C=C(C=C5)S(=O)(=O)CCOS(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
3483,163484,"2,7-Naphthalenedisulfonic acid, 5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthalenyl)azo)-",C1=CC=C(C=C1)C(=O)NC2=C3C(=CC(=C2)S(=O)(=O)O)C=C(C(=C3O)N=NC4=C(C5=C(C=C4)C=C(C=C5)S(=O)(=O)CCOS(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3484,163485,Ccris 5420,C1=CC=C2C(=C1)C=CC3=CC4=C(C5C(O5)C(C4O)O)N=C32,,,,,,
3485,163486,Ccris 5421,C1=CC=C2C(=C1)C=CC3=CC4=C(C(C(C5C4O5)O)O)N=C32,,,,,,
3486,163487,"2,7-Naphthalenedisulfonic acid, 5-((4-chloro-6-(methylphenylamino)-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-((4-methoxy-2-sulfophenyl)azo)-, trisodium salt",CN(C1=CC=CC=C1)C2=NC(=NC(=N2)NC3=C4C(=CC(=C3)S(=O)(=O)[O-])C=C(C(=C4O)N=NC5=C(C=C(C=C5)OC)S(=O)(=O)[O-])S(=O)(=O)[O-])Cl.[Na+].[Na+].[Na+],,,,,,
3487,163488,Ccris 5417,C1=CC=C2C(=C1)C=C3C=CC4=C(C3=N2)C5C(O5)C(C4O)O,,,,,,
3488,163489,"5,7-Dibromo-2-(5-bromo-7-chloro-1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,2-dihydro-3H-indol-3-one",C1=C(C=C(C2=C1C(=C(N2)C3=NC4=C(C3=O)C=C(C=C4Br)Br)O)Cl)Br,,,,,,
3489,163490,Sesbanimide,CC1C(=C)COC1(C2C(C(OCO2)C3CC(=O)NC(=O)C3)O)O,,,,,,
3490,163491,2-Deoxy-2-fluoro-beta-D-glucopyranosyl fluoride,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)[18F])[18F])O)O)O,,,,,,
3491,163492,"[(1R,8R,9S,10R,14S,17S)-1-acetyloxy-13-ethyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate",CCC12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)C)CCC4=CC(=O)C[C@H]([C@H]34)OC(=O)C,,,,,,
3492,163493,"Mono(2,3-dibromopropyl)phosphate ammonium salt",C(C(CBr)Br)OP(=O)(O)O.N.N,,,,,,
3493,163494,Rhizonin A,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N1)CC2=COC=C2)C)C)C)CC(C)C)CC3=COC=C3)C)C(C)C)C(C)C,,,,,,
3494,163495,CID 163495,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)O[C@H]3C[C@@H](O[C@@H]3COP(=O)(O)O)N4C=NC5=C4NC(=NC5=O)N)O.C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O[C@H]4C[C@H](O[C@@H]4COP(=O)(O)O)N5C=CC(=NC5=O)N)O,,,,,,
3495,163496,"[(2R,3S,5S)-5-(4-amino-2-oxopyrimidin-1-yl)-2-(phosphonooxymethyl)oxolan-3-yl] [(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl hydrogen phosphate",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O[C@H]4C[C@H](O[C@@H]4COP(=O)(O)O)N5C=CC(=NC5=O)N)O,,,,,,
3496,163497,"2-Methyl-5,6-dihydro-1,3-thiazino(2,3-b)quinazolin-4-one",CC1=CC(=O)N2CC3=CC=CC=C3N=C2S1,,,,,,
3497,163498,Fe-Ehpg,C1=CC=C(C(=C1)C(C(=O)[O-])NCCNC(C2=CC=CC=C2[O-])C(=O)[O-])[O-].[Fe+3],,,,,,
3498,163499,2-Tert-butylpyrimidin-5-ol,CC(C)(C)C1=NC=C(C=N1)O,,,,,,
3499,163500,"Benzoic acid, 2-((4-amino-9,10-dihydro-9,10-dioxo-3-sulfo-1-anthracenyl)amino)-4-((2-(sulfooxy)ethyl)sulfonyl)-, potassium sodium salt",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=C(C=CC(=C4)S(=O)(=O)CCOS(=O)(=O)[O-])C(=O)O)S(=O)(=O)[O-])N.[Na+].[K+],,,,,,
3500,163501,"2-((4-Amino-9,10-dioxo-3-sulfo-9,10-dihydroanthracen-1-yl)amino)-4-((2-(sulfooxy)ethyl)sulfonyl)benzoic acid",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=C(C=CC(=C4)S(=O)(=O)CCOS(=O)(=O)O)C(=O)O)S(=O)(=O)O)N,,,,,,
3501,163502,"Benzenesulfonic acid, 5-methoxy-4-((2-((2-methoxy-5-methyl-4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)azo)-1,3-dioxobutyl)amino)-2-methyl-, ammonium sodium salt",CC1=CC(=C(C=C1S(=O)(=O)[O-])OC)NC(=O)C(C(=O)C)N=NC2=C(C=C(C(=C2)C)S(=O)(=O)CCOS(=O)(=O)[O-])OC.[NH4+].[Na+],,,,,,
3502,163503,"Trisodium 5-(acetylamino)-4-hydroxy-3-((4-(((3-((2-(sulphonatooxy)ethyl)sulphonyl)phenyl)amino)carbonyl)phenyl)azo)naphthalene-2,7-disulphonate",CC(=O)NC1=C2C(=CC(=C1)S(=O)(=O)[O-])C=C(C(=C2O)N=NC3=CC=C(C=C3)C(=O)NC4=CC(=CC=C4)S(=O)(=O)CCOS(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
3503,163504,"Sodium (7-((5-chloro-2-hydroxyphenyl)azo)-8-hydroxynaphthalene-1,6-disulphonato(4-))chromate(1-)",C1=CC2=CC(=C(C(=C2C(=C1)S(=O)(=O)[O-])[O-])N=NC3=C(C=CC(=C3)Cl)[O-])S(=O)(=O)[O-].[Na+].[Cr+3],,,,,,
3504,163505,"2-[(5-Chloro-2-hydroxyphenyl)azo]-1-hydroxy-3,8-naphthalenedisulfonic acid",C1=CC2=CC(=C(C(=C2C(=C1)S(=O)(=O)O)O)N=NC3=C(C=CC(=C3)Cl)O)S(=O)(=O)O,,,,,,
3505,163506,"Chromate(1-), (3-(((4,5-dihydro-3-methyl-5-(oxo-kappaO)-1-(3-sulfophenyl)-1H-pyrazol-4-yl)methylene)amino-kappaN)-2-(hydroxy-kappaO)-5-nitrobenzenesulfonato(4-))-, sodium (1:1)",CC1=NN(C(=C1C=NC2=C(C(=CC(=C2)[N+](=O)[O-])S(=O)(=O)[O-])[O-])[O-])C3=CC(=CC=C3)S(=O)(=O)[O-].[Na+].[Cr+3],,,,,,
3506,163507,CID 163507,CC1=NN(C(=O)C1=CN=C2C=C(C=C(C2=O)S(=O)(=O)O)N([O-])[O-])C3=CC(=CC=C3)S(=O)(=O)O,,,,,,
3507,163508,"2-Naphthalenesulfonic acid, 7-(acetylamino)-4-hydroxy-3-((6-sulfo-8-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthalenyl)azo)-, sodium salt",CC(=O)NC1=CC2=CC(=C(C(=C2C=C1)O)N=NC3=CC4=C(C=C(C=C4C=C3)S(=O)(=O)[O-])S(=O)(=O)CCOS(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
3508,163509,CID 163509,CC(=O)C(=C([N-]C1=CC=CC=C1)[O-])[N-]N=C2C=C(C=C(C2=O)S(=O)(=O)[O-])[N+](=O)O.CC(=O)C(=NN=C1C=C(C=C(C1=O)S(=O)(=O)[O-])N([O-])[O-])C(=O)NC2=CC=CC=C2.[Na+].[Na+].[Na+].[Co+3],,,,,,
3509,163510,CID 163510,C1=CC2=C(NOC2=CC1=O)O,,,,,,
3510,163511,Bis(dichloromethyl)sulfone,C(S(=O)(=O)C(Cl)Cl)(Cl)Cl,,,,,,
3511,163512,Decilorubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C=CC6=C5OC7C(C(C(C6(O7)C)OC8CC(C(C(O8)C)OC9CC(C(C(O9)C)OC1CC(C(C(O1)C)OC(=O)CCC(=O)O)OC)(C)[N+](=O)[O-])(C)[N+](=O)[O-])N(C)C)O)O)(C)O)N(C)C)O,,,,,,
3512,163513,"Phosphorodithioic acid, S-(1,1-dimethylethyl) O-ethyl S-(1-methylpropyl) ester",CCC(C)SP(=O)(OCC)SC(C)(C)C,,,,,,
3513,163514,"2-Propanesulfenamide, N,N',N''-1,3,5-triazine-2,4,6-triyltris[N-[(1-methylethyl)thio]-",CC(C)SN(C1=NC(=NC(=N1)N(SC(C)C)SC(C)C)N(SC(C)C)SC(C)C)SC(C)C,,,,,,
3514,163515,CID 163515,CC1=CC=CC=C1N=C(C(=NNC2=C(C=CC(=C2)S(=O)(=O)N)C(=O)[O-])C(=O)C)[O-].COC1=CC(=N[N-]C2=C(C=CC3=C2C(=CC=C3)[N-]S(=O)(=O)C)O)C(=O)C=C1Cl.[Na+].[Cr+3],,,,,,
3515,163516,CID 163516,CC1=CC=CC=C1NC(=O)C(=NNC2=C(C=CC(=C2)S(=O)(=O)N)C(=O)O)C(=O)C,,,,,,
3516,163517,N-[8-[(4-chloro-2-hydroxy-5-methoxyphenyl)diazenyl]-7-hydroxynaphthalen-1-yl]methanesulfonamide,COC1=C(C=C(C(=C1)N=NC2=C(C=CC3=C2C(=CC=C3)NS(=O)(=O)C)O)O)Cl,,,,,,
3517,163518,"Benzamide, N-(((2,6-difluorophenyl)amino)carbonyl)-2,6-dimethoxy-",COC1=C(C(=CC=C1)OC)C(=O)NC(=O)NC2=C(C=CC=C2F)F,,,,,,
3518,163519,TA-2711 disodium salt,CC(C)C1=C(C=C2C(=C1)CC[C@H]3[C@]2(CCC[C@H]3C(=O)OC)C)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
3519,163520,"(4bR,8R,8aR)-8-methoxycarbonyl-4b-methyl-2-propan-2-yl-6,7,8,8a,9,10-hexahydro-5H-phenanthrene-3-sulfonic acid",CC(C)C1=C(C=C2C(=C1)CC[C@H]3[C@]2(CCC[C@H]3C(=O)OC)C)S(=O)(=O)O,,,,,,
3520,163521,CID 163521,CC(C)C1=C(C=C2C(=C1)CC[C@H]3[C@@]2(CCC[C@H]3C(=O)OC)C)S(=O)(=O)[O-].[Na+],,,,,,
3521,163522,"(4bS,8R,8aR)-8-methoxycarbonyl-4b-methyl-2-propan-2-yl-6,7,8,8a,9,10-hexahydro-5H-phenanthrene-3-sulfonic acid",CC(C)C1=C(C=C2C(=C1)CC[C@H]3[C@@]2(CCC[C@H]3C(=O)OC)C)S(=O)(=O)O,,,,,,
3522,163523,CID 163523,C[C@H]1C(=O)O[C@@H]2C13[C@H]([C@@H]4[C@]([C@H](CC[C@]45CO5)OC(=O)C)([C@H]([C@@H]([C@@H](O3)C(=C)[C@@H]2Cl)OC(=O)C)OC(=O)C)C)OC(=O)C,,,,,,
3523,163524,"3,4-Dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrodibenz(a,h)anthracene",C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC5=C(C4=C3)C6C(O6)C(C5O)O,,,,,,
3524,163525,CID 163525,C(CP(CCC#N)CCS(=O)(=O)[O-])C#N.[K+],,,,,,
3525,163526,Tatsiensine,CCN1CC2(C=CC(C34C2C(C5(C31)C6(CC(C7CC4C6C7OC)OC)OCO5)OC(=O)C)OC)C,,,,,,
3526,163527,Ascidiacyclamide,CC[C@H](C)[C@H]1C2=N[C@@H]([C@H](O2)C)C(=O)N[C@@H](C3=NC(=CS3)C(=O)N[C@H](C4=N[C@@H]([C@H](O4)C)C(=O)N[C@@H](C5=NC(=CS5)C(=O)N1)C(C)C)[C@@H](C)CC)C(C)C,,,,,,
3527,163528,"4-(6-((2,5-Dimethylpyrrol-1-yl)amino)-3-pyridazinyl)morpholine hydrochloride",CC1=CC=C(N1NC2=NN=C(C=C2)N3CCOCC3)C.Cl,,,,,,
3528,163529,Scentenal,COC1CC2CC1C3C2CC(C3)C=O,,,,,,
3529,163530,Vanoxonin,C[C@H]([C@@H](C(=O)N[C@@H](CCCN(C(=O)C)O)C(=O)O)NC(=O)C1=C(C(=CC=C1)O)O)O,,,,,,
3530,163531,CID 163531,C[C@H](CO)NC(=O)C(=CC=CC=CC=CC(=C[C@@H](C)[C@H](C(=CC(C)C)C)O)C)C,,,,,,
3531,163532,"[(2R,3S,5S)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl tetradecyl hydrogen phosphate",CCCCCCCCCCCCCCOP(=O)(O)OC[C@@H]1[C@H](C[C@H](O1)N2C=C(C(=O)NC2=O)F)O,,,,,,
3532,163533,Pts-substance P (4-11),CC(C)C[C@@H](C(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@@H](CC4=CNC5=CC=CC=C54)NC(=O)C(CCC(=O)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H]6CCCN6,,,,,,
3533,163534,CID 163534,C1=CC(=C[N+](=C1)[C@H](C=O)O[C@H](COP(=O)([O-])OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)OP(=O)(O)O)O)C=O)C(=O)N,,,,,,
3534,163535,CID 163535,C1=CC(=C[N+](=C1)[C@H](C=O)O[C@H](COP(=O)(O)OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)OP(=O)(O)O)O)C=O)C(=O)N,,,,,,
3535,163536,"5-Chloro-4-(2-oxazolidinylideneamino)-2,1,3-benzothiadiazole",C1COC(=N1)NC2=C(C=CC3=NSN=C32)Cl,,,,,,
3536,163537,1-Methyl-4-(2-oxazolidinylideneamino)indole,CN1C=CC2=C(C=CC=C21)NC3=NCCO3,,,,,,
3537,163538,1-Methyl-7-(2-oxazolidinylideneamino)indole,CN1C=CC2=C1C(=CC=C2)NC3=NCCO3,,,,,,
3538,163539,Ccris 5867,C1=CC=C2C(=C1)C=CC3=C2C=C4C=C[C@H]([C@@H](C4=C3[N+](=O)[O-])O)O,,,,,,
3539,163540,"7-Nitrobenz(a)anthracene-trans-3,4-dihydrodiol",C1=CC=C2C(=C1)C=C3C4=C(C=CC3=C2[N+](=O)[O-])[C@H]([C@@H](C=C4)O)O,,,,,,
3540,163541,CID 163541,CCNC(=NCCCN(C)C)N[C@H]1[C@@H]([C@H](O[C@H]([C@H]1O)O[C@@H]2C[C@H]3[C@@H]([C@H](C[C@](O3)(C[C@H](CC(C(CCC(C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]([C@H](C=CC=CC=CC=CC=CC=CC=C2)C)O)C)C)O)O)O)O)O)O)O)C(=O)O)C)O,,,,,,
3541,163542,Ffdump,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)F)COP(=O)(O)O)F,,,,,,
3542,163543,CID 163543,[H+].[H+].[H+].[H+].C1C(C(OC1N2C=NC3=C2NC(=NC3=O)N)COP(=O)([O-])[O-])O.C1C(C(OC1N2C=NC3=C2NC(=NC3=O)N)COP(=O)([O-])[O-])O.N.N.[Pt+2],,,,,,
3543,163544,5-(4-Benzoquinonyl)-2'-deoxyuridine 5'-phosphate,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C3=CC(=O)C=CC3=O)COP(=O)(O)O)O,,,,,,
3544,163545,9-Anthrylmethyl glycidyl ether,C1C(O1)COCC2=C3C=CC=CC3=CC4=CC=CC=C42,,,,,,
3545,163546,"2'-Methylspiro[bicyclo[2.2.1]heptane-2,5'-[1,3]dioxane]",CC1OCC2(CC3CCC2C3)CO1,,,,,,
3546,163547,Netzahualcoyone,CC1=C2C3=CC=C4C(=C(C(=O)C=C4C3(CCC2(C5CC(C(C(=O)C5(C1)C)O)(C)C(=O)OC)C)C)O)C,,,,,,
3547,163548,Dibutyltin;triethoxy(hydroxy)silane,CCCC[Sn]CCCC.CCO[Si](O)(OCC)OCC.CCO[Si](O)(OCC)OCC,,,,,,
3548,163549,Azebcap,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC(=O)N2)CCC4=C3C=CC(=C4)OC(=O)CC5=CC=C(C=C5)N(CCCl)CCCl,,,,,,
3549,163550,CID 163550,CCCCCCCCC=CC(=O)O[C@@H]1[C@H]2C(=C)[C@H]([C@]3([C@H]4[C@@]2(CO3)[C@@H](C[C@@H]5[C@@]4([C@@H](C(=O)C=C5C)O)C)OC1=O)O)O,,,,,,
3550,163551,"[(2R,3S,4R,5R)-5-(3-aminopyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl [hydroxy-[[(2R,3R,4R,5R)-3-hydroxy-5-imidazo[2,1-f]purin-3-yl-4-phosphonooxyoxolan-2-yl]methoxy]phosphoryl] phosphate",C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C4N=CN6C5=NC=C6)OP(=O)(O)O)O)O)O)N,,,,,,
3551,163552,"[[(2R,3S,4R,5R)-5-(3-aminopyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4R,5R)-3-hydroxy-5-imidazo[2,1-f]purin-3-yl-4-phosphonooxyoxolan-2-yl]methyl hydrogen phosphate",C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C4N=CN6C5=NC=C6)OP(=O)(O)O)O)O)O)N,,,,,,
3552,163553,CID 163553,CC1C=CC=C(C(=O)NC2=C(C(=O)C3=C(C2=O)C(=C(C(=C3C(=O)C(=CC(C(C(C(C(C(C(C1O)C)O)C(=O)OC)O)C)O)C)C)OC)C)O)SC)C,,,,,,
3553,163554,Bis(mu-propionato)diaquatetrabromodirhenium (III),CCC(=O)[O-].CCC(=O)[O-].O.O.[Br-].[Br-].[Br-].[Br-].[Re].[Re],,,,,,
3554,163555,Silver norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)[O-].[Ag+],,,,,,
3555,163556,"(2R,3S,4R,5R,6R)-3-[(2R,3R,4R,5R,6R)-5-[(2R,3R,4R,5S,6S)-6-carboxy-5-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfoamino)-6-(sulfooxymethyl)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-3-(sulfoamino)-4-sulfooxy-6-(sulfooxymethyl)oxan-2-yl]oxy-6-[(1R,2S,3R,4R)-1,3-dihydroxy-5-oxo-4-(sulfoamino)-1-sulfooxypentan-2-yl]oxy-4-hydroxy-5-(sulfooxymethyl)oxane-2-carboxylic acid",C([C@@H]1[C@H]([C@@H]([C@@H](O[C@H]1O[C@@H]([C@@H]([C@H](C=O)NS(=O)(=O)O)O)[C@H](O)OS(=O)(=O)O)C(=O)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)COS(=O)(=O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O,,,,,,
3556,163557,Oxirapentyn,CC(=C)C#C[C@@]12[C@@H](O1)[C@H]3[C@]4(C[C@H](C(O3)(C)C)OC(=O)C)[C@@H](C2=O)O4,,,,,,
3557,163558,Ruppuran,C1C=CC=C1.C1=CC(=C(NCC(=O)O)[O-])C=C1.[103Ru+2],,,,,,
3558,163559,"2-[[Cyclopenta-2,4-dien-1-ylidene(hydroxy)methyl]amino]acetic acid",C1=CC(=C(NCC(=O)O)O)C=C1,,,,,,
3559,163560,"NCGC00381062-01_C32H36N4O2_8a,16a-Bis(2-methyl-3-buten-2-yl)-5a,8,8a,13,13a,15a,16,16a-octahydroindolo[3''',2''':4'',5'']pyrrolo[1'',2'':4',5']pyrazino[1',2':1,5]pyrrolo[2,3-b]indole-7,15(5H,7aH)-dione",CC(C)(C=C)C12CC3C(=O)N4C(CC5(C4NC6=CC=CC=C65)C(C)(C)C=C)C(=O)N3C1NC7=CC=CC=C27,,,,,,
3560,163561,"Quinolinium, 6-amino-4-((4-(((4-((((aminoiminomethyl)amino)iminomethyl)amino)phenyl)amino)carbonyl)phenyl)amino)-1-methyl-",C[N+]1=C2C=CC(=CC2=C(C=C1)NC3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)N=CNN=C(N)N)N,,,,,,
3561,163562,"Quinolinium, 1-butyl-4-((4-(((4-((1-butylpyridinium-4-yl)amino)phenyl)amino)carbonyl)phenyl)amino)-",CCCC[N+]1=CC=C(C=C1)NC2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)NC4=CC=[N+](C5=CC=CC=C45)CCCC,,,,,,
3562,163563,Solanapyrone E,C[C@H]1C=C[C@H]2CCCCC2[C@@H]1C3=CC(=C(C(=O)O3)CO)OC,,,,,,
3563,163564,"1,3,4-Thiadiazole-2-sulfonamide, N,N-diethyl-5-(5-hydroxy-3-methyl-2-oxo-1-imidazolidinyl)-",CCN(CC)S(=O)(=O)C1=NN=C(S1)N2C(CN(C2=O)C)O,,,,,,
3564,163565,CID 163565,C[C@H]1CC(=CC=C[C@@H](C(OC(=O)C(=CC(=C[C@H]([C@H]1O)C)C)OC)[C@@H](C)[C@H]([C@H](C)[C@]2(C[C@H]([C@@H]([C@H](O2)C(C)C)C)OC(=O)C=CC(=O)O)O)O)OC)C,,,,,,
3565,163566,"1,2,4,5-Tetrahydro-1-(phenylmethyl)-5,9b(1',2')-benzeno-9bH-benz(g)indol-3(3aH)-one",C1C2C3=CC=CC=C3C4(C1C(=O)CN4CC5=CC=CC=C5)C6=CC=CC=C26,,,,,,
3566,163567,Nbeta-Acetylstreptothricin D,CC(=O)N[C@@H](CCCNC(=O)C[C@H](CCCNC(=O)C[C@H](CCCN)N)N)CC(=O)N[C@@H]1[C@@H]([C@H]([C@H](O[C@H]1NC2=N[C@H]3[C@H](N2)[C@@H](CNC3=O)O)CO)OC(=O)N)O,,,,,,
3567,163568,"5-Ethyl-1,3,8-trimethyl-1H-imidazo(1,2-c)pyrazolo(3,4-e)pyrimidine",CCC1=NC2=C(C3=NC(=CN13)C)N(N=C2C)C,,,,,,
3568,163569,CID 163569,CC(=O)CC(C1=CC=C(C=C1)S(=O)C)C2=C(OC3=CC=CC=C3C2=O)O,,,,,,
3569,163570,"2-Butyl-1,2-dihydro-3H-indazol-3-one",CCCCN1C(=O)C2=CC=CC=C2N1,,,,,,
3570,163571,Naphthalene-1-sulfonamide,C1=CC=C2C(=C1)C=CC=C2S(=O)(=O)N,,,,,,
3571,163572,CID 163572,CCCCCCCCC(=O)OC1=CC=C(C=C1)S(=O)(=O)[O-].[Na+],,,,,,
3572,163573,"Nonanoic acid, 4-sulfophenyl ester",CCCCCCCCC(=O)OC1=CC=C(C=C1)S(=O)(=O)O,,,,,,
3573,163574,2-Deoxy-4-O-phosphono-3-O-tetradecanoyl-2-(3-tetradecanoyloxytetradecanamido)-D-glucose,CCCCCCCCCCCCCC(=O)O[C@H]([C@H](C=O)NC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H]([C@@H](CO)O)OP(=O)(O)O,,,,,,
3574,163575,"[4-acetyloxy-6-[(3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl)oxy]-5-iodo-2-methyloxan-3-yl] acetate",CC1C(C(C(C(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)I)OC(=O)C)OC(=O)C,,,,,,
3575,163576,"1,3-Dimethyl-2-((4-(methylamino)phenyl)azo)-1H-imidazolium chloride",CNC1=CC=C(C=C1)N=NC2=[N+](C=CN2C)C.[Cl-],,,,,,
3576,163577,"3-((1,2-Dimethyl-1H-indol-3-yl)azo)-1,5-dimethyl-2-phenyl-1H-pyrazolium methyl sulphate",CC1=C(C2=CC=CC=C2N1C)N=NC3=C[N+](=C(N3C4=CC=CC=C4)C)C.COS(=O)(=O)[O-],,,,,,
3577,163578,"(1,2-Dimethylindol-3-yl)-(1,2-dimethyl-3-phenylimidazol-1-ium-4-yl)diazene",CC1=C(C2=CC=CC=C2N1C)N=NC3=C[N+](=C(N3C4=CC=CC=C4)C)C,,,,,,
3578,163579,"Benzothiazolium, 6-methoxy-3-methyl-2-[3-methyl-3-(4-nitrophenyl)-1-triazenyl]-, methyl sulfate",C[N+]1=C(SC2=C1C=CC(=C2)OC)N=NN(C)C3=CC=C(C=C3)[N+](=O)[O-].COS(=O)(=O)[O-],,,,,,
3579,163580,"N-[(6-methoxy-3-methyl-1,3-benzothiazol-3-ium-2-yl)diazenyl]-N-methyl-4-nitroaniline;sulfate",C[N+]1=C(SC2=C1C=CC(=C2)OC)N=NN(C)C3=CC=C(C=C3)[N+](=O)[O-].C[N+]1=C(SC2=C1C=CC(=C2)OC)N=NN(C)C3=CC=C(C=C3)[N+](=O)[O-].[O-]S(=O)(=O)[O-],,,,,,
3580,163581,1-Propylagroclavine,CCCN1C=C2C[C@@H]3[C@H](C=C(CN3C)C)C4=C2C1=CC=C4,,,,,,
3581,163582,"3-Pyridinemethanamine, N-(2,4-dichlorophenyl)-N-(4,5-dihydro-2-thiazolyl)-",C1CSC(=N1)N(CC2=CN=CC=C2)C3=C(C=C(C=C3)Cl)Cl,,,,,,
3582,163583,"3-Pyridinemethanamine, N-(4-chlorophenyl)-N-(4,5-dihydro-2-thiazolyl)-",C1CSC(=N1)N(CC2=CN=CC=C2)C3=CC=C(C=C3)Cl,,,,,,
3583,163584,"3-Pyridinemethanamine, N-(4,5-dihydro-2-thiazolyl)-N-(4-phenoxyphenyl)-",C1CSC(=N1)N(CC2=CN=CC=C2)C3=CC=C(C=C3)OC4=CC=CC=C4,,,,,,
3584,163585,"2H-1-Benzopyran-4-carbonitrile, 3-(6-ethoxy-2-benzothiazolyl)-7-methoxy-2-oxo-",CCOC1=CC2=C(C=C1)N=C(S2)C3=C(C4=C(C=C(C=C4)OC)OC3=O)C#N,,,,,,
3585,163586,"[(1R,7R,17R)-4-ethylidene-7-methyl-6-methylidene-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-en-7-yl] acetate",CC=C1CC(=C)[C@@](C(=O)OCC2=CCN3[C@H]2[C@@H](CC3)OC1=O)(C)OC(=O)C,,,,,,
3586,163587,"12-Hydroxy-1,2-dihydrosenecionan-11,16-dione",CC=C1CC(C(C(=O)OCC2CCN3C2C(CC3)OC1=O)(C)O)C,,,,,,
3587,163588,2-Methylpentyl 2-methylpentanoate,CCCC(C)COC(=O)C(C)CCC,,,,,,
3588,163589,"Octadecanoic acid, reaction products with diethylenetriamine, di-Me sulfate-quaternized",CCCCCCCCCCCCCCCCCC(=O)O.COS(=O)(=O)OC.C(CNCCN)N,,,,,,
3589,163590,"Acetamide, 2-chloro-N-(2-ethoxy-6-methylphenyl)-N-(propoxymethyl)-",CCCOCN(C1=C(C=CC=C1OCC)C)C(=O)CCl,,,,,,
3590,163591,"4,4'-(3,4,7,15,16-Pentahydroxy-4,9-epoxycevane-3,15-diyl)bis(2-methylbut-2-enoic acid)",C[C@H]1CC[C@H]2[C@@H]([C@@H]3[C@@H](CN2C1)[C@@H]4CC56[C@H](C4[C@@]([C@@H]3O)(CC=C(C)C(=O)O)O)[C@@H](CC7[C@@]5(CC[C@]([C@]7(O6)O)(CC=C(C)C(=O)O)O)C)O)C,,,,,,
3591,163592,CID 163592,CC1=CC(=O)C(=CO)C2=C1C(=O)OC3=C(C(=O)C(=C(O)O)C(=C3O2)C)COC(=O)C,,,,,,
3592,163593,"3a,4,5,6,7,7a-Hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,2-benzisoxazol-5-ol",CN1C(=CN=C1C2=NOC3C2CC(CC3)O)[N+](=O)[O-],,,,,,
3593,163594,Dichlorobis(azomycin)platinum II,C1=CN=C(N1)[N+](=O)[O-].C1=CN=C(N1)[N+](=O)[O-].[Cl-].[Cl-].[Pt+2],,,,,,
3594,163595,"1H-1,2,4-Triazole-1-methanamine, N,N-bis(2-ethylhexyl)-",CCCCC(CC)CN(CC(CC)CCCC)CN1C=NC=N1,,,,,,
3595,163596,2-(4-Cyclohexylpiperazin-1-yl)ethanimidic acid--hydrogen chloride (1/1),C1CCC(CC1)N2CCN(CC2)CC(=O)N.Cl,,,,,,
3596,163597,2-(4-Cyclohexylpiperazin-1-yl)acetamide,C1CCC(CC1)N2CCN(CC2)CC(=O)N,,,,,,
3597,163598,2-Benzyloxycarbonylphenyl trans-4-guanidinomethylcyclohexanecarboxylate-cyclodextrin,C1CC(CCC1CN=C(N)N)C(=O)OC2=CC=CC=C2C(=O)OCC3=CC=CC=C3.C([C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](O[C@@H]([C@@H]([C@H]7O)O)O[C@@H]8[C@H](O[C@H](O2)[C@@H]([C@H]8O)O)CO)CO)CO)CO)CO)CO)O)O)O.Cl,,,,,,
3598,163599,1-Allylelymoclavine,CN1CC(=C[C@H]2[C@H]1CC3=CN(C4=CC=CC2=C34)CC=C)CO,,,,,,
3599,163600,"(4S,5R,7S,8R,11R,13S,17S,18S,19R)-4,5,17-trihydroxy-8-methoxy-14,18-dimethyl-6-methylidene-3,10-dioxapentacyclo[9.8.0.01,7.04,19.013,18]nonadec-14-ene-9,16-dione",CC1=CC(=O)[C@H]([C@]2([C@H]1C[C@@H]3C45[C@@H]2[C@@]([C@@H](C(=C)[C@@H]4[C@H](C(=O)O3)OC)O)(OC5)O)C)O,,,,,,
3600,163601,"2-Pyrrolidinone, 1-(5-(1,1-dimethylethyl)-3-isoxazolyl)-3-methyl-",CC1CCN(C1=O)C2=NOC(=C2)C(C)(C)C,,,,,,
3601,163602,Bis(tri-n-hexylsiloxy)silicon phthalocyanine,CCCCCC[Si](CCCCCC)(CCCCCC)[O-].CCCCCC[Si](CCCCCC)(CCCCCC)[O-].C1=CC=C2C=C3C(=CC2=C1)C4=NC5=C6C=C7C=CC=CC7=CC6=C([N-]5)N=C8C9=CC1=CC=CC=C1C=C9C(=N8)N=C1C2=CC5=CC=CC=C5C=C2C(=N1)N=C3[N-]4.[Si+4],,,['Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. (See all compounds classified as Photosensitizing Agents.)'],,,
3602,163603,Trihexylsilanol,CCCCCC[Si](CCCCCC)(CCCCCC)O,,,,,,
3603,163604,"2,15,28,41,53,54,55,56-Octazatridecacyclo[40.10.1.13,14.116,27.129,40.04,13.06,11.017,26.019,24.030,39.032,37.043,52.045,50]hexapentaconta-1,3(56),4,6,8,10,12,14,16(55),17,19,21,23,25,27,29,31,33,35,37,39,42(53),43,45,47,49,51-heptacosaene",C1=CC=C2C=C3C(=CC2=C1)C4=NC3=NC5=NC(=NC6=NC(=NC7=C8C=C9C=CC=CC9=CC8=C(N7)N4)C1=CC2=CC=CC=C2C=C16)C1=CC2=CC=CC=C2C=C15,,,,,,
3604,163605,"sodium;(2S,4S,5R,6R)-5-acetamido-2,4-dihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid",CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O.[Na+],,,,,,
3605,163606,"(2S,4S,5R,6R)-5-Acetamido-2,4-dihydroxy-6-((1R,2R)-1,2,3-trihydroxypropyl)tetrahydro-2H-pyran-2-carboxylic acid",CC(=O)N[C@@H]1[C@H](C[C@](OC1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)O,,,,,,
3606,163607,CID 163607,CC=C[C@H](C)[C@@H]1[C@@](O1)(C)[C@H]([C@H]2COC(=O)[C@@H]([C@H]([C@@H](C(=O)[C@@H]([C@H](C(=C[C@@H](C(=O)C[C@@H]([C@H](C2=O)C)O)C)C)O)C)C)OC)O)O,,,,,,
3607,163608,Diethylamine dinitric oxide adduct,CCNCC.N=O,,,"['A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)']",,,
3608,163609,"2-[bis[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;(2S)-2,6-diaminohexanoic acid;gadolinium(3+);hydron",[H+].[H+].C(CCN)C[C@@H](C(=O)O)N.C(CCN)C[C@@H](C(=O)O)N.C(CN(CC(=O)[O-])CC(=O)[O-])N(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],,,,,,
3609,163610,Bcancttf,CC#N.[CH-]1C=CC=C1.[CH-]1C=CC=C1.[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Ti+4].[Fe+3],,,,,,
3610,163611,"9-Amino-12-(2-amino-1-hydroxy-2-oxoethyl)-4-hydroxy-10,13-dioxo-2-oxa-11,14-diazatricyclo[15.2.2.13,7]docosa-1(19),3,5,7(22),17,20-hexaene-15-carboxylic acid",C1C(C(=O)NC(C(=O)NC(CC2=CC=C(C=C2)OC3=C(C=CC1=C3)O)C(=O)O)C(C(=O)N)O)N,,,,,,
3611,163612,"9-Amino-12-(2-amino-1-hydroxy-2-oxoethyl)-4-methoxy-10,13-dioxo-2-oxa-11,14-diazatricyclo[15.2.2.13,7]docosa-1(19),3,5,7(22),17,20-hexaene-15-carboxylic acid",COC1=C2C=C(CC(C(=O)NC(C(=O)NC(CC3=CC=C(O2)C=C3)C(=O)O)C(C(=O)N)O)N)C=C1,,,,,,
3612,163613,Ara-cdp hexadecyl ester,CCCCCCCCCCCCCCCCOP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@@H]([C@@H](O1)N2C=CC(=NC2=O)N)O)O,,,,,,
3613,163614,Acdpcme,C1CCC(CC1)COP(=O)(O)OP(=O)(O)OC[C@@H]2[C@H]([C@@H]([C@@H](O2)N3C=CC(=NC3=O)N)O)O,,,,,,
3614,163615,3-(3-Chlorophenyl)-1-methyl-1H-pyrazole-5-carboxylic acid,CN1C(=CC(=N1)C2=CC(=CC=C2)Cl)C(=O)O,,,,,,
3615,163616,"Benzenamine, 4-chloro-, sulfate (1:1)",C1=CC(=CC=C1N)Cl.OS(=O)(=O)O,,,,,,
3616,163617,"6-Ethylideneoctahydro-5,8-methano-2H-benzo-1-pyran",CC=C1CC2CC1C3C2OCCC3,,,,,,
3617,163618,"2-Propenoic acid, 2-methyl-, 1-methylethenyl ester",CC(=C)C(=O)OC(=C)C,,,,,,
3618,163619,Lactardial,C[C@H](CC1=C(CO[C@@H]1O)C=O)C2=CCC(C2)(C)C,,,,,,
3619,163620,"Carbonic acid, ethyl 2,3,6-trimethylcyclohexyl ester",CCOC(=O)OC1C(CCC(C1C)C)C,,,,,,
3620,163621,"Cobaltate(1-), (4-(hydroxy-kappaO)-3-((2-(hydroxy-kappaO)-1-naphthalenyl)azo-kappaN1)-N-(1-methylethyl)benzenesulfonamidato(2-))(4-(hydroxy-kappaO)-3-((2-(hydroxy-kappaO)-1-naphthalenyl)azo-kappaN1)-N-phenylbenzenesulfonamidato(2-))-, sodium",CC(C)NS(=O)(=O)C1=CC(=C(C=C1)[O-])N=NC2=C(C=CC3=CC=CC=C32)[O-].C1=CC=C(C=C1)NS(=O)(=O)C2=CC(=C(C=C2)[O-])N=NC3=C(C=CC4=CC=CC=C43)[O-].[Na+].[Co+3],,,,,,
3621,163622,4-hydroxy-3-[(2-hydroxynaphthalen-1-yl)diazenyl]-N-propan-2-ylbenzenesulfonamide,CC(C)NS(=O)(=O)C1=CC(=C(C=C1)O)N=NC2=C(C=CC3=CC=CC=C32)O,,,,,,
3622,163623,4-Hydroxy-3-[(2-hydroxynaphthalen-1-yl)diazenyl]-N-phenylbenzene-1-sulfonamide,C1=CC=C(C=C1)NS(=O)(=O)C2=CC(=C(C=C2)O)N=NC3=C(C=CC4=CC=CC=C43)O,,,,,,
3623,163624,2-[3-(2-Chlorophenyl)propyl]pyridine,C1=CC=C(C(=C1)CCCC2=CC=CC=N2)Cl,,,,,,
3624,163625,2-[3-(4-Chlorophenyl)propyl]pyridine,C1=CC=NC(=C1)CCCC2=CC=C(C=C2)Cl,,,,,,
3625,163626,Tat-BP,C[C@@H](C(=O)N[C@H](CCC(=O)N[C@@H](CCC[C@H](C(=O)O)N)C(=O)N[C@H](C)C(=O)O)C(=O)O)NC(=O)[C@@H](C)O[C@@H]1[C@H]([C@@H]2OC[C@H]([C@H]1O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)NC(=O)C)O2)NC(=O)C,,,,,,
3626,163627,CID 163627,COC(=C1C(C(=O)N(N1)C2=CC(=C(C=C2)N=C3C=C(C(=N)C4=C3C(=O)C5=CC=CC=C5C4=O)S(=O)(=O)[O-])S(=O)(=O)[O-])N=NC6=CC=C(C=C6)S(=O)(=O)CCOS(=O)(=O)[O-])O.[Na+].[Na+].[Na+],,,,,,
3627,163628,CID 163628,COC(=C1C(C(=O)N(N1)C2=CC(=C(C=C2)N=C3C=C(C(=N)C4=C3C(=O)C5=CC=CC=C5C4=O)S(=O)(=O)O)S(=O)(=O)O)N=NC6=CC=C(C=C6)S(=O)(=O)CCOS(=O)(=O)O)O,,,,,,
3628,163629,CID 163629,CC1=C(C=CC(=C1)N(CCOS(=O)(=O)O)CCOS(=O)(=O)[O-])N=NC2=CC=C(C=C2)S(=O)(=O)CCOS(=O)(=O)O.[Na+],,,,,,
3629,163630,"2,2'-[[3-Methyl-4-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]phenyl]imino]diethanol bis(hydrogen sulfate)",CC1=C(C=CC(=C1)N(CCOS(=O)(=O)O)CCOS(=O)(=O)O)N=NC2=CC=C(C=C2)S(=O)(=O)CCOS(=O)(=O)O,,,,,,
3630,163631,"Benzenesulfonic acid, 4-((2-((2,5-dimethoxy-4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)azo)-1,3-dioxobutyl)amino)-5-methoxy-2-methyl-, sodium salt",CC1=CC(=C(C=C1S(=O)(=O)[O-])OC)NC(=O)C(C(=O)C)N=NC2=CC(=C(C=C2OC)S(=O)(=O)CCOS(=O)(=O)[O-])OC.[Na+].[Na+],,,,,,
3631,163632,"Benzenesulfonic acid, 4-((2-((2,5-dimethoxy-4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)azo)-1,3-dioxobutyl)amino)-5-methoxy-2-methyl-",CC1=CC(=C(C=C1S(=O)(=O)O)OC)NC(=O)C(C(=O)C)N=NC2=CC(=C(C=C2OC)S(=O)(=O)CCOS(=O)(=O)O)OC,,,,,,
3632,163633,"Chromate(1-), (4-(hydroxy-kappaO)-6-hydroxy-3-(2-(2-(hydroxy-kappaO)phenyl)diazenyl-kappaN1)-2-naphthalenesulfonato(3-))hydroxy-, sodium (1:1)",C1=CC=C(C(=C1)N=NC2=C(C=C3C=CC(=CC3=C2[O-])O)S(=O)(=O)[O-])[O-].[OH-].[Na+].[Cr+3],,,,,,
3633,163634,"6-Hydroxy-3-[2-(2-hydroxyphenyl)hydrazinylidene]-4-oxo-3,4-dihydronaphthalene-2-sulfonic acid",C1=CC=C(C(=C1)N=NC2=C(C=C3C=CC(=CC3=C2O)O)S(=O)(=O)O)O,,,,,,
3634,163635,"Chromate(1-), (4-hydroxy-6-(hydroxy-kappaO)-5-(2-(2-(hydroxy-kappaO)phenyl)diazenyl-kappaN1)-2-naphthalenesulfonato(3-))hydroxy-, sodium (1:1)",C1=CC=C(C(=C1)N=NC2=C(C=CC3=CC(=CC(=C32)O)S(=O)(=O)[O-])[O-])[O-].[OH-].[Na+].[Cr+3],,,,,,
3635,163636,"4-Hydroxy-5-[2-(2-hydroxyphenyl)hydrazinylidene]-6-oxo-5,6-dihydronaphthalene-2-sulfonic acid",C1=CC=C(C(=C1)N=NC2=C(C=CC3=CC(=CC(=C32)O)S(=O)(=O)O)O)O,,,,,,
3636,163637,"Chromate(1-), hydroxy[2-(hydroxy-kappaO)-5-nitro-3-[[2-(oxo-kappaO)-1-[(phenylamino)carbonyl]propyl]azo-kappaN1]benzenesulfonato(3-)]-, hydrogen, compd. with 3-[(2-ethylhexyl)oxy]-1-propanamine (1:1)",[H+].CCCCC(CC)COCCCN.CC(=O)C(=NN=C1C=C(C=C(C1=O)S(=O)(=O)[O-])N([O-])[O-])C(=O)NC2=CC=CC=C2.[OH-].[Cr+3],,,,,,
3637,163638,CID 163638,CCN(CC)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](CC)CC)C=C3O2)C4=CC=CC=C4C(=O)O.CC(=O)C(=NNC1=C(C(=CC(=C1)[N+](=O)[O-])S(=O)(=O)[O-])[O-])C(=NC2=CC=CC=C2)[O-].[OH-].[Cr+3],,,,,,
3638,163639,CID 163639,CC(=O)C(=NN=C1C=C(C=C(C1=O)S(=O)(=O)O)N(O)O)C(=O)NC2=CC=CC=C2,,,,,,
3639,163640,"Chromium, [5-chloro-2-(hydroxy-kappaO)-3-[[2-(hydroxy-kappaO)-1-naphthalenyl]azo-kappaN1]benzenesulfonato(3-)]-",C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C(=CC(=C3)Cl)S(=O)(=O)[O-])[O-])[O-].[Cr+3],,,,,,
3640,163641,Magnezon,C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C(=CC(=C3)Cl)S(=O)(=O)O)O)O,,,,,,
3641,163642,"Benzenamine, N-ethyl-4-[[4-(ethylamino)-3-methylphenyl][4-(ethylimino)-3-methyl-2,5-cyclohexadien-1-ylidene]methyl]-2-methyl-, monoacetate",CCNC1=C(C=C(C=C1)C(=C2C=CC(=NCC)C(=C2)C)C3=CC(=C(C=C3)NCC)C)C.CC(=O)O,,,,,,
3642,163643,"N-Ethyl-4-[[4-(ethylamino)-3-methylphenyl][4-(ethylimino)-3-methyl-2,5-cyclohexadien-1-ylidene]methyl]-2-methylbenzenamine",CCNC1=C(C=C(C=C1)C(=C2C=CC(=NCC)C(=C2)C)C3=CC(=C(C=C3)NCC)C)C,,,,,,
3643,163644,Thiochrome caproate,CCCCCC(=O)OCCC1=C(N2CC3=CN=C(N=C3N=C2S1)C)C,,,,,,
3644,163645,"but-2-enedioic acid;N',N'-diethyl-N-(9-methoxy-5,11-dimethyl-6H-pyrido[4,3-b]carbazol-1-yl)propane-1,3-diamine",CCN(CC)CCCNC1=NC=CC2=C(C3=C(C(=C21)C)C4=C(N3)C=CC(=C4)OC)C.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,,,,,,
3645,163646,"Acetamide, 2-chloro-N-(2,6-dimethylphenyl)-N-(3-pyridinylmethyl)-",CC1=C(C(=CC=C1)C)N(CC2=CN=CC=C2)C(=O)CCl,,,,,,
3646,163647,"1H-Imidazolium, 1-ethenyl-3-methyl-, chloride, polymer with 1-ethenyl-2-pyrrolidinone",C[N+]1=CN(C=C1)C=C.C=CN1CCCC1=O.[Cl-],,,,,,
3647,163648,1-Ethenyl-3-methylimidazol-3-ium,C[N+]1=CN(C=C1)C=C,,,,,,
3648,163649,"N,N-Dimethyl-N'-(3-isopropyl-5-isothiazolyl)urea",CC(C)C1=NSC(=C1)NC(=O)N(C)C,,,,,,
3649,163650,N'-(3-tert-Butyl-5-isothiazolyl)-N-methoxy-N-methylurea,CC(C)(C)C1=NSC(=C1)NC(=O)N(C)OC,,,,,,
3650,163651,"2H-Isoxazolo(2,3-a)-1,3,5-triazine-2,4(3H)-dione, 7-(1,1-dimethylethyl)-3-methyl-",CC(C)(C)C1=CC2=NC(=O)N(C(=O)N2O1)C,,,,,,
3651,163652,N-Methoxy-N-methyl-N'-(3-(4-methylphenyl)-5-isothiazolyl)urea,CC1=CC=C(C=C1)C2=NSC(=C2)NC(=O)N(C)OC,,,,,,
3652,163653,"N,N-Dimethyl-N'-(3-phenyl-5-isothiazolyl)urea",CN(C)C(=O)NC1=CC(=NS1)C2=CC=CC=C2,,,,,,
3653,163654,4-(3-Cyclohexylpropionyl)-1-(2-ethoxyphenyl)piperazine,CCOC1=CC=CC=C1N2CCN(CC2)C(=O)CCC3CCCCC3.Cl,,,,,,
3654,163655,1-(2-Ethoxyphenyl)-4-(3-cyclohexylpropionyl)piperazine,CCOC1=CC=CC=C1N2CCN(CC2)C(=O)CCC3CCCCC3,,,,,,
3655,163656,Ccris 2342,C1[C@H](N([C@H](S1)C2=CC=CC=C2O)C(=O)CCSSCCC(=O)N3[C@@H](CS[C@@H]3C4=CC=CC=C4O)C(=O)O)C(=O)O,,,,,,
3656,163657,"[(3S)-3-amino-3-carboxypropyl]-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-methylsulfanium;hydrogen sulfate;4-methylbenzenesulfonate;sulfate",CC1=CC=C(C=C1)S(=O)(=O)[O-].C[S+](CC[C@@H](C(=O)O)N)C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O.OS(=O)(=O)[O-].[O-]S(=O)(=O)[O-],,,,,,
3657,163658,CID 163658,C[C@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N3CCC[C@H]3C(=O)O)NC(=O)[C@H](CC(=O)N)N,,,,,,
3658,163659,Plicamycin,C[C@@H]1[C@H]([C@@H](C[C@@H](O1)O[C@@H]2C[C@@H](O[C@@H]([C@H]2O)C)OC3=CC4=CC5=C(C(=O)[C@H]([C@@H](C5)[C@@H](C(=O)[C@H]([C@@H](C)O)O)OC)O[C@H]6C[C@H]([C@@H]([C@H](O6)C)O)O[C@H]7C[C@H]([C@H]([C@H](O7)C)O)O[C@H]8C[C@]([C@@H]([C@H](O8)C)O)(C)O)C(=C4C(=C3C)O)O)O)O,"['For the treatment of testicular cancer, as well as hypercalcemia and hypercalciuria associated with a variety of advanced forms of cancer.']",['Plicamycin is lethal to Hela cells in 48 hours at concentrations as low as 0.5 micrograms per milliliter of tissue culture medium. Plicamycin has shown significant anti-tumor activity against experimental leukemia in mice when administered intraperitoneally.'],"['Hormones and molecules with calcium-regulating hormone-like actions that modulate OSTEOLYSIS and other extra-skeletal activities to maintain calcium homeostasis. (See all compounds classified as Calcium-Regulating Hormones and Agents.)', 'Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)', 'Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)', 'Compounds that inhibit cell production of DNA or RNA. (See all compounds classified as Nucleic Acid Synthesis Inhibitors.)', 'Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)']","['Radioautography studies with 3H-labeled plicamycin in mice show that the greatest concentrations of the isotope are in the Kupffer cells of the liver and cells of the renal tubules. Plicamycin is rapidly cleared from the blood within the first 2 hours and excretion is also rapid. 67% percent of measured excretion occurs within 4 hours, 75% within 8 hours, and 90% is recovered in the first 24 hours after injection.', 'It is not known whether plicamycin is excreted in breast milk.', 'Duration of action: 7 to 10 days with a single dose.', 'Time to peak effect: 72 hours with a single dose.', 'Onset of action: When used for hypercalcemia, a reduction in plasma calcium usually occurs within 24 to 48 hours following administration.', 'Plicamycin is concentrated in the Kupffer cells of the liver, in renal tubular cells, and along formed bone surfaces. It may localize in areas of active bone resorption. Plicamycin also crosses the blood-brain barrier and enters the cerebrospinal fluid (CSF).']",,
3659,163660,"(1R,3S,5R,8R,10R,11S,12S,13R,14S)-5-butyl-8,12,14-trihydroxy-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one;sulfate",CCCC[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)NC)O)O.[O-]S(=O)(=O)[O-],,,,,,
3660,163661,(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-1-[(2S)-1-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-thiophen-2-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-3-thiophen-2-ylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid,C1C[C@H](N(C1)C(=O)[C@@H]2CCCN2C(=O)[C@H](CCCN=C(N)N)N)C(=O)NCC(=O)N[C@@H](CC3=CC=CS3)C(=O)N[C@@H](CO)C(=O)N[C@H](CC4=CC=CC=C4)C(=O)N[C@@H](CC5=CC=CS5)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,,,,,,
3661,163662,"3,5-Pyridinedicarboxylic acid, 2-(difluoromethyl)-4-(2-methylpropyl)-6-(trifluoromethyl)-, dimethyl ester",CC(C)CC1=C(C(=NC(=C1C(=O)OC)C(F)(F)F)C(F)F)C(=O)OC,,,,,,
3662,163663,"Substance P, C-terminal glycine extended",CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)O)NC(=O)CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)C(CCC(=O)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CCCCN)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCN=C(N)N)N,,,,,,
3663,163664,Acrip,CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)N)NC(=O)CC(C(CC2CCCCC2)NC(=O)C(CC3=NC=CN3)NC(=O)C(CC4=CC=CC=C4)NC(=O)C5CCCN5C(=O)C(CC6=CN=CN6)NC(=O)CC(C)C)O,,,,,,
3664,163665,"Thiocyanic acid, 3-nitro-4-pyridinyl ester",C1=CN=CC(=C1SC#N)[N+](=O)[O-],,,,,,
3665,163666,Methyl 4-(4-chlorophenyl)-3-(4-morpholinyl)-1H-pyrrole-2-carboxylate,COC(=O)C1=C(C(=CN1)C2=CC=C(C=C2)Cl)N3CCOCC3,,,,,,
3666,163667,"Benzo(1,2-b:4,3-b')dipyrrole-2-carboxylic acid, 6-((6-(aminocarbonyl)-3,6,7,8-tetrahydro-5-hydroxy-4-methoxybenzo(1,2-b:4,3-b')dipyrrol-2-yl)carbonyl)-3,6,7,8-tetrahydro-5-hydroxy-4-methoxy-",COC1=C2C(=C3CCN(C3=C1O)C(=O)C4=CC5=C6CCN(C6=C(C(=C5N4)OC)O)C(=O)N)C=C(N2)C(=O)O,,,,,,
3667,163668,"Benzo(1,2-b:4,3-b')dipyrrole-1(2H)-carboxamide, 5-((5-((3-((acetyloxy)methyl)-3,6-dihydro-7-hydroxy-4-methylbenzo(1,2-b:4,3-b')dipyrrol-1(2H)-yl)carbonyl)-3,6-dihydro-8-hydroxy-7-methoxybenzo(1,2-b:4,3-b')dipyrrol-1(2H)-yl)carbonyl)-3,6-dihydro-8-hydroxy-7-methoxy-",CC1=CNC2=C(C=C3C(=C12)C(CN3C(=O)C4=CC5=C6CCN(C6=C(C(=C5N4)OC)O)C(=O)C7=CC8=C9CCN(C9=C(C(=C8N7)OC)O)C(=O)N)COC(=O)C)O,,,,,,
3668,163669,"N-(4-ethoxyphenyl)-N,3-dihydroxybutanamide",CCOC1=CC=C(C=C1)N(C(=O)CC(C)O)O,,,,,,
3669,163670,Bis(4-phenoxyphenyl)diazene,C1=CC=C(C=C1)OC2=CC=C(C=C2)N=NC3=CC=C(C=C3)OC4=CC=CC=C4,,,,,,
3670,163671,"1H-Pyrazole-4-carboxamide, 1-(4-chlorophenyl)-5-cyano-N-methyl-",CNC(=O)C1=C(N(N=C1)C2=CC=C(C=C2)Cl)C#N,,,,,,
3671,163672,"1H-Pyrazole-4-carboxylic acid, 5-cyano-1-(3-methylphenyl)-, ethyl ester",CCOC(=O)C1=C(N(N=C1)C2=CC=CC(=C2)C)C#N,,,,,,
3672,163673,"1H-Pyrazole-4-carboxamide, 1-(4-chlorophenyl)-5-cyano-N-ethyl-N-methyl-",CCN(C)C(=O)C1=C(N(N=C1)C2=CC=C(C=C2)Cl)C#N,,,,,,
3673,163674,"1H-Pyrazole-4-carboxamide, 5-cyano-N-methoxy-N-methyl-1-(2-pyridinyl)-",CN(C(=O)C1=C(N(N=C1)C2=CC=CC=N2)C#N)OC,,,,,,
3674,163675,"1H-Pyrazole-4-carboxamide, 5-cyano-N-methyl-1-phenyl-",CNC(=O)C1=C(N(N=C1)C2=CC=CC=C2)C#N,,,,,,
3675,163676,"1H-Pyrazole-4-carboxamide, 5-bromo-N-methyl-1-phenyl-",CNC(=O)C1=C(N(N=C1)C2=CC=CC=C2)Br,,,,,,
3676,163677,"1H-Pyrazole-4-carboxylic acid, 5-cyano-1-(1,1-dimethylethyl)-, ethyl ester",CCOC(=O)C1=C(N(N=C1)C(C)(C)C)C#N,,,,,,
3677,163678,"1H-Pyrazole-4-carboxamide, 5-bromo-1-(3-fluorophenyl)-N-methyl-",CNC(=O)C1=C(N(N=C1)C2=CC(=CC=C2)F)Br,,,,,,
3678,163679,"1H-Pyrazole-4-carboxamide, 1-(4-bromophenyl)-5-chloro-N-methyl-",CNC(=O)C1=C(N(N=C1)C2=CC=C(C=C2)Br)Cl,,,,,,
3679,163680,"1H-Pyrazole-4-carboxamide, 5-chloro-1-(1,1-dimethylethyl)-N-methyl-",CC(C)(C)N1C(=C(C=N1)C(=O)NC)Cl,,,,,,
3680,163681,"1H-Pyrazole-4-carboxamide, 1-(2,4-dichlorophenyl)-N-methyl-5-(trifluoromethyl)-",CNC(=O)C1=C(N(N=C1)C2=C(C=C(C=C2)Cl)Cl)C(F)(F)F,,,,,,
3681,163682,"1H-Pyrazole-4-carboxamide, 1-(4-chlorophenyl)-N-methyl-5-(trifluoromethyl)-",CNC(=O)C1=C(N(N=C1)C2=CC=C(C=C2)Cl)C(F)(F)F,,,,,,
3682,163683,"Phosphonic acid, [[[2-[methyl(methylsulfonyl)amino]-2-oxoethyl]amino]methyl]-",CN(C(=O)CNCP(=O)(O)O)S(=O)(=O)C,,,,,,
3683,163684,"1-((Acetyl(4-(2,4,6-trichlorophenoxy)phenyl)amino)oxy)-1-deoxy-beta-D-glucopyranose",CC(=O)N(C1=CC=C(C=C1)OC2=C(C=C(C=C2Cl)Cl)Cl)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
3684,163685,Diclegis,CC1=NC=C(C(=C1O)CO)CO.CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C.C(CC(=O)O)C(=O)O.Cl,,,"['Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)', 'Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)']",,,
3685,163686,(2-Hydroxyethylpyridine)trichlorogold,C1=CC=NC(=C1)CCO.[Cl-].[Cl-].[Cl-].[Au+3],,,,,,
3686,163687,1-Benzoyloxy-2-acetylaminofluorene,CC(=O)NC1=C(C2=C(C=C1)C3=CC=CC=C3C2)OC(=O)C4=CC=CC=C4,,,,,,
3687,163688,3-Benzoyloxy-2-acetylaminofluorene,CC(=O)NC1=C(C=C2C(=C1)CC3=CC=CC=C32)OC(=O)C4=CC=CC=C4,,,,,,
3688,163689,CID 163689,C[C@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)C2CCCN2C(=O)[C@H](C(C)C)N,,,,,,
3689,163690,Azauracil monoethanolamine salt,C1=NNC(=O)NC1=O.C(CO)N,,,,,,
3690,163691,Azauracil diethanolamine salt,C1=NNC(=O)NC1=O.C(CO)NCCO,,,,,,
3691,163692,Ritipenem Acoxil,C[C@H]([C@H]1[C@@H]2N(C1=O)C(=C(S2)COC(=O)N)C(=O)OCOC(=O)C)O,,,,,,
3692,163693,"Phenol, polymer with formaldehyde, glycidyl ether, polymers with ((methylphenoxy)methyl)oxirane and triethylenetetramine",CC1=CC=CC=C1OCC2CO2.C=O.C1=CC=C(C=C1)O.C(CNCCNCCN)N,,,,,,
3693,163694,"trans-1,2-Dihydro-1,2-dihydroxyindeno(1,2,3-cd)pyrene",C1=CC=C2C(=C1)C3=CC4=CC=CC5=C4C6=C(C=C5)[C@H]([C@@H](C2=C36)O)O,,,,,,
3694,163695,Piperdial,C[C@H]1C=C([C@@H]([C@H]([C@H]2[C@@H]1CC(C2)(C)C)O)C=O)C=O,,,,,,
3695,163696,Rodilemid,C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].C([C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O)O.C([C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O)O.C([C@@H](C(=O)O)N)S.[Na+].[Na+].[Ca+2].[Ca+2],,,,,,
3696,163697,"6-Methyl-8-(22,25,26-trihydroxy-21,40-dimethyl-3-oxo-2,11,15,35,39-pentaoxapentacyclo[32.2.2.112,16.120,24.010,14]tetraconta-4,6,8,17,27,31,37-heptaen-36-yl)non-7-enoic acid",CC1C2CC=CC3C(C4CC(O3)C(O4)C=CC=CC=CC(=O)OC5C=CC(CC=CCCC=CC(C(C(O2)CC1O)O)O)OC5C(=CC(C)CCCCC(=O)O)C)C,,,,,,
3697,163698,"2,2'-(4,7-Phenanthroline-3,8-diylbis(oxy))bis(N,N-diethylethanamine) dihydrochloride",CCN(CC)CCOC1=NC2=C(C=C1)C3=C(C=C2)N=C(C=C3)OCCN(CC)CC.Cl.Cl,,,,,,
3698,163699,"2-[[8-[2-(diethylamino)ethoxy]-4,7-phenanthrolin-3-yl]oxy]-N,N-diethylethanamine",CCN(CC)CCOC1=NC2=C(C=C1)C3=C(C=C2)N=C(C=C3)OCCN(CC)CC,,,,,,
3699,163700,CID 163700,C([C@H]1[C@@H]([C@H]([C@H]([C@H](O1)O[C@H]2[C@@H](OC([C@@H]([C@@H]2O)O)OC[C@H]3[C@H]4[C@H]([C@H]([C@@H](O3)O[C@H]5[C@@H](O[C@H]([C@@H]([C@@H]5O)O)O[C@H]6[C@@H](O[C@H]([C@@H]([C@@H]6O)O)O[C@H]7[C@@H](O[C@H]([C@@H]([C@@H]7O)O)O[C@H]8[C@@H](O[C@H]([C@@H]([C@@H]8O)O)O[C@H]9[C@@H](O[C@@H](O4)[C@@H]([C@@H]9O)O)CO)CO)CO)CO)CO)O)O)CO)O)O)O)O,,,,,,
3700,163701,Milnacipran hydrochloride,CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2.Cl,,,"['A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)', 'Drugs that selectively block or suppress the plasma membrane transport of SEROTONIN and NORADRENALINE into axon terminals and are used as ANTIDEPRESSIVE AGENTS. (See all compounds classified as Serotonin and Noradrenaline Reuptake Inhibitors.)']",,,
3701,163702,1-Pentylagroclavine,CCCCCN1C=C2C[C@@H]3[C@H](C=C(CN3C)C)C4=C2C1=CC=C4,,,,,,
3702,163703,"Ergoline, 8,9-didehydro-6,8-dimethyl-1-pentyl-, (R-(R*,R*))-2,3-bis((4-methylbenzoyl)oxy)butanedioate (1:1)",CCCCCN1C=C2C[C@@H]3[C@H](C=C(CN3C)C)C4=C2C1=CC=C4.CC1=CC=C(C=C1)C(=O)O[C@H]([C@H](C(=O)O)OC(=O)C2=CC=C(C=C2)C)C(=O)O,,,,,,
3703,163704,"(6aR)-7,9-dimethyl-4-pentyl-6,6a,8,10a-tetrahydroindolo[4,3-fg]quinoline",CCCCCN1C=C2C[C@@H]3C(C=C(CN3C)C)C4=C2C1=CC=C4,,,,,,
3704,163705,Homohalichondrin B,CC1CC2CCC3C(=C)CC(O3)CCC45CC6C(O4)C7C(O6)C(O5)C8C(O7)CCC(O8)CC(=O)OC9C(C3C(CC4C(O3)CC3(O4)CC4C(O3)C(CC3(O4)CC(C4C(O3)CC3C(O4)CC(O3)C(CO)O)C)C)OC9CC(C1=C)O2)C,,,,,,
3705,163706,CID 163706,C1CO[C@H]2[C@@H]1C3=C(O2)C=C4C(=C3O)C(=C5C(=O)C=CC=C5O4)O,,,,,,
3706,163707,Ccris 2344,CS(=O)CCC(=O)N1[C@@H](CS[C@@H]1C2=CC=CC=C2O)C(=O)O,,,,,,
3707,163708,CID 163708,CC=C1CN2[C@H]3C[C@@H]1C([C@@]45[C@@]3(NC6=CC=CC=C64)O[C@H]2C5)(COC(=O)C7=CC(=C(C(=C7)OC)OC)OC)C(=O)OC,,,,,,
3708,163709,"1,3-Isobenzofurandione, polymer with 1,3-butanediol, 1,2-ethanediol and 2,5-furandione, reaction products with 3-(triethoxysilyl)-1-propanamine",CCO[Si](CCCN)(OCC)OCC.CC(CCO)O.C1=CC=C2C(=C1)C(=O)OC2=O.C1=CC(=O)OC1=O.C(CO)O,,,,,,
3709,163710,Tris(picolinato)manganese(II),[H+].C1=CC=NC(=C1)C(=O)[O-].C1=CC=NC(=C1)C(=O)[O-].C1=CC=NC(=C1)C(=O)[O-].O.[Mn+2],,,,,,
3710,163711,Nbg-dtc,C1=CC=C(C=C1)CN(C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)C(=S)S.[Na+],,,['Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)'],,,
3711,163712,CID 163712,C1=CC=C(C=C1)CN(CC([C@H]([C@@H](C(CO)O)O)O)O)C(=S)S,,,,,,
3712,163713,"Phenyl (6-chloro-5-(1,1-dimethylethyl)-3-pyridazinyl)carbamate",CC(C)(C)C1=CC(=NN=C1Cl)NC(=O)OC2=CC=CC=C2,,,,,,
3713,163714,"3-Pyridazinamine, 6-chloro-5-(1,1-dimethylethyl)-",CC(C)(C)C1=CC(=NN=C1Cl)N,,,,,,
3714,163715,"1H-Pyrazole-4-carboxylic acid, 5-(aminocarbonyl)-1-(3-chlorophenyl)-",C1=CC(=CC(=C1)Cl)N2C(=C(C=N2)C(=O)O)C(=O)N,,,,,,
3715,163716,"1H-Pyrazole-4-carboxylic acid, 5-(aminocarbonyl)-1-(4-methylphenyl)-",CC1=CC=C(C=C1)N2C(=C(C=N2)C(=O)O)C(=O)N,,,,,,
3716,163717,"1H-Pyrazole-4-carboxylic acid, 5-(aminocarbonyl)-1-(3-methylphenyl)-",CC1=CC(=CC=C1)N2C(=C(C=N2)C(=O)O)C(=O)N,,,,,,
3717,163718,CID 163718,C1=CC(=CC(=C1)Cl)N2C(=C(C=N2)C(=O)[O-])C(=O)N.[Na+],,,,,,
3718,163719,"1H-Pyrazole-4-carboxylic acid, 5-(aminocarbonyl)-1-(3,4-dimethylphenyl)-",CC1=C(C=C(C=C1)N2C(=C(C=N2)C(=O)O)C(=O)N)C,,,,,,
3719,163720,"3,3'-Dimethoxybenzidine diethyl malonate hydrazone",CCOC(=O)C(=NNC1=C(C=C(C=C1)C2=CC(=C(C=C2)NN=C(C(=O)OCC)C(=O)OCC)OC)OC)C(=O)OCC,,,,,,
3720,163721,Benzidine diethyl malonate hydrazone,CCOC(=O)C(=NNC1=CC=C(C=C1)C2=CC=C(C=C2)NN=C(C(=O)OCC)C(=O)OCC)C(=O)OCC,,,,,,
3721,163722,"Tin, dioctyldiphenyl-",CCCCCCCC[Sn](CCCCCCCC)(C1=CC=CC=C1)C2=CC=CC=C2,,,,,,
3722,163723,"2-Imidazolidinone, 3-(5-(1,1-dimethylethyl)-3-pyridazinyl)-4-hydroxy-1-methyl-",CC(C)(C)C1=CC(=NN=C1)N2C(CN(C2=O)C)O,,,,,,
3723,163724,"Benzoic acid, 4-chloro-, 3-(6-chloro-5-(1,1-dimethylethyl)-3-pyridazinyl)-1-methyl-2-oxo-4-imidazolidinyl ester",CC(C)(C)C1=CC(=NN=C1Cl)N2C(CN(C2=O)C)OC(=O)C3=CC=C(C=C3)Cl,,,,,,
3724,163725,Folligen,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC4=CNC5=CC=CC=C54)NC(=O)[C@H](CC6=CN=CN6)NC(=O)C7CCC(=O)N7,,,,,,
3725,163726,Galtamycin,CC1C(CCC(O1)OC2CC(OC(C2O)C)OC3CCC(OC3C)OC4CC(OC(C4O)C)C5=C(C6=C(C=C5)C(=O)C7=C(C6=O)C=C8C(=CC(=CC8=C7O)C)O)O)O,,,,,,
3726,163727,Lazabemide hydrochloride,C1=CC(=NC=C1Cl)C(=O)NCCN.Cl,,,"['Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)', 'A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed, p414) (See all compounds classified as Monoamine Oxidase Inhibitors.)']",,,
3727,163728,"Pentanedinitrile, 2,4-dinitro-3-(2-thienyl)-, compd. with 2-chloro-N-(2-chloroethyl)ethanamine (1:2)",C1=CSC(=C1)C(C(C#N)[N+](=O)[O-])C(C#N)[N+](=O)[O-].C(CCl)NCCCl.C(CCl)NCCCl,,,,,,
3728,163729,"2,4-Dinitro-3-thiophen-2-ylpentanedinitrile",C1=CSC(=C1)C(C(C#N)[N+](=O)[O-])C(C#N)[N+](=O)[O-],,,,,,
3729,163730,HC Yellow NO. 7,CC1=C(C=CC(=C1)N(CCO)CCO)N=NC2=CC=C(C=C2)N,,,,,,
3730,163731,CID 163731,C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)OC[C@H]2[C@@H]([C@H]([C@H](C(O2)OC3=C(OC4=CC(=O)C=C(C4=C3O)O)C5=CC(=C(C=C5)O)OC)O[C@@H]6[C@@H]([C@@H]([C@H]([C@@H](O6)C)O)O)O)O)O)O)O)O,,,,,,
3731,163732,"Substance P, pro(9)-",CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)[C@@H]5CCCN5C(=O)[C@H](CCCN=C(N)N)N,,,,,,
3732,163733,"3-O-methyl 5-O-[(3S)-pyrrolidin-3-yl] (4S)-1-benzyl-2,6-dimethyl-4-(3-nitrophenyl)-4H-pyridine-3,5-dicarboxylate;hydrochloride",CC1=C([C@@H](C(=C(N1CC2=CC=CC=C2)C)C(=O)O[C@H]3CCNC3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC.Cl,,,,,,
3733,163734,"3-O-methyl 5-O-[(3S)-pyrrolidin-3-yl] (4S)-1-benzyl-2,6-dimethyl-4-(3-nitrophenyl)-4H-pyridine-3,5-dicarboxylate",CC1=C([C@@H](C(=C(N1CC2=CC=CC=C2)C)C(=O)O[C@H]3CCNC3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC,,,,,,
3734,163735,"2-Imidazolidinone, 3-(4-(1,1-dimethylethyl)-2-pyridinyl)-4-hydroxy-1-methyl-",CC(C)(C)C1=CC(=NC=C1)N2C(CN(C2=O)C)O,,,,,,
3735,163736,CID 163736,CCCCCCCCC=CCCCCCCCC(=O)OC1CC(OC1COP(=O)([O-])OCC[N+](C)(C)C)N2C=C(C(=O)NC2=O)F,,,,,,
3736,163737,CID 163737,CCCCCCCCC=CCCCCCCCC(=O)OC1CC(OC1COP(=O)(O)OCC[N+](C)(C)C)N2C=C(C(=O)NC2=O)F,,,,,,
3737,163738,"6-Isoquinolinol, decahydro-5,8a-dimethyl-2-(1,5,9-trimethyldecyl)-",C[C@@H]1[C@H]2CCN(C[C@@]2(CC[C@H]1O)C)C(C)CCCC(C)CCCC(C)C,,,,,,
3738,163739,(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[[1-[2-(2-hydroxyethylamino)-2-oxoethyl]imidazol-2-yl]amino]sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid,C1=CN(C(=N1)NSC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)CC(=O)NCCO,,,,,,
3739,163740,"(3S,5R,10S,13R,14R,17R)-17-[(2R)-4-(3,3-dimethylaziridin-2-yl)butan-2-yl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol",C[C@H](CCC1C(N1)(C)C)[C@H]2CC[C@@]3([C@@]2(CCC4=C3CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)O)C)C)C,,,,,,
3740,163741,"1,13-Dihydroxy-11-[1-(4-hydroxy-3-methoxycyclohexyl)prop-1-en-2-yl]-22,24-dimethoxy-12,18,20,26-tetramethyl-16-prop-2-enyl-10,27-dioxa-4-azatricyclo[21.3.1.04,8]heptacos-17-ene-2,3,9,15-tetrone",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,,,,,,
3741,163742,GlcNS6S(a1-4)GlcA(b1-4)GlcNS3S6S(?1-4)IdoA2S(a1-4)GlcNS6S(a)-O-Me,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)O)OC3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O,,,,,,
3742,163743,Morpholinoanthracycline MY5,CCC1(CC(C2=C(C3=C(C=C2C1)C(=O)C4=C(C3=O)C(=CC=C4)O)O)OC5CC(C(C(O5)C)O)N6CCOCC6)O,,,,,,
3743,163744,Uralsaponin B,CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C,,,,,,
3744,163745,"but-2-enedioic acid;N-[4-(2-fluorobenzoyl)-2,5-dimethylpyrazol-3-yl]-2-[3-(2-methylpiperidin-1-yl)propylamino]acetamide",CC1CCCCN1CCCNCC(=O)NC2=C(C(=NN2C)C)C(=O)C3=CC=CC=C3F.C(=CC(=O)O)C(=O)O,,,,,,
3745,163746,"2-[(4R)-4-[(3S,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]pentylidene]propane-1,3-diol",C[C@H](CCC=C(CO)CO)[C@H]1CC[C@@]2([C@@]1(CC=C3C2=CCC4[C@@]3(CC[C@@H](C4(C)C)O)C)C)C,,,,,,
3746,163747,CID 163747,C[C@H]1C[C@H](C[C@@H](O1)CC[C@H](C)[C@@H]([C@H](C)[C@@H]2[C@H]([C@@H](C[C@@H]([C@@H]([C@H](C[C@@H]3CC=C[C@H](O3)C[C@H](CC=C(C(=O)O[C@@H]([C@H]([C@@H](C[C@@H]([C@@H]([C@H](C[C@@H]4CC=C[C@H](O4)C[C@H](CC=C(C(=O)O2)C)O)OC)C)O)O)C)[C@@H](C)[C@H]([C@@H](C)CC[C@H]5C[C@@H](C[C@@H](O5)C)OC)O)C)O)OC)C)O)O)C)O)OC,,,,,,
3747,163748,CID 163748,C[C@H]1[C@@H](C(=O)C[C@H]2[C@H]1[C@H]([C@H]([C@@]3([C@@]2(CCCC3(C)C)C)O)OC(=O)C=CC4=CC=CC=C4)O)CC(=O)OC,,,,,,
3748,163749,"2,3-Dihydroauriculatin",CC(=CCC1=C2C(=C(C3=C1OCC(C3=O)C4=C(C=C(C=C4)O)O)O)C=CC(O2)(C)C)C,,,,,,
3749,163750,CID 163750,C[C@@]12[C@H](CC[C@@]1([C@@H]3CC[C@]45C[C@H]6C[C@H]([C@@]4([C@H]3C(C2=O)O)CO)O[C@@](O6)(O5)C)O)C7=COC(=O)C=C7,,,,,,
3750,163751,Fasudil hydrochloride,C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3.Cl,['Treatment of non-traumatic subarachnoid haemorrhage'],,"['A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)', 'Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)', 'Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)']",,,
3751,163752,Xenocoumacin 1,CC(C)CC(C1CC2=C(C(=CC=C2)O)C(=O)O1)NC(=O)C(C(C(CCCN=C(N)N)N)O)O,,,,,,
3752,163753,6-Acetoxymethylanthanthrene,CC(=O)OCC1=C2C=CC3=C4C2=C5C(=CC4=CC=C3)C=CC6=C5C1=CC=C6,,,,,,
3753,163754,6-Bromomethylanthanthrene,C1=CC2=C3C(=C1)C=C4C=CC5=C6C4=C3C(=C(C6=CC=C5)CBr)C=C2,,,,,,
3754,163755,"Propanamide, N-(2-bromo-4-nitrophenyl)-2,3,3,3-tetrafluoro-2-(trifluoromethyl)-",C1=CC(=C(C=C1[N+](=O)[O-])Br)NC(=O)C(C(F)(F)F)(C(F)(F)F)F,,,,,,
3755,163756,"1-Propanaminium, N,N,N-tripropyl-, salt with N-(2-bromo-4-nitrophenyl)-2,3,3,3-tetrafluoro-2-(trifluoromethyl)propanamide (1:1)",CCC[N+](CCC)(CCC)CCC.C1=CC(=C(C=C1[N+](=O)[O-])Br)N=C(C(C(F)(F)F)(C(F)(F)F)F)[O-],,,,,,
3756,163757,"Pentanamide, N-(2-bromo-4-nitrophenyl)-2,3,3,4,4,5,5,5-octafluoro-2-(trifluoromethyl)-",C1=CC(=C(C=C1[N+](=O)[O-])Br)NC(=O)C(C(C(C(F)(F)F)(F)F)(F)F)(C(F)(F)F)F,,,,,,
3757,163758,4-Nitroso-5-phenylimidazole,C1=CC=C(C=C1)C2=C(N=CN2)N=O,,,,,,
3758,163759,"trans-Benzo(j)fluoranthene-4,5-diol",C1=CC=C2C(=C1)C=CC3=C2C4=C[C@@H]([C@H](C5=CC=CC3=C54)O)O,,,,,,
3759,163760,CID 163760,C[C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)O[C@H]2[C@@H](O[C@@H]([C@@H]([C@]2(C)O)O)C)OC3=CC=CC4=C3C5=C6C7=C(C=CC(=C7C(=O)O5)C)OC(=C6C4=O)O)NC(=O)C)OC)O,,,,,,
3760,163761,Tafenoquine succinate,CC1=CC(=NC2=C1C(=C(C=C2NC(C)CCCN)OC)OC3=CC=CC(=C3)C(F)(F)F)OC.C(CC(=O)O)C(=O)O,,,"['Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)']",,,
3761,163762,"1-(Phenylmethanesulfonyl)-1a,9b-dihydro-1H-phenanthro[9,10-b]azirene",C1=CC=C(C=C1)CS(=O)(=O)N2C3C2C4=CC=CC=C4C5=CC=CC=C35,,,,,,
3762,163763,Chimassorb 119,CCCCN(C1CC(N(C(C1)(C)C)C)(C)C)C2=NC(=NC(=N2)NCCCN(CCN(CCCNC3=NC(=NC(=N3)N(CCCC)C4CC(N(C(C4)(C)C)C)(C)C)N(CCCC)C5CC(N(C(C5)(C)C)C)(C)C)C6=NC(=NC(=N6)N(CCCC)C7CC(N(C(C7)(C)C)C)(C)C)N(CCCC)C8CC(N(C(C8)(C)C)C)(C)C)C9=NC(=NC(=N9)N(CCCC)C1CC(N(C(C1)(C)C)C)(C)C)N(CCCC)C1CC(N(C(C1)(C)C)C)(C)C)N(CCCC)C1CC(N(C(C1)(C)C)C)(C)C,,,,,,
3763,163764,CID 163764,COC1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO[C@H]3[C@@H]4[C@@H]([C@H]([C@H](O3)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](O[C@@H]([C@@H]([C@H]7O)O)O[C@@H]8[C@H](O[C@@H]([C@@H]([C@H]8O)O)O[C@@H]9[C@H](O[C@@H]([C@@H]([C@H]9O)O)O[C@@H]1[C@H](O[C@H](O4)[C@@H]([C@H]1O)O)CO)CO)COC1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)O)O)CO)CO)CO)O)O)O)O)O)O)O,,,,,,
3764,163765,CID 163765,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N)NC(=O)[C@H](CCCCN)NC(=O)C(CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)N,,,,,,
3765,163766,Znoppc,CCCCOC1=C2C(=C(C=C1)OCCCC)C3=NC4=NC(=NC5=C6C(=CC=C(C6=C([N-]5)N=C7C8=C(C=CC(=C8C(=N7)N=C2[N-]3)OCCCC)OCCCC)OCCCC)OCCCC)C9=C(C=CC(=C94)OCCCC)OCCCC.[Zn+2],,,,,,
3766,163767,CID 163767,CCCCOC1=C2C(=C(C=C1)OCCCC)C3=NC4=NC(=NC5=NC(=NC6=C7C(=CC=C(C7=C(N6)NC2=N3)OCCCC)OCCCC)C8=C(C=CC(=C85)OCCCC)OCCCC)C9=C(C=CC(=C94)OCCCC)OCCCC,,,,,,
3767,163768,"N'-(4-((6-Chloro-5-(1,1-dimethylethyl)-3-pyridazinyl)oxy)phenyl)-N,N-dimethylurea",CC(C)(C)C1=CC(=NN=C1Cl)OC2=CC=C(C=C2)NC(=O)N(C)C,,,,,,
3768,163769,N-Decyl-idp,CCCCCCCCCCN(CC(=O)[O-])CC(=O)[O-].C1CCC(C(C1)N)N.[Pt+2],,,,,,
3769,163770,N-decyliminodiacetic acid,CCCCCCCCCCN(CC(=O)O)CC(=O)O,,,,,,
3770,163771,"7-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;2-methylpropan-2-amine;platinum(2+);dichloride",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.CC(C)(C)N.[Cl-].[Cl-].[Pt+2],,,,,,
3771,163772,"Cyclohexanecarboxamide, N-(2-bromo-4-nitrophenyl)-1,2,2,3,3,4,4,5,5,6,6-undecafluoro-",C1=CC(=C(C=C1[N+](=O)[O-])Br)NC(=O)C2(C(C(C(C(C2(F)F)(F)F)(F)F)(F)F)(F)F)F,,,,,,
3772,163773,"N-(2,4-Dinitrophenyl)-1,2,2,3,3,4,4,5,5,6,6-undecafluorocyclohexanecarboxamide",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])NC(=O)C2(C(C(C(C(C2(F)F)(F)F)(F)F)(F)F)(F)F)F,,,,,,
3773,163774,"Cyclohexanecarboxamide, 1,2,2,3,3,4,4,5,5,6,6-undecafluoro-N-(2,3,4,5-tetrachlorophenyl)-",C1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)NC(=O)C2(C(C(C(C(C2(F)F)(F)F)(F)F)(F)F)(F)F)F,,,,,,
3774,163775,"7-(4,5-dihydroxy-3-iodo-6-methyloxan-2-yl)oxy-6,9,11-trihydroxy-9-(hydroxymethyl)-8,10-dihydro-7H-tetracene-5,12-dione",CC1C(C(C(C(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(CO)O)I)O)O,,,,,,
3775,163776,Ginkgolide J,CC1C(=O)OC2C1(C34C(=O)OC5C3(C2)C6(C(C5O)C(C)(C)C)C(C(=O)OC6O4)O)O,,,,,,
3776,163777,CID 163777,CCC1=C(C2=NC1=CC3=C(C(=C(N3)C=C4C(=CC)C5(C(=C(O)OCC)C=C(C5=N4)C6=NC(=C2)C(=C6CC)CC)CC)CC)CC)CC,,,,,,
3777,163778,"Phosphinodithioic acid, bis(2,4,4-trimethylpentyl)-",CC(CC(C)(C)C)CP(=S)(CC(C)CC(C)(C)C)S,,,,,,
3778,163779,"8-(22,26-Dihydroxy-21,40-dimethyl-3-oxo-2,11,15,35,39-pentaoxapentacyclo[32.2.2.112,16.120,24.010,14]tetraconta-4,6,8,17,27,31,37-heptaen-36-yl)-6-methylnon-7-enoic acid",CC1C2CC=CC3C(C4CC(O3)C(O4)C=CC=CC=CC(=O)OC5C=CC(CC=CCCC=CC(CC(O2)CC1O)O)OC5C(=CC(C)CCCCC(=O)O)C)C,,,,,,
3779,163780,2-Octulosonic acid,C(C(C(C(C(C(C(=O)C(=O)O)O)O)O)O)O)O,,,,,,
3780,163781,Cholecystokinin-9,CSCC[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N)NC(=O)[C@H](CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N,,,,,,
3781,163782,"2-(Hydroxymethyl)-6-[2-(10-hydroxy-3,7,9,11-tetramethyltrideca-2,5,7,11-tetraenyl)-5,6-dimethoxy-3-methylpyridin-4-yl]oxyoxane-3,4,5-triol",CC=C(C)C(C(C)C=C(C)C=CCC(=CCC1=C(C(=C(C(=N1)OC)OC)OC2C(C(C(C(O2)CO)O)O)O)C)C)O,,,,,,
3782,163783,"Pyridazine, 3,6-dichloro-4-(2-chloro-1,1-dimethylethyl)-",CC(C)(CCl)C1=CC(=NN=C1Cl)Cl,,,,,,
3783,163784,"Pyridazine, 4-(2-bromo-1,1-dimethylethyl)-3,6-dichloro-",CC(C)(CBr)C1=CC(=NN=C1Cl)Cl,,,,,,
3784,163785,Eudistomin T,C1=CC=C(C=C1)CC(=O)C2=NC=CC3=C2NC4=CC=CC=C34,,,,,,
3785,163786,Mulundocandin,CCC(C)CCCCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(C(CN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)CO)C)O)O)O,,,"['Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)']",,,
3786,163787,Rodaplutin,CC(C)CC(C(=O)NC(CCN(C)C(=N)N)CC(=O)NC1C=CC(OC1C(=O)O)N2C=C(C(=NC2=O)N)CO)N,,,,,,
3787,163788,Antibiotic MT 0703,C1C(=C(N2[C@@H](S1)[C@H](C2=O)NC(=O)C(C3=CSC(=N3)N)NC(=O)C4=CC(=O)C(=CN4O)O)C(=O)[O-])CSC5=CC=[N+](C=C5)CCO,,,,,,
3788,163789,"(6S,7S)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-[(1,5-dihydroxy-4-oxopyridine-2-carbonyl)amino]acetyl]amino]-3-[[1-(2-hydroxyethyl)pyridin-1-ium-4-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C1C(=C(N2[C@@H](S1)[C@H](C2=O)NC(=O)C(C3=CSC(=N3)N)NC(=O)C4=CC(=O)C(=CN4O)O)C(=O)O)CSC5=CC=[N+](C=C5)CCO,,,,,,
3789,163790,"D-Glucose, 6-deoxy-6-((7-nitro-4-benzofurazanyl)amino)-",C1=C(C2=NON=C2C(=C1)[N+](=O)[O-])NC[C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O,,,,,,
3790,163791,Acetylmerulidial,CC(=O)O[C@H]1[C@@H]2CC(CC2=C([C@@]3([C@]1(C3)C)C=O)C=O)(C)C,,,,,,
3791,163792,14-N-Succinimidocarminomycin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CN6C(=O)CCC6=O)O)N)O,,,,,,
3792,163793,14-Carminomycyl-N-pyridinium bromide,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)O)O)(C(=O)C[N+]6=CC=CC=C6)O)N)O.[Br-],,,,,,
3793,163794,"7-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-4,6,9,11-tetrahydroxy-9-(2-pyridin-1-ium-1-ylacetyl)-8,10-dihydro-7H-tetracene-5,12-dione",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)O)O)(C(=O)C[N+]6=CC=CC=C6)O)N)O,,,,,,
3794,163795,"Heptadeca-8,10,12-trien-4,6-diyn-1-ol",CCCCC=CC=CC=CC#CC#CCCCO,,,,,,
3795,163796,Caryophyllone,C[C@]12CC[C@H]3[C@@H](CC3(C)C)[C@H](C1)C(=O)CC2,,,,,,
3796,163797,"1-Acetyl-1,2,3,3a,8,8a-hexahydro-8a-hydroxy-5-methoxypyrrolo(2,3-b)indole",CC(=O)N1CCC2C1(NC3=C2C=C(C=C3)OC)O,,,,,,
3797,163798,CID 163798,COC1=C2C(=C3C(=O)C=CC=C3OC2=C4C5CC(OC5OC4=C1)O)O,,,,,,
3798,163799,"Phosphonium, tetrabutyl-, salt with 1H-benzotriazole (1:1)",CCCC[P+](CCCC)(CCCC)CCCC.C1=CC2=NNN=C2C=C1,,,,,,
3799,163800,"(1S,9R,12S,13S)-4,11-dimethoxy-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5,10-tetraene-3,12,13-triol",COC1=C(C2=C(C[C@@H]3C4=C([C@H]([C@H](C[C@]42CCN3)O)O)OC)C=C1)O,,,,,,
3800,163801,"[(2R,3S,4R,5R)-5-amino-1,2,4-trihydroxy-6-oxohexan-3-yl] dihydrogen phosphate",C([C@H]([C@H]([C@@H]([C@H](C=O)N)O)OP(=O)(O)O)O)O,,,,,,
3801,163802,CID 163802,CC1(CCC2=C3C(=C(C(=CO3)C4=CC=C(C=C4)O)O)C(=O)C=C2O1)C,,,,,,
3802,163803,"2-tert-Butyl-4,6-dinitro-N-(2,4,6-tribromophenyl)aniline",CC(C)(C)C1=C(C(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-])NC2=C(C=C(C=C2Br)Br)Br,,,,,,
3803,163804,"3(2H)-Pyridazinone, 6-(1,1-dimethylethyl)-, [1-(2-thienyl)ethylidene]hydrazone",CC(=NNC1=NN=C(C=C1)C(C)(C)C)C2=CC=CS2,,,,,,
3804,163805,"3(2H)-Pyridazinone, 6-(1,1-dimethylethyl)-, [1-(4-pyridinyl)ethylidene]hydrazone",CC(=NNC1=NN=C(C=C1)C(C)(C)C)C2=CC=NC=C2,,,,,,
3805,163806,Iso-isovelleral,C[C@@]12C[C@@]1(C(=C[C@H]3[C@@H]2CC(C3)(C)C)C=O)C=O,,,,,,
3806,163807,Iso-9beta-hydroxyisovelleral,C[C@@]12C[C@@]1(C(=C[C@]3([C@@H]2CC(C3)(C)C)O)C=O)C=O,,,,,,
3807,163808,Regelin,C[C@H]1[C@@H](C[C@@H]([C@]2([C@H]1C3=CC[C@@H]4[C@]5(CCC(=O)C(C5CC[C@]4([C@@]3(CC2)C)C)(C)C)C)C)O)C(=O)OC,,,,,,
3808,163809,Regelinol,C[C@H]1[C@@H](C[C@@H]([C@]2([C@@H]1C3=CC[C@@H]4[C@]5(CCC(=O)[C@@]([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)CO)C)C)O)C(=O)OC,,,,,,
3809,163810,"(1R,9S,10R)-14,16-dimethyl-6,14-diazatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,16-trien-5-one",CC1=C[C@@H]2CC3=C(C=CC(=O)N3)[C@@]4(C1)[C@@H]2CCCN4C,,,,,,
3810,163811,"6-beta,7-beta-Epoxy-canrenone",C[C@]12CCC(=O)C=C1[C@H]3[C@H](O3)[C@@H]4[C@@H]2CC[C@]5([C@H]4CC[C@@]56CCC(=O)O6)C,,,,,,
3811,163812,4-Propyl-5-(4-pyridinyl)-2(3H)-oxazolone,CCCC1=C(OC(=O)N1)C2=CC=NC=C2,,,,,,
3812,163813,"3-[(2,6-Dideoxy-3-o-methylhexopyranosyl)oxy]-14,19-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)CO)OC)O,,,,,,
3813,163814,CID 163814,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@@H]2CC6=C4C(=C(C=C6)OC(=O)C7=CC=CC=C7O)O5)O,,,,,,
3814,163815,"2-[3-[4,5-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxyphenyl]-5,7-dimethoxychromen-4-one",COC1=CC2=C(C(=C1)OC)C(=O)C=C(O2)C3=CC(=CC=C3)OC4CC(C(O4)(CO)O)O,,,,,,
3815,163816,Cyclodecyl xanthogenate,C1CC2CC1CC3CC(C2)C(C3)OC(=S)S.[Na+],,,,,,
3816,163817,"4-Tricyclo[6.2.1.13,6]dodecanyloxymethanedithioic acid",C1CC2CC1CC3CC(C2)C(C3)OC(=S)S,,,,,,
3817,163818,7-Benzyl-9-phenyl-9-piperidin-1-yl-3-oxa-7-azabicyclo[3.3.1]nonane,C1CCN(CC1)C2(C3CN(CC2COC3)CC4=CC=CC=C4)C5=CC=CC=C5,,,,,,
3818,163819,Homodestruxin B,CC[C@H](C)[C@H]1C(=O)N(C(C(=O)N([C@H](C(=O)NCCC(=O)O[C@@H](C(=O)N2CCC[C@H]2C(=O)N1)CC(C)C)C)C)[C@@H](C)CC)C,,,,,,
3819,163820,"Ethyl 2-((1-(4-chlorophenyl)-1H-1,2,4-triazol-3-yl)oxy)propanoate",CCOC(=O)C(C)OC1=NN(C=N1)C2=CC=C(C=C2)Cl,,,,,,
3820,163821,"Propanoic acid, 2-((1-(3-chlorophenyl)-5-methyl-1H-1,2,4-triazol-3-yl)oxy)-, ethyl ester",CCOC(=O)C(C)OC1=NN(C(=N1)C)C2=CC(=CC=C2)Cl,,,,,,
3821,163822,"Propanamide, 2-((1-(3-chlorophenyl)-1H-1,2,4-triazol-3-yl)oxy)-",CC(C(=O)N)OC1=NN(C=N1)C2=CC(=CC=C2)Cl,,,,,,
3822,163823,"10-Fluoro-1,2,3,4,4a,5-hexahydro-7-(2-thienyl)pyrazino(1,2-a)(1,4)benzodiazepine",C1CN2C(CN1)CN=C(C3=C2C=C(C=C3)F)C4=CC=CS4,,,,,,
3823,163824,"5-(4-Chlorophenyl)-2,4-Dimethyl-3H-1,2,4-Triazole-3-Thione",CN1C(=NN(C1=S)C)C2=CC=C(C=C2)Cl,,,,,,
3824,163825,"2-(3-(Benzo(1,4)dioxan-2-ylmethylamino)-1-propyl)-3(2H)-pyridazinone hydrochloride",C1C(OC2=CC=CC=C2O1)CNCCCN3C(=O)C=CC=N3.Cl,,,,,,
3825,163826,"3(2H)-Pyridazinone, 2-[3-[[(2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amino]propyl]-",C1C(OC2=CC=CC=C2O1)CNCCCN3C(=O)C=CC=N3,,,,,,
3826,163827,3-(1-Methylazetidin-2-yl)pyridine,CN1CCC1C2=CN=CC=C2,,,,,,
3827,163828,"Neurokinin A (4-10), nle(10)-",CCCC[C@@H](C(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N,,,,,,
3828,163829,Bhsar-SP,CC(C)C[C@@H](C(=O)N[C@@H](CCS(=O)(=O)C)C(=O)N)NC(=O)CN(C)C(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CCCCN)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCN=C(N)N)N,['Investigated for use/treatment in acute respiratory distress syndrome (ARDS) and viral infection.'],,,,,
3829,163830,Dcmda-Pt,[H+].[H+].C1=CC(=CC(=C1)NC(=O)C(CN)N)CN(CC(=O)[O-])CC(=O)[O-].[Cl-].[Cl-].[Pt+2],,,,,,
3830,163831,"2-[Carboxymethyl-[[3-(2,3-diaminopropanoylamino)phenyl]methyl]amino]acetic acid",C1=CC(=CC(=C1)NC(=O)C(CN)N)CN(CC(=O)O)CC(=O)O,,,,,,
3831,163832,Dmidp-Pt,COC(=O)CN(CC1=CC(=CC=C1)NC(=O)C(CN)N)CC(=O)OC.[Cl-].[Cl-].[Pt+2],,,,,,
3832,163833,"Methyl 2-[[3-(2,3-diaminopropanoylamino)phenyl]methyl-(2-methoxy-2-oxoethyl)amino]acetate",COC(=O)CN(CC1=CC(=CC=C1)NC(=O)C(CN)N)CC(=O)OC,,,,,,
3833,163834,2-(2-Hydroxy-4-methylphenyl)aminothiazole,CC1=CC(=C(C=C1)NC2=NC=CS2)O.Cl,,,,,,
3834,163835,Icoduline,CC1=CC(=C(C=C1)NC2=NC=CS2)O,,,,,,
3835,163836,Dhmd-Pt,[H+].[H+].C1=CC(=C(C=C1NC(=O)C(CN)N)CN(CC(=O)[O-])CC(=O)[O-])O.[Cl-].[Cl-].[Pt+2],,,,,,
3836,163837,"2-[Carboxymethyl-[[5-(2,3-diaminopropanoylamino)-2-hydroxyphenyl]methyl]amino]acetic acid",C1=CC(=C(C=C1NC(=O)C(CN)N)CN(CC(=O)O)CC(=O)O)O,,,,,,
3837,163838,Efonidipine hydrochloride ethanolate,CCO.CC1=C(C(C(=C(N1)C)P2(=O)OCC(CO2)(C)C)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCN(CC4=CC=CC=C4)C5=CC=CC=C5.Cl,,,"['Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)', 'Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)', 'A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)']",,,
3838,163839,"2(1H)-Quinolinone, 7-(3-(4-(2,3-dimethylphenyl)-1-piperazinyl)propoxy)-",CC1=C(C(=CC=C1)N2CCN(CC2)CCCOC3=CC4=C(C=C3)C=CC(=O)N4)C,,,,,,
3839,163840,"3-[(3E,7E)-4,8-dimethyl-10-(2,6,6-trimethylcyclohexen-1-yl)deca-3,7-dienyl]-2-hydroxy-2H-furan-5-one",CC1=C(C(CCC1)(C)C)CCC(=CCCC(=CCCC2=CC(=O)OC2O)C)C,,,,,,
3840,163841,"Octadeca-6,9,12,15-tetraenoic acid",CCC=CCC=CCC=CCC=CCCCCC(=O)O,,,,,,
3841,163842,CID 163842,CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OC5C(C(C(C(O5)C(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C.N.N.N.N.N.N.N.N,,,,,,
3842,163843,"6-[(11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl)oxy]-5-(6-carboxy-3,4,5-trisulfooxyoxan-2-yl)oxy-3,4-disulfooxyoxane-2-carboxylic acid",CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OC5C(C(C(C(O5)C(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C,,,,,,
3843,163844,"Cyclohepta(b)pyrazolo(3,4-d)pyridin-3(2H)-one, 5,6,7,8,9,10-hexahydro-2-(4-methoxyphenyl)-",COC1=CC=C(C=C1)N2C(=O)C3=CN=C4CCCCCC4=C3N2,,,,,,
3844,163845,"5-Amino-4-cyano-1-(2,6-dichloro-4-trifluoromethylphenyl)pyrazole",C1=C(C=C(C(=C1Cl)N2C=C(C(=N2)N)C#N)Cl)C(F)(F)F,,,,,,
3845,163846,"Benzene, 1-fluoro-4-(2-propynylsulfonyl)-",C#CCS(=O)(=O)C1=CC=C(C=C1)F,,,,,,
3846,163847,Conopressin G,CC[C@H](C)C1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=CC=C2)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N)CC(=O)N)CCCN=C(N)N,,,,,,
3847,163848,CID 163848,CC=CC=CC(=O)NC[C@@H](C[C@H](CC(=O)NCCC(=N)N)N)O,,,,,,
3848,163849,1-Methyl-4-(2-methylphenyl)pyridinium,CC1=CC=CC=C1C2=CC=[N+](C=C2)C,,,,,,
3849,163850,"1,5,11,13-Tetramethyl-16-methylidene-2,17-dioxo-1,4,5,7a,8,9,10,11,12,13,14,15a-dodecahydro-2h-1,14-ethanofuro[2,3-o][2]benzoxacycloundecine-6-carboxylic acid",CC1CCCC2C=C(C(CC23C4C(C(=O)C(=C)C(O4)C(C1)C)(C(=O)O3)C)C)C(=O)O,,,,,,
3850,163851,1-Methyl-4-nitroso-5-phenylimidazole,CN1C=NC(=C1C2=CC=CC=C2)N=O,,,,,,
3851,163852,1-Methyl-4-nitro-5-phenylimidazole,CN1C=NC(=C1C2=CC=CC=C2)[N+](=O)[O-],,,,,,
3852,163853,Iaps-forskolin,C[C@@]1(CC(=O)[C@]2([C@@]3([C@@H](CCC([C@H]3[C@H]([C@H]([C@@]2(O1)C)OC(=O)CCC(=O)NCCC4=CC(=C(C=C4)N=[N+]=[N-])I)O)(C)C)O)C)O)C=C,,,,,,
3853,163854,"(S)-6,7-Dihydro-2-hydroxy-7-(((2-hydroxyphenyl)methyl)methylamino)-1,3,10-trimethoxybenzo(a)heptalen-9(5H)-one",CN(CC1=CC=CC=C1O)[C@H]2CCC3=CC(=C(C(=C3C4=CC=C(C(=O)C=C24)OC)OC)O)OC,,,,,,
3854,163855,CID 163855,C[C@@H]1CC(=CCO)C(=O)O[C@@H]2CC[N+]3([C@@]2(C(=CC3)COC(=O)[C@]1(C)O)O)C,,,,,,
3855,163856,CID 163856,C1C[C@@H]2C3=CC=CC=C3C[C@@H](C(=O)N2[C@@H](C1)C(=O)O)N[C@H](CCC4=CC=CC=C4)C(=O)O,,,,,,
3856,163857,CID 163857,CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@H]2CC3=CC=CC=C3[C@H]4CCC[C@H](N4C2=O)C(=O)O,,,,,,
3857,163858,"2-[2-({Amino[bis(2-chloroethyl)amino]phosphoryl}oxy)ethyl]-1,3-thiazinane-4-carboxylic acid",C1CSC(NC1C(=O)O)CCOP(=O)(N)N(CCCl)CCCl,,,,,,
3858,163859,Diphyllin acetyl apioside,CC(=O)OC[C@]1(COC([C@@H]1O)OC2=C3COC(=O)C3=C(C4=CC(=C(C=C42)OC)OC)C5=CC6=C(C=C5)OCO6)O,,,,,,
3859,163860,DE-beta-Cyd,CCOC[C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)OCC)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)OCC)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)OCC)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)OCC)O[C@@H]7[C@H](O[C@@H]([C@@H]([C@H]7O)OCC)O[C@@H]8[C@H](O[C@H](O2)[C@@H]([C@H]8O)OCC)COCC)COCC)COCC)COCC)COCC)COCC)OCC)O,,,,,,
3860,163861,CID 163861,[B+3].CC1=C(C=C[N+]2=C1CSN3C2=NC4=CC=CC=C43)OCC(F)(F)F.[F-].[F-].[F-].[F-],,,,,,
3861,163862,AG-2000 free base,CC1=C(C=C[N+]2=C1CSN3C2=NC4=CC=CC=C43)OCC(F)(F)F,,,,,,
3862,163863,"Tris(2-methyl-2,3-dibromopropyl)phosphate",CC(COP(=O)(OCC(C)(CBr)Br)OCC(C)(CBr)Br)(CBr)Br,,,,,,
3863,163864,"Tris(3-methyl-2,3-dibromobutyl)phosphate",CC(C)(C(COP(=O)(OCC(C(C)(C)Br)Br)OCC(C(C)(C)Br)Br)Br)Br,,,,,,
3864,163865,"Tris(3,4-dibromobutyl)phosphate",C(COP(=O)(OCCC(CBr)Br)OCCC(CBr)Br)C(CBr)Br,,,,,,
3865,163866,"3-Methyl-2,3-dibromo-1-chlorobutane",CC(C)(C(CCl)Br)Br,,,,,,
3866,163867,"Methanimidamide, N,N''-(6-(diethylamino)-1,3,5-triazine-2,4-diyl)bis(N,N'-bis(2,2,6,6-tetramethyl-4-piperidinyl)-",CCN(CC)C1=NC(=NC(=N1)N(C=NC2CC(NC(C2)(C)C)(C)C)C3CC(NC(C3)(C)C)(C)C)N(C=NC4CC(NC(C4)(C)C)(C)C)C5CC(NC(C5)(C)C)(C)C,,,,,,
3867,163868,CID 163868,CC1CC23C(C=CCCCCC4C=CC5C(C4(C(=O)OC(=C(O2)O)C3=O)C)CCCC5OC6C(C(C(C(O6)C)OC7CC(C(C(O7)C)O)OC(=O)C8=C(C=CC(=C8C)Cl)OC)O)O)C=C1C(=O)O,,,,,,
3868,163869,N-4-Isopropylbenzylglucamine dithiocarbamate,CC(C)C1=CC=C(C=C1)CN(CC(C(C(C(CO)O)O)O)O)C(=S)S,,,,,,
3869,163870,CID 163870,CC=C1C[C@H]([C@@](C(=O)OCC2=C3[C@@H]([C@@H](CN3C=C2)O)OC1=O)(C)O)C,,,,,,
3870,163871,"2H-1-Benzothiopyran-4-ol, 8-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-",CC(C)(C)NCC(COC1=CC=CC2=C1SCCC2O)O,,,,,,
3871,163872,Ciprofibrate-coenzyme A,CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)C(C)(C)OC4=CC=C(C=C4)C5CC5(Cl)Cl)O,,,,,,
3872,163873,Argiotoxin 673,CN(CCCCN(C)CCCNC(=O)[C@H](CC(=O)N)NC(=O)CC1=C(C=C(C=C1)O)O)CCCNC(=O)[C@H](CCCN=C(N)N)N,,,,,,
3873,163874,Argiotoxin 659,C1=CC2=C(C(=C1)O)C(=CN2)CC(=O)N[C@@H](CC(=O)N)C(=O)NCCCCCNCCCNCCCNC(=O)[C@H](CCCN=C(N)N)N,,,,,,
3874,163875,"1,6-Hexanediaminium, N,N,N',N'-tetrabutyl-N,N'-diethyl-, dihydroxide",CCCC[N+](CC)(CCCC)CCCCCC[N+](CC)(CCCC)CCCC.[OH-].[OH-],,,,,,
3875,163876,4-(4-Fluorophenyl)-3-(4-hydroxy-3-methoxyphenoxymethyl)piperidine,COC1=C(C=CC(=C1)OC[C@@H]2CNCC[C@H]2C3=CC=C(C=C3)F)O,,,,,,
3876,163877,"(1R,4S,5'S,6R,6'S,8R,13R,20R,21R,24S)-6'-but-2-en-2-yl-21,24-dihydroxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",CC=C(C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)CC=C(C[C@H](C=CC=C4CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)C)C,,,,,,
3877,163878,"N,N',N''-Tris(4-phenylbutyl)benzene-1,3,5-trimethanamine",C1=CC=C(C=C1)CCCCNCC2=CC(=CC(=C2)CNCCCCC3=CC=CC=C3)CNCCCCC4=CC=CC=C4,,,,,,
3878,163879,CID 163879,CCOC(=O)C(C1=C(OC2=CC(=O)C=CC2=C1O)O)C3=C(OC4=CC=CC=C4C3=O)O,,,,,,
3879,163880,"(1S,9S,10R)-17-(cyclopropylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2,4,6-trien-13-one",C1CC(=O)C[C@@]23[C@@H]1[C@H](CC4=CC=CC=C42)N(CC3)CC5CC5,,,,,,
3880,163881,"2-Iodo-3,7,8-trichlorodibenzo-4-dioxin",C1=C2C(=CC(=C1Cl)Cl)OC3=CC(=C(C=C3O2)Cl)I,,,,,,
3881,163882,6-Epitetrodotoxin,C([C@]1([C@H]2C3[C@H](N=C(N[C@]34[C@@H]([C@](O2)(O[C@H]1C4O)O)O)N)O)O)O,,,,,,
3882,163883,Carbanicotinamide adenine dinucleotide,C1[C@@H]([C@H]([C@H]([C@@H]1[N+]2=CC=CC(=C2)C(=O)N)O)O)COP(=O)([O-])OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O,,,,,,
3883,163884,Carba-nicotinamide-adenine-dinucleotide,C1[C@@H]([C@H]([C@H]([C@@H]1[N+]2=CC=CC(=C2)C(=O)N)O)O)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O,,,,,,
3884,163885,Soluflazine,C1CN(C(CN1CC(=O)NC2=C(C=CC=C2Cl)Cl)C(=O)N)CCCC(C3=CC=C(C=C3)F)C4=CN=CC=C4.Cl.Cl,,,,,,
3885,163886,"4-(2-((2,6-Dichlorophenyl)amino)-2-oxoethyl)-1-(4-(4-fluorophenyl)-4-(pyridin-3-yl)butyl)piperazine-2-carboxamide",C1CN(C(CN1CC(=O)NC2=C(C=CC=C2Cl)Cl)C(=O)N)CCCC(C3=CC=C(C=C3)F)C4=CN=CC=C4,,,,,,
3886,163887,"1,O(6)-Ethanoguanosine",[H+].C1COC2=C3C(=NC(=N)N21)N(C=N3)C4[C@@H]([C@@H]([C@H](O4)CO)O)O,,,,,,
3887,163888,"(2R,3S,4R)-2-(hydroxymethyl)-5-(5-imino-7,8-dihydro-[1,3]oxazolo[2,3-f]purin-3-yl)oxolane-3,4-diol",C1COC2=C3C(=NC(=N)N21)N(C=N3)C4[C@@H]([C@@H]([C@H](O4)CO)O)O,,,,,,
3888,163889,I-Abopx,CCCN1C(=O)C2=C(N=C(N2)C3=CC=C(C=C3)OCC(=O)O)N(C1=O)CC4=CC(=C(C=C4)N)I,,,,,,
3889,163890,N-(3-(1H-Imidazol-1-yl)phenyl)-4-(2-pyridinyl)-2-pyrimidinamine,C1=CC=NC(=C1)C2=NC(=NC=C2)NC3=CC(=CC=C3)N4C=CN=C4,,,,,,
3890,163891,"L-Cysteine, N-acetyl-S-(1,1-dichloro-2,2-difluoroethyl)-",CC(=O)N[C@@H](CSC(C(F)F)(Cl)Cl)C(=O)O,,,,,,
3891,163892,"2-(Methyl(phenylmethyl)amino)ethyl 4-(2-chloro-6-fluorophenyl)-1,4,6,7,8,9-hexahydro-2-methylthiepino(3,2-b)pyridine-3-carboxylate 5,5-dioxide",CC1=C(C(C2=C(N1)CCCCS2(=O)=O)C3=C(C=CC=C3Cl)F)C(=O)OCCN(C)CC4=CC=CC=C4,,,,,,
3892,163893,Furconazole-cis,C1C[C@](O[C@H]1OCC(F)(F)F)(CN2C=NC=N2)C3=C(C=C(C=C3)Cl)Cl,,,,,,
3893,163894,"1,2,4-Benzenetrisulfonic acid, 5,6-dihydroxy-, trisodium salt",C1=C(C(=C(C(=C1S(=O)(=O)[O-])S(=O)(=O)[O-])O)O)S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
3894,163895,"5,6-dihydroxybenzene-1,2,4-trisulfonic Acid",C1=C(C(=C(C(=C1S(=O)(=O)O)S(=O)(=O)O)O)O)S(=O)(=O)O,,,,,,
3895,163896,"1H-Pyrazole-4-carboxylic acid, 5-(aminocarbonyl)-1-(3,5-dichlorophenyl)-",C1=C(C=C(C=C1Cl)Cl)N2C(=C(C=N2)C(=O)O)C(=O)N,,,,,,
3896,163897,"1H-Indole(3,2-c)quinoline-1,4(7H)-dione, 8,9,10,11-tetrahydro-3-methoxy-",COC1=CC(=O)C2=C3C(=CN=C2C1=O)C4=C(N3)CCCC4,,,,,,
3897,163898,Ibuprofen dimethyl aminoethanol octyl,CCCCCCCC[N+](C)(C)CCOC(=O)C(C)C1=CC=C(C=C1)CC(C)C.[Br-],,,,,,
3898,163899,2-(4-Isobutylphenyl)propionic acid 2-[dimethyl(octyl)aminio]ethyl ester,CCCCCCCC[N+](C)(C)CCOC(=O)C(C)C1=CC=C(C=C1)CC(C)C,,,,,,
3899,163900,"4,5-Dihydroxyhexan-2-one",CC(C(CC(=O)C)O)O,,,,,,
3900,163901,"Methanesulfonamide, N-(4-fluorophenyl)-N-(1-(3-pyridinyl)ethyl)-",CC(C1=CN=CC=C1)N(C2=CC=C(C=C2)F)S(=O)(=O)C,,,,,,
3901,163902,"Methanesulfonamide, N-(4-chloro-2-methylphenyl)-N-(3-pyridinylmethyl)-",CC1=C(C=CC(=C1)Cl)N(CC2=CN=CC=C2)S(=O)(=O)C,,,,,,
3902,163903,"L-Cysteine, N-acetyl-S-(2-bromophenyl)-",CC(=O)N[C@@H](CSC1=CC=CC=C1Br)C(=O)O,,,,,,
3903,163904,"L-Cysteine, N-acetyl-S-(3-bromophenyl)-",CC(=O)N[C@@H](CSC1=CC(=CC=C1)Br)C(=O)O,,,,,,
3904,163905,"Phosphorodiamidic acid, N,N-bis(2-chloroethyl)-, 3,3-bis(acetyloxy)propyl ester",CC(=O)OC(CCOP(=O)(N)N(CCCl)CCCl)OC(=O)C,,,,,,
3905,163906,"1-(2,6-Dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane",CC1=C(C(=CC=C1)C)OCC(C)NCCC2=CC(=C(C=C2)OC)OC,,,,,,
3906,163907,CID 163907,CC(C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)CC3=CC=C(C=C3)NC(=O)C)CC4=CC=CC=C4)CC5=CNC6=CC=CC=C65)CCCCN=C(C7=CC=C(C=C7)N[N+]#N)[O-])O,,,,,,
3907,163908,CID 163908,CC(C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)CC3=CC=C(C=C3)NC(=O)C)CC4=CC=CC=C4)CC5=CNC6=CC=CC=C65)CCCCNC(=O)C7=CC=C(C=C7)N[N+]#N)O,,,,,,
3908,163909,CID 163909,CCCCCCCCCCCC=CCCC1C(=N1)C(=O)OC,,,,,,
3909,163910,Alterporriol A,CC1=CC2=C(C=C1O)C(=O)C3=C(C2=O)C(=C(C=C3O)OC)C4=C(C=C(C5=C4C(=O)C6=C(C5=O)[C@@H]([C@H]([C@@]([C@@H]6O)(C)O)O)O)O)OC,,,,,,
3910,163911,11-Deoxytetrodotoxin,C[C@@]1([C@H]2[C@@H]3[C@@H](N=C(N[C@]34[C@@H]([C@](O2)(O[C@H]1C4O)O)O)N)O)O,,,,,,
3911,163912,"cis-3,5-Bis(4-chlorophenyl)-3-((1H-imidazol-1-yl)-methyl)-2-methylisoxazolidine",CN1[C@@](C[C@@H](O1)C2=CC=C(C=C2)Cl)(CN3C=CN=C3)C4=CC=C(C=C4)Cl,,,,,,
3912,163913,S-(2-Chloroacetyl)glutathione,C(CC(=O)N[C@@H](CSC(=O)CCl)C(=O)NCC(=O)O)[C@@H](C(=O)O)N,,,,,,
3913,163914,1-(2-Chloroethyl)-3-[2-hydroxy-3-(2-nitroimidazol-1-yl)propyl]-1-nitrosourea,C1=CN(C(=N1)[N+](=O)[O-])CC(CNC(=O)N(CCCl)N=O)O,,,,,,
3914,163915,"8-((Aminocarbonyl)oxy)methyl-4,8a-dimethoxy-1,1a,2,8,8a,8b-hexahydro-7-hydroxy-5-methyl-6-nitrosoazirino(2',3'-3,4)-pyrrolo-(1,2-a)indole",CC1=C(C(=C2[C@@H]([C@@]3([C@@H]4[C@@H](N4)CN3C2=C1OC)OC)COC(=O)N)O)N=O,,,,,,
3915,163916,15-Hydroperoxyabietic acid,C[C@@]12CCC[C@H]([C@H]1CC=C3[C@@H]2CCC(=C3)C(C)(C)OO)C(=O)OC,,,,,,
3916,163917,4-methoxy-N-(1H-pyrrol-2-ylmethylideneamino)benzamide,COC1=CC=C(C=C1)C(=O)NN=CC2=CC=CN2,,,,,,
3917,163918,"2-[[5-cyclohexyl-3-hydroxy-4-[[3-(1H-imidazol-5-yl)-2-[[3-phenyl-2-(3-pyridin-3-ylpropanoylamino)propanoyl]amino]propanoyl]amino]pentanoyl]amino]-N-(1,3-dihydroxy-2-methylpropan-2-yl)-3-methylpentanamide",CCC(C)C(C(=O)NC(C)(CO)CO)NC(=O)CC(C(CC1CCCCC1)NC(=O)C(CC2=CN=CN2)NC(=O)C(CC3=CC=CC=C3)NC(=O)CCC4=CN=CC=C4)O,,,,,,
3918,163919,Desethylaprophen,CCNCCOC(=O)C(C)(C1=CC=CC=C1)C2=CC=CC=C2,,,,,,
3919,163920,"2,3-Dihydro-2-(((4-chlorophenyl)sulfonyl)amino)-1H-indene-5-acetic acid",C1C(CC2=C1C=CC(=C2)CC(=O)O)NS(=O)(=O)C3=CC=C(C=C3)Cl,,,,,,
3920,163921,Articainic acid,CCCNC(C)C(=O)NC1=C(SC=C1C)C(=O)O,,,,,,
3921,163922,"2-Methoxy-3-(octadecyloxy)propyl 2-(1,3-thiazol-3-ium-3-yl)ethyl phosphate",CCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+]1=CSC=C1)OC,,,,,,
3922,163923,"(2-Methoxy-3-octadecoxypropyl) 2-(1,3-thiazol-3-ium-3-yl)ethyl hydrogen phosphate",CCCCCCCCCCCCCCCCCCOCC(COP(=O)(O)OCC[N+]1=CSC=C1)OC,,,,,,
3923,163924,Pphte,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCNC1=C(C=C(C=C1[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-])OC(=O)CCCCCC2=C3C=CC4=CC=CC5=C4C3=C(C=C5)C=C2,,,,,,
3924,163925,Zalospirone,C1CN(CCN1CCCCN2C(=O)[C@@H]3[C@@H]4C=C[C@H]([C@@H]3C2=O)[C@@H]5[C@H]4C=C5)C6=NC=CC=N6,,,,,,
3925,163926,"(7s,8s)-7,8-Dihydrobenzo[f]quinoline-7,8-diol",C1=CC2=C(C=CC3=C2C=C[C@@H]([C@H]3O)O)N=C1,,,,,,
3926,163927,1-(2-Chloroethyl)-1-nitroso-3-thiomorpholin-4-ylurea,C1CSCCN1NC(=O)N(CCCl)N=O,,,,,,
3927,163928,"3-alpha-Hydroxy-6-beta,7-beta-epoxy-canrenone",C[C@]12CC[C@H](C=C1[C@H]3[C@H](O3)[C@@H]4[C@@H]2CC[C@]5([C@H]4CC[C@@]56CCC(=O)O6)C)O,,,,,,
3928,163929,"3-beta-Hydroxy-6-beta,7-beta-epoxy-canrenone",C[C@]12CC[C@@H](C=C1[C@H]3[C@H](O3)[C@@H]4[C@@H]2CC[C@]5([C@H]4CC[C@@]56CCC(=O)O6)C)O,,,,,,
3929,163930,CID 163930,CCC=C1C=CC(=O)[C@H](C12C(=O)C(=C)N(C2=O)OC)O,,,,,,
3930,163931,Sdz mks 492,CN1C2=C(C(=O)N(C1=O)C)N(C(=N2)N[C@@H](CO)C3=CC(=C(C=C3)OC)OC)CCOC,,,,,,
3931,163932,CID 163932,CC1=NC2=NC(=NN2C(=C1)SCC3=C(N4[C@@H]([C@@H](C4=O)NC(=O)C(=NO[C@@H](C5=CC(=C(C=C5)O)O)C(=O)[O-])C6=CN=C(S6)N)SC3)C(=O)[O-])C(=O)[O-].[Na+].[Na+].[Na+],,,,,,
3932,163933,CID 163933,CC1=NC2=NC(=NN2C(=C1)SCC3=C(N4[C@@H]([C@@H](C4=O)NC(=O)C(=NO[C@@H](C5=CC(=C(C=C5)O)O)C(=O)O)C6=CN=C(S6)N)SC3)C(=O)O)C(=O)O,,,,,,
3933,163934,"Cyclohexanemethanol, 4-((ethenyloxy)methyl)-",C=COCC1CCC(CC1)CO,,,,,,
3934,163935,Antibiotic SF 2315B,CC1=C[C@H]([C@H]2[C@@](C1)(CC[C@@]34[C@@]2(O3)[C@H](C5=C(C4=O)C(=CC=C5)O)O)O)O,,,,,,
3935,163936,8-Ethenylfluoranthene,C=CC1=CC2=C(C=C1)C3=CC=CC4=C3C2=CC=C4,,,,,,
3936,163937,CID 163937,C1[C@@H]([C@H](O[C@@H]1N2C=CC(=NC2=O)N)CO)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C5=C(C(=O)N=C(N5)N)N=C4NC6=CC=CC=C6)O)O,,,,,,
3937,163938,"5-(1-Azabicyclo[2.2.1]heptan-3-yl)-1,2,4-oxadiazol-3-amine",C1CN2CC1C(C2)C3=NC(=NO3)N,,,,,,
3938,163939,CID 163939,CC(C(C(=O)N(C=C1CC(C(O1)N2C=CC(=O)NC2=O)O)C(=O)[C@H](CCSC)NC(=O)NC(CC3=CC(=CC=C3)O)C(=O)O)N)N(C)C(=O)[C@H](CC4=CC(=CC=C4)O)N,,,,,,
3939,163940,CID 163940,CN(C(CC(=O)[C@H](CCSC)N)C(C(=O)N(C=C1CC(C(O1)N2C=CC(=O)NC2=O)O)C(=O)NC(CC3=CC(=CC=C3)O)C(=O)O)N)C(=O)[C@H](CC4=CC(=CC=C4)O)NC(=O)CN,,,,,,
3940,163941,"[(1S,3R,7R,8R,8aS)-3-(hydroxymethyl)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate",CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@@H]1[C@@H]([C@@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)CO,,,['Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. (See all compounds classified as Hydroxymethylglutaryl-CoA Reductase Inhibitors.)'],,,
3941,163942,Periplocoside A,CC1C=C(C(=O)C(O1)OC2CCC3(C4CCC5(C(C4CC=C3C2)CCC5(C(C)OC6CC7C(C(O6)C)OOC8(CC(C(C(O8)C)OC9CC(C(C(O9)C)OC1CC(C(C(O1)C)OC1CC(C(C(O1)C)OC1C(C(C(C(O1)C)O)OC)OC(=O)C)OC)OC)OC)OC)CO7)O)C)C)OC,,,,,,
3942,163943,Periplocoside C,CC1C=C(C(=O)C(O1)OC2CCC3(C4CCC5(C(C4CC=C3C2)CCC5(C(C)OC6CC7C(C(O6)C)OOC8(CC(C(C(O8)C)OC9CC(C(C(O9)C)O)OC)OC)CO7)O)C)C)OC,,,,,,
3943,163944,"Methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate",COC(=O)C1=CC=CC=C1NC2=CC(=O)C(=O)C3=CC=CC=C32,,,,,,
3944,163945,9alpha-Hydroxyacetylmerulidial,CC(=O)O[C@@H]1[C@@]2(C[C@@]2(C(=C3[C@@]1(CC(C3)(C)C)O)C=O)C=O)C,,,,,,
3945,163946,CID 163946,CCC1=C(C2=NC1=CC3=C(C(=C(NCCN)O)C(=N3)C(=C4[C@H]([C@@H](C(=CC5=NC(=C2)C(=C5C)C=C)N4)C)CCC(=O)O)CC(=O)OC)C)C,,,,,,
3946,163947,"2-Bromo-2',3'-dideoxyadenosine",C1C[C@@H](O[C@@H]1CO)N2C=NC3=C(N=C(N=C32)Br)N,,,,,,
3947,163948,N-9H-Carbazol-2-yl-N-hydroxyacetamide,CC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3N2)O,,,,,,
3948,163949,5-(3-Hydroxybenzoyl)-2-thiophenesulfonamide,C1=CC(=CC(=C1)O)C(=O)C2=CC=C(S2)S(=O)(=O)N,,,,,,
3949,163950,Ciwujianoside C1,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)OC[C@@H]3[C@H]([C@@H]([C@H]([C@@H](O3)OC(=O)[C@]45CCC(=C)C[C@H]4C6=CC[C@@H]7[C@]8(CC[C@@H](C([C@@H]8CC[C@]7([C@@]6(CC5)C)C)(C)C)O[C@H]9[C@@H]([C@H]([C@H](CO9)O)O)O)C)O)O)O)CO)O)O)O,,,,,,
3950,163951,Ciwujianoside D1,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)OC[C@@H]3[C@H]([C@@H]([C@H]([C@@H](O3)OC(=O)[C@@]45CC[C@@]6(C(=CC[C@H]7[C@]6(CC[C@@H]8[C@@]7(CC[C@@H](C8(C)C)O[C@H]9[C@@H]([C@H]([C@H](CO9)O)O)O)C)C)[C@@H]4CC(CC5)(C)C)C)O)O)O)COC(=O)C)O)O)O,,,,,,
3951,163952,Vatinoxan,CS(=O)(=O)NCCN1C(=O)NC[C@]12CCN3CCC4=C([C@@H]3C2)OC5=CC=CC=C45,,,,,,
3952,163953,9alpha-Hydroxymerulidial,C[C@@]12C[C@@]1(C(=C3CC(C[C@@]3([C@@H]2O)O)(C)C)C=O)C=O,,,,,,
3953,163954,CID 163954,CC=C(C)[C@@H]1[C@H](C[C@H]([C@@]2(O1)C[C@@H]3C[C@H](O2)CC=C(C[C@H](C=CC=C4CO[C@H]5[C@@]4(C(C=C([C@H]5OC)C)C(=O)O3)O)C)C)O)C,,,,,,
3954,163955,CID 163955,CC=C(C)[C@@H]1[C@H](C[C@H]([C@@]2(O1)C[C@@H]3C[C@H](O2)CC=C(C[C@H](C=CC=C4CO[C@H]5[C@@]4(C(C=C([C@H]5O)C)C(=O)O3)O)C)C)O)C,,,,,,
3955,163956,CID 163956,CC=C(C)[C@@H]1[C@H](C[C@H]([C@@]2(O1)C[C@@H]3C[C@H](O2)CC=C(C[C@H](C=CC=C4CO[C@H]5[C@@]4(C(C=C([C@H]5OC)COC(=O)C(=CC)C)C(=O)O3)O)C)C)O)C,,,,,,
3956,163957,"Benzonitrile, 2-(3-((2-(2,4-dioxo-3-phenyl-1-imidazolidinyl)ethyl)amino)-2-hydroxypropoxy)-, monohydrochloride, (+-)-",C1C(=O)N(C(=O)N1CCNCC(COC2=CC=CC=C2C#N)O)C3=CC=CC=C3.Cl,,,,,,
3957,163958,"2-[3-[2-(2,4-Dioxo-3-phenylimidazolidin-1-yl)ethylamino]-2-hydroxypropoxy]benzonitrile",C1C(=O)N(C(=O)N1CCNCC(COC2=CC=CC=C2C#N)O)C3=CC=CC=C3,,,,,,
3958,163959,1-(alpha-Methyl-4-(2-methylpropyl)benzeneacetate)-beta-D-Glucopyranuronic acid,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O,,,,,,
3959,163960,Antagonist G,CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)[C@@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC3=CC=CC=C3)N(C)C(=O)[C@@H](CC4=CNC5=CC=CC=C54)NC(=O)[C@H](CCCN=C(N)N)N,,,,,,
3960,163961,4-Bromooct-2-enoic acid,CCCCC(C=CC(=O)O)Br,,,,,,
3961,163962,Gliadin peptide A (206-217),CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N,,,,,,
3962,163963,CID 163963,CC[N+]1=CC=C(C=C1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)C(=NO[C@@H](C)C(=O)O)C4=CSC(=N4)N)SC2)C(=O)[O-],,,,,,
3963,163964,"(6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-[(1S)-1-carboxyethoxy]iminoacetyl]amino]-3-[(1-ethylpyridin-1-ium-4-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CC[N+]1=CC=C(C=C1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)C(=NO[C@@H](C)C(=O)O)C4=CSC(=N4)N)SC2)C(=O)O,,,,,,
3964,163965,Agaglu,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)NC(=O)CNC(=O)C(CCC(=O)NC(C=O)C(C(C(CO)O)O)O)NC(=O)C(CC5=CN=CN5)NC6=CC=CC(=N6)CNCCN,,,,,,
3965,163966,Aceco,CC(=O)N[C@@H](CS(=O)CCC(=O)O)C(=O)O,,,,,,
3966,163967,"(9,9'-Bi-4,11-Propano-4H-cyclopent(e)azecine)-5,5',10,10'(1H,1'H,6H,6'H)-tetrone, 2,2',3,3',7,7',8,8',9,9',11,11'-dodecahydro-7,7'-dimethyl-",CC1CC2=C3CCCN(CCCC3C(=O)C2C4C5=C6CCCN(CCCC6C4=O)C(=O)CC(C5)C)C(=O)C1,,,,,,
3967,163968,"1,4,5,6,7,7-Hexachlorobicyclo(2.2.1)hept-5-ene-2-carboxylic acid",C1[C@H]([C@]2(C(=C([C@@]1(C2(Cl)Cl)Cl)Cl)Cl)Cl)C(=O)O,,,,,,
3968,163969,"Cyclobutane-1,1-dicarboxylate;2-(methoxymethyl)-2-methylpropane-1,3-diamine;platinum(2+)",CC(CN)(CN)COC.C1CC(C1)(C(=O)[O-])C(=O)[O-].[Pt+2],,,,,,
3969,163970,"2-(Methoxymethyl)-2-methylpropane-1,3-diamine",CC(CN)(CN)COC,,,,,,
3970,163971,(S)-3-tert-Butylamino-1-(4-(2-hydroxyethyl)phenoxy)-2-propanol,CC(=O)OCCC1=CC=C(C=C1)OC[C@H](CNC(C)(C)C)O,,,,,,
3971,163972,"(2-acetyloxy-3-hydroxypropyl) (1R,2S,4aS,4bS,10aS)-2,4a,8,8,10a-pentamethyl-2,3,4,4b,5,6,7,10-octahydro-1H-phenanthrene-1-carboxylate",C[C@H]1CC[C@]2([C@@H]3CCCC(C3=CC[C@]2([C@@H]1C(=O)OCC(CO)OC(=O)C)C)(C)C)C,,,,,,
3972,163973,CID 163973,CC(C)(C)C1=CC(=CC=CC2=CC(=[Te+]C(=C2)C(C)(C)C)C(C)(C)C)C=C([Se]1)C(C)(C)C.[O-]Cl(=O)(=O)=O,,,,,,
3973,163974,Periplocoside B,CC1C=C(C(=O)C(O1)OC2CCC3(C4CCC5(C(C4CC=C3C2)CCC5(C(C)OC6CC7C(C(O6)C)OOC8(CC(C(C(O8)C)OC9CC(C(C(O9)C)OC1CC(C(C(O1)C)O)OC)OC)OC)CO7)O)C)C)OC,,,,,,
3974,163975,"1H-Purine-2,6-dione, 3,7-dihydro-3-methyl-7-((5-methyl-1,2,4-oxadiazol-3-yl)methyl)-",CC1=NC(=NO1)CN2C=NC3=C2C(=O)NC(=O)N3C,,,,,,
3975,163976,CID 163976,C1=CSC=C1CC2=C(NC3=C2NC(=NC3=O)N)N.Cl,,,,,,
3976,163977,CID 163977,C1=CSC=C1CC2=C(NC3=C2NC(=NC3=O)N)N,,,,,,
3977,163978,"1,3-Di-tert-butyl-5-methylcyclohexane",CC1CC(CC(C1)C(C)(C)C)C(C)(C)C,,,,,,
3978,163979,Conotoxin SI,CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)N1CCCC1C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N)N,,,,,,
3979,163981,3-benzyl-5-bromo-2-hydroxy-N-(4-nitrophenyl)benzamide; piperazine,C1CNCCN1.C1=CC=C(C=C1)CC2=C(C(=CC(=C2)Br)C(=O)NC3=CC=C(C=C3)[N+](=O)[O-])O,,,,,,
3980,163982,3-benzyl-5-bromo-2-hydroxy-N-(4-nitrophenyl)benzamide,C1=CC=C(C=C1)CC2=C(C(=CC(=C2)Br)C(=O)NC3=CC=C(C=C3)[N+](=O)[O-])O,,,,,,
3981,163983,"Pyrazolo(1,5-a)pyrimidine-3-carbonitrile, 4,5-dihydro-4-((4-(phenylmethyl)-1-piperazinyl)acetyl)-7-(3-(trifluoromethyl)phenyl)-",C1CN(CCN1CC2=CC=CC=C2)CC(=O)N3CC=C(N4C3=C(C=N4)C#N)C5=CC(=CC=C5)C(F)(F)F,,,,,,
3982,163984,CID 163984,C1=CC(=C(C=C1C[C@H](C(=O)O)OC(=O)C=CC2=C3[C@H]([C@@H](OC3=C(C=C2)O)C4=CC(=C(C=C4)O)O)C(=O)OC(CC5=CC(=C(C=C5)O)O)C(=O)O)O)O,,,,,,
3983,163985,CID 163985,CC1=C(SC=[N+]1CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O)CCO.OS(=O)(=O)[O-],,,,,,
3984,163986,"(6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[[5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium-3-yl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CC1=C(SC=[N+]1CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O)CCO,,,,,,
3985,163987,"2-[2-({Amino[bis(2-chloroethyl)amino]phosphoryl}oxy)ethyl]-1,3-thiazolidine-4-carboxylic acid",C1C(NC(S1)CCOP(=O)(N)N(CCCl)CCCl)C(=O)O,,,,,,
3986,163988,"[(3aR,4R,5R,9aR,9bS)-4,9a-dihydroxy-6,9-dimethyl-3-methylidene-2,7-dioxo-3a,4,5,9b-tetrahydroazuleno[4,5-b]furan-5-yl] 3-methylbut-2-enoate",CC1=CC(=O)C2=C([C@H]([C@@H]([C@@H]3[C@@H]([C@@]12O)OC(=O)C3=C)O)OC(=O)C=C(C)C)C,,,,,,
3987,163989,Tomencephalin,CC1=C2C[C@@H]3[C@]([C@@H]2[C@@H]4[C@@H]([C@H]([C@@H]1OC(=O)C=C(C)C)O)C(=C)C(=O)O4)(O3)C,,,,,,
3988,163990,5-Hydroxytomacephalin,CC1=C2C[C@@H]3[C@]([C@@]2([C@@H]4[C@@H]([C@H]([C@@H]1OC(=O)C=C(C)C)O)C(=C)C(=O)O4)O)(O3)C,,,,,,
3989,163991,"2-[4-[1-(4-iodophenyl)-2-phenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine",CCC(=C(C1=CC=C(C=C1)OCCN(C)C)C2=CC=C(C=C2)I)C3=CC=CC=C3,,,,,,
3990,163992,CID 163992,COC1=CC=CC2=C3C(=CNC(=C3N=C21)C4CCCC5=C6C(=C7C=CC=C(C7=N6)OC)C(=CN45)OC)OC,,,,,,
3991,163993,2'-Chloroflavone,C1=CC=C2C(=C1)C(=O)C=C(O2)C3=CC=CC=C3Cl,,,,,,
3992,163994,"O(6),7-Dimethylguanine",CN1C=NC2=C1C(=NC(=N2)N)OC,,,,,,
3993,163995,"1-tert-butyl-7-[(1R,4R)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid",CC(C)(C)N1C=C(C(=O)C2=CC(=C(N=C21)N3C[C@H]4C[C@@H]3CN4)F)C(=O)O,,,,,,
3994,163996,"3H-Naphtho[1,2,3-de]quinoline-1-carbonitrile, 2,7-dihydro-6-[[4-(2-hydroxyethyl)phenyl]amino]-3-methyl-2,7-dioxo-",CN1C2=C3C(=C(C=C2)NC4=CC=C(C=C4)CCO)C(=O)C5=CC=CC=C5C3=C(C1=O)C#N,,,,,,
3995,163997,"1H-Indole-2-propanoic acid, alpha-amino-2,3-dihydro-",C1C(NC2=CC=CC=C21)CC(C(=O)O)N,,,,,,
3996,163998,Bactenecin,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CCCN=C(N)N)N)C(=O)NC(CCCN=C(N)N)C(=O)O)C(C)C)CCCN=C(N)N)C(C)CC)C(C)C)C(C)C,,,['Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)'],,,
3997,163999,Urorost,C1N2CN3CN1CN(C2)C3.C1=CC(=C(C=C1S(=O)(=O)O)O)C(=O)O,,,,,,
3998,164000,4-Sulfosalicylic acid,C1=CC(=C(C=C1S(=O)(=O)O)O)C(=O)O,,,,,,
3999,164001,"6-Bromo-2,5-dihydroxythiophenol",C1=CC(=C(C(=C1O)S)Br)O,,,,,,
4000,164002,Glutamine monofluorophosphate,C(CC(=O)N)[C@@H](C(=O)O)N.C(CC(=O)N)[C@@H](C(=O)O)N.[O-]P(=O)([O-])F.[Na+].[Na+].[Cl-].[Cl-],,,,,,
4001,164003,Penasterol,C[C@H](CCC=C(C)C)[C@H]1CC[C@@]2([C@@]1(CCC3=C2CCC4[C@@]3(CC[C@@H](C4(C)C)O)C)C)C(=O)O,,,,,,
4002,164004,CID 164004,CC(=CCO)CC[C@@H]1C(=C)C[C@H]([C@H]2[C@@]1(CCC[C@H]2C(=O)OC)C)OC(=O)C3=CC=CC=C3,,,,,,
4003,164005,Krds tetrapeptide,C(CCN)C[C@@H](C(=O)C(C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)O)N)CN=C(N)N)N,,,,,,
4004,164006,Chema,CC(=O)N[C@@H](CSC(CO)C#N)C(=O)O,,,,,,
4005,164007,Desoxoamiodrone,CCCCC1=C(C2=CC=CC=C2O1)CC3=CC(=C(C(=C3)I)OCCN(CC)CC)I,,,,,,
4006,164008,"3-Thiophenecarbonitrile, 4-(4-chlorophenyl)-2-(methylthio)-",CSC1=C(C(=CS1)C2=CC=C(C=C2)Cl)C#N,,,,,,
4007,164009,"N-(4-Acetyl-2-(2,4-difluorophenoxy)phenyl)methanesulfonamide",CC(=O)C1=CC(=C(C=C1)NS(=O)(=O)C)OC2=C(C=C(C=C2)F)F,,,,,,
4008,164010,CID 164010,CC(C)C1=CC(=C(C(=C1)C(=O)[O-])O)C(C)C.CC(C)C1=CC(=C(C(=C1)C(=O)[O-])O)C(C)C.CC(C)C1=CC(=C(C(=C1)C(=O)[O-])O)C(C)C.CC(C)C1=CC(=C(C(=C1)C(=O)[O-])O)C(C)C.[Cu+2].[Cu+2],,,,,,
4009,164011,"4,7-Methano-1H-isoindole-1,3(2H)-dione, 4,5,6,7-tetrachloro-3a,4,7,7a-tetrahydro-",C1C2(C3C(C1(C(=C2Cl)Cl)Cl)C(=O)NC3=O)Cl,,,,,,
4010,164012,CID 164012,C[C@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)C1=CC=C(C=C1)N(C)CC2=CN=C3C(=N2)C(=NC(=N3)N)N,,,,,,
4011,164013,"4-Methyl-3-(methylsulfonyl)-5-phenyl-4H-1,2,4-triazole",CN1C(=NN=C1S(=O)(=O)C)C2=CC=CC=C2,,,,,,
4012,164014,"6-Ethoxy-2,3-dihydro-3,3-dimethyl-1H-indole",CCOC1=CC2=C(C=C1)C(CN2)(C)C.CS(=O)(=O)O,,,,,,
4013,164015,"1H-Indole, 6-ethoxy-2,3-dihydro-3,3-dimethyl-",CCOC1=CC2=C(C=C1)C(CN2)(C)C,,,,,,
4014,164016,6-Piperidino-2(1H)-quinolinone hydrochloride,C1CCN(CC1)C2=CC3=C(C=C2)NC(=O)C=C3.Cl,,,,,,
4015,164017,"2(1H)-Quinolinone, 6-(1-piperidinyl)-",C1CCN(CC1)C2=CC3=C(C=C2)NC(=O)C=C3,,,,,,
4016,164018,"[3-Hydroxy-1-(9-methoxy-7-oxofuro[3,2-g]chromen-4-yl)oxy-3-methylbutan-2-yl] 2-methylbut-2-enoate",CC=C(C)C(=O)OC(COC1=C2C=COC2=C(C3=C1C=CC(=O)O3)OC)C(C)(C)O,,,,,,
4017,164019,Boc-Asp(Ofm)-OH,CC(C)(C)OC(=O)N[C@@H](CC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)C(=O)O,,,,,,
4018,164020,"5-[2-(3,4-Dimethoxyphenyl)ethenyl]-2,3-dimethoxyphenol",COC1=C(C=C(C=C1)C=CC2=CC(=C(C(=C2)OC)OC)O)OC,,,,,,
4019,164021,Carmethizole,CNC(=O)OCC1=C(N(C(=N1)SC)C)COC(=O)NC,,,,,,
4020,164022,"6-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyridine-2-carboxamide",C1=CC(=NC(=C1)C(=O)N)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
4021,164023,(E)-2-diazonio-1-[[4-(pyridin-2-yldisulfanyl)phenyl]methoxy]ethenolate,C1=CC=NC(=C1)SSC2=CC=C(C=C2)COC(=O)C=[N+]=[N-],,,,,,
4022,164024,CID 164024,C1=CC=NC(=C1)SSC2=CC=C(C=C2)COC(=C[N+]#N)O,,,,,,
4023,164025,Benzyloxycarbonyltyrosylalanine diazomethane,CC(C(=O)C=[N+]=[N-])NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)OCC2=CC=CC=C2,,,,,,
4024,164026,2-Hydroxy-3-[[3-(4-hydroxyphenyl)-2-(phenylmethoxycarbonylamino)propanoyl]amino]but-1-ene-1-diazonium,CC(C(=C[N+]#N)O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)OCC2=CC=CC=C2,,,,,,
4025,164027,"Tetramethylene bis(2,2,2-trifluoroethanesulfonate)",C(CCOS(=O)(=O)CC(F)(F)F)COS(=O)(=O)CC(F)(F)F,,,,,,
4026,164028,CID 164028,C1=NC2=C(N1CC(CCO)CO)NC(=NC2=O)N.OP(=O)(O)OP(=O)(O)OP(=O)(O)O,,,,,,
4027,164029,Boholmycin,CNC1C(C(COC1OC2C(C(C(C(C2OC(=O)N)O)OC(=O)N)OC3C(C(C(C(O3)CO)O)N)O)O)OC4C(C(C(C(O4)C(CO)O)O)O)O)O,,,,,,
4028,164030,"(3beta,4beta)-23-Hydroxy-22-oxoolean-12-en-3-yl O-6-deoxy-alpha-L-mannopyranosyl-(1-2)-O-beta-D-galactopyranosyl-(1-2)-beta-D-glucopyranosiduronic acid",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H]([C@H](O[C@H]2O[C@@H]3[C@H]([C@@H]([C@H](OC3O[C@H]4CC[C@]5([C@H]([C@@]4(C)CO)CC[C@@]6([C@@H]5CC=C7[C@]6(CC[C@@]8([C@H]7CC(CC8=O)(C)C)C)C)C)C)C(=O)O)O)O)CO)O)O)O)O)O,,,,,,
4029,164031,"3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2,2-dimethyl-3-(4-(2-propenyl)-1-piperazinyl)propyl methyl ester, dihydrochloride",CC1=C(C(C(=C(N1)C)C(=O)OCC(C)(C)CN2CCN(CC2)CC=C)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC.Cl.Cl,,,,,,
4030,164032,CID 164032,CC(CC(=O)O)(CC(=O)OCC=CC1=CC(=C(C(=C1)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)OC)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
4031,164033,Oagpc,CCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC(=O)O,,,,,,
4032,164034,2-[[2-(8-Carboxyoctanoyloxy)-3-octadecoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCCCCOCC(COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC(=O)O,,,,,,
4033,164035,"1H-Pyrazole-4-carboxylic acid, 1-(3-methylphenyl)-5-(methylthio)-, ethyl ester",CCOC(=O)C1=C(N(N=C1)C2=CC=CC(=C2)C)SC,,,,,,
4034,164036,"1H-Pyrazole-4-carboxylic acid, 1-(3-methylphenyl)-5-(methylsulfonyl)-, ethyl ester",CCOC(=O)C1=C(N(N=C1)C2=CC=CC(=C2)C)S(=O)(=O)C,,,,,,
4035,164037,"2,5,6-Trichloro-3-(glutathion-S-yl)-1,4-benzoquinone",C(CC(=O)N[C@@H](CSC1=C(C(=O)C(=C(C1=O)Cl)Cl)Cl)C(=O)NCC(=O)O)[C@@H](C(=O)O)N,,,,,,
4036,164038,Dibromosceptrin,C1=C(NC(=C1Br)Br)C(=O)NCC2C(C(C2C3=CN=C(N3)N)C4=CN=C(N4)N)CNC(=O)C5=CC(=C(N5)Br)Br,,,,,,
4037,164039,"4-tert-Butyl-1-(4-iodophenyl)-2,6,7-trioxabicyclo(2.2.2)octane",CC(C)(C)C12COC(OC1)(OC2)C3=CC=C(C=C3)I,,,,,,
4038,164040,26-(2'-Aminoethylthio)tetrahydroteleocidin A-2,CCC(C)(CCCC(C)(C)SCCN)C1=C2C3=C(C=C1)N(C(C(=O)NC(CC3=CN2)CO)C(C)C)C,,,,,,
4039,164041,CID 164041,C1=NC(=O)C2=C(N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)F)O,,,,,,
4040,164042,N(6)-((Chrysen-5-yl)methyl)adenine,C1=CC=C2C(=C1)C=CC3=C2C(=CC4=CC=CC=C34)CNC5=NC=NC6=C5NC=N6,,,,,,
4041,164043,CID 164043,C1=CC=C2C(=C1)C=CC3=C2C(=CC4=CC=CC=C34)CNC5=NC(=O)C6=C(N5)N=CN6,,,,,,
4042,164044,Octyldichloropropyl phosphate,CCCCCCCCOP(=O)(O)OCCC(Cl)Cl,,,,,,
4043,164045,3-Cyano-7-ethoxycoumarin,CCOC1=CC2=C(C=C1)C=C(C(=O)O2)C#N,,,,,['3-cyano-7-ethoxycoumarin has known human metabolites that include 3-Cyano-7-hydroxycoumarin.'],
4044,164046,"(-)-3,4-Dihydro-3-hydroxy-8-methoxy-3-methylbenz(a)anthracene-1,7,12(2H)-trione",CC1(CC2=C(C(=O)C1)C3=C(C=C2)C(=O)C4=C(C3=O)C=CC=C4OC)O,,,,,,
4045,164047,3-(Ethylsulfonyl)pyridine-2-sulfonamide,CCS(=O)(=O)C1=C(N=CC=C1)S(=O)(=O)N,,,,,,
4046,164048,"1-(3,7-Dimethylocta-2,6-dienyl)azepan-2-one",CC(=CCCC(=CCN1CCCCCC1=O)C)C,,,,,,
4047,164049,"(2S)-N-[1-[[(3S,6S,8S,12S,13R,16S,17R,20S,23S)-12-hydroxy-20-[(4-methoxyphenyl)methyl]-6,17,21-trimethyl-3-(2-methylpropyl)-2,5,7,10,15,19,22-heptaoxo-8,13-di(propan-2-yl)-9,18-dioxa-1,4,14,21-tetrazabicyclo[21.3.0]hexacosan-16-yl]amino]-4-methyl-1-oxopentan-2-yl]-1-[(2S)-2-hydroxypropanoyl]-N-methylpyrrolidine-2-carboxamide",C[C@@H]1[C@@H](C(=O)N[C@@H]([C@H](CC(=O)O[C@H](C(=O)[C@@H](C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N([C@H](C(=O)O1)CC3=CC=C(C=C3)OC)C)CC(C)C)C)C(C)C)O)C(C)C)NC(=O)C(CC(C)C)N(C)C(=O)[C@@H]4CCCN4C(=O)[C@H](C)O,,,,,,
4048,164050,Neriproct,CCCCC(=O)OCC(=O)[C@H]1[C@@H](C[C@@H]2[C@@]1(C[C@@H](C3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C.CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,,,,,,
4049,164051,Ferric chlorin,[H+].CC1C2=CC3=NC(=CC4=C(C(=C([N-]4)C=C5C(=C(C(=CC(=N2)C1(C)C)[N-]5)C)C)C)CCC(=O)[O-])C(=C3C)CCC(=O)[O-].[Fe+3],,,,,,
4050,164052,"3-[18-(2-carboxyethyl)-3,7,8,8,12,13,17-heptamethyl-21,24-dihydro-7H-porphyrin-2-yl]propanoic acid",CC1C2=NC(=CC3=NC(=CC4=C(C(=C(N4)C=C5C(=C(C(=C2)N5)C)CCC(=O)O)CCC(=O)O)C)C(=C3C)C)C1(C)C,,,,,,
4051,164053,"S-(2,3-Bis(palmitoyloxy)propyl)-N-palmitoylcysteinyl-alanyl-glycine",CCCCCCCCCCCCCCCC(=O)N[C@@H](CSCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)N[C@@H](C)C(=O)NCC(=O)O,,,,,,
4052,164054,CID 164054,CC(=O)OC(C)(C)C=CC(=O)[C@@](C)([C@H]1[C@@H](C[C@@]2([C@@]1(CC(=O)[C@@]3([C@H]2CC=C4[C@H]3C[C@@H]([C@H](C4(C)C)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)C)C)O)O,,,,,,
4053,164055,Sialyl-Le(a) oligosaccharide,CC1C(C(C(C(O1)OC2C(OC(C(C2OC3C(C(C(C(O3)CO)O)OC4(CC(C(C(O4)C(C(CO)O)O)N)O)C(=O)O)O)NC(=O)C)OC5C(C(OC(C5O)OC(C(CO)O)C(C(C=O)O)O)CO)O)CO)O)O)O,,,,,,
4054,164056,Cyclopentenylcytosine 6-triphosphate,C1=CN(C(=O)N=C1N)[C@@H]2C=C([C@H]([C@H]2O)O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O,,,,,,
4055,164057,N-[[4-(2-aminoethoxy)-3-methoxyphenyl]methyl]octadec-9-enamide,CCCCCCCCC=CCCCCCCCC(=O)NCC1=CC(=C(C=C1)OCCN)OC,,,,,,
4056,164058,"Phosphine oxide, octylbis(2,4,4-trimethylpentyl)-",CCCCCCCCP(=O)(CC(C)CC(C)(C)C)CC(C)CC(C)(C)C,,,,,,
4057,164059,4-tert-Butyl-(3-(2-chloroethyl)ureido)benzene,CC(C)(C)C1=CC=C(C=C1)NC(=O)NCCCl,,,,,,
4058,164060,CID 164060,C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCCCC2=C(NC(=NC2=O)N)N,,,,,,
4059,164061,"2-Cyano-3-(1,4-dihydro-1-phenyl-(1)-benzothiopyrano(4,3-c)pyrazol-3-yl)-3-oxo-N-phenylpropanamide",C1C2=C(C3=CC=CC=C3S1)N(N=C2C(=O)C(C#N)C(=O)NC4=CC=CC=C4)C5=CC=CC=C5,,,,,,
4060,164062,Chloroorienticin A,C[C@H]1[C@@H]([C@@](C[C@@H](O1)O[C@H]2[C@@H](O[C@@H]([C@H](C2O)O)CO)OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H]7C(=O)N[C@@H](C8=C(C(=CC(=C8)O)O)C9=C(C=CC(=C9)[C@H](C(=O)N7)NC(=O)[C@@H]5NC(=O)[C@@H](NC(=O)[C@@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC(=O)[C@@H](CC(C)C)NC)CC(=O)N)O)C(=O)O)O[C@H]1C[C@]([C@H]([C@@H](O1)C)O)(C)N)Cl)(C)N)O,,,,,,
4061,164063,CID 164063,C1[C@H](NC(=O)N=C1S)C(=O)O,,,,,,
4062,164064,Asperdurin,CC1=C(C(=C2C(OC(=O)C2=C1OC)O)CC=C(C)C)O,,,,,,
4063,164065,Amino-5-phosphono-3-pentenoic acid,C(C=CC(C(=O)O)N)P(=O)(O)O,,,,,,
4064,164066,CID 164066,C1CC2=C(C[C@@H]1CCC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N=C(N2)N,,,,,,
4065,164067,CID 164067,C1CC2=C(C[C@@H]1CCC3=CC=C(C=C3)C(=O)N[C@@H](CCCN)C(=O)O)C(=O)N=C(N2)N,,,,,,
4066,164068,CID 164068,CCCCCCCCCCCCC=C[C@H]([C@H](COP(=O)([O-])OCC[N+](C)(C)C)NC(=O)CCCCCCCCCCCNS(=O)(=O)C1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C=C1)O,,,,,,
4067,164069,CID 164069,CCCCCCCCCCCCC=C[C@H]([C@H](COP(=O)(O)OCC[N+](C)(C)C)NC(=O)CCCCCCCCCCCNS(=O)(=O)C1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C=C1)O,,,,,,
4068,164070,Edihyp,CC[N+](C)(C)NCCC(=O)OCC.[I-],,,,,,
4069,164071,"2-(2-Ethoxycarbonylethyl)-1-ethyl-1,1-dimethylhydrazinium",CC[N+](C)(C)NCCC(=O)OCC,,,,,,
4070,164072,Tilnoprofen arbamel,CC1=NC2=C(CC3=C(O2)C=CC(=C3)C(C)C(=O)OCC(=O)N(C)C)C=C1,,,,,,
4071,164073,Lysyl-arginyl-alanyl-lysyl-alanyl-lysyl-threonyl-threonyl-lysyl-lysyl-arginine,C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)N)O,,,,,,
4072,164074,Anpirtolin,C1CNCCC1S[14C]2=N[14C](=CC=C2)Cl.Cl,,,,,,
4073,164075,"2-chloro-6-piperidin-4-ylsulfanyl(2,6-14C2)pyridine",C1CNCCC1S[14C]2=N[14C](=CC=C2)Cl,,,,,,
4074,164076,Tetranitrosyltetra-mu3-sulfidotetrahedro-tetrairon,N#[O+].N#[O+].N#[O+].N#[O+].[S-2].[S-2].[S-2].[S-2].[Fe].[Fe].[Fe].[Fe+3],,,,,,
4075,164077,Silaplatin,C[Si](C)(CN)CN.[Cl-].[Cl-].[Pt+2],,,,,,
4076,164078,[Aminomethyl(dimethyl)silyl]methanamine,C[Si](C)(CN)CN,,,,,,
4077,164079,CID 164079,CC=CC=CC(=O)C1C2=C(C(=CC=C2)O)C(=O)C3=C1C=CC=C3O,,,,,,
4078,164080,3-[(2-Amino-7h-purin-6-yl)oxy]propanenitrile,C1=NC2=C(N1)C(=NC(=N2)N)OCCC#N,,,,,,
4079,164081,Cmc-cdi,CC1=CC=C(C=C1)S(=O)(=O)O.C[N+]1(CCOCC1)CCN=C(C2CCCCC2)N,,,,,,
4080,164082,4-(2-{[Cyclohexyl(imino)methyl]amino}ethyl)-4-methylmorpholin-4-ium,C[N+]1(CCOCC1)CCN=C(C2CCCCC2)N,,,,,,
4081,164083,Methionyl-glutaminyl-methionyl-lysyl-lysyl-valyl-leucyl-aspartyl-serine,CC(C)CC(C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)C(CCCCN)NC(=O)[C@H](CCCCN)NC(=O)C(CCSC)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCSC)N,,,,,,
4082,164084,2-Desaminopterin,C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=NC=N3)N,,,,,,
4083,164085,2-Desamino-2-methylaminopterin,CC1=NC2=NC=C(N=C2C(=N1)N)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
4084,164086,2-Methyl-1-oxo-1H-phenalene-3-acetic acid,CC1=C(C2=CC=CC3=C2C(=CC=C3)C1=O)CC(=O)O,,,,,,
4085,164087,"1,2-Diphenylpropan-2-amine",CC(CC1=CC=CC=C1)(C2=CC=CC=C2)N,,,,,,
4086,164088,"4-Amino-6,7-dimethoxy-2-(1,2,3,4-tetrahydro-6,7-dimethoxyisoquinol-2-yl)quinoline methanesulfonate",COC1=C(C=C2CN(CCC2=C1)C3=NC4=CC(=C(C=C4C(=C3)N)OC)OC)OC.CS(=O)(=O)O,,,,,,
4087,164089,Abanoquil,COC1=C(C=C2CN(CCC2=C1)C3=NC4=CC(=C(C=C4C(=C3)N)OC)OC)OC,,,,,,
4088,164090,"11-(4-Dimethylaminophenyl)-6-methyl-4',5'-dihydro(estra-4,9-diene-17,2'-(3H)-furan)-3-one",C[C@@H]1C[C@H]2[C@@H]3CC[C@]4([C@]3(C[C@@H](C2=C5C1=CC(=O)CC5)C6=CC=C(C=C6)N(C)C)C)CCCO4,,,,,,
4089,164091,"9-Acridinamine, 1,2,3,4-tetrahydro-N-hydroxy-",C1CCC2=NC3=CC=CC=C3C(=C2C1)NO,,,,,,
4090,164092,"L-Cysteine, N-acetyl-S-(1,1-dibromo-2,2-difluoroethyl)-",CC(=O)N[C@@H](CSC(C(F)F)(Br)Br)C(=O)O,,,,,,
4091,164093,"L-Cysteine, N-acetyl-S-(1,1,2,2-tetrafluoroethyl)-",CC(=O)N[C@@H](CSC(C(F)F)(F)F)C(=O)O,,,,,,
4092,164094,CID 164094,CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC5=CC(=C(C=C5C=C4)O)O)C(=O)[O-],,,,,,
4093,164095,CID 164095,CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC5=CC(=C(C=C5C=C4)O)O)C(=O)O,,,,,,
4094,164096,CID 164096,C[C@H](CC[C@H]([C@@H](CO)COS(=O)(=O)O)O)[C@H]1CCC2[C@@]1([C@H](CC3C2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)[O-])C)O)O)C.[Na+],,,,,,
4095,164097,CID 164097,C[C@H](CC[C@H]([C@H](CO)COS(=O)(=O)O)O)[C@H]1CCC2[C@@]1([C@H](CC3C2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,,,,,,
4096,164098,CID 164098,CC1=C(C(=C(C(=C1OCC(=O)OCCN(C)C2=CC=C(C3=NON=C23)[N+](=O)[O-])OC)OC)O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,,,,,,
4097,164099,"2-Furanmethanol, alpha-(2,6-dichlorophenyl)-",C1=CC(=C(C(=C1)Cl)C(C2=CC=CO2)O)Cl,,,,,,
4098,164100,Drummondin C,CC(=O)C1=C(C(=C(C(C1=O)(C)C)O)CC2=C(C(=C3C(=C2O)C=CC(O3)(C)C)C(=O)C)O)O,,,,,,
4099,164101,"Cholanthrene-9,10-diol-7,8-epoxide",C1CC2=C3C1=CC=CC3=CC4=C2C=CC5=C4[C@H]6[C@H](O6)[C@@H]([C@H]5O)O,,,,,,
4100,164102,"2,2-Dibutyl-5-(2-quinolylmethoxy)-1,2,3,4-tetrahydro-1-naphthol",CCCCC1(CCC2=C(C1O)C=CC=C2OCC3=NC4=CC=CC=C4C=C3)CCCC,,,,,,
4101,164103,CID 164103,C1=[N+](C2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)NC(=NC2=O)N)[O-],,,,,,
4102,164104,"Estra-1,3,5(10)-triene-3,17-diol, 7-(4-(2-(dimethylamino)ethoxy)phenyl)-, (7alpha,17beta)-",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@@H](CC4=C3C=CC(=C4)O)C5=CC=C(C=C5)OCCN(C)C,,,,,,
4103,164105,"4-[(3,5-Di-tert-butyl-4-hydroxybenzoyl)amino]benzoic acid",CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C(=O)NC2=CC=C(C=C2)C(=O)O,,,,,,
4104,164106,"1-Butanone, 2-(dimethylamino)-1-(4-(dimethylamino)phenyl)-2-(phenylmethyl)-",CCC(CC1=CC=CC=C1)(C(=O)C2=CC=C(C=C2)N(C)C)N(C)C,,,,,,
4105,164107,tert-Butoxycarbonyl-sulfo-tyrosyl-norleucyl-glycyl-tryptophyl-norleucyl-aspartic acid phenethyl ester,CCCC[C@@H](C(=O)NCC(=O)N[C@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CC(=O)O)C(=O)OCCC3=CC=CC=C3)NC(=O)[C@H](CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)OC(C)(C)C,,,,,,
4106,164108,4-Amino-1-(2-deoxy-2-ethyl-beta-D-arabinofuranosyl)-2(1H)-pyrimidinone monohydrochloride,CC[C@H]1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)N)CO)O.Cl,,,,,,
4107,164109,CID 164109,CC[C@H]1[C@@H](C(O[C@H]1N2C=CC(=NC2=O)N)CO)O,,,,,,
4108,164110,A2-Binding peptide,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NC(CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)CNC(=O)[C@H](CCCCN)N,,,,,,
4109,164111,"Methyldioxy, fluoro-",C(O[O])F,,,,,,
4110,164112,"17-(Cyclopropylmethyl)-14-hydroxy-6-methylidene-4,5-epoxymorphinan-3-yl 2-o-hexopyranuronosylhexopyranosiduronic acid",C=C1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)OC6C(C(C(C(O6)C(=O)O)O)O)OC7C(C(C(C(O7)C(=O)O)O)O)O)CCN3CC8CC8)O,,,,,,
4111,164113,9-Diazofluorene-2-butyric acid,C1=CC=C2C(=C1)C3=C(C2=[N+]=[N-])C=C(C=C3)CCCC(=O)O,,,,,,
4112,164114,"3,5-diamino-N-[2-[2-[(3-bromo-5-tert-butyl-2-hydroxyphenyl)methylamino]ethyl-methylamino]ethyl]-6-chloropyrazine-2-carboxamide",CC(C)(C)C1=CC(=C(C(=C1)Br)O)CNCCN(C)CCNC(=O)C2=C(N=C(C(=N2)Cl)N)N,,,,,,
4113,164115,"3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-(1-methylethyl)pyrazolo(1,5-a)pyridin-3-yl)-, methyl 2-(methyl(phenylmethyl)amino)ethyl ester",CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=C4C=CC=CN4N=C3C(C)C)C(=O)OC,,,,,,
4114,164116,"4-(7-hydroxy-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-ylamino)benzonitrile",C1CC2=C(C1O)N=CN=C2NC3=CC=C(C=C3)C#N,,,"['A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed, p414) (See all compounds classified as Monoamine Oxidase Inhibitors.)']",,,
4115,164117,CID 164117,CC(=NN=C(N)S)C1=NC=C2C(=C1)C3=CC=CC=C3N2,,,,,,
4116,164118,"Aflatoxin B1-8,9-dichloride",COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4[C@H]5[C@@H](OC4=C1)OC(=C5Cl)Cl,,,,,,
4117,164119,"10-[3-(Dimethylamino)-4-hydroxy-3,5-dimethyloxan-2-yl]-11-hydroxy-5-methyl-2-[2-methyl-3-(3-methyloxiran-2-yl)oxiran-2-yl]naphtho[2,3-h]chromene-4,7,12-trione",CC1COC(C(C1O)(C)N(C)C)C2=C(C3=C(C=C2)C(=O)C4=C(C3=O)C5=C(C(=C4)C)C(=O)C=C(O5)C6(C(O6)C7C(O7)C)C)O,,,,,,
4118,164120,"1H-Pyrazole-4-carboxamide, 5-cyano-N-methyl-1-(1-methylcyclopentyl)-",CC1(CCCC1)N2C(=C(C=N2)C(=O)NC)C#N,,,,,,
4119,164121,"1,5-Dihydro-1-(5-(1,1-dimethylethyl)-3-isoxazolyl)-5-hydroxy-3,4-dimethyl-2H-pyrrol-2-one",CC1=C(C(=O)N(C1O)C2=NOC(=C2)C(C)(C)C)C,,,,,,
4120,164122,"1,5-Dihydro-5-chloro-1-(5-(1,1-dimethylethyl)-3-isoxazolyl)-3,4-dimethyl-2H-pyrrol-2-one",CC1=C(C(=O)N(C1Cl)C2=NOC(=C2)C(C)(C)C)C,,,,,,
4121,164123,"1,5-Pentanediamine, 2-methyl-N,N'-bis(1-methylethyl)-",CC(C)NCCCC(C)CNC(C)C,,,,,,
4122,164124,Pphpa,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)O)OC(=O)CCCCCC1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C=C1,,,,,,
4123,164125,"3,5-Pyridinedicarboxylic acid, 1,4-dihydro-4-(2-((methoxycarbonyl)amino)-1H-benzimidazol-5-yl)-2,6-dimethyl-, dimethyl ester",CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC3=C(C=C2)N=C(N3)NC(=O)OC)C(=O)OC,,,,,,
4124,164126,Physodine A,CC1C(C(C(C(O1)OC2CCC3(C4CCC5(C(CCC5(C4CCC3(C2)O)O)C6=COC(=O)C=C6)C)C=O)O)OC)O,,,,,,
4125,164127,"3,3,14,14-Tetramethoxy-2,15-dioxa-3,14-disilahexadecane",CO[Si](CCCCCCCCCC[Si](OC)(OC)OC)(OC)OC,,,,,,
4126,164128,Platinum(II) tetrachlorodianion (fast black)2,COC1=CC(=C(C=C1N=NC2=CC=C(C=C2)[N+](=O)[O-])OC)[N+]#N.COC1=CC(=C(C=C1N=NC2=CC=C(C=C2)[N+](=O)[O-])OC)[N+]#N.[Cl-].[Cl-].[Cl-].[Cl-].[Pt+2],,,,,,
4127,164129,"(2R,3S,4S)-2-(6-aminopurin-9-yl)-5-(fluoromethylidene)oxolane-3,4-diol",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H](C(=CF)O3)O)O)N,,,,,,
4128,164130,Yttrium ethylenediaminetetra(methylenephosphonic acid),C(CN(CP(=O)([O-])[O-])CP(=O)([O-])[O-])N(CP(=O)([O-])[O-])CP(=O)([O-])[O-].[90Y+3],,,,,,
4129,164131,Angiotensin I/II (3-7),CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)[C@H](C(C)C)N,,,,,,
4130,164132,L-3-(3-Hydroxy-4-pivaloyloxyphenyl)alanine,CC(C)(C)C(=O)OC1=C(C=C(C=C1)C[C@@H](C(=O)O)N)O,,,,,,
4131,164133,Samarium (153Sm) lexidronam,[H+].[H+].[H+].[H+].[H+].C(CN(CP(=O)([O-])[O-])CP(=O)([O-])[O-])N(CP(=O)([O-])[O-])CP(=O)([O-])[O-].[153Sm+3],,,"['A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)']",,,
4132,164134,26-Deoxymonensin A,CCC1(CCC(O1)C2(CCC3(O2)CC(C(C(O3)C(C)C(C(C)C(=O)O)OC)C)O)C)C4C(CC(O4)C5C(CC(C(O5)(C)O)C)C)C,,,,,,
4133,164135,Shijiaocaolactone A,CC(C)C[C@@]1([C@H](CC2=C(O1)C=C3C(=C2)C=C(C(=O)O3)C(C)(C)C=C)OC(=O)C)C,,,,,,
4134,164136,"4-(3-(Biotinylaminohexamethylenaminocarbonyl)propanoylaminomethyl)-2-methyl-1,3-dithiolane-2-yl-(ala(7))phalloidin",CC1C(=O)NC2CC3=C(NC4=CC=CC=C34)SCC(C(=O)N5CC(CC5C(=O)N1)O)NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CC6(SCC(S6)CNC(=O)CCC(=O)NCCCCCCNC(=O)CCCCC7C8C(CS7)NC(=O)N8)C)C)C(C)O,,,,,,
4135,164137,"[3-[8-(2-Aminoethyl)-10-(3-ethyl-6-oxo-2,3-dihydropyran-2-yl)-5,8-dihydroxy-7-phosphonooxydeca-1,3,9-trienyl]cyclohexyl] cyclohexanecarboxylate",CCC1C=CC(=O)OC1C=CC(CCN)(C(CC(C=CC=CC2CCCC(C2)OC(=O)C3CCCCC3)O)OP(=O)(O)O)O,,,,,,
4136,164138,CID 164138,CC=CC[C@@H](C)[C@H](C1C(=O)N[C@H](C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)O[C@@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N1C)C(C)C)C)CC(C)C)CC(C)C)C)C(C)C)C)CC(C)C)C)CC(C)C)CC(C)C)C)C)[C@@H](C)O)O,,,,,,
4137,164139,CID 164139,C[C@H]1C=CC=C(C2=NC3=C(O2)C4=C(C(=C5C(=C4C(=C3N6CCN(CC6)CC7=C(C=C(C=C7C)C)C)O)C(=O)[C@](O5)(OC=C[C@@H]([C@H]([C@@H]([C@@H]([C@@H](C(C1O)C)O)C)OC(=O)C)C)OC)C)C)OC(=O)C(C)(C)C)C,,,,,,
4138,164140,Sdz mrl 953,CCCCCCCCCCC[C@H](CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1OP(=O)(O)O)CO)OC(=O)C[C@@H](CCCCCCCCCCC)O)OC(=O)C[C@@H](CCCCCCCCCCC)O)O,,,,,,
4139,164141,Mycoticin a,CC1C=CC(CC(CC(CC(CC(CC(CC(C(C(CC=CC=CC=CC=CC=CC(=O)OC1C(C)C)O)C)O)O)O)O)O)O)O,,,,,,
4140,164142,"32-Butan-2-yl-14,16,18,20,22,24,26,28-octahydroxy-15,31-dimethyl-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one",CCC(C)C1C(C=CC(CC(CC(CC(CC(CC(CC(C(C(CC=CC=CC=CC=CC=CC(=O)O1)O)C)O)O)O)O)O)O)O)C,,,,,,
4141,164143,"(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one;methyl (9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate",CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O.C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,,,,,,
4142,164144,"(6S,8S,10R,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one",C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(CC(C2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,,,,,,
4143,164145,"methyl (9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate",CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,,,,,,
4144,164146,Cassiaside,CC1=CC(=O)C2=C(O1)C=C3C=CC=C(C3=C2O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
4145,164147,"(7S,8S,11R,13S,14S,17R)-11-[4-(dimethylamino)phenyl]-7,13-dimethylspiro[1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthrene-17,2'-oxolane]-3-one",C[C@H]1CC2=CC(=O)CCC2=C3[C@@H]1[C@@H]4CC[C@]5([C@]4(C[C@@H]3C6=CC=C(C=C6)N(C)C)C)CCCO5,,,,,,
4146,164148,"[3-[2-[2,5-Bis(3-aminopropylamino)pentanoylamino]ethoxy-hydroxyphosphoryl]oxy-2-hexadecanoyloxypropyl] hexadecanoate",CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCNC(=O)C(CCCNCCCN)NCCCN)OC(=O)CCCCCCCCCCCCCCC,,,,,,
4147,164149,"2-(2-methylpropoxycarbonyl)pent-2-enyl (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(azidomethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CCC=C(COC(=O)C1=C(CS[C@H]2N1C(=O)[C@H]2NC(=O)C(=NOC)C3=CSC(=N3)N)CN=[N+]=[N-])C(=O)OCC(C)C,,,,,,
4148,164150,Benzyldimethyloctadecyl ammonium 3-nitrobenzenesulfonate,CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1.C1=CC(=CC(=C1)S(=O)(=O)O)[N+](=O)[O-],,,,,,
4149,164151,"8-((4-Bromo-2,3-dioxobutyl)thio)adenosine cyclic 3',5'-(hydrogen phosphate)",C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C4=NC=NC(=C4N=C3SCC(=O)C(=O)CBr)N)O)OP(=O)(O1)O,,,,,,
4150,164152,Octahydromezerein,CC1CC2C34C(C(C5(C(C3C6C(O6)(C(C2(C1=O)O)O)CO)OC(O4)(O5)C7=CC=CC=C7)C(C)C)OC(=O)CCCCC8=CC=CC=C8)C,,,,,,
4151,164153,"Benzamide, 2,6-dichloro-N-((4-(trifluoromethyl)phenyl)methyl)-",C1=CC(=C(C(=C1)Cl)C(=O)NCC2=CC=C(C=C2)C(F)(F)F)Cl,,,,,,
4152,164154,"Quinazoline, 4-(2-(4-chlorophenyl)ethoxy)-",C1=CC=C2C(=C1)C(=NC=N2)OCCC3=CC=C(C=C3)Cl,,,,,,
4153,164155,"Quinazoline, 4-(2-(3-methoxyphenyl)ethoxy)-",COC1=CC=CC(=C1)CCOC2=NC=NC3=CC=CC=C32,,,,,,
4154,164156,"Quinazoline, 8-fluoro-4-(2-(4-(1-methylethyl)phenyl)ethoxy)-",CC(C)C1=CC=C(C=C1)CCOC2=NC=NC3=C2C=CC=C3F,,,,,,
4155,164157,"4-Quinazolinamine, N-[2-(3-phenoxyphenyl)ethyl]-",C1=CC=C(C=C1)OC2=CC=CC(=C2)CCNC3=NC=NC4=CC=CC=C43,,,,,,
4156,164158,"Quinazoline, 4-(2-(4-methoxyphenyl)ethoxy)-",COC1=CC=C(C=C1)CCOC2=NC=NC3=CC=CC=C32,,,,,,
4157,164159,8-Fluoro-N-(2-(3-(trifluoromethyl)phenyl)ethyl)-4-quinazolinamine,C1=CC(=CC(=C1)C(F)(F)F)CCNC2=NC=NC3=C2C=CC=C3F,,,,,,
4158,164160,"4-Quinazolinamine, N-(2-(4-(trifluoromethyl)phenyl)ethyl)-",C1=CC=C2C(=C1)C(=NC=N2)NCCC3=CC=C(C=C3)C(F)(F)F,,,,,,
4159,164161,"4-Quinazolinamine, N-(2-(2-naphthalenyl)ethyl)-",C1=CC=C2C=C(C=CC2=C1)CCNC3=NC=NC4=CC=CC=C43,,,,,,
4160,164162,"Quinazoline, 4-(2-(4-phenoxyphenyl)ethoxy)-",C1=CC=C(C=C1)OC2=CC=C(C=C2)CCOC3=NC=NC4=CC=CC=C43,,,,,,
4161,164163,"Quinazoline, 4-(2-(2-naphthalenyl)ethoxy)-",C1=CC=C2C=C(C=CC2=C1)CCOC3=NC=NC4=CC=CC=C43,,,,,,
4162,164164,"Quinazoline, 4-(2-(1,1'-biphenyl)-4-ylethoxy)-8-fluoro-",C1=CC=C(C=C1)C2=CC=C(C=C2)CCOC3=NC=NC4=C3C=CC=C4F,,,,,,
4163,164165,"Quinazoline, 4-(2-(4-(1,1-dimethylethyl)phenyl)ethoxy)-8-fluoro-",CC(C)(C)C1=CC=C(C=C1)CCOC2=NC=NC3=C2C=CC=C3F,,,,,,
4164,164166,"Quinazoline, 4-(2-(3,4-dimethoxyphenyl)ethoxy)-8-fluoro-",COC1=C(C=C(C=C1)CCOC2=NC=NC3=C2C=CC=C3F)OC,,,,,,
4165,164167,"Quinazoline, 8-fluoro-4-(2-(3-(trifluoromethyl)phenyl)ethoxy)-",C1=CC(=CC(=C1)C(F)(F)F)CCOC2=NC=NC3=C2C=CC=C3F,,,,,,
4166,164168,"Quinazoline, 4-(2-(4-ethoxyphenyl)ethoxy)-8-fluoro-",CCOC1=CC=C(C=C1)CCOC2=NC=NC3=C2C=CC=C3F,,,,,,
4167,164169,"Quinazoline, 8-fluoro-4-(2-(4-(2-fluorophenoxy)phenyl)ethoxy)-",C1=CC=C(C(=C1)OC2=CC=C(C=C2)CCOC3=NC=NC4=C3C=CC=C4F)F,,,,,,
4168,164170,CID 164170,C1=CC(=CC=C1C2=NNC(=CC3=CNC(=O)NC3=O)OC2[O-])Br.[Na+].[Na+],,,,,,
4169,164171,7-Chloro-4-(4-fluorophenoxy)quinoline,C1=CC(=CC=C1OC2=C3C=CC(=CC3=NC=C2)Cl)F,,,,,,
4170,164172,7-Chloro-4-(2-nitrophenoxy)quinoline,C1=CC=C(C(=C1)[N+](=O)[O-])OC2=C3C=CC(=CC3=NC=C2)Cl,,,,,,
4171,164173,7-Chloro-4-[2-(trifluoromethyl)phenoxy]quinoline,C1=CC=C(C(=C1)C(F)(F)F)OC2=C3C=CC(=CC3=NC=C2)Cl,,,,,,
4172,164174,8-Chloro-4-(2-methylphenoxy)quinoline,CC1=CC=CC=C1OC2=C3C=CC=C(C3=NC=C2)Cl,,,,,,
4173,164175,7-Chloro-4-[(4-fluorophenyl)methyl]quinoline,C1=CC(=CC=C1CC2=C3C=CC(=CC3=NC=C2)Cl)F,,,,,,
4174,164176,8-Chloro-4-(2-chlorophenoxy)quinoline,C1=CC=C(C(=C1)OC2=C3C=CC=C(C3=NC=C2)Cl)Cl,,,,,,
4175,164177,"[(1R,2S,3R,4R,5S)-2,5-dihydroxy-3,4-diphosphonooxycyclohexyl] dihydrogen phosphate",C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1OP(=O)(O)O)O)OP(=O)(O)O)OP(=O)(O)O)O,,,,,,
4176,164178,"4-Quinolinamine, 8-fluoro-N-(2-phenylethyl)-",C1=CC=C(C=C1)CCNC2=C3C=CC=C(C3=NC=C2)F,,,,,,
4177,164179,"Acetamide, N-(2-(4-chlorophenyl)ethyl)-N-(8-fluoro-4-quinolinyl)-",CC(=O)N(CCC1=CC=C(C=C1)Cl)C2=C3C=CC=C(C3=NC=C2)F,,,,,,
4178,164180,"4-Quinolinamine, N-(2-(4-chlorophenyl)ethyl)-8-fluoro-",C1=CC2=C(C=CN=C2C(=C1)F)NCCC3=CC=C(C=C3)Cl,,,,,,
4179,164181,"4-Quinolinamine, 8-fluoro-N-(2-(2-(trifluoromethyl)phenyl)ethyl)-",C1=CC=C(C(=C1)CCNC2=C3C=CC=C(C3=NC=C2)F)C(F)(F)F,,,,,,
4180,164182,"4-Quinolinamine, 8-fluoro-N-(2-(2-naphthalenyl)ethyl)-",C1=CC=C2C=C(C=CC2=C1)CCNC3=C4C=CC=C(C4=NC=C3)F,,,,,,
4181,164183,"4-Quinolinamine, 8-fluoro-N-(2-(2-thienyl)ethyl)-",C1=CC2=C(C=CN=C2C(=C1)F)NCCC3=CC=CS3,,,,,,
4182,164184,8-Fluoro-4-[2-(3-methoxyphenyl)ethoxy]quinoline,COC1=CC=CC(=C1)CCOC2=C3C=CC=C(C3=NC=C2)F,,,,,,
4183,164185,8-Fluoro-4-[2-(4-methoxyphenyl)ethoxy]quinoline,COC1=CC=C(C=C1)CCOC2=C3C=CC=C(C3=NC=C2)F,,,,,,
4184,164186,"4-(2-(1,1'-Biphenyl)-4-ylethoxy)-8-fluoroquinoline",C1=CC=C(C=C1)C2=CC=C(C=C2)CCOC3=C4C=CC=C(C4=NC=C3)F,,,,,,
4185,164187,4-[2-(3-Chlorophenyl)ethoxy]-8-fluoroquinoline,C1=CC(=CC(=C1)Cl)CCOC2=C3C=CC=C(C3=NC=C2)F,,,,,,
4186,164188,8-Fluoro-4-[2-(4-methylphenyl)ethoxy]quinoline,CC1=CC=C(C=C1)CCOC2=C3C=CC=C(C3=NC=C2)F,,,,,,
4187,164189,8-Fluoro-4-(2-phenylethoxy)quinoline,C1=CC=C(C=C1)CCOC2=C3C=CC=C(C3=NC=C2)F,,,,,,
4188,164190,"4-(2-(4-(1,1-Dimethylethyl)phenyl)ethoxy)-8-fluoroquinoline",CC(C)(C)C1=CC=C(C=C1)CCOC2=C3C=CC=C(C3=NC=C2)F,,,,,,
4189,164191,4-[2-(4-Butoxyphenyl)ethoxy]-8-fluoroquinoline,CCCCOC1=CC=C(C=C1)CCOC2=C3C=CC=C(C3=NC=C2)F,,,,,,
4190,164192,8-Fluoro-4-(2-(3-(trifluoromethyl)phenyl)ethoxy)quinoline,C1=CC(=CC(=C1)C(F)(F)F)CCOC2=C3C=CC=C(C3=NC=C2)F,,,,,,
4191,164193,7-Chloro-4-[1-(2-fluorophenyl)ethoxy]quinoline,CC(C1=CC=CC=C1F)OC2=C3C=CC(=CC3=NC=C2)Cl,,,,,,
4192,164194,"Benzenediazonium, 4-(dimethylamino)-, salt with 2-hydroxy-5-sulfobenzoic acid (1:1)",CN(C)C1=CC=C(C=C1)[N+]#N.C1=CC(=C(C=C1S(=O)(=O)[O-])C(=O)O)O,,,,,,
4193,164195,"2-[7-bromo-5-(2-fluorophenyl)-1-methyl-3H-1,4-benzodiazepin-2-ylidene]acetamide",CN1C(=CC(=O)N)CN=C(C2=C1C=CC(=C2)Br)C3=CC=CC=C3F,,,,,,
4194,164196,"cyclopenta-1,3-diene;1-(2,4-difluorophenyl)-3H-pyrrol-3-ide;titanium(4+)",[CH-]1C=CC=C1.[CH-]1C=CC=C1.C1=CN(C=[C-]1)C2=C(C=C(C=C2)F)F.C1=CN(C=[C-]1)C2=C(C=C(C=C2)F)F.[Ti+4],,,,,,
4195,164197,"1-(2,4-Difluorophenyl)-1h-pyrrole",C1=CN(C=C1)C2=C(C=C(C=C2)F)F,,,,,,
4196,164198,"2-[21,24-Bis(2-aminoethyl)-15-(3-aminopropyl)-3-(2-chloro-1-hydroxyethyl)-9-ethylidene-12-(1-hydroxyethyl)-18-(2-hydroxyethyl)-27-(3-hydroxytetradecanoylamino)-2,5,8,11,14,17,20,23,26-nonaoxo-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-6-yl]-2-hydroxyacetic acid",CCCCCCCCCCCC(CC(=O)NC1COC(=O)C(NC(=O)C(NC(=O)C(=CC)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CCN)CCO)CCCN)C(C)O)C(C(=O)O)O)C(CCl)O)O,,,,,,
4197,164199,Emethallicin A,C1C2=CC=C[C@@H]([C@H]2N3[C@]14C(=O)N5[C@@H]6[C@H](C=COC=C6C[C@]5(C3=O)SS4)OC(=O)[C@@H](C7=CC=CC=C7)O)OC(=O)CC8=CC=CC=C8,,,,,,
4198,164200,CID 164200,CC1C(C(=O)OC2C(C(C3(C(C(C4C(C3(C2(C)O)OC4(COC(=O)C5=C1N=CC=C5)C)OC(=O)C)OC(=O)C)OC(=O)C)COC(=O)C)OC(=O)C)OC(=O)C6=CN(C(=O)C=C6)C)C,,,,,,
4199,164201,CID 164201,CCC(C)CC1CCC(OC1C)(C(C)(C(=O)NC2C(OC(=O)C(N(C(=O)C3CCCNN3C(=O)CNC(=O)C(N(C(=O)C4CCCNN4C2=O)O)C)O)C)C(C)C)O)O,,,,,,
4200,164202,CID 164202,CCCCCCCCCCCCCCCCCCSCC(COP(O)([O-])OP(O)([O-])OC[C@@H]1[C@H]([C@@H]([C@@H](O1)N2C=CC(=NC2=O)N)O)O)OC(=O)CCCCCCCCCCCCCCC.[Na+].[Na+],,,,,,
4201,164203,CID 164203,CCCCCCCCCCCCCCCCCCSCC(COP(O)(O)OP(O)(O)OC[C@@H]1[C@H]([C@@H]([C@@H](O1)N2C=CC(=NC2=O)N)O)O)OC(=O)CCCCCCCCCCCCCCC,,,,,,
4202,164204,CID 164204,CCCCCCCCCCCCCCCCSCC(COP(O)([O-])OP(O)([O-])OC[C@@H]1[C@H]([C@@H]([C@@H](O1)N2C=CC(=NC2=O)N)O)O)OC(=O)CCCCCCCCCCCCCCC.[Na+].[Na+],,,,,,
4203,164205,CID 164205,CCCCCCCCCCCCCCCCSCC(COP(O)(O)OP(O)(O)OC[C@@H]1[C@H]([C@@H]([C@@H](O1)N2C=CC(=NC2=O)N)O)O)OC(=O)CCCCCCCCCCCCCCC,,,,,,
4204,164206,CID 164206,CC[C@@H]1CC[C@H]2C([C@H]([C@@H]([C@]3(O2)C(=O)C[C@@H]([C@@H](O3)C[C@@H](C)O)C)CC)OC(=O)C=C[C@@H]([C@H]([C@@H](C(=O)[C@@H]([C@H]([C@@H](C(=O)[C@]([C@H]([C@@H](CC=CC=C1)C)O)(C)O)C)O)C)C)O)C)C,,,,,,
4205,164207,"4-(2,2,6,6-Tetramethyl-1-oxylpiperidin-4-ylamino)-4'-demethylepipodophyllotoxin",CC1(CC(CC(N1[O])(C)C)N[C@@H]2[C@@H]3COC(=O)[C@H]3[C@H](C4=CC5=C(C=C24)OCO5)C6=CC(=C(C(=C6)OC)O)OC)C,,,,,,
4206,164208,"N-[6-(2-amino-2-oxoethyl)-12-benzyl-9-(1-hydroxyethyl)-3-(hydroxymethyl)-18-[(4-hydroxyphenyl)methylidene]-19,22-dimethyl-15-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1-oxa-4,7,10,13,16,19-hexazacyclodocos-21-yl]-3-(2-pent-1-enylphenyl)prop-2-enamide",CCCC=CC1=CC=CC=C1C=CC(=O)NC2C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(=CC3=CC=C(C=C3)O)N(C2=O)C)CC(C)C)CC4=CC=CC=C4)C(C)O)CC(=O)N)CO)C,,,,,,
4207,164209,Pentetate zinc trisodium,C(CN(CC(=O)[O-])CC(=O)[O-])N(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Na+].[Zn+2],,,"['Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)', 'Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems. (See all compounds classified as Iron Chelating Agents.)', 'Agents counteracting or neutralizing the action of POISONS. (See all compounds classified as Antidotes.)']","['Following intravenous administration, Zn-DTPA is rapidly distributed throughout the extracellular fluid space. No significant amount of Zn-DTPA penetrates into erythrocytes or other cells. No accumulation of Zn-DTPA in specific organs has been observed. There is little or no binding of the chelating agent by the renal parenchyma.', 'Zn-DTPA is poorly absorbed in the GI tract. In animal studies, after oral administration, absorption was approximately 5%. In a U.S. Registry of 18 patients who received a single inhaled or intravenous dose of 1 gram, urine data indicate that the inhaled product was absorbed and resulted in a comparable elimination of the radiocontaminant. One study of 2 human subjects that received Ca-DTPA with (14)C-DTPA by inhalation revealed approximately 20% absorption from the lungs.', 'Zn-DTPA is cleared from the plasma in the first few hours after dosing through urinary excretion by glomerular filtration. Renal tubular excretion has not been documented. In stool samples, only a very small amount of radioactivity (<3%) was detected.', 'Plasma retention and urinary excretion data were obtained in 2 subjects that received 750 kBq of (14)C-DTPA. ... The radiolabeled DTPA was rapidly distributed throughout the extracellular fluid space and was cleared by glomerular filtration. The plasma retention up to 7 hours post dosing was expressed by the sum of three exponential components with average halflives of 1.4 min, 14.5 min, and 94.4 min. The level of activity in the plasma was below the limit of detection 24 hours after injection. During the study, no detectable activity was exhaled or excreted in the feces. By 24 hours, cumulative urinary excretion was more than 99% of the injected dose. /DTPA/']",['Zn-DTPA undergoes a minimal amount of metabolic change in the body.'],
4208,164210,Manganese desferioxamine,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)[O-])[O-])[O-].[Mn],,,,,,
4209,164211,"[(2R,3S,5R)-5-(1-hydroxy-6-iminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=CN(C3=N)O)CO)OP(=O)(O)O,,,,,,
4210,164212,Alosenn,CC(C(C(=O)C(C(O)OC1=CC=CC2=C1C(=O)C3=C(C2C4C5=C(C(=CC=C5)OC(C(C(=O)C(C(C)O)O)O)O)C(=O)C6=C4C=C(C=C6O)C(=O)O)C=C(C=C3O)C(=O)O)O)O)O,,,,,,
4211,164213,"3-[(2S,8S,14S,17S)-8-benzyl-5-(1H-indol-3-ylmethyl)-14-(2-methylpropyl)-17-(2-methylsulfanylethyl)-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]propanamide",CC(C)C[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)NC(C(=O)N[C@H](C(=O)NCC(=O)N1)CC2=CC=CC=C2)CC3=CNC4=CC=CC=C43)CCC(=O)N)CCSC,,,,,,
4212,164214,Dregeoside B,CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4(C3CC(C5(C4(CCC5(C(C)O)O)O)C)OC(=O)CC(C)C)O)C)OC)OC6CC(C(C(O6)C)OC7C(C(C(C(O7)C)OC8C(C(C(C(O8)CO)O)O)O)OC)O)OC,,,,,,
4213,164215,Sigmoidin F,CC(=CCC1=C(C=C2C=CC(OC2=C1O)(C)C)[C@H]3CC(=O)C4=C(C=C(C=C4O3)O)O)C,,,,,,
4214,164216,Isomallotolerin,CC1=C(C(=C(C(=C1OC)CC2=C(C(=C(C(=C2O)C(=O)C(C)C)O)CC(C(=C)C)O)O)O)C(=O)C)O,,,,,,
4215,164217,CID 164217,CC(C)(C=NOC)C(CN1C=NC=N1)(C2=CC=C(C=C2)Cl)O,,,,,,
4216,164218,"2-[(4R,7S,13S,16R)-16-acetamido-4-carbamoyl-13-[3-(diaminomethylideneamino)propyl]-3,3,14-trimethyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetrazacycloheptadec-7-yl]acetic acid",CC(=O)N[C@H]1CSSC([C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N(C1=O)C)CCCN=C(N)N)CC(=O)O)C(=O)N)(C)C,,,,,,
4217,164219,CID 164219,CC1=CC2=C(C=C1)NC(=C2NC3=NC(=O)CS3)C4=CC=CC=C4,,,,,,
4218,164220,"Bis(pyridin-4-ylmethyl) 2,6-dimethyl-4-(6-methyl-2,3-dihydro-1,4-dithiin-5-yl)-1,4-dihydropyridine-3,5-dicarboxylate",CC1=C(C(C(=C(N1)C)C(=O)OCC2=CC=NC=C2)C3=C(SCCS3)C)C(=O)OCC4=CC=NC=C4,,,,,,
4219,164221,"4-(isobutylamino)-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride",CC(C)CNC1CCS(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N.Cl,,,['A class of compounds that reduces the secretion of H+ ions by the proximal kidney tubule through inhibition of CARBONIC ANHYDRASES. (See all compounds classified as Carbonic Anhydrase Inhibitors.)'],,,
4220,164222,CID 164222,CCCCCCCCCCCCCC=CC(C(COC1C(C(C(C(O1)CO)OC2C(C(C(C(O2)CO)OC3C(C(C(C(O3)CO)O)OC4C(C(C(C(O4)CO)O)O)O)NC(=O)C)OC5(CC(C(C(O5)C(C(CO)O)O)NC(=O)C)O)C(=O)O)O)O)O)NC(=O)C(Cl)Cl)O,,,,,,
4221,164223,"[[(2R,3S,4R,5R)-5-(6-amino-2-azidopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate",C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=C(N=C54)N=[N+]=[N-])N)O)O)O)O)C(=O)N,,,,,,
4222,164224,Nicotinamide 2-azidoadenosine dinucleotide,C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=C(N=C54)N=[N+]=[N-])N)O)O)O)O)C(=O)N,,,,,,
4223,164225,6-Acetyl-4-(3-hydroxybutyl)-2-methyl-5-methylthioresorcinol,CC1=C(C(=C(C(=C1C(=O)SC)O)C)O)CCC(C)O,,,,,,
4224,164226,"[2-[4-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]-2-oxoethyl] 3-hydroxyquinoline-2-carboxylate",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)COC(=O)C6=NC7=CC=CC=C7C=C6O)O)N)O,,,,,,
4225,164227,Cyclophellitol,C([C@@H]1[C@H]([C@@H]([C@H]([C@H]2[C@@H]1O2)O)O)O)O,,,,,,
4226,164228,CID 164228,CC(C)CCCC(C)C1CCC2C1(CCC3C2C(C=C4C3(CCC(C4)OP(=O)(O)OCC5C(CC(O5)N6C=CC(=O)NC6=O)O)C)O)C.[Na+],,,,,,
4227,164229,"[5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl [7-hydroxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen phosphate",CC(C)CCCC(C)C1CCC2C1(CCC3C2C(C=C4C3(CCC(C4)OP(=O)(O)OCC5C(CC(O5)N6C=CC(=O)NC6=O)O)C)O)C,,,,,,
4228,164230,"sodium;[5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl [7-hydroxy-17-(6-hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen phosphate",CC(CCCC(C)(C)O)C1CCC2C1(CCC3C2C(C=C4C3(CCC(C4)OP(=O)(O)OCC5C(CC(O5)N6C=CC(=O)NC6=O)O)C)O)C.[Na+],,,,,,
4229,164231,"[5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl [7-hydroxy-17-(6-hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen phosphate",CC(CCCC(C)(C)O)C1CCC2C1(CCC3C2C(C=C4C3(CCC(C4)OP(=O)(O)OCC5C(CC(O5)N6C=CC(=O)NC6=O)O)C)O)C,,,,,,
4230,164232,CID 164232,CC=C(C)C(=O)OC1C(OC(CC1O)C2=C(C3=C(C=C2)C(C4CC5C(C(=O)C(=C(N)O)C(=O)C5(C(=O)C4=C3O)OC)OC(=O)C6=CC=CC=C6O)(C)OC)O)C,,,,,,
4231,164233,Diazoluminolmelanin,C1=CC2=C(C(=C1)N)C(=O)NNC2=O.C1=CC(=C(C=C1C[C@@H](C(=O)O)N)N)O,,,,,,
4232,164234,(2R)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[2-[[(2S)-1-[(2S)-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(methylamino)acetyl]amino]pentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid,CNCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)NCC(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CO)C(=O)N4CCC[C@H]4C(=O)N[C@H](CC5=CC=CC=C5)C(=O)O,,,,,,
4233,164235,"1H-Indene-2-carbonitrile, 3-(1,1-dimethylpropyl)-1-oxo-",CCC(C)(C)C1=C(C(=O)C2=CC=CC=C21)C#N,,,,,,
4234,164236,"2-Pyrrolidinone, 1-(5-(1,1-dimethylethyl)-1H-pyrazol-3-yl)-5-hydroxy-3-methyl-",CC1CC(N(C1=O)C2=NNC(=C2)C(C)(C)C)O,,,,,,
4235,164237,"N-[(2R,3R,4R,5S,6R)-2-[[(3S,4S,5R,6S)-4-[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[(2R,3S,4R,5R)-5-acetamido-1,2,4-trihydroxy-6-oxohexan-3-yl]oxy-3,5-dihydroxyoxan-2-yl]methoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide",CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OCC2[C@@H]([C@@H]([C@H]([C@@H](O2)O[C@H]([C@@H](CO)O)[C@@H]([C@H](C=O)NC(=O)C)O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)NC(=O)C)O)CO)O)O,,,,,,
4236,164238,"9-(2-Chlorophenyl)-14-hexadecylsulfonyl-3-methyl-17-thia-2,4,5,8,14-pentazatetracyclo[8.7.0.02,6.011,16]heptadeca-1(10),3,5,8,11(16)-pentaene",CCCCCCCCCCCCCCCCS(=O)(=O)N1CCC2=C(C1)SC3=C2C(=NCC4=NN=C(N43)C)C5=CC=CC=C5Cl,,,,,,
4237,164239,"[3-Azido-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl 2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl hydrogen phosphate",CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OCCOC3C(C(C(C(O3)CO)O)O)O)N=[N+]=[N-],,,,,,
4238,164240,CID 164240,CC=C(C)[C@@H]1[C@H](C[C@H]([C@@]2(O1)C[C@@H]3C[C@H](O2)CC=C(C([C@H](C=CC=C4CO[C@H]5[C@@]4(C(C=C([C@H]5O)C)C(=O)O3)O)C)OC(=O)C(C)C)C)O)C,,,,,,
4239,164241,CID 164241,CC=C(C)[C@@H]1[C@H](C[C@H]([C@@]2(O1)C[C@@H]3C[C@H](O2)CC=C(C([C@H](C=CC=C4CO[C@H]5[C@@]4(C(C=C([C@H]5OC)C)C(=O)O3)O)C)OC(=O)C(C)C)C)O)C,,,,,,
4240,164242,CID 164242,CC=C(C)[C@@H]1[C@H](C([C@H]([C@@]2(O1)C[C@@H]3C[C@H](O2)CC=C(C([C@H](C=CC=C4CO[C@H]5[C@@]4(C(C=C([C@H]5O)C)C(=O)O3)O)C)OC(=O)C(C)C)C)O)OC(=O)C(C)C)C,,,,,,
4241,164243,CID 164243,CC=C(C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)CC=C(C([C@H](C=CC=C4CO[C@H]5[C@@]4(C(C=C([C@H]5O)C)C(=O)O3)O)C)OC(=O)C(C)C)C)C,,,,,,
4242,164244,1-(m-Astatobenzyl)guanidine,C1=CC(=CC(=C1)[211At])CN=C(N)N,,,,,,
4243,164245,Calystegine B1,C1[C@H]2[C@@H](C[C@](N2)([C@H]([C@@H]1O)O)O)O,,,,,,
4244,164246,"[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 2,2,2-triphenylethyl hydrogen phosphate",C1=CC=C(C=C1)C(COP(=O)(O)OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC(=O)NC3=O)O)O)(C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
4245,164247,"4-[2-[5-[5-[2-Hydroxy-5-(1-hydroxypropyl)-3,5-dimethyloxolan-2-yl]-3-methyloxolan-2-yl]-3-(5-methoxy-6-methyloxan-2-yl)oxy-5-methyloxolan-2-yl]-7-methoxy-2,6,8-trimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-3-methoxy-2-methylpentanoic acid",CCC(C1(CC(C(O1)(C2CC(C(O2)C3(CC(C(O3)C4(CCC5(O4)C(C(C(C(O5)C(C)C(C(C)C(=O)O)OC)C)OC)C)C)OC6CCC(C(O6)C)OC)C)C)O)C)C)O,,,,,,
4246,164248,CID 164248,CCCC[C@@H](C(=O)NCC(=O)N(CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCCC)C(=O)NC(=O)C3=CC=CC=C3C[C@H](C)NC(=O)[C@H](CC(=O)O)NC)NC(=O)CCC4=CC=C(C=C4)OS(=O)(=O)O,,,,,,
4247,164249,CID 164249,CC1=NC=C(C(=C1[O-])C=NN=C(N)[S-])CO.O.Cl.[Cu+2],,,,,,
4248,164250,"[(5S,6S,7S,8R,9S,13S,14S,15S,18S)-8,14,18-trihydroxy-19-[(2S,3R,4S,5R)-4-hydroxy-3,5-dimethyl-6-oxooxan-2-yl]-5,7,9,11,13,15-hexamethylnonadeca-1,3,11,16-tetraen-6-yl] carbamate",C[C@H]1[C@@H](OC(=O)[C@@H]([C@H]1O)C)C[C@@H](C=C[C@H](C)[C@@H]([C@@H](C)C=C(C)C[C@H](C)[C@H]([C@H](C)[C@H]([C@@H](C)C=CC=C)OC(=O)N)O)O)O,,,,,,
4249,164251,"N,N-Dimethylpradimicin E",CC1C(C(C(C(O1)OC2C(C3=CC4=C(C(=C3C5=C2C=C(C(=C5O)C(=O)NCC(=O)O)C)O)C(=O)C6=C(C4=O)C(=CC(=C6)OC)O)O)O)OC7C(C(C(CO7)O)O)O)N(C)C,,,,,,
4250,164252,"5-(2,3-Dihydrobenzofuran-7-yl)-3-methyl-8-nitro-2,3,4,5-tetrahydro-1H-3-benzazepin-7-ol",CN1CCC2=CC(=C(C=C2[C@H](C1)C3=CC=CC4=C3OCC4)O)[N+](=O)[O-],"['Investigated for use/treatment in sleep disorders, smoking cessation, and substance abuse.']",,,,,
4251,164253,Methylpheophorbide-a-(hexyl-ether),CCCCCCOC(C)C1=C(C2=NC1=CC3=NC(=CC4=C(C5=C([C@@H](C(=C6[C@H]([C@@H](C(=C2)N6)C)CCC(=O)OC)C5=N4)C(=O)OC)O)C)C(=C3C)CC)C,,,,,,
4252,164254,N-[[1-methyl-3-[(3-methyl-3-nitrobutoxy)methyl]imidazol-1-ium-2-yl]methylidene]hydroxylamine;chloride,CC(C)(CCOCN1C=C[N+](=C1C=NO)C)[N+](=O)[O-].[Cl-],,,,,,
4253,164255,N-[[1-methyl-3-[(3-methyl-3-nitrobutoxy)methyl]imidazol-1-ium-2-yl]methylidene]hydroxylamine,CC(C)(CCOCN1C=C[N+](=C1C=NO)C)[N+](=O)[O-],,,,,,
4254,164256,"2-Amino-3,4,14-trihydroxy-2-hydroxymethyl-6-eicosenoic acid",CCCCCCC(CCCCCCC=CCC(C(C(CO)(C(=O)O)N)O)O)O,,,,,,
4255,164257,"(2S)-1-N-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]-2-N-[(2S)-1-[[(2S)-1-[[(4S,5S,7S)-5-hydroxy-2,8-dimethyl-7-[[(2S,3S)-3-methyl-1-[(1-oxidopyridin-1-ium-2-yl)methylamino]-1-oxopentan-2-yl]carbamoyl]nonan-4-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-methylamino]-1-oxo-3-phenylpropan-2-yl]pyrrolidine-1,2-dicarboxamide",CC[C@H](C)[C@@H](C(=O)NCC1=CC=CC=[N+]1[O-])NC(=O)[C@@H](C[C@@H]([C@H](CC(C)C)NC(=O)[C@H](CC2=CN=CN2)N(C)C(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@@H]4CCCN4C(=O)NC(CO)(CO)CO)O)C(C)C,,,,,,
4256,164258,2-(Nitrooxy)ethyl apovincaminate,CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4C(=C2)C(=O)OCCO[N+](=O)[O-],,,,,,
4257,164259,Tin(IV) chlorin e6,[H+].CCC1=C(C2=CC3=NC(=CC4=NC(=C(C5=NC(=C(C5=C([O-])[O-])C)C=C1[N-]2)CC(=O)[O-])C(C4C)CCC(=O)[O-])C(=C3C=C)C)C.[Sn+4],,,,,,
4258,164260,1-(3-Bromobenzo[B]furan-2-ylsulfonyl)hydantoin,C1C(=O)NC(=O)N1S(=O)(=O)C2=C(C3=CC=CC=C3O2)Br,,,,,,
4259,164261,CID 164261,CCCCCCCCCCCCCC=C[C@H]([C@H](CO[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)OS(=O)(=O)O)O)NC(=O)CCCCCCCCCCCNS(=O)(=O)C2=CC(=C(C=C2)C3=C4C=CC(=[N+](CC)CC)C=C4OC5=C3C=CC(=C5)N(CC)CC)S(=O)(=O)[O-])O,,,,,,
4260,164262,CID 164262,CCCCCCCCCCCCCC=C[C@H]([C@H](CO[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)OS(=O)(=O)O)O)NC(=O)CCCCCCCCCCCNS(=O)(=O)C2=CC(=C(C=C2)C3=C4C=CC(=[N+](CC)CC)C=C4OC5=C3C=CC(=C5)N(CC)CC)S(=O)(=O)O)O,,,,,,
4261,164263,Tetrachloroplatinate dianion-methyl green complex,CC[N+](C)(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C.[Cl-].[Cl-].[Cl-].[Cl-].[Pt+2],,,,,,
4262,164264,Boc-Asp-Ofm,CC(C)(C)OC(=O)N[C@@H](CC(=O)O)C(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13,,,,,,
4263,164265,CID 164265,CC(=CCO[C@H]1COC2=C(C=C(C=C2)C=CC=C(C)C(=COC)C(=O)OC)OC1(C)C)C,,,,,,
4264,164266,"Methyl 2-(methoxymethylidene)-6-(3-methoxyphenyl)-3-methylhexa-3,5-dienoate",CC(=CC=CC1=CC(=CC=C1)OC)C(=COC)C(=O)OC,,,,,,
4265,164267,"1,4-Benzenedicarboxaldehyde, polymer with benzenamine and 2-methylbenzenamine, maleated",CC1=CC=CC=C1N.C1=CC=C(C=C1)N.C1=CC(=CC=C1C=O)C=O,,,,,,
4266,164268,I-Admp-platinum,CP(=O)(C)CN.N.[Cl-].[Cl-].[Pt+2],,,,,,
4267,164269,"Methanamine, 1-(dimethylphosphinyl)-",CP(=O)(C)CN,,,,,,
4268,164270,II-Dmpb-platinum,CP(=O)(CN)CN.[Cl-].[Cl-].[Pt+2],,,,,,
4269,164271,Methylbis(aminomethyl)phosphine oxide,CP(=O)(CN)CN,,,,,,
4270,164272,1-(3-(Naphth-2-ylmethoxy)phenyl)-1-(thiazol-2-yl)propyl methyl ether,CCC(C1=CC(=CC=C1)OCC2=CC3=CC=CC=C3C=C2)(C4=NC=CS4)OC,,,,,,
4271,164273,Succinyl-tyrosyl-glutamyl-prolyl-isoleucyl-prolyl-glutamyl-glutamyl-alanyl-beta-cyclohexylalanyl-glutamine,CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@H](CCC(=O)O)C(=O)O)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)CCC(=O)O,,,,,,
4272,164274,Goniopypyrone,C1[C@H]2C([C@H]([C@@H]([C@@H](O2)C3=CC=CC=C3)O)OC1=O)O,,,,,,
4273,164275,Ammine dibenzoatodichloro(propylamine)platinum IV,CCCN.C1=CC=C(C=C1)C(=O)[O-].C1=CC=C(C=C1)C(=O)[O-].N.[Cl-].[Cl-].[Pt+4],,,,,,
4274,164276,4-{(1Z)-1-{4-[2-(Dimethylamino)ethoxy]phenyl}-2-[4-(propan-2-yl)phenyl]but-1-en-1-yl}phenol,CCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)OCCN(C)C)C3=CC=C(C=C3)C(C)C,,,,,,
4275,164277,CID 164277,CC1C(NC(=O)C(NC(=O)C(C(NC(=O)C(NC(=O)C(NC(=O)C(N(C(=O)CCC(NC1=O)C(=O)O)C)C)C)CC(C)C)C(=O)O)C)CCCN=C(N)N)C=CC(=CC(C)C(CC2=CC=CC=C2)OC)C,,,,,,
4276,164278,"(2S)-2-[[2-[[2-[[(2S)-2-[[(2S)-4-amino-2-[[(2R)-3-[2,3-di(hexadecanoyloxy)propylsulfanyl]-2-(hexadecanoylamino)propanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]acetyl]amino]-3-hydroxypropanoic acid",CCCCCCCCCCCCCCCC(=O)N[C@@H](CSCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)O,,,,,,
4277,164279,"[(2R,2aR,4aR,7aR,7bS)-3-formyl-4a-hydroxy-6,6,7b-trimethyl-1,2,2a,5,7,7a-hexahydrocyclobuta[e]inden-2-yl] 2-hydroxy-4-methoxy-6-methylbenzoate",CC1=CC(=CC(=C1C(=O)O[C@@H]2C[C@]3([C@@H]2C(=C[C@]4([C@@H]3CC(C4)(C)C)O)C=O)C)O)OC,,,,,,
4278,164280,CID 164280,C[C@@H](CCC=C(C)CCC=C(C)C)C=CC(=O)NC[C@@H]1CC[N@+]2([C@@H]1CCCC2)C,,,,,,
4279,164281,"Bis(2,2,6,6-tetramethyl-4-piperidyl) Decanedioate; 2-hydroperoxy-2-methyl-propane; Octane",CCCCCCCC.CC1(CC(CC(N1)(C)C)OC(=O)CCCCCCCCC(=O)OC2CC(NC(C2)(C)C)(C)C)C.CC(C)(C)OO,,,,,,
4280,164282,"Bis(2,2,6,6-tetramethyl-4-piperidyl) sebacate",CC1(CC(CC(N1)(C)C)OC(=O)CCCCCCCCC(=O)OC2CC(NC(C2)(C)C)(C)C)C,,,,,,
4281,164283,(2S)-2-amino-5-[[(2R)-3-(2-amino-5-hydroxyphenyl)sulfanyl-1-(carboxymethylamino)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid,C1=CC(=C(C=C1O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)N,,,,,,
4282,164284,Tetrachloroplatinate dianion-basic fuchsin complex,[H+].[H+].C1=CC(=N)C=CC1=C(C2=CC=C(C=C2)N)C3=CC=C(C=C3)N.C1=CC(=N)C=CC1=C(C2=CC=C(C=C2)N)C3=CC=C(C=C3)N.[Cl-].[Cl-].[Cl-].[Cl-].[Pt+2],,,,,,
4283,164285,"2-(Acetylamino)-2,4-dideoxy-4-fluoro-alpha-D-glucopyranose 1,3,6-triacetate",CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1OC(=O)C)COC(=O)C)F)OC(=O)C,,,,,,
4284,164286,Ac-Leu-Asp-Gln-Trp-Phe-Gly-NH2,CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)NCC(=O)N)NC(=O)C,,,,,,
4285,164287,Cyclo-(pec1-meval2-val3-(O-t-Bu-measp4)-melle5-melle6-gly7-meval8-(O-Me-tyr)-L-hpa10),CC[C@H](C)[C@H]1C(=O)NCC(=O)N([C@H](C(=O)N[C@H](C(=O)O[C@H](C(=O)N2CCCC[C@H]2C(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N(C(C(=O)N1C)[C@@H](C)CC)C)CC(=O)OC(C)(C)C)C)C(C)C)C(C)C)C)C)CC3=CC=C(C=C3)OC)C(C)C)C,,,,,,
4286,164288,"Furan, 2-((2,3,4,5-tetrachloro-2,4-cyclopentadien-1-ylidene)methyl)-",C1=COC(=C1)C=C2C(=C(C(=C2Cl)Cl)Cl)Cl,,,,,,
4287,164289,AF1 Neuropeptide,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCCN)N,,,,,,
4288,164290,CID 164290,CCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)[C@@H](C)NC(=O)CC[C@H](C(=O)N)NC(=O)[C@@H](C)NC(=O)[C@H](C)O[C@H]([C@H](C=O)NC(=O)C)C([C@@H](CO)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)NC(=O)C)OC(=O)CCCCCCCCCCCCCCC,,,,,,
4289,164291,CID 164291,CC(C)(C)C1=CC(=CC(=C1[O-])C(C)(C)C)C2=NN=C(S2)S.C[N+](C)(C)CCO,,,,,,
4290,164292,CID 164292,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C2=NN=C(S2)S,,,,,,
4291,164293,Saenta,C1=CC(=CC=C1CNC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CSCCN)O)O)[N+](=O)[O-],,,,,,
4292,164294,"1,2,4-Benzotriazine, 1,2-dihydro-1-methyl-6-(trifluoromethyl)-",CN1C2=C(C=C(C=C2)C(F)(F)F)N=CN1,,,,,,
4293,164295,"1,2,4-Benzotriazine-6-carbonitrile, 1,2-dihydro-1-propyl-3-(trifluoromethyl)-",CCCN1C2=C(C=C(C=C2)C#N)N=C(N1)C(F)(F)F,,,,,,
4294,164296,CID 164296,CCCCCCCCC=CCCCCCCCCNC1=NC(=O)N(C=C1)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
4295,164297,CID 164297,C1[C@@H]([C@H](O[C@H]1N2C3=C(C(=O)N=CN3)N=C2NC4=CC5=C(C=C4)C6=CC=CC=C6C5)COP(=O)(O)O)OP(=O)(O)O,,,,,,
4296,164298,CID 164298,CC1CCC2(CCCCO2)OC1C(C)CC(C3C(=C)C(C4C(O3)CCC5(O4)CCC(O5)C=CC(C)C6CC(=CC7(O6)C(CCC(O7)CC(C)(C(=O)OC)O)OC(=O)C8=CC=C(C=C8)N=[N+]=[N-])C)O)O,,,,,,
4297,164299,CID 164299,CC1CCC2(CCCCO2)OC1C(C)CC(C3C(=C)C(C4C(O3)CCC5(O4)CCC(O5)C=CC(C)C6CC(=CC7(O6)C(CCC(O7)CC(C)(C(=O)OC)O)OC(=O)C8=CC=C(C=C8)N[N+]#N)C)O)O,,,,,,
4298,164300,Euglobal G3,CC(C)CC(=O)C1=C(C(=C2C(=C1O)CC[C@]3(O2)CC[C@H]4C[C@@H]3C4(C)C)C=O)O,,,,,,
4299,164301,"L-Aspartic acid, monoammonium salt",C([C@@H](C(=O)O)N)C(=O)[O-].[NH4+],,,,,,
4300,164302,"(2S)-2-amino-5-[[(2R)-2-amino-3-[[3-(2-aminoethyl)-4,5-dioxo-1H-indol-7-yl]sulfanyl]propanoyl]-(carboxymethyl)amino]-5-oxopentanoic acid",C1=C(C2=C(C(=CN2)CCN)C(=O)C1=O)SC[C@@H](C(=O)N(CC(=O)O)C(=O)CC[C@@H](C(=O)O)N)N,,,,,,
4301,164303,CID 164303,C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)OC[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)OC3=C(OC4=CC(=O)C=C(C4=C3O)O)C5=CC(=C(C=C5)O)O)O)O)O[C@@H]6[C@@H]([C@@H]([C@H]([C@@H](O6)CO)O)O)O)O)O)O,,,,,,
4302,164304,N-Methylmesoporphyrin IX,CCC1=C(C2=CC3=NC(=CC4=C(C(=C(N4C)C=C5C(=C(C(=N5)C=C1N2)C)CC)C)CCC(=O)O)C(=C3C)CCC(=O)O)C,,,,,,
4303,164305,Sdz-wag-994,CO[C@@H]1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)NC4CCCCC4)CO)O,,,,,,
4304,164306,1-[2-Methylsulfanyl-1-(2-pentoxyphenyl)ethenyl]imidazole hydrochloride,CCCCCOC1=CC=CC=C1C(=CSC)N2C=CN=C2.Cl,,,,,,
4305,164307,"N-[2-[9-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]ethylideneamino]acetamide",CCC1C(C2C(O2)(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC3C(C(CC(O3)C)N(C)C)O)CC=NNC(=O)C)C)C)C,,,,,,
4306,164308,"2-Amino-3-[2-[9-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]-1-hydroxyethyl]sulfanylpropanoic acid",CCC1C(C2C(O2)(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC3C(C(CC(O3)C)N(C)C)O)CC(O)SCC(C(=O)O)N)C)C)C,,,,,,
4307,164309,"9-[4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-10-(4-oxopent-2-enyl)-4,17-dioxabicyclo[14.1.0]heptadec-14-ene-5,13-dione",CCC1C(C2C(O2)(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC3C(C(CC(O3)C)N(C)C)O)CC=CC(=O)C)C)C)C,,,,,,
4308,164310,Net-opc,CC1=C2C=CN(C=C2C(=C3C1[NH2+]C4=C3C5=C(C=C4)OC(=N5)CCCCC(=O)NC6=CN(C(=C6)C(=O)NC7=CN(C(=C7)C(=O)NCCC(=N)N)C)C)C)C.CC(=O)O.CC(=O)[O-],,,,,,
4309,164311,"N-[5-[(3-amino-3-iminopropyl)carbamoyl]-1-methylpyrrol-3-yl]-1-methyl-4-[5-(13,17,20-trimethyl-6-oxa-4,11,17-triazapentacyclo[10.8.0.02,10.03,7.014,19]icosa-1(20),2(10),3(7),4,8,13,15,18-octaen-5-yl)pentanoylamino]pyrrole-2-carboxamide",CC1=C2C=CN(C=C2C(=C3C1NC4=C3C5=C(C=C4)OC(=N5)CCCCC(=O)NC6=CN(C(=C6)C(=O)NC7=CN(C(=C7)C(=O)NCCC(=N)N)C)C)C)C,,,,,,
4310,164312,Hbdcp,C1[C@@H]([C@H](O[C@H]1N2C=CC3=NC4=C(N3C2=O)C=CC(=C4)O)CO)OP(=O)(O)O,,,,,,
4311,164313,Pneumadin,C[C@@H](C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC2=CC=C(C=C2)O)N,,,,,,
4312,164314,Tris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate,C[N+](C)(C)C.C[N+](C)(C)C.C[N+](C)(C)C.C1=CC(=CC=C1N=NC2C(=NN(C2=O)C3=CC=C(C=C3)S(=O)(=O)O)C(=O)O)S(=O)(=O)O,,,,,,
4313,164315,"Methanaminium, N,N,N-trimethyl-, salt with 3,3'-((6-((2-hydroxyethyl)amino)-1,3,5-triazine-2,4-diyl)bis(imino(2-methyl-4,1-phenylene)azo))bis(1,5-naphthalenedisulfonic acid) (4:1)",CC1=C(C=CC(=C1)NC2=NC(=NC(=N2)NCCO)NC3=CC(=C(C=C3)N=NC4=CC5=C(C=CC=C5S(=O)(=O)O)C(=C4)S(=O)(=O)O)C)N=NC6=CC7=C(C=CC=C7S(=O)(=O)O)C(=C6)S(=O)(=O)O.C[N+](C)(C)C.C[N+](C)(C)C.C[N+](C)(C)C.C[N+](C)(C)C,,,,,,
4314,164316,"3-[[4-[[4-[4-[(4,8-Disulfonaphthalen-2-yl)diazenyl]-3-methylanilino]-6-(2-hydroxyethylamino)-1,3,5-triazin-2-yl]amino]-2-methylphenyl]diazenyl]naphthalene-1,5-disulfonic acid",CC1=C(C=CC(=C1)NC2=NC(=NC(=N2)NCCO)NC3=CC(=C(C=C3)N=NC4=CC5=C(C=CC=C5S(=O)(=O)O)C(=C4)S(=O)(=O)O)C)N=NC6=CC7=C(C=CC=C7S(=O)(=O)O)C(=C6)S(=O)(=O)O,,,,,,
4315,164317,CID 164317,C[C@H]1[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)C(=C)NC(=O)CC[C@@H](NC1=O)C(=O)O)C)CCCN=C(N)N)C(=O)O)C)CCCN=C(N)N)C=CC(=C[C@H](C)[C@H](CC2=CC=CC=C2)OC)C,,,,,,
4316,164318,"4-chloro-N-(4-chlorophenyl)-2,2-dimethylbut-3-enamide",CC(C)(C=CCl)C(=O)NC1=CC=C(C=C1)Cl,,,,,,
4317,164319,Caldiamide sodium,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Na+].[Ca+2],,,,,,
4318,164320,CID 164320,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O[C@@H]4[C@H](O[C@H]([C@@H]4F)N5C=NC6=C5NC(=NC6=O)N)COP(=O)(O)O[C@@H]7[C@H](O[C@H]([C@@H]7O)N8C=NC9=C(N=CN=C98)N)CO)O)O)N,,,,,,
4319,164321,"4-[4-(2,6,6-Trimethylcyclohexen-1-yl)but-3-en-1-ynyl]benzoic acid",CC1=C(C(CCC1)(C)C)C=CC#CC2=CC=C(C=C2)C(=O)O,,,,,,
4320,164322,"9-ethyl-6,9,11-trihydroxy-7-(5-hydroxy-6-methyl-4-morpholin-4-yloxan-2-yl)oxy-8,10-dihydro-7H-tetracene-5,12-dione",CCC1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=CC=CC=C4C3=O)O)OC5CC(C(C(O5)C)O)N6CCOCC6)O,,,,,,
4321,164323,Peptide 74,C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O,,,,,,
4322,164324,Glabredelphinine,CCN1C[C@@]2(C=C[C@@H](C34[C@@H]2[C@@H](C(C31)([C@]5(C[C@@H]([C@H]6C[C@@H]4[C@@H]5[C@H]6O)OC)O)O)O)O)C,,,,,,
4323,164325,Hippocrateine I,CC1C(C(=O)OC2C(C(C3(C(C(C4C(C3(C2(C)O)OC4(COC(=O)C5=C1N=CC=C5)C)OC(=O)C)OC(=O)C)OC(=O)C)COC(=O)C)OC(=O)C6=CC=CC=C6)OC(=O)C7=CN(C(=O)C=C7)C)C,,,,,,
4324,164326,Hippocrateine II,CCC(C)C(=O)OCC12C(C(C3C(C14C(C(C(C2OC(=O)C5=CC=CC=C5)OC(=O)C6=CN(C(=O)C=C6)C)OC(=O)C(C(C7=C(C=CC=N7)C(=O)OCC3(O4)C)C)C)(C)O)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
4325,164327,CID 164327,CC1C=CC=C(C(=O)N=C2C(=CNOCCOC3=CC=CC=C3)C(=C4C(=C2O)C(=C(C5=C4C(=O)C(O5)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C,,,,,,
4326,164328,"(1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,11a-tetramethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a,8-dicarboxylic acid",CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CCC(C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C(=O)O)O)C)C(=O)O,,,,,,
4327,164329,"LHRH, his(6)-N-Et-pronh2(9)-",CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC2=CN=CN2)NC(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC4=CNC5=CC=CC=C54)NC(=O)[C@H](CC6=CN=CN6)NC(=O)[C@@H]7CCC(=O)N7,,,,,,
4328,164330,Pt-Bis-netropsin,CCCN1C=C(C=C1C(=O)NC2=CN(C(=C2)C(=O)NCCCN(C)C)CCC)NC(=O)CN.CCCN1C=C(C=C1C(=O)NC2=CN(C(=C2)C(=O)NCCCN(C)C)CCC)NC(=O)CN.N.N.[N+](=O)(O)[O-].[N+](=O)(O)[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Pt+2],,,,,,
4329,164331,N-[3-(Dimethylamino)propyl]-1-propyl-4-[[[1-propyl-4-(aminoacetylamino)-1H-pyrrole-2-yl]carbonyl]amino]-1H-pyrrole-2-carboxamide,CCCN1C=C(C=C1C(=O)NC2=CN(C(=C2)C(=O)NCCCN(C)C)CCC)NC(=O)CN,,,,,,
4330,164332,"22,28-Diethyl-7,11,14,15-tetrahydroxy-6'-(2-hydroxypropyl)-5',6,8,10,12,14,16,29-octamethylspiro[2,26-dioxabicyclo[23.3.1]nonacosa-4,18,20-triene-27,2'-oxane]-3,9,13-trione",CCC1CCC2C(C(C(C3(O2)CCC(C(O3)CC(C)O)C)CC)OC(=O)C=CC(C(C(C(=O)C(C(C(C(=O)C(C(C(CC=CC=C1)C)O)(C)O)C)O)C)C)O)C)C,,,,,,
4331,164333,3-[(1-Tert-butoxypropan-2-yl)oxy]propan-1-ol,CC(COC(C)(C)C)OCCCO,,,,,,
4332,164334,Schweinine,CC(=O)OC1=C2C=C(C=C1)[C@H]3CC(=O)NCCCN(CCCCNCCCN3)C(=O)[C@H]2CC4=CC=C(C=C4)O,,,,,,
4333,164335,CID 164335,CC(C)[C@H]1C(=O)N[C@@H](CC2=CNC3=C(C=CC(=C23)N1C)[C@](C)(CC=CC(C)(C)O)C=C)CO,,,,,,
4334,164336,CID 164336,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OC[C@@H]3[C@H]([C@@H]([C@@H]([C@H](O3)O)O)O)O)N=[N+]=[N-].[Na+],,,,,,
4335,164337,"[3-azido-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl [(2R,3S,4S,5S,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl hydrogen phosphate",CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OC[C@@H]3[C@H]([C@@H]([C@@H]([C@H](O3)O)O)O)O)N=[N+]=[N-],,,,,,
4336,164338,CID 164338,CC1=CC(=C(C=C1S(=O)(=O)[O-])OC)NC(=O)CC(=O)C.[Na+],,,,,,
4337,164339,"[[(2R,3S,5R)-5-(5-amino-4-carbamoylimidazol-1-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate",C1[C@@H]([C@H](O[C@H]1N2C=NC(=C2N)C(=O)N)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,,,,,,
4338,164340,"2,3-Bis(14-pyren-1-yltetradecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate",C[N+](C)(C)CCOP(=O)([O-])OCC(COC(=O)CCCCCCCCCCCCCC1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C=C1)OC(=O)CCCCCCCCCCCCCC5=C6C=CC7=CC=CC8=C7C6=C(C=C8)C=C5,,,,,,
4339,164341,"2-[2,3-Bis(14-pyren-1-yltetradecanoyloxy)propoxy-hydroxyphosphoryl]oxyethyl-trimethylazanium",C[N+](C)(C)CCOP(=O)(O)OCC(COC(=O)CCCCCCCCCCCCCC1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C=C1)OC(=O)CCCCCCCCCCCCCC5=C6C=CC7=CC=CC8=C7C6=C(C=C8)C=C5,,,,,,
4340,164342,Lamotrigine N2-glucuronide,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C([N+](=N2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O)N)N,,,,,,
4341,164343,"Formic acid, compd. with 2-[[4-[3-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]phenyl]sulfonyl]-N,N-dimethylethanamine (1:1)",CN(C)CCS(=O)(=O)C1=CC=C(C=C1)N2CCC(=N2)C3=CC=C(C=C3)Cl.C(=O)O,,,,,,
4342,164344,"Methyl 2-[(1S,3S,5S,7S,8S,9R,11S,12S,13R,16S)-5,11-diacetyloxy-13-(furan-3-yl)-16-hydroxy-6,6,8,12-tetramethyl-17-methylidene-15-oxo-2,14-dioxatetracyclo[7.7.1.01,12.03,8]heptadecan-7-yl]acetate",CC(=O)O[C@H]1C[C@H]2C(=C)[C@@]3([C@@]1([C@H](OC(=O)[C@H]3O)C4=COC=C4)C)O[C@@H]5[C@]2([C@H](C([C@H](C5)OC(=O)C)(C)C)CC(=O)OC)C,,,,,,
4343,164345,"4,4,6,6-Tetrakis(aziridin-1-yl)spiro[1,3,5-triaza-2lambda5,4lambda5,6lambda5-triphosphacyclohexa-1,3,5-triene-2,2'-1,3-dihydro-1,3,2lambda5-benzodiazaphosphole]",C1CN1P2(=NP(=NP3(=N2)NC4=CC=CC=C4N3)(N5CC5)N6CC6)N7CC7,,,,,,
4344,164346,"Methanesulfonamide, N-(2-chloro-5-(3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl)-4-fluorophenyl)-N-methyl-",CN1C(=CC(=O)N(C1=O)C2=CC(=C(C=C2F)Cl)N(C)S(=O)(=O)C)C(F)(F)F,,,,,,
4345,164347,"2,4(1H,3H)-Pyrimidinedione, 3-(4-chloro-3-(1-methylethoxy)phenyl)-1-methyl-6-(trifluoromethyl)-",CC(C)OC1=C(C=CC(=C1)N2C(=O)C=C(N(C2=O)C)C(F)(F)F)Cl,,,,,,
4346,164348,"Benzoic acid, 2-chloro-5-(6,7-dihydro-2,4-dioxo-2H-thiazolo(3,2-a)-1,3,5-triazin-3(4H)-yl)-4-fluoro-, 1-methylethyl ester",CC(C)OC(=O)C1=CC(=C(C=C1Cl)F)N2C(=O)N=C3N(C2=O)CCS3,,,,,,
4347,164349,"Benzoic acid, 2-chloro-5-(3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl)-, 2-fluoro-1-(fluoromethyl)ethyl ester",CN1C(=CC(=O)N(C1=O)C2=CC(=C(C=C2)Cl)C(=O)OC(CF)CF)C(F)(F)F,,,,,,
4348,164350,"Methanesulfonamide, N-(2-chloro-5-(3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl)phenyl)-",CN1C(=CC(=O)N(C1=O)C2=CC(=C(C=C2)Cl)NS(=O)(=O)C)C(F)(F)F,,,,,,
4349,164351,CID 164351,CC[C@@H]1C=C(C[C@@H](CC([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC1=O)O)C)C(=CC4CC[C@H]([C@@H](C4)OC)O)C)O)C)OC)OC)C)C,,,,,,
4350,164352,"9-[4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy-7-[4-(dimethylamino)-5-[5-(5-hydroxy-6-methyloxan-2-yl)oxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-9-ethyl-1,6,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione",CCC1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C(=CC=C4)O)O)OC5CC(C(C(O5)C)OC6CCC(C(O6)C)OC7CCC(C(O7)C)O)N(C)C)OC8CC(C(C(O8)C)O)N(C)C,,,,,,
4351,164353,"tert-butyl N-[1-[[2-[[5-[[1-[(6-amino-2-methylpyrimidin-4-yl)methylamino]-3-methyl-1-oxopentan-2-yl]amino]-1-cyclohexyl-3-hydroxy-5-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-(2,6-ditritiophenyl)-1-oxopropan-2-yl]carbamate",[3H]C1=C(C(=CC=C1)[3H])CC(C(=O)NCC(=O)NC(CC2CCCCC2)C(CC(=O)NC(C(C)CC)C(=O)NCC3=CC(=NC(=N3)C)N)O)NC(=O)OC(C)(C)C,,,,,,
4352,164354,CID 164354,CC[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)CC=C(C([C@H](C=CC=C4CO[C@H]5[C@@]4(C(C=C([C@H]5O)C)C(=O)O3)O)C)O)CO)C,,,,,,
4353,164355,"3-(4-Ethylphenyl)-2,2-dimethylpropanenitrile",CCC1=CC=C(C=C1)CC(C)(C)C#N,,,,,,
4354,164356,"Oxirane, methyl-, polymer with oxirane, mono(3-(1,3,3,3-tetramethyl-1-((trimethylsilyl)oxy)disiloxanyl)propyl) ether",CC1CO1.C[Si](C)(C)O[Si](C)(CCCO)O[Si](C)(C)C.C1CO1,,,,,,
4355,164357,3-(3-Hydroxypropyl)heptamethyltrisiloxane,C[Si](C)(C)O[Si](C)(CCCO)O[Si](C)(C)C,,,,,,
4356,164358,CID 164358,CCCCC[C@@H](C=CC1=C(C(=O)CC1)CC=CCCCC(=O)O)O.C([C@@H]([C@@H]1C(=O)C(=C(O1)O)O)O)O,,,,,,
4357,164359,"6-(1,2-Dihydroxyethyl)-5-[6-(1,2-dihydroxyethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-4-hydroxy-2-[2-hydroxy-6-oxo-3-phosphonooxy-5-(3-tetradecanoyloxytetradecanoylamino)-4-(3-tetradecanoyloxytetradecanoyloxy)hexoxy]oxane-2-carboxylic acid",CCCCCCCCCCCCCC(=O)OC(CCCCCCCCCCC)CC(=O)NC(C=O)C(C(C(COC1(CC(C(C(O1)C(CO)O)OC2C(C(C(C(O2)C(CO)O)O)O)O)O)C(=O)O)O)OP(=O)(O)O)OC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC,,,,,,
4358,164360,9beta-Hydroxymarasmic acid,CC1(C[C@@H]2[C@]3(C[C@]3(C(=C[C@@]2(C1)O)C=O)C=O)C(=O)O)C,,,,,,
4359,164361,"Diamine((bis-(phosphonatomethyl)amino)acetato(2-)-O(1),N(1))platinum(II)",[H+].[H+].[H+].C(C(=O)[O-])N(CP(=O)([O-])[O-])CP(=O)([O-])[O-].N.N.[Pt],,,,,,
4360,164362,"Phenol, 2,4-dimethyl-6-(1-methylpentadecyl)-",CCCCCCCCCCCCCCC(C)C1=CC(=CC(=C1O)C)C,,,,,,
4361,164363,CID 164363,C[C@H]1[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)CNC(=O)CC[C@@H](NC1=O)C(=O)O)C)CC(C)C)C(=O)O)C)CCCN=C(N)N)C=CC(=C[C@H](C)[C@H](CC2=CC=CC=C2)OC)C,,,,,,
4362,164364,CID 164364,C[C@H]1[C@@H](O[C@@](O1)(C)C(=O)O)C=CC=CC=CC(=O)OC2CC[C@@H](O[C@@H]2C)C3=C(C4=C(C=C3)C(=O)C5=C(C4=O)C=C[C@]6([C@@]5(C(=O)[C@@H]([C@@](C6)(C)O)O)O)O)O,,,,,,
4363,164365,Spartanamicin B,CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C=CC(=C4C3=O)O)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@@H](O7)C)O)N(C)C)O,,,,,,
4364,164366,"sodium;[7-hydroxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] [(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl hydrogen phosphate",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)OC3CCC4(C5CCC6(C(C5C(C=C4C3)O)CCC6C(C)CCCC(C)C)C)C)O.[Na+],,,,,,
4365,164367,"[7-hydroxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] [(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl hydrogen phosphate",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)OC3CCC4(C5CCC6(C(C5C(C=C4C3)O)CCC6C(C)CCCC(C)C)C)C)O,,,,,,
4366,164368,CID 164368,C1CNC(=C(CC2=CC(=C(C(=C2)Br)O)OC3=C(C=C(CC(=C(NCCC4=CC(=C(C=C4)OC5=C(C=CC1=C5)O)Br)O)N=O)C=C3Br)Br)N=O)O,,,,,,
4367,164369,"Pyrido(2,3-d)pyrimidine, 4-(2-(4-chlorophenyl)ethoxy)-",C1=CC2=C(N=C1)N=CN=C2OCCC3=CC=C(C=C3)Cl,,,,,,
4368,164370,"Pyrido(2,3-d)pyrimidine, 4-(2-(4-ethoxyphenyl)ethoxy)-",CCOC1=CC=C(C=C1)CCOC2=NC=NC3=C2C=CC=N3,,,,,,
4369,164371,"Pyrido(2,3-d)pyrimidine, 4-(2-(1,1'-biphenyl)-4-ylethoxy)-",C1=CC=C(C=C1)C2=CC=C(C=C2)CCOC3=NC=NC4=C3C=CC=N4,,,,,,
4370,164372,4-Ethoxyamphetamine hydrochloride,CCOC1=CC=C(C=C1)CC(C)N.Cl,,,,,,
4371,164373,"N-(2,4-Bis(methylthio)-6-methylpyridin-3-yl)-2-(hexylthio)decanoic acid amide",CCCCCCCC[C@@H](C(=O)NC1=C(C=C(N=C1SC)C)SC)SCCCCCC,,,,,,
4372,164374,CID 164374,C1=CC=C2C(=C1)C3=NNN(C(=O)C3=N2)N=CC4=CC=C(C=C4)[N+](=O)[O-],,,,,,
4373,164375,CID 164375,C1=CC=C2C(=C1)C3=NNN(C(=O)C3=N2)N=CC4=CC=C(C=C4)Cl,,,,,,
4374,164376,CID 164376,COC1=CC=C(C=C1)C=NN2C(=O)C3=NC4=CC=CC=C4C3=NN2,,,,,,
4375,164377,CID 164377,CC(=O)NC1=CC=C(C=C1)C=NN2C(=O)C3=NC4=CC=CC=C4C3=NN2,,,,,,
4376,164378,"2,4-Bis(1-decyloxyethyl)-Ga(III)-1,3,5,8-tetramethylporphyrin-6,7-dipropionyl diaspartic acid",[H+].[H+].[H+].CCCCCCCCCCOC(C)C1=C(C2=NC1=CC3=C(C(=C([N-]3)C=C4C(=C(C(=CC5=NC(=C2)C(=C5C)C(C)OCCCCCCCCCC)[N-]4)C)CCC(=O)NC(CC(=O)[O-])C(=O)[O-])CCC(=O)NC(CC(=O)[O-])C(=O)[O-])C)C.[Ga+3],,,,,,
4377,164379,"2,2'-[2,7,12,18-Tetramethyl-3,8-bis[1-(decyloxy)ethyl]-21H,23H-porphyrin-13,17-diylbis(1-oxo-3,1-propanediylimino)]bis(butanedioic acid)",CCCCCCCCCCOC(C)C1=C(C2=CC3=C(C(=C(N3)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C1N2)C)CCC(=O)NC(CC(=O)O)C(=O)O)CCC(=O)NC(CC(=O)O)C(=O)O)C)C)C(C)OCCCCCCCCCC)C,,,,,,
4378,164380,Poststatin,CC[C@@H](C(=O)C(=O)N[C@H](CC(C)C)C(=O)N([C@@H](C(C)C)C(=O)O)C(=O)[C@H](C(C)CC(=O)[C@H](C(C)C)N)N)N,,,,,,
4379,164381,Trijuganone C,CC1COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4(C)C(=O)OC,,,,,,
4380,164382,Crambescidin 816,CCC1C=CCCC2(O1)CC3CCC4(N3C(=NC5(C4C(=O)OCCCCCCCCCCCCCCCC(=O)N(CCCN)CC(CCN)O)CCCC(O5)C)N2)O,,,,,,
4381,164383,"1-[4-Hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-[(2,3,4-trihydroxy-1,2,3,4-tetrahydronaphthalen-1-yl)amino]pyrimidin-2-one",C1C(C(OC1N2C=CC(=NC2=O)NC3C(C(C(C4=CC=CC=C34)O)O)O)CO)O,,,,,,
4382,164384,CID 164384,C[C@@H]1C[C@@]23C(=O)[C@@H]([C@H]([C@H]4[C@H](C4(C)C)[C@@H]([C@H](C(=C[C@]2([C@@H]1OC(=O)C)O3)C)OC(=O)C5=CC=CC=C5)OC(=O)C)OC(=O)C)C,,,,,,
4383,164385,"(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-(2,5-dichloro-3,6-dioxocyclohexa-1,4-dien-1-yl)sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid",C1=C(C(=O)C(=C(C1=O)Cl)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)Cl,,,,,,
4384,164386,Mimonoside A,CC1C(C(C(C(O1)OC2C(C(C(OC2OC3C(C(OC(C3O)OC4C(C(C(OC4OC5CCC6(C(C5(C)C)CCC7(C6CC=C8C7(CCC9(C8CC(CC9)(C)C)C(=O)OC1C(C(C(C(O1)C)O)O)O)C)C)C)CO)OC1C(C(C(CO1)O)O)O)O)C1C(C(C(CO1)O)O)O)O)CO)O)O)O)O)O,,,,,,
4385,164387,Mimonoside B,CC1C(C(C(C(O1)OC2C(C(C(OC2OC3C(C(OC(C3O)OC4C(C(C(OC4OC5CCC6(C(C5(C)C)CCC7(C6CC=C8C7(CCC9(C8CC(CC9)(C)C)C(=O)O)C)C)C)CO)OC1C(C(C(CO1)O)O)O)O)C1C(C(C(CO1)O)O)O)O)CO)O)O)O)O)O,,,,,,
4386,164388,Dimethylsulfoxideimidazoletetrachlororuthenate(III),CS(=O)C.C1=CN=CN1.[Na+].[Cl-].[Cl-].[Cl-].[Cl-].[Ru+3],,,,,,
4387,164389,"N-methyl-3-octadecoxy-N-(2,3,4,5,6-pentahydroxyhexyl)-2-tetradecoxypropanamide",CCCCCCCCCCCCCCCCCCOCC(C(=O)N(C)CC(C(C(C(CO)O)O)O)O)OCCCCCCCCCCCCCC,,,,,,
4388,164390,"Methanesulfonamide, N-(1'-(2-(2,1,3-benzoxadiazol-5-yl)ethyl)-3,4-dihydro-4-oxospiro(2H-1-benzopyran-2,4'-piperidin)-6-yl)-, monohydrochloride",CS(=O)(=O)NC1=CC2=C(C=C1)OC3(CCN(CC3)CCC4=CC5=NON=C5C=C4)CC2=O.Cl,,,,,,
4389,164391,"2-[[4-[3-(Ethylamino)pyridin-2-yl]piperazin-1-yl]methyl]-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-ol;hydrochloride",CCNC1=C(N=CC=C1)N2CCN(CC2)CC3(CCC4=C(O3)C(=C(C(=C4C)O)C)C)C.Cl,,,,,,
4390,164392,"2-[[4-[3-(Ethylamino)-2-pyridyl]piperazino]methyl]-3,4-dihydro-2,5,7,8-tetramethyl-2H-1-benzopyran-6-ol",CCNC1=C(N=CC=C1)N2CCN(CC2)CC3(CCC4=C(O3)C(=C(C(=C4C)O)C)C)C,,,,,,
4391,164393,"Cyclo-S,S-(mba-(N(alpha)-Me)arg-gly-asp-man)",CN1[C@H](C(=O)NCC(=O)N[C@H](C(=O)NC2=CC=CC=C2SSC3=CC=CC=C3C1=O)CC(=O)O)CCCN=C(N)N,,,,,,
4392,164394,CID 164394,C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=C(C(=C(C=C4)N[N+]#N)[125I])N=C3[O-],,,,,,
4393,164395,CID 164395,C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=C(C(=C(C=C4)N[N+]#N)[125I])NC3=O,,,,,,
4394,164396,"N(1)-Cyclopentyl-5-nitropyrimidine-2,4-dione",C1CCC(C1)N2C=C(C(=O)NC2=O)[N+](=O)[O-],,,,,,
4395,164397,Contignasterol,C[C@H]([C@H]1C[C@@H](CC(O1)O)C(C)C)[C@H]2CC(=O)[C@H]3[C@@]2(CC[C@H]4[C@H]3[C@H]([C@@H]([C@@H]5[C@@]4(CC[C@H]([C@@H]5O)O)C)O)O)C,,,,,,
4396,164398,CID 164398,[B+3].CC1=CC(=NC1=CC2=CC=C([N-]2)CCC(=O)NCC(CCCN(C)CCC3=CC(=C(C=C3)OC)OC)(C4=CC(=C(C=C4)OC)OC)C(C)C)C.[F-].[F-],,,,,,
4397,164399,"N-[2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentyl]-3-[5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]pyrrol-2-yl]propanamide",CC1=CC(=C(N1)C=C2C=CC(=N2)CCC(=O)NCC(CCCN(C)CCC3=CC(=C(C=C3)OC)OC)(C4=CC(=C(C=C4)OC)OC)C(C)C)C,,,,,,
4398,164400,"ab-(3-Aminopyrrolidine)-cd-(glycolato(2-)-O,O')platinum(II)",C1CNCC1N.C(C(=O)[O-])[O-].[Pt+2],,,,,,
4399,164401,3-Aminopyrrolidine,C1CNCC1N,,,,,,
4400,164402,"4-[[[(9R,10S,11R,12R,19R)-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carbonyl]amino]carbamoyloxymethyl]-5,8-dioxo-7-[(2-thiophen-2-ylacetyl)amino]-5lambda4-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)NNC(=O)OCC1C=C(N2C(S1=O)C(C2=O)NC(=O)CC1=CC=CS1)C(=O)O)O)O)CC)OC)C(=O)OC)O,,,,,,
4401,164403,CID 164403,C[C@]12CC[C@@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC(=O)N4)C)OC(=O)C=CC5=CC(=CC=C5)N(CCCl)CCCl,,,,,,
4402,164404,CID 164404,C[C@@H]1CC(=CCOC(=O)C)C(=O)O[C@@H]2CCN(CC=C(C2=O)COC(=O)[C@]1(C)O)C,,,,,,
4403,164405,N-Cyclopropylcarbonyl-2-(7-methoxy-1-naphthyl)ethylamine,COC1=CC2=C(C=CC=C2CCNC(=O)C3CC3)C=C1,,,,,,
4404,164406,"(3R,6R,11R,14S,20S,23R)-6-acetamido-20-[[4-(aminomethyl)phenyl]methyl]-3-(2-amino-2-oxoethyl)-14-(carboxymethyl)-24,24-dimethyl-2,5,13,16,19,22-hexaoxo-8,9,25-trithia-1,4,12,15,18,21-hexazabicyclo[21.3.0]hexacosane-11-carboxylic acid",CC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H]2C(SCN2C(=O)[C@H](NC1=O)CC(=O)N)(C)C)CC3=CC=C(C=C3)CN)CC(=O)O)C(=O)O,,,,,,
4405,164407,Bhpedp,C1=CC=C(C(=C1)C(C(C2=CC=CC=C2O)N)N)O.[Cl-].[Cl-].[Pt+2],,,,,,
4406,164408,"1,2-Diaminoethane, 1,2-bis(2-hydroxyphenyl)-",C1=CC=C(C(=C1)C(C(C2=CC=CC=C2O)N)N)O,,,,,,
4407,164409,Boneloc,CCCCCCCCCCOC(=O)C(=C)C.CC(=C)C(=O)OC.CC(=C)C(=O)O[C@H]1CC2CC[C@@]1(C2(C)C)C,,,,,,
4408,164410,"[(1R,2S)-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanyl] 2-methylprop-2-enoate",CC(=C)C(=O)O[C@H]1CC2CC[C@@]1(C2(C)C)C,,,,,,
4409,164411,Respinomycin A1,CC1C(C(C(C(O1)OC2C(C(CC3=CC4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC6=C5OC7C(C(C(C6(O7)C)OC8CC(C(C(O8)C)OC9C(C(C(C(O9)C)O)(C)O)OC)(C)N)N(C)C)O)(C)O)OC)OC)(C)O)O,,,,,,
4410,164412,CID 164412,C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O[C@@H]3[C@H](O[C@H]([C@@H]3F)N4C=NC5=C4NC(=NC5=O)N)CO)O)O,,,,,,
4411,164413,Dapdox,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)NCCCCC(OC(=O)C)OC(=O)C)O,,,,,,
4412,164414,"[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-methylphosphoryl] phosphono hydrogen phosphate",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(C)OP(=O)(O)OP(=O)(O)O)O,,,,,,
4413,164415,"(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-2,6-diaminohexyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoic acid",CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC[C@H](CCCCN)N,,,,,,
4414,164416,5-(S-Glutathionyl)-2-tert-butylhydroquinone,CC(C)(C)C1=CC(=C(C=C1O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)O,,,,,,
4415,164417,6-(S-Glutathionyl)-2-tert-butylhydroquinone,CC(C)(C)C1=C(C(=CC(=C1)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)O,,,,,,
4416,164418,"Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-6-((4-oxo-4-((3,4,6-trio-O-acetyl-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl)amino)butyl)amino)-, (1aS-(1aalpha,8beta,8aalpha,8balpha))-",CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)NCCCC(=O)NC5C(C(C(C(O5)COC(=O)C)OC(=O)C)OC(=O)C)NC(=O)C,,,,,,
4417,164419,2-Chloro-3-[di(propan-2-yl)carbamoylsulfanyl]prop-2-enoic acid,CC(C)N(C(C)C)C(=O)SC=C(C(=O)O)Cl,,,,,,
4418,164420,"Furo(2,3-d)pyrimidin-4-amine, N-(2-(4-methoxyphenyl)ethyl)-5-methyl-",CC1=COC2=NC=NC(=C12)NCCC3=CC=C(C=C3)OC,,,,,,
4419,164421,"[[(2R,3S,5R)-3-fluoro-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-methylphosphoryl] phosphono hydrogen phosphate",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(C)OP(=O)(O)OP(=O)(O)O)F,,,,,,
4420,164422,"2-Butanol, 1-[[2-(1,1-dimethylethyl)cyclohexyl]oxy]-",CCC(COC1CCCCC1C(C)(C)C)O,,,,,,
4421,164423,CID 164423,CCCC[C@@H](CC)C(=O)[O-].[Na+],,,,,,
4422,164424,"2,7-Difluoro-4,5-dimethoxyspiro-(9H-fluorene-9,4'-imidazoline)-2',5'-dione",COC1=CC(=CC2=C1C3=C(C24C(=O)NC(=O)N4)C=C(C=C3OC)F)F,,,,,,
4423,164425,Cephalosporin mustard,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)COC(=O)NC4=CC=C(C=C4)N(CCCl)CCCl,,,,,,
4424,164426,CID 164426,C1=CC=C2C(=C1)C3=NNN(C(=O)C3=N2)N=CC4=CC=C(C=C4)O,,,,,,
4425,164427,CID 164427,C1=CC=C2C(=C1)C3=NNN(C(=O)C3=N2)N=CC4=CC=C(C=C4)C(=O)O,,,,,,
4426,164428,CID 164428,COC(=O)C1=CC=C(C=C1)C=NN2C(=O)C3=NC4=CC=CC=C4C3=NN2,,,,,,
4427,164429,CID 164429,C1=CC=C(C(=C1)CN2C=NC3=C2NC(=NC3=O)N)C=CP(=O)(O)O,,,,,,
4428,164430,CID 164430,CCC1=C(C2=CC3=C(C(=C(N3)C=C4[C@H]([C@@H](C(=N4)C(=C(O)O)C5=NC(=CC1=N2)C(=C5C(=O)NCCCC[C@H](C(=O)O)N)C)CCC(=O)OC)C)C)C=C)C,,,,,,
4429,164431,CID 164431,CC[C@@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@@H]2CCCN2,,,,,,
4430,164432,Pt-Dpzm,C1=C(C=NN1)CC2=CNN=C2.C1=C(C=NN1)CC2=CNN=C2.[Cl-].[Cl-].[Cl-].[Cl-].[Pt+2].[Pt+2],,,,,,
4431,164433,"4,4'-Methylenedipyrazole",C1=C(C=NN1)CC2=CNN=C2,,,,,,
4432,164434,Aminopotentidine oxalate,C1CCN(CC1)CC2=CC(=CC=C2)OCCCN=C(NCCNC(=O)C3=CC=C(C=C3)N)NC#N.C(=O)(C(=O)O)O,,,,,,
4433,164435,Aminopotentidine,C1CCN(CC1)CC2=CC(=CC=C2)OCCCN=C(NCCNC(=O)C3=CC=C(C=C3)N)NC#N,,,,,,
4434,164436,Serrawettin W2,CCCCCCCC1CC(=O)N[C@@H](C(=O)N[C@H](C(=O)NC(C(=O)N[C@@H](C(=O)N[C@H](C(=O)O1)[C@@H](C)CC)CC2=CC=CC=C2)[C@@H](C)O)CO)CC(C)C,,,,,,
4435,164437,2-Hexynyl-NECA,CCCCC#CC1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)C(=O)NCC)O)O)N,,,,,,
4436,164438,CID 164438,CCCC[C@@H](C)C[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)NC(=O)[C@H]([C@@H](C)OC(=O)C)N(C)[C@H](C(C)C)C(=O)N1C[C@H](C[C@H]1C(=O)N2[C@H](C=CC2=O)C)O,,,,,,
4437,164439,"(5R,8S,11R,15S,18S,19S,22R)-18-[(5S,6S)-6-acetyloxy-3,5-dimethyl-7-phenylhepta-1,3-dienyl]-15-[4-(diaminomethylideneamino)butyl]-1,5,19-trimethyl-2-methylidene-8-(2-methylpropyl)-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21-heptazacyclopentacosane-11,22-dicarboxylic acid",C[C@H]1[C@@H](NC(=O)[C@@H](NC(=O)C[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)C(=C)N(C(=O)CC[C@@H](NC1=O)C(=O)O)C)C)CC(C)C)C(=O)O)CCCCN=C(N)N)C=CC(=C[C@H](C)[C@H](CC2=CC=CC=C2)OC(=O)C)C,,,,,,
4438,164440,CID 164440,C[C@@H]1CC2=C(C(=CC(=C2)O)O)C(=O)O[C@@H](CC(=O)OC[C@H](CC(=O)O[C@@H](CC3=C(C(=CC(=C3)O)O)C(=O)O[C@@H](CC(=O)O1)C)C)O)C,,,,,,
4439,164441,D-Name,COC(=O)[C@@H](CCCN=C(N)N[N+](=O)[O-])N,,,,,,
4440,164442,(2R)-1-[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]-N-[(2S)-1-[[(2S)-2-[[(2S)-3-(1H-imidazol-5-yl)-2-(3-phenylpropanoylamino)propanoyl]amino]-3-(1H-indol-3-yl)propyl]amino]-1-oxo-3-phenylpropan-2-yl]pyrrolidine-2-carboxamide,C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)NC[C@H](CC4=CNC5=CC=CC=C54)NC(=O)[C@H](CC6=CN=CN6)NC(=O)CCC7=CC=CC=C7)N,,,,,,
4441,164443,CID 164443,C[C@@H]1C[C@H]2[C@@H](C[C@H]3[C@H](O2)[C@H]([C@@H]([C@H]4[C@H](O3)[C@H]([C@@H]([C@@]5(O4)CCCO5)C)C)O)C)O[C@H]6C[C@@H]7[C@]([C@@H](C[C@@H]8[C@@H](O7)CC=CC[C@@H]9[C@@H](O8)C=C[C@@H]2[C@@H](O9)C=C[C@@H]3[C@@H](O2)C[C@@H]2[C@@H](O3)[C@@H]([C@@H]3[C@@H](O2)CC=C[C@@H](O3)C=C[C@@H](CO)O)O)O)(O[C@@H]6C1)C,,,,,,
4442,164444,"5-amino-1-[(2R,3R,4S,5R)-5-[(benzylamino)methyl]-3,4-dihydroxyoxolan-2-yl]imidazole-4-carboxamide",C1=CC=C(C=C1)CNC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC(=C3N)C(=O)N)O)O,,,,,,
4443,164445,Chx-A dtpa,C1CCC([C@@H](C1)N(C[C@H](CC2=CC=C(C=C2)N=C=S)N(CC(=O)O)CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,,,,,,
4444,164446,"4-Ethyl-3-(methoxycarbonyl)-5-methyl-3,4-didehydro-gamma-butyrolactone",CCC1=C(C(=O)OC1C)C(=O)OC,,,,,,
4445,164447,CID 164447,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=C(OC3=CC(=O)C=C(C3=C2O)O)C4=CC=C(C=C4)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O,,,,,,
4446,164448,"Monoisoamyl-2,3-dimercaptosuccinate",CC(C)CCOC(=O)[C@H]([C@H](C(=O)O)S)S,,,,,,
4447,164449,3'-Azido-3'-deoxy-3-methylthymidine 5'-(tetrahydrogen triphosphate),CC1=CN(C(=O)N(C1=O)C)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)N=[N+]=[N-],,,,,,
4448,164450,"(3R,6S,12S,15R)-6-(Carboxymethyl)-12-[3-(diaminomethylideneamino)propyl]-15-[(4-hydroxyphenyl)methyl]-1,5,8,11,14,17-hexaoxo-1lambda4-thia-4,7,10,13,16-pentazacyclooctadecane-3-carboxylic acid",C1[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)CS1=O)CC2=CC=C(C=C2)O)CCCN=C(N)N)CC(=O)O)C(=O)O,,,,,,
4449,164451,2-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethoxy]phenoxy]acetic acid,C1=CC=C(C=C1)OC[C@H](CNCCOC2=CC=C(C=C2)OCC(=O)O)O,,,,,,
4450,164452,"tert-butyl 2-[[(3S)-2-[(2S)-2-[3-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]propanoylamino]-3-phenylpropanoyl]-1,2-oxazolidine-3-carbonyl]amino]acetate",CC(C)(C)OC(=O)CNC(=O)[C@@H]1CCON1C(=O)[C@H](CC2=CC=CC=C2)NC(=O)CCNC3=CC=C(C4=NON=C34)[N+](=O)[O-],,,,,,
4451,164453,Soyasaponin VI,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H]([C@H](O[C@H]2O[C@@H]3[C@H]([C@@H]([C@H](O[C@H]3O[C@H]4CC[C@]5([C@H]([C@@]4(C)CO)CC[C@@]6([C@@H]5CC=C7[C@]6(CC[C@@]8([C@H]7CC(C[C@H]8O[C@H]9CC(=O)C(=C(O9)C)O)(C)C)C)C)C)C)C(=O)O)O)O)CO)O)O)O)O)O,,,,,,
4452,164454,Ustiloxin A,CC[C@@]1([C@H](NC(=O)[C@@H](NC(=O)[C@H]([C@@H](C2=CC(=C(C=C2S(=O)C[C@H](C[C@@H](C(=O)O)N)O)O)O1)O)NC)C(C)C)C(=O)NCC(=O)O)C,,,,,,
4453,164455,CID 164455,CC(C)C1=CC(=C(C(=C1)C(=O)O)O)C(C)C.C1=CC=C(C=C1)[SnH](C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
4454,164456,6-(4-Methoxy-3-(1-methylcyclohexyl)phenyl)-2-naphthalenecarboxylic acid,CC1(CCCCC1)C2=C(C=CC(=C2)C3=CC4=C(C=C3)C=C(C=C4)C(=O)O)OC,,,,,,
4455,164457,Landiolol hydrochloride,CC1(OC[C@H](O1)COC(=O)CCC2=CC=C(C=C2)OC[C@H](CNCCNC(=O)N3CCOCC3)O)C.Cl,['Treatment of supraventricular arrhythmias'],,,,,
4456,164458,"Ethyl 3-(2-acetamidopropanoylsulfanyl)-2-(2,2-dimethylpropanoylamino)propanoate",CCOC(=O)C(CSC(=O)C(C)NC(=O)C)NC(=O)C(C)(C)C,,,,,,
4457,164459,"Phosphine oxide, bis(2,6-dimethoxybenzoyl)(2,4,4-trimethylpentyl)-",CC(CC(C)(C)C)CP(=O)(C(=O)C1=C(C=CC=C1OC)OC)C(=O)C2=C(C=CC=C2OC)OC,,,,,,
4458,164460,"(6aR,9R)-N,7-dimethyl-N-prop-2-ynyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid",CN1C[C@@H](C=C2[C@H]1CC3=CNC4=CC=CC2=C34)C(=O)N(C)CC#C.CS(=O)(=O)O,,,,,,
4459,164461,"9,10-Didehydro-N-(2-propynyl)-6-methylergoline-8-carboxamide",CN1C[C@@H](C=C2[C@H]1CC3=CNC4=CC=CC2=C34)C(=O)N(C)CC#C,,,,,,
4460,164462,Copper benzochlorin,CCC1=C(C2=NC1=CC3=C(C(=C([N-]3)C(=CN(C)C)C4=NC5=C(C=CC=C5C4(CC)CC)C6=NC(=C2)C(=C6CC)CC)CC)CC)CC.[Cl-].[Cu+2],,,,,,
4461,164463,"N,N-dimethyl-1-(12,13,17,18,22,23,27,27-octaethyl-8,24,25,26-tetrazahexacyclo[19.2.1.16,9.111,14.116,19.02,7]heptacosa-1(24),2(7),3,5,8,11(26),12,14,16,18,20,22-dodecaen-10-ylidene)methanamine",CCC1=C(C2=NC1=CC3=C(C(=C(N3)C=C4C(=C(C(=N4)C(=CN(C)C)C5=NC6=C2C=CC=C6C5(CC)CC)CC)CC)CC)CC)CC,,,,,,
4462,164464,CID 164464,C1CNC(=C(CC2=CC(=C(C=C2)OC3=C(C(=CC(=C3)CC(=C(NC=CC4=CC(=C(C(=C4)Br)OC5=C(C(=CC1=C5)Br)O)Br)O)N=O)Br)O)Br)N=O)O,,,,,,
4463,164465,"2-[[5-[4-[3,5-Dihydroxy-6-(hydroxymethyl)-4-sulfooxyoxan-2-yl]oxy-3-hydroxy-6-methyl-5-(methylamino)oxan-2-yl]oxy-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxo-5,6-dihydrobenzo[a]tetracene-2-carbonyl]amino]propanoic acid",CC1C(C(C(C(O1)OC2C(C3=CC4=C(C(=C3C5=C2C=C(C(=C5O)C(=O)NC(C)C(=O)O)C)O)C(=O)C6=C(C4=O)C(=CC(=C6)OC)O)O)O)OC7C(C(C(C(O7)CO)O)OS(=O)(=O)O)O)NC,,,,,,
4464,164466,"bis[[(2S,5R)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)-2,5-dihydrofuran-2-yl]methyl] hydrogen phosphate",CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@H](O2)COP(=O)(O)OC[C@@H]3C=C[C@@H](O3)N4C=C(C(=O)NC4=O)C,,,,,,
4465,164467,CID 164467,C[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC(=O)N4)C)OC(=O)C=CC5=CC(=CC=C5)N(CCCl)CCCl,,,,,,
4466,164468,CID 164468,C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC(=O)N4)C)OC(=O)C=CC5=CC(=CC=C5)N(CCCl)CCCl,,,,,,
4467,164469,H-D-Phe-Cys(1)-Tyr-DL-Trp-Lys-Cys(1)-Thr-NH2,C[C@H]([C@@H](C(=O)N)NC(=O)[C@@H]1CSSC[C@@H](C(=O)N[C@H](C(=O)NC(C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)[C@@H](CC5=CC=CC=C5)N)O,,,,,,
4468,164470,Cyclothialidine,CC1=C2C(=C(C=C1O)O)CSC[C@H](NC(=O)[C@H](COC2=O)NC(=O)[C@@H]3[C@@H](CCN3C(=O)[C@H](CO)N)O)C(=O)N[C@@H](C)C(=O)O,,,['Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)'],,,
4469,164471,5-(Saenta-x8)fluorescein,C1=CC(=CC=C1CNC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CSCCNC(=O)CCCCCNC(=O)C5=CC6=C(C=C5)C7(C8=C(C=C(C=C8)O)OC9=C7C=CC(=C9)O)OC6=O)O)O)[N+](=O)[O-],,,,,,
4470,164472,1-[2-(4-Benzylphenoxy)ethyl]pyrrolidine,C1CCN(C1)CCOC2=CC=C(C=C2)CC3=CC=CC=C3,,,,,,
4471,164473,"Bis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4-methoxybenzylidene)malonate",CC1(CC(CC(N1C)(C)C)OC(=O)C(=CC2=CC=C(C=C2)OC)C(=O)OC3CC(N(C(C3)(C)C)C)(C)C)C,,,,,,
4472,164474,"Alanine, N-((3-hydroxy-2-quinolinyl)carbonyl)cysteinylglycyl-N-methylcysteinyl-2,3-didehydro-N-methylthio-, bimol. (4-1'),(4'-1)-(thio lactone), cyclic (3-3')-disulfide",CN1[C@H]2CSSC[C@@H](C(=O)N(C(=C)C(=O)SC[C@H](C(=O)NCC1=O)NC(=O)C3=NC4=CC=CC=C4C=C3O)C)N(C(=O)CNC(=O)[C@@H](CSC(=O)C(=C)N(C2=O)C)NC(=O)C5=NC6=CC=CC=C6C=C5O)C,,,['Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)'],,,
4473,164475,Flaxseed,COC1=C(C=CC(=C1)C[C@@H](CO)[C@@H](CC2=CC(=C(C=C2)O)OC)CO)O.C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)O)O)O)O,,,,,,
4474,164476,CID 164476,CC1=C2C(=C(NC2=C(C=C1)C)C(=O)NNC(=NC3=CC=CC=C3)S)C4=CC=CC=C4,,,,,,
4475,164477,CID 164477,CC1=CC2=C(C=C1)NC(=C2C3=CC=CC=C3)C(=O)NNC(=NC4=CC=C(C=C4)Cl)S,,,,,,
4476,164478,CID 164478,CC1=C(NC2=CC=CC=C12)C(=O)NNC(=NC3=CC=CC=C3)S,,,,,,
4477,164479,"[(2S,3S,4R,5R,6S)-2-Methyl-5-[(2S)-2-methylbutanoyl]oxy-6-[[(1S,3R,4S,5R,6R,8R,10S,22S,23R,24R)-4,5,23-trihydroxy-24-(hydroxymethyl)-6-methyl-20-oxo-10-pentyl-2,7,9,21,25-pentaoxatricyclo[20.3.1.03,8]hexacosan-26-yl]oxy]-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl] (2S)-2-methylbutanoate",CCCCC[C@H]1CCCCCCCCCC(=O)O[C@H]2[C@@H]([C@H](O[C@H](C2O[C@H]3[C@@H]([C@@H]([C@H]([C@@H](O3)C)OC(=O)[C@@H](C)CC)O[C@H]4[C@@H]([C@@H]([C@H]([C@@H](O4)C)O)O)O)OC(=O)[C@@H](C)CC)O[C@@H]5[C@H]([C@H]([C@H](O[C@H]5O1)C)O)O)CO)O,,,,,,
4478,164480,"9H-Fluoren-9-one, 1,9a-dihydro-1,9a-dihydroxy-, cis-(+)-",C1=CC=C2C(=C1)C3=CC=C[C@H]([C@@]3(C2=O)O)O,,,,,,
4479,164481,"2,4-Di-tert-butyl-6-[hydroxy(1-methyl-5-nitro-1h-imidazol-2-yl)methyl]phenol",CC(C)(C)C1=CC(=C(C(=C1)C(C)(C)C)O)C(C2=NC=C(N2C)[N+](=O)[O-])O,,,,,,
4480,164482,"1H-Imidazole-2-methanol, alpha-(3-(1,1-dimethylethyl)-2-hydroxy-5-methylphenyl)-1-methyl-5-nitro-",CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C2=NC=C(N2C)[N+](=O)[O-])O,,,,,,
4481,164483,"1H-Imidazole-2-methanol, alpha-(3-(1,1-dimethylethyl)-2-hydroxy-6-methylphenyl)-1-methyl-5-nitro-",CC1=C(C(=C(C=C1)C(C)(C)C)O)C(C2=NC=C(N2C)[N+](=O)[O-])O,,,,,,
4482,164484,CID 164484,CCC(C)C1C(=O)OC2N1C3=C(C4=C2C=C(C=C4O)C)C(=O)C5=C(C3=O)C(=CC=C5)OC6CC(C(C(O6)C)O)O,,,,,,
4483,164485,CID 164485,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC(=NC3=O)NC4=C5C=CC6=C(C=CC7=C6C5=C(C=C7)C8=CC=CC=C84)N)CO)O,,,,,,
4484,164486,Doranidazole,C1=CN(C(=N1)[N+](=O)[O-])CO[C@@H](CO)[C@@H](CO)O,,,,,,
4485,164487,1-(2-(2-(Diphenyl)methoxy)ethyl)-4-(3-phenylpropyl)homopiperazine,C1CN(CCN(C1)CCOC(C2=CC=CC=C2)C3=CC=CC=C3)CCCC4=CC=CC=C4,,,,,,
4486,164488,Cypenhymustine,C1CCC2(C1)C(=O)N(C(=O)N2)CCN(CCCl)CCCl,,,,,,
4487,164489,"16-(4-aminobutyl)-22-benzyl-N-(1,3-dihydroxy-2-methylpropan-2-yl)-13-(1-hydroxyethyl)-19-(1H-indol-3-ylmethyl)-12,15,18,21,24-pentaoxo-7,8-dithia-11,14,17,20,23-pentazaspiro[5.19]pentacosane-10-carboxamide",CC(C1C(=O)NC(CSSC2(CCCCC2)CC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)C(=O)NC(C)(CO)CO)O,,,,,,
4488,164490,"16-(4-aminobutyl)-22-benzyl-13-(1-hydroxyethyl)-N-(2-hydroxyethyl)-19-(1H-indol-3-ylmethyl)-12,15,18,21,24-pentaoxo-7,8-dithia-11,14,17,20,23-pentazaspiro[5.19]pentacosane-10-carboxamide",CC(C1C(=O)NC(CSSC2(CCCCC2)CC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)C(=O)NCCO)O,,,,,,
4489,164491,1-Fluorobenzo(a)pyrene,C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=C(C=C5)F)C=C3,,,,,,
4490,164492,3-Fluorobenzo(a)pyrene,C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C(C=CC(=C54)C=C3)F,,,,,,
4491,164493,CID 164493,C[C@@H]1CC[C@@H](C(=CC[C@H](C[C@@H](C=CC[C@@H](OC(=O)C=CC=CC[C@H]([C@H]([C@@H]1O)C)OC(=O)[C@H](COC)N(C)C)[C@H](C)[C@H]([C@H](C)CC[C@H]([C@@H](C)[C@@H]([C@@H](C)C=CN(C)C=O)OC(=O)C)OC(=O)[C@H](C)N(C)C)O)OC)C)C)OC,,,,,,
4492,164494,"Glycine, N,N-bis(2-((carboxymethyl)amino)ethyl)-, potassium salt",C(CN(CCNCC(=O)[O-])CC(=O)[O-])NCC(=O)[O-].[K+].[K+].[K+],,,,,,
4493,164495,"Glycine, N,N-bis[2-[(carboxymethyl)amino]ethyl]-",C(CN(CCNCC(=O)O)CC(=O)O)NCC(=O)O,,,,,,
4494,164496,"Trans-11,12-dihydroxy-11,12-dihydrodibenzo(a,l)pyrene",C1=CC=C2C(=C1)C3=CC=CC4=C3C5=C2C6=C(C=C5C=C4)[C@H]([C@@H](C=C6)O)O,,,,,,
4495,164497,"anti-11,12,12a,13a-Tetrahydrodibenzo(5,6:10,11)chryseno(3,4-b)oxirene-11,12-diol",C1=CC=C2C(=C1)C3=CC=CC4=C3C5=C2C6=C(C=C5C=C4)[C@H]([C@@H]([C@H]7[C@@H]6O7)O)O,,,,,,
4496,164498,CID 164498,C[C@H]1[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@@H](NC(=O)[C@@H](NC(=O)C(NC(=O)C(=C)N(C(=O)CC[C@@H](NC1=O)C(=O)O)C)C)CC(C)C)C(=O)O)C)CC(C)C)C=CC(=C[C@H](C)[C@H](CC2=CC=CC=C2)OC)C,,,,,,
4497,164499,"3,9-Bis(2,4-dicumylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane",CC(C)(C1=CC=CC=C1)C2=CC(=C(C=C2)OP3OCC4(CO3)COP(OC4)OC5=C(C=C(C=C5)C(C)(C)C6=CC=CC=C6)C(C)(C)C7=CC=CC=C7)C(C)(C)C8=CC=CC=C8,,,,,,
4498,164500,"6-(2-Hydroxypentan-2-yl)-7-methoxy-3-methyl-1,2,3,4,5,6,7,7a-octahydro-4a,7-ethano-4,12-methano[1]benzofuro[3,2-e]isoquinolin-9-ol--hydrogen chloride (1/1)",CCC[C@](C)([C@H]1CC23CCC1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)C)OC)O.Cl,,,,,,
4499,164501,"(2S,6R,14R,16R)-16-[(2R)-2-hydroxypentan-2-yl]-15-methoxy-5-methyl-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol",CCC[C@](C)([C@H]1CC23CCC1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)C)OC)O,,,,,,
4500,164502,"3,9-dihydroxy-N-[2-hydroxy-4-[3-[8-(6-hydroxy-3,5-dimethylhept-4-enyl)-3-methyl-1,7-dioxaspiro[5.5]undecan-2-yl]propylamino]-3-methyl-4-oxobutyl]-4-methyldodeca-6,10-dienamide",CC=CC(CC=CCC(C)C(CC(=O)NCC(C(C)C(=O)NCCCC1C(CCC2(O1)CCCC(O2)CCC(C)C=C(C)C(C)O)C)O)O)O,,,,,,
4501,164503,Asiminacin,CCCCCC[C@@H](CCC[C@H]([C@H]1CC[C@@H](O1)[C@H]2CCC(O2)[C@@H](CCCCCCCCCCCCC3=C[C@@H](OC3=O)C)O)O)O,,,,,,
4502,164504,"Aqua(1,1-bis(4-hydroxyphenyl)-1,2-diamino-2-phenylethane)platinum(II) sulfate",C1=CC=C(C=C1)C(C(C2=CC=C(C=C2)O)(C3=CC=C(C=C3)O)N)N.O.[O-]S(=O)(=O)[O-].[Pt+2],,,,,,
4503,164505,"4-[1,2-Diamino-1-(4-hydroxyphenyl)-2-phenylethyl]phenol",C1=CC=C(C=C1)C(C(C2=CC=C(C=C2)O)(C3=CC=C(C=C3)O)N)N,,,,,,
4504,164506,CID 164506,C[C@@H](C(=O)NC(=O)[C@@H](C)NC1[C@H]2[C@@H]1CN(C2)C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F)N.CS(=O)(=O)O,,,,,,
4505,164507,CID 164507,C[C@@H](C(=O)NC(=O)[C@@H](C)NC1[C@H]2[C@@H]1CN(C2)C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F)N,,,,,,
4506,164508,Pseudostellarin D,CC[C@H](C)C1C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N1)CC(C)C)CC3=CC=C(C=C3)O)CC(C)C,,,,,,
4507,164509,Talampanel,C[C@@H]1CC2=CC3=C(C=C2C(=NN1C(=O)C)C4=CC=C(C=C4)N)OCO3,['For the treatment of epilepsy.'],"['Talampanel, a potent and selective alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA)-receptor antagonist, is a potential new antiepileptic drug (AED). Talampanel dosing strategies may be reliant on concomitant AED medication, as enzyme-inducing AEDs enhance, whereas VPA inhibits its metabolism. Talampanel was well tolerated, although adverse events occurred at lower doses compared with those in healthy subjects, probably because of the additive effect of concomitant AEDs.']",,"['Rapidly absorbed, with maximal plasma concentrations achieved within 1-3 hours.']",,['3-6 hours']
4508,164510,"Cyclohexanamine, 4,4'-methylenebis(N-(2-methylpropylidene)-",CC(C)C=NC1CCC(CC1)CC2CCC(CC2)N=CC(C)C,,,,,,
4509,164511,"[7-[2-hydroxy-3-[11-hydroxy-2-[4-[4-hydroxy-2-[1-hydroxy-3-(3-methyl-1,7-dioxaspiro[5.5]undecan-2-yl)butyl]-3-methylidenespiro[4a,7,8,8a-tetrahydro-4H-pyrano[3,2-b]pyran-6,5'-oxolane]-2'-yl]but-3-en-2-yl]-4-methyl-1,7-dioxaspiro[5.5]undec-4-en-8-yl]-2-methylpropanoyl]oxy-6-methylhepta-3,5-dienyl] 7,11,13-trihydroxy-9,12,14-trisulfooxytetradec-3-enoate",CC1CCC2(CCCCO2)OC1C(C)CC(C3C(=C)C(C4C(O3)CCC5(O4)CCC(O5)C=CC(C)C6CC(=CC7(O6)C(CCC(O7)CC(C)(C(=O)OCC(=CC=CCCOC(=O)CC=CCCC(CC(CC(C(C(COS(=O)(=O)O)O)OS(=O)(=O)O)O)OS(=O)(=O)O)O)C)O)O)C)O)O,,,,,,
4510,164512,"Phenylbis(2,4,6-trimethylbenzoyl)phosphine oxide",CC1=CC(=C(C(=C1)C)C(=O)P(=O)(C2=CC=CC=C2)C(=O)C3=C(C=C(C=C3C)C)C)C,,,,,,
4511,164513,"2,3,4,5-Tetradehydroprolyl-2-aminobutanoyl-seryl-3-phenyl-beta-alanyl-2-aminobutanoic acid",CCC(C(=O)NC(CO)C(=O)NC(CC(=O)NC(CC)C(=O)O)C1=CC=CC=C1)NC(=O)C2=CC=CN2,,,,,,
4512,164514,"Butane, 1,1,1,2,2,3,3,4,4-nonafluoro-4-methoxy-",COC(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
4513,164515,methyl N-carbonochloridoyl-N-[4-(trifluoromethoxy)phenyl]carbamate,COC(=O)N(C1=CC=C(C=C1)OC(F)(F)F)C(=O)Cl,,,,,,
4514,164516,"N~2~-(1-Hydroxyethylidene)arginylprolyl-4-imino-N-(2-methylpropyl)homoserine--2-hydroxypropane-1,2,3-tricarboxylic acid (1/1)",CC(C)CN([C@@H](CC(=O)N)C(=O)O)C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,,,,,,
4515,164517,CID 164517,CC(C)CN(C(CC(=O)N)C(=O)O)C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)C,,,,,,
4516,164518,Roxifiban acetate,CCCCOC(=O)N[C@@H](CNC(=O)C[C@H]1CC(=NO1)C2=CC=C(C=C2)C(=N)N)C(=O)OC.CC(=O)O,,,,,,
4517,164519,(2S)-2-(Butoxycarbonylamino)-3-[2-[3-(4-amidinophenyl)-2-isoxazoline-5-yl]acetylamino]propanoic acid methyl ester,CCCCOC(=O)N[C@@H](CNC(=O)CC1CC(=NO1)C2=CC=C(C=C2)C(=N)N)C(=O)OC,,,,,,
4518,164520,"11,12-Dihydrobenzo(g)chrysene-11,12-diol",C1=CC=C2C(=C1)C3=C(C4=C(C=C3)C(C(C=C4)O)O)C5=CC=CC=C25,,,,,,
4519,164521,Bepotastine besilate,C1CN(CCC1O[C@@H](C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O.C1=CC=C(C=C1)S(=O)(=O)O,,,"['Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)']",,,
4520,164522,Bepotastine,C1CN(CCC1O[C@@H](C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O,,,,,,
4521,164523,"6-Methoxy-7H-dibenzo(c,g)carbazole",COC1=CC2=CC=CC=C2C3=C1NC4=C3C5=CC=CC=C5C=C4,,,,,,
4522,164524,Naftoxate,CN(C1=CC=CC2=CC=CC=C21)C(=S)SC3=NC4=CC=CC=C4O3,,,,,,
4523,164525,CID 164525,CC(=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@@H]1CC5=C3C(=C(C=C5)O)O4)O)C.Cl,,,,,,
4524,164526,Nandrolone cyclotate,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)C45CCC(CC4)(C=C5)C)CCC6=CC(=O)CC[C@H]36,,,,,,
4525,164527,CID 164527,CC(C(=NO)N)OC1=CC=CC2=CC=CC=C21,,,,,,
4526,164528,"1-(Chloromethyl)-3-(2,2-dimethylpropyl)-1-nitrosourea",CC(C)(C)CNC(=O)N(CCl)N=O,,,,,,
4527,164529,(2R)-1-phenylpropan-2-amine;sulfate,C[C@H](CC1=CC=CC=C1)N.C[C@H](CC1=CC=CC=C1)N.[O-]S(=O)(=O)[O-],,,,,,
4528,164530,"4,6-Dimethyl-2-(5-nitro-2-furyl)pyrimidine",CC1=CC(=NC(=N1)C2=CC=C(O2)[N+](=O)[O-])C,,,,,,
4529,164531,3-(2-aminoethyl)-1H-indol-5-ol;2-amino-3-methyl-4H-imidazol-5-one;sulfuric acid;hydrate,CN1CC(=O)N=C1N.C1=CC2=C(C=C1O)C(=CN2)CCN.O.OS(=O)(=O)O,,,,,,
4530,164532,4-Chloro-N-hydroxy-alpha-methylbenzeneethanamine,CC(CC1=CC=C(C=C1)Cl)NO,,,,,,
4531,164533,alpha-Ketoglutarate,C(CC(=O)[O-])C(=O)C(=O)[O-],,,,,,
4532,164534,"1,1'-((3,3'-Dimethyl-4,4'-biphenylylene(ethylidynenitrilo)))diguanidine dinitrate",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)C(=NN=C(N)N)C)C)C(=NN=C(N)N)C.[N+](=O)(O)[O-].[N+](=O)(O)[O-],,,,,,
4533,164535,2-[1-[4-[4-[N-(diaminomethylideneamino)-C-methylcarbonimidoyl]-3-methylphenyl]-2-methylphenyl]ethylideneamino]guanidine,CC1=C(C=CC(=C1)C2=CC(=C(C=C2)C(=NN=C(N)N)C)C)C(=NN=C(N)N)C,,,,,,
4534,164536,2-Ethyl-4-methylpentanoic acid,CCC(CC(C)C)C(=O)O,,,,,,
4535,164537,Magnesium methanolate,C[O-].C[O-].[Mg+2],,,,,,
4536,164538,Estriol sodium succinate,C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@@H]2OC(=O)CCC(=O)[O-])OC(=O)CCC(=O)[O-])CCC4=C3C=CC(=C4)O.[Na+].[Na+],,,,,,
4537,164539,"Copper, (2,9,16,23-tetranitro-29H,31H-phthalocyaninato(2-)-kappaN29,kappaN30,kappaN31,kappaN32)-, (SP-4-1)-",C1=CC2=C(C=C1N([O-])[O-])C3=NC4=NC(=NC5=NC(=NC6=NC(=NC2=N3)C7=C6C=CC(=C7)[N+](=O)[O-])C8=C5C=CC(=C8)[N+](=O)[O-])C9=C4C=CC(=C9)[N+](=O)[O-].[Cu+2],,,,,,
4538,164540,"15,24,33-trinitro-N,N-dioxido-2,11,20,29,37,38,39,40-octazanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1(37),2,4(9),5,7,10(40),11,13(18),14,16,19(39),20,22(27),23,25,28(38),29,31(36),32,34-icosaen-6-amine",C1=CC2=C(C=C1N([O-])[O-])C3=NC4=NC(=NC5=NC(=NC6=NC(=NC2=N3)C7=C6C=CC(=C7)[N+](=O)[O-])C8=C5C=CC(=C8)[N+](=O)[O-])C9=C4C=CC(=C9)[N+](=O)[O-],,,,,,
4539,164541,Pentaerythritol tetraabietate,CC(C)C1=CC2=CC[C@@H]3[C@@]([C@H]2CC1)(CCC[C@@]3(C)C(=O)OCC(COC(=O)[C@@]4(CCC[C@]5([C@H]4CC=C6[C@@H]5CCC(=C6)C(C)C)C)C)(COC(=O)[C@@]7(CCC[C@]8([C@H]7CC=C9[C@@H]8CCC(=C9)C(C)C)C)C)COC(=O)[C@@]1(CCC[C@]2([C@H]1CC=C1[C@@H]2CCC(=C1)C(C)C)C)C)C,,,,,,
4540,164542,"1-Phenanthrenecarboxylic acid, 1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydro-1,4a-dimethyl-7-(1-methylethyl)-, 2,2-bis((((1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydro-1,4a-dimethyl-7-(1-methylethyl)-1-phenanthrenyl)carbonyl)oxy)methyl)-1,3-propanediyl ester",CC(C)C1CCC2C(=C1)CCC3C2(CCCC3(C)C(=O)OCC(COC(=O)C4(CCCC5(C4CCC6=CC(CCC65)C(C)C)C)C)(COC(=O)C7(CCCC8(C7CCC9=CC(CCC98)C(C)C)C)C)COC(=O)C1(CCCC2(C1CCC1=CC(CCC12)C(C)C)C)C)C,,,,,,
4541,164543,(-)-Berbine,C1CN2CC3=CC=CC=C3C[C@H]2C4=CC=CC=C41,,,,,,
4542,164544,Peonidin chloride,COC1=C(C=CC(=C1)C2=[O+]C3=CC(=CC(=C3C=C2O)O)O)O.[Cl-],,,,,,
4543,164545,"3,5-Dihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromen-7-one",COC1=C(C=CC(=C1)C2=C(C=C3C(=CC(=O)C=C3O2)O)O)O,,,,,,
4544,164546,CID 164546,C1CCC(CC1)C(=O)[O-].[Na+],,,,,,
4545,164547,Butenedioate,C(=CC(=O)[O-])C(=O)[O-],,,,,,
4546,164548,(1-Chlorophthalocyaninato)copper,C1=CC=C2C(=C1)C3=NC4=C5C=CC=CC5=C([N-]4)N=C6C7=C(C(=CC=C7)Cl)C(=N6)N=C8C9=CC=CC=C9C(=N8)N=C2[N-]3.[Cu+2],,,,,,
4547,164549,Phenoxymethylpenicillin calcium,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C.[Ca+2],,,,,,
4548,164550,Oxaloacetate,C(C(=O)C(=O)[O-])C(=O)[O-],,,,,,
4549,164551,2-[2-[Bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate,C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-],,,,,,
4550,164552,"Pyreno(2,1-b)thiophene",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C=CS5)C=C2,,,,,,
4551,164553,"Pyreno(1,2-b)thiophene",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4SC=C5)C=C2,,,,,,
4552,164554,"Benzo[4,5]phenaleno[9,1-bc]thiophene",C1=CC=C2C3=C4C(=CC2=C1)C=CC5=CSC(=C54)C=C3,,,,,,
4553,164555,"6,12-Diazaanthanthrene",C1=CC2=C3C(=C1)N=C4C=CC5=C6C4=C3C(=NC6=CC=C5)C=C2,,,,,,
4554,164556,"9h-Indeno[2,1-c]phenanthrene",C1C2=C(C3=CC=CC=C31)C4=C(C=C2)C=CC5=CC=CC=C54,,,,,,
4555,164557,"Phenanthro[4,3-b]thiophene",C1=CC=C2C(=C1)C=CC3=C2C4=C(C=C3)C=CS4,,,,,,
4556,164558,11h-Benz[bc]aceanthrylene,C1C2=CC=CC3=C2C4=C1C5=CC=CC=C5C=C4C=C3,,,,,,
4557,164559,"Indeno[1,2,3-fg]naphthacene",C1=CC=C2C(=C1)C=C3C=C4C=CC=CC4=C5C3=C2C6=CC=CC=C65,,,,,,
4558,164560,CID 164560,B1C2=C(C3=CC=CC=C31)C4=CC=CC=C4C=C2,,,,,,
4559,164561,"7H-Pyrido[3,4-c]carbazole",C1=CC=C2C(=C1)C3=C(N2)C=CC4=C3C=CN=C4,,,,,,
4560,164562,"7H-Pyrido[2,3-c]carbazole",C1=CC=C2C(=C1)C3=C(N2)C=CC4=C3C=CC=N4,,,,,,
4561,164563,"7H-Pyrido[3,2-c]carbazole",C1=CC=C2C(=C1)C3=C(N2)C=CC4=C3N=CC=C4,,,,,,
4562,164564,"Dibenzo(e,k)acephenanthrylene",C1=CC=C2C=C3C4=C5C(=CC=C4)C6=CC=CC=C6C5=CC3=CC2=C1,,,,,,
4563,164565,"Acenaphtho(1,2-b)pyrazine",C1=CC2=C3C(=C1)C4=NC=CN=C4C3=CC=C2,,,,,,
4564,164566,"Phenanthro[2,3-b]thiophene",C1=CC=C2C(=C1)C=CC3=C2C=C4C=CSC4=C3,,,,,,
4565,164567,"Dibenz(a,i)acridine",C1=CC=C2C(=C1)C=CC3=NC4=CC5=CC=CC=C5C=C4C=C32,,,,,,
4566,164568,"Dibenz(b,h)acridine",C1=CC=C2C(=C1)C=CC3=CC4=CC5=CC=CC=C5C=C4N=C32,,,,,,
4567,164569,"1H-Imidazo[4,5-f]quinoline",C1=CNC2=CC=C3C(=NC=N3)C2=C1,,,,,,
4568,164570,"1h-Pyrrolo[3,2-h]quinoline",C1=CC2=C(C3=C(C=C2)C=CN3)N=C1,,,,,,
4569,164571,"Tetrazolo[5,1-a]phthalazine",C1=CC=C2C(=C1)C=NN3C2=NN=N3,,,,,,
4570,164572,"Phenanthro[9,10-b]thiophene",C1=CC=C2C(=C1)C3=C(C4=CC=CC=C24)SC=C3,,,,,,
4571,164573,"13H-Benzo(a)pyrido(2,3-i)carbazole",C1=CC=C2C(=C1)C=CC3=C2N=C4C3=CC=C5C4=CC=CN5,,,,,,
4572,164574,"Naphth(2,1-a)azulene",C1=CC=C2C=C3C(=C2C=C1)C=CC4=CC=CC=C43,,,,,,
4573,164575,1H-phosphole,C1=CPC=C1,,,,,,
4574,164576,"N-(3-Diethylaminopropyl)-2,2-diphenylacetamide",CCN(CC)CCCNC(=O)C(C1=CC=CC=C1)C2=CC=CC=C2,,,,,,
4575,164577,Disodium 2-oxosuccinate,C(C(=O)C(=O)[O-])C(=O)[O-].[Na+].[Na+],,,,,,
4576,164578,4-Trifluoromethylsalicylic acid,C1=CC(=C(C=C1C(F)(F)F)O)C(=O)O,,,,,,
4577,164579,"1-Chloro-1,2-difluoroethane",C(C(F)Cl)F,,,,,,
4578,164580,5-Trifluoromethyl-2'-deoxyuridylic acid,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C(F)(F)F)COP(=O)(O)O)O,,,,,,
4579,164581,5-Trifluoromethyl-2'-deoxyuridine 5'-triphosphate,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C(F)(F)F)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,,,,,,
4580,164582,"3,6,9-Tris(3-(hydroxyamino)propyl)-1,4,7,10,13,16-hexaazacyclooctadecane-2,5,8,11,14,17-hexone",C1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCC(=O)N1)CCCNO)CCCNO)CCCNO,,,,,,
4581,164583,"1,1-Difluoro-1,2-diphenylethane",C1=CC=C(C=C1)CC(C2=CC=CC=C2)(F)F,,,,,,
4582,164584,"4-Fluorobenzene-1,2-diamine",C1=CC(=C(C=C1F)N)N,,,,,,
4583,164585,"2,6-Piperidinedione, 4-[2-(3,5-dimethyl-2-oxocyclohexylidene)ethyl]-, (3S-trans)-",C[C@H]1C[C@@H](C(=O)C(=CCC2CC(=O)NC(=O)C2)C1)C,,,,,,
4584,164586,"1,1-Difluorocyclohexane",C1CCC(CC1)(F)F,,,,,,
4585,164587,"5,5,5-Trifluoro-l-leucine",CC(C[C@@H](C(=O)O)N)C(F)(F)F,,,,,,
4586,164588,CID 164588,[B+3].CO.[F-].[F-].[F-],,,,,,
4587,164589,CID 164589,[H+].[H+].[B+3].CC(=O)[O-].CC(=O)[O-].[F-].[F-].[F-],,,,,,
4588,164590,"Butane, 1,2,3,4-tetrabromohexafluoro-",C(C(C(F)(F)Br)(F)Br)(C(F)(F)Br)(F)Br,,,,,,
4589,164591,"2,6-Dinitro-4-(trifluoromethyl)phenol",C1=C(C=C(C(=C1[N+](=O)[O-])O)[N+](=O)[O-])C(F)(F)F,,,,,,
4590,164592,2-Amino-5-hydroxybenzoic acid,C1=CC(=C(C=C1O)C(=O)O)N,,,,,,
4591,164593,4-(Trifluoromethyl)mandelic acid,C1=CC(=CC=C1C(C(=O)O)O)C(F)(F)F,,,,,,
4592,164594,2-Chloro-1-nitro-4-(trifluoromethyl)benzene,C1=CC(=C(C=C1C(F)(F)F)Cl)[N+](=O)[O-],,,,,,
4593,164595,4-Fluoro-N-hydroxybenzenamine,C1=CC(=CC=C1NO)F,,,,,,
4594,164596,"1,1,2,2-Tetrafluoroethyl 2,2,2-trifluoroethyl ether",C(C(F)(F)F)OC(C(F)F)(F)F,,,,,,
4595,164597,3-Hydroxyphenobarbital,CCC1(C(=O)NC(=O)NC1=O)C2=CC(=CC=C2)O,,,,,,
4596,164598,"1,1,1,2,3-Pentafluoropropane",C(C(C(F)(F)F)F)F,,,,,,
4597,164599,"2-Propanone,1-[(2R)-1-methyl-2-pyrrolidinyl]-3-[(2S)-1-methyl-2-pyrrolidinyl]-, rel-",CN1CCC[C@H]1CC(=O)CC2CCCN2C,,,,,,
4598,164600,3-Chlorobenzenediazonium tetrafluoroborate,[B-](F)(F)(F)F.C1=CC(=CC(=C1)Cl)[N+]#N,,,,,,
4599,164601,Hydnocarpic acid,C1C[C@H](C=C1)CCCCCCCCCCC(=O)O,,,,,,
4600,164602,Chlorocarbonic acid,C(=O)(O)Cl,,,,,,
4601,164603,"2,2-Dichloro-2-fluoroethanol",C(C(F)(Cl)Cl)O,,,,,"['2,2-dichloro-2-fluoroethanol has known human metabolites that include (2S,3S,4S,5R)-6-(2,2-dichloro-2-fluoroethoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid.']",
4602,164604,Einecs 207-358-9,C[C@]12CC[C@H](C[C@H]1CC[C@@H]3[C@@H]2C[C@H]([C@]4(C3(CC[C@@H]4C5=CC(=O)OC5)O)C)O)O,,,,,,
4603,164605,"11,15-Dioxo-12,20-epoxypregn-5-en-3-yl 2,6-dideoxy-3-o-methylhexopyranoside",CC1C2CC(=O)C3C2(C(O1)C(=O)C4C3CC=C5C4(CCC(C5)OC6CC(C(C(O6)C)O)OC)C)C,,,,,,
4604,164606,Ibogaine pseudoindoxyl,CCC1CC2CC3C1N(C2)CCC34C(=O)C5=C(N4)C=CC(=C5)OC,,,,,,
4605,164607,Felinine,CC(C)(CCO)SC[C@@H](C(=O)O)N,,,,,,
4606,164608,L-tert-Leucine,CC(C)(C)[C@@H](C(=O)O)N,,,,,,
4607,164609,Homochelidonine,CN1CC2=C(C=CC(=C2OC)OC)[C@@H]3[C@H]1C4=CC5=C(C=C4C[C@@H]3O)OCO5,,,,,,
4608,164610,Isoindigotin,C1=CC=C2C(=C1)C(=C(N2)O)C3=C4C=CC=CC4=NC3=O,,,['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)'],,,
4609,164611,Domesticine,CN1CCC2=CC(=C(C3=C2[C@@H]1CC4=CC5=C(C=C43)OCO5)O)OC,,,,,,
4610,164612,Colchinol,COC1=C(C(=C2C(=C1)CC[C@@H](C3=C2C=CC(=C3)O)N)OC)OC,,,,,,
4611,164613,Khellol,COC1=C2C=COC2=CC3=C1C(=O)C=C(O3)CO,,,,,,
4612,164614,Isohelenalin,C[C@@H]1C[C@@H]2C(=C(C(=O)O2)C)[C@@H]([C@]3([C@H]1C=CC3=O)C)O,,,,,,
4613,164615,"3,4-Dihydro-8-hydroxy-3-(3-hydroxy-4-methoxyphenyl) 1H-2-benzopyran-1-one",COC1=C(C=C(C=C1)C2CC3=C(C(=CC=C3)O)C(=O)O2)O,,,,,,
4614,164616,"5-Hydroxy-4,5-dimethyl-3-(propan-2-yl)-4,5,8,10,12,13,13a,13b-octahydro-2h-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3h)-dione",CC1C(C(=O)OC2CCN3C2C(=CC3)COC(=O)C1(C)O)C(C)C,,,,,,
4615,164617,Tetraphylline,C[C@H]1[C@H]2CN3CCC4=C([C@@H]3C[C@@H]2C(=CO1)C(=O)OC)NC5=C4C=CC(=C5)OC,,,,,,
4616,164618,"(2R,3S,4S,5R)-3-[[(1S,3S,4S,5R)-4,8-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-2,4,5,6-tetrahydroxyhexanal",C1[C@H]2C([C@@H](O1)[C@@H]([C@@H](O2)O[C@H]([C@H](C=O)O)[C@H]([C@@H](CO)O)O)O)O,,,,,,
4617,164619,D-Pinitol,COC1[C@@H]([C@H](C([C@@H]([C@@H]1O)O)O)O)O,,,,,,
4618,164620,CID 164620,CC1=C2C(=C(C(=C(O2)O)NC(=O)C3=CC(=C(C=C3)O)CC=C(C)C)O)C=CC1=O,,,,,,
4619,164621,CID 164621,COC1=C2C(=CC=C(O2)O)C=CC1=O,,,,,,
4620,164622,Lindelofine,C[C@H]([C@@](C(C)C)(C(=O)OC[C@@H]1CCN2[C@@H]1CCC2)O)O,,,,,,
4621,164623,2-Hydroxy-3-methylpentanoic acid,CCC(C)C(C(=O)O)O,,,,,,
4622,164624,CID 164624,COC1=C(C=CC(=C1)C2=C(C(=C3C(=CC(=O)C(=C3O2)OC)O)O)O)O,,,,,,
4623,164625,CID 164625,CC1=CC(=O)C(=CO)C2=C1C(=O)OC3=C(C(=O)C(=C(O)O)C(=C3O2)C)CO,,,,,,
4624,164626,CID 164626,C1=CC(=C(C=C1O)C(=O)[O-])O,,,,,,
4625,164627,"3-hydroxy-2,3-dihydro-1H-indole-5,6-dione",C1C(C2=CC(=O)C(=O)C=C2N1)O,,,,,,
4626,164628,Thymidine-5'-diphosphate,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)O)O,,,"['Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)', 'Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)']",,,
4627,164629,CID 164629,C1=CC=C(C=C1)C2=C(C(=C3C=CC(=O)C=C3O2)O)O,,,,,,
4628,164630,Butrin,C1[C@H](OC2=C(C1=O)C=CC(=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C4=CC(=C(C=C4)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O,,,,,,
4629,164631,"Serine, 3-(3,4-dihydroxyphenyl)-",C1=CC(=C(C=C1C([C@@H](C(=O)O)N)O)O)O,,,,,,
4630,164632,"2,2'-(Ethylenediimino)-dibutyric acid",CCC(C(=O)O)NCCNC(CC)C(=O)O,,,,,,
4631,164633,Sedridine,C[C@@H](C[C@@H]1CCCCN1)O,,,,,,
4632,164634,Carlina oxide,C1=CC=C(C=C1)CC#CC2=CC=CO2,,,,,,
4633,164635,"2,3-Dihydroxypropyl hexanoate",CCCCCC(=O)OCC(CO)O,,,,,,
4634,164636,"7',8'-Dihydro-psi,psi-carotene",CC(=CCCC(=CCCC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC=C(C)CCC=C(C)C)C)C)C)C,,,,,,
4635,164637,"3alpha,5-Cyclo-5alpha-cholestan-6alpha-ol",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@@H]([C@@]45[C@@]3(CC[C@@H]4C5)C)O)C,,,,,,
4636,164638,"(12S)-3-methoxy-8-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-2,4,6(17),13-tetraen-15-one",CC1CC2C3=C(C1)C=NC(=CC34CC(=O)C=C[C@@H]4O2)OC,,,,,,
4637,164639,"(6aS,9R)-N-[(1S,2S,4R,7R)-7-benzyl-2-hydroxy-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide",CC(C)[C@@]1(C(=O)N2[C@@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@H]5CN([C@H]6CC7=CNC8=CC=CC(=C78)C6=C5)C,,,,,,
4638,164640,"(6aS,9R)-N-[(1S,2S,4R,7R)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide",CC(C)C[C@@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@H]5CC6=CNC7=CC=CC(=C67)C5=C4)C)O,,,,,,
4639,164641,5alpha-Ergostane,C[C@H](CC[C@H](C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CCCC4)C)C,,,,,,
4640,164642,Betonicine,C[N+]1(C[C@@H](C[C@H]1C(=O)[O-])O)C,,,,,,
4641,164643,"(2S,4R)-4-hydroxy-1,1-dimethylpyrrolidin-1-ium-2-carboxylic acid",C[N+]1(C[C@@H](C[C@H]1C(=O)O)O)C,,,,,,
4642,164644,CID 164644,CCC1=C(C2=C(C(=O)C(=O)C(=C2C(=C1O)O)O)O)O,,,,,,
4643,164645,CID 164645,CCCC1=C2C(=C(C(=C(C2=O)CC=C(C)C)O)C(=O)CC(C)C)OC(=C1)O,,,,,,
4644,164646,Isoemetine,CC[C@H]1CN2CCC3=CC(=C(C=C3[C@@H]2C[C@@H]1C[C@H]4C5=CC(=C(C=C5CCN4)OC)OC)OC)OC,,,,,,
4645,164647,CID 164647,COC1=CC(=O)C=C2C1=C(C(=C(O2)C3=CC(=C(C=C3)O)O)O)O,,,,,,
4646,164648,Androsin,CC(=O)C1=CC(=C(C=C1)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)OC,,,,,,
4647,164649,Silver benzoate,C1=CC=C(C=C1)C(=O)[O-].[Ag+],,,,,,
4648,164650,Cupric benzoate,C1=CC=C(C=C1)C(=O)[O-].C1=CC=C(C=C1)C(=O)[O-].[Cu+2],,,,,,
4649,164651,"Butanamide, N-(aminocarbonyl)-2-iodo-3-methyl-",CC(C)C(C(=O)NC(=O)N)I,,,,,,
4650,164652,Etilefrine hydrochloride,CCNCC(C1=CC(=CC=C1)O)O.Cl,,,"['Drugs that selectively bind to and activate alpha adrenergic receptors. (See all compounds classified as Adrenergic alpha-Agonists.)', 'Compounds that bind to and activate ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Agonists.)', 'Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)', 'Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)', 'Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)']",,,
4651,164653,"3-(3,4-dihydroxyphenyl)-1-[2,3-dihydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-2-en-1-one",C1=CC(=C(C=C1C=CC(=O)C2=C(C(=C(C=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)O)O,,,,,,
4652,164654,Lanthanum oxalate,C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].[La+3].[La+3],,,,,,
4653,164655,Aluminum thiocyanate,C(#N)[S-].C(#N)[S-].C(#N)[S-].[Al+3],,,,,,
4654,164656,"1,4-Diamino-2-butanol",C(CN)C(CN)O,,,,,,
4655,164657,Mevaldic acid,CC(CC=O)(CC(=O)O)O,,,,,,
4656,164658,gamma-Aminobutyrylcholine,C[N+](C)(C)CCOC(=O)CCCN,,,,,,
4657,164659,Pyridine sulfate (1:1),C1=CC=NC=C1.[O-]S(=O)(=O)[O-],,,,,,
4658,164660,Protohypericin,CC1=CC(=O)C2=C(C3=C(C=C(C4=C3C(=C5C6=CC(=CC(=O)C6=C(C7=C(C=C(C4=C57)O)O)O)C)C2=C1)O)O)O,,,,,,
4659,164661,2-((2-Amino-2-carboxyethyl)thio)tryptophan,C1=CC=C2C(=C1)C(=C(N2)SCC(C(=O)O)N)C[C@@H](C(=O)O)N,,,,,,
4660,164662,"2-[2-(2,6-Dichlorophenoxy)ethylamino]guanidine;sulfate",C1=CC(=C(C(=C1)Cl)OCCNN=C(N)N)Cl.C1=CC(=C(C(=C1)Cl)OCCNN=C(N)N)Cl.[O-]S(=O)(=O)[O-],,,,,,
4661,164663,Supinidine,C1C[C@H]2C(=CCN2C1)CO,,,,,,
4662,164664,3-((1-Methylhydrazino)methyl)phenol,CN(CC1=CC(=CC=C1)O)N,,,['Compounds and drugs that block or inhibit the enzymatic action of AROMATIC AMINO ACID DECARBOXYLASES. Pharmaceutical agents in this category are used in conjunction with LEVODOPA in order to slow its metabolism. (See all compounds classified as Aromatic Amino Acid Decarboxylase Inhibitors.)'],,,
4663,164665,Yttrium Carbonate,C(=O)([O-])[O-].C(=O)([O-])[O-].C(=O)([O-])[O-].[Y+3].[Y+3],,,,,,
4664,164666,23-Hydroxy-22-[(2-methylbut-2-enoyl)oxy]-3-oxoolean-12-en-28-oic acid,CC=C(C)C(=O)O[C@@H]1CC(C[C@H]2[C@]1(CC[C@@]3(C2=CC[C@H]4[C@]3(CCC5[C@@]4(CCC(=O)[C@]5(C)CO)C)C)C)C(=O)O)(C)C,,,,,,
4665,164667,Solanidane,C[C@H]1CC[C@@H]2[C@H]([C@H]3[C@@H](N2C1)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CCC6[C@@]5(CCCC6)C)C)C,,,,,,
4666,164668,Dipotassium tetracyanoplatinate,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[K+].[K+].[Pt+2],,,,,,
4667,164669,Ammonium platinous cyanide,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[NH4+].[NH4+].[Pt+2],,,,,,
4668,164670,CID 164670,CC(=O)[O-].[Rb+],,,,,,
4669,164671,"(6aS,9R)-N-[(1S,2S,4R,7R)-2-hydroxy-5,8-dioxo-4,7-di(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide",CC(C)[C@@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@H]5CC6=CNC7=CC=CC(=C67)C5=C4)C)O,,,,,,
4670,164672,Isodeoxycholic acid,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CCCC4)C)O)O)C,,,,,,
4671,164673,"3beta,7alpha-Dihydroxy-5beta-cholan-24-oic Acid",C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@@H](C4)O)C)O)C,,,,,,
4672,164674,"Allopregnane-3alpha,20alpha-diol",C[C@@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@H](C4)O)C)C)O,,,,,,
4673,164675,"Cholesta-1,4-dien-3-one",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)C,,,,,,
4674,164676,Tanshinone IIA,CC1=COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4(C)C,,,"['Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)', 'Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)', 'Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)', 'Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)', 'Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)']",,,
4675,164677,6-Hydroxycorticosterone,C[C@]12CCC(=O)C=C1[C@@H](C[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@H]4C(=O)CO)C)O)O,,,,,,
4676,164678,"Cholestane-3,6-diol, (3beta,5alpha,6beta)-",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@H]([C@@H]4[C@@]3(CC[C@@H](C4)O)C)O)C,,,,,,
4677,164679,CID 164679,COC1=C2C(=C(C(=C(O2)C3=CC=C(C=C3)O)O)O)C(=CC1=O)O,,,,,,
4678,164680,"Benzenediazonium, 2,4,6-trichloro-, tetrafluoroborate(1-)",[B-](F)(F)(F)F.C1=C(C=C(C(=C1Cl)[N+]#N)Cl)Cl,,,,,,
4679,164681,"2,4,6-Trichlorobenzenediazonium",C1=C(C=C(C(=C1Cl)[N+]#N)Cl)Cl,,,,,,
4680,164682,5-Fluorotryptamine,C1=CC2=C(C=C1F)C(=CN2)CCN,,,,,,
4681,164683,3-Amino-3-deoxyglucose,C([C@H]([C@H]([C@@H]([C@H](C=O)O)N)O)O)O,,,,,,
4682,164684,Tetraiodo-p-benzoquinone,C1(=C(C(=O)C(=C(C1=O)I)I)I)I,,,,,,
4683,164685,Noprylsulfamide,C1=CC=C(C=C1)C(CC(NC2=CC=C(C=C2)S(=O)(=O)N)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
4684,164686,Noprylsulfamide free acid,C1=CC=C(C=C1)C(CC(NC2=CC=C(C=C2)S(=O)(=O)N)S(=O)(=O)O)S(=O)(=O)O,,,,,,
4685,164687,"1,2-Dihydro-1,2-anthracenediol",C1=CC=C2C=C3C(C(C=CC3=CC2=C1)O)O,,,,,,
4686,164688,"Carbamic acid, hydroxy-, methyl ester",COC(=O)NO,,,,,,
4687,164689,Dipotassium malate,C(C(C(=O)[O-])O)C(=O)[O-].[K+].[K+],,,,,,
4688,164690,2-(4-Fluorophenoxy)-2-methylpropanoic acid,CC(C)(C(=O)O)OC1=CC=C(C=C1)F,,,,,,
4689,164691,"Carbamic acid, hydroxy-, butyl ester",CCCCOC(=O)NO,,,,,,
4690,164692,Barium(2+);octadec-9-enoate,CCCCCCCCC=CCCCCCCCC(=O)[O-].CCCCCCCCC=CCCCCCCCC(=O)[O-].[Ba+2],,,,,,
4691,164693,CID 164693,CC1=C(C2=CC=CC=C2C(=C1CC=C(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)OC(=O)C)OC(=O)C,,,,,,
4692,164694,"2,2'-Diaminobenzophenone",C1=CC=C(C(=C1)C(=O)C2=CC=CC=C2N)N,,,,,,
4693,164695,Leucomethylene blue,CN(C)C1=CC2=C(C=C1)NC3=C(S2)C=C(C=C3)N(C)C,,,,,,
4694,164696,"1,2-Dimethyl-3,5-dinitrobenzene",CC1=CC(=CC(=C1C)[N+](=O)[O-])[N+](=O)[O-],,,,,,
4695,164697,"4,5-Diamino-5-oxopentanoic acid",C(CC(=O)O)C(C(=O)N)N,,,,,,
4696,164698,2-(Iodomethyl)oxirane,C1C(O1)CI,,,,,,
4697,164699,Ethylenediamine dihydrobromide,C(CN)N.Br.Br,,,,,,
4698,164700,"Ethanamine, N-hydroxy-",CCNO,,,,,,
4699,164701,L-Serine O-sulfate,C([C@@H](C(=O)O)N)OS(=O)(=O)O,,,,,,
4700,164702,4-Oxopentanal,CC(=O)CCC=O,,,,,,
4701,164703,"(1S,2S,4S,8S,9S,11S,12S,13R)-8-(2-Chloroacetyl)-11-hydroxy-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icos-17-en-16-one",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3C[C@H]5[C@]4(OC(O5)(C)C)C(=O)CCl)C)O,,,,,,
4702,164704,Einecs 211-163-4,C(=O)(C(=O)[O-])[O-].C(=O)(N)N.C(=O)(N)N,,,,,,
4703,164705,17-Hydroxy-3-oxoandrost-4-ene-17-carboxylic acid,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4(C(=O)O)O)C,,,,,,
4704,164706,Glutamic acid beta-naphthylamide,C1=CC=C2C=C(C=CC2=C1)NC(=O)[C@H](CCC(=O)O)N,,,,,,
4705,164707,Manganese benzoate,C1=CC=C(C=C1)C(=O)[O-].C1=CC=C(C=C1)C(=O)[O-].[Mn+2],,,,,,
4706,164708,Octadecanoic 1-14C acid,CCCCCCCCCCCCCCCCC[14C](=O)O,,,,,,
4707,164709,"(1R,3S,6S)-6-[18-[(4R)-4-hydroxy-2,6,6-trimethylcyclohexen-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol",CC1=C(C(C[C@@H](C1)O)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=C[C@]23[C@](O2)(C[C@H](CC3(C)C)O)C)C)C,,,,,,
4708,164710,Anolobine,C1CN[C@@H]2CC3=C(C=CC(=C3)O)C4=C2C1=CC5=C4OCO5,,,,,,
4709,164711,"[(2R)-3-hydroxy-3-methyl-1-(7-oxofuro[3,2-g]chromen-4-yl)oxybutan-2-yl] 2-methylbut-2-enoate",CC=C(C)C(=O)O[C@H](COC1=C2C=CC(=O)OC2=CC3=C1C=CO3)C(C)(C)O,,,,,,
4710,164712,Oxypressin,CC(C)C[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N,,,,,,
4711,164713,"Manganese(2+);octadeca-9,12-dienoate",CCCCCC=CCC=CCCCCCCCC(=O)[O-].CCCCCC=CCC=CCCCCCCCC(=O)[O-].[Mn+2],,,,,,
4712,164714,"4-Hydroxypregn-4-ene-3,20-dione",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=C(C(=O)CC[C@]34C)O)C,,,,,,
4713,164715,"3-(1,2,3,4-Tetrahydro-1-oxo-2-naphthyl)pyridine",C1CC2=CC=CC=C2C(=O)C1C3=CN=CC=C3,,,,,,
4714,164716,2-Methylquinoline;sulfate,CC1=NC2=CC=CC=C2C=C1.[O-]S(=O)(=O)[O-],,,,,,
4715,164717,Dipotassium succinate,C(CC(=O)[O-])C(=O)[O-].[K+].[K+],,,,,,
4716,164718,"1,1,2-Trichloro-2-ethoxyethane",CCOC(C(Cl)Cl)Cl,,,,,,
4717,164719,5-Hydroxykynurenamine,C1=CC(=C(C=C1O)C(=O)CCN)N,,,,,,
4718,164720,4-(Ethoxycarbonyl)benzoic acid,CCOC(=O)C1=CC=C(C=C1)C(=O)O,,,,,,
4719,164721,Phenyl phenylacetate,C1=CC=C(C=C1)CC(=O)OC2=CC=CC=C2,,,,,,
4720,164722,Hamaudol,CC1=CC(=O)C2=C(C3=C(C=C2O1)OC([C@H](C3)O)(C)C)O,,,,,,
4721,164723,Byssochlamic acid,CCC[C@H]1CC2=C(C[C@H](CC3=C1C(=O)OC3=O)CC)C(=O)OC2=O,,,,,,
4722,164724,"7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3S)-3-hydroxyocta-1,5-dienyl]cyclopentyl]hept-5-enoic acid",CCC=CC[C@@H](C=C[C@H]1[C@@H](C[C@@H]([C@@H]1CC=CCCCC(=O)O)O)O)O,,,,,,
4723,164725,CID 164725,CC1=C(C(CCC1)(C)C)C=CC(=CC[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)C.[O-]S(=O)(=O)[O-],,,,,,
4724,164726,"[3-Methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4-pentadienyl] triphenyl phosphonium",CC1=C(C(CCC1)(C)C)C=CC(=CC[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)C,,,,,,
4725,164727,"Sulfamic acid, compd. with N,N-diethylethanamine (1:1)",CCN(CC)CC.NS(=O)(=O)O,,,,,,
4726,164728,1-Diazobutane,CCCC=[N+]=[N-],,,,,,
4727,164729,Hexadecanoic-1-14C acid,CCCCCCCCCCCCCCC[14C](=O)O,,,,,,
4728,164730,CID 164730,C1=CC(=O)C2=NSNC2=C1,,,,,,
4729,164731,"Carbostyril, 3,4-dihydro-1-hydroxy-",C1CC(=O)N(C2=CC=CC=C21)O,,,,,,
4730,164732,"2,4,6-Trimethylpyrylium tetrafluoroborate",[B-](F)(F)(F)F.CC1=CC(=[O+]C(=C1)C)C,,,,,,
4731,164733,Octafluorotetrahydrofuran,C1(C(C(OC1(F)F)(F)F)(F)F)(F)F,,,,,,
4732,164734,CID 164734,C1=CC=C(C=C1)C=CC2=CC=C(O2)[N+](=O)[O-],,,,,,
4733,164735,"Sedoheptulose 1,7-bisphosphate",C([C@H]([C@H]([C@H]([C@@H](C(=O)COP(=O)(O)O)O)O)O)O)OP(=O)(O)O,,,,,,
4734,164736,Iodo(phenyl)mercury,C1=CC=C(C=C1)[Hg]I,,,,,,
4735,164737,N-Ethyl-N-methylaniline N-oxide,CC[N+](C)(C1=CC=CC=C1)[O-],,,,,,
4736,164738,"5-Methoxy-2,3-dimethyl-1H-indole",CC1=C(NC2=C1C=C(C=C2)OC)C,,,,,,
4737,164739,Levonordefrin,C[C@@H]([C@@H](C1=CC(=C(C=C1)O)O)O)N,['Used as a topical nasal decongestant and vasoconstrictor in dentistry.'],"['Levonordefrin is a sympathomimetic amine used as a vasoconstrictor in local anesthetic solutions. It has pharmacologic activity similar to that of Epinephrine but it is more stable than Epinephrine. In equal concentrations, Levonordefrin is less potent than Epinephrine in raising blood pressure, and as a vasoconstrictor.']",['Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)'],,,
4738,164740,2-Naphthylthiolacetate,CC(=O)SC1=CC2=CC=CC=C2C=C1,,,,,,
4739,164741,CID 164741,[Li+].C[O-],,,,,,
4740,164742,"3,3-Dimethyl-2,5-hexanedione",CC(=O)CC(C)(C)C(=O)C,,,,,,
4741,164743,Didysprosium trioxalate,C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].[Dy+3].[Dy+3],,,,,,
4742,164744,Dierbium trioxalate,C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].[Er+3].[Er+3],,,,,,
4743,164745,Yttrium oxalate,C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].[Y+3].[Y+3],,,,,,
4744,164746,"Dimethyl (2,2,2-trichloro-1-methoxyethyl)phosphonate",COC(C(Cl)(Cl)Cl)P(=O)(OC)OC,,,,,,
4745,164747,"Butanedioic acid, 2,3-dihydroxy-(2R,3R)-, strontium salt (1:1)",[C@@H]([C@H](C(=O)[O-])O)(C(=O)[O-])O.[Sr+2],,,,,,
4746,164748,Magnesium malate,C(C(C(=O)[O-])O)C(=O)[O-].[Mg+2],,,,,,
4747,164749,"2-[[3-(Diaminomethylidenehydrazinylidene)-1,1,1-trifluoropropan-2-ylidene]amino]guanidine",C(=NN=C(N)N)C(=NN=C(N)N)C(F)(F)F,,,,,,
4748,164750,"1,4-Benzenediol, compd. with piperazine (1:1)",C1CNCCN1.C1=CC(=CC=C1O)O,,,,,,
4749,164751,"(S)-1,2,3,4-Tetrahydro-6,7-dimethoxy-1-methylisoquinolinium chloride",C[C@H]1C2=CC(=C(C=C2CCN1)OC)OC.Cl,,,,,,
4750,164752,Salsolidine,C[C@H]1C2=CC(=C(C=C2CCN1)OC)OC,,,['Compounds and drugs that inhibit or block the activity of CATECHOL O-METHYLTRANSFERASE enzymes. Drugs in this class are used in management of central nervous system disorders such as PARKINSON DISEASE. (See all compounds classified as Catechol O-Methyltransferase Inhibitors.)'],,,
4751,164753,CID 164753,C1[C@H](N=C(C=C1C=CN[C@@H](CCC(=O)N)C(=O)O)C(=O)O)C(=O)O,,,,,,
4752,164754,Enniatin B,CC(C)[C@H]1C(=O)O[C@@H](C(=O)N([C@H](C(=O)O[C@@H](C(=O)N([C@H](C(=O)O[C@@H](C(=O)N1C)C(C)C)C(C)C)C)C(C)C)C(C)C)C)C(C)C,,,['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)'],,,
4753,164755,Valine-1-14C,CC(C)([14C](=O)O)N,,,,,,
4754,164756,"Nitric acid, 1,1-dimethylethyl ester",CC(C)(C)O[N+](=O)[O-],,,,,,
4755,164757,CID 164757,CC(=O)C=C[O-].[Na+],,,,,,
4756,164758,3-Hydroxy-2-butenal,CC(=O)C=CO,,,,,,
4757,164759,CID 164759,C(C(=O)O)C(=O)[O-].[K+],,,,,,
4758,164760,Cobalt dibenzoate,C1=CC=C(C=C1)C(=O)[O-].C1=CC=C(C=C1)C(=O)[O-].[Co+2],,,,,,
4759,164761,(-)-alpha-(1-Aminoethyl)-3-hydroxybenzenemethanol,CC(C(C1=CC(=CC=C1)O)O)N.[C@H]([C@@H](C(=O)O)O)(C(=O)O)O,,,,,,
4760,164762,Fisetinidol-4alpha-ol,C1=CC(=C(C=C1[C@@H]2[C@H]([C@@H](C3=C(O2)C=C(C=C3)O)O)O)O)O,,,,,,
4761,164763,"[2,2'-Biquinoline]-4,4'-dicarboxylic acid, disodium salt",C1=CC=C2C(=C1)C(=CC(=N2)C3=NC4=CC=CC=C4C(=C3)C(=O)[O-])C(=O)[O-].[Na+].[Na+],,,,,,
4762,164764,(6R-trans)-3-((((Dimethylamino)thioxomethyl)thio)methyl)-8-oxo-7-((((phenylmethyl)thio)acetyl)amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid,CN(C)C(=S)SCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CSCC3=CC=CC=C3)SC1)C(=O)O,,,,,,
4763,164765,Testosterone palmitate,CCCCCCCCCCCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,,,,,,
4764,164766,"2-(4-(3-(10H-Phenothiazin-10-yl)propyl)-1-piperazinyl)ethyl 3,4,5-trimethoxybenzoate",COC1=CC(=CC(=C1OC)OC)C(=O)OCCN2CCN(CC2)CCCN3C4=CC=CC=C4SC5=CC=CC=C53,,,,,,
4765,164767,Titanium tetra(methanolate),C[O-].C[O-].C[O-].C[O-].[Ti+4],,,,,,
4766,164768,CID 164768,C[14C](=O)[O-].[Na+],,,,,,
4767,164769,Acetic acid C-14,C[14C](=O)O,,,,,,
4768,164770,Diterbium trioxalate,C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].[Tb+3].[Tb+3],,,,,,
4769,164771,Diytterbium trioxalate,C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].[Yb+3].[Yb+3],,,,,,
4770,164772,4-Aminopyridine hydrochloride,C1=CN=CC=C1N.Cl,,,,,,
4771,164773,"Phosphonic acid, (2-(1-aziridinyl)ethyl)-, diethyl ester",CCOP(=O)(CCN1CC1)OCC,,,,,,
4772,164774,2-Chloro-3-((p-chlorophenyl)sulfonyl)propionitrile,C1=CC(=CC=C1S(=O)(=O)CC(C#N)Cl)Cl,,,,,,
4773,164775,"1,4-Dihydro-3-hydroxy-1,4-dioxo-2-naphthonitrile",C1=CC=C2C(=C1)C(=C(C(=O)C2=O)C#N)O,,,,,,
4774,164776,"10,12-Dimethylbenz(a)acridine",CC1=CC2=C(C3=C(C=CC4=CC=CC=C43)N=C2C=C1)C,,,,,,
4775,164777,N-(p-Chlorobenzhydryl)piperazine dihydrochloride,C1CN(CCN1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl,,,,,,
4776,164778,"(8R,9S,10R,14S)-17-ethynyl-17-hydroxy-13-propyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one",CCCC12CC[C@H]3[C@H]([C@@H]1CCC2(C#C)O)CCC4=CC(=O)CC[C@H]34,,,,,,
4777,164779,Anordiol,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CC[C@@H]4[C@@]3(C[C@](C4)(C#C)O)C,,,"['Postcoital contraceptives which owe their effectiveness to hormonal preparations. (See all compounds classified as Contraceptives, Postcoital, Hormonal.)']",,,
4778,164780,Diethanolamine triiodothyroacetate,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(=O)O)I)I)O.C(CO)NCCO,,,,,,
4779,164781,Cephalosporin 87/30,CN(C)C(=S)SCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)O,,,,,,
4780,164782,"m-Terphenyl-3,3'',5'-tripropionic acid, alpha,alpha',alpha''-triamino-2',6',6''-trihydroxy-",C1=CC(=C(C=C1CC(C(=O)O)N)C2=CC(=CC(=C2O)C3=C(C=CC(=C3)CC(C(=O)O)N)O)CC(C(=O)O)N)O,,,,,,
4781,164783,"(3R,4S,5R)-2-(2,8-diaminopurin-7-yl)-5-(hydroxymethyl)oxolane-3,4-diol",C1=C2C(=NC(=N1)N)N=C(N2C3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,,,,,,
4782,164784,CID 164784,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C(N)O)C(=O)[C@]3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)N(C)C)O.C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C(N)O)C(=O)[C@]3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)N(C)C)O.C1=CC=C(C=C1)CNCCNCC2=CC=CC=C2,,,,,,
4783,164785,"Cyclohexanecarboxamide, 1-methyl-",CC1(CCCCC1)C(=O)N,,,,,,
4784,164786,"3,5-diamino-N-[amino(dimethylamino)methylidene]-6-chloropyrazine-2-carboxamide;hydrochloride",CN(C)C(=NC(=O)C1=C(N=C(C(=N1)Cl)N)N)N.Cl,,,,,,
4785,164787,"6-Chloro-3,5-diaminopyrazine-3-carboxamide",CN(C)C(=NC(=O)C1=C(N=C(C(=N1)Cl)N)N)N,,,,,,
4786,164788,"5,7-Dimethoxycyclopentene[c]coumarin",COC1=CC2=C(C3=C(CCC3)C(=O)O2)C(=C1)OC,,,,,,
4787,164789,CID 164789,C1=CC=C(C(=C1)CNNC=NC(=O)C2=C(N=C(C(=N2)Cl)N)N)Cl,,,,,,
4788,164790,Bis(pentachlorophenyl) oxalate,C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)OC(=O)C(=O)OC2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)Cl,,,,,,
4789,164791,Podophyllotoxin acetate,CC(=O)O[C@@H]1[C@H]2COC(=O)[C@@H]2[C@@H](C3=CC4=C(C=C13)OCO4)C5=CC(=C(C(=C5)OC)OC)OC,,,,,,
4790,164792,Europium(3+) acetate,CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].[Eu+3],,,,,,
4791,164793,O-[(2-aminoethoxy)(hydroxy)phosphoryl]-L-serine,C(COP(=O)(O)OC[C@@H](C(=O)O)N)N,,,,,,
4792,164794,Neodymium oxalate,C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].[Nd+3].[Nd+3],,,,,,
4793,164795,N(6)-Methyllysine,CNCCCC[C@@H](C(=O)O)N,,,,,,
4794,164796,CID 164796,CC(=CCCC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC=C(C)C=CCCC(C)(C)O)C)C)CCCC(C)(C)O,,,,,,
4795,164797,"Thiophene, 2-phenyl-5-(1-propynyl)-",CC#CC1=CC=C(S1)C2=CC=CC=C2,,,,,,
4796,164798,Bendazol hydrochloride,C1=CC=C(C=C1)CC2=NC3=CC=CC=C3N2.Cl,,,,,,
4797,164799,beta-Acetyldigitoxin,CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)C)O)OC7CC(C(C(O7)C)OC8CC(C(C(O8)C)OC(=O)C)O)O,,,,,,
4798,164800,Decanoyl-coa,CCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O,,,,,,
4799,164801,CID 164801,[Li+].C1=CC=C(C(=C1)O)S(=O)(=O)[O-],,,,,,
4800,164802,Barium anilinobenzenesulphonate,C1=CC=C(C=C1)NC2=CC=CC=C2S(=O)(=O)[O-].C1=CC=C(C=C1)NC2=CC=CC=C2S(=O)(=O)[O-].[Ba+2],,,,,,
4801,164803,2-(Phenylamino)benzenesulfonic acid,C1=CC=C(C=C1)NC2=CC=CC=C2S(=O)(=O)O,,,,,,
4802,164804,Aluminium selenide,[Al+3].[Al+3].[Se-2].[Se-2].[Se-2],,,,,,
4803,164805,Gold(III) oxide,[O-2].[O-2].[O-2].[Au+3].[Au+3],,,,,,
4804,164806,Tetracalcium phosphate,[O-2].[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[Ca+2].[Ca+2].[Ca+2].[Ca+2],,,,,,
4805,164807,Dysprosium trihydroxide,[OH-].[OH-].[OH-].[Dy+3],,,,,,
4806,164808,Manganite (Mn(OH)O) (mineral),O[Mn](=O)[O-],,,,,,
4807,164809,Vanadium sulfide,[S-2].[S-2].[S-2].[S-2].[S-2].[V].[V],,,,,,
4808,164810,Kainite,O.O.O.[O-]S(=O)(=O)[O-].[Mg+2].[Cl-].[K+],,,,,,
4809,164811,CID 164811,C1=CC2=C(C(=C1)S(=O)(=O)[O-])C(=O)C3=C(C2=O)C(=C(C(=C3N)Cl)Cl)N.[Na+],,,,,,
4810,164812,"Sodium 5,8-diamino-6,7-dichloro-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",C1=CC2=C(C(=C1)S(=O)(=O)O)C(=O)C3=C(C2=O)C(=C(C(=C3N)Cl)Cl)N,,,,,,
4811,164813,C.I. Acid Violet 15,CCOC1=CC(=C(C=C1C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C)S(=O)(=O)[O-])NC4=C(C=C(C=C4)C)S(=O)(=O)[O-].[Na+],,,,,,
4812,164814,"[4-[[4-(Dimethylamino)phenyl]-[2-ethoxy-4-(4-methyl-2-sulfoanilino)-5-sulfophenyl]methylidene]cyclohexa-2,5-dien-1-ylidene]-dimethylazanium",CCOC1=CC(=C(C=C1C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C)S(=O)(=O)O)NC4=C(C=C(C=C4)C)S(=O)(=O)O,,,,,,
4813,164815,"Disodium 1-amino-4-(4-dodecylsulphonatoanilino)-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",CCCCCCCCCCCCC1=CC(=C(C=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
4814,164816,"1-Amino-4-(4-dodecyl-2-sulfoanilino)-9,10-dioxoanthracene-2-sulfonic acid",CCCCCCCCCCCCC1=CC(=C(C=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)O)S(=O)(=O)O,,,,,,
4815,164817,"Dichloroviolanthrene-5,10-dione",C1=CC=C2C(=C1)C3=C4C(=CC=C5C4=C(C=C3)C6=C(C(=C7C8=CC=CC=C8C(=O)C9=C7C6=C5C=C9)Cl)Cl)C2=O,,,,,,
4816,164818,"2-[4-[(4-Anilinophenyl)-[4-(2-sulfophenyl)iminocyclohexa-2,5-dien-1-ylidene]methyl]anilino]benzenesulfonic acid",C1=CC=C(C=C1)NC2=CC=C(C=C2)C(=C3C=CC(=NC4=CC=CC=C4S(=O)(=O)O)C=C3)C5=CC=C(C=C5)NC6=CC=CC=C6S(=O)(=O)O,,,,,,
4817,164819,CID 164819,CC1=C(C=CC(=C1)C(=C2C=CC(=NC3=C(C4=CC=CC=C4C=C3)S(=O)(=O)[O-])C=C2)C5=CC=C(C=C5)NC6=C(C7=CC=CC=C7C=C6)S(=O)(=O)O)N.[Na+],,,,,,
4818,164820,"2-[4-[(4-Amino-3-methylphenyl)-[4-(1-sulfonaphthalen-2-yl)iminocyclohexa-2,5-dien-1-ylidene]methyl]anilino]naphthalene-1-sulfonic acid",CC1=C(C=CC(=C1)C(=C2C=CC(=NC3=C(C4=CC=CC=C4C=C3)S(=O)(=O)O)C=C2)C5=CC=C(C=C5)NC6=C(C7=CC=CC=C7C=C6)S(=O)(=O)O)N,,,,,,
4819,164821,"5-Chloro-5-(1-chlorocyclohexa-2,4-dien-1-yl)sulfonylcyclohexa-1,3-diene",C1C=CC=CC1(S(=O)(=O)C2(CC=CC=C2)Cl)Cl,,,,,,
4820,164822,"1,2-Dimethylcyclohexanol",CC1CCCCC1(C)O,,,,,,
4821,164823,Antimony potassium oxide,[O-2].[O-2].[K+].[Sb+3],,,,,,
4822,164824,"Glucitol, borate, sodium salt",B([O-])([O-])[O-].C([C@H]([C@H]([C@@H]([C@H](CO)O)O)O)O)O.[Na+].[Na+].[Na+],,,,,,
4823,164825,Tartrazine,C1=CC(=CC=C1N=NC2C(=NN(C2=O)C3=CC=C(C=C3)S(=O)(=O)[O-])C(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,"['Natural or synthetic dyes used as coloring agents in processed foods. (See all compounds classified as Food Coloring Agents.)', 'Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)']","['... The fate of the pyrazole fragment of Tartrazine /was examined/ using sulphur-35 labelled Tartrazine and 1-(4-sulphophenyl)-3-methyl-4-(4-sulphophenylazo)-5-pyrazolone (SPMP an analogue of Tartrazine) and carbon-14 labeled SPMP. Following oral administration, both Tartrazine and SPMP labeled with sulphur-35 were predominantly excreted in feces (90 and 89 % of the dose respectively after 72 hours) with small amounts in urine (8 and 7.2 % of the dose, respectively, after 72 hours). The urinary radioactivity excreted in 48 hours with sulphanilic acid and 4-sulphophenylhydrazine was 23 and 23 % after Tartrazine administration, and 54 and 22 % after SPMP administration; the remaining radioactivity was not characterized.', '... The metabolism of carbon-14 Tartrazine randomly labeled in the phenyl azo group /was studied/ in rat, rabbit and human. In both animal species Tartrazine was administered orally and intraperitoneally whilst humans received oral Tartrazine. ... After intraperitoneal administration to 6 rats of 2.4 mg/kg bw of Tartrazine, between 64 and 96 % of the dose was recovered unchanged in urine within 24 hours; no other products were reported. In rabbit, at a dose of 2.4 mg/kg bw of Tartrazine administered intraperitoneally, 94 % of the dose was recovered unchanged in urine within 24 hours, with a further 1.4 % recovered as conjugated sulphanilic acid. However, after an intraperitoneal dose of 1000 mg in the rabbit ... only 57.3% was recovered unchanged in urine within 24 hours, with a further 25.7 and 6 % recovered as free and conjugated sulphanilic acid, respectively. After oral administration to 3 rats at 5 mg/rat ..., no free Tartrazine was measured but means of 28 and 34.6 % were recovered in urine as free and conjugated sulphanilic acid, respectively. In the rabbit dosed 1000 mg ... 8.2 % was recovered unchanged in urine within 24 hours with a further 27 and 26.8 % as free and conjugated sulphanilic acid respectively within 72 hours. In 4 humans receiving a single capsule containing 89-100 mg of Tartrazine ..., no free Tartrazine was measured in urine for any subject; in one subject 106 % was recovered as free sulphanilic acid whilst for the other 3 subjects mean recoveries of free and conjugated sulphanilic acid were 40.6 and 49.7 % respectively. ...', 'Low biliary excretion of Tartrazine (1 %) /was demonstrated/ following intravenous administration of an unspecified dose. ... low biliary excretion was due to the carboxyl group. After a dose of 2 mg ... unchanged Tartrazine could be detected in bile, but there was no evidence of ring fission products. Following intraperitoneal injection, an unidentified and unquantified Tartrazine conjugate was rapidly excreted in bile, but again none of the previously reported reductive ring fission products.']","['After oral administration there is extensive metabolism of Tartrazine by the gastrointestinal microflora to sulphanilic acid and aminopyrazalone (which may then be subsequently cleaved to sulphanilic acid and alpha-amino-beta-ketobutyric acid fragments with the latter breaking down further via intermediary metabolism with release of carbon dioxide).', 'Absorption and metabolism of (14)C-labelled tartrazine (FD & C Yellow No. 5) and high molecular weight polymeric derivatives  were compared in rats. A trace to 1.5% of unchanged monomeric dyes was excreted in urine and bile during the first 24 hr after dosing. No unchanged dye was absorbed after administration of the polymeric derivatives. ...In animals dosed with tartrazine and its polymer derivative, absorption of the cleavage product aminopyrazolone and its metabolites was 4.0 and 4.6%, respectively. Azo bond cleavage did not appear to be decreased in the polymer derivatives. However, the sulphanilic acid moiety of both dyes remained attached to the polymer backbone, resulting in a 95% decrease in sulphanilic acid absorption with polymeric tartrazine.', 'The 4-sulphophenylhydrazine metabolite was also labeled with sulphur-35 and administered orally and intraperitoneally. Excretion of this metabolite differed with the route of administration (35 and 49 % in urine and feces, respectively, 48 hours following oral, and 90 and 5 % in urine and feces, respectively, 48 hours following intraperitoneal administration). Following oral administration, 69 % of urinary radioactivity excreted in 48 hours was sulphanilic acid and 21 % was 4-sulphophenylhydrazine, whereas following intraperitoneal administration, 9 % of urinary radioactivity excreted in 48 hours was sulphanilic acid and 73% was 4-sulphophenylhydrazine. These data suggest there is a marked conversion of 4- sulphophenylhydrazine to sulphanilic acid presumably in the gut lumen. /4-sulphophenylhydrazine/']",
4824,164826,Copper hydroxide,[OH-].[OH-].[Cu+2],,,,,,
4825,164827,Cu(II) oxide,[O-2].[Cu+2],['No FDA- or EMA-approved therapeutic indications.'],"['For pharmacodynamic information of copper, refer to drug entry for [DB09130]. Copper(II) oxide nanoparticles are known to generate reactive oxygen species (ROS), leading to cytotoxicity. In a comparative toxicity assay, nanoparticles caused significant mitochondrial depolarization leading to DNA damage. In the human skin organ culture study, topical application of copper oxide (CuO) nanoparticles induced inflammatory cytokine secretion and necrosis _in vitro_, indicating that the nanoparticles may adhere to the skin surface and react with the local acidic environment.']",,"['Following oral administration, copper is mainly absorbed through the gastrointestinal tract from the stomach, duodenum, and jejunum. All other intakes of copper (inhalation and dermal) are insignificant in comparison to the oral route. The bioavailability of copper from cupric oxide depends on the solubilization of the oxide in the gastrointestinal tract. According to studies on cattle and swine, copper oxide displays low absorption rate and high excretion rate. In rats exposed to aerosols containing 50-80 mg/m^3, pulmonary uptake of copper oxide occurred.', 'Copper undergoes biliary excretion.', 'Following exposure to cupric oxide aerosols containing 50-80 mg/m^3 in rats, particles were found in plasma 6 hours post-exposure and copper oxide was also observed in the proximal convoluted tubules of the kidney.', 'No pharmacokinetic data available.']","['Cupric oxide may dissolve in acids including hydrochloric acid to form copper (II) chloride. As an inorganic compound, cupric oxide is unlikely to undergo biological degradation.']",['No pharmacokinetic data available.']
4826,164828,CID 164828,CCC(=C1C(=O)O[C@@H]([C@@H](C(=O)N[C@H]([C@H]([C@H](C(=O)O1)C)O)CC2=CN=CC=C2)NC(=O)C3=C(C=CC=N3)O)C)C.Cl,,,,,,
4827,164829,"N-[(5R,6S,9S,10S,11R)-2-butan-2-ylidene-10-hydroxy-5,11-dimethyl-3,7,12-trioxo-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododec-6-yl]-3-hydroxypyridine-2-carboxamide",CCC(=C1C(=O)O[C@@H]([C@@H](C(=O)N[C@H]([C@H]([C@H](C(=O)O1)C)O)CC2=CN=CC=C2)NC(=O)C3=C(C=CC=N3)O)C)C,,,,,,
4828,164830,"Dibenz(a,h)anthracen-3-ol",C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC5=C(C4=C3)C=CC(=C5)O,,,,,,
4829,164831,"Dibenz(a,h)anthracen-4-ol",C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC5=C(C4=C3)C=CC=C5O,,,,,,
4830,164832,"3-Pentanone, 1,1,2,2,4,4,5,5-octafluoro-1,5-dimethoxy-",COC(C(C(=O)C(C(OC)(F)F)(F)F)(F)F)(F)F,,,,,,
4831,164833,2-Chloro-3-(p-tolylsulfonyl)propionitrile,CC1=CC=C(C=C1)S(=O)(=O)CC(C#N)Cl,,,,,,
4832,164834,"N-Butyl-2,4-dinitropyrrole-1-acetamide",CCCCNC(=O)CN1C=C(C=C1[N+](=O)[O-])[N+](=O)[O-],,,,,,
4833,164835,"2,4-Dinitro-N-propylpyrrole-1-acetamide",CCCNC(=O)CN1C=C(C=C1[N+](=O)[O-])[N+](=O)[O-],,,,,,
4834,164836,"N-Ethyl-2,4-dinitropyrrole-1-acetamide",CCNC(=O)CN1C=C(C=C1[N+](=O)[O-])[N+](=O)[O-],,,,,,
4835,164837,Morinamide hydrochloride,C1COCCN1CNC(=O)C2=NC=CN=C2.Cl,,,,,,
4836,164838,Dihydrocortisol,C[C@]12CCC(=O)C[C@H]1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O,,,,,,
4837,164839,"Phosphorotrithioic acid, S,S,S-triethyl ester",CCSP(=O)(SCC)SCC,,,,,,
4838,164840,CID 164840,COC1=CC(=O)C=C2C1=C(C(=C(O2)C3=CC(=C(C=C3)O)O)OC)O,,,,,,
4839,164841,"2,3-Dihydro-1h-3a,7a-epoxyindene",C1CC23C=CC=CC2(C1)O3,,,,,,
4840,164842,Tetrahydrodeoxoaflatoxin B1,COC1=C2C3=C(CCC3)C(=O)OC2=C4[C@@H]5CCO[C@@H]5OC4=C1,,,,,,
4841,164843,4-Nitrobenzenediazonium hexafluorophosphate,C1=CC(=CC=C1[N+]#N)[N+](=O)[O-].F[P-](F)(F)(F)(F)F,,,,,,
4842,164844,CID 164844,[B+3].CN(C)C.[Cl-].[Cl-].[Cl-],,,,,,
4843,164845,"2-Azido-3-methylnaphtho(1,2-d)imidazole",CN1C2=C(C3=CC=CC=C3C=C2)N=C1N=[N+]=[N-],,,,,,
4844,164846,2-Azido-1-methylbenzimidazole,CN1C2=CC=CC=C2N=C1N=[N+]=[N-],,,,,,
4845,164847,"4,4'-Ethylenebis(2,6-di-tert-butylphenol)",CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)CCC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C,,,,,,
4846,164848,"2,5-Diamino-1,4-benzoquinone",C1=C(C(=O)C=C(C1=O)N)N,,,,,,
4847,164849,4-(1-Aziridinylmethyl)morpholine,C1CN1CN2CCOCC2,,,,,,
4848,164850,"1-Aziridinemethanamine, N,N-diethyl-",CCN(CC)CN1CC1,,,,,,
4849,164851,1-(1-Aziridinylmethyl)pyrrolidine,C1CCN(C1)CN2CC2,,,,,,
4850,164852,1-(1-Aziridinylmethyl)piperidine,C1CCN(CC1)CN2CC2,,,,,,
4851,164853,Isolithocholic acid,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@@H](C4)O)C)C,,,"['Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties. (See all compounds classified as Detergents.)']",,,
4852,164854,5-Chloro-6-fluoroacenaphthene,C1CC2=CC=C(C3=C(C=CC1=C23)F)Cl,,,,,,
4853,164855,"Propane, 2-(chlorodifluoromethyl)-1,1,1,3,3,3-hexafluoro-",C(C(F)(F)F)(C(F)(F)F)C(F)(F)Cl,,,,,,
4854,164856,3-Ethylphenanthrene,CCC1=CC2=C(C=CC3=CC=CC=C32)C=C1,,,,,,
4855,164857,"1,1'-(Phenylmethylene)bisaziridine",C1CN1C(C2=CC=CC=C2)N3CC3,,,,,,
4856,164858,1-(Ethoxymethyl)aziridine,CCOCN1CC1,,,,,,
4857,164859,"1H-Indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-alpha,2-dimethyl-",CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)C(C)C(=O)O,,,,,,
4858,164860,15-Methylhexadecanoic acid,CC(C)CCCCCCCCCCCCCC(=O)O,,,,,,
4859,164861,N-Acetoxymethyl-N-methylformamide,CC(=O)OCN(C)C=O,,,,,,
4860,164862,1-Ethyl-2-[(1-ethylquinolin-1-ium-2-yl)methylidene]quinoline;bromide,CCN1C(=CC2=[N+](C3=CC=CC=C3C=C2)CC)C=CC4=CC=CC=C41.[Br-],,,,,,
4861,164863,"1,5-Bis((2-(diethylamino)ethyl)amino)-9,10-anthracenedione",CCN(CC)CCNC1=CC=CC2=C1C(=O)C3=C(C2=O)C(=CC=C3)NCCN(CC)CC,,,,,,
4862,164864,1-Methyl-2-(methylthio)-5-nitro-1H-imidazole,CN1C(=CN=C1SC)[N+](=O)[O-],,,,,,
4863,164865,"6-Hydroxy-3-(hydroxymethyl)-2-methyl-2,3-dihydro-10H-3,10a-epidithiopyrazino[1,2-a]indole-1,4-dione",CN1C(=O)C23CC4=C(N2C(=O)[C@]1(SS3)CO)C(=CC=C4)O,,,,,,
4864,164866,"N,N-Bis(2-chloroethyl)-4-methylsulfonylaniline",CS(=O)(=O)C1=CC=C(C=C1)N(CCCl)CCCl,,,,,,
4865,164867,Sulfachlorpyrazine,C1=CC(=CC=C1N)S(=O)(=O)NC2=CN=C(C=N2)Cl,,,,,,
4866,164868,"2,3,5-Tris(1-aziridinyl)-6-fluoro-2,5-cyclohexadiene-1,4-dione",C1CN1C2=C(C(=O)C(=C(C2=O)N3CC3)F)N4CC4,,,,,,
4867,164869,"1-Piperidinemethanol, acetate (ester)",CC(=O)OCN1CCCCC1,,,,,,
4868,164870,1-Diphenylmethyl-4-nitrosopiperazine,C1CN(CCN1C(C2=CC=CC=C2)C3=CC=CC=C3)N=O,,,,,,
4869,164871,6-Chloro-5-methylpyridazin-3(2h)-one,CC1=CC(=O)NN=C1Cl,,,,,,
4870,164872,6-Methoxy-3(2H)-pyridazinone,COC1=NNC(=O)C=C1,,,,,,
4871,164873,Chloromethyl ethyl sulfide,CCSCCl,,,,,,
4872,164874,Diplopterol,C[C@]12CC[C@@H]([C@@H]1CC[C@@]3([C@@H]2CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CCCC5(C)C)C)C)C)C(C)(C)O,,,,,,
4873,164875,6-Nitropyren-1-YL acetate,CC(=O)OC1=C2C=CC3=C4C2=C(C=CC4=C(C=C3)[N+](=O)[O-])C=C1,,,,,,
4874,164876,"1-Pyrenol, 8-nitro-, acetate (ester)",CC(=O)OC1=C2C=CC3=C(C=CC4=C3C2=C(C=C4)C=C1)[N+](=O)[O-],,,,,,
4875,164877,C.I. Solvent Violet 8,CN=C1C=CC(=C(C2=CC=C(C=C2)N(C)C)C3=CC=C(C=C3)N(C)C)C=C1,,,,,,
4876,164878,"[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(phosphonooxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl dihydrogen phosphate",C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)O)O)O)O)OP(=O)(O)O,,,,,,
4877,164879,Carabrone,CC(=O)CC[C@H]1[C@H]2[C@@]1(C[C@@H]3[C@H](C2)C(=C)C(=O)O3)C,,,,,,
4878,164880,CID 164880,C1=CC(=O)C2=NSNC2=C1N,,,,,,
4879,164881,Chlorendate dimethyl,COC(=O)C1C(C2(C(=C(C1(C2(Cl)Cl)Cl)Cl)Cl)Cl)C(=O)OC,,,,,,
4880,164882,Dicyclohexyldiazene 1-oxide,C1CCC(CC1)N=[N+](C2CCCCC2)[O-],,,,,,
4881,164883,"Pregn-4-ene-3,20-dione-4-14C",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=[14CH]C(=O)CC[C@]34C)C,,,,,,
4882,164884,"9,10-Anthracenedione, 1,5-bis((2-(dimethylamino)ethyl)amino)-",CN(C)CCNC1=CC=CC2=C1C(=O)C3=C(C2=O)C(=CC=C3)NCCN(C)C,,,,,,
4883,164885,CID 164885,CCC(C1=C(OC2=CC=CC=C2C1=O)O)C3=C(OC4=CC=CC=C4C3=O)O,,,,,,
4884,164886,6-Chloro-4-methylpyridazin-3(2H)-one,CC1=CC(=NNC1=O)Cl,,,,,,
4885,164887,Ferric acetate,CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].[Fe+3],,,,,,
4886,164888,cis-Verbenol,CC1=C[C@H]([C@@H]2C[C@H]1C2(C)C)O,,,,,,
4887,164889,5-Deoxypyridoxal,CC1=CN=C(C(=C1C=O)O)C,,,,,,
4888,164890,"4-Androstene-3alpha,17beta-diol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C[C@@H](CC[C@]34C)O,,,,,,
4889,164891,"Cytidine, 2'-deoxy-N-hydroxy-5-methyl-",CC1=CN(C(=O)N=C1NO)[C@H]2C[C@@H]([C@H](O2)CO)O,,,,,,
4890,164892,Ammonium hexadecafluorononanoate,C(C(C(C(C(C(C(C(C(=O)[O-])(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F.[NH4+],,,,,,
4891,164893,5-p-Coumaroylquinic acid,C1[C@H]([C@H]([C@@H](C[C@@]1(C(=O)O)O)OC(=O)C=CC2=CC=C(C=C2)O)O)O,,,,,,
4892,164894,"2-(p-(6-Methoxy-2-phenyl-3,4-dihydro-1-naphthyl)phenoxy)triethylamine",CCN(CC)CCOC1=CC=C(C=C1)C2=C(CCC3=C2C=CC(=C3)OC)C4=CC=CC=C4,,,,,,
4893,164895,"1,1'-(Iminobis(trimethylene))bisaziridine",C1CN1CCCNCCCN2CC2,,,,,,
4894,164896,"2,2,6-Trimethyl-1-[3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-7-oxabicyclo[4.1.0]heptane",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC23C(CCCC2(O3)C)(C)C)C)C,,,,,,
4895,164897,N-Methyl-1H-purin-2-amine,CNC1=NC=C2C(=N1)N=CN2,,,,,,
4896,164898,"3',5'-Dibromoaminopterin",C1=C(C=C(C(=C1Br)NCC2=CN=C3C(=N2)C(=NC(=N3)N)N)Br)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
4897,164899,1-Methyl-4-piperidinyl 1-phenylcyclopentanecarboxylate hydrochloride,CN1CCC(CC1)OC(=O)C2(CCCC2)C3=CC=CC=C3.Cl,,,,,,
4898,164900,N-Methyl-4-piperidyl 1-phenylcyclopentanecarboxylate,CN1CCC(CC1)OC(=O)C2(CCCC2)C3=CC=CC=C3,,,,,,
4899,164901,4-Methoxy-6-(2-phenylethenyl)-2h-pyran-2-one,COC1=CC(=O)OC(=C1)C=CC2=CC=CC=C2,,,,,,
4900,164902,Mecaphane,COC1=C(C=CC(=C1)N(CCCl)CCCl)C[C@@H](C(=O)O)N,,,,,,
4901,164903,(2-Hydroxy-5-phenylbenzyl)trimethylammonium bromide,CN(C)C(=O)OC1=C(C=C(C=C1)C2=CC=CC=C2)C[N+](C)(C)C.[Br-],,,,,,
4902,164904,"4-[[(Dimethylamino)carbonyl]oxy]-N,N,N-trimethyl[1,1'-biphenyl]-3-methanaminium",CN(C)C(=O)OC1=C(C=C(C=C1)C2=CC=CC=C2)C[N+](C)(C)C,,,,,,
4903,164905,Cannabidiol-3-monomethyl ether,CCCCCC1=CC(=C(C(=C1)OC)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O,,,,,,
4904,164906,25-Azacholesterol,C[C@H](CCCN(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
4905,164907,"Aniline, m-fluoro-N-methyl-N-nitroso-",CN(C1=CC(=CC=C1)F)N=O,,,,,,
4906,164908,Adenylyl-3'-5'-phospho-uridine-3'-monophosphate,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O[C@@H]3[C@H](O[C@H]([C@@H]3O)N4C=NC5=C(N=CN=C54)N)CO)OP(=O)(O)O)O,,,,,,
4907,164909,"1,4,7-Triaminoheptane",C(CC(CCCN)N)CN,,,,,,
4908,164910,6-Methyltryptophan,CC1=CC2=C(C=C1)C(=CN2)C[C@@H](C(=O)O)N,,,,,,
4909,164911,Tetraphenylphosphonium chloride,C1=CC=C(C=C1)[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4.[Cl-],,,"['Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)', 'Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)']",,,
4910,164912,Tetraphenylphosphonium,C1=CC=C(C=C1)[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4,,,"['Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)', 'Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)']",,,
4911,164913,Bis(2-methyl-4-((2-methylphenyl)azo)phenyl)diazene,CC1=CC=CC=C1N=NC2=CC(=C(C=C2)N=NC3=C(C=C(C=C3)N=NC4=CC=CC=C4C)C)C,,,,,,
4912,164914,2-Methyl-2-[4-(1-methyl-1-phenylethyl)phenoxy]propanoic acid,CC(C)(C1=CC=CC=C1)C2=CC=C(C=C2)OC(C)(C)C(=O)O,,,,,,
4913,164915,2-(4-Hydroxy-3-methoxyphenyl)-2-oxoacetic acid,COC1=C(C=CC(=C1)C(=O)C(=O)O)O,,,,,,
4914,164916,"Benz(a)anthracene, 7,12-dimethyl-8-fluoro-",CC1=C2C=CC=C(C2=C(C3=C1C4=CC=CC=C4C=C3)C)F,,,,,,
4915,164917,"2-Pyrrolidinone, 4-(2-aminoethyl)-1-ethyl-3,3-diphenyl-",CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN,,,,,,
4916,164918,CID 164918,C1=CC(=CC=C1C2=C(C(=C3C=CC(=O)C=C3O2)O)O)O,,,,,,
4917,164919,CID 164919,[H-].[H-].[H-].[H-].[H-].[H-].[B+3].[B+3].CN(C)N,,,,,,
4918,164920,Thiomethoxyflurane,CSC(C(Cl)Cl)(F)F,,,,,,
4919,164921,N-[[1-[[4-(hydroxyiminomethyl)pyridin-1-ium-1-yl]methyl]pyridin-1-ium-4-yl]methylidene]hydroxylamine;dibromide,C1=C[N+](=CC=C1C=NO)C[N+]2=CC=C(C=C2)C=NO.[Br-].[Br-],,,,,,
4920,164922,"1,1'-Methylenebis[4-(hydroxyiminomethyl)pyridinium]",C1=C[N+](=CC=C1C=NO)C[N+]2=CC=C(C=C2)C=NO,,,,,,
4921,164923,"Cyclopentasiloxane, 2,4,6,8,10-pentamethyl-2,4,6,8,10-pentakis(3,3,3-trifluoropropyl)-",C[Si]1(O[Si](O[Si](O[Si](O[Si](O1)(C)CCC(F)(F)F)(C)CCC(F)(F)F)(C)CCC(F)(F)F)(C)CCC(F)(F)F)CCC(F)(F)F,,,,,,
4922,164924,CID 164924,C1=C(C=C(C(=N)C1=N)N(O)O)C(F)(F)F,,,,,,
4923,164925,"3-Nitro-N2,N2-dipropyl-5-(trifluoromethyl)-1,2-benzenediamine",CCCN(CCC)C1=C(C=C(C=C1[N+](=O)[O-])C(F)(F)F)N,,,,,,
4924,164926,"Pyrazinecarboxamide, 3-amino-N-(aminoiminomethyl)-6-chloro-5-(diethylamino)-",CCN(CC)C1=NC(=C(N=C1Cl)C(=O)N=C(N)N)N,,,,,,
4925,164927,Chloro(2-hydroxyethyl)mercury,C(C[Hg]Cl)O,,,,,,
4926,164928,Barium thiocyanate,C(#N)[S-].C(#N)[S-].[Ba+2],,,,,,
4927,164929,D-ribo-Hexos-3-ulose,C([C@H]([C@H](C(=O)[C@H](C=O)O)O)O)O,,,,,,
4928,164930,Hex-4-enal,CC=CCCC=O,,,,,,
4929,164931,2-Amino-1-pentanethiol,CCCC(CS)N,,,,,,
4930,164932,CID 164932,CC(=O)C1=C(NCC1=O)O,,,,,,
4931,164933,Uric acid ribonucleoside,C([C@@H]1[C@H]([C@H]([C@@H](O1)N2C3=C(C(=O)NC2=O)NC(=O)N3)O)O)O,,,,,,
4932,164934,"alpha,alpha'-Bis(3-(N,N-diethylcarbamoyl)piperidinyl)-p-xylene dihydrobromide",CCN(CC)C(=O)C1CCCN(C1)CC2=CC=C(C=C2)CN3CCCC(C3)C(=O)N(CC)CC.Br.Br,,,,,,
4933,164935,A-1 Nipecotamide,CCN(CC)C(=O)C1CCCN(C1)CC2=CC=C(C=C2)CN3CCCC(C3)C(=O)N(CC)CC,,,,,,
4934,164936,"Methyl (20beta)-19,20-dihydro-3-oxovobasan-17-oate",CC[C@@H]1CN([C@H]2CC3=C(C(=O)CC1[C@@H]2C(=O)OC)NC4=CC=CC=C34)C,,,,,,
4935,164937,"2-Hydroxypropane-1,2,3-tricarboxylate;1-(5-phenyl-1,2-oxazol-3-yl)-2-piperidin-1-ylethanol",C1CCN(CC1)CC(C2=NOC(=C2)C3=CC=CC=C3)O.C1CCN(CC1)CC(C2=NOC(=C2)C3=CC=CC=C3)O.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O,,,,,,
4936,164938,Ethyl acetoxycarbamate,CCOC(=O)NOC(=O)C,,,,,,
4937,164939,Kojibiose,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O)O)O)O)O,,,,,,
4938,164940,1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-5-fluoro-2(1H)-pyrimidinone,C1[C@@H]([C@H](O[C@@H]1N2C=C(C=NC2=O)F)CO)O,,,,,,
4939,164941,CID 164941,C1=CC(=C(C=C1C2=CC(=C3C=CC(=O)C=C3O2)O)O)O,,,,,,
4940,164942,"n-(3,4-Dichlorophenyl)-n-hydroxypropanamide",CCC(=O)N(C1=CC(=C(C=C1)Cl)Cl)O,,,,,,
4941,164943,Lycorine hydrochloride,C1CN2CC3=CC4=C(C=C3[C@H]5[C@H]2C1=C[C@@H]([C@H]5O)O)OCO4.Cl,,,,,,
4942,164944,Aminoguanidine bicarbonate,C(=NN)(N)N.C(=O)(O)O,,,,,,
4943,164945,"Hexadecanoic acid, compd. with 2-aminoethanol (1:1)",CCCCCCCCCCCCCCCC(=O)O.C(CO)N,,,,,,
4944,164946,"2,2',6,6'-Tetranitro-1,1'-biphenyl",C1=CC(=C(C(=C1)[N+](=O)[O-])C2=C(C=CC=C2[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],,,,,,
4945,164947,Serratenediol,C[C@@]12CC[C@@H]3[C@@]([C@H]1CC[C@H]4C(=CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)O)C)C2)(CC[C@@H](C3(C)C)O)C,,,,,,
4946,164948,3-Carbamoyl-1-hexylpyridinium chloride,CCCCCC[N+]1=CC=CC(=C1)C(=O)N.[Cl-],,,,,,
4947,164949,1-Hexyl-3-carbamoylpyridinium,CCCCCC[N+]1=CC=CC(=C1)C(=O)N,,,,,,
4948,164950,Robustine,COC1=C2C=COC2=NC3=C1C=CC=C3O,,,,,,
4949,164951,"Anguidine, 3 keto",CC1=C[C@@H]2[C@](CC1)([C@]3([C@@H](C(=O)[C@H]([C@@]34CO4)O2)OC(=O)C)C)COC(=O)C,,,,,,
4950,164952,Corynan-17-ol,CC[C@H]1CN2CCC3=C([C@@H]2C[C@@H]1CCO)NC4=CC=CC=C34,,,,,,
4951,164953,p-Nitrophenyl thymidine 5'-monophosphate,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)OC3=CC=C(C=C3)[N+](=O)[O-])O,,,,,,
4952,164954,"4H-Pyran-4-one, 3,5-dihydroxy-2-(hydroxymethyl)-",C1=C(C(=O)C(=C(O1)CO)O)O,,,,,,
4953,164955,Methyl phosphorylcholine,C[N+](C)(C)CCOP(=O)([O-])OC,,,,,,
4954,164956,Methylphosphorylcholine,C[N+](C)(C)CCOP(=O)(O)OC,,,,,,
4955,164957,5-Hydroxy-6-methoxyindole,COC1=C(C=C2C=CNC2=C1)O,,,,,,
4956,164958,Phosphine E,CC1=CC2=C(C3=CC=CC=C3N=C2C=C1N)C4=CC=C(C=C4)N.[N+](=O)(O)[O-],,,,,,
4957,164959,9-(4-Aminophenyl)-2-methyl-3-acridinamine,CC1=CC2=C(C3=CC=CC=C3N=C2C=C1N)C4=CC=C(C=C4)N,,,,,,
4958,164960,3alpha-Hydroxy-6-oxo-5beta-cholan-24-oic Acid,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC(=O)[C@H]4[C@@]3(CC[C@H](C4)O)C)C,,,,,,
4959,164961,19-Hydroxydeoxycorticosterone,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)CO)CCC4=CC(=O)CC[C@]34CO,,,,,,
4960,164962,Triethylamine hydrogen sulfate,CCN(CC)CC.CCN(CC)CC.[O-]S(=O)(=O)[O-],,,,,,
4961,164963,Magnesium ethanolate,CC[O-].CC[O-].[Mg+2],,,,,,
4962,164964,Siglure,CCC(C)OC(=O)C1CC=CCC1C,,,,,,
4963,164965,"3-[(3S,5R,8R,9S,10S,13R,14S,17R)-3-[(3S,4S,6S)-3,4-dihydroxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one",C[C@H]1C([C@H]([C@@H](C(O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3CC[C@]5([C@@]4(CC[C@@H]5C6=CC(=O)OC6)O)C)C)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O,,,,,,
4964,164966,2-Benzylphenyl glycidyl ether,C1C(O1)COC2=CC=CC=C2CC3=CC=CC=C3,,,,,,
4965,164967,1-Imino-2-phenyl-1H-inden-3-amine monohydrochloride,C1=CC=C(C=C1)C2=C(C3=CC=CC=C3C2=N)N.Cl,,,,,,
4966,164968,3-Amino-1-imino-2-phenylinden,C1=CC=C(C=C1)C2=C(C3=CC=CC=C3C2=N)N,,,,,,
4967,164969,"Tridecasiloxane, octacosamethyl-",C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C,,,,,,
4968,164970,Thymidylyl-(3'-5')-3'-thymidylic acid,CC1=CN(C(=O)NC1=O)[C@@H]2C[C@@H]([C@H](O2)CO)OP(=O)(O)OC[C@@H]3[C@H](C[C@@H](O3)N4C=C(C(=O)NC4=O)C)OP(=O)(O)O,,,,,,
4969,164971,Silver behenate,CCCCCCCCCCCCCCCCCCCCCC(=O)[O-].[Ag+],,,,,,
4970,164972,Disodium 2-(4-((2-cyano-3-(4-(methyl(2-sulphonatoethyl)amino)phenyl)-1-oxoallyl)amino)phenyl)-6-methylbenzothiazole-7-sulphonate,CC1=C(C2=C(C=C1)N=C(S2)C3=CC=C(C=C3)NC(=O)C(=CC4=CC=C(C=C4)N(C)CCS(=O)(=O)[O-])C#N)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
4971,164973,"2-[4-[[2-Cyano-3-[4-[methyl(2-sulfoethyl)amino]phenyl]prop-2-enoyl]amino]phenyl]-6-methyl-1,3-benzothiazole-7-sulfonic acid",CC1=C(C2=C(C=C1)N=C(S2)C3=CC=C(C=C3)NC(=O)C(=CC4=CC=C(C=C4)N(C)CCS(=O)(=O)O)C#N)S(=O)(=O)O,,,,,,
4972,164974,2-heptylquinolin-4(1H)-one,CCCCCCCC1=CC(=O)C2=CC=CC=C2N1,,,,,,
4973,164975,Acetylpenicillamine,CC(=O)N[C@H](C(=O)O)C(C)(C)S,,,,,,
4974,164976,"O,S-Diethyl ethylphosphonothioate",CCOP(=O)(CC)SCC,,,,,,
4975,164977,"1,2-Benzisothiazoline, 5-chloro-, 1,1-dioxide",C1C2=C(C=CC(=C2)Cl)S(=O)(=O)N1,,,,,,
4976,164978,"Bis(2,2,6,6-tetramethyl-1-oxyl-4-piperidinyl) succinate",CC1(CC(CC(N1[O])(C)C)OC(=O)CCC(=O)OC2CC(N(C(C2)(C)C)[O])(C)C)C,,,,,,
4977,164979,"9-Methyl-9h-pyrido[3,4-b]indole",CN1C2=CC=CC=C2C3=C1C=NC=C3,,,,,,
4978,164980,gamma-Hydroxy-L-arginine,C([C@@H](C(=O)O)N)C(CN=C(N)N)O,,,,,,
4979,164981,"1,2-Benzisothiazol-3(2H)-one, 2-phenyl-",C1=CC=C(C=C1)N2C(=O)C3=CC=CC=C3S2,,,,,,
4980,164982,"9,10-Anthracenedione, 1-hydroxy-3-methyl-",CC1=CC2=C(C(=C1)O)C(=O)C3=CC=CC=C3C2=O,,,,,,
4981,164983,Dimonochloroacetylajmaline hydrochloride,CC[C@@H]1[C@H](N2[C@H]3CC1C4[C@@H]2CC5([C@H]3N(C6=CC=CC=C65)C)[C@@H]4OC(=O)CCl)OC(=O)CCl.Cl,,,,,,
4982,164984,"Ajmalan-17,21-diol, bis(chloroacetate) (ester), (17R,21alpha)-",CC[C@@H]1[C@H](N2[C@H]3CC1C4[C@@H]2CC5([C@H]3N(C6=CC=CC=C65)C)[C@@H]4OC(=O)CCl)OC(=O)CCl,,,,,,
4983,164985,"Methanol, calcium salt",C[O-].C[O-].[Ca+2],,,,,,
4984,164986,O-Ethyl S-(beta-ethylthioethyl)(methyl)thiophosphonate methosulfate,CCOP(=O)(C)SCC[S+](C)CC.COS(=O)(=O)[O-],,,,,,
4985,164987,2-[Ethoxy(methyl)phosphoryl]sulfanylethyl-ethyl-methylsulfanium,CCOP(=O)(C)SCC[S+](C)CC,,,,,,
4986,164988,Gallium triacetate,CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].[Ga+3],,,,,,
4987,164989,Diisopropyl chlorophosphate,CC(C)OP(=O)(OC(C)C)Cl,,,,,,
4988,164990,CID 164990,CC[C@H]1C[C@@H]2C[C@@]3([C@H]1N(C2)CCC4=C3NC5=CC(=C(C=C45)C6CC7C(C(CC8=C6NC9=CC=CC=C89)N(CC7=CC)C)C(=O)OC)OC)C(=O)OC,,,,,,
4989,164991,Atrovenetin,C[C@@H]1C(C2=C(C3=C4C(=C2O1)C(=CC(=O)C4=C(C(=C3O)O)O)C)O)(C)C,,,,,,
4990,164992,CID 164992,C1=C(C=C(C(=C1Cl)[O-])Cl)Cl.[K+],,,,,,
4991,164993,Methylethylthiophos,CCOP(=S)(OC)OC1=CC=C(C=C1)[N+](=O)[O-],,,,,,
4992,164994,"Hydrazine, 1-(p-chlorophenethyl)-, sulfate (1:1)",C1=CC(=CC=C1CCNN)Cl.OS(=O)(=O)O,,,,,,
4993,164995,1-(2-(o-Chlorophenoxy)ethyl)hydrazine hydrogen sulfate,C1=CC=C(C(=C1)OCCNN)Cl.[O-]S(=O)(=O)[O-],,,,,,
4994,164996,[2-(2-Chlorophenoxy)ethyl]hydrazine,C1=CC=C(C(=C1)OCCNN)Cl,,,,,,
4995,164997,"N,N-Diethyl-2-(2,4-dichloro-6-phenylphenoxy)ethylamine",CCN(CC)CCOC1=C(C=C(C=C1Cl)Cl)C2=CC=CC=C2,,,,,,
4996,164998,"1H-Azepine-1-carbodithioic acid, hexahydro-, compd. with hexahydro-1H-azepine (1:1)",C1CCCNCC1.C1CCCN(CC1)C(=S)S,,,,,,
4997,164999,Cyanin chloride,C1=CC(=C(C=C1C2=C(C=C3C(=CC(=CC3=[O+]2)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O.[Cl-],,,,,,
4998,165000,"cyanidin 3,5-di-O-beta-D-glucoside",C1=CC(=C(C=C1C2=C(C=C3C(=CC(=O)C=C3O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O2)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O,,,,,,
